Breast cancer
Lymphocyte count
BMI in non-smokers
Lung cancer in ever smokers
Immature fraction of reticulocytes
Neutrophil count
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
Modified Stumvoll Insulin Sensitivity Index
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)
Preterm birth (maternal effect)
Gestational age at birth (maternal effect)
Early onset atrial fibrillation
Body mass index
Mean corpuscular hemoglobin
Cutaneous squamous cell carcinoma
Tanning
Skin pigmentation
Lung adenocarcinoma
Barrett's esophagus
Esophageal adenocarcinoma
Barrett's esophagus  or Esophageal adenocarcinoma
Lung cancer
Height
Alopecia areata
BMI in smokers
Waist-to-hip ratio adjusted for BMI in non-smokers
Waist circumference adjusted for BMI in smokers
Core binding factor acute myeloid leukemia
Waist circumference adjusted for body mass index
High density lipoprotein cholesterol levels
Low density lipoprotein cholesterol levels
Benign prostatic hyperplasia and/or lower urinary tract symptoms
Squamous cell lung carcinoma
Plasma trimethylamine N-oxide levels
Sarcoidosis
Breast cancer, ovarian cancer or prostate cancer (pleiotropy)
Nasopharyngeal carcinoma
Type 2 diabetes
Mood instability
Systolic blood pressure
Peak insulin response
Acute insulin response
Insulin secretion rate
Insulin disposition index
Peak insulin response (BMI and insulin secretion adjusted)
Peak insulin response (insulin secretion adjusted)
Acute insulin response (insulin secretion adjusted)
Vitiligo
Common carotid intima-media thickness in HIV negative individuals
Common carotid intima-media thickness in HIV infection
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes
Basophil percentage of white cells
Subcutaneous adipose tissue (sex interaction)
Subcutaneous adipose tissue
Body mass index (joint analysis main effects and smoking interaction)
Waist circumference adjusted for BMI in non-smokers
Methotrexate-induced interstitial lung disease in rheumatoid arthritis
Alloimmunization response to pregnancy (HLA class I)
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
Familial hepatitis B virus-related hepatocellular carcinoma
Branched-chain amino acid levels (Isoleucine)
Branched-chain amino acid levels (Leucine)
Branched-chain amino acid levels (Valine)
Common carotid intima-media thickness
Rubella-specific interleukin-6 secretion
Major depressive disorder
Small cell lung carcinoma
Post bronchodilator FEV1/FVC ratio
Language performance in older adults (adjusted for episodic memory)
Spontaneous dizygotic twinning
Pulse pressure
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes
Waist-to-hip ratio adjusted for BMI in smokers
Diastolic blood pressure
Response to statins (HDL cholesterol change)
Left ventricular function change in anthracycline treatment
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer
Foot ulcer in diabetes and neuropathy
Foot ulcer and neuropathy in diabetes
Energy expenditure (24h)
Resting metabolic rate
Tuberculosis
Severe gingival inflammation
Lung cancer in never smokers
Appendicular lean mass
Lean body mass
Glomerular filtration rate
Survival in pancreatic cancer
Serum sulfate level
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)
Bone fracture in osteoporosis
Kawasaki disease
Response to exercise (triglyceride level interaction)
TB-LM or TBLH-BMD (pleiotropy)
Bone mineral density (paediatric, total body less head)
Iris color (b* coordinate)
Iris heterochromicity
Iris color (L* coordinate)
Iris color (a* coordinate)
Relapse in multiple sclerosis
Bronchial hyperresponsiveness in asthma
Waist-to-hip ratio adjusted for body mass index
Cancer (pleiotropy)
Cancer
Mean corpuscular volume
Serum parathyroid hormone levels
Arthritis (juvenile idiopathic)
High fetal hemoglobin in sickle cell disease
Systemic lupus erythematosus
Gastroesophageal reflux disease
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)
Response to bupropion and depression
Response to selective serotonin reuptake inhibitors and depression
Response to citalopram or escitalopram in depression
Response to antidepressants in depression
Non-response to citalopram or escitalopram and depression
Non-response to bupropion and depression
Response to citalopram or escitalopram and depression
Non-response to antidepressants and depression
Non-response to selective serotonin reuptake inhibitors and depression
Response to selective serotonin reuptake inhibitors in depression
Response to antidepressants and depression
Response to bupropion in depression
Monocyte-lymphocyte ratio
Monocyte count
Bone mineral density (hip)
Platelet count
Hematocrit
Carotid plaque burden
Antithyroid drug-induced agranulocytosis
Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
Advanced glycation end-product levels
Systolic blood pressure (long-term average)
Diastolic blood pressure (long-term average)
Mean arterial pressure (long-term average)
Menarche (age at onset)
Age at voice drop
Total cholesterol levels
LDL cholesterol levels
HDL cholesterol levels
Eosinophil counts
Plateletcrit
Educational attainment (years of education)
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)
C-reactive protein levels or triglyceride levels (pleiotropy)
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)
Venous thromboembolism adjusted for sickle cell variant rs77121243-T
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
Kidney disease (early and late stages) in type 1 diabetes
Kidney disease (early stage) in type 1 diabetes
Kidney disease (late stage) in type 1 diabetes
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes
Night sleep phenotypes
Pre-treatment pain in head and neck squamous cell carcinoma
Granulocyte percentage of myeloid white cells
Otitis media
Otitis media (chronic)
Otitis media (recurrent)
Response to Pazopanib in cancer (hepatotoxicity)
Isovolumetric relaxation time
Left atrial antero-posterior diameter
Peak velocity of the mitral A-wave
Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.
Aortic root size
Left ventricle wall thickness
Left ventricle diastolic internal dimension
Left ventricular mass
Left ventricular fractional shortening
Left  ventricle systolic dysfunction
Fasting plasma glucose
HDL cholesterol
Primary sclerosing cholangitis
White blood cell count
HIV progression (CD4 and viral load)
Idiopathic osteonecrosis of the femoral head
Crohn's disease
Sum neutrophil eosinophil counts
Post traumatic stress disorder symptom count in trauma-exposed individuals
Gout
Renal underexcretion gout
Renal overload gout
Developmental language disorder
Developmental language disorder (linguistic errors)
Developmental language disorder (syntactic complexity)
Prostate cancer
Breast cancer (estrogen-receptor negative)
Major depressive disorder (stressful life events interaction)
Midgestational circulating levels of organochlorine pesticides
Midgestational circulating levels of PCBs (fetal genetic effect)
Midgestational circulating levels of PBDEs
Midgestational circulating levels of PBDEs (fetal genetic effect)
Midgestational circulating levels of PCBs
Severity of facial solar lentigines
Mathematical ability
Vertical cup-disc ratio
Optic disc area
Intraocular pressure
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia
Glomerular load of uric acid
Uric acid clearance
Fractional excretion of uric acid
Creatinine clearance
Urinary uric acid to urinary creatinine ratio
Posterior cortical atrophy and Alzheimer's disease
Tonsillectomy
Monobrow
Triglyceride levels
Daytime sleep phenotypes
Essential tremor
Resting heart rate
Emphysema distribution in smoking
Bortezomib-induced peripheral neuropathy in multiple myeloma
Urinary 1,3-butadiene metabolite levels in smokers
Fibrinogen levels
Pediatric bone mineral density (spine)
Pediatric bone mineral content (femoral neck)
Pediatric bone mineral density (femoral neck)
Pediatric bone mineral density (hip)
Pediatric bone mineral content (radius)
Pediatric areal bone mineral density (radius)
Serum galactose-deficient IgA1 levels
Monocyte percentage of white cells
Orofacial clefts
Cleft lip with or without cleft palate
Cleft palate
Pediatric bone mineral content (spine)
Pediatric bone mineral content (hip)
Parkinson's disease
Frontotemporal dementia (age at onset)
Systemic sclerosis
Acute-on-chronic liver failure in hepatitis B
Chronic obstructive pulmonary disease
Colorectal cancer
High light scatter reticulocyte count
Early-onset Parkinson's disease
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase
Antineutrophil cytoplasmic antibody-associated vasculitis
Palmitoleic acid (16:1n-7) levels
Vaccenic acid (18:1n-7) levels
Oleic acid (18:1n-9) levels
Gondoic acid (20:1n-9) levels
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)
Educational attainment (college completion)
C-reactive protein levels or total cholesterol levels (pleiotropy)
Colon cancer
Alzheimer's disease
Alzheimer's disease (APOE e4 interaction)
Alzheimer's disease in APOE e4- carriers
Rheumatoid arthritis
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Melanoma
Plasma t-tau levels
Creatinine levels
Urea levels
Cholesterol, total
Body fat percentage
Urate levels
Gallstone disease
Ulcerative colitis
Endometriosis
Ovarian disease with few adhesions
Deep ovarian and/or rectovaginal disease with dense adhesions
Methadone dose in opioid dependence
Plasma thyroid-stimulating hormone levels
QRS duration
QRS complex (12-leadsum)
QRS complex (Cornell)
QRS complex (Sokolow-Lyon)
Cerebrospinal fluid AB1-42 levels
Cerebrospinal P-tau181p levels
Cerebrospinal T-tau levels
Achilles tendinopathy
Anterior cruciate ligament rupture
Resistin levels
Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease
Body mass index (change over time) in cancer or chronic obstructive pulmonary disease
Body mass index (change over time) in lung cancer
Body mass index (change over time) in gastrointestinal cancer
Body mass index (change over time) in chronic obstructive pulmonary disease
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease
Body mass index (change over time) in cancer
Liver injury in anti-tuberculosis drug treatment
Immune response to measles vaccine (measles-specific neutralising antibody titre)
Immune response to measles vaccine (measles-induced IFN gamma)
Urinary albumin-to-creatinine ratio
Nonsyndromic cleft lip with or without cleft palate
L-arginine levels
Emotional dysregulation
Lung function (FVC)
Lung function (FEV1/FVC)
Prostate-specific antigen levels (conditioned on lead SNPs)
B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)
Hippocampal volume
Atrial fibrillation
Incident atrial fibrillation
Prevalent atrial fibrillation
Spine bone mineral density and alcohol drinking
Carotenoid levels (alpha-carotene)
Lung function (FEV1)
Prostate-specific antigen levels
Takotsubo syndrome
QT interval (tricyclic/tetracyclic antidepressant use interaction)
RR interval (tricyclic/tetracyclic antidepressant use interaction)
Self-reported tiredness
Protein C levels
Central corneal thickness
Basal cell carcinoma
Venous thromboembolism
Inflammatory bowel disease
Cognitive ability
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)
Interleukin-10 levels
Interleukin-6 levels
Body mass index (joint analysis main effects and physical activity interaction)
Neutrophil percentage of white cells
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)
Immunoglobulin light chain (AL) amyloidosis (liver involvement)
Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)
Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)
Immunoglobulin light chain (AL) amyloidosis (heart involvement)
Immunoglobulin light chain (AL) amyloidosis (kidney involvement)
Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)
B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio
Midregional pro atrial natriuretic peptide levels
N-terminal pro B-type natriuretic peptide levels
B-type natriuretic peptide levels
Dupuytren's disease
General cognitive ability
Plasma kynurenine levels in major depressive disorder
Plasma kynurenine to tryptophan ratio in major depressive disorder
Atazanavir levels
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)
Mean platelet volume
B cell acute lymphoblastic leukaemia (normal cytogenetics)
B cell acute lymphoblastic leukaemia (hyperdiploid negative)
B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)
B cell acute lymphoblastic leukaemia (abnormal cytogenetics)
Acute lymphoblastic leukemia in childhood (B cell precursor)
B cell acute lymphoblastic leukaemia in young adulthood
B cell acute lymphoblastic leukaemia in adulthood
Acute lymphoblastic leukemia (B-cell precursor)
Lobe attachment (rater-scored or self-reported)
Matrix metalloproteinase-8 levels
Red blood cell count
Intelligence (MTAG)
Response to metformin (IC50)
Atopic dermatitis
Subjective response to lithium treatment
Subjective response to lithium treatment in bipolar disorder
Objective response to lithium treatment
Objective response to lithium treatment in bipolar disorder
Lymphocyte percentage of white cells
Response to radiotherapy in prostate cancer (toxicity, urinary frequency)
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)
Response to radiotherapy in prostate cancer (overall toxicity)
Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)
Basophil percentage of granulocytes
Serum 25-Hydroxyvitamin D levels
Peripheral artery disease
Mean arterial pressure
Body fat mass
Neovascular age-related macular degeneration
Waist-to-hip ratio adjusted for BMI
Post bronchodilator FEV1
Coenzyme Q10 levels
Cognitive ability (MTAG)
Disease progression in age-related macular degeneration
Disease progression to geographic atrophy form in age-related macular degeneration
Disease progression to choroidal neovascularization form in age-related macular degeneration
Disease progression in age-related macular degeneration (adjusted for baseline)
Epstein-Barr virus copy number in lymphoblastoid cell lines
Progranulin levels
Heel bone mineral density
Lobe attachment (rater scored)
Multiple sclerosis
Hand grip strength
Lower body strength
Circulating chemerin levels
Waist circumference
Acute lymphoblastic leukemia (childhood)
Selective IgA deficiency
Interleukin-1-receptor antagonist levels
Cirrhosis (alcohol related)
Prudent dietary pattern
Western dietary pattern
Apolipoprotein A-IV levels
Nucleus accumbens volume in trauma-exposed individuals
Caudate volume in trauma-exposed individuals
Pallidum volume in trauma-exposed individuals
Lateral ventricle volume in trauma-exposed individuals
Recurrent major depressive disorder
Prevalent type 2 diabetes
Immunoglobulin A vasculitis
Helping behaviour (self reported)
Clinically amyopathic dermatomyositis
Hypertension
Obsessive-compulsive disorder or autism spectrum disorder
HER2 status in breast cancer
Low vWF levels
Estradiol levels
Estrone levels
Coffee consumption
QT interval (ambient particulate matter interaction)
Metabolic syndrome
Fasting blood glucose
Glaucoma (primary open-angle)
Body mass index (physical activity interaction)
P wave terminal force
P wave duration
Thyroid stimulating hormone levels
Free thyroxine concentration
Type 1 diabetes
Thrombin-activatable fibrinolysis inhibitor levels
Thrombin-activatable fibrinolysis inhibitor activation peptide
Response to metformin in type 2 diabetes (HbA1c reduction)
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)
Alzheimer's disease (late onset)
Amyotrophic lateral sclerosis
Body mass index in physically active individuals
Hip circumference
Serum total cholesterol levels
Total triglycerides levels
Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)
Dermatomyositis
Dysmenorrheic pain
Waist circumference adjusted for BMI in active individuals
Coronary artery disease
Serum uric acid levels in response to allopurinol in gout
Response to cognitive-behavioural therapy in anxiety disorder
Asthma
Asthma (childhood onset)
Drug abuse
Apolipoprotein B levels
Ratio of apolipoprotein A1 to apolipoprotein B
Esterified cholesterol levels
Free cholesterol levels
Total cholesterol levels in HDL
Total cholesterol levels in LDL
Free cholesterol levels in large LDL
Medium LDL particle concentration
Phospholipid levels in medium LDL
Total cholesterol levels in medium LDL
Cholesterol ester levels in medium LDL
Total cholesterol levels in large LDL
Cholesterol ester levels in large LDL
Small LDL particle concentration
Hair shape
Cognitive function
Knee osteoarthritis
Survival in head and neck cancer
Attention deficit hyperactivity disorder
Taxane-induced peripheral neuropathy in breast cancer
Psoriasis vulgaris
Vitamin D levels
Male sexual orientation
Waist-to-hip ratio adjusted for BMI in active individuals
Neuroticism
Sulfasalazine-induced agranulocytosis
Huntington's disease progression
Alcohol dependence
Duloxetine response in major depressive disorder (% change in symptom score)
Placebo response in major depressive disorder (% change in symptom score)
Phospholipid levels in medium VLDL
Total cholesterol levels in medium VLDL
Very large VLDL particle concentration
Phospholipid levels in large VLDL
Triglyceride levels in large VLDL
Medium VLDL particle concentration
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer
High altitude adaptation
Insulin sensitivity index
Insulin levels
Insulin levels adjusted for BMI
Ratio of the area under the curve for insulin and the area under the curve for glucose
Area under the curve of insulin levels
Incremental insulin
Corrected insulin response
Corrected insulin response adjusted for insulin sensitivity index
Late-onset Alzheimer's disease
Chronic rhinosinusitis with nasal polyps
Testicular germ cell tumor
Multiple myeloma
Alcohol dependence symptom count
Bipolar disorder lithium response (continuous) or schizophrenia
Bipolar disorder lithium response (categorical) or schizophrenia
Glaucoma (primary angle closure)
Pediatric areal bone mineral density (concordant skeletal phenotype)
Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)
Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)
Delayed reward discounting
Free cholesterol levels in medium VLDL
Triglyceride levels in medium VLDL
Cholesterol ester levels in medium VLDL
Small VLDL particle concentration
Phospholipid levels in small VLDL
Narcolepsy
Phospholipid levels in large HDL
Total cholesterol levels in large HDL
Cholesterol ester levels in very large HDL
Free cholesterol levels in large HDL
Medium HDL particle concentration
Oral cavity cancer
Large HDL particle concentration
Very large HDL particle concentration
Free cholesterol levels in very large HDL
Triglyceride levels in very large HDL
Total cholesterol levels in small LDL
Body mass index in physically inactive individuals
Glycated hemoglobin levels
Luteinizing hormone levels in polycystic ovary syndrome
Follicle stimulating hormone levels in polycystic ovary syndrome
Sex hormone-binding globulin levels in polycystic ovary syndrome
Testosterone levels in polycystic ovary syndrome
Polycystic ovary syndrome
Mean diameter of LDL particles
Mean diameter of VLDL particles
Phospholipid levels in very large VLDL
Triglyceride levels in very large VLDL
Mean diameter of HDL particles
Sleep latency
Oral cavity and pharyngeal cancer
Total cholesterol levels in medium HDL
Cholesterol ester levels in medium HDL
Free cholesterol levels in medium HDL
Small HDL particle concentration
Triglyceride levels in small HDL
Chylomicron and largest VLDL particle concentration
Phospholipid levels in chylomicrons and largest VLDL
Triglyceride levels in chylomicrons and largest VLDL
Apolipoprotein A1 levels
Oropharynx cancer
Phospholipid levels in medium HDL
Age-related hearing impairment
Waist circumference adjusted for BMI in inactive individuals
Celiac disease
Peanut allergy
Food allergy
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia
Suicide attempts in major depressive disorder
Suicide attempts in bipolar disorder
Suicide attempts in schizophrenia
Suicide attempts in bipolar disorder or schizophrenia
Multiple keratinocyte cancers
Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)
Moderate to vigorous physical activity levels
Vigorous physical activity
Strenuous sports or other exercises
Bitter taste perception (multivariate analysis)
Bitter taste perception
Accelerometer-based physical activity measurement (average acceleration)
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Systolic blood pressure x alcohol consumption interaction (2df test)
Family history of Alzheimer's disease
Alzheimer's disease or family history of Alzheimer's disease
Neuritic plaque
Neurofibrillary tangles
Adverse response to drug
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+)
Alzheimer’s disease (clinical subgroup AD+)
Alzheimer’s disease (clinical subgroup AD++)
Alzheimer’s disease (clinical subgroup AD+++)
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)
Estimated glomerular filtration rate
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia
Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia
Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia
Hippocampal volume in Alzheimer's disease dementia
Logical memory (immediate recall) in Alzheimer's disease dementia
Logical memory (delayed recall) in Alzheimer's disease dementia
Cerebrospinal AB1-42 levels in mild cognitive impairment
Cerebrospinal fluid t-tau levels in mild cognitive impairment
Cerebrospinal fluid p-tau levels in mild cognitive impairment
Hippocampal volume in mild cognitive impairment
Cisplatin-induced ototoxicity
Nose morphology
Lip morphology
Upper eyelid morphology
Pulse pressure x alcohol consumption interaction (2df test)
Intake of total sugars
Perceived intensity of glucose
Risky sexual behaviors (alcohol dependence interaction)
Mean arterial pressure x alcohol consumption interaction (2df test)
Middle temporal gyrus volume
Parahippocampal gyrus volume
Paracentral lobule volume
Pars opercularis volume
Pars orbitalis volume
Lingual gyrus volume
Medial orbital frontal cortex volume
IgG glycosylation patterns
Fractures (vertebral)
Diastolic blood pressure x alcohol consumption interaction (2df test)
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)
Smoking behaviour (cigarettes smoked per day)
Smoking behaviour (age at first cigarette)
Smoking behaviour (cigarette pack-years)
Insular cortex volume
Thalamus volume
Caudate nucleus volume
Putamen volume
Pallidum volume
Anti-Toxoplasma gondii IgG seropositivity
Colorectal cancer or advanced adenoma
Smoking initiation (ever regular vs never regular)
Alcohol consumption (drinks per week)
Bone mineral density (lumbar spine) in inflammatory bowel disease
Bone mineral density (femoral neck) in inflammatory bowel disease
Psychotic experience
Psychotic experience (distressing)
Lateral ventricle temporal horn volume
Third ventricle volume
Fourth ventricle volume
Parental longevity (combined parental attained age, Martingale residuals)
Parental longevity (both parents in top 10%)
Parental longevity (mother's age at death)
Corpus callosum central volume
Corpus callosum mid-anterior volume
Corpus callosum anterior volume
Cortex volume
Bicuspid aortic valve without aortic dilation
Allergic disease (asthma, hay fever or eczema)
Asthma or allergic disease (pleiotropy)
Attention deficit hyperactivity disorder or cannabis use
Whole brain grey matter density
Total intracranial volume
Estimated glomerular filtration rate in diabetes
Estimated glomerular filtration rate in non-diabetics
Cerebellum cortex volume
Superior temporal sulcus banks volume
Cerebellum white matter volume
Blood protein levels
Waist-hip ratio
Bacterial meningitis
Pneumococcal meningitis x streptococcus pneumoniae genotype cluster interaction
Pneumococcal meningitis x streptococcus pneumoniae antigen allele interaction
Pneumococcal meningitis
Severe bacterial meningitis
Familial lung cancer
Familial lung adenocarcinoma
Systemising
Adolescent idiopathic scoliosis
Lateral ventricle volume
Corpus callosum posterior volume
Corpus callosum Mid-posterior volume
Parental longevity (mother's attained age)
Parental longevity (father's age at death)
Parental longevity (father's attained age)
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia
Parental longevity (combined parental age at death)
Cerebral white matter volume
Sub-cortical grey matter volume
Total grey matter volume
Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
Response to placebo treatment in childhood asthma (FVC change)
Childhood dental caries in primary teeth
Childhood dental caries in permanent teeth
Familial squamous cell lung carcinoma
Gait speed in old age
Red cell distribution width
Progesterone levels
17-hydroxyprogesterone (17-OHP) levels
Androstenedione levels
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Perceived intensity of neohesperidin dihydrochalcone
Perceived intensity of aspartame
Perceived intensity of sweet substances
Perceived intensity of sucrose
Intake of sweets
Perceived intensity of fructose
Maximum habitual alcohol consumption
Perceived sweetness of sucrose
Sucrose liking
Pericalcarine cortex volume
Postcentral gyrus volume
Posterior-cingulate cortex volume
Precentral gyrus volume
Pars triangularis volume
Childhood steroid-sensitive nephrotic syndrome
N-glycan levels
Liver disease severity in Alagille syndrome
Vitiligo (late onset)
Vitiligo (early onset)
Predicted suicide risk
DHEAS levels
Testosterone levels
Migraine without aura
Logical memory (immediate recall) in mild cognitive impairment
Logical memory (delayed recall) in mild cognitive impairment
Cerebrospinal AB1-42 levels in normal cognition
Cerebrospinal fluid t-tau levels in normal cognition
Cerebrospinal fluid p-tau levels in normal cognition
Hippocampal volume in normal cognition
Logical memory (immediate recall) in normal cognition
Logical memory (delayed recall) in normal cognition
Cerebrospinal fluid t-tau levels
Cerebrospinal fluid p-tau levels
Logical memory (immediate recall)
Logical memory (delayed recall)
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)
Caudal anterior-cingulate cortex volume
Caudal middle frontal gyrus volume
Cuneus cortex volume
Entorhinal cortical volume
Fusiform gyrus volume
Normal facial asymmetry (deformation magnitude)
Rostral anterior cingulate cortex volume
Rostral middle frontal gyrus volume
Superior frontal gyrus volume
Superior parietal cortex volume
Superior temporal gyrus volume
Supramarginal gyrus volume
Precuneus cortex volume
Verbal intelligence quotient (cesarean section interaction)
Performance intelligence quotient (cesarean section interaction)
Full scale intelligence quotient (cesarean section interaction)
Depressive symptom improvement
Giant cell arteritis
Pyridoxal 5'-phosphate levels
Nonsyndromic cleft lip
Nonsyndromic cleft palate
Leukocyte telomere length
Cortisol levels (plasma)
Alzheimer's disease in hypertension-negative individuals
Alzheimer's disease in hypertension
Facial morphology
Forehead morphology
Eye morphology
HDL cholesterol and triglyceride levels
Fatty acid desaturase activity (serum)
Fatty acid desaturase activity (adipose tissue)
Urinary haptoglobin levels in type 2 diabetes
Plasma haptoglobin levels in type 2 diabetes
Triacylglycerol 56:6 levels
Malate levels
Niacinamide levels
Sphingomyelin 24:0 levels
Uridine levels
Triacylglycerol 56:2 levels
Tyrosine levels
Xanthine levels
Metabolite risk score for predicting weight gain
Isthmus-cingulate cortex volume
Lateral occipital cortex volume
Inferior parietal cortex volume
Inferior temporal gyrus volume
Lateral orbital frontal cortex volume
Depressive symptom (depressed mood) (binary trait)
Depressive symptom (sleep problems) (binary trait)
Depressive symptom (appetite changes) (binary trait)
Depressive symptoms (binary sum-score)
Depressive symptoms (sum-score)
Depressive symptom (fatigue) (ordinal trait)
Depressive symptom (low self-esteem) (ordinal trait)
Depressive symptom (anhedonia) (ordinal trait)
Depressive symptom (depressed mood) (ordinal trait)
Depressive symptom (anhedonia) (binary trait)
Normal facial asymmetry (angle of surface orientation score)
Normal facial asymmetry (angle of deformation score)
Frontal pole volume
Temporal pole volume
Transverse temporal cortex volume
Treatment resistant depression
Hemoglobin levels
Infant, child and juvenile death (proportion of children died <15 years)
Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)
Number of stillbirths in continuous marriage
Oxygenated hemoglobin levels
Number of live births
Number of pregnancies
Nucleus accumbens volume
Ventral diencephalon volume
Choroid plexus volume
Amygdala volume
Regular attendance at a gym or sports club
Regular attendance at a pub or social club
Regular attendance at a religious group
Loneliness
Ability to confide in someone
Non-muscle-invasive bladder cancer tumour size
Appendicitis
Differential aging in older adults (frontal cortex)
Differential aging (frontal cortex)
Obsessive-compulsive disorder
Obsessive-compulsive disorder x sex interaction
Loneliness (MTAG)
Asthma x air pollution interaction (2df)
Asthma x Hispanic interaction (2df)
Cervical cancer
Response to interferon treatment in hepatitis C virus genotype 3
Response to direct-acting antiviral treatment in hepatitis C virus genotype 3
Pre-treatment viral load in hepatitis C virus genotype 3
Diabetic maculopathy with decreased visual acuity in type 2 diabetes
Diabetic maculopathy in type 2 diabetes
Attention function
Working memory
Verbal memory
Visual memory
Reasoning
Information processing speed
Pemphigus
Pemphigus vulgaris
Blood urea nitrogen levels
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)
Hearing loss in Charcot-Marie-Tooth disease 1A
Decreased sensory function in Charcot-Marie-Tooth disease type 1A
Neuropathy in Charcot-Marie-Tooth disease type 1A
Balance difficulty in Charcot-Marie-Tooth disease type 1A
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)
Walking difficulty in Charcot-Marie-Tooth disease 1A
Foot deformity in Charcot-Marie-Tooth disease 1A
Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A
Scoliosis in Charcot-Marie-Tooth disease 1A
Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A
Cognitive performance (processing speed)
Mild to moderate chronic kidney disease
Chronic kidney disease
End-stage kidney disease
Post-traumatic stress disorder
Number of alcoholic drinks required to feel an effect (first five times drinking)
Number of alcoholic drinks required to feel an effect (long-term average)
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)
Systolic blood pressure x physical activity (less vs more active half) interaction (2df)
Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)
Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)
Systolic blood pressure x physical activity interaction (2df)
Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)
Estimated glomerular filtration rate reduction (30%)
Incident chronic kidney disease
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)
Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)
Systolic blood pressure x physical activity (less vs more active half) interaction (1df)
Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)
Systolic blood pressure x physical activity interaction (1df)
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)
Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)
Diastolic blood pressure x physical activity interaction (1df)
DIastolic blood pressure x physical activity interaction (2df)
Joint damage in rheumatoid arthritis
Schizophrenia
Schizophrenia vs type 2 diabetes
Schizophrenia and type 2 diabetes
Retinal arteriolar tortuosity
Maximum retinal arteriolar tortuosity
Retinal venular tortuosity
Maximum retinal venular tortuosity
Central retinal arteriolar equivalent
Central retinal vein equivalent
Retinal arteriole-to-venule ratio
Optic disc radius
Chronic lymphocytic leukemia or multiple sclerosis
Diffuse large B-cell lymphoma or multiple sclerosis
Follicular lymphoma or multiple sclerosis
Marginal zone lymphoma or multiple sclerosis
Chronic lymphocytic leukemia or rheumatoid arthritis
Diffuse large B-cell lymphoma or rheumatoid arthritis
Follicular lymphoma or rheumatoid arthritis
Marginal zone lymphoma or rheumatoid arthritis
Chronic lymphocytic leukemia or systemic lupus erythematosus
Diffuse large B-cell lymphoma or systemic lupus erythematosus
Marginal zone lymphoma or systemic lupus erythematosus
LDL cholesterol levels in current drinkers
Hip circumference adjusted for BMI
Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)
Delta-5 desaturase activity
Delta-6 desaturase activity
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)
Optic cup area
Molybdenum levels
Lead levels
Mercury levels
Cadmium levels
Zinc levels
Early childhood aggressive behavior
Middle childhood and early adolescence aggressive behavior
Childhood and early adolescence aggressive behavior
Copper levels
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)
Serum uric acid levels
Polychlorinated biphenyl levels
Number of children (6+ vs. 0 or 1)
Number of children
Metabolite levels
Psoriasis
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Serum tamsulosin hydrochloride concentration
Sasang constitutional medicine type (So-Eum)
Serum total protein level
Serum albumin levels
Antibody level in response to infection
Birth weight
Alzheimer's disease in APOE e4+ carriers
Diisocyanate-induced asthma
Expressive vocabulary in infants
Takayasu arteritis
Response to Homoharringtonine (cytotoxicity)
Myopia (pathological)
Abdominal aortic aneurysm
Response to inhaled glucocorticoid treatment in asthma (change in FEV1)
Motion sickness
Trans fatty acid levels
Plasma plasminogen levels
Nickel levels
Chromium levels
Cobalt levels
Aluminium levels
Manganese levels
Basal metabolic rate
Glioblastoma
Non-glioblastoma glioma
Glioma
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)
Heschl's gyrus morphology
Cytokine-stimulated IL-6 production
Cytokine and corticosteroid-stimulated IL-6 production
Urate levels in lean individuals
Urate levels (BMI interaction)
Urate levels in overweight individuals
Carotid artery intima media thickness (sex interaction)
Asthma or chronic obstructive pulmonary disease
Non-small cell lung cancer (survival)
Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)
Serum IgE levels
Mammographic density
Hip circumference (psychosocial stress interaction)
Exfoliation syndrome
C-reactive protein
Iris characteristics
Periodontitis
Type 1 diabetes and autoimmune thyroid diseases
Depressive symptoms (SSRI exposure interaction)
Exudative age-related macular degeneration
Chronic hepatitis C infection
Chronic obstructive pulmonary disease-related biomarkers
Gray matter volume (schizophrenia interaction)
Alzheimer's disease or small vessel stroke
Graves' disease
Hashimoto thyroiditis
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)
Idiopathic pulmonary fibrosis
Vaso-occlusive pain in sickle-cell anemia
Severe malaria (adjusted for sickle cell variant rs334)
Severe malaria
Reticulocyte count
Obstructive sleep apnea trait (apnea hypopnea index)
Obstructive sleep apnea during REM sleep (apnea hypopnea index)
Alcohol consumption in current drinkers
Peripheral arterial disease (traffic-related air pollution interaction)
Tooth agenesis
Tooth agenesis (mandibular second premolars)
Tooth agenesis (maxillary lateral incisors)
Tooth agenesis (maxillary second premolars)
Autism spectrum disorder or schizophrenia
Menopause (age at onset)
Neutrophil percentage of granulocytes
Body mass index (age <50)
Body mass index x age interaction
Body mass index (age>50)
Weight
Plantar warts
Waist-to-hip ratio adjusted for BMI x sex interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)
Waist-to-hip ratio adjusted for BMI (age >50)
Cerebrospinal fluid t-tau:AB1-42 ratio
Major depression and alcohol dependence
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms
Lipoprotein (a) levels
Neuroblastoma (11q deletion)
Neuroblastoma (1p deletion)
Neuroblastoma (MYCN amplification)
Alcohol consumption
Body mass index x sex x age interaction (4df test)
Hepatocellular carcinoma in hepatitis C infection
Shingles
Cold sores
Subjective well-being (MTAG)
Depressive symptoms (MTAG)
Mumps
Depressive symptoms
Neuroticism (MTAG)
Subjective well-being
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)
Craniofacial microsomia
Rate of cognitive decline in mild cognitive impairment (time interaction)
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer
Plasma androstenedione levels in resected early stage-receptor positive breast cancer
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer
Waist-to-hip ratio adjusted for BMI (age <50)
Sum eosinophil basophil counts
Yeast infection
Number of children ever born
Age at first birth
Smoking status (current vs former)
Drug-induced liver injury (terbinafine)
Drug-induced hepatocellular liver injury
Drug-induced liver injury (statins)
Drug-induced cholestatic/mixed liver injury
Drug-induced liver injury (nitrofurantoin)
Drug-induced liver injury (diclofenac)
Drug-induced liver injury (anti-tuberculosis drugs)
Drug-induced liver injury (fluoroquinolones)
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)
Presence of antiphospholipid antibodies
Nonsyndromic cleft lip with cleft palate
Ischemic stroke (cardioembolic)
Stroke
Clopidogrel active metabolite levels
Response to clopidogrel therapy
Response to paliperidone in schizophrenia (positive Marder score)
Response to paliperidone in schizophrenia (negative Marder score)
Myopia
Joint mobility (Beighton score)
Nose size
Resistance to antihypertensive treatment in hypertension
Sepsis in extremely premature infants
Male-pattern baldness
Nicotine metabolite ratio
Eosinophil percentage of white cells
Pericardial adipose tissue adjusted for height and weight
Visceral adipose tissue adjusted for BMI
Pericardial fat
Visceral adipose tissue/subcutaneous adipose tissue ratio
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI
Visceral adipose tissue
Endometrial endometrioid carcinoma
Endometrial cancer
Drug-induced liver injury
Skin fluorescence in type 1 diabetes
Age-related diseases, mortality and associated endophenotypes
Age-related disease endophenotypes
Photic sneeze reflex
Liver injury in anti-retroviral drug treated HIV
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder
Mean corpuscular hemoglobin concentration
Response to paliperidone in schizophrenia (PANSS score)
Breast size
Migraine
Response to paliperidone in schizophrenia (Multivariate)
Response to paliperidone in schizophrenia (CGI-S score)
Hypothyroidism
Chin dimples
Age-related diseases and mortality
Paneth cell defects in Crohn's disease
Allergy
Childhood ear infection
Corticobasal degeneration
Bone mineral density (femoral neck)
Bone mineral density (total hip)
Bone mineral density (spine)
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder
Bipolar disorder or attention deficit hyperactivity disorder
Response to carboplatin in ovarian cancer (MTT IC50)
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)
Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)
Response to paclitaxel in ovarian cancer (MTT IC50)
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)
Gut microbiota (bacterial taxa)
Gut microbiota (beta diversity)
Excessive daytime sleepiness
Sleep duration
Sleep traits (multi-trait analysis)
Insomnia
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
Cannabis dependence symptom count
Gallbladder cancer
Chronotype
Morning vs. evening chronotype
Sleep duration (oversleepers vs undersleepers)
Heroin dependence
Depressive symptoms measurement (somatic complaints domain)
Ischemic stroke
Small vessel stroke
Large artery stroke
Loneliness (multivariate analysis)
Loneliness (linear analysis)
Small intestine neuroendocrine tumor
Bronchial neuroendocrine tumor
Osteoarthritis (with total hip replacement)
Macular telangiectasia type 2
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)
C-reactive protein levels
Very low density lipoprotein cholesterol levels
Hemoglobin
High light scatter reticulocyte percentage of red cells
Thyroid cancer
Fasting blood glucose adjusted for BMI
Diastolic blood pressure (cigarette smoking interaction)
Hemoglobin concentration
Platelet distribution width
Heart rate response to recovery post exercise (50 sec)
Heart rate response to recovery post exercise (10 sec)
Heart rate response to recovery post exercise (20 sec)
Heart rate increase in response to exercise
Heart rate response to recovery post exercise (30 sec)
Decline in glucose metabolism in posterior cingulate cortex
Pursuit maintenance gain in psychotic disorders
Initial pursuit acceleration
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)
Hen's egg allergy
Eosinophil percentage of granulocytes
beta-nerve growth factor levels
Vascular endothelial growth factor levels
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Neuritic plaques or neurofibrillary tangles (pleiotropy)
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
White blood cell count (basophil)
Reticulocyte fraction of red cells
Gut microbiota (functional units)
Interleukin-17 levels
Interleukin-18 levels
Interleukin-9 levels
Interleukin-13 levels
Sum basophil neutrophil counts
Stromal-cell-derived factor 1 alpha levels
Tumor necrosis factor alpha levels
Stem cell growth factor beta levels
Macrophage inflammatory protein 1a levels
Macrophage inflammatory protein 1b levels
Chronic lymphocytic leukemia
RANTES levels
Platelet-derived growth factor BB levels
Epithelial ovarian cancer
Low-grade serous and serous borderline ovarian cancer
Ovarian clear cell cancer
Endometrioid ovarian cancer
Mucinous ovarian carcinoma
Serous invasive ovarian cancer
Ovarian cancer in BRCA2 mutation carriers
Serous borderline ovarian cancer
Stem cell factor levels
Alcohol consumption over the past year
Colorectal adenoma (advanced)
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease
Major coronary event in placebo-treated cardiovascular disease (time to event)
Diarrhoea in darapladib-treated cardiovascular disease (time to event)
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)
Major coronary event in darapladib-treated cardiovascular disease (time to event)
Lipoprotein phospholipase A2 activity in cardiovascular disease
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)
Tumor necrosis factor beta levels
TRAIL levels
Chronic venous disease
Smoking status (heavy vs light)
Granulocyte count
Heart rate response to beta blockers (atenolol monotherapy)
Immunoglobulin light chain (AL) amyloidosis
Idiopathic dilated cardiomyopathy
Primary vesicoureteric reflux
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)
Sperm motility
Pursuit maintenance gain
Anti-saccade response
NHDL cholesterol to HDL cholesterol ratio
LDL cholesterol to HDL cholesterol ratio
Triglyceride to HDL cholesterol ratio
Food allergy (parent-of-origin effect)
Peanut allergy (parent-of-origin effect)
Milk allergy (parent-of-origin effect)
Egg allergy (parent-of-origin effect)
Food allergy (maternal genetic effects)
Peanut allergy (maternal genetic effects)
CTACK levels
Milk allergy (maternal genetic effects)
Egg allergy (maternal genetic effects)
Exhaled nitric oxide output
Exhaled nitric oxide levels
Depressive symptoms (stressful life events interaction)
Interleukin-7 levels
Interleukin-8 levels
Bipolar disorder
Monocyte chemoattractant protein-1 levels
Monocyte chemoattractant protein-3 levels
Macrophage colony stimulating factor levels
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Alcohol consumption (max-drinks)
Response to alcohol consumption (flushing response)
Femoral neck bone mineral density
Lumbar spine bone mineral density
Multiple system atrophy (pathologically confirmed)
Multiple system atrophy
Blood osmolality (transformed sodium)
Iron status biomarkers (ferritin levels)
Iron status biomarkers (iron levels)
Iron status biomarkers (total iron binding capacity)
Iron status biomarkers (transferrin saturation)
Eotaxin levels
Fibroblast growth factor basic levels
Granulocyte-colony stimulating factor levels
Gout vs. Hyperuricemia
Hyperuricemia
Macrophage Migration Inhibitory Factor levels
Interferon gamma-induced protein 10 levels
Colonoscopy-negative controls vs population controls
Lung function (maximal voluntary ventilation)
Lung function (forced expiratory volume in 1 second)
Lung function (forced vital capacity)
Response to platinum-based neoadjuvant chemotherapy in cervical cancer
Adiponectin levels in pregnancy
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)
Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)
Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)
Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)
Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)
Interleukin-1-beta levels
Growth-regulated protein alpha levels
Hepatocyte growth factor levels
Interferon gamma levels
Interleukin-2 levels
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Interleukin-16 levels
Interleukin-12p70 levels
Open-angle glaucoma and optic cup area
Open-angle glaucoma and vertical cup-disc ratio
Insulin levels in response to oral glucose tolerance test (fasting)
Glucagon levels in response to oral glucose tolerance test (fasting)
GIP levels in response to oral glucose tolerance test (fasting)
GLP-1 levels in response to oral glucose tolerance test (fasting)
Insulin levels in response to oral glucose tolerance test (30 minutes)
Insulin levels in response to oral glucose tolerance test (120 minutes)
GLP-1 levels in response to oral glucose tolerance test (120 minutes)
GIP levels in response to oral glucose tolerance test (120 minutes)
Glucagon levels in response to oral glucose tolerance test (120 minutes)
Urinary magnesium-to-creatinine ratio
Serum magnesium levels
Systolic blood pressure (dietary potassium intake interaction)
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin
Paclitaxel disposition in epithelial ovarian cancer
Carboplatin disposition in epthelial ovarian cancer
Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)
Attention deficit hyperactivity disorder symptom score
Alcohol misuse (trauma interaction)
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)
Diffuse cutaneous systemic sclerosis
Limited cutaneous systemic scleroderma
Opioid dependence
Initial pursuit acceleration in psychotic disorders
Anti-saccade error rate in psychotic disorders
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy
Breast cancer in childhood cancer survivors
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy
Alzheimer's disease (age of onset)
Ovarian cancer in BRCA1 mutation carriers
Invasive epithelial ovarian cancer
High-grade serous ovarian cancer
Low-grade serous ovarian cancer
Breast Cancer in BRCA1 mutation carriers
Problematic alcohol use in trauma-exposed individuals
Waist circumference adjusted for BMI (adjusted for smoking behaviour)
Mononucleosis
Hepatitis B
Rubella
Renal cell carcinoma
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
Scarlet fever
Pneumonia
Rheumatic heart disease
Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)
Itch intensity from mosquito bite adjusted by bite size
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)
Nevirapine-induced hypersensitivity in HIV
Intelligence
Psychosis proneness (hypomanic personality scale)
Psychosis proneness (perceptual aberration scale)
Psychosis proneness (revised physical anhedonia scale)
Psychosis proneness (revised social anhedonia scale)
Psychosis proneness (hypomanic personality scale and perceptual aberration scale)
Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)
Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)
Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)
Parental longevity (at least one long-lived parent)
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
Seborrheic dermatitis
DDT metabolite (p,p'-DDE levels)
Restricted and repetitive behaviours in autism spectrum disorder
Myeloid white cell count
Strep throat
Telomere length
Waist-to-hip ratio adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (smoking interaction)
Dehydroepiandrosterone sulphate levels
Alanine transaminase levels
Sjögren's syndrome
Chronic sinus infection
Facial morphology (factor 15, philtrum width)
Facial morphology (factor 16)
Facial morphology (factor 17, height of vermillion upper lip)
Facial morphology (factor 3, length of philtrum)
Body mass index (adult)
Autism spectrum disorder
Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)
Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)
Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)
Facial morphology (factor 9, facial height related to vertical position of nasion)
Facial morphology (factor 11, projection of the nose)
Nicotine metabolite ratio in current smokers
Facial morphology (factor 14, intercanthal width)
Facial morphology (factor 21, depth of nasal alae)
BMI (smoking interaction)
Itch intensity from mosquito bite
Measles
Hepatitis A
Myringotomy
Nodular sclerosis Hodgkin lymphoma
Mixed cellularity Hodgkin lymphoma
Hodgkin's lymphoma
Rheumatic fever
Aggressive periodontitis
Verbal memory performance (delayed recall level)
Verbal memory performance (residualized delayed recall change)
Verbal memory performance (immediate recall change)
Verbal memory performance (residualized delayed recall level)
Verbal memory performance (immediate recall level)
Facial morphology (factor 2, vertical position of orbits relative to midface)
Facial morphology (factor 4, facial height related to vertical position of gnathion)
Facial morphology (factor 20)
Pediatric non-alcoholic fatty liver disease activity score
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
Pediatric nonalcoholic steatohepatitis
Fuchs's corneal dystrophy
Motor development (prenatal lead exposure interaction)
Mental development (prenatal lead exposure interaction)
Blood pressure traits (multi-trait analysis)
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
Facial morphology (factor 7, width of cartilaginous portion of nose)
Facial morphology (factor 6, height of vermillion lower lip)
Facial morphology (factor 22)
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)
Spontaneous preterm birth (maternal effect)
Facial morphology (factor 23)
Glomerular filtration rate (cystatin C)
Glomerular filtration rate (creatinine)
Trunk fat mass
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)
Cerebral blood flow
White blood cell count (eosinophil)
White blood cell count (lymphocyte)
White blood cell count (monocyte)
Obstetric antiphospholipid syndrome
White blood cell count (neutrophil)
Primary biliary cholangitis
Borderline personality disorder
Skin aging (microtopography measurement)
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)
Number of common colds
Facial morphology (factor 1, breadth of lateral portion of upper face)
Facial morphology (factor 10, width of nasal floor)
Elevated serum prostate-specific antigen levels in healthy men
Urinary tract infection frequency
Facial morphology (factor 18)
Facial morphology (factor 19)
Facial morphology (factor 5, width of mouth relative to central midface)
Alcohol consumption (drinkers vs non-drinkers)
Red blood cell density in sickle cell anemia
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)
Total mean fractional anisotropy measurement in first episode schizophrenia
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
Heart rate
Heart rate variability traits (RMSSD)
Heart rate variability traits (SDNN)
Tacrolimus trough concentration in kidney transplant patients
Neurocognitive impairment in HIV-1 infection (continuous)
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)
HIV-associated neurocognitive disorder (mild neurocognitive disorder)
HIV-associated neurocognitive disorder
Neurocognitive impairment in HIV-1 infection (dichotomous)
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
Fear of minor pain
Fear of medical pain (dental)
Fear of pain
Diastolic blood pressure x sodium interaction (1df test)
Systolic blood pressure x sodium interaction (2df test)
Diastolic blood pressure x sodium interaction (2df test)
Mean arterial pressure x sodium interaction (2df test)
Trans-epidermal water loss
Hepcidin/transferrin saturation ratio
Hepcidin/ferritin ratio
Hepcidin levels
ACPA-positive rheumatoid arthritis (smoking interaction)
Primary biliary cirrhosis
PR interval
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia
Insomnia complaints
Insomnia complaints (continuous)
Insomnia complaints (dichotomous)
Ease of getting up in the morning
Daytime nap
Snoring
Daytime sleepiness
Atopy
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)
IgG galactosylation phenotypes (multivariate analysis)
IgG monogalactosylation phenotypes (multivariate analysis)
IgG digalactosylation phenotypes (multivariate analysis)
IgG N-glycosylation phenotypes (multivariate analysis)
Chickenpox
IgG sialylation phenotypes (multivariate analysis)
IgG disialylation phenotypes (multivariate analysis)
IgG monosialylation phenotypes (multivariate analysis)
IgG fucosylation phenotypes (multivariate analysis)
Extrinsic epigenetic age acceleration
Intrinsic epigenetic age acceleration
Facial emotion recognition
Facial emotion recognition (happy faces)
Facial emotion recognition (sad faces)
Facial emotion recognition (angry faces)
Facial emotion recognition (fearful faces)
Fear of severe pain
Caudate activity during reward
Advanced age-related macular degeneration
Age-related macular degeneration (SNP x mitochondrial A4917G interaction)
Age-related macular degeneration (SNP x mitochondrial G12771A interaction)
Leprosy
Amyotrophic lateral sclerosis (sporadic)
1,5-anhydroglucitol levels
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma
Nonalcoholic fatty liver disease
Heart rate response to beta blockers (atenolol add-on therapy)
Heart rate response to beta blockers
Rheumatoid arthritis (ACPA-positive)
Circulating chromogranin peptide levels
Vitamin B12 levels
Systolic blood pressure (cigarette smoking interaction)
Heart rate response to recovery post exercise (40 sec)
Interleukin-2 receptor antagonist levels
Interleukin-4 levels
Interleukin-5 levels
Pulmonary arterial hypertension
Monokine induced by gamma interferon levels
Systolic blood pressure change trajectory
Heart rate variability traits (pvRSA/HF)
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)
Mosquito bite size
Cannabis dependence
Chronic periodontitis (mean interproximal clinical attachment level)
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
BMI (adjusted for smoking behaviour)
Bone ultrasound measurement (broadband ultrasound attenuation)
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)
Bone ultrasound measurement (velocity of sound)
Residual cognition
Left ventricular obstructive tract defect (maternal effect)
Congenital heart disease (inherited effect)
Congenital heart disease (maternal effect)
Interleukin-6 (red blood cell fatty acid level interaction)
Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)
Cellular adhesion molecule (red blood cell fatty acid level interaction)
Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)
Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)
C-reactive protein (red blood cell fatty acid level interaction)
vWF levels in ischaemic stroke and hyperhomocysteinaemia
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
Ankylosing spondylitis
Perceived unattractiveness to mosquitoes
Tenofovir clearance in HIV infection
Anorexia nervosa
Conotruncal heart defects (inherited effects)
Left ventricular obstructive tract defect (inherited effect)
Conotruncal heart defects (maternal effects)
Ankylosing spondylitis (SNP x SNP interaction)
Theory of mind score in adolescence (Emotional Triangles Task)
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes
Breast cancer (estrogen-receptor positive)
Bilirubin levels in tenofovir-treated HIV infection
Bone erosion in rheumatoid arthritis
Acute graft versus host disease in bone marrow transplantation (recipient effect)
Acute graft versus host disease in bone marrow transplantation (donor effect)
Nicotine dependence
Hypertriglyceridemia
Sporadic neuroblastoma
Reaction time
Nicotine dependence symptom count
Cardiorespiratory fitness (800m run time)
Peak expiratory flow
Rate of cognitive decline in Alzheimer's disease
White matter microstructure (radial diusivities)
Conjunctival UV autofluorescence (CUVAF)
Serum metabolite levels
Essential hypertension (time to event)
Hyperlipidemia (time to event)
Osteoarthrosis (time to event)
Cardiac dysrhythmias (time to event)
Asthma (time to event)
Cataract (time to event)
Coronary atherosclerosis (time to event)
Type 2 diabetes (time to event)
Cortical surface area
Attention deficit hyperactivity disorder (inattention symptoms)
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
Receptive language ability
Parent of origin effect on receptive language ability (paternal)
Parent of origin effect on receptive language ability (maternal)
Fractures
Sepsis (hospital admission)
Pneumonia (28-day mortality)
Pneumonia (90-day mortality)
Sepsis (28-day mortality)
Sepsis (90-day mortality)
Emotional recognition
Carotid intima media thickness x smoking interaction
Autism spectrum disorders (social interaction)
Autism spectrum disorders (peer interaction)
Autism spectrum disorders (repetitive sensory-motor behaviour)
Creativity
Attention deficit hyperactivity disorder (persistent)
Attention deficit hyperactivity disorder (childhood)
Optic disc size
Evening vs. morning chronotype (self-assessed)
Chronotype (sMEQ score)
Evening vs. morning chronotype (sMEQ score)
Glycated hemoglobin levels in type 1 diabetes
Morningness
Follicle stimulating hormone levels
Follicle stimulating hormone in healthy women
Luteinizing hormone levels in healthy women
Spontaneous coronary artery dissection
Thrombin-induced platelet aggregation
Migraine and/or pulse pressure
Migraine with aura and/or diastolic blood pressure
Migraine with aura and/or systolic blood pressure
Migraine with aura and/or pulse pressure
Migraine without aura and/or diastolic blood pressure
Migraine without aura and/or systolic blood pressure
Migraine without aura and/or pulse pressure
Migraine and/or diastolic blood pressure
Migraine and/or systolic blood pressure
CV-A6-associated hand, foot, and mouth disease (severe vs mild)
Anthracycline-induced cardiotoxicity in early breast cancer
Estrogen level change in anastrozole-treated breast cancer
Pelvic organ prolapse
Suicide attempts
Deliberate self-harm
Plasma selenium concentration
Response to selenium supplementation (change in plasma selenium concentration)
Trauma exposure in major depressive disorder-negative individuals
Creatine kinase levels
Creatine kinase levels in statin users
Creatine kinase levels in off-statin users
Lactate dehydrogenase levels in statin users
Lactate dehydrogenase levels in off-statin users
White matter microstructure (axial diusivities)
FEV1
Brain region volumes
Thyroxine levels
Triiodothyronine levels
Triiodothyronine/thyroxine ratio
Cortical thickness
Adult diffuse glioma (IDH mutation)
Adult diffuse glioma (IDH wildtype)
Adult diffuse glioma (IDH mutation, 1p/19q codeletion)
Adult diffuse glioma (IDH mutation, 1p/19q non-codeleted)
Adult diffuse triple positive glioma (IDH and TERT mutations, 1p19q codeletion)
Adult diffuse glioma (IDH mutation only)
Adult diffuse glioma (TERT mutation only)
Sweet taste preference
Behcet's disease
Response to antiepileptic mood-stabilizing treatment in bipolar disorder
Left ventricular end-diastolic volume
Left ventricular end-systolic volume
Left ventricular ejection fraction
Acute anterior uveitis in ankylosing spondylitis
Chronic hepatitis B infection
Adenosine Deaminase levels
CCL23 levels
CCL25 levels
CD40 levels
CD6 levels
Cystatin D levels
CXCL5 levels
CXCL6 levels
Fibroblast growth factor 5 levels
Interleukin-10 receptor B levels
Interleukin-12 subunit B levels
interleukin 15 receptor subunit alpha levels
interleukin-18 receptor 1 levels
Monocyte chemoattractant protein-4 levels
Matrix metalloproteinase levels
Matrix metalloproteinase-10 levels
Tumor necrosis factor ligand superfamily member 12 levels
Platelet reactivity in response to clopidogrel treatment
Diabetic neuropathy in type 2 diabetes
Macrovascular complications in type 2 diabetes
Ophthalmic complications in type 2 diabetes
Cardiovascular death or myocardial infarction in response to clopidogrel treatment
Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment
Stent thrombosis in response to clopidogrel treatment
Caffeine consumption from tea
Caffeine consumption from coffee or tea
Caffeine consumption from coffee
Opioid exposure
Obese vs. thin
Obesity (extreme)
Normal body mass index vs. thin
Autism spectrum disorder (MTAG)
Cognitive function in depression
Cognitive impairment in depression
Cognitive decline in depression
Bipolar disorder (MTAG)
Brain amyloid deposition (PET imaging)
Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis)
Schizophrenia (MTAG)
Preeclampsia (fetal genotype effect)
Preeclampsia (maternal genotype effect)
Leg fat mass (lean adjusted)
Leg lean mass (fat adjusted)
Leg fat mass and leg lean mass (pleiotropy)
Tau burden
Attention deficit hyperactivity disorder (MTAG)
Lung cancer (survival time) in never smokers
Lung adenocarcinoma (survival time) in never smokers
L-selectin levels
HDL cholesterol x physical activity interaction (2df test)
Parkinson's disease in GBA mutation carriers
Serum total polyunsaturated fatty acid concentration in metabolic syndrome
Serum docosahexaenoic fatty acid concentration in metabolic syndrome
Serum linoleic acid concentration in metabolic syndrome
Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome
Serum omega-6 polyunsaturated fatty acid concentration in metabolic syndrome
Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome
Serum polyunsaturated fatty acid concentration x Mediterranean diet adherence interaction in metabolic syndrome
Serum metabolite levels (CMS)
Memory decline
Lifetime anxiety disorder
Anxiety symptoms
Opioid use cessation
Cervical cancer (MTAG)
Fasting total cholesterol in HDL2
Fasting total cholesterol in HDL3
Fasting total cholesterol in HDL
Fasting mean diameter of HDL particles
Fasting triglycerides in HDL
Postprandial mean diameter of VLDLD particles
Fasting docosahexaenoic acid (22:6)
Fasting esterified cholesterol
Fasting estimated description of fatty acid chain length (not actual carbon number)
Fasting omega-3 fatty acids
Fasting omega-6 fatty acids
Fasting free cholesterol
Fasting glucose
Fasting glutamine
Fasting glycoprotein acetyls (mainly a1-acid glycoprotein)
Axial length
Axial length or spherical error (univariate decomposition analysis)
Fasting total lipids in medium HDL
Fasting medium HDL particle concentration
Fasting phospholipid levels in medium HDL
Fasting triglycerides levels in medium HDL
Fasting total cholesterol in medium LDL
Fasting cholesterol esters in medium LDL
Fasting phospholipid levels in medium LDL
Fasting triglycerides levels in medium LDL
Fasting monounsaturated fatty acids (16:1, 18:1)
Fasting total cholesterol in medium VLDL
Fasting cholesterol esters in medium VLDL
Fasting free cholesterol in medium LDL
Fasting total lipids in medium LDL
Fasting medium LDL particle concentration
Non-small cell lung cancer
Fasting free cholesterol in small VLDL
Fasting total lipids in small VLDL
Fasting small VLDL particle concentration
Fasting phospholipid levels in small VLDL
Fasting triglycerides levels in small VLDL
Postprandial total cholesterol in HDL
Postprandial mean diameter of HDL particles
Postprandial triglycerides in HDL
Postprandial total cholesterol in IDL
Postprandial cholesterol esters in IDL
Postprandial IDL particle concentration
Postprandial phospholipid levels in IDL
Postprandial triglycerides levels in IDL
Postprandial isoleucine
Postprandial linoleic acid (18:2)
Postprandial free cholesterol in IDL
Postprandial total lipids in IDL
Postprandial triglycerides levels in medium HDL
Postprandial total cholesterol in medium LDL
Postprandial cholesterol esters in medium LDL
Postprandial free cholesterol in medium LDL
Postprandial total lipids in medium LDL
Postprandial medium LDL particle concentration
Postprandial phospholipid levels in medium LDL
Postprandial triglycerides levels in medium LDL
Opioid dependence x sex interaction
Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)
Myopia (age of diagnosis)
Spherical equivalent or myopia (age of diagnosis)
Postprandial cholesterol esters in small HDL
Postprandial free cholesterol in small HDL
Postprandial total lipids in small HDL
Postprandial small HDL particle concentration
Postprandial phospholipid levels in small HDL
Postprandial triglycerides levels in small HDL
Postprandial total cholesterol in small LDL
Menstruation quality of life impact (stiff neck)
Vaginal discharge (itching)
Vaginal discharge (metrorrhagia)
Vaginal discharge (smell)
Postprandial cholesterol esters in small LDL
Postprandial free cholesterol in small LDL
Postprandial total lipids in small LDL
Postprandial small LDL particle concentration
White matter microstructure (mean diusivities)
Ewing sarcoma
Low tan response
Non-melanoma skin cancer
Penicillin allergy
Urinary calcium excretion
Urinary magnesium excretion
Urinary uric acid excretion
Alzheimer's disease (onset between ages 58 and 79)
Urinary volume
Reading disability
Basophil count
Nonatopic asthma
Atopic asthma
Household income (MTAG)
Change in serum metabolite levels
Change in serum metabolite levels (CMS)
Stimulated adipocyte lipolysis
Postprandial total cholesterol in LDL
Postprandial mean diameter of LDL particles
Postprandial triglycerides in LDL
Postprandial leucine
Postprandial total cholesterol in large HDL
Postprandial cholesterol esters in large HDL
Postprandial free cholesterol in large HDL
Postprandial total lipids in large HDL
Postprandial large HDL particle concentration
Postprandial phospholipid levels in large HDL
Postprandial triglycerides levels in large HDL
Postprandial total cholesterol in large LDL
Postprandial medium VLDL particle concentration
Postprandial phospholipid levels in medium VLDL
Postprandial triglycerides levels in medium VLDL
Postprandial phosphatidylcholine and other cholines
Postprandial phenylalanine
Postprandial polyunsaturated fatty acids
Glycosuria in pregnancy (maternal genotype effect)
Glycosuria in pregnancy (offspring genotype effect)
Glycosuria in pregnancy (maternal and offspring genotype effect)
Huntington's disease (age at onset)
Lactose tolerance test
Self-reported risk-taking behaviour
Smoking status (ever vs never smokers)
Rosacea symptom severity
Electroencephalogram traits
Spontaneous adipocyte lipolysis
Red blood cell traits (multivariate analysis)
Frontotemporal dementia with GRN mutation (age at onset)
Memory dysfunction in frontotemporal lobe dementia
Language impairment in frontotemporal lobe dementia
Parkinsonism in frontotemporal lobe dementia
Frontotemporal dementia
Postprandial cholesterol esters in large LDL
Postprandial free cholesterol in large LDL
Postprandial total lipids in large LDL
Cognitive decline (age-related)
Hirschsprung disease
Postprandial monounsaturated fatty acids (16:1, 18:1)
Postprandial total cholesterol in medium VLDL
Postprandial cholesterol esters in medium VLDL
Postprandial free cholesterol in medium VLDL
Postprandial total lipids in medium VLDL
Exacerbations requiring hospitalisation in asthma
White matter integrity (fractional anisotropy)
White matter integrity (mean diffusivity)
White matter hyperintensity volume
Postprandial triglycerides levels in small VLDL
Postprandial total cholines
Postprandial total fatty acids
Postprandial total phosphoglycerides
Postprandial tyrosine
Postprandial estimated degree of unsaturation
Postprandial valine
Postprandial total cholesterol in VLDL
Cholesterol esters in chylomicron and extremely large VLDL meal response (LMM)
Tyrosine meal response (LMM)
Lactate meal response (LMM)
Valine meal response (LMM)
Phospholipid levels in very large VLDL meal response (LMM)
Histidine meal response (LMM)
Disease free survival in colon cancer
Survival in colon cancer
Mucinous adenocarcinoma in colorectal cancer
Serum folate levels
Lung cancer x radon exposure interaction (1df)
Cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional vitamin use interaction (parent of origin effect)
Accrued duration of remission in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
Frequency of relapse in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
Average oral glucocorticoid dose in mepolizumab-treated eosinophilic granulomatosis with polyangiitis
Insulin-related traits (multivariate analysis)
Behavioural changes in frontotemporal lobe dementia
Frontotemporal dementia with GRN mutation
Postprandial cholesterol esters in large VLDL
Postprandial free cholesterol in large VLDL
Postprandial total lipids in large VLDL
Postprandial large VLDL particle concentration
Postprandial phospholipid levels in large VLDL
Postprandial triglycerides levels in large VLDL
Postprandial large LDL particle concentration
Postprandial phospholipid levels in large LDL
Postprandial triglycerides levels in large LDL
Postprandial total cholesterol in large VLDL
Menstruation quality of life impact (acne)
Menstruation quality of life impact (aggressiveness)
Menstruation quality of life impact (increased appetite)
Menstruation quality of life impact (bowel movement)
Menstruation quality of life impact (depression)
Menstruation quality of life impact (edema)
Menstruation quality of life impact (headache)
Menstruation quality of life impact (joint pain)
Menstruation quality of life impact (loss of concentration)
Menstruation quality of life impact (nervousness)
Menstruation quality of life impact (pressure in breast)
Menstruation quality of life impact (sleepiness)
Dysmenorrheic pain severity
Menstruation quality of life impact (dysmenorrhea)
Pain medicine use during menstruation
Menstruation quality of life impact (fever)
Heavy vaginal discharge
Postprandial remnant cholesterol
Postprandial serum total cholesterol
Postprandial serum total triglycerides
Postprandial saturated fatty acids
Postprandial total cholesterol in small HDL
Cannabis use (age at onset)
Systolic blood pressure night-to-day ratio in hypertension
Diastolic blood pressure night-to-day ratio in hypertension
Type 1 diabetes in high risk HLA genotype individuals (time to event)
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
Freckles
Double-edged eyelids
Thick vs thin eyebrows
Straight vs curly hair
Excessive hairiness
Excessive sweating
Age spots
Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease
Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase  (TPOAb) levels)
Postprandial omega-6 fatty acids
Postprandial free cholesterol
Postprandial glutamine
Postprandial glycoprotein acetyls (mainly a1-acid glycoprotein)
Postprandial total cholesterol in HDL2
Postprandial total cholesterol in HDL3
Basal ganglia growth
White matter growth
Cerebellum growth
Cerebral cortical growth
Right lateral prefrontal cortical growth
Plasma neurofilament light levels
Spherical equivalent
Optic nerve head parameters (multi-trait analysis)
Intraocular pressure and central corneal thickness (multi-trait analysis)
Postprandial total cholesterol in medium HDL
Postprandial cholesterol esters in medium HDL
Postprandial free cholesterol in medium HDL
Postprandial total lipids in medium HDL
Postprandial medium HDL particle concentration
Postprandial phospholipid levels in medium HDL
Postprandial total cholesterol in small VLDL
Postprandial cholesterol esters in small VLDL
Postprandial free cholesterol in small VLDL
Postprandial total lipids in small VLDL
Postprandial small VLDL particle concentration
Postprandial phospholipid levels in small VLDL
Postprandial phospholipid levels in small LDL
Postprandial triglycerides levels in small LDL
Postprandial sphingomyelins
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement
Delta-6 desaturase activity response to n3-polyunsaturated fat supplement
Neuromyelitis optica
Neuromyelitis optica (AQP4-IgG-positive)
Cerebrospinal fluid α-synuclein levels
Coronary artery disease in diabetes
Alzheimer's disease (onset at age over 80)
Meningioma
Myocardial infarction
NASH resolution in nonalcoholic steatohepatitis
Pruritus in nonalcoholic steatohepatitis
Fibrosis improvement in nonalcoholic steatohepatitis
Cryptosporidiosis
Heel bone mineral density (MTAG)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-30 minutes)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-120 minutes)
Glucagon levels in response to oral glucose tolerance test (30 minutes)
Smoking initiation
Childhood body mass index
Plasma free amino acid levels
Cirrhosis
Triglycerides x physical activity interaction (2df test)
LDL cholesterol x physical activity interaction (1df test)
HDL cholesterol x physical activity interaction (1df test)
Eye color (saturation)
Eye color
Hair color
Eye color (brightness)
Total body bone mineral density (MTAG)
Cotinine and 3'-hydroxycotinine levels in current smokers
Smoking intensity (cotinine levels/cigarettes per day)
Cotinine levels in current smokers
Postprandial very large HDL particle concentration
Postprandial phospholipid levels in very large HDL
Postprandial triglycerides levels in very large HDL
Postprandial total cholesterol in very large VLDL
Fasting acetate
Fasting alanine
Fasting apolipoprotein A-I
Fasting apolipoprotein B
Fasting 3-hydroxybutyrate
Fasting citrate
Postprandial triglycerides in VLDL
Postprandial total cholesterol in very large HDL
Postprandial cholesterol esters in very large HDL
Postprandial free cholesterol in very large HDL
Postprandial total lipids in very large HDL
Acute respiratory distress syndrome in sepsis
Short-term memory (visuospatial task)
Long-term memory (delayed word recall task)
Prostate cancer (early onset)
Fasting phospholipid levels in IDL
Fasting triglycerides levels in IDL
Fasting isoleucine
Fasting linoleic acid (18:2)
Fasting lactate
Fasting total cholesterol in LDL
Fasting free cholesterol in IDL
Fasting total lipids in IDL
Fasting IDL particle concentration
Alcohol-associated liver disease in non drinkers
Age at loss of ambulation in Duchenne muscular dystrophy
Fasting free cholesterol in medium VLDL
Fasting total lipids in medium VLDL
Fasting medium VLDL particle concentration
Fasting phospholipid levels in medium VLDL
Fasting triglycerides levels in medium VLDL
Fasting serum total cholesterol
Fasting serum total triglycerides
Fasting saturated fatty acids
Fasting total cholesterol in small HDL
Fasting cholesterol esters in small HDL
Fasting free cholesterol in small HDL
Fasting total lipids in small HDL
Fasting small HDL particle concentration
Fasting phospholipid levels in small HDL
Fasting phosphatidylcholine and other cholines
Fasting phenylalanine
Fasting polyunsaturated fatty acids
Fasting remnant cholesterol
Fasting very large HDL particle concentration
Fasting phospholipid levels in very large HDL
Fasting triglycerides levels in very large HDL
Fasting total cholesterol in very large VLDL
Fasting cholesterol esters in very large VLDL
Fasting free cholesterol in very large VLDL
Fasting total lipids in very large VLDL
Fasting very large VLDL particle concentration
Fasting phospholipid levels in very large VLDL
Fasting triglycerides levels in very large VLDL
Fasting total cholesterol in very small VLDL
Fasting cholesterol esters in very small VLDL
Response to statins (LDL cholesterol percent change)
Low density lipoprotein cholesterol levels (on statin treatment)
Response to statins (LDL cholesterol change)
Plasma free amino acid levels (adjusted for one other PFAA)
Smoking status (current vs mixed)
Maternal nondisjunction of chromosome 21 (mothers vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs fathers)
Maternal nondisjunction of chromosome 21 (MII error vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs MII error)
Hepatocellular carcinoma in hepatitis B infection
Severe aplastic anemia
Response to antidepressants (non-treatment-resistant vs treatment-resistant depression)
Response to SSRI (responders vs non-responders)
Postprandial cholesterol esters in very large VLDL
Postprandial free cholesterol in very large VLDL
Postprandial total lipids in very large VLDL
Postprandial very large VLDL particle concentration
Postprandial phospholipid levels in very large VLDL
Postprandial triglycerides levels in very large VLDL
Postprandial total cholesterol in very small VLDL
Postprandial cholesterol esters in very small VLDL
Postprandial cholesterol esters in chylomicrons and extremely large VLDL
Postprandial free cholesterol in chylomicrons and extremely large VLDL
Postprandial total lipids in chylomicrons and extremely large VLDL
Postprandial chylomicrons and extremely large VLDL particle concentration
Postprandial phospholipid levels in chylomicrons and extremely large VLDL
Postprandial triglycerides levels in chylomicrons and extremely large VLDL
Docosahexaenoic acid (22:6) meal response (OrNLSr)
Free cholesterol meal response (OrNLSr)
Glucose meal response (OrNLSr)
Histidine meal response (﻿OrNLSr)
Triglycerides levels in IDL meal response (﻿OrNLSr)
Triglycerides in LDL meal response (OrNLSr)
Triglycerides levels in medium LDL meal response (﻿OrNLSr)
Free cholesterol in small HDL meal response (﻿OrNLSr)
Total cholesterol in small LDL meal response (﻿OrNLSr)
Cholesterol esters in small LDL meal response (﻿OrNLSr)
Free cholesterol in very large HDL meal response (﻿OrNLSr)
Total cholesterol in very large VLDL meal response (﻿OrNLSr)
Cholesterol esters in very large VLDL meal response (﻿OrNLSr)
Free cholesterol in very large VLDL meal response (﻿OrNLSr)
Total cholesterol in chylomicron and extremely large VLDL meal response (﻿OrNLSr)
Cholesterol esters in chylomicron and extremely large VLDL meal response (﻿OrNLSr)
Free cholesterol in chylomicron and extremely large VLDL meal response (﻿OrNLSr)
Total lipids in chylomicrons and extremely large VLDL meal response (﻿OrNLSr)
Chylomicron and extremely large VLDL particle concentration meal response (﻿OrNLSr)
Phospholipid levels in chylomicrons and extremely large VLDL meal response (﻿OrNLSr)
Triglycerides levels in chylomicrons and extremely large VLDL meal response (﻿OrNLSr)
Triglycerides levels in medium HDL meal response (LMM)
Triglycerides levels in small HDL meal response (LMM)
Citrate meal response (LMM)
Total cholesterol in very large HDL meal response (LMM)
Free cholesterol in very large HDL meal response (LMM)
Total lipids in very large HDL meal response (LMM)
Cholesterol esters in very large HDL meal response (LMM)
Glycoprotein acetyls (mainly a1-acid glycoprotein) meal response (LMM)
Glucose meal response (LMM)
Postprandial very small VLDL particle concentration
Postprandial phospholipid levels in very small VLDL
Postprandial triglycerides levels in very small VLDL
Postprandial total cholesterol in chylomicrons and extremely large VLDL
Postprandial free cholesterol in very small VLDL
Postprandial total lipids in very small VLDL
Bipolar disorder or major depressive disorder
Dermatomyositis or juvenile dermatomyositis
Polymyositis
Idiopathic inflammatory myopathy
Fasting cholesterol esters in large HDL
Fasting free cholesterol in large HDL
Fasting total lipids in large HDL
Fasting large HDL particle concentration
LDL cholesterol x physical activity interaction (2df test)
Cutaneous malignant melanoma
Longitudinal brain connectivity change (Louvain modularity)
Longitudinal brain connectivity change (transitivity)
Longitudinal brain connectivity change (global efficiency)
Longitudinal brain connectivity change (characteristic path length)
Green tea consumption
Milk consumption
Yoghurt consumption
Natto consumption
Tofu consumption
Response to serotonin-norepinephrine reuptake inhibitors (responders vs non-responders)
Response to norepinephrine-dopamine reuptake inhibitors (responders vs non-responders)
Fish intake frequency
Small whole fish consumption
Ovarian cancer (MTAG)
Endometrial cancer (MTAG)
Gynecologic disease
Ovarian cancer
Airflow obstruction in ever smokers
Fasting phospholipid levels in large HDL
Fasting triglycerides levels in large HDL
Fasting total cholesterol in large LDL
Fasting cholesterol esters in large LDL
Fasting free cholesterol in large LDL
Fasting total lipids in large LDL
Fasting large LDL particle concentration
Serum creatinine levels
Glycemic traits (multi-trait analysis)
Fasting total cholines
Fasting total fatty acids
Fasting total phosphoglycerides
Fasting tyrosine
Fasting estimated degree of unsaturation
Fasting valine
Fasting total cholesterol in VLDL
Obstructive sleep apnea trait (apnea hypopnea index, change over time)
Plasma free proline levels
Plasma free asparagine levels
Smoking cessation
Cigarettes smoked per day (current)
Cigarettes smoked per day (past)
Smoking status (current vs never)
Eye color (hue)
Skin, hair and eye pigmentation (multivariate analysis)
Uterine fibroids
Uterine fibroids (MTAG)
Alcohol consumption (heavy vs. light/non-drinkers)
Prostate cancer (advanced)
Gynecologic disease (multivariate analysis)
Fasting histidine
Fasting total cholesterol in IDL
Fasting cholesterol esters in IDL
Alcohol-associated liver disease in light drinkers
Alcohol-associated liver disease in heavy drinkers
Fasting triglycerides levels in small HDL
Fasting total cholesterol in small LDL
Fasting cholesterol esters in small LDL
Fasting free cholesterol in small LDL
Fasting total lipids in small LDL
Fasting small LDL particle concentration
Fasting phospholipid levels in small LDL
Coronary heart disease
Diabetes mellitus
Blood glucose levels
Circulating odd-numbered chain saturated fatty acid levels (C15:0)
Circulating odd-numbered chain saturated fatty acid levels (C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C19:0)
Cephalic index
Maximum cranial width
Circulating odd-numbered chain saturated fatty acid levels (C23:0)
Fasting total cholesterol in chylomicrons and extremely large VLDL
Fasting cholesterol esters in chylomicrons and extremely large VLDL
Fasting free cholesterol in chylomicrons and extremely large VLDL
Fasting total lipids in chylomicrons and extremely large VLDL
Fasting chylomicrons and extremely large VLDL particle concentration
Fasting phospholipid levels in chylomicrons and extremely large VLDL
Fasting triglycerides levels in chylomicrons and extremely large VLDL
Postprandial apolipoprotein A-I
Postprandial apolipoprotein B
Fasting very small VLDL particle concentration
Fasting phospholipid levels in very small VLDL
Fasting triglycerides levels in very small VLDL
Fasting free cholesterol in very small VLDL
Fasting total lipids in very small VLDL
Response to ketogenic dietary therapies in epilepsy
Executive function in ADHD
Nevus count or cutaneous melanoma
Blood protein levels in cardiovascular risk
Head and neck squamous cell carcinoma
Cerebrospinal fluid neurofilament light levels
Opioid use disorder
Endometriosis (MTAG)
Midgestational total 25-hydroxyvitamin D levels (maternal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (maternal genetic effect)
Midgestational total 25-hydroxyvitamin D levels (fetal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (fetal genetic effect)
Allergic rhinitis
Allergic sensitization
Fasting mean diameter of LDL particles
Fasting triglycerides in LDL
Fasting leucine
Fasting total cholesterol in large HDL
Complete remission in asthma
Fasting triglycerides levels in small LDL
Fasting sphingomyelins
Fasting total cholesterol in small VLDL
Fasting cholesterol esters in small VLDL
Maximum cranial length
Cutaneous melanoma or hair colour
Activity variability during wake
Sleep duration (< 5 hours)
Sleep duration (> 10 hours)
Sleep start time
Sleep end time
Sleep (1-day periodicity)
Sleep (1/2-day periodicity)
Sleep (1/3-day periodicity)
Sleep activity levels
Fasting phospholipid levels in large LDL
Fasting triglycerides levels in large LDL
Fasting total cholesterol in large VLDL
Fasting cholesterol esters in large VLDL
Fasting free cholesterol in large VLDL
Fasting total lipids in large VLDL
Fasting large VLDL particle concentration
Fasting phospholipid levels in large VLDL
Fasting triglycerides levels in large VLDL
Fasting total cholesterol in medium HDL
Fasting cholesterol esters in medium HDL
Fasting free cholesterol in medium HDL
Fasting mean diameter of VLDLD particles
Fasting triglycerides in VLDL
Fasting total cholesterol in very large HDL
Fasting cholesterol esters in very large HDL
Fasting free cholesterol in very large HDL
Fasting total lipids in very large HDL
Nonunion in individuals with fractures
Current cigarettes per day in chronic obstructive pulmonary disease
Diabetic macular edema in type 2 diabetes
Proliferative diabetic retinopathy in type 2 diabetes
Postprandial 3-hydroxybutyrate
Postprandial citrate
Postprandial conjugated linoleic acid
Postprandial docosahexaenoic acid (22:6)
Postprandial esterified cholesterol
Postprandial estimated description of fatty acid chain length (not actual carbon number)
Postprandial omega-3 fatty acids
Depressed affect
Serum alpha-fetoprotein levels
Serum carcinoembryonic antigen levels
Serum cancer antigen 15.3 levels
Serum cancer antigen 19.9 levels
Serum cancer antigen 125 (CA 125) levels
Serum alkaline phosphatase levels
Worry
Hay fever and/or eczema
Weight gain in amisulpride-treated first-episode psychosis
End stage renal disease x APOL1 genotype interaction
End stage renal disease in APOL1 risk genotype-negative individuals
End-stage renal disease
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection
Ocular sarcoidosis
Intracranial aneurysm
Ocular sarcoidosis in sarcoidosis
Elevated fasting plasma glucose
Major depressive disorder in trauma exposed individuals
Major depressive disorder in trauma-unexposed individuals
Uric acid levels
Crohn's disease or systemic sclerosis
Modic changes
Insomnia symptoms (never/rarely vs. sometimes/usually)
Insomnia symptoms (never/rarely vs. usually)
Autism and major depressive disorder (MTAG)
Dietary macronutrient intake
Arsenic metabolism
Crohn's disease (time to progression)
Crohn's disease (time to first abdominal surgery)
Crohn's disease (indolent vs progressive)
Urine 6-bromotryptophan levels in chronic kidney disease
Trauma exposure
Bladder cancer
Depression
Cerebrospinal fluid beta-site APP cleaving enzyme levels
Tourette syndrome
Eczema
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Household income
Anti-chlamydia trachomatis IgG seropositivity
Café-au-lait macule number in neurofibromatosis type1
Autism and schizophrenia (MTAG)
Autism and educational attainment (MTAG)
Endometriosis or migraine
Meconium ileus in cystic fibrosis
Clozapine-induced myocarditis in schizophrenia
Breast cancer (progesterone-receptor positive)
Osteoarthritis of the hand
Lean mass index
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function
Thyroid volume in Hashimoto’s thyroiditis
Osteoporosis-related phenotypes (MTAG)
Refractory celiac disease type II
Drug-induced liver injury in interferon-beta-treated multiple sclerosis
Thiopurine-induced myelosuppression in inflammatory bowel disease
Recurrence of Clostridium difficile infection x bezlotuxumab treatment interaction (2df test)
Serum urea levels
Trauma exposure in major depressive disorder
Chronic rhinosinusitis
Nasal polyps
Drug-induced liver injury (flucloxacillin)
Time to aseptic loosening in total joint arthroplasty
Aseptic loosening in total joint arthroplasty
Aortic valve stenosis
Polycystic ovary syndrome (reproductive subtype)
Polycystic ovary syndrome (metabolic subtype)
Polycystic ovary syndrome (indeterminate subtype)
Acute cholecystitis
Alzheimer's disease or HDL levels (pleiotropy)
World class endurance athleticism
Childhood onset systemic lupus erythematosus
Calcific aortic valve stenosis
Lactate dehydrogenase levels
Postoperative myocardial infarction after cardiac surgery
Postoperative stroke after cardiac surgery
Postoperative acute renal failure after cardiac surgery
Postoperative atrial fibrillation after cardiac surgery
Postoperative delirium after cardiac surgery
Postoperative complication after cardiac surgery
Depressive symptoms x herpes simplex 1 infection interaction
Depression x herpes simplex 1 infection interaction
Alzheimer's disease or fasting glucose levels (pleiotropy)
Alzheimer's disease or fasting insulin levels (pleiotropy)
Systolic blood pressure x educational attainment (some college) interaction (2df)
Systolic blood pressure x educational attainment (graduated college) interaction (2df)
Diastolic blood pressure x educational attainment (some college) interaction (2df)
Diastolic blood pressure x educational attainment (graduated college) interaction (2df)
Mean arterial pressure x educational attainment (some college) interaction (2df)
Mean arterial pressure x educational attainment (graduated college) interaction (2df)
Pulse pressure x educational attainment (some college) interaction (2df)
Benign childhood epilepsy with centro-temporal spikes
First year height change in growth hormone-treated short stature
Adverse response to inhaled corticosteroid treatment x age interaction in asthma
Parkinson's disease progression (composite)
Percent liver fat
Arterial stiffness (carotid-femoral pulse wave velocity)
Arterial stiffness (brachial-femoral pulse wave velocity)
Arterial stiffness (brachial-ankle pulse wave velocity)
Triglyceride levels in HIV infection
White matter hyperintensity volume x hypertension interaction (2df)
Homeostasis model assessment of insulin resistance
LDL cholesterol levels in HIV infection
Septic shock (28-day mortality)
Septic shock resolution
Septic shock
White matter hyperintensity volume (adjusted for hypertension)
HDL cholesterol levels in HIV infection
Distal/Left-sided colorectal cancer
Proximal colorectal cancer
Distal colorectal cancer
Rectal cancer
White matter microstructure (mode of anisotropy)
Problematic alcohol use (MTAG)
Total carotid plaque area (excess vs minimal atherosclerosis)
Major depressive disorder (lifetime)
Help-seeking from a GP
Help-seeking from a psychiatrist
Help-seeking from a GP (without major depressive disorder symptoms)
Severe COVID-19 infection with respiratory failure (analysis I)
Severe COVID-19 infection with respiratory failure (analysis II)
Parkinson's disease progression (motor)
Parkinson's disease progression (cognitive)
Liver fat content (MRI proton density fat fraction measure)
Liver fibrosis and steatohepatitis severity (MRI cT1 measure)
Hip bone mineral content accrual during adolescent growth spurt
Peak hip bone mineral content
Parental lifespan
Tumor necrosis factor levels
CDH6 protein levels in plasma
Myocardial fractal dimension (slice 2)
Myocardial fractal dimension (slice 5)
Myocardial fractal dimension (slice 3)
Myocardial fractal dimension (slice 4)
Myocardial fractal dimension (slice 6)
Myocardial fractal dimension (slice 7)
Myocardial fractal dimension (slice 8)
Myocardial fractal dimension (slice 9)
Alcohol use disorder
Early-onset ischemic stroke
Vaginal microbiome composition (L. iners)
Vaginal microbiome composition (G. vaginalis)
Vaginal microbiome composition (Shannon diversity index)
Vaginal microbiome composition (community state type)
Vaginal microbiome composition (L. crispatus)
Alcohol consumption (drinks per week) (MTAG)
Pancreatic beta-cell glucose sensitivity
Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)
Intracranial volume
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)
Attention deficit hyperactivity disorder or putamen volume (pleiotropy)
Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)
Glucocorticoid receptor gene expression in B-cell precursor acute lymphoblastic leukaemia
prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia
dexamethasone sensitivity in B-cell precursor acute lymphoblastic leukaemia
Gut microbiota (bacterial taxa, hurdle binary method)
Thrombosis in response to liver transplant
Problematic alcohol use
Facial morphology traits (59 NSCL/P endophenotypic segments)
White matter microstructure (fractional anisotropy)
Combined resilience (covariance of educational attainment with residual cognitive resilience)
Residual cognitive resilience
circulating leptin levels
Neonatal white matter microstructure
Sporadic miscarriage
Multiple consecutive miscarriage
circulating leptin levels adjusted for BMI
Serum C-reactive protein concentration
Serum C-reactive protein concentration in non-obese individuals
Serum C-reactive protein concentration in obesity
Serum C-reactive protein concentration in inactive individuals
Serum C-reactive protein concentration in low fat diet
Serum C-reactive protein concentration in high fat diet
Serum C-reactive protein concentration in visceral obesity (waist-hip ratio)
Serum C-reactive protein concentration in visceral obesity (waist circumference)
Serum interleukin-6 concentration
Serum interleukin-6 concentration in non-visceral-obese individuals
Serum interleukin-6 concentration in high fat diet
Serum interleukin-6 concentration in active individuals
Theta EEG coherence
Long QT syndrome
Aspartate aminotransferase to alanine aminotransferase ratio x alcohol consumption interaction
High myopia
Multiple severe cisplatin-induced neurotixicitiies in testicular cancer survivors
Shoulder impingement syndrome
Autoimmune traits
Mental disorder (without autoimmune disease)
Autoimmune disease and mental disorder
Deep white matter hyperintensities
Periventricular white matter hyperintensities
Physical aggression in schizophrenia
Verbal aggression in schizophrenia
vWF levels
Factor VIII levels
Adventurousness
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Automobile speeding propensity
Type 2 diabetes (adjusted for BMI)
Ebbinghaus illusion (overestimation)
OTU97_74 (Alistipes) abundance
OTU97_8 (Ruminococcaceae) abundance
OTU97_80 (Ruminococcus) abundance
OTU97_86 (Phascolarctobacterium) abundance
OTU97_9 (Alistipes) abundance
OTU97_95 (Cytophagales) abundance
Glaucoma
Glaucoma (multi-trait analysis)
Adiponectin levels
OTU99_132 (Bacteroidales) abundance
OTU99_137 (Ruminococcus) abundance
OTU99_140 (Desulfovibrio) abundance
Corneal resistance factor
Corneal hysteresis
Voxel-wise structural brain imaging measurements in Alzheimer’s disease
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Acne (severe)
Red vs. brown/black hair color
Blond vs. brown/black hair color
Alloimmunization response to red blood cell transfusion in sickle cell anemia
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Fat-free mass
Cocaine use disorder
Cocaine use disorder x non-traditional parental care interaction
Cocaine use disorder x change in residence interaction
Cocaine use disorder x household tobacco use interaction
Brown vs. black hair color
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
LDL cholesterol levels in current smokers
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
LDL cholesterol levels in ever smokers
LDL cholesterol levels in never smokers
Diastolic blood pressure response to chlorthalidone in hypertension
Platelet reactivity measurement (collagen-ADP)
Platelet reactivity measurement (collagen-epinephrine)
Schizoaffective disorder-bipolar type
Mosaic loss of chromosome Y (Y chromosome dosage)
Age-related cognitive decline (memory) (slope of z-scores)
Age-related cognitive decline (visuospatial skill) (slope of z-scores)
Age-related cognitive decline (attention/processing speed) (slope of z-scores)
Age-related cognitive decline (global cognition) (slope of z-scores)
Age-related cognitive decline (executive function) (slope of z-scores)
Age-related cognitive decline (language) (slope of z-scores)
Epigenetic age acceleration in alcohol use disorder
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)
Triglyceride levels in non smokers
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)
Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)
Subpleural-predominant interstitial lung abnormalities
Interstitial lung abnormalities
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
Hematological and biochemical traits
Physiological traits
Lung function
Cholesterol
vWF and FVIII levels
Handedness (non-right-handed vs right-handed)
Handedness (Left-handed vs. non-left-handed)
Handedness (left-handed vs. right-handed)
Trastuzumab-induced cardiotoxicity in cancer
Vertical cup-disc ratio (multi-trait analysis)
Machado-Joseph disease (age at onset)
TPE interval (resting)
OTU99_110 (Clostridiales) abundance
OTU99_116 (Sutterella) abundance
OTU99_12 (Bacteroides) abundance
OTU99_106 (Barnesiella) abundance
OTU99_108 (Cytophagales) abundance
OTU99_11 (Parabacteroides) abundance
OTU97_97 (Clostridiales) abundance
OTU99_1 (Bacteroides) abundance
Chronic postoperative pain
OTU99_150 (Prevotella) abundance
OTU99_155 (Butyrivibrio) abundance
OTU99_123 (Phascolarctobacterium) abundance
OTU99_124 (Paraprevotella) abundance
OTU99_13 (Subdoligranulum) abundance
OTU99_120 (Ruminococcaceae) abundance
OTU99_121 (Ruminococcaceae) abundance
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
Severe gastric atrophy
Pepsinogen I/II ratio
Gastric atrophy
Pancreatic ductal adenocarcinoma
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Hypotension and cognitive impairment
Cytokine levels
Cytokine network levels (multivariate analysis)
Age of smoking initiation
B6 vitamer levels (multivariate analysis)
Cerebrospinal fluid pyridoxal phosphate levels
Plasma pyridoxal phosphate levels
Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxic acid to pyridoxal phosphate ratio
Vertical cup-disc ratio (adjusted for vertical disc diameter)
Ebbinghaus illusion (underestimation)
TPE interval (response to exercise)
TPE interval (recovery after exercise)
Intracerebral hemorrhage
Temporomandibular joint disorder
OTU99_171 (Bacteroides) abundance
OTU99_197 (Bacteroides) abundance
OTU99_2 (Bacteroides) abundance
OTU99_21 (Parasutterella) abundance
OTU99_166 (Prevotella) abundance
OTU99_17 (Parabacteroides) abundance
OTU99_157 (Barnesiella) abundance
OTU99_16 (Faecalibacterium) abundance
Triglyceride levels in current drinkers
Sphingomyelin levels
Balding type 1
Change in neurofilament light levels
Verbal cognitive ability
Numerical cognitive ability
Figural/spatial cognitive ability
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Blood pressure
Glucose homeostasis traits
Hematology traits
Hormone measurements
Esotropia
Accommodative esotropia
Amblyopia
Hyperopia
Non-accommodative esotropia
Predicted visceral adipose tissue
Diabetic retinopathy (all NPDR and PDR)
Proliferative diabetic retinopathy (vs NPDR and no DR)
Urinary sodium excretion
Urinary potassium excretion
White coat effect (clinic systolic blood pressure minus ambulatory systolic blood pressure)
White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure)
Leukocyte count in ischemic stroke
HDL cholesterol levels in current drinkers
Uveal melanoma
Uveal melanoma with any chromosomal aberration
Choroidal melanoma
Uveal melanoma with chromosome 3 loss
Uveal melanoma with epithelioid cells
Presence of epithelioid cells in uveal melanoma
Uveal melanoma (TNM stage 1 or 2)
Uveal melanoma (TNM stage 3 or 4)
Disease severity in uveal melanoma (TNM stage 3 or 4 vs TNM stage 1 or 2)
Spatial processing
California verbal learning test score
Sensorimotor dexterity
Spatial memory
Fagerstrӧm test for nicotine dependence
Time to smoke first cigarette in the morning
Neuroblastoma or malignant cutaneous melanoma
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)
Rate of ventricular enlargement
Cerebrospinal fluid sTREM-2 levels
Cerebral microbleed progression
Cerebral microbleeds
Dentures
Dentate gyrus volume x schizophrenia interaction
Proliferative diabetic retinopathy (vs no DR)
Longevity
Dental caries (decayed, missing and filled teeth)
Dental caries (decayed and filled deciduous teeth)
Lysophosphatidylethanolamine levels
Phosphatidylcholine levels
Dental caries (decayed, missing and filled tooth surfaces)
Ceramide levels
Diacylglyceride levels
Lysophosphatidylcholine levels
Phosphatidylcholine-ether levels
Phosphatidylethanolamine levels
Triacylglyceride levels
Gut microbiota relative abundance (bacterial taxa)
Dental caries (decayed and filled deciduous tooth surfaces)
Heparin-induced thrombocytopenia
Stress sensitivity (neuroticism score x major depressive disorder status interaction)
Parental longevity (mother's age at death or mother's attained age)
Non-lobar intracerebral hemorrhage (MTAG)
Left ventricular mass x antihypertensive treatment interaction
Relative wall thickness x antihypertensive treatment interaction
Hydrolysed wheat protein allergy
Phosphatidylethanolamine-ether levels
Phosphatidylinositol levels
Cholesteryl ester levels
Mental health study participation (completed survey)
Chromosomal aberration frequency (total)
High chromosomal aberration frequency (total)
High chromosomal aberration frequency (chromatid type)
Chromosomal aberration frequency (chromatid type)
High chromosomal aberration frequency (chromosome type)
Chromosomal aberration frequency (chromosome type)
High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure
Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure
High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure
Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure
Mental health study participation (provided email address)
Chromosomal aberration frequency (total) in genotoxic compound exposure
Erectile dysfunction
Moderate-to-late spontaneous preterm birth
Spontaneous preterm birth with premature rupture of membranes
Spontaneous preterm birth without premature rupture of membranes
Plasma anti-thyroglobulin levels
Response to adalimumab in hidradenitis suppurativa (abscess and inflammatory nodule count increase)
Longitudinal cocaine use
Response to allopurinol in gout (change in serum uric acid levels)
Diabetic retinopathy (moderate NPDR and PDR)
Recurrence of malaria infection (mild or asymptomatic)
Recurrence of mild malaria attacks
Ankle-brachial index
Peripheral artery disease (borderline)
Age at suicide
Suicide
Antisaccade task score
Degraded stimulus continuous performance test score
Letter-number span reordering
Prepulse inhibition of the startle response
Gut microbiota (alpha diversity)
Diabetic nephropathy in type 1 diabetes
Macroalbuminuria in type 1 diabetes
End-stage renal disease in Type 1 diabetics
Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes
Microalbuminuria in type 1 diabetes
Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes
Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes
Bilirubin levels
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)
Plasma anti-thyroid peroxidase levels
Phenylephrine infusion rate during anesthesia
Longevity (age >90th survival percentile)
Longevity (age >99th survival percentile)
Non-lobar intracerebral hemorrhage
Lobar intracerebral hemorrhage
Early cardiac repolarization
Chronic central serous retinopathy
Abstraction and mental flexibility
Face memory
Schizophrenia or schizoaffective disorder
Alcohol withdrawal symptoms
Breast milk fatty acid composition (maternal genotype effect)
Breast milk fatty acid composition (infant genotype effect)
Plasma factor V levels in venous thrombosis
Plasma factor V levels in venous thrombosis (conditioned on rs6027)
Microalbuminuria
Urinary albumin-to-creatinine ratio in diabetes
Asthma (time to onset)
Skin aging measurement
Response to antidepressants (symptom improvement)
Response to SSRI (symptom remission)
Response to antidepressants (symptom remission)
Chronic mountain sickness
Iron status biomarkers
Lipid traits
Liver disease biomarker
Anthropometric traits
Early onset periodontitis x smoking status interaction
Stress-related phenotypes (multivariate analysis)
Benign prostatic hyperplasia and lower urinary tract symptoms
Diabetes (gestational)
Serum platinum levels after completion of cisplatin chemotherapy
Relative fat intake
Relative protein intake
Relative carbohydrate intake
Relative sugar intake
OTU97_140 (Bacteroides) abundance
OTU97_15 (Parasutterella) abundance
OTU97_150 (Bacteroides) abundance
OTU97_16 (Faecalibacterium) abundance
OTU97_163 (Bacteroides) abundance
OTU97_165 (Porphyromonadaceae) abundance
Lifetime smoking index
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Number of sexual partners
F_Acidaminococcaceae abundance
F_Bacteroidaceae abundance
F_Coriobacteriaceae abundance
F_Erysipelotrichaceae abundance
F_Lachnospiraceae abundance
F_Porphyromonadaceae abundance
OTU97_3 (Bacteroides) abundance
OTU97_30 (Roseburia) abundance
OTU97_31 (Prevotella) abundance
OTU97_33 (Holdemanella) abundance
Anxiety
Anxiety disorders
Alcohol dependence or heroin dependence or methamphetamine dependence
Urinary metabolite levels in chronic kidney disease
OTU97_354 (Alloprevotella) abundance
OTU97_38 (Alphaproteobacteria) abundance
OTU97_39 (Proteobacteria) abundance
OTU97_4 (Alistipes) abundance
OTU97_34 (Ruminococcus) abundance
General risk tolerance (MTAG)
Gastrointestinal infection
OTU99_59 (Prevotella) abundance
OTU99_6 (Sutterella) abundance
OTU99_62 (Ruminococcaceae) abundance
Meat-related diet
Pork consumption
G_Paraprevotella abundance
G_Parasutterella abundance
G_Phascolarctobacterium abundance
G_Porphyromonadaceae abundance
Oily fish consumption
Fruit consumption
Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome
Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome
Bipolar disorder or body mass index
Bipolar disorder or type 2 diabetes
OTU97_130 (Butyrivibrio) abundance
OTU97_137 (Catenibacterium) abundance
OTU97_138 (Oscillibacter) abundance
OTU97_119 (Desulfovibrio) abundance
OTU97_12 (Bacteroides) abundance
OTU97_126 (Prevotella) abundance
OTU97_13 (Subdoligranulum) abundance
Rapid automised naming and rapid alternating stimulus test performance
Latent naming speed
Rapid automised naming of letters
Rapid alternating stimulus test for letters/numbers
F_Rikenellaceae abundance
F_Ruminococcaceae abundance
F_Prevotellaceae abundance
diarrhoeal disease at age 1
diarrhoeal disease at age 1 with doctor diagnosis
diarrhoeal disease at age 2
diarrhoeal disease at age 2 with doctor diagnosis
Urinary metabolite modules (eigenmetabolites) in chronic kidney disease
G_Bacteroidetes abundance
G_Barnesiella abundance
OTU97_2 (Bacteroides) abundance
Low HDL-cholesterol levels
OTU99_4 (Alistipes) abundance
OTU99_40 (Proteobacteria) abundance
OTU99_45 (Faecalibacterium) abundance
OTU99_47 (Prevotella) abundance
OTU99_5 (Sutterella) abundance
OTU99_53 (Aestuariispira) abundance
Aortic valve area
Sweet taste perception in obesity with metabolic syndrome
Salty taste perception in obesity with metabolic syndrome
Sour taste perception in obesity with metabolic syndrome
Umami taste perception in obesity with metabolic syndrome
Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome
Taste perception (total score including 6-n-propylthiouracil) in obesity with metabolic syndrome
Carotid intima media thickness (mean)
Carotid intima media thickness (maximum)
Carotid intima media thickness (mean-maximum)
G_Prevotella abundance
Early spontaneous preterm birth
Post-term birth
Gestational age at birth (child effect)
OTU99_3 (Bacteroides) abundance
OTU99_30 (Parasutterella) abundance
OTU97_100 (Ruminococcaceae) abundance
OTU97_101 (Sutterella) abundance
OTU99_211 (Bacteroides) abundance
OTU99_23 (Faecalibacterium) abundance
OTU97_102 (Prevotella) abundance
OTU97_105 (Ruminococcaceae) abundance
OTU99_271 (Prevotella) abundance
OTU99_298 (Phascolarctobacterium) abundance
OTU99_24 (Prevotella) abundance
OTU99_26 (Parasutterella) abundance
Midline nonsyndromic craniosynostosis
Metopic nonsyndromic craniosynostosis
OTU97_17 (Parabacteroides) abundance
OTU97_173 (Bacteroides) abundance
Cerebral cortex AV-45 amyloid PET measurement
C_Actinobacteria abundance
C_Alphaproteobacteria abundance
C_Gammaproteobacteria abundance
C_Negativicutes abundance
C_Clostridia abundance
C_Erysipelotrichia abundance
C_Bacteroidia abundance
C_Betaproteobacteria abundance
OTU97_26 (Parasutterella) abundance
OTU97_27 (Bacteroides) abundance
OTU97_277 (Prevotella) abundance
OTU97_24 (Prevotella) abundance
OTU97_257 (Mitsuokella) abundance
Graft survival time in renal transplantation (donor effect)
Graft survival time in renal transplantation (donor effect) x APOL1 genotype interaction
OTU97_51 (Barnesiella) abundance
OTU97_53 (Bacteroides) abundance
OTU97_56 (Ruminococcaceae) abundance
OTU97_58 (Sutterellaceae) abundance
OTU97_6 (Sutterella) abundance
OTU97_65 (Parabacteroides) abundance
Gamma glutamyl transferase levels
Coronary artery disease in type 1 diabetes
OTU97_73 (Prevotella) abundance
OTU99_32 (Prevotella) abundance
OTU99_34 (Holdemanella) abundance
OTU99_35 (Ruminococcus) abundance
OTU99_39 (Alphaproteobacteria) abundance
OTU97_69 (Clostridiales) abundance
OTU97_7 (Lachnospiraceae) abundance
High fasting blood glucose
Hallux valgus
G_Firmicutes abundance
G_Holdemanella abundance
G_Lachnospiraceae abundance
G_Oscillibacter abundance
G_Parabacteroides abundance
Raw vegetable consumption
Cooked vegetable consumption
Bone mineral density or trunk lean mass (pleiotropy)
Trunk lean mass
Bone mineral density
G_Roseburia abundance
G_Ruminococcaceae abundance
G_Ruminococcus abundance
G_Ruminococcus2 abundance
G_Subdoligranulum abundance
G_Sutterella abundance
O_Bacteroidales abundance
O_Burkholderiales abundance
Non-oily fish consumption
Lamb consumption
OTU97_106 (Ruminococcaceae) abundance
OTU97_108 (Phascolarctobacterium) abundance
OTU97_109 (Paraprevotella) abundance
OTU97_11 (Parabacteroides) abundance
OTU97_113 (Bacteroidales) abundance
BMI at adiposity peak
Age at adiposity rebound
BMI at adiposity rebound
Serum immune biomarker levels
Cerebrospinal fluid immune biomarker levels
Thoracic aortic calcification levels
Abdominal aortic calcification levels
OTU99_54 (Holdemanella) abundance
OTU99_55 (Barnesiella) abundance
OTU99_558 (Bacteroidales) abundance
OTU99_58 (Bacteroides) abundance
O_Coriobacteriales abundance
O_Erysipelotrichales abundance
O_Selenomonadales abundance
Processed meat consumption
Fish- and plant-related diet
O_Clostridiales abundance
Obsessive compulsive disorder severity
Compulsion score in obsessive compulsive disorder
Obsession score in obsessive compulsive disorder
Knee pain
OTU97_117 (Ruminococcus) abundance
Proliferative diabetic retinopathy
G_Alistipes abundance
G_Alloprevotella abundance
G_Alphaproteobacteria abundance
F_Sutterellaceae abundance
G_Bacteroidales abundance
G_Bacteroides abundance
Epilepsy
Childhood absence epilepsy
Juvenile myoclonic epilepsy
Focal epilepsy (with hippocampal sclerosis)
Focal epilepsy
Generalized epilepsy
Heart failure
OTU97_21 (Parasutterella) abundance
OTU97_23 (Faecalibacterium) abundance
OTU97_235 (Phascolarctobacterium) abundance
OTU97_46 (Lachnospiraceae) abundance
OTU97_5 (Sutterella) abundance
OTU97_50 (Aestuariispira) abundance
G_Catenibacterium abundance
G_Clostridiales abundance
G_Clostridium_XlVa abundance
G_Coprococcus abundance
G_Faecalibacterium abundance
Poultry consumption
G_Prevotellaceae abundance
Diastolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Diastolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
OTU99_3 (Bacteroides) prevalence
OTU99_30 (Parasutterella) prevalence
OTU99_32 (Prevotella) prevalence
OTU99_34 (Holdemanella) prevalence
OTU99_35 (Ruminococcus) prevalence
Cardioembolic stroke (CCSc classification)
Gout (combined type)
Gout (normal type)
Trunk fat mass adjusted for trunk lean mass
Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass
OTU99_55 (Barnesiella) prevalence
OTU99_558 (Bacteroidales) prevalence
Survival in breast cancer (estrogen-receptor positive)
Risk-taking tendency (4-domain principal component model)
Lung function in heavy smokers (low FEV1 vs high FEV1)
Lung function in never smokers (high FEV1 vs average FEV1)
Lung function in heavy smokers (high FEV1 vs average FEV1)
Lung function in never smokers (low FEV1 vs average FEV1)
Smoking status (heavy vs never)
TestASV_12 (Bacteroides) prevalence
TestASV_13 (Bacteroides) prevalence
TestASV_14 (Lachnospiraceae) prevalence
TestASV_15 (Bacteroides) prevalence
OTU99_94 (Bacteroides) prevalence
OTU99_98 (Phascolarctobacterium) prevalence
TestASV_1 (Bacteroides) prevalence
TestASV_10 (Parabacteroides) prevalence
TestASV_11 (Lachnospiraceae) prevalence
Childhood maltreatment
Post bronchodilator FEV1/FVC ratio in COPD
TestASV_3 (Bacteroides) prevalence
TestASV_30 (Paraprevotella) prevalence
TestASV_27 (Ruminococcaceae) prevalence
TestASV_28 (Holdemanella) prevalence
TestASV_29 (Barnesiella) prevalence
TestASV_12 (Bacteroides) abundance
TestASV_13 (Bacteroides) abundance
TestASV_14 (Lachnospiraceae) abundance
TestASV_15 (Bacteroides) abundance
TestASV_16 (Bacteroides) abundance
TestASV_17 (Bacteroides) abundance
TestASV_18 (Prevotella) abundance
Panic disorder
Refractive error
Response to antiepileptic drugs in genetic generalized epilepsy
Response to valproic acid in genetic generalized epilepsy
Response to lamotrigine in genetic generalized epilepsy
Response to levetiracetam in genetic generalized epilepsy
Response to lamotrigine and valproic acid in genetic generalized epilepsy
TestASV_28 (Holdemanella) abundance
TestASV_29 (Barnesiella) abundance
TestASV_3 (Bacteroides) abundance
TestASV_30 (Paraprevotella) abundance
TestASV_46 (Sutterella) abundance
TestASV_47 (Parasutterella) abundance
TestASV_48 (Sutterella) abundance
TestASV_49 (Parasutterella) abundance
TestASV_5 (Bacteroides) abundance
TestASV_6 (Subdoligranulum) abundance
TestASV_7 (Bacteroides) abundance
TestASV_44 (Parasutterella) abundance
TestASV_45 (Clostridiales) abundance
OTU99_2 (Bacteroides) prevalence
OTU99_21 (Parasutterella) prevalence
OTU99_211 (Bacteroides) prevalence
Externalizing behaviour score
OTU99_5 (Sutterella) prevalence
OTU99_53 (Aestuariispira) prevalence
OTU99_54 (Holdemanella) prevalence
Salivary metabolite levels
Lipoprotein (a) levels in response to niacin in statin-treated individuals
HDL cholesterol change in response to niacin in statin-treated individuals
OTU99_8 (Ruminococcaceae) prevalence
OTU99_84 (Prevotella) prevalence
OTU99_85 (Alistipes) prevalence
OTU99_65 (Sutterellaceae) prevalence
OTU99_7 (Lachnospiraceae) prevalence
OTU99_72 (Parabacteroides) prevalence
OTU99_78 (Clostridiales) prevalence
Physiological dysregulation (Mahalanobis distance)
Hand grip strength (Mahalanobis distance)
Lung function (low FEV1 vs high FEV1)
Lung function in never smokers (low FEV1 vs high FEV1)
Lung function (low FEV1 vs high FEV1) x smoking interaction
TestASV_16 (Bacteroides) prevalence
TestASV_17 (Bacteroides) prevalence
TestASV_18 (Prevotella) prevalence
TestASV_19 (Prevotella) prevalence
Parkinson's disease or first degree relation to individual with Parkinson's disease
TestASV_35 (Alphaproteobacteria) prevalence
TestASV_36 (Aestuariispira) prevalence
TestASV_37 (Ruminococcaceae) prevalence
TestASV_38 (Ruminococcus) prevalence
TestASV_39 (Bacteroides) prevalence
Two-hour glucose
OTU99_72 (Parabacteroides) abundance
OTU99_78 (Clostridiales) abundance
OTU99_8 (Ruminococcaceae) abundance
OTU99_84 (Prevotella) abundance
TestASV_40 (Barnesiella) prevalence
OTU99_65 (Sutterellaceae) abundance
OTU99_7 (Lachnospiraceae) abundance
OTU99_85 (Alistipes) abundance
Birth length (MTAG)
Infant head circumference (MTAG)
TestASV_19 (Prevotella) abundance
TestASV_2 (Bacteroides) abundance
TestASV_20 (Phascolarctobacterium) abundance
TestASV_21 (Ruminococcaceae) abundance
Brain imaging measurements (variance)
Skin pigmentation (conditioned on rs1426654 and rs35397)
TestASV_31 (Ruminococcus) abundance
TestASV_32 (Ruminococcaceae) abundance
TestASV_33 (Paraprevotella) abundance
Stress urinary incontinence
Fecal incontinence
Kidney stones
Hospital contact for infections
TestASV_42 (Alphaproteobacteria) abundance
TestASV_43 (Parasutterella) abundance
B-cell acute lymphoblastic leukaemia
B-cell acute lymphoblastic leukaemia (high-hyperdiploidy)
B-cell acute lymphoblastic leukaemia (ETV6-RUNX1 positive)
TestASV_9 (Alistipes) abundance
C_Alphaproteobacteria prevalence
C_Negativicutes prevalence
Membranous nephropathy
OTU99_166 (Prevotella) prevalence
OTU99_17 (Parabacteroides) prevalence
OTU99_171 (Bacteroides) prevalence
OTU97_1 (Bacteroides) abundance
OTU99_19 (Bacteria) prevalence
OTU99_197 (Bacteroides) prevalence
Beef consumption
Cardioembolic stroke (CCSp classification)
Cardioembolic stroke (TOAST classification)
Cardioembolic stroke (CCS and TOAST classification)
Cardioembolic stroke (CCS or TOAST classification)
Large artery stroke (CCSp classification)j
Large artery stroke (TOAST classification)
Large artery stroke (CCS and TOAST classification)
Large artery stroke (CCS or TOAST classification)
Small vessel stroke (CCSp classification)
Small vessel stroke (CCS and TOAST classification)
Small vessel stroke (CCS or TOAST classification)
OTU99_39 (Alphaproteobacteria) prevalence
OTU99_4 (Alistipes) prevalence
OTU99_47 (Prevotella) prevalence
OTU99_40 (Proteobacteria) prevalence
OTU99_45 (Faecalibacterium) prevalence
OTU99_9 (Alistipes) prevalence
OTU99_92 (Ruminococcus) prevalence
Cannabis use disorder
TestASV_24 (Bacteroides) prevalence
TestASV_25 (Sutterella) prevalence
TestASV_26 (Phascolarctobacterium) prevalence
TestASV_22 (Sutterella) prevalence
TestASV_23 (Barnesiella) prevalence
TestASV_4 (Alistipes) prevalence
Birth weight (MTAG)
P_Bacteroidetes abundance
P_Firmicutes abundance
P_Proteobacteria abundance
TestASV_1 (Bacteroides) abundance
TestASV_10 (Parabacteroides) abundance
TestASV_11 (Lachnospiraceae) abundance
Uterine fibroids and heavy menstrual bleeding
Heavy menstrual bleeding
TestASV_34 (Phascolarctobacterium) abundance
TestASV_35 (Alphaproteobacteria) abundance
TestASV_36 (Aestuariispira) abundance
F_Acidaminococcaceae prevalence
F_Prevotellaceae prevalence
G_Alloprevotella prevalence
G_Alphaproteobacteria prevalence
Ankle injury
Angioedema in response to angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker
OTU99_23 (Faecalibacterium) prevalence
OTU99_24 (Prevotella) prevalence
OTU99_26 (Parasutterella) prevalence
OTU99_271 (Prevotella) prevalence
OTU99_298 (Phascolarctobacterium) prevalence
OTU99_58 (Bacteroides) prevalence
OTU99_59 (Prevotella) prevalence
OTU99_6 (Sutterella) prevalence
OTU99_62 (Ruminococcaceae) prevalence
TestASV_2 (Bacteroides) prevalence
TestASV_20 (Phascolarctobacterium) prevalence
TestASV_21 (Ruminococcaceae) prevalence
Adult onset Still's disease
Alanine aminotransferase levels
Hemoglobin A1c levels
TestASV_31 (Ruminococcus) prevalence
TestASV_32 (Ruminococcaceae) prevalence
TestASV_33 (Paraprevotella) prevalence
TestASV_34 (Phascolarctobacterium) prevalence
Subscapular skin fold thickness
OTU99_98 (Phascolarctobacterium) abundance
P_Actinobacteria abundance
OTU99_9 (Alistipes) abundance
OTU99_92 (Ruminococcus) abundance
TestASV_26 (Phascolarctobacterium) abundance
TestASV_27 (Ruminococcaceae) abundance
TestASV_23 (Barnesiella) abundance
TestASV_24 (Bacteroides) abundance
TestASV_25 (Sutterella) abundance
TestASV_22 (Sutterella) abundance
TestASV_4 (Alistipes) abundance
TestASV_41 (Barnesiella) abundance
TestASV_38 (Ruminococcus) abundance
TestASV_39 (Bacteroides) abundance
TestASV_37 (Ruminococcaceae) abundance
TestASV_8 (Bacteroides) abundance
Impaired insulin sensitivity in response to n-3 PUFA supplementation
G_Bacteroidales prevalence
G_Bacteroidetes prevalence
G_Barnesiella prevalence
G_Catenibacterium prevalence
Parental longevity (father's age at death or father's attained age)
Resistant hypertension
Poor prognosis in Crohn's disease
Asthma and attention deficit hyperactivity disorder
Asthma and anxiety disorder
Asthma and major depressive disorder
Nevus count
Spontaneous preterm birth (preterm birth)
Number of decayed, missing and filled tooth surfaces or use of dentures
Number of decayed, missing and filled tooth surfaces
Minimum ankle–brachial index
T wave morphology restitution during exercise (MTAG)
T wave morphology restitution during exercise
T wave morphology restitution during recovery from exercise
T wave morphology restitution during recovery from exercise (MTAG)
3-month functional outcome in ischaemic stroke (modified Rankin score)
Childhood obesity
Systolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Systolic blood pressure response to chlorthalidone in hypertension
Bipolar I disorder
Bipolar II disorder
Antipsychotic drug-induced weight gain in schizophrenia
Antipsychotic drug-induced weight gain in schizophrenia or autism
Age-related hearing impairment (high minus low frequency)
Age-related hearing impairment (low/mid frequency)
Age-related hearing impairment (high frequency)
Alanine aminotransferase levels in excessive alcohol consumption
Aspartate aminotransferase levels in excessive alcohol consumption
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
HDL cholesterol levels in non smokers
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
HDL cholesterol levels in never smokers
Fasting glucose change
Fasting glucose change (long-term)
Fasting glucose change (short-term)
Adult asthma
Left planum temporale grey matter volume
Right planum temporale grey matter volume
Planum temporale asymmetry index
Tendinopathy
Response to beta blocker use in hypertension (systolic blood pressure)
Gamma glutamyl transferase levels in excessive alcohol consumption
Eosinophilic esophagitis
Alanine aminotransferase levels in low alcohol consumption
Aspartate aminotransferase levels in low alcohol consumption
Gamma glutamyl transferase levels in low alcohol consumption
Response to ketamine in bipolar disorder or major depression (antidepressant effects)
Response to ketamine in bipolar disorder or major depression (dissociation effects)
Blood metabolite levels
Triglyceride levels in ever smokers
Brainstem volume
G_Sutterella prevalence
O_Selenomonadales prevalence
OTU97_1 (Bacteroides) prevalence
G_Phascolarctobacterium prevalence
G_Porphyromonadaceae prevalence
G_Prevotella prevalence
G_Prevotellaceae prevalence
G_Ruminococcus prevalence
OTU97_100 (Ruminococcaceae) prevalence
OTU97_101 (Sutterella) prevalence
OTU97_150 (Bacteroides) prevalence
OTU97_16 (Faecalibacterium) prevalence
OTU97_163 (Bacteroides) prevalence
OTU97_138 (Oscillibacter) prevalence
OTU97_140 (Bacteroides) prevalence
OTU97_15 (Parasutterella) prevalence
Occipital lobe volume
Parietal lobe volume
Temporal lobe volume
Complement factor H binding to malondialdehyde
Protein level change in low calorie diet obesity intervention
Protein levels in obesity
OTU97_165 (Porphyromonadaceae) prevalence
OTU97_17 (Parabacteroides) prevalence
OTU97_173 (Bacteroides) prevalence
OTU97_19 (Bacteria) prevalence
OTU97_2 (Bacteroides) prevalence
Triglyceride levels x loop diuretics use interaction
HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
LDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
Triglyceride levels x thiazide or thiazide-like diuretics use interaction
HDL cholesterol levels x loop diuretics use interaction
OTU97_31 (Prevotella) prevalence
OTU97_33 (Holdemanella) prevalence
OTU97_34 (Ruminococcus) prevalence
OTU97_354 (Alloprevotella) prevalence
OTU97_3 (Bacteroides) prevalence
OTU97_30 (Roseburia) prevalence
Retinal detachment or retinal break
Retinal detachment with retinal break
Retinal detachment
OTU97_80 (Ruminococcus) prevalence
OTU97_82 (Bacteroides) prevalence
OTU97_86 (Phascolarctobacterium) prevalence
OTU97_9 (Alistipes) prevalence
OTU97_95 (Cytophagales) prevalence
OTU97_97 (Clostridiales) prevalence
Adipose morphology
OTU99_108 (Cytophagales) prevalence
OTU99_11 (Parabacteroides) prevalence
OTU99_110 (Clostridiales) prevalence
Youthful appearance (self-reported)
Colorectal cancer x BMI interaction (2df)
HDL cholesterol levels x short total sleep time interaction (2df test)
OTU99_124 (Paraprevotella) prevalence
OTU99_13 (Subdoligranulum) prevalence
OTU99_132 (Bacteroidales) prevalence
OTU99_123 (Phascolarctobacterium) prevalence
Leisure sedentary behaviour (computer use)
Driving (hours per day)
Buruli ulcer
Buruli ulcer (age at onset)
G_Coprococcus prevalence
G_Holdemanella prevalence
G_Parabacteroides prevalence
G_Paraprevotella prevalence
G_Parasutterella prevalence
Suicidal or self-harm ideation
Circulating leptin levels in high cardiovascular risk
OTU97_102 (Prevotella) prevalence
OTU97_105 (Ruminococcaceae) prevalence
OTU97_108 (Phascolarctobacterium) prevalence
OTU97_109 (Paraprevotella) prevalence
OTU97_11 (Parabacteroides) prevalence
OTU97_113 (Bacteroidales) prevalence
OTU97_106 (Ruminococcaceae) prevalence
Circulating leptin levels x sex interaction in high cardiovascular risk
OTU97_130 (Butyrivibrio) prevalence
OTU97_137 (Catenibacterium) prevalence
OTU97_126 (Prevotella) prevalence
OTU97_13 (Subdoligranulum) prevalence
OTU97_21 (Parasutterella) prevalence
OTU97_23 (Faecalibacterium) prevalence
OTU97_235 (Phascolarctobacterium) prevalence
OTU97_24 (Prevotella) prevalence
OTU97_257 (Mitsuokella) prevalence
OTU97_26 (Parasutterella) prevalence
OTU97_27 (Bacteroides) prevalence
OTU97_277 (Prevotella) prevalence
Serum sclerostin levels
Circulating leptin levels or fasting insulin levels
Circulating leptin levels or HOMA-B
Circulating leptin levels or HOMA-IR
Circulating leptin levels or type 2 diabetes
Idiopathic downbeat nystagmus
HDL cholesterol levels x long total sleep time interaction (2df test)
OTU97_8 (Ruminococcaceae) prevalence
OTU97_73 (Prevotella) prevalence
OTU97_74 (Alistipes) prevalence
Leisure sedentary behaviour (television watching)
OTU99_12 (Bacteroides) prevalence
OTU99_120 (Ruminococcaceae) prevalence
OTU99_121 (Ruminococcaceae) prevalence
OTU99_116 (Sutterella) prevalence
Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Hippocampal atrophy rate
Cortical surface area (visual PC2)
Cortical surface area (global PC1)
OTU97_117 (Ruminococcus) prevalence
OTU97_119 (Desulfovibrio) prevalence
OTU97_12 (Bacteroides) prevalence
LDL cholesterol levels x loop diuretics use interaction
OTU97_39 (Proteobacteria) prevalence
OTU97_4 (Alistipes) prevalence
OTU97_46 (Lachnospiraceae) prevalence
OTU97_5 (Sutterella) prevalence
OTU97_50 (Aestuariispira) prevalence
OTU97_51 (Barnesiella) prevalence
OTU97_38 (Alphaproteobacteria) prevalence
OTU97_56 (Ruminococcaceae) prevalence
OTU97_58 (Sutterellaceae) prevalence
OTU97_6 (Sutterella) prevalence
OTU97_53 (Bacteroides) prevalence
OTU97_65 (Parabacteroides) prevalence
OTU97_69 (Clostridiales) prevalence
OTU97_7 (Lachnospiraceae) prevalence
Cataracts (operation)
Triglyceride levels x long total sleep time interaction (1df test)
OTU99_1 (Bacteroides) prevalence
OTU99_106 (Barnesiella) prevalence
Levodopa wearing off effect (time symptoms uncontrolled) in Parkinson's disease (response to zonisamide)
Levodopa wearing off effect (motor symptom score change) in Parkinson's disease (response to zonisamide)
LDL cholesterol levels x long total sleep time interaction (2df test)
OTU99_137 (Ruminococcus) prevalence
OTU99_140 (Desulfovibrio) prevalence
OTU99_150 (Prevotella) prevalence
OTU99_155 (Butyrivibrio) prevalence
OTU99_157 (Barnesiella) prevalence
Hip bone size
Bone mineral density (hip) and hip bone size
OTU99_16 (Faecalibacterium) prevalence
TestASV_41 (Barnesiella) prevalence
TestASV_42 (Alphaproteobacteria) prevalence
TestASV_43 (Parasutterella) prevalence
Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)
Eosinophilic granulomatosis with polyangiitis (ANCA negative)
Eosinophilic granulomatosis with polyangiitis
Body fat distribution (arm fat ratio)
TestASV_5 (Bacteroides) prevalence
TestASV_6 (Subdoligranulum) prevalence
TestASV_7 (Bacteroides) prevalence
TestASV_48 (Sutterella) prevalence
TestASV_49 (Parasutterella) prevalence
TestASV_8 (Bacteroides) prevalence
TestASV_9 (Alistipes) prevalence
LDL cholesterol levels x short total sleep time interaction (2df test)
Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals
Corneal astigmatism
Refractive astigmatism
Triglyceride levels x long total sleep time interaction (2df test)
Triglyceride levels x short total sleep time interaction (2df test)
Uric acid elevation in response to thiazide-like diuretic in hypertension
Body fat distribution (leg fat ratio)
Inhibin B levels
QT interval
JT interval
Hallucinations in long-term cannabis use
Lung function (FVC) in asthma
Lung function (FEV1/FVC) in asthma
Post-bronchodilator lung function in asthma (FEV1)
Post-bronchodilator lung function in asthma (FVC)
Post-bronchodilator lung function in asthma (FEV1/FVC)
Lung function (FEV1) in asthma
TestASV_44 (Parasutterella) prevalence
TestASV_45 (Clostridiales) prevalence
TestASV_46 (Sutterella) prevalence
BMI in adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
BMI in adult survivors of childhood acute lymphoblastic leukemia not treated with cranial radiation
BMI in adult survivors of childhood acute lymphoblastic leukemia
Vascular endothelial growth factor levels in major depressive disorder
TestASV_47 (Parasutterella) prevalence
COVID-19 (critical illness vs population)
Testosterone levels x fluid intelligence interaction
Testosterone levels x alcohol consumption (drinks per week) interaction
Testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
HDL cholesterol levels x long total sleep time interaction (1df test)
Triglyceride levels x short total sleep time interaction (1df test)
HDL cholesterol levels x short total sleep time interaction (1df test)
LDL cholesterol levels x long total sleep time interaction (1df test)
LDL cholesterol levels x short total sleep time interaction (1df test)
Body mass index variance
Body fat percentage variance
Basal metabolic rate variance
Waist circumference variance
Hip circumference variance
White matter hyperintensities
Waist-hip ratio variance
Lung function (FEV1/FVC) variance
Heel bone mineral density variance
Birth weight variance
Proportion of activated microglia (midfrontal cortex)
Proportion of activated microglia (inferior temporal cortex)
Disability (impaired activities of daily living)
Diffuse plaques
Cerebral amyloid angiopathy
Non-del(5q) myelodysplastic syndromes
Dementia with Lewy bodies
Neuropathologic traits (pleiotropy)
Microscopic brain infarct
Macroscopic brain infarct
Narcolepsy with cataplexy
Parkinson's disease (age of onset)
Body fat distribution (trunk fat ratio)
Fasting insulin
Mastocytosis (KIT D816V positive)
Decreased low contrast letter acuity in multiple sclerosis
Interleukin-6 receptor subunit alpha levels
C-X-C motif chemokine 10 levels
CCL24 levels
MHC class I polypeptide-related sequence A levels
CD40 ligand levels
kallikrein-11 levels
epithelial cell adhesion molecule levels
interleukin 17 receptor B levels
interleukin 12 receptor subunit beta-1 levels
vascular endothelial growth factor D levels
E-selectin levels
melanoma-derived growth regulatory protein levels
CCL19 levels
Hepatitis C (spontaneous viral clearance)
Pre bronchodilator FEV1/FVC ratio
Response to (pegylated) interferon in HBeAg-negative hepatitis B
Response to (pegylated) interferon in HBeAG-positive hepatitis B
Response to (pegylated) interferon in chronic hepatitis B
Pre bronchodilator FEV1
Bone mineral content
Breslow thickness in cutaneous melanoma
Plasma free amino acid levels (adjusted for twenty other PFAAs)
Neck pain or shoulder pain
Invasive breast cancer
Nonalcoholic steatohepatitis
Brain morphology (MOSTest)
Tafenoquine efficacy in P. vivax malaria (recurrence by 6 months)
Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months)
Cerebral aneurysm
Congestive heart failure
Self-rated health
Protein quantitative trait loci
Lean nonalcoholic fatty liver disease
Etoposide drug response (IC50)
Carboplatin drug response (IC50)
Cisplatin drug response (IC50)
Daunorubicin drug response (IC50)
Cortical thickness (MOSTest)
Percent mammographic density
Gut microbiota (bacterial taxa, rank normal transformation method)
Restless legs syndrome in migraine without aura
Restless legs syndrome in migraine
Anorectal malformation
First fracture in long-term childhood cancer survivors (time to event)
Urolithiasis
Esophageal cancer
Arrhythmia
Cataracts
Osteoporosis
Interstitial lung disease
Keloid
Diffuse plaques (SNP x SNP interaction)
Interstitial lung diseases in rheumatoid arthritis
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels
Mortality in COVID-19
Dietary fat liking
Myeloid clonal hematopoiesis
Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism
Fasting triglyceride levels
Postprandial triglyceride levels
Postprandial triglyceride response
Brugada syndrome
Gastric cancer
Hepatocellular carcinoma
Pancreatic cancer
Persistent chemotherapy-induced alopecia in breast cancer
Factor VII activity or levels
Factor VII activity
Subcortical volume (MOSTest)
Nontraumatic osteonecrosis of the femoral head
Allergic disease (asthma, hay fever and/or eczema) (age of onset)
Electrocardiographic traits (multivariate)
Age-related macular degeneration
Mammographic density (non-dense area)
Mammographic density (dense area)
Clozapine concentration in schizophrenia
N-desmethylclozapine concentration in schizophrenia
Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia
Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
Ceramide levels (C24:0)
Ceramide levels (C22:0)
Capecitabine-induced hand-foot syndrome in breast or colorectal cancer
Fractures (paediatric)
Neuritic plaques (SNP x SNP interaction)
Motor fluctuations in levodopa treated Parkinson's disease
Levodopa-induced dyskinesia in levodopa treated Parkinson's disease
Simvastatin-induced myopathy
Atorvastatin-induced myopathy
Statin-induced myopathy (severe)
Statin-induced myopathy
Response to esketamine in treatment resistant depression
Response to esketamine (responder status) in treatment resistant depression
Response to esketamine (remission) in treatment resistant depression
Self-harm ideation
Autoimmune thyroid disease
Cognitive function (kinship model)
Cognitive function (mixed linear model)
Cognitive function (generalized correlation coefficient)
Helicobacter pylori OMP antibody levels
Anti-herpes simplex virus 2 IgG seropositivity
Chlamydia trachomatis PorB antibody levels
Herpes simplex virus 2 mgG-1 antibody levels
Cytomegalovirus pp28 antibody levels
Anti-polyomavirus 2 IgG seropositivity
Polyomavirus 2  JC VP1 antibody levels
Epstein-Barr virus EA-D antibody levels
Anti-Merkel cell polyomavirus IgG seropositivity
Epstein-Barr virus EBNA-1 antibody levels
Merkel cell polyomavirus VP1 antibody levels
Epstein-Barr virus VCA p18 antibody levels
Toxoplasma gondii sag1 antibody levels
Epstein-Barr virus ZEBRA antibody levels
Anti-human herpes virus 6 IE1A IgG seropositivity
Varicella zoster virus glycoproteins E and I antibody levels
BK polyomavirus VP1 antibody levels
Helicobacter pylori UREA antibody levels
Chlamydia trachomatis pGP3 antibody levels
Anti-Epstein-Barr virus IgG seropositivity
Anti-varicella zoster virus IgG seropositivity
Human herpes virus 6 IE1A antibody levels
Human herpes virus 7 U14 antibody levels
Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer
Gestational insulin sensitivity
Cutaneous mastocytosis
Systemic mastocytosis
Cutaneous mastocytosis (adult)
Mastocytosis
Cutaneous mastocytosis (childhood)
Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)
Bone mineral density or leg lean mass (pleiotropy)
Leg lean mass
Obsessive-compulsive traits
Length of menstrual cycle
Medial temporal lobe substructure volumes
Gut microbiota relative abundance (Ruminococcus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (Blautia)
Gut microbiota relative abundance (unclassified genus belonging to family Ruminococcaceae)
Gut microbiota relative abundance (Faecalibacterium)
Gut microbiota relative abundance (Oscillospira)
Gut microbiota relative abundance (Ruminococcus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unassigned genus belonging to family Clostridiales)
Gut microbiota relative abundance (Coprococcus)
Gut microbiota relative abundance (Dorea)
Gut microbiota relative abundance (unassigned genus belonging to family Lachnospiraceae)
Cortical surface area (MOSTest)
Subcortical volume (min-P)
Acceptance of an invitation to participate in a mental health questionnaire
Completion of the aide-memoire
Participation in an health questionnaire (not invited vs invited)
Opioid overdose severity score
Cortical surface area (min-P)
Cortical thickness (min-P)
Blood cell traits (multivariate analysis)
Emphysema annual change measurement in smokers (adjusted lung density)
Emphysema annual change measurement in smokers (percent low attenuation area)
Bitter alcoholic beverage consumption
3-hydroxybutyrate + 3-aminoisobutyrate levels
Glycine levels
Lysine levels
N-acetyl neuraminic acid levels
Taurine levels
Trimethylamine levels
Carbamazepine-induced reaction with eosinophilia and systemic symptoms
Carbamazepine-induced serious cutaneous adverse reaction
Multisite chronic pain
Annualised percent change of cerebrospinal fluid AB1-42 levels
Male puberty timing (early vs. average onset facial hair)
Male puberty timing (late vs. average onset facial hair)
Male puberty timing (early vs. average onset voice breaking)
Male puberty timing (late vs. average onset voice breaking)
Brain morphology (min-P)
Gut microbiota relative abundance (Sutterella)
Gut microbiota relative abundance (Prevotella)
Gut microbiota relative abundance (unclassified genus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (Eubacterium belonging to family Erysipelotrichaceae)
Chemerin levels
Rapid automised naming of pictures
Short-term memory (digit-span task)
Non-word reading
Word spelling
Rapid automised naming of digits
Word reading
Cognitive impairment
same-sex sexual behaviour
Cortical volume
Airway obstruction (FEV1/FVC<70%) in never smokers
Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers
Total PHF-tau (SNP x SNP interaction)
Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A
Aspartate aminotransferase levels
Facial morphology (nostril size)
Facial morphology (columella size)
Facial morphology (lip thickness 1)
Facial morphology (lower lip thickness 1)
Facial morphology (lower lip thickness 2)
Facial morphology (lip thickness ratio 1)
Facial morphology (lip thickness ratio 2)
Facial morphology (lower lip protrusion)
Facial morphology (lip protrusion)
Facial morphology (philtrum length)
Facial morphology (chin protrusion 1)
Facial morphology (chin protrusion 2)
Facial morphology (ear size)
Facial morphology (forehead protrusion 1)
Facial morphology (brow ridge protrusion 1)
Facial morphology (brow ridge protrusion 2)
Facial morphology (nasion depth 1)
Facial morphology (nasion depth 2)
Facial morphology (nasion position 2)
Facial morphology (eye position 1)
Facial morphology (nose height)
Facial morphology (nose protrusion)
Facial morphology (nose size)
Facial morphology (nose roundness 1)
Facial morphology (nose roundness 3)
Facial morphology (columella inclination)
Post-traumatic stress disorder (re-experiencing symptoms)
Facial morphology (jaw protrusion 2)
Facial morphology (jaw protrusion 5)
Facial morphology (jaw slope 2)
Facial morphology (upper face flatness)
Facial morphology (brow ridge protrusion 3)
Facial morphology (lower face flatness)
Psychological distress
Tuberculosis (SNP x SNP interaction)
Thiopurine-induced early leukopenia in Crohn's disease
Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease
Hematuria (moderate to severe)
Glucosuria (moderate to severe)
Hematuria (mild)
Urine pH measurement
Glucosuria (mild)
Ketonuria
Ketonuria (moderate to severe)
Ketonuria (mild)
Proteinuria
Proteinuria (moderate to severe)
Glucosuria
Proteinuria (mild)
Hematuria
Aspartate aminotransferase levels in non-alcoholic fatty liver disease
Alanine aminotransferase levels in non-alcoholic fatty liver disease
Liver fibrosis in non-alcoholic fatty liver disease
Low urine pH
Nonalcoholic fatty liver disease (SNP x SNP interaction)
Circulating fibroblast growth factor 21 levels
Circulating fibroblast growth factor 23 levels
Neuroblastoma (pediatric)
Breast cancer (male)
Gut microbiota relative abundance (unclassified genus belonging to family Clostridiaceae)
Gut microbiota relative abundance (unclassified genus belonging to the order Clostridiales)
Gut microbiota relative abundance (Bifidobacterium)
Gut microbiota relative abundance (Bacteroides)
Gut microbiota relative abundance (Parabacteroides)
Gut microbiota relative abundance (Streptococcus)
Concussion
Trigger finger
Phoneme awareness
Reading ability (multivariate)
Negative urgency
Sensation seeking
Lack of perseverance
Impulsivity (attentional)
Impulsivity
Impulsivity (motor)
Impulsivity (non-planning)
Lack of premeditation
Drug experimentation measurement
Positive urgency
Serum oxytocin levels
Varicose veins
Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)
Bitter non-alcoholic beverage consumption
Acute post-radiotherapy pain in breast cancer
Hypopharyngeal or laryngeal cancer
Mitochondrial DNA copy number (white blood cells)
Mitochondrial DNA copy number
Male puberty timing (age at voice breaking MTAG)
Gut microbiota alpha diversity (Chao1 index)
Gut microbiota alpha diversity (PD_whole_tree index)
Amyloid status (abnormal vs normal)
Central cerebrospinal fluid amyloid beta 42 to 40 ratio (abnormal vs normal)
Amyloid pathology
Central cerebrospinal fluid amyloid beta 42 levels
Central cerebrospinal fluid amyloid beta 42 to 40 ratio
Body mass index and systolic blood pressure (bivariate analysis)
Body mass index and diastolic blood pressure (bivariate analysis)
Systolic blood pressure and diastolic blood pressure (bivariate analysis)
spontaneous preterm birth x maternal stress interaction (1df)
Gut microbiota alpha diversity (Shannon index)
Gut microbiota beta diversity (weighted UniFrac distance)
Sudden cardiac arrest in coronary artery disease
Percentage of invited food questionnaires completed
Acceptance of an invitation to wear a physical activity monitor
Cerebellum cortex volume change rate
Amygdala volume change rate
Cerebellum white matter volume change rate
Caudate volume change rate
Cerebral white matter volume change rate
Cortex volume change rate
Type 2 diabetes nephropathy
Type 2 diabetes nephropathy including microalbuminuria
Amygdala volume change rate x age interaction (1df)
Caudate volume change rate x age interaction (1df)
Cerebellum cortex volume change rate x age interaction (1df)
Cerebellum white matter volume change rate x age interaction (1df)
Cortical thickness change rate
Lateral ventricle volume change rate
Hippocampus volume change rate
Nucleus accumbens volume change rate
Corneal curvature
Allergic march (atopic dermatitis to allergic rhinitis)
Allergic march (atopic dermatitis to asthma)
Cerebellum cortex volume change rate x age interaction (2df)
Cerebellum white matter volume change rate x age interaction (2df)
Cerebral white matter volume change rate x age interaction (2df)
Cortex volume change rate x age interaction (2df)
Cortical thickness change rate x age interaction (2df)
Hippocampus volume change rate x age interaction (2df)
Response to treatment in irritable bowel syndrome (pain frequency)
Response to treatment in irritable bowel syndrome (pain severity)
Corneal endothelial cell density
Corneal endothelial cell size variation coefficient
Response to treatment in irritable bowel syndrome (symptom severity)
Early chronic obstructive pulmonary disease in never smokers
Early chronic obstructive pulmonary disease
3-Indolepropionic acid to L-Pipecolic acid ratio in coronary artery disease
3-Indolepropionic acid to 3-Hydroxybutyrate ratio in coronary artery disease
3-Indolepropionic acid to (S)-(-)-2-Hydroxyisocaproic acid ratio in coronary artery disease
3-Indolepropionic acid to Creatinine ratio in coronary artery disease
L-Pyroglutamic acid to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to gamma-Linolenic acid (C18:3n6) ratio in coronary artery disease
3-Indolepropionic acid to N,N-Dimethylglycine ratio in coronary artery disease
3-Indolepropionic acid to SubericAcid ratio in coronary artery disease
3-Indolepropionic acid to 2-(dimethylamino) guanosine ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 14:0 ratio in coronary artery disease
3-Indolepropionic acid to 4-Hydroxybenzaldehyde ratio in coronary artery disease
3-Indolepropionic acid to Azelaic acid ratio in coronary artery disease
3-Indolepropionic acid to cis-5,8,11,14,17-Eicosapentaenoic acid (C20:5n3) ratio in coronary artery disease
3-Indolepropionic acid to Hypoxanthine ratio in coronary artery disease
L-Proline to 3-Indolepropionic acid ratio in coronary artery disease
D-Trehalose to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Methylmalonic acid ratio in coronary artery disease
3-Indolepropionic acid to alpha-Linolenic acid (C18:3n3) ratio in coronary artery disease
3-Indolepropionic acid to S-Sulfo-L-cysteine ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 20:0 ratio in coronary artery disease
3-Indolepropionic acid to beta-Pseudouridine ratio in coronary artery disease
Dulcitol to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to 4-Nitrophenol ratio in coronary artery disease
3-Indolepropionic acid to Indole-5-carboxylic acid ratio in coronary artery disease
Pantothenate to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Taurocholic acid sodium salt hydrate ratio in coronary artery disease
3-Indolepropionic acid to L-Valine ratio in coronary artery disease
Asp-phe to 3-Indolepropionic acid ratio in coronary artery disease
L-Histidine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to 3,3',5-Triiodo-L-thyronine ratio in coronary artery disease
D-Arabinose to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 16:0 ratio in coronary artery disease
L-Threonine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 18:1 ratio in coronary artery disease
3-Indolepropionic acid to N6-Acetyl-L-lysine ratio in coronary artery disease
L-Thyroxine to 3-Indolepropionic acid ratio in coronary artery disease
L-Aspartic acid to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Trimethylamine N-oxide ratio in coronary artery disease
3-Indolepropionic acid to Uric acid ratio in coronary artery disease
3-Indolepropionic acid to D-Fructose ratio in coronary artery disease
3-Indolepropionic acid to Sarcosine ratio in coronary artery disease
3-Indolepropionic acid to Choline ratio in coronary artery disease
L-Glutamic acid to 3-Indolepropionic acid ratio in coronary artery disease
L-Serine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to S-(5-Adenosy) -L-homocysteine ratio in coronary artery disease
3-Indolepropionic acid to D-2-Aminobutyric acid ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 16:1 ratio in coronary artery disease
3-Indolepropionic acid to Hippuric acid ratio in coronary artery disease
3-Indolepropionic acid to Pipecolinic acid ratio in coronary artery disease
L-Citrulline to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to L-Saccharopine ratio in coronary artery disease
3-Indolepropionic acid to 5-oxoproline ratio in coronary artery disease
L-Asparagine Anhydrous to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Kinurenine ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 18:0 ratio in coronary artery disease
3-Indolepropionic acid to L-2-Aminobutyric acid ratio in coronary artery disease
3-Indolepropionic acid to 2-Picolinic acid ratio in coronary artery disease
3-Indolepropionic acid to 2-Methylsuccinic acid ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 20:2 ratio in coronary artery disease
3-Indolepropionic acid to 4-Guanidinobutyric acid ratio in coronary artery disease
3-Indolepropionic acid to Isonicotinamide ratio in coronary artery disease
5-Methyluridine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to N-acetylglycine ratio in coronary artery disease
3-Indolepropionic acid to N-Acetyl-L-tyrosine ratio in coronary artery disease
L-Cystine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Cyclic AMP ratio in coronary artery disease
3-Indolepropionic acid to L-Carnitine ratio in coronary artery disease
3-Indolepropionic acid to 1,4-dihydro-1-Methyl-4-oxo-3-pyridinecarboxamide ratio in coronary artery disease
3-Indolepropionic acid to Creatine ratio in coronary artery disease
3-Indolepropionic acid to Dodecanedioic aicd ratio in coronary artery disease
3-Indolepropionic acid to LysoPC 20:1 ratio in coronary artery disease
3-Indolepropionic acid to L-Arginine ratio in coronary artery disease
3-Indolepropionic acid to Kynurenic acid ratio in coronary artery disease
3-Indolepropionic acid to 2-Hydroxyisocaproic acid ratio in coronary artery disease
3-Indolepropionic acid to 4-Pyridoxic acid ratio in coronary artery disease
Cryptococcosis in HIV infection
Childhood asthma with severe exacerbations
Bioavailable testosterone levels
interferon-related traits
Leukoderma in response to rhododendrol
HIgh-sensitivity cardiac troponin T levels (high vs low)
High-sensitivity cardiac troponin T levels
Cerebral white matter volume change rate x age interaction (1df)
Cortex volume change rate x age interaction (1df)
Cortical thickness change rate x age interaction (1df)
Hippocampus volume change rate x age interaction (1df)
Lateral ventricle volume change rate x age interaction (1df)
Tea consumption
Grapefruit juice consumption
Sweet beverage consumption
Osteoarthritis (hip)
Osteoarthritis of the hip or knee
Coronary artery disease and HDL cholesterol levels (multivariate analysis)
Coronary artery disease and LDL cholesterol levels (multivariate analysis)
Coronary artery disease and triglyceride levels (multivariate analysis)
Coronary artery disease and total cholesterol levels (multivariate analysis)
Corneal endothelial cell shape (percentage of hexagonally shaped cells)
Brain surface area change rate x age interaction (2df)
Thalamus volume change rate x age interaction (2df)
Total brain volume change rate x age interaction (2df)
Caudate volume change rate x age interaction (2df)
Pallidum volume change rate
Pallidum volume change rate x age interaction (1df)
Brain surface area change rate x age interaction (1df)
Total brain volume change rate
Diabetic kidney disease in type 2 diabetes
Osteoarthritis
Protein quantitative trait loci (liver)
Anti-drug antibodies in autoimmune disease (time to event)
Hypertension in type 2 diabetes
Adverse response to chemotherapy (amenorrhea) in breast cancer
Nucleus accumbens volume change rate x age interaction (1df)
Putamen volume change rate x age interaction (1df)
Sugar-sweetened beverage consumption
Artificially sweetened beverage consumption
Pure non-grapefruit juice consumption
Bitter beverage consumption
Chronic kidney disease in type 2 diabetes
Chronic kidney disease in diabetes
Chronic kidney disease and diabetic kidney disease in type 2 diabetes
Chronic kidney disease and diabetic kidney disease in diabetes
End-stage renal disease in type 2 diabetes
Late diabetic kidney disease in type 2 diabetes
Early diabetic kidney disease in type 2 diabetes
Early diabetic kidney disease in diabetes
Glomerular filtration rate in type 2 diabetes
Glomerular filtration rate in diabetes
Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)
Pallidum volume change rate x age interaction (2df)
Putamen volume change rate x age interaction (2df)
Diabetic kidney disease in diabetes (ESRD vs. no ESRD)
Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)
Response to tofacitinib treatment in psoriasis (herpes zoster)
Response to tofacitinib treatment (herpes zoster)(time to event)
Response to tofacitinib treatment (herpes zoster)
3-Indolepropionic acid to Lauric acid/Dodecanoic acid (C12:0) ratio in coronary artery disease
3-Indolepropionic acid to Homovanillic acid ratio in coronary artery disease
N-acetyl-l-leucine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Myoinositol ratio in coronary artery disease
3-Indolepropionic acid to Urocanic acid ratio in coronary artery disease
Riboflavin to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to Maltose ratio in coronary artery disease
D-Malic acid to 3-Indolepropionic acid ratio in coronary artery disease
D-Sucrose to 3-Indolepropionic acid ratio in coronary artery disease
Non-alcoholic chronic pancreatitis
Coffee consumption (cups per day)
Red blood cell folate levels
Plasma homocysteine levels
Putamen volume change rate
Brain surface area change rate
Thalamus volume change rate
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)
Sedentary behaviour duration
Physical activity (walking duration)
Physical activity (moderate intensity activity duration)
Physical activity (overall physical activity time)
Substance use disorder
Total brain volume change rate x age interaction (1df)
Amygdala volume change rate x age interaction (2df)
Thalamus volume change rate x age interaction (1df)
Intraocular pressure (corneal compensated)
Intraocular pressure (Goldman correlated)
Severe skin toxicity response to cetuximab in colorectal cancer
Nocturnal enuresis
1,4-dihydro-1-Methyl-4-oxo-3-pyridinecarboxamide levels in coronary artery disease
2-Methylsuccinic acid levels in coronary artery disease
3-Indolepropionic acid levels in coronary artery disease
Cis-5,8,11,14,17-eicosapentaenoic acid (C20:5n3) levels in coronary artery disease
Dodecanedioic aicd levels in coronary artery disease
Eudesmic acid (3,4,5-trimethoxybenzoic acid) levels in coronary artery disease
Glycochenodeoxycholic acid levels in coronary artery disease
Glycocholic acid levels in coronary artery disease
Hydrocinnamic acid levels in coronary artery disease
Hypoxanthine levels in coronary artery disease
Inosine levels in coronary artery disease
L-Histidine to Uric acid ratio in coronary artery disease
L-Tryptophan to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to L-Lysine ratio in coronary artery disease
3-Indolepropionic acid to Uridine ratio in coronary artery disease
3-Indolepropionic acid to Adenine ratio in coronary artery disease
3-Indolepropionic acid to L-Methionine ratio in coronary artery disease
L-Phenylalanine to 3-Indolepropionic acid ratio in coronary artery disease
3-Indolepropionic acid to L-Tyrosine ratio in coronary artery disease
3-Indolepropionic acid to Phenylpyruvic acid ratio in coronary artery disease
3-Indolepropionic acid to L-Ornithine ratio in coronary artery disease
L-Glutamine to 3-Indolepropionic acid ratio in coronary artery disease
Breakfast cereal skipping frequency
Breakfast skipping
Inflammatory biomarkers (multivariate analysis)
Cirrhosis (multi-trait analysis)
Non-tuberculous mycobacterial pulmonary disease
Mitochondrial DNA levels
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)
Lateral ventricle volume change rate x age interaction (2df)
Nucleus accumbens volume change rate x age interaction (2df)
Depressive symptoms x dependent stressful life events interaction (1df test)
Depressive symptoms x dependent stressful life events interaction (2df test)
Depressive symptoms x independent stressful life events interaction (1df test)
Depressive symptoms x independent stressful life events interaction (2df test)
Fasting blood insulin
Asthma (moderate or severe)
Major depressive disorder (MTAG)
Chronic periodontitis (localised)
Neuropsychiatric disorders
Neurological blood protein biomarker levels
Cryptic phenotype that captures alpha-1-antitrypsin deficiency severity
Anti-anoctamin 2 antibody levels
BRCA1/2-negative high-risk breast cancer
Kidney cancer
Non-Hodgkin's lymphoma
D-dimer levels in HIV infection
Interleukin-6 levels in HIV infection
High-sensitivity C-reactive protein levels in HIV infection
Meningococcal C IgG concentrations post childhood immunization
Meningococcal C functional antibody titers post childhood immunization
Tetanus toxoid IgG concentrations post childhood immunization
Lipid or lipoprotein levels
Vitamin levels
Pyridoxal levels
Sex hormone-binding globulin levels adjusted for BMI
Intra-individual response time variability (selective attention)
Fasting blood proinsulin levels
Insulinogenic index
Proinsulin levels (late-phase conversion)
Proinsulin levels (early-phase conversion)
Major depressive episode treated with electroconvulsive therapy
Major depressive disorder and major depressive episode treated with electroconvulsive therapy
Thyrotoxic periodic paralysis
Differentiated thyroid cancer
Non-HDL cholesterol levels
Lymphocytic leukemia
Colorectal cancer x fine particulate matter exposure levels interaction
Homocysteine levels
Carotenoid levels
Spondylosis
Cerebrospinal fluid p-Tau181p:AB1-42 ratio
Cognitive impairment test score
Testicular cancer
Alcohol use disorder (dependence and problematic use scores)
Coronary artery disease in individuals without type 2 diabetes
Priapism in sickle cell disease
Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity
Cryptic phenotype that captures Alport syndrome severity
Esophageal or stomach cancer
Alcohol use disorder (total score)
Alcohol use disorder (consumption score)
Hip shape (DXA scan)
Parkinson's disease (age at diagnosis)
Cancer (pleiotropy)(bidirectional)
Body size at age 10
Plasma cortisol levels (morning)
Microscopic colitis
Life satisfaction
Diverticular disease
Sex hormone-binding globulin levels
Adult body size
Serum urate levels in chronic kidney disease
Gout in chronic kidney disease
Metabolic coherence (transcriptomic)
Childhood onset type 2 diabetes
Positive affect
Peptic ulcer disease
Irritable bowel syndrome
Vesicoureteral reflux
Walking pace
Nose length
Eye length
Mouth morphology (principal component model)
Side of face morphology (partial least square model)
Cheek morphology (partial least square model)
Nose morphology (partial least square model)
Sodium levels in epilepsy
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Carbamazepine-induced hyponatremia in epilepsy
Oxcarbazepine-induced hyponatremia in epilepsy
Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy
Total body bone mineral density
Malaria
Diabetic retinopathy in type 2 diabetes
Carpal tunnel syndrome
Ulna and radius bone mineral density
Hyperglycemia
Hyperglycemia in higher physical activity
Hyperglycemia in more-fat diet
Homeostasis model assessment of insulin resistance in more-fat diet
Homeostasis model assessment of insulin resistance in less-fat diet
Hyperinsulinemia x BMI interaction
Hyperinsulinemia x physical activity interaction
Hyperinsulinemia x saturated fatty acids interaction
Homeostasis model assessment of insulin resistance x saturated fatty acids interaction
Hyperinsulinemia in obesity
Hyperinsulinemia in lower physical activity
Hyperinsulinemia in less-fat diet
Myeloproliferative neoplasms
Autoimmune pulmonary alveolar proteinosis
Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
Adenocarcinoma in never smokers
Barrett's esophagus or esophageal adenocarcinoma x sex interaction (1df test)
Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test)
Composite immunoglobulin trait (IgG/IgM)
IgM levels
IgG levels
IgA levels
Composite immunoglobulin trait (IgA x IgG x IgM)
Composite immunoglobulin trait (IgA x IgG/IgM)
Composite immunoglobulin trait (IgA x IgG)
Composite immunoglobulin trait (IgA/IgG)
Composite immunoglobulin trait (IgA/IgM)
Sphingolipid d18:1/d18:2 ratio
Anti-sp100 seropositivity in primary biliary cholangitis
Psychological resilience (outcome-based) in high deployment stress exposure
Psychological resilience (self-assessed)
Psychological resilience (outcome-based)
BRCA1 mutation in breast cancer
BRCA2 mutation in breast cancer
Diverticulitis
Suicidal ideation
Cognitive function in longevity
Carotid intima media thickness in rheumatoid arthritis
Cardiovascular event in rheumatoid arthritis
Ischemic heart disease in rheumatoid arthritis
Carotid plaques in rheumatoid arthritis
Severe diabetic retinopathy in type 2 diabetes
Emotional lability
Lack of behavioral control
Type A behavior
Locus of control over disease
Psychoticism
Insulin-like growth factor 1 levels
Metabolically unhealthy in obesity
Metabolically unhealthy in normal weight
Motor composite score
Mental composite score
Facial pigmentation measurement (UV light)
Facial pigmentation measurement (polar light)
Asthma (time to childhood onset) in early life tobacco smoke exposure
Asthma (time to childhood onset) x early life tobacco smoke interaction
Chronic kidney disease x type 2 diabetes interaction
Peripheral arterial disease x type 2 diabetes interaction
Coronary heart disease x type 2 diabetes interaction
Acute ischemic stroke x type 2 diabetes interaction
Retinopathy x type 2 diabetes interaction
Neuropathy x type 2 diabetes interaction
Asthma with severe exacerbations
Ferritin levels
Declining hemoglobin trajectory in blood donors
Addison's disease
Red blood cell traits
Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)
Personality dimensions
Cardiac Troponin-T levels
Urgency urinary incontinence
Cognitive decline
Elevated serum carcinoembryonic antigen levels
Smoking behavior
Beta-2 microglubulin plasma levels
Lipid metabolism phenotypes
Response to methotrexate in juvenile idiopathic arthritis
Digit length ratio
Febrile seizures
Febrile seizures (MMR vaccine-unrelated)
Febrile seizures (MMR vaccine-related)
Paclitaxel-induced neuropathy
Body mass index (change over time)
Systemic lupus erythematosus and Systemic sclerosis
Rheumatoid arthritis (ACPA-negative)
Thoracic aortic aneurysms and dissections
Handedness
Complement C3 and C4 levels
Maximal oxygen uptake response
Cytomegalovirus antibody response
Magnesium levels
Calcium levels
Myopia (severe)
Plasma renin activity levels
Serum VEGFR2 concentration
Schizophrenia (inflammation and infection response interaction)
Bipolar disorder (inflammation and infection response interaction)
Sitting height ratio
Exhaled carbon monoxide levels
Spine bone size
Cutaneous lupus erythematosus
Response to methotrexate in rheumatoid arthritis
Mathematical ability in children with dyslexia
Very long-chain saturated fatty acid levels (fatty acid 20:0)
Very long-chain saturated fatty acid levels (fatty acid 22:0)
Anxiety disorder
Total bilirubin levels in HIV-1 infection
Neutrophil count in HIV-infection
HDL Cholesterol in HIV-infection
Acute lymphoblastic leukemia (adolescents and young adults)
Disease-free survival in breast cancer
Airway responsiveness in chronic obstructive pulmonary disease
Kashin-Beck disease
Bone mineral density (paediatric, skull)
Parent of origin effect on language impairment (paternal)
Pulmonary emphysema
Educational attainment
Reading disability or specific language impairment (pleiotropy)
Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)
Infantile hypertrophic pyloric stenosis
Exfoliation glaucoma or exfoliation syndrome
Blood pressure (age interaction)
Airway wall thickness
Puberty onset (genital enlargement)
Puberty onset (breast development)
Puberty onset
Obesity
Response to temozolomide
Cystic fibrosis-related diabetes
Asthma and hay fever
Cocaine dependence
Pain
Serum lipase activity
High serum lipase activity
Opioid sensitivity
Stroke (ischemic)
Response to radiotherapy in prostate cancer (toxicity)
White matter integrity
White matter integrity (bipolar disorder risk interaction)
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)
Carotid intima media thickness
Underweight status
Overweight status
Hepatitis B vaccine response
Lung cancer (smoking interaction)
Red wine liking
White wine liking
Spontaneous preterm birth (preterm delivery)
Insulin resistance/response
Psychotic symptoms and prion disease
Mood disorder and prion disease
Behavioral disturbance or psychiatric symptoms and prion disease
Psychotic symptoms in prion disease
Mood disorder in prion disease
Behavioral disturbance or psychiatric symptoms in prion disease
Lipoprotein (a) - cholesterol levels
Leishmaniasis (visceral)
Creutzfeldt-Jakob disease (sporadic)
Airway hyperresponsiveness
Plasma amyloid beta peptide concentrations (ABx-40)
Plasma amyloid beta peptide concentrations (ABx-42)
Methotrexate pharmacokinetics (acute lymphoblastic leukemia)
Serum thyroid-stimulating hormone levels
Enteric fever
Colorectal cancer (calcium intake interaction)
Sleep-related phenotypes
Acute anterior uveitis (with or without ankylosing spondylitis)
Otitis media (chronic/recurrent)
Schizophrenia or bipolar disorder
Political ideology
Neuroblastoma
Adverse response to radiation therapy
Conotruncal heart defects
Response to antipsychotic treatment
Carotid plaque burden (smoking interaction)
Memory performance
Narcolepsy (onset before 2009 H1N1 influenza pandemic)
Narcolepsy (age of onset)
AIDS progression
Glioma (high-grade)
Cleft plate (environmental tobacco smoke interaction)
Chronic mucus hypersecretion
Bladder cancer (smoking interaction)
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
Asymmetrical dimethylarginine levels
Symmetrical dimethylarginine levels
Serum dimethylarginine levels (asymmetric/symetric ratio)
PR segment duration
Survival in microsatellite instability low/stable colorectal cancer
Survival in rectal cancer
Follicular lymphoma
Lupus nephritis in systemic lupus erythematosus
Apolipoprotein Levels
Cholesterol and Triglycerides
Inflammatory biomarkers in Kawasaki disease
Non-alcoholic fatty liver disease histology (other)
Personality traits in bipolar disorder
Ossification of the posterior longitudinal ligament of the spine
Bronchopulmonary dysplasia
Electrocardiographic traits
Recombination measurement (females)
Recombination measurement (males)
Tourette's syndrome or obsessive-compulsive disorder
Crohn's disease-related phenotypes
Recombination measurement
Non-small cell lung cancer (recurrence rate)
Height adjusted BMI
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection
IgE levels in asthmatics
IgE levels in asthmatics (D.p. specific)
IgE levels in asthmatics (D.f. specific)
Sleep time
Sleep quality
Sleep depth
Social autistic-like traits
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)
Lung Cancer (DNA repair capacity)
Allergic dermatitis (nickel)
Serum vitamin D-binding protein levels
Cotinine glucuronidation
Nicotine glucouronidation
Schizophrenia (treatment resistant)
Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
Mesial temporal lobe epilepsy with hippocampal sclerosis
Protein biomarker
Fractional exhaled nitric oxide levels
HIV-1 susceptibility
Very long-chain saturated fatty acid levels (fatty acid 24:0)
Vein graft stenosis in coronary artery bypass grafting
Bone mineral density (paediatric, upper limb)
Bone mineral density (paediatric, lower limb)
Body mass index (education interaction)
Response to cytidine analogues (gemcitabine)
Response to cytadine analogues (cytosine arabinoside)
Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)
Psychosis (atypical)
Response to platinum-based chemotherapy in non-small-cell lung cancer
Androgen levels
Binge eating behaviour in bipolar disorder
Binge eating behaviour and bipolar disorder
Lifespan
Breast cancer (survival)
ADAMTS13 activity
Developmental dysplasia of the hip
Prostate cancer aggressiveness
Age-related nuclear cataracts
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor
Alzheimer disease and age of onset
Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)
Exploratory eye movement dysfunction in schizophrenia (responsive search score)
Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)
Cognitive decline rate in late mild cognitive impairment
Exploratory eye movement dysfunction in schizophrenia (cognitive search score)
Acoustic startle blink response
Triglycerides
LDL cholesterol
Obstructive sleep apnea trait (average respiratory event duration)
Classic bladder exstrophy
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)
Multiple myeloma and monoclonal gammopathy
3-hydroxypropylmercapturic acid levels in smokers
Skin colour saturation
Perceived skin darkness
Skin sensitivity to sun
Epilepsy and lamotrigine-induced maculopapular eruptions
Cerebral amyloid deposition positivity (PET imaging)
Obstructive sleep apnea (average oxygen saturation during sleep)
Glaucoma (low intraocular pressure)
Glaucoma (high intraocular pressure)
Perioperative myocardial infarction in coronary artery bypass surgery
Parkinson disease and lewy body pathology
HIV-1 viral setpoint
Inguinal hernia
IgA nephropathy
3-hydroxy-1-methylpropylmercapturic acid levels in smokers
Ischemic stroke (large artery atherosclerosis)
Paclitaxel-induced cytotoxicity
Cough in response to angiotensin-converting enzyme inhibitor drugs
Obesity in adult survivors of childhood cancer exposed to cranial radiation
Obesity in adult survivors of childhood cancer not exposed to cranial radiation
Bone mineral accretion in asthma (oral corticosteroid dose interaction)
Sex hormone levels
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis
Hypersomnia during a major depressive episode in bipolar disorder
Lewy body disease
Dementia and core Alzheimer's disease neuropathologic changes
Multiple myeloma (survival)
Vascular brain injury
Hippocampal sclerosis
Sporadic pituitary adenoma
Pediatric autoimmune diseases
Attention function in attention deficit hyperactive disorder
Bone mineral density (spine) and age at menarche
Bone mineral density (hip) and age at menarche
Warfarin maintenance dose
Urinary metabolites
Peak creatinine levels in vancomycin therapy
Rotator cuff tears
Postburn hypertrophic scarring severity
Soluble interleukin-2 receptor subunit alpha
Glucocorticoid-induced osteonecrosis (time dependent analysis)
Glucocorticoid-induced osteonecrosis (age 10 years and older)
Glucocorticoid-induced osteonecrosis
Urinary albumin-to-creatinine ratio in non-diabetics
Asparaginase hypersensitivity in acute lymphoblastic leukemia
MGMT methylation in smokers
White matter lesion progression
White matter lesion progression (adjusted for white matter lesion burden at baseline)
Longitudinal alcohol consumption
Juvenile osteochondritis dissecans
Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)
Suicide behavior
Suicide ideation score in major depressive disorder
Cingulate cortical amyloid beta load
Plasma lactate levels
Coronary artery aneurysm in Kawasaki disease
Antipsychotic drug-induced weight gain
Antipsychotic drug-induced weight gain (time interaction)
Lung disease severity in cystic fibrosis
Metastasis at diagnosis in osteosarcoma
Response to montelukast in asthma (change in FEV1)
Staphylococcus aureus infection
Skin and soft tissue Staphylococcus aureus infection
Joint damage progression in ACPA-negative rheumatoid arthritis
Myositis
Gastric adenocarcinoma (histologically verified)
Prostate cancer (survival)
Gait variability
Gait rhythm
Tandem gait
Diabetic kidney disease
Cardiovascular disease in hypertension (ACE inhibitor interaction)
Cardiovascular disease in hypertension (calcium channel blocker interaction)
Myocardial infarction in hypertension (calcium channel blocker interaction)
Setpoint viral load in HIV-1 infection
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression
Pelvic organ prolapse (moderate/severe)
Ear protrusion
Tragus size
Antitragus size
Superior crus of antihelix expression
Ear morphology
Lobe size
Lobe attachment
Survival in colorectal cancer
Survival in colorectal cancer (non-distant metastatic)
Survival in colorectal cancer (distant metastatic)
Helix rolling
Folding of antihelix
Survival in endocrine treated breast cancer (estrogen-receptor positive)
Atopic march
Mitral valve prolapse
Hearing loss in noise exposure
Cardia gastric cancer
Non-cardia gastric cancer
Platinum-induced myelosuppression in non-small cell lung cancer
Thionamide-induced agranulocytosis in Graves' disease
Triptolide cytotoxicity
Atrioventricular septal defects in Down syndrome
Dysphagia
Adiponectin levels (BMI-adjusted)
Response to interferon beta in multiple sclerosis
Spherical equivalent (joint analysis main effects and education interaction)
Late-onset myasthenia gravis
Response to lithium treatment in bipolar disorder (dichotomous phenotype)
Response to lithium treatment in bipolar disorder (continuous phenotype)
Sense of smell
Cannabis use
Lapatinib-induced hepatotoxicity
Rheumatoid factor seropositivity in rheumatoid arthritis
Aggressiveness in attention deficit hyperactivity disorder
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
Collagenous colitis
Response to fenofibrate (HDL cholesterol levels)
Response to fenofibrate (LDL cholesterol levels)
Response to fenofibrate (total cholesterol levels)
Response to fenofibrate (triglyceride levels)
Parental extreme longevity (95 years and older)
S-phenylmercapturic acid levels in smokers
Thyroid-associated orbitopathy in graves' disease
Anterior chamber depth
Epstein Barr virus nuclear antigen 1 IgG levels
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis
Glomerular filtration rate in non diabetics (creatinine)
Glomerular filtration rate in diabetics (creatinine)
Calcaneal bone ultrasound measurement (speed of sound)
Colorectal or endometrial cancer
Serum lycopene concentrations
Gut microbiome composition (summer)
Gut microbiome composition (winter)
Rapid functional decline in sporadic amyotrophic lateral sclerosis
Ischemic stroke (small artery occlusion)
Ischemic stroke (undetermined subtype)
Chronic bronchitis and chronic obstructive pulmonary disease
Chronic bronchitis in chronic obstructive pulmonary disease
Cutaneous psoriasis
Psoriatic arthritis
antipsychotic drug dosage in schizophrenia or schizoaffective disorder
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)
Response to anti-TNF therapy in rheumatoid arthritis
Lead levels in blood
Betaine levels in individuals undergoing cardiac evaluation
Thoracic-to-hip circumference ratio
Post bronchodilator FEV1 in COPD
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
Congenital left-sided heart lesions
White matter hyperintensity burden
Squamous cell carcinoma
Obsessive-compulsive symptoms
Oligoclonal band status in multiple sclerosis
Immunoglobulin G index levels in multiple sclerosis
Colorectal cancer (aspirin and/or NSAID use interaction)
Myasthenia gravis
Gut microbiome composition (summer and winter)
Body mass index (age interaction)
Facial pigmentation
Plasma plasminogen activator levels
Low high density lipoprotein cholesterol levels
Anxiety disorder (factor score)
Subcortical brain region volumes
Eyebrow thickness
Scalp hair shape
Monobrow thickness
Hair greying
Beard thickness
White matter hyperintensities in ischemic stroke
Balding
Thrombosis
Entorhinal cortical thickness
Whole-brain volume
Entorhinal cortical thickness (Alzheimer's disease interaction)
Total ventricular volume
Entorhinal cortical volume (Alzheimer's disease interaction)
Total ventricular volume (Alzheimer's disease interaction)
Whole-brain volume (Alzheimer's disease interaction)
NT-proBNP levels in acute coronary syndrome
Sex ratio
Incident coronary heart disease
Incident myocardial infarction
Manic episodes in bipolar disorder
Depressive episodes in bipolar disorder
Depressive and manic episodes in bipolar disorder
Periodontal disease-related phenotype (Socransky)
Periodontal disease related phenotype (PCT3)
Periodontal disease related phenotype (PCT4)
Periodontal disease related phenotype (PCT5)
Lung cancer (SNP x SNP interaction)
Nasopharyngeal carcinoma (SNP x SNP interaction)
Low bone mineral density (spine)
Low bone mineral density (hip)
Early response to risperidone in schizophrenia
Airway imaging phenotypes
Emphysema imaging phenotypes
Percentage gas trapping
Cerebral amyloid deposition (PET imaging)
Suicide in bipolar disorder
Alcohol and nicotine co-dependence
Yang-deficiency constitution
Sagittal craniosynostosis
Cataracts in type 2 diabetes
Urate levels in obese individuals
Food antigen IgG levels
Diffuse large B cell lymphoma
Response to serotonin reuptake inhibitors in major depressive disorder
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)
Gene methylation in lung tissue
Neuropathic pain in type 2 diabetes
Milk allergy
Egg allergy
Circulating phylloquinone levels
Birdshot chorioretinopathy
Vogt-Koyanagi-Harada syndrome
Aggressive periodontitis (sex interaction)
Hepatitis
Homoarginine levels
Sickle cell anemia (haemolysis)
Verbal declarative memory
Iron status biomarkers (transferrin levels)
Clozapine-induced cytotoxicity
Alzheimer's disease (survival time)
Recalcitrant atopic dermatitis
Body mass (lean)
Dental caries
Obesity (early onset extreme)
Pulmonary function in asthmatics
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Thiazide-induced adverse metabolic effects in hypertensive patients
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia
Musician's dystonia
Proinsulin levels
Hippocampal atrophy
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement
Gastritis
Sight-threatening diabetic retinopathy in type 2 diabetes
Proteinuria in chronic kidney disease
Proteinuria and chronic kidney disease
Glomerular filtration rate in chronic kidney disease
Response to zileuton treatment in asthma (FEV1 change interaction)
Staphylococcus aureus nasal carriage (persistent)
Staphylococcus aureus nasal carriage (intermittent)
Trichloroethylene-induced hypersensitivity syndrome
Adenocarcinoma
Response to simvastatin treatment (PCSK9 protein level change)
IgG1 response to Plasmodium falciparum antigen (GLURP)
IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)
Blond vs non-blond hair color
Brown vs. non-brown hair color
Light vs. dark hair color
Red vs non-red hair color
Postprandial triglyceride response to high fat diet meal
Forced expiratory volume in 1 second (occupational environmental exposures interaction)
Yu-Zhi constitution type in type 2 diabetes
Black vs. non-black hair color
C-reactive protein levels in ischemic stroke
Thrombomodulin levels in ischemic stroke
Creatinine levels in ischemic stroke
Thrombin-antithrombin complex levels in ischemic stroke
Fibrinogen levels in ischemic stroke
Prothrombin fragments F1+2 levels in ischemic stroke
Anthracycline-induced cardiotoxicity in childhood cancer
Postoperative atrial fibrillation in coronary artery bypass grafting surgery
Platelet thrombus formation
Longitudinal change in brain amyloid plaque burden
Serum alpha1-antitrypsin levels
Pyoderma gangrenosum in inflammatory bowel disease
Erythema nodosum in inflammatory bowel disease
middle facial morphology traits (quantitative measurement)
lower facial morphology traits (quantitative measurement)
facial morphology traits (multivariate analysis)
Verbal-numerical reasoning
Liver fibrosis severity in HIV/hepatitis C co-infection
Left superior temporal gyrus thickness (schizophrenia interaction)
Anti-thyroid drug induced agranulocytosis
Non-chemotherapy drug induced agranulocytosis
Influenza A (H1N1) severity
Influenza A (H1N1) infection
Mild influenza (H1N1) infection
Severe influenza A (H1N1) infection
Diastolic blood pressure response to hydrochlorothiazide in hypertension
Systolic blood pressure response to hydrochlorothiazide in hypertension
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)
Gestational age at birth in labor-initiated deliveries (child effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)
Gestational age at birth in labor-initiated deliveries (maternal effect)
Estrogen receptor status in HER2 negative breast cancer
Estrogen receptor status in breast cancer
Eating disorder in bipolar disorder
Bipolar disorder and eating disorder
Pathological gambling
Ideal cardiovascular health (clinical and behavioral)
Ideal cardiovascular health (clinical)
Conscientiousness
Extraversion
Acute kidney injury in coronary artery bypass surgery (creatinine rise)
LDL peak particle diameter (total fat intake interaction)
EGFR mutation-positive lung adenocarcinoma
Cannabis use (initiation)
Parkinson's disease (familial, age at onset)
Celiac disease and Rheumatoid arthritis
QT interval (sulfonylurea treatment interaction)
JT interval (sulfonylurea treatment interaction)
QRS interval (sulfonylurea treatment interaction)
Systemic juvenile idiopathic arthritis
Erythrocyte cadmium concentration
Erythrocyte cadmium concentration in never smokers
Clinical laboratory measurements
Cluster headache
Cerebrospinal fluid clusterin levels
Plasma clusterin levels
Bone mineral density (Ward's triangle area)
Cerebrospinal fluid clusterin levels in APOEe4- carriers
Cerebrospinal fluid clusterin levels in APOEe4+ carriers
Urinary electrolytes (magnesium/calcium ratio)
Pneumococcal bacteremia
Bacteremia
Subcutaneous adipose tissue attenuation (Hounsfield unit scale)
Visceral adipose tissue attenuation (Hounslow unit scale)
Discordance in emotional problems in monozygotic twins
C4b binding protein levels
Response to hepatitis C treatment
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Hoarding
Response to metformin in type 2 diabetes (glycemic)
Lp (a) levels
Anti-cyclic Citrullinated Peptide Antibody
Prion diseases
Phytosterol levels
Major depressive disorder (broad)
Platelet aggregation
Speech perception in dyslexia
HIV-1 control
Myocardial infarction in coronary artery disease
Nephrotic syndrome (acquired)
Response to treatment for acute lymphoblastic leukemia
Asthma (toluene diisocyanate-induced)
Idiopathic membranous nephropathy
Blue vs. green eyes
Burning and freckling
Blond vs. brown hair color
Red vs. non-red hair color
Homeostasis model assessment of beta-cell function
Inflammatory biomarkers
Response to citalopram treatment
Ribavirin-induced anemia
Hepatitis C induced liver cirrhosis
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
Lipoprotein-associated phospholipase A2 activity and mass
Waist circumference and related phenotypes
AIDS
Metabolic traits
Fibrinogen
Monocyte early outgrowth colony forming units
Neuroticism (age interaction)
Emphysema-related traits
Major mood disorders
Alzheimer's disease biomarkers
Diabetic retinopathy
Menarche and menopause (age at onset)
Autism
Brain cytoarchitecture
Multiple sclerosis (severity)
Creutzfeldt-Jakob disease
Angiotensin-converting enzyme activity
Lumiracoxib-related liver injury
Otosclerosis
Two-hour glucose challenge
Moyamoya disease
Inflammatory bowel disease (early onset)
Bitter taste response
Coagulation factor levels
Circulating cell-free DNA
HIV-1 replication
Male infertility
Response to statin therapy
Brachial circumference
Permanent tooth development
Helicobacter pylori serologic status
Bipolar disorder and schizophrenia
Lentiform nucleus volume
Pulmonary function
Renal function-related traits (eGRFcrea)
Renal function-related traits (urea)
Renal function-related traits (BUN)
Renal function-related traits (sCR)
Pit-and-Fissure caries
Smooth-surface caries
Circulating vasoactive peptide levels
Aging (facial)
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
Schizophrenia (negative symptoms)
IgE levels
Response to diuretic therapy
End-stage coagulation
Blood trace element (Zn levels)
Blood trace element (Se levels)
Blood trace element (Cu levels)
Hematological parameters
Ovarian reserve
Leisure-time exercise behaviour
Cognitive performance
Schizophrenia, bipolar disorder and depression (combined)
Pubertal anthropometrics
Ileal carcinoids
Adverse response to aromatase inhibitors
IgE grass sensitization
Soluble ICAM-1
Activated partial thromboplastin time
Prothrombin time
Response to TNF antagonist treatment
Hypospadias
Hypertension (young onset)
Attention deficit hyperactivity disorder and conduct disorder
Response to anti-TNF alpha therapy in inflammatory bowel disease
Crohn's disease and sarcoidosis (combined)
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)
Conduct disorder (maternal expressed emotions interaction)
Life threatening arrhythmia
Black vs. blond hair color
Black vs. red hair color
Coronary artery calcification
Cardiovascular disease risk factors
Pulmonary arterial hypertension (without BMPR2 mutations)
&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
Scoliosis
Relative hand skill in reading disability
Relative hand skill
Biliary atresia
Response to Vitamin E supplementation
Immune response to anthrax vaccine
Response to dabigatran etexilate treatment
Response to antipsychotic treatment in schizophrenia (working memory)
Response to antipsychotic treatment in schizophrenia (reasoning)
Ulcerative colitis or Crohn's disease
Electroencephalographic traits in alcoholism
DNA methylation (parent-of-origin)
DNA methylation (variation)
Partial epilepsies
Renal sinus fat
Depression (quantitative trait)
Gamma glutamyl transpeptidase
Airflow obstruction
Tumor biomarkers
Metabolite levels (MHPG)
Metabolite levels (5-HIAA/ MHPG Ratio)
Metabolite levels (HVA/MHPG ratio)
Metabolite levels (HVA/5-HIAA ratio)
Metabolite levels (HVA)
Metabolite levels (5-HIAA)
Metabolite levels (HVA-5-HIAA Factor score)
Clozapine-induced agranulocytosis
Body mass index in non-asthmatics
Body mass index in asthmatics
Paraoxonase activity
Urinary symptoms in response to radiotherapy in prostate cancer
Response to fenofibrate (adiponectin levels)
Non-obstructive azoospermia
Non-albumin protein levels
Aging
Femoral neck bone geometry
Amyotrophic lateral sclerosis (age of onset)
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals
Chronic kidney disease and serum creatinine levels
Vitamin E levels
Serum ceruloplasmin levels
HPV seropositivity
Progressive supranuclear palsy
Esophageal cancer and gastric cancer
Neonatal lupus
Wilms tumor
Age-related macular degeneration (wet)
Anthropometric traits in newborns
Adiposity
Response to fenofibrate
Select biomarker traits
F-cell distribution
Recombination rate (males)
Recombination rate (females)
Eye color traits
Brain structure (hippocampal volume)
Brain structure (temporal lobe volume)
Other erythrocyte phenotypes
Retinal vascular caliber
Urinary albumin excretion
Restless legs syndrome
Osteonecrosis of the jaw
Blue vs. brown eyes
Suicide risk
IgG glycosylation
Crohn's disease (time to surgery)
Crohn's disease (need for surgery)
Diabetes (incident)
Diabetes related insulin traits
Waist Circumference - Triglycerides (WC-TG)
Metabolic syndrome (bivariate traits)
HDL Cholesterol - Triglycerides (HDLC-TG)
Triglycerides-Blood Pressure (TG-BP)
Testicular germ cell cancer
Corneal structure
HIV-1 progression
Fetal hemoglobin levels
Response to tamoxifen in breast cancer
Prostate cancer (SNP x SNP interaction)
Intelligence (childhood)
Asperger disorder
Non-alcoholic fatty liver disease histology (AST)
Temperament (bipolar disorder)
RR interval (heart rate)
Glaucoma (exfoliation)
Non-alcoholic fatty liver disease histology (lobular)
Rhegmatogenous retinal detachment
Neuranatomic and neurocognitive phenotypes
Vaccine-related adverse events
Freckling
Common traits (Other)
Liver enzyme levels
Iron levels
Factor VII
Hemostatic factors and hematological phenotypes
Biomedical quantitative traits
Vitamin D insufficiency
F-cell distribution in sickle cell anaemia
Serum prostate-specific antigen levels
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)
Psychosis (methamphetamine induced)
Methamphetamine dependence
Quantitative traits
Alcoholism (heaviness of drinking)
Alcoholism (12-month weekly alcohol consumption)
Alcoholism (alcohol use disorder factor score)
Alcoholism (alcohol dependence factor score)
Obesity-related traits
Optic disc parameters
Neuroblastoma (high-risk)
Hyperactive-impulsive symptoms
Inattentive symptoms
Age-related macular degeneration (smoking status interaction)
Age-related macular degeneration (extreme sampling)
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
Brain structure
Heart rate variability traits
Brain imaging
Attention deficit hyperactivity disorder (time to onset)
Beta thalassemia/hemoglobin E disease
Hair morphology
Response to interferon beta therapy
Acenocoumarol maintenance dosage
Folate pathway vitamin levels
Coronary spasm
Exercise treadmill test traits
Echocardiographic traits
Endothelial function traits
Primary tooth development (number of teeth)
Primary tooth development (time to first tooth eruption)
Subclinical atherosclerosis traits (other)
Volumetric brain MRI
Cognitive test performance
Cardiac muscle measurement
Large B-cell lymphoma
Attention deficit hyperactivity disorder motor coordination
Functional MRI
Iron deficiency
Optic nerve measurement (cup area)
Optic nerve measurement (rim area)
Optic nerve measurement (disc area)
Optic nerve measurement (cup-to-disc ratio)
5-HTT brain serotonin transporter levels
Major CVD
Cystatin C levels
Carotenoid and tocopherol levels
Iris color
Hip geometry
Insulin-like growth factors
Response to acetaminophen (hepatotoxicity)
Tonometry
Lymphoma
Aging traits
Morbidity-free survival
YKL-40 levels
Atrial fibrillation/atrial flutter
Myocardial infarction (early onset)
Natriuretic peptide levels
Hearing impairment
Parkinson's disease (familial)
Celiac disease or Rheumatoid arthritis
Bipolar disorder (age of onset and psychotic symptoms)
Sphingolipid levels
Multiple sclerosis (age of onset)
Normalized brain volume
Brain lesion load
Carotid atherosclerosis in HIV infection
Multiple sclerosis--Brain Glutamate Levels
Creutzfeldt-Jakob disease (variant)
Beta-trace protein levels
Cardiovascular risk factors (age interaction)
Cardiovascular risk factors
Cardiac structure and function
Electrocardiographic conduction measures
Soluble E-selectin levels
Osteosarcoma
Serum selenium levels
Urinary bladder cancer
Osteoporosis-related phenotypes
Erectile dysfunction and prostate cancer treatment
Atrioventricular conduction
Pulmonary function (smoking interaction)
Biochemical measures
Body mass in chronic obstructive pulmonary disease
Alcohol consumption (transferrin glycosylation)
Event-related brain oscillations
Orofacial clefts (maternal alcohol consumption interaction)
Congenital heart malformation
Vitiligo (non-segmental)
Sudden cardiac arrest
Mean forced vital capacity from 2 exams
Soluble levels of adhesion molecules
Cardiac hypertrophy
Glomerulosclerosis
Cutaneous nevi
Immunoglobulin A
Obesity and osteoporosis
Arterial stiffness
Radiation response
Disc degeneration (lumbar)
Stroke (pediatric)
HbA2 levels
Sunburns
Caffeine consumption
Cholelithiasis-related traits in sickle cell anemia
LDL (oxidized)
Venous thromboembolism (SNP x SNP interaction)
Drinking behavior
Periodontal microbiota
Dengue shock syndrome
Circulating myeloperoxidase levels (serum)
Circulating myeloperoxidase levels (plasma)
Liver enzyme levels (alanine transaminase)
Liver enzyme levels (gamma-glutamyl transferase)
Liver enzyme levels (alkaline phosphatase)
Hypersomnia (HLA-DQB1*06:02 negative)
White blood cell types
Erythrocyte sedimentation rate
Palmitic acid (16:0) levels
Stearic acid (18:0) levels
QT interval (drug interaction)
Formal thought disorder in schizophrenia
Aspirin hydrolysis (plasma)
Head circumference (infant)
Brain connectivity
Attention deficit hyperactivity disorder (combined symptoms)
Psychosis and Alzheimer's disease
Psychosis in Alzheimer's disease
Lung cancer (asbestos exposure interaction)
Response to amphetamines
Bone mineral density (wrist)
Age-related macular degeneration (choroidal neovascularisation)
Age-related macular degeneration (geographic atrophy)
Age-related macular degeneration (CNV vs. GA)
Cardiovascular heart disease in diabetics
Preeclampsia
Sexual dysfunction (SSRI/SNRI-related)
Response to gemcitabine in pancreatic cancer
Visceral fat
Sexual dysfunction (female)
Esophageal cancer (squamous cell)
Esophageal cancer  (alcohol interaction)
Estradiol plasma levels (breast cancer)
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
Type 2 diabetes (dietary heme iron intake interaction)
Capecitabine sensitivity
Pulmonary function decline
Age at smoking initiation in chronic obstructive pulmonary disease
Smoking cessation in chronic obstructive pulmonary disease
Lifetime average cigarettes per day in chronic obstructive pulmonary disease
Hypertension risk in short sleep duration
Self-employment
Adverse response to carbamazepine
Small-cell lung cancer (survival)
Retinopathy in non-diabetics
Alzheimer's disease (cognitive decline)
Insulin-related traits
Cystic fibrosis severity
Response to bleomycin (chromatid breaks)
Thyroid hormone levels
Aspirin exacerbated respiratory disease in asthmatics
Response to cholinesterase inhibitors in Alzheimer's disease
Hypertension (SNP x SNP interaction)
Coronary heart disease (SNP X SNP interaction)
C-reactive protein and white blood cell count
Gambling
Response to anti-depressant treatment in major depressive disorder
Epirubicin-induced leukopenia
Anxiety in major depressive disorder
Anxiety and major depressive disorder
Molar-incisor hypomineralization
Odorant perception (isobutyraldehyde)
Odorant perception (&beta;-damascenone)
Odorant perception (&beta;-ionone)
Lean body mass and age at menarche (combined)
Epstein-Barr virus immune response (EBNA-1)
Type 1 diabetes nephropathy
Periodontitis (DPAL)
Periodontitis (PAL4Q3)
Periodontitis (Mean PAL)
Periodontitis (CDC/AAP)
Multiple sclerosis (OCB status)
Serum protein levels (sST2)
Esophageal squamous cell cancer (length of survival)
Comprehensive strength and appendicular lean mass
Response to tocilizumab in rheumatoid arthritis
Body mass index and cholesterol (psychopharmacological treatment)
Response to antineoplastic agents
Asthma (bronchodilator response)
Thyroid function
Breast cancer in BRCA2 mutation carriers
Lipid levels in hepatitis C treatment
Handedness in dyslexia
Vascular dementia
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes
Gastric parietal cell autoantibody levels in type 1 diabetes
Thyroid peroxidase autoantibody levels in type 1 diabetes
Response to angiotensin II receptor blocker therapy
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
Hepatitis B (viral clearance)
Thyroid cancer (Papillary, radiation-related)
Renal transplant outcome
Economic and political preferences
Economic and political preferences (environmentalism)
Economic and political preferences (fairness)
Economic and political preferences (feminism/equality)
Antipsychotic drug-induced QTc interval prolongation
Economic and political preferences (immigration/crime)
Economic and political preferences (time)
Haptoglobin levels
Male fertility
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
Cerivastatin-induced rhabdomyolysis
Dialysis-related mortality
Response to antidepressants
Nephropathy
Immune response to smallpox vaccine (IL-6)
Fat distribution (HIV)
Coronary restenosis
HIV-associated dementia
Drug-induced liver injury (amoxicillin-clavulanate)
Immune reponse to smallpox (secreted IL-12p40)
Immune reponse to smallpox (secreted IL-2)
Immune reponse to smallpox (secreted IL-10)
Immune reponse to smallpox (secreted IL-1beta)
Crohn's disease and celiac disease
Immune reponse to smallpox (secreted IFN-alpha)
Immune reponse to smallpox (secreted TNF-alpha)
Duodenal ulcer
Femoral neck bone geometry and menarche (age at onset)
Phospholipid levels (plasma)
Coronary heart disease event reduction (statin therapy interaction)
Crohn's disease and psoriasis
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
Adverse response to chemotherapy in breast cancer (alopecia)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
Response to TNF-alpha inhibitors in rheumatoid arthritis
Mortality in heart failure
B cell non-Hodgkin lymphoma
Adolescent idiopathic scoliosis (severe)
End-stage renal disease (non-diabetic)
Parkinson's disease (motor and cognition)
Sexual dimorphism in anthropometric traits
Sclerosing cholangitis and ulcerative colitis (combined)
Weight loss (gastric bypass surgery)
Anticoagulant levels
Premature ovarian failure
Nevirapine-induced rash
Paget's disease
Thyrotoxic hypokalemic periodic paralysis
Multiple myeloma (IgH translocation)
Multiple myeloma (hyperdiploidy)
Addiction
Post-traumatic stress disorder (asjusted for relatedness)
Substance dependence
Callous-unemotional behaviour
Bulimia nervosa
Eating disorders (purging via substances)
Eating disorders
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)
Tetralogy of Fallot
Treatment response for severe sepsis
Schizophrenia (cytomegalovirus infection interaction)
IFN-related cytopenia
Food addiction
Headache
Systemic lupus erythematosus or rheumatoid arthritis
Neurociticism
Irritable mood
Feeling lonely
Feeling miserable
Mortality
Experiencing mood swings
Feeling guilty
Worry too long after an embarrassing experience
Feeling fed-up
Feeling nervous
Forearm bone mineral density
Feeling worry
Suffering from nerves
Early age at menarche
Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)
Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
Response to hepatitis B vaccine
Carotid artery external diameter
Carotid artery internal diameter
Dimensional psychopathology (Negative)
Dimensional psychopathology (Arousal)
Dimensional psychopathology (Social)
Dimensional psychopathology (Positive)
Dimensional psychopathology (Cognitive)
Multiple sclerosis and systolic blood pressure (pleiotropy)
Multiple sclerosis and body mass index (pleiotropy)
Multiple sclerosis and waist-to-hip-ratio (pleiotropy)
Multiple sclerosis and type 2 diabetes (pleiotropy)
Multiple sclerosis and C-reactive protein levels (pleiotropy)
Multiple sclerosis and triglyceride levels (pleiotropy)
Multiple sclerosis and LDL levels (pleiotropy)
Multiple sclerosis and HDL levels (pleiotropy)
Survival in sporadic amyotrophic lateral sclerosis
Age at first sexual intercourse
Overall survival in osteosarcoma
Possible neuropathic pain in post total joint replacement surgery for osteoarthritis
Pre bronchodilator FEV1/FVC ratio in never-smokers
Serum metabolite concentrations in chronic kidney disease
Urinary metabolite ratios in chronic kidney disease
Depressive symptom measurement or major depressive disorder
Factor XI
Response to antipsychotic treatment in schizophrenia
Response to ziprazidone in schizophrenia
Response to quetiapine in schizophrenia
Response to haloperidol in schizophrenia
Response to perphenazine in schizophrenia
Response to aripiprazole in schizophrenia
Response to risperidone in schizophrenia
Response to olanzapine in schizophrenia
Serum metabolite ratios in chronic kidney disease
Empathy quotient
Bone mineral density x blood lead interaction in current smokers (2df test)
Bone mineral density x blood lead interaction in current smokers (1df test)
Type 2 diabetes (age of onset)
Angiotensin-converting enzyme inhibitor intolerance
Erosive tooth wear (severe vs non-severe)
Depression in response to interferon-based therapy in chronic hepatitis C
Total cholesterol levels in small VLDL
Free cholesterol levels in small VLDL
Triglyceride levels in small VLDL
Free cholesterol levels in IDL
Triglyceride levels in IDL
Large LDL particle concentration
Very small VLDL particle concentration
Phospholipid levels in very small VLDL
Triglyceride levels in very small VLDL
IDL particle concentration
Mortality in sepsis
Breast cancer-free interval (treatment with aromatase inhibitor)
Thiopurine S-methyltransferase activity
Inhibitory control
Heart rate response to exercise
Heart rate response to recovery post exercise
Cranial base width
Lower facial height
Facial depth
CSF tryptophan concentration in tuberculous meningitis
Autoimmune hepatitis in primary sclerosing cholangitis
Liver transplant-free survival in primary sclerosing cholangitis (time to event)
Cholangiocarcinoma in primary sclerosing cholangitis
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)
Colorectal carcinoma in primary sclerosing cholangitis
Papillary thyroid cancer
Offspring birth weight
Phosphorus levels
Total bilirubin levels
Ejection fraction
Left ventricular internal dimension in diastole
Left ventricular internal dimension in systole
Relative wall thickness
Fractional shortening
Blood sugar levels
Carbamazepine-induced maculopapular exanthema
Phenytoin-induced maculopapular exanthema
Parkinson's disease (pesticide exposure interaction)
Opioid requirements during laparoscopic-assisted colectomy
Bipolar disorder (early onset)
Albumin-globulin ratio
Epstein Barr virus nuclear antigen 1 IgG seropositivity
Viral capsid antigen IgG seropositivity
Epstein-Barr virus immune response (multivariate analysis)
Osteoarthritis of the hip or knee (with total joint replacement)
Osteoarthritis of the hip (with total joint replacement)
Osteoarthritis of the knee (with total joint replacement)
Serum C3d:C3 ratio (systemic complement activation)
Potassium levels
Chloride levels
Sodium levels
Laterality in neovascular age-related macular degeneration
Curve progression in adolescent idiopathic scoliosis
Immunoglobulin measurement (zinc sulfate turbidity test)
Persistent hepatitis B virus infection
Acute kidney injury in critical illness
Feeling hurt
Feeling tense
Virologic severity in Herpes simplex virus type 2 infection
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy
Nontyphoidal Salmonella bacteraemia
Uveitis (juvenile idiopathic arthritis-associated)
Esophageal adenocarcinoma x smoking interaction
Esophageal adenocarcinoma x pack-years of smoking exposure interaction
Esophageal adenocarcinoma x gastroesophageal reflux disease interaction
Barrett's esophagus x BMI interaction
Barrett's esophagus x pack-years of smoking exposure interaction
Thiopurine-induced leukopenia in inflammatory bowel disease
Serum bilirubin levels x sex interaction in metabolic syndrome
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome
Serum bilirubin levels in metabolic syndrome
Nonobstructive coronary artery disease
Change in glucose in response to thiazide diuretic treatment in hypertension
Broad depression or major depressive disorder (self-reported)
Broad depression or major depressive disorder (recurrent)
Broad depression or bipolar disorder
Broad depression or schizophrenia
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)
Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels
Ischemic stroke (small-vessel)
Antipsychotic drug-induced QTc interval change in schizophrenia
Plasma trimethyllysine levels
Sarcoidosis (non-Lofgren's syndrome)
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
Alcoholic chronic pancreatitis
Vitamin D levels (dietary vitamin D intake interaction)
Sarcoidosis (Lofgren's syndrome)
Total body bone mineral density (age 15-30)
Total body bone mineral density (age 30-45)
Total body bone mineral density (age 45-60)
Colorectal cancer (alcohol consumption interaction)
Plantar fascial disorders
Osteoarthritis (self-reported)
Osteoarthritis of the hip (hospital diagnosed)
Osteoarthritis (hospital diagnosed)
Osteoarthritis of the knee (hospital diagnosed)
Osteoarthritis of the hip or knee (hospital diagnosed)
Fast beta electroencephalogram
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced severe leukopenia in inflammatory bowel disease
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease
Thiopurine-induced alopecia in inflammatory bowel disease
Thiopurine-induced severe alopecia in inflammatory bowel disease
Thiopurine-induced pancreatitis in inflammatory bowel disease
Thiopurine-induced digestive symptoms in inflammatory bowel disease
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Hip minimal joint space width
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)
Systemic sclerosis (anti-centromere-positive)
Systemic sclerosis (anti-topoisomerase-positive)
Stimulated C-peptide levels in type I diabetes
Random C-peptide levels in type I diabetes
C-peptide levels in type I diabetes
Waist-to-hip ratio adjusted for BMI in inactive individuals
ADAMTS13 levels
Pseudoexfoliation syndrome
Risky sexual behaviors in alcohol dependence
Job-related exhaustion in shift workers
Hepatitis B virus-related hepatocellular carcinoma
Cortisol levels (saliva)
Maternal history of Alzheimer's disease
Response to mepolizumab in severe asthma
Mosaic loss of chromosome Y
Cardiometabolic and hematological traits
Paternal history of Alzheimer's disease
Total body bone mineral density (age 0-15)
Total body bone mineral density (age over 60)
Premature menopause in childhood cancer survivors
Severe progression in rheumatoid arthritis
Erosive tooth wear (severe vs none or mild)
Brain volume in infants (white matter)
Brain volume in infants (cerebrospinal fluid)
Brain volume in infants (grey matter)
Brain volume in infants (intracranial brain volume)
Smoking behaviour (maximum cigarettes in a 24 hour period)
Nicotine withdrawal symptom count
Nicotine withdrawal
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
Hyperthyroidism
Cerebrospinal fluid biomarker levels
Hematoma volume in lobar spontaneous intracerebral hemorrhage
Hematoma volume in non-lobar spontaneous intracerebral hemorrhage
Left ventricular QRS voltage
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines
Fractional excretion of metabolites in chronic kidney disease
Major depressive disorder (unexposed to adversity)
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
Keratinocyte cancer (MTAG)
Surgical necrotising enterocolitis in extremely premature birth
Suicidality (suicidal ideation/attempts)
Suicidality
Brain glucose metabolism (fluorodeoxyglucose uptake)
Self-reported allergy
Aortic stiffness
Bipolar disorder (mania)
Hepatitis C induced liver fibrosis
Migraine - clinic-based
Migraine with aura
Epilepsy (remission after treatment)
Body mass index (SNP x SNP interaction)
Response to platinum-based chemotherapy (carboplatin)
Response to platinum-based chemotherapy (cisplatin)
Reading and spelling
Factor VII levels
Non-word repetition
Glycemic traits
Occipital cortical area (total cortical area interaction)
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)
Eosinophilic esophagitis (pediatric)
Plasminogen activator inhibitor type 1 levels (PAI-1)
Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
Vaspin levels
Hashimoto thyroiditis versus Graves' disease
Electrodermal activity
Bone properties (heel)
Cleft lip
Esophageal squamous cell carcinoma
Aortic-valve calcification
Job-related exhaustion
Chronic myeloid leukemia
Wegener's granulomatosis
Borderline personality disorder features
Response to platinum-based agents
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)
Colorectal cancer (SNP x SNP interaction)
Systolic blood pressure in sickle cell anemia
Pancreatitis
Depression and alcohol dependence
Bipolar disorder with mood-incongruent psychosis
Fasting blood insulin (BMI interaction)
Fasting blood glucose (BMI interaction)
Aging (time to death)
Aging (time to event)
PR interval in Tripanosoma cruzi seropositivity
QT interval in Tripanosoma cruzi seropositivity
Ejection fraction in Tripanosoma cruzi seropositivity
Local histogram emphysema pattern
Bronchodilator response in asthma
Erectile dysfunction in type 1 diabetes
Nephrolithiasis
Metabolite levels (Pyroglutamine)
Metabolite levels (Dihydroxy docosatrienoic acid)
Metabolite levels  (X-11787)
Response to mTOR inhibitor (everolimus)
Response to mTOR inhibitor (rapamycin)
Response to antipsychotic therapy (extrapyramidal side effects)
Breast cancer (prognosis)
QRS duration in Tripanosoma cruzi seropositivity
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity
Antibody status in Tripanosoma cruzi seropositivity
Coronary artery disease or ischemic stroke
Coronary artery disease or large artery stroke
Insomnia (caffeine-induced)
Schizophrenia (age at onset)
Liver enzyme levels (aspartate transaminase)
Response to irinotecan in non-small-cell lung cancer
Homeostasis model assessment of beta-cell function (dietary factor interaction)
Fasting insulin (dietary factor interaction)
Homeostasis model assessment of insulin resistance (dietary factor interaction)
Orthostatic hypotension
Retinol levels
Gaucher disease severity
Tardive dyskinesia
Adverse response to lamotrigine and phenytoin
D-dimer levels
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)
Butyrylcholinesterase levels
Temperament
Response to iloperidone treatment (QT prolongation)
Parasitemia in Tripanosoma cruzi seropositivity
Multiple sclerosis or amyotrophic lateral sclerosis
Retinal arteriolar caliber
Waist-to-hip circumference ratio (ever vs never smoking interaction)
Body mass index (alcohol intake interaction)
Body mass index (dietary energy interaction)
Body mass index (recreational physical activity interaction)
Body mass index (ever vs never smoking interaction)
Body mass index  (smoking years interaction)
Waist-to-hip circumference ratio (dietary energy interaction)
Waist-to-hip circumference ratio (smoking years interaction)
Waist-to-hip circumference ratio (recreational physical activity interaction)
Waist-to-hip circumference ratio (alcohol intake interaction)
Coronary arterial lesions in patients with Kawasaki disease
Blood pressure measurement (low sodium intervention)
Blood pressure measurement (high sodium intervention)
Blood pressure measurement (cold pressor test)
Blood pressure measurement (high sodium and potassium intervention)
Meningococcal disease
Platelet function and related traits
Longevity (90 years and older)
Hemoglobin A2 levels in sickle cell anemia
Conduct disorder (symptom count)
Conduct disorder
Toenail selenium levels
Blood and toenail selenium levels
Osteoarthritis biomarkers
Response to radiotherapy in cancer (late toxicity)
Hearing function
Obstructive sleep apnea
Non-substance related behavioral disinhibition
Nicotine use
Behavioural disinhibition (generation interaction)
Illicit drug use
Thrombin generation potential phenotypes
Serum IgA levels
Contrast sensitivity
Episodic memory
Pulse pressure (alcohol consumption interaction)
Systolic blood pressure (alcohol consumption interaction)
Diastolic blood pressure (alcohol consumption interaction)
Mean arterial pressure (alcohol consumption interaction)
Anger
Pulse pressure in young-onset hypertension
Age-related hearing impairment (SNP x SNP interaction)
Medication adherence in chronic diseases
Morphine dose requirement in tonsillectomy and adenoidectomy surgery
Plasma homocysteine levels (post-methionine load test)
Birth length
Infant length
Longevity (85 years and older)
Smoking quantity
Preschool internalizing problems
CD4:CD8 lymphocyte ratio
CD8-positive T-lymphocyte count
Antinuclear antibody levels
Glycemic traits (pregnancy)
Asthma (sex interaction)
Breast cancer (early onset)
Chronic obstructive pulmonary disease (moderate to severe)
Chronic obstructive pulmonary disease (severe)
Sensory disturbances after bilateral sagittal split ramus osteotomy
Reading or mathematical ability
Inflammatory skin disease
Blood pressure (smoking interaction)
Fat body mass
Tooth agenesis (mandibular third molar)
Tooth agenesis (third molar)
Osteoarthritis (hand, severe)
Red blood cell fatty acid levels
Urinary uromodulin levels
Thyroid volume
Plasma cystastin c levels in acute coronary syndrome
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)
Response to antidepressant treatment (citalopram)
Marginal zone lymphoma
Fasting plasma glucose (childhood)
Clubfoot
Allergic rhinitis in asthma
Allergic rhinitis in non-asthmatics
Superior frontal gyrus grey matter volume
Endothelial growth factor levels
Schizophrenia, schizoaffective disorder or bipolar disorder
Autism spectrum disorder-related traits
Renal function and chronic kidney disease
Seasonality
Age-related cataracts
Age-related cataracts (age at onset)
Congenital heart disease
Pulmonary artery enlargement and chronic obstructive pulmonary disease
Pulmonary artery enlargement in chronic obstructive pulmonary disease
Congenital left-sided heart lesions (maternal effect)
Social communication problems
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
Urinary metabolites (H-NMR features)
Colorectal cancer (diet interaction)
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)
Sepsis from pneumonia (survival)
White matter microstructure (global fractional anisotropy)
Vitamin B levels in ischemic stroke
Asthma (corticosteroid response)
Response to haloperidol in psychosis
Suicidal ideation in depression or bipolar disorder
Suicide attempts in depression or bipolar disorder
Response to Dalcetrapib treatment in acute coronary syndrome
Response to inhaled corticosteroid treatment in asthma (change in FEV1)
Autoimmune hepatitis type-1
Blood pressure (anthropometric measures interaction)
Laryngeal squamous cell carcinoma
Openness
Urinary albumin excretion rate in type 1 diabetes
Chronic periodontitis
Alcohol dependence (age at onset)
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)
Drug-induced torsades de pointes
Fetal hemoglobin levels in sickle cell anemia
Thyroid peroxidase antibody positivity
Thyroid peroxidase antibody levels
Amyotrophic lateral sclerosis or frontotemporal dementia
Pneumoconiosis in silica exposure
Response to diuretic therapy in hypertension
Type 2 diabetes (young onset) and obesity
Breastfeeding duration
Bipolar disorder (body mass index interaction)
Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)
Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)
Interferon alpha levels in systemic lupus erythematosus
Fractional exhaled nitric oxide (childhood)
Amyloid A serum levels
Kidney function decline traits
Cervical artery dissection
Immune response to measles-mumps-rubella vaccine
Hepatic lipid content in extreme obesity
Bilirubin levels in extreme obesity
Soluble leptin receptor levels
Hippocampal sclerosis of aging
Osteoprotegerin levels
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)
Breast cancer (menopausal hormone therapy interaction)
Lobular breast cancer (menopausal hormone therapy interaction)
Response to taxane treatment (docetaxel)
PCA3 expression level
Response to taxane treatment (placlitaxel)
Cerebrospinal fluid levels of Alzheimer's disease-related proteins
Methotrexate clearance (acute lymphoblastic leukemia)
Uterine fibroid number (single vs multiple)
Uterine fibroid size (maximum dimension)
Uterine fibroid size (maximum volume)
Electrocardiogram morphology (amplitude at temporal datapoints)
Digit length ratio (right hand)
Digit length ratio (left hand)
Healthspan
Serum erythropoietin levels
Waist-to-hip ratio adjusted for BMI (additive genetic model)
Waist-to-hip ratio adjusted for BMI (recessive genetic model)
Frontal fibrosing alopecia
Obesity without metabolic disease
Nicotine dependence and major depression (severity of comorbidity)
Fasting plasma glycodeoxycholate 3-O-glucuronide concentration
Fasting plasma glycochenodeoxycholate 3-O-glucuronide concentration
Mouth ulcers
Affective disorder and suicide attempts
Falling risk
Depression (broad)
Hip bone mineral density and total body fat mass (bivariate analysis)
Anti-rubella virus IgG levels
Diffusing capacity of the lung for carbon monoxide traits
Leisure-time exercise behaviour (age-stratified)
Neonatal cytokine/chemokine levels (fetal genetic effect)
Bronchopulmonary dysplasia in preterm infants
Plasma parathyroid hormone levels
Alzheimer's disease (SNP x SNP interaction)
Response to ranibizumab in age-related macular degeneration (exudative)
Serum CC16 levels
Asthma-chronic obstructive  pulmonary disease overlap syndrome
Vestibular neuritis
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)
Midgestational cytokine/chemokine levels (maternal genetic effect)
Neonatal cytokine/chemokine levels (maternal genetic effect)
Midgestational cytokine/chemokine levels (fetal genetic effect)
Severe aortic features in Marfan syndrome
Peginterferon alfa-2a treatment response in chronic hepatitis B infection
Cigarettes smoked per day (MTAG)
Age of smoking initiation (MTAG)
Smoking initiation (ever regular vs never regular) (MTAG)
Body mass index and waist-hip ratio (pleiotropy)
Asthma (adult onset)
Total testosterone levels
Thyroid nodules
Asthma (age of onset)
DNA methylation variation (age effect)
Antidepressant treatment resistance (> 2 drugs prescribed)
Antidepressant treatment resistance (number of drugs prescribed)
Thyrotoxic hypokalemic periodic paralysis in Graves disease
Thyrotoxic hypokalemic periodic paralysis and Graves disease
Monoclonal gammopathy of undetermined significance
Smoking cessation (MTAG)
Bisphosphonate-associated atypical femoral fracture
Atypical femoral fracture in phosphonate treatment
Cognitive ability in schizophrenia
Self-reported childhood asthma in adult smokers
Fasting blood insulin adjusted for BMI
Type 2 diabetes (SNP x SNP interaction, 2df)
Type 2 diabetes (SNP x SNP interaction, 1df)
Asthma onset (childhood vs adult)
Growth differentiation factor-15 levels
Ventricular ectopy or supraventricular ectopy (pleiotropy)
Ventricular ectopy
Supraventricular ectopy
Warfarin-associated bleeding
Severity of nausea and vomiting of pregnancy
Hyperemesis gravidarum
Diffusing capacity of carbon monoxide
Non-steroidal anti-inflammatory drug-induced enteropathy
Neuropathic pain in head and neck cancer
Asthma control x inhaled corticosteroid treatment interaction (2df)
Neutrophil level response to clozapine in treatment-resistant schizophrenia
Anti-adalimumab antibody production in response to treatment in Crohn's disease
Cardiac troponin-I levels
Philtrum width
Upper eyelid sagging severity
Lymphangioleiomyomatosis (sporadic)
Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)
Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)
Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)
Estimated glomerular filtration rate change in renal transplantation (recipient effect)
Estimated glomerular filtration rate change in renal transplantation (donor effect)
Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)
Systolic blood pressure x sodium interaction (1df test)
Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis
Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis
Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis
ICD10 R55: Syncope and collapse
Plasma factor VII activating protease levels
Facial attractiveness (female raters)
Facial attractiveness (male raters)
Thyroglobulin plasma levels
Allergic rhinitis x sex interaction
Benign prostatic hyperplasia
Low white blood cell count
Low white blood cell count (conditioned on rs2814778)
Growth differentiation factor-15 levels (conditioned on rs888663)
Clostridium difficile infection in multiple myeloma
Post-traumatic stress disorder symptoms in trauma-exposed soldiers
CD39+ secreting CD4 regulatory T cell %secreting CD4 regulatory T cell
CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell
Activated & resting CD4 regulatory T cell Absolute Count
Activated & resting CD4 regulatory T cell %CD4 regulatory T cell
Activated & resting CD4 regulatory T cell %CD4+ T cell
Activated & secreting CD4 regulatory T cell Absolute Count
Activated & secreting CD4 regulatory T cell %CD4 regulatory T cell
Activated & secreting CD4 regulatory T cell %CD4+ T cell
CD25++ CD4+ T cell Absolute Count
CD25++ CD4+ T cell %CD4+ T cell
CD25++ CD4+ T cell %T cell
CD25++ CD45RA+ CD4 not regulatory T cell Absolute Count
CD25++ CD45RA+ CD4 not regulatory T cell %CD4+ T cell
CD25++ CD45RA+ CD4 not regulatory T cell %T cell
CD25++ CD45RA- CD4 not regulatory T cell Absolute Count
CD25++ CD45RA- CD4 not regulatory T cell %CD4+ T cell
CD25++ CD45RA- CD4 not regulatory T cell %T cell
CD45RA- CD4+ T cell Absolute Count
CD45RA- CD4+ T cell %CD4+ T cell
CD45RA- CD4+ T cell %T cell
IDP SWI T2star right caudate
IDP SWI T2star left putamen
IDP SWI T2star right putamen
IDP SWI T2star left pallidum
Rotator cuff injury
CD20 on IgD- CD38dim B cell
CD20 on memory B cell
CD20 on naive-mature B cell
CD20 on unswitched memory B cell
CD20 on switched memory B cell
CD20 on IgD+ B cell
CD20 on transitional B cell
CD24 on CD24+ CD27+ B cell
CD24 on IgD+ CD24+ B cell
CD24 on IgD+ CD38- B cell
CD24 on IgD+ CD38+ B cell
CD24 on IgD- CD38- B cell
CD24 on IgD- CD38dim B cell
CD24 on memory B cell
CD24 on unswitched memory B cell
CD24 on switched memory B cell
CD24 on transitional B cell
CD25 on B cell
IDP dMRI TBSS MD Posterior thalamic radiation R
IDP dMRI TBSS MD Posterior thalamic radiation L
IDP dMRI TBSS MD Sagittal stratum R
IDP dMRI TBSS MD Sagittal stratum L
IDP dMRI TBSS MD External capsule R
IDP dMRI TBSS MD External capsule L
rfMRI connectivity (ICA100 edge 464)
rfMRI connectivity (ICA100 edge 471)
rfMRI connectivity (ICA100 edge 485)
rfMRI connectivity (ICA100 edge 488)
rfMRI connectivity (ICA100 edge 495)
aparc-DKTatlas rh volume lingual
aparc-DKTatlas rh volume parahippocampal
aparc-DKTatlas rh volume parsopercularis
IDP dMRI TBSS MD Posterior limb of internal capsule L
IDP dMRI TBSS MD Retrolenticular part of internal capsule R
IDP dMRI TBSS MD Retrolenticular part of internal capsule L
IDP dMRI TBSS MD Anterior corona radiata R
IDP dMRI TBSS MD Anterior corona radiata L
IDP dMRI TBSS MD Superior corona radiata R
IDP dMRI TBSS MD Superior corona radiata L
IDP dMRI TBSS MD Posterior corona radiata R
IDP dMRI TBSS MD Posterior corona radiata L
Upper cheek morphology
Chin morphology
Mouth morphology
TNF-related activation-induced cytokine levels
P-selectin glycoprotein ligand 1 levels
Myoglobin levels
Thrombomodulin levels
Pro-interleukin-16 levels
CD3 on CD4 regulatory T cell
CD3 on resting CD4 regulatory T cell
CD34 on Hematopoietic Stem Cell
HVEM on T cell
HVEM on naive CD8+ T cell
HVEM on Effector Memory CD8+ T cell
HVEM on CD4+ T cell
HVEM on Central Memory CD4+ T cell
HVEM on naive CD4+ T cell
HVEM on Effector Memory CD4+ T cell
B cell lymphocyte profile difference (1 day post influenza vaccination)
B cell lymphocyte profile difference (7 days post influenza vaccination)
B cell lymphocyte profile difference (90 days post influenza vaccination)
T cell lymphocyte profile difference
T cell lymphocyte profile difference (1 day post influenza vaccination)
IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L
IDP dMRI TBSS L2 Uncinate fasciculus R
IDP dMRI TBSS L2 Uncinate fasciculus L
IDP dMRI TBSS L2 Tapetum L
IDP dMRI TBSS L3 Middle cerebellar peduncle
IDP dMRI TBSS L3 Genu of corpus callosum
IDP dMRI TBSS L3 Body of corpus callosum
IDP dMRI TBSS L3 Splenium of corpus callosum
IDP dMRI TBSS L3 Fornix
IDP dMRI TBSS L3 Inferior cerebellar peduncle R
IDP dMRI TBSS L3 Inferior cerebellar peduncle L
IDP dMRI TBSS L3 Superior cerebellar peduncle R
IDP dMRI TBSS L3 Superior cerebellar peduncle L
Body composition traits
Aortic vascular smooth muscle cell calcification in response to osteogenic stimuli
Aortic vascular smooth muscle cell proliferation in response to IL-1 beta
Pancreatic ductal adenocarcinoma x smoking interaction
SSC-A on plasmacytoid Dendritic Cell
SSC-A on monocyte
SSC-A on CD14+ monocyte
SSC-A on B cell
SSC-A on Natural Killer
SSC-A on HLA DR+ Natural Killer
SSC-A on granulocyte
SSC-A on lymphocyte
SSC-A on T cell
SSC-A on CD4+ T cell
SSC-A on HLA DR+ T cell
SSC-A on Natural Killer T
CD11c on myeloid Dendritic Cell
CD11c on CD62L+ myeloid Dendritic Cell
CD11c on monocyte
CD11c on granulocyte
CD11b on CD14+ monocyte
CD11b on Monocytic Myeloid-Derived Suppressor Cells
CD11b on CD33dim HLA DR-
CD11b on basophil
IDP dMRI ProbtrackX L3 str r
IDP dMRI ProbtrackX L3 unc l
IDP dMRI ProbtrackX L3 unc r
IDP dMRI TBSS ICVF Middle cerebellar peduncle
IDP dMRI TBSS ICVF Pontine crossing tract
IDP dMRI TBSS ICVF Genu of corpus callosum
IDP dMRI TBSS ICVF Body of corpus callosum
IDP dMRI ProbtrackX L3 fmi
IDP dMRI ProbtrackX L3 ifo l
IDP dMRI ProbtrackX L3 ifo r
IDP dMRI ProbtrackX L3 ilf l
IDP dMRI ProbtrackX L3 ilf r
IDP dMRI ProbtrackX L3 ptr l
IDP dMRI ProbtrackX L3 ptr r
IDP dMRI ProbtrackX L3 slf l
IDP dMRI ProbtrackX L3 slf r
IDP dMRI ProbtrackX L3 str l
IDP dMRI TBSS ICVF Cingulum hippocampus R
IDP dMRI TBSS ICVF Cingulum hippocampus L
IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R
IDP dMRI TBSS ICVF Fornix cres+Stria terminalis L
IDP dMRI TBSS ICVF Superior longitudinal fasciculus R
IDP dMRI TBSS ICVF External capsule L
IDP dMRI TBSS ICVF Cingulum cingulate gyrus R
IDP dMRI TBSS ICVF Cingulum cingulate gyrus L
HDL levels x fish oil supplementation interaction (2df)
Total cholesterol levels x fish oil supplementation interaction (2df)
HDL levels x fish oil supplementation interaction (1df)
Total cholesterol levels x fish oil supplementation interaction (1df)
Triglyceride levels x fish oil supplementation interaction (1df)
LDL levels x fish oil supplementation interaction (1df)
Triglyceride levels x fish oil supplementation interaction (2df)
LDL levels x fish oil supplementation interaction (2df)
Serum type 1 collagen metabolite levels
Type 2 diabetes or prostate cancer (pleiotropy)
wg lh intensity-contrast lateraloccipital
wg lh intensity-contrast lateralorbitofrontal
wg lh intensity-contrast lingual
wg lh intensity-contrast medialorbitofrontal
wg lh intensity-contrast middletemporal
Terminally Differentiated CD4-CD8- T cell Absolute Count
Terminally Differentiated CD4-CD8- T cell %CD4-CD8- T cell
Terminally Differentiated CD4-CD8- T cell %T cell
Naive CD4+ T cell %T cell
Transitional B cell Absolute Count
CD28- CD4-CD8- T cell %CD4-CD8- T cell
CD28- CD4-CD8- T cell Absolute Count
CD28+ CD4-CD8- T cell %T cell
CD28+ CD4-CD8- T cell %CD4-CD8- T cell
CD39+ CD4+ T cell %T cell
CD39+ CD4+ T cell %CD4+ T cell
CD39+ CD4+ T cell Absolute Count
CD28- CD8dim T cell %T cell
CD28- CD8dim T cell %CD8dim T cell
CD28- CD8dim T cell Absolute Count
CD28+ CD45RA+ CD8dim T cell %T cell
CD28+ CD45RA+ CD8dim T cell %CD8dim T cell
CD28+ CD45RA+ CD8dim T cell Absolute Count
CD39+ CD8+ T cell %T cell
CD39+ CD8+ T cell %CD8+ T cell
CD39+ CD8+ T cell Absolute Count
CD28- CD127- CD25++ CD8+ T cell Absolute Count
CD28- CD25++ CD8+ T cell %T cell
CD28- CD25++ CD8+ T cell %CD8+ T cell
CD28- CD25++ CD8+ T cell Absolute Count
aparc-Desikan rh volume cuneus
IDP dMRI TBSS FA Middle cerebellar peduncle
IDP dMRI TBSS FA Genu of corpus callosum
IDP dMRI TBSS FA Body of corpus callosum
IDP dMRI TBSS FA Splenium of corpus callosum
IDP dMRI TBSS FA Fornix
IDP dMRI TBSS FA Superior cerebellar peduncle R
IDP dMRI TBSS FA Superior cerebellar peduncle L
IDP dMRI TBSS FA Cerebral peduncle R
IDP dMRI TBSS FA Anterior limb of internal capsule R
IDP dMRI TBSS FA Anterior limb of internal capsule L
IDP dMRI TBSS FA Posterior limb of internal capsule R
IDP dMRI TBSS FA Posterior limb of internal capsule L
IDP dMRI TBSS FA Retrolenticular part of internal capsule R
IDP dMRI TBSS FA Retrolenticular part of internal capsule L
IDP dMRI TBSS FA Anterior corona radiata R
IDP dMRI TBSS FA Anterior corona radiata L
IDP dMRI TBSS FA Superior corona radiata R
IDP dMRI TBSS FA Superior corona radiata L
IDP dMRI TBSS FA Posterior corona radiata L
IDP dMRI TBSS FA Posterior thalamic radiation R
IDP dMRI TBSS FA Posterior thalamic radiation L
IDP dMRI TBSS FA Sagittal stratum R
IDP dMRI TBSS FA Sagittal stratum L
IDP dMRI TBSS FA External capsule R
IDP dMRI TBSS FA External capsule L
IDP dMRI TBSS FA Cingulum cingulate gyrus R
IDP dMRI TBSS FA Superior fronto-occipital fasciculus R
IDP dMRI TBSS FA Superior fronto-occipital fasciculus L
Brainstem global volume Whole-brainstem
aparc-Desikan lh volume caudalmiddlefrontal
aparc-Desikan lh volume cuneus
aparc-Desikan lh volume lateraloccipital
aparc-Desikan lh volume lingual
aparc-Desikan lh volume parsopercularis
aparc-Desikan lh volume parstriangularis
aparc-Desikan lh volume pericalcarine
aparc-Desikan lh volume postcentral
aparc-Desikan lh volume precentral
aparc-Desikan lh volume precuneus
aparc-Desikan lh volume superiorparietal
aparc-Desikan lh volume supramarginal
Interleukin-27 levels
Macrophage colony-stimulating factor 1 levels
C-X-C motif chemokine 1 levels
Lectin-like oxidized LDL receptor 1 levels
TNF-related apoptosis-inducing ligand receptor 2 levels
Tissue factor levels
Tumor necrosis factor receptor 1 levels
Platelet-derived growth factor subunit B levels
CD38 on IgD+ CD38+ B cell
CD38 on IgD+ CD38dim B cell
CD38 on IgD- CD38dim B cell
CD38 on naive-mature B cell
CD38 on IgD+ B cell
CD38 on transitional B cell
IgD on IgD+ CD24+ B cell
IgD on IgD+ CD24- B cell
IgD on IgD+ CD38-  B cell
IgD on IgD+ CD38+ B cell
IgD on IgD+ CD38dim B cell
IDP dMRI TBSS L1 Fornix
IDP dMRI TBSS L1 Corticospinal tract R
IDP dMRI TBSS L1 Inferior cerebellar peduncle L
IDP dMRI TBSS L1 Cerebral peduncle R
IDP dMRI TBSS L1 Cerebral peduncle L
IDP dMRI TBSS L1 Anterior limb of internal capsule R
IDP dMRI TBSS L1 Anterior limb of internal capsule L
IDP dMRI TBSS L1 Posterior limb of internal capsule R
IDP dMRI TBSS L1 Posterior limb of internal capsule L
IDP dMRI TBSS L1 Retrolenticular part of internal capsule R
IDP dMRI TBSS L1 Retrolenticular part of internal capsule L
IDP dMRI TBSS L1 Anterior corona radiata R
IDP dMRI TBSS L1 Anterior corona radiata L
IDP dMRI TBSS L1 Superior corona radiata R
Receptor for advanced glycosylation end products levels
C-C motif chemokine 3 levels
Matrix metalloproteinase-7 levels
C-X-C motif chemokine 6 levels
Melusin levels
C-X-C motif chemokine 16 levels
Dickkopf-related protein 1 levels
SIR2-like protein 2 levels
Galanin peptide levels
Agouti-related protein levels
CX3CR1 on CD14+ CD16+ monocyte
CX3CR1 on CD14+ CD16- monocyte
PDL-1 on CD14+ CD16+ monocyte
PDL-1 on CD14- CD16+ monocyte
PDL-1 on CD14- CD16-
CD64 on CD14- CD16-
PDL-1 on monocyte
CCR2 on CD14- CD16-
CCR2 on CD14+ CD16- monocyte
CD16 on CD14+ CD16+ monocyte
CD64 on monocyte
HLA DR on CD14+ CD16+ monocyte
CCR2 on monocyte
HLA DR on CD14- CD16-
HLA DR on monocyte
CD64 on CD14+ CD16+ monocyte
CX3CR1 on CD14- CD16+ monocyte
CCR2 on myeloid Dendritic Cell
CCR2 on CD62L+ myeloid Dendritic Cell
CCR2 on plasmacytoid Dendritic Cell
CCR2 on CD62L+ plasmacytoid Dendritic Cell
IDP dMRI ProbtrackX MD unc r
IDP dMRI ProbtrackX L1 atr l
IDP dMRI ProbtrackX L1 atr r
IDP dMRI ProbtrackX L1 cgc l
IDP dMRI ProbtrackX L1 cgc r
IDP dMRI ProbtrackX L1 cgh l
aparc-Desikan lh area rostralmiddlefrontal
aparc-Desikan lh area superiorparietal
aparc-Desikan lh area supramarginal
aparc-Desikan rh area TotalSurface
aparc-Desikan rh area caudalmiddlefrontal
aparc-Desikan rh area cuneus
Carotid artery stenosis
HDL levels x SSRI levels interaction in schizophrenia or bipolar disorder
LDL levels x SSRI levels interaction in schizophrenia or bipolar disorder
Total cholesterol levels x SSRI levels interaction in schizophrenia or bipolar disorder
BMI x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
HDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
LDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
Total cholesterol levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
aparc-DKTatlas lh area cuneus
aparc-DKTatlas lh area entorhinal
aparc-DKTatlas lh area fusiform
aparc-DKTatlas lh area lateraloccipital
aparc-DKTatlas lh area lingual
aparc-DKTatlas lh area parstriangularis
aparc-DKTatlas lh area pericalcarine
aparc-DKTatlas lh area postcentral
aparc-DKTatlas lh area precentral
aparc-DKTatlas lh area precuneus
aparc-DKTatlas lh area rostralmiddlefrontal
aparc-DKTatlas lh area superiorparietal
Chronic hepatitis B infection vs asymptomatic persistence
Hepatitis B virus-related hepatocellular carcinoma vs chronic hepatitis B infection
Hepatitis B virus-related hepatocellular carcinoma vs hepatitis B virus-related decompensated cirrhosis
Development of chronic hepatitis B
Left–right brain asymmetry
Cognitive traits (MTAG)
IDP dMRI ProbtrackX ICVF ptr l
IDP dMRI ProbtrackX ICVF ptr r
IDP dMRI ProbtrackX ICVF slf l
Liver fibrogenesis (alpha smooth muscle actin levels)
Liver fibrosis (total hepatic collagen content)
Gut microbiota abundance (family Peptostreptococcaceae id.2042)
Gut microbiota abundance (family Streptococcaceae id.1850)
Gut microbiota abundance (genus Ruminococcaceae UCG013 id.11370)
Gut microbiota abundance (genus Ruminococcus1 id.11373)
Gut microbiota abundance (genus Ruminococcus torques group id.14377)
Gut microbiota abundance (genus Streptococcus id.1853)
Gut microbiota abundance (genus Tyzzerella3 id.11335)
Gut microbiota abundance (unknown genus id.1000001215)
Gut microbiota abundance (order Bifidobacteriales id.432)
Gut microbiota abundance (order Gastranaerophilales id.1591)
Gut microbiota abundance (unknown family id.1000001214)
Gut microbiota abundance (genus Allisonella id.2174)
Gut microbiota abundance (phylum Actinobacteria id.400)
Bell's palsy
wg lh intensity-contrast parstriangularis
wg lh intensity-contrast pericalcarine
wg lh intensity-contrast postcentral
wg lh intensity-contrast posteriorcingulate
wg lh intensity-contrast precentral
wg lh intensity-contrast precuneus
wg lh intensity-contrast parahippocampal
wg lh intensity-contrast paracentral
wg lh intensity-contrast parsopercularis
wg lh intensity-contrast parsorbitalis
B cell %CD3- lymphocyte
B cell %lymphocyte
Natural Killer Absolute Count
Natural Killer %CD3- lymphocyte
Natural Killer %lymphocyte
HLA DR+ Natural Killer Absolute Count
HLA DR+ Natural Killer %Natural Killer
HLA DR+ Natural Killer  %CD3- lymphocyte
Granulocyte Absolute Count
Granulocyte %leukocyte
IgD+ B cell %B cell
IgD+ CD38+ B cell Absolute Count
IgD+ CD38dim B cell Absolute Count
IgD+ CD38- B cell %B cell
IgD+ CD38- B cell Absolute Count
Unswitched memory B cell %B cell
Unswitched memory B cell Absolute Count
IgD- CD27- B cell %B cell
IgD+ B cell Absolute Count
IgD- CD27- B cell Absolute Count
Switched memory B cell Absolute Count
Plasma Blast-Plasma Cell %B cell
Plasma Blast-Plasma Cell Absolute Count
Memory B cell %B cell
Memory B cell Absolute Count
Naive-mature B cell %B cell
Naive-mature B cell Absolute Count
IgD- CD38+ B cell %B cell
IgD+ CD24+ B cell %B cell
IgD+ CD24+ B cell Absolute Count
IgD+ CD24- B cell %B cell
IgD+ CD24- B cell Absolute Count
CD24+ CD27+ B cell %B cell
CD24+ CD27+ B cell Absolute Count
CD20- CD38- B cell %B cell
IgD+ B cell %Lymphocyte
IgD- CD38dim B cell %lymphocyte
AmygNuclei rh volume Accessory-Basal-nucleus
AmygNuclei rh volume Central-nucleus
AmygNuclei rh volume Medial-nucleus
AmygNuclei rh volume Cortical-nucleus
AmygNuclei rh volume Paralaminar-nucleus
AmygNuclei rh volume Whole-amygdala
HippSubfield lh volume Hippocampal-tail
HippSubfield lh volume subiculum-body
HippSubfield lh volume CA1-body
HippSubfield lh volume subiculum-head
HippSubfield lh volume hippocampal-fissure
HippSubfield lh volume presubiculum-head
HippSubfield lh volume CA1-head
HippSubfield lh volume molecular-layer-HP-head
HippSubfield lh volume GC-ML-DG-head
HippSubfield lh volume CA3-body
HippSubfield lh volume GC-ML-DG-body
HippSubfield lh volume CA4-head
HippSubfield lh volume CA4-body
HippSubfield lh volume CA3-head
HippSubfield lh volume Whole-hippocampal-body
HippSubfield lh volume Whole-hippocampal-head
Rapid response to perioperative phenylephrine (change in mean arterial pressure)
Rapid response to perioperative phenylephrine (change in diastolic blood pressure)
Rapid response to perioperative phenylephrine (change in systolic blood pressure)
Vegetable consumption
CD33+ HLA DR+ CD14- %CD33+ HLA DR+
CD33+ HLA DR+ CD14dim Absolute Count
CD33+ HLA DR+ CD14dim %CD33+ HLA DR+
CD33- HLA DR- Absolute Count
CD33- HLA DR+ Absolute Count
Granulocytic Myeloid-Derived Suppressor Cells Absolute Count
CD33dim HLA DR+ CD11b+ Absolute Count
CD33dim HLA DR+ CD11b+ %CD33dim HLA DR+
CD33dim HLA DR+ CD11b- Absolute Count
CD33dim HLA DR+ CD11b- %CD33dim HLA DR+
Monocytic Myeloid-Derived Suppressor Cells Absolute Count
CD33dim HLA DR- Absolute Count
Basophil Absolute Count
Basophil %CD33dim HLA DR- CD66b-
BAFF-R on CD20- CD38- B cell
BAFF-R on CD24+ CD27+ B cell
BAFF-R on IgD+ CD24+ B cell
IDP dMRI ProbtrackX FA ilf l
IDP dMRI ProbtrackX FA ilf r
IDP dMRI ProbtrackX FA ptr l
IDP dMRI ProbtrackX FA ptr r
IDP dMRI ProbtrackX FA slf l
IDP dMRI ProbtrackX FA slf r
IDP dMRI ProbtrackX FA str l
IDP dMRI ProbtrackX FA str r
IDP dMRI ProbtrackX FA unc l
IDP dMRI ProbtrackX FA unc r
IDP dMRI TBSS MO Middle cerebellar peduncle
IDP dMRI TBSS MO Pontine crossing tract
Urokinase plasminogen activator surface receptor levels
C-C motif chemokine 4 levels
HVEM on Terminally Differentiated CD4+ T cell
HVEM on CD45RA- CD4+ T cell
HVEM on CD8+ T cell
HVEM on Central Memory CD8+ T cell
CD16-CD56 on Natural Killer T
CD16-CD56 on Natural Killer
CD16-CD56 on HLA DR+ Natural Killer
CD28 on CD39+ activated CD4 regulatory T cell
CD28 on secreting CD4 regulatory T cell
CD28 on CD39+ secreting CD4 regulatory T cell
CD28 on activated & secreting CD4 regulatory T cell
CD28 on CD45RA+ CD4+ T cell
CD28 on CD45RA- CD4 not regulatory T cell
CD28 on CD39+ CD4+ T cell
CD28 on CD28+ CD45RA- CD8+ T cell
CD28 on CD28+ CD4+ T cell
CD28 on CD28+ CD4-CD8- T cell
CD28 on CD28+ CD45RA+ CD8+ T cell
CD28 on CD39+ CD8+ T cell
CD28 on CD4+ T cell
CD28 on CD4 regulatory T cell
CD28 on resting CD4 regulatory T cell
IDP dMRI TBSS L3 Cerebral peduncle R
IDP dMRI TBSS L3 Anterior limb of internal capsule R
IDP dMRI TBSS L3 Anterior limb of internal capsule L
IDP dMRI TBSS L3 Posterior limb of internal capsule R
IDP dMRI TBSS L3 Posterior limb of internal capsule L
IDP dMRI TBSS L3 Retrolenticular part of internal capsule R
IDP dMRI TBSS L3 Retrolenticular part of internal capsule L
IDP dMRI TBSS L3 Anterior corona radiata R
IDP dMRI TBSS L3 Anterior corona radiata L
IDP dMRI TBSS L3 Superior corona radiata R
IDP dMRI TBSS L3 Superior corona radiata L
IDP dMRI TBSS L3 Posterior corona radiata R
IDP dMRI TBSS L3 Posterior corona radiata L
IDP dMRI TBSS L3 Posterior thalamic radiation R
HLA DR on HLA DR+ T cell
HLA DR on HLA DR+ CD4+ T cell
HLA DR on B cell
HLA DR on HLA DR+ Natural Killer
CD8 on CD28+ CD45RA- CD8+ T cell
CD8 on CD28+ CD45RA+ CD8+ T cell
CD8 on CD28- CD8+ T cell
CD8 on CD39+ CD8+ T cell
IDP dMRI TBSS ICVF Retrolenticular part of internal capsule R
IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L
aparc-pial rh area pericalcarine
aparc-pial rh area postcentral
aparc-pial rh area precentral
aparc-pial rh area precuneus
aparc-pial rh area superiorparietal
aparc-pial rh area supramarginal
IDP dMRI TBSS ICVF Posterior limb of internal capsule R
IDP dMRI TBSS ICVF Posterior limb of internal capsule L
BA-exvivo lh area BA1
BA-exvivo lh area BA2
BA-exvivo lh area BA3a
BA-exvivo lh area BA3b
BA-exvivo lh area BA4p
BA-exvivo lh area BA6
BA-exvivo lh area BA45
BA-exvivo lh area V1
BA-exvivo lh area V2
BA-exvivo lh area entorhinal
BA-exvivo rh area BA1
Serum 25-Hydroxyvitamin D level variance
IDP dMRI ProbtrackX ICVF cst l
IDP dMRI ProbtrackX ICVF cst r
IDP dMRI ProbtrackX ICVF fma
IDP dMRI ProbtrackX ICVF fmi
Adipsin levels in type 2 diabetes
Adipsin levels
ghrelin levels
ghrelin levels in lean individuals
ghrelin levels in overweight individuals
aparc-a2009s rh area Pole-occipital
aparc-a2009s rh area S-calcarine
aparc-a2009s rh area S-central
aparc-a2009s rh area S-collat-transv-ant
aparc-a2009s rh area S-intrapariet+P-trans
aparc-a2009s rh area S-oc-middle+Lunatus
aparc-a2009s rh area S-oc-temp-med+Lingual
aparc-a2009s rh area S-orbital-H-Shaped
aparc-a2009s rh area S-parieto-occipital
aparc-a2009s rh area S-postcentral
aparc-a2009s rh area S-precentral-sup-part
aparc-a2009s rh area S-subparietal
aparc-Desikan lh thickness GlobalMeanThickness
aparc-Desikan lh thickness cuneus
aparc-Desikan lh thickness inferiortemporal
aparc-Desikan lh thickness lateraloccipital
aparc-Desikan lh thickness paracentral
aparc-Desikan lh thickness postcentral
IDP dMRI ProbtrackX ISOVF atr l
IDP dMRI ProbtrackX ISOVF cgc l
IDP dMRI ProbtrackX ISOVF cgc r
IDP dMRI ProbtrackX ISOVF fma
IDP dMRI ProbtrackX ISOVF fmi
IDP dMRI ProbtrackX ISOVF ifo l
IDP dMRI ProbtrackX ISOVF ifo r
IDP dMRI ProbtrackX ISOVF ilf l
IDP dMRI ProbtrackX ISOVF ilf r
IDP T1 FAST ROIs L postcent gyrus
aparc-a2009s rh area G+S-occipital-inf
aparc-a2009s rh area G+S-subcentral
aparc-a2009s rh area G-cingul-Post-ventral
aparc-a2009s rh area G-cuneus
aparc-a2009s rh area G-occipital-sup
aparc-a2009s rh area G-oc-temp-lat-fusifor
aparc-a2009s rh area G-oc-temp-med-Lingual
aparc-a2009s rh area G-pariet-inf-Angular
aparc-a2009s rh area G-pariet-inf-Supramar
aparc-a2009s rh area G-postcentral
aparc-a2009s rh area G-precentral
aparc-a2009s rh area G-precuneus
Gut microbiota presence (family Peptococcaceae id.2024)
Gut microbiota presence (genus Enterorhabdus id.820)
Type 1 diabetes (age at diagnosis)
wg lh intensity-contrast superiorparietal
wg lh intensity-contrast superiortemporal
wg lh intensity-contrast supramarginal
CD25++ CD8+ T cell %T cell
CD25++ CD8+ T cell %CD8+ T cell
CD25++ CD8+ T cell Absolute Count
CD127- CD8+ T cell Absolute Count
CD28- CD8+ T cell %T cell
CD28- CD8+ T cell %CD8+ T cell
CD28- CD8+ T cell Absolute Count
CD28+ CD45RA+ CD8+ T cell %T cell
CD28+ CD45RA+ CD8+ T cell Absolute Count
CD28+ CD45RA- CD8+ T cell %CD8+ T cell
CD28- CD4-CD8- T cell %T cell
Pediatric central nervous system tumors (early onset)(pleiotropy)
Pediatric central nervous system tumors (late onset)(pleiotropy)
Pediatric central nervous system tumors (pleiotropy)
CD14- CD16+ monocyte Absolute Count
CD14+ CD16+ monocyte Absolute Count
CD14- CD16- Absolute Count
CD14+ CD16- monocyte Absolute Count
Monocyte Absolute Count
CD14- CD16+ monocyte %monocyte
CD14+ CD16+ monocyte %monocyte
CD14+ CD16- monocyte %monocyte
CD16+ monocyte %monocyte
Hematopoietic Stem Cell Absolute Count
Immature Myeloid-Derived Suppressor Cells Absolute Count
Immature Myeloid-Derived Suppressor Cells %CD33dim HLA DR- CD66b-
CD33+ HLA DR+ Absolute Count
CD33+ HLA DR+ CD14- Absolute Count
IDP dMRI TBSS FA Uncinate fasciculus R
IDP dMRI TBSS FA Uncinate fasciculus L
IDP dMRI TBSS FA Tapetum R
IDP dMRI TBSS FA Tapetum L
IDP dMRI ProbtrackX FA ar l
IDP dMRI ProbtrackX FA ar r
IDP dMRI ProbtrackX FA atr l
IDP dMRI ProbtrackX FA atr r
IDP dMRI ProbtrackX FA cgc r
IDP dMRI ProbtrackX FA cst l
IDP dMRI ProbtrackX FA cst r
IDP dMRI ProbtrackX FA fma
IDP dMRI ProbtrackX FA fmi
IDP dMRI ProbtrackX FA ifo l
IDP dMRI ProbtrackX FA ifo r
Chronic lymphocytic leukemia (time to first treatment)
Tumor necrosis factor receptor 2 levels
Matrix metalloproteinase-3 levels
Heat shock 27 kDa protein levels
Tumor necrosis factor ligand superfamily member 14 levels
Myeloperoxidase levels
Matrix metalloproteinase-1 levels
Tumor necrosis factor receptor superfamily member 6 levels
Pappalysin-1 levels
Fibroblast growth factor 23 levels
IgD on unswitched memory B cell
IgD on IgD+ B cell
IgD on transitional B cell
BAFF-R on B cell
BAFF-R on CD20- B cell
CD62L on CD62L+ myeloid Dendritic Cell
CD62L on CD62L+ plasmacytoid Dendritic Cell
CD62L on CD62L+ Dendritic Cell
CD62L on monocyte
CD3 on naive CD8+ T cell
CD3 on Effector Memory CD8+ T cell
CD3 on Terminally Differentiated CD8+ T cell
CD3 on Central Memory CD4+ T cell
CD3 on Naive CD4+ T cell
CD3 on Effector Memory CD4+ T cell
IDP dMRI TBSS L1 Superior corona radiata L
IDP dMRI TBSS L1 Posterior corona radiata R
IDP dMRI TBSS L1 Posterior corona radiata L
IDP dMRI TBSS L1 Sagittal stratum R
IDP dMRI TBSS L1 Sagittal stratum L
IDP dMRI TBSS L1 External capsule R
IDP dMRI TBSS L1 External capsule L
IDP dMRI TBSS L1 Cingulum cingulate gyrus R
IDP dMRI TBSS L1 Cingulum hippocampus R
IDP dMRI TBSS L1 Cingulum hippocampus L
IDP dMRI TBSS L1 Superior longitudinal fasciculus R
IDP dMRI TBSS L1 Superior longitudinal fasciculus L
IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R
IDP dMRI TBSS L1 Uncinate fasciculus L
IDP dMRI TBSS L2 Middle cerebellar peduncle
IDP dMRI TBSS L2 Pontine crossing tract
IDP dMRI TBSS L2 Genu of corpus callosum
IDP dMRI TBSS L2 Body of corpus callosum
IDP dMRI TBSS L2 Splenium of corpus callosum
IDP dMRI TBSS L2 Fornix
IDP dMRI TBSS L2 Corticospinal tract R
IDP dMRI TBSS L2 Inferior cerebellar peduncle R
HLA DR on plasmacytoid Dendritic Cell
HLA DR on Dendritic Cell
HLA DR on Hematopoietic Stem Cell
HLA DR on CD33+ HLA DR+ CD14-
HLA DR on CD33+ HLA DR+ CD14dim
HLA DR on CD33dim HLA DR+ CD11b+
HLA DR on CD33dim HLA DR+ CD11b-
HLA DR on CD33- HLA DR+
CD11b on CD33+ HLA DR+ CD14dim
CD45RA on naive CD4+ T cell
CD4RA on Terminally Differentiated CD4+ T cell
CD45RA on naive CD8+ T cell
CD45RA on Terminally Differentiated CD8+ T cell
CD45RA on resting CD4 regulatory T cell
CD45RA on CD39+ resting CD4 regulatory T cell
HLA DR on myeloid Dendritic Cell
IDP dMRI TBSS ICVF Cerebral peduncle L
IDP dMRI TBSS ICVF Anterior limb of internal capsule R
IDP dMRI TBSS ICVF Anterior limb of internal capsule L
IDP dMRI TBSS ICVF Splenium of corpus callosum
IDP dMRI TBSS ICVF Fornix
IDP dMRI TBSS ICVF Medial lemniscus R
IDP dMRI TBSS ICVF Medial lemniscus L
IDP dMRI TBSS ICVF Inferior cerebellar peduncle R
IDP dMRI TBSS ICVF Inferior cerebellar peduncle L
IDP dMRI TBSS ICVF Superior cerebellar peduncle R
IDP dMRI TBSS ICVF Superior cerebellar peduncle L
IDP dMRI TBSS ICVF Cerebral peduncle R
Response to ondansetron (change in QTc)
Ondansetron-induced QT prolongation
IDP dMRI TBSS ICVF Posterior corona radiata L
IDP dMRI TBSS ICVF Posterior thalamic radiation R
IDP dMRI TBSS ICVF Posterior thalamic radiation L
IDP dMRI TBSS ICVF Sagittal stratum R
IDP dMRI TBSS ICVF Sagittal stratum L
IDP dMRI TBSS ICVF External capsule R
Estimated glomerular filtration rate (creatinine, Rapid3)
Estimated glomerular filtration rate (creatinine, CKDi25)
Serum 25-Hydroxyvitamin D levels x season interaction
IDP dMRI ProbtrackX ICVF ifo l
IDP dMRI ProbtrackX ICVF ifo r
IDP dMRI ProbtrackX ICVF ilf l
IDP dMRI ProbtrackX ICVF ilf r
IDP dMRI ProbtrackX ICVF mcp
IDP dMRI ProbtrackX ICVF ml l
IDP dMRI ProbtrackX ICVF ml r
aparc-DKTatlas rh thickness postcentral
aparc-DKTatlas rh thickness transversetemporal
aparc-a2009s lh thickness G-cuneus
aparc-a2009s lh thickness G-postcentral
aparc-a2009s lh thickness G-precuneus
rfMRI connectivity (ICA25 edge 101)
rfMRI connectivity (ICA25 edge 103)
rfMRI connectivity (ICA25 edge 132)
aparc-a2009s lh thickness Pole-occipital
aparc-a2009s lh thickness S-cingul-Marginalis
rfMRI connectivity (ICA100 edge 39)
aparc-a2009s lh thickness S-intrapariet+P-trans
aparc-a2009s lh thickness S-orbital-H-Shaped
aparc-a2009s lh thickness S-postcentral
aparc-a2009s rh thickness G+S-cingul-Ant
aparc-a2009s rh thickness G-cuneus
aparc-a2009s rh thickness G-oc-temp-med-Lingual
aparc-a2009s rh thickness G-postcentral
aparc-a2009s rh thickness G-temporal-middle
aparc-a2009s rh thickness Pole-occipital
aparc-a2009s rh thickness Pole-temporal
aseg global intensity 4th-Ventricle
rfMRI connectivity (ICA100 edge 43)
rfMRI connectivity (ICA100 edge 52)
aseg global intensity WM-hypointensities
aseg lh intensity Lateral-Ventricle
aseg lh intensity Inf-Lat-Vent
aseg lh intensity Cerebellum-Cortex
aseg lh intensity Thalamus-Proper
aseg lh intensity Caudate
aseg lh intensity Putamen
aseg lh intensity Pallidum
BA-exvivo rh thickness BA3b
BA-exvivo rh thickness BA4a
BA-exvivo rh thickness V1
BA-exvivo rh thickness V2
rfMRI amplitudes (ICA100 node 28)
rfMRI amplitudes (ICA100 node 30)
rfMRI amplitudes (ICA100 node 35)
rfMRI amplitudes (ICA100 node 38)
rfMRI amplitudes (ICA100 node 40)
rfMRI amplitudes (ICA100 node 44)
rfMRI amplitudes (ICA100 node 45)
rfMRI connectivity (ICA25 edge 65)
aparc-DKTatlas lh thickness cuneus
aparc-DKTatlas lh thickness lateraloccipital
aparc-DKTatlas lh thickness paracentral
aparc-DKTatlas lh thickness postcentral
aparc-DKTatlas lh thickness precentral
aparc-DKTatlas lh thickness precuneus
aparc-DKTatlas rh thickness cuneus
aparc-DKTatlas rh thickness lateraloccipital
aparc-DKTatlas rh thickness lingual
aparc-DKTatlas rh thickness paracentral
aparc-DKTatlas rh thickness pericalcarine
IDP SWI T2star right pallidum
rfMRI connectivity (ICA100 edge 380)
ThalamNuclei lh volume PuA
Central Memory CD4+ T cell Absolute Count
Central Memory CD4+ T cell %CD4+ T cell
ThalamNuclei lh volume Pf
ThalamNuclei lh volume VAmc
Central Memory CD4+ T cell %T cell
ThalamNuclei lh volume MDl
ThalamNuclei lh volume CeM
ThalamNuclei lh volume VLp
ThalamNuclei rh volume MGN
Effector Memory CD4+ T cell Absolute Count
Effector Memory CD4+ T cell %CD4+ T cell
Effector Memory CD4+ T cell %T cell
Terminally Differentiated CD4+ T cell Absolute Count
Terminally Differentiated CD4+ T cell %CD4+ T cell
Naive CD4+ T cell Absolute Count
Naive CD4+ T cell %CD4+ T cell
ThalamNuclei rh volume PuI
ThalamNuclei rh volume CM
ThalamNuclei rh volume Pf
Mental health related quality of life
Physical health related quality of life
CD20 on IgD+ CD38- B cell
CD20 on IgD+ CD38+ B cell
CD20 on IgD+ CD38dim B cell
CD20 on IgD- CD24- B cell
CD20 on IgD- CD27- B cell
CD20 on IgD- CD38- B cell
CD19 on unswitched memory B cell
CD19 on switched memory B cell
CD19 on IgD+ B cell
CD19 on transitional B cell
CD20 on B cell
CD20 on CD24+ CD27+ B cell
CD20 on IgD+ CD24+ B cell
CD20 on IgD+ CD24- B cell
aparc-DKTatlas lh volume pericalcarine
aparc-DKTatlas lh volume postcentral
aparc-DKTatlas lh volume precentral
aparc-DKTatlas lh volume precuneus
aparc-DKTatlas lh volume rostralmiddlefrontal
aparc-DKTatlas lh volume superiorparietal
aparc-DKTatlas lh volume supramarginal
aparc-DKTatlas lh volume insula
aparc-DKTatlas rh volume cuneus
aparc-DKTatlas rh volume fusiform
aparc-DKTatlas rh volume lateraloccipital
IDP dMRI TBSS MO Cerebral peduncle R
IDP dMRI TBSS MO Cerebral peduncle L
IDP dMRI TBSS MO Posterior limb of internal capsule R
IDP dMRI TBSS MO Posterior limb of internal capsule L
IDP dMRI TBSS MO Retrolenticular part of internal capsule R
IDP dMRI TBSS MO Anterior corona radiata R
IDP dMRI TBSS MO Anterior corona radiata L
IDP dMRI TBSS MO Superior corona radiata R
IDP dMRI TBSS MO Superior corona radiata L
IDP dMRI TBSS MO Posterior corona radiata R
IDP dMRI ProbtrackX MO atr r
IDP dMRI ProbtrackX MO str l
IDP dMRI ProbtrackX MO str r
IDP dMRI TBSS MD Middle cerebellar peduncle
IDP dMRI TBSS MD Pontine crossing tract
IDP dMRI TBSS MD Genu of corpus callosum
IDP dMRI TBSS MD Body of corpus callosum
IDP dMRI TBSS MD Splenium of corpus callosum
IDP dMRI TBSS MD Fornix
IDP dMRI TBSS MD Corticospinal tract R
IDP dMRI TBSS MD Inferior cerebellar peduncle R
IDP dMRI TBSS MD Inferior cerebellar peduncle L
IDP dMRI TBSS MD Superior cerebellar peduncle R
IDP dMRI TBSS MD Cerebral peduncle L
IDP dMRI TBSS MD Anterior limb of internal capsule R
IDP dMRI TBSS MD Anterior limb of internal capsule L
IDP dMRI TBSS MD Posterior limb of internal capsule R
Sick sinus syndrome
Chitinase-3-like protein 1 levels
ST2 protein levels
Kidney injury molecule 1 levels
Membrane-bound aminopeptidase P levels
aparc-Desikan lh area pericalcarine
aparc-Desikan lh area postcentral
aparc-Desikan lh area precentral
aparc-Desikan lh area precuneus
IDP dMRI TBSS L2 Cingulum cingulate gyrus R
IDP dMRI TBSS L2 Cingulum cingulate gyrus L
IDP dMRI TBSS L2 Cingulum hippocampus R
IDP dMRI TBSS L2 Cingulum hippocampus L
IDP dMRI TBSS L2 Superior longitudinal fasciculus R
IDP dMRI TBSS L2 Superior longitudinal fasciculus L
Telomere length x n-3 polyunsaturated fatty acid level interaction
T cell lymphocyte profile difference (90 days post influenza vaccination)
B cell lymphocyte profile difference
aparc-Desikan lh area fusiform
aparc-Desikan lh area lateraloccipital
aparc-Desikan lh area lingual
aparc-Desikan lh area parstriangularis
Adherence to a Japanese dietary pattern
T cell lymphocyte profile difference (7 days post influenza vaccination)
Cathepsin D levels
CD40 on monocytes
CD14 on CD14+ CD16- monocyte
CD64 on CD14+ CD16- monocyte
HLA DR on CD14+ CD16- monocyte
CD40 on CD14- CD16+ monocyte
CD64 on CD14- CD16+ monocyte
HLA DR on CD14+ monocyte
CCR2 on CD14+ CD16+ monocyte
PDL-1 on CD14+ CD16- monocyte
CX3CR1 on CD14- CD16-
CX3CR1 on monocyte
CD28 on CD39+ resting CD4 regulatory T cell
CD28 on activated CD4 regulatory T cell
CD86 on monocyte
CD86 on granulocyte
CCR7 on naive CD4+ T cell
CD40 on CD14+ CD16- monocyte
CD40 on CD14+ CD16+ monocyte
CCR2 on CD14- CD16+ monocyte
CD14 on CD14+ CD16+ monocyte
HLA DR on CD14- CD16+ monocyte
IDP dMRI TBSS L3 Superior longitudinal fasciculus L
IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R
IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L
IDP dMRI TBSS L3 Uncinate fasciculus R
IDP dMRI TBSS L3 Uncinate fasciculus L
IDP dMRI ProbtrackX MD ar l
IDP dMRI ProbtrackX MD ar r
IDP dMRI ProbtrackX MD atr l
IDP dMRI ProbtrackX MD atr r
IDP dMRI ProbtrackX MD cgc l
IDP dMRI ProbtrackX MD cgc r
IDP dMRI ProbtrackX MD cgh l
IDP dMRI ProbtrackX MD cst l
IDP dMRI ProbtrackX MD cst r
IDP dMRI ProbtrackX MD fma
IDP dMRI ProbtrackX MD fmi
IDP dMRI TBSS L3 Posterior thalamic radiation L
IDP dMRI TBSS L3 Sagittal stratum R
IDP dMRI TBSS L3 Sagittal stratum L
IDP dMRI TBSS L3 External capsule R
IDP dMRI TBSS L3 External capsule L
IDP dMRI TBSS L3 Cingulum cingulate gyrus R
IDP dMRI TBSS L3 Cingulum cingulate gyrus L
IDP dMRI TBSS L3 Cingulum hippocampus R
IDP dMRI TBSS L3 Cingulum hippocampus L
IDP dMRI TBSS L3 Superior longitudinal fasciculus R
IDP dMRI ProbtrackX MD ifo l
IDP dMRI ProbtrackX MD ifo r
IDP dMRI ProbtrackX MD ilf l
IDP dMRI ProbtrackX MD ilf r
IDP dMRI ProbtrackX MD ptr l
IDP dMRI ProbtrackX MD ptr r
IDP dMRI ProbtrackX MD slf l
IDP dMRI ProbtrackX MD slf r
IDP dMRI ProbtrackX MD str l
IDP dMRI ProbtrackX MD str r
IDP dMRI ProbtrackX MD unc l
BA-exvivo rh area BA2
BA-exvivo rh area BA3a
BA-exvivo rh area BA3b
BA-exvivo rh area BA4a
BA-exvivo rh area BA4p
BA-exvivo rh area BA6
BA-exvivo rh area BA45
BA-exvivo rh area V1
BA-exvivo rh area V2
BA-exvivo rh area MT
BA-exvivo rh area perirhinal
BA-exvivo rh area entorhinal
aparc-DKTatlas lh area caudalmiddlefrontal
Skin reflectance (Melanin index)
IDP dMRI TBSS ICVF Superior corona radiata R
IDP dMRI TBSS ICVF Superior corona radiata L
IDP dMRI TBSS ICVF Posterior corona radiata R
Right-sided colonic diverticulosis
IDP dMRI ProbtrackX ICVF str r
IDP dMRI ProbtrackX ICVF unc l
IDP dMRI ProbtrackX ICVF unc r
IDP dMRI TBSS OD Pontine crossing tract
IDP dMRI TBSS OD Genu of corpus callosum
IDP dMRI TBSS OD Body of corpus callosum
IDP dMRI TBSS OD Fornix
IDP dMRI TBSS OD Cerebral peduncle R
IDP dMRI TBSS OD Cerebral peduncle L
IDP dMRI ProbtrackX ICVF slf r
IDP dMRI ProbtrackX ICVF str l
Gut microbiota abundance (class Actinobacteria id.419)
Gut microbiota abundance (family Bifidobacteriaceae id.433)
Gut microbiota abundance (family Oxalobacteraceae id.2966)
Gut microbiota abundance (genus Intestinibacter id.11345)
Gut microbiota abundance (genus Oxalobacter id.2978)
Gut microbiota abundance (genus Peptococcus id.2037)
Gut microbiota abundance (genus Romboutsia id.11347)
Gut microbiota abundance (genus Ruminococcaceae UCG009 id.11366)
Alzheimer's disease or body fat percentage (pleiotropy)
Alzheimer's disease or diastolic blood pressure (pleiotropy)
Alzheimer's disease or LDL levels (pleiotropy)
Alzheimer's disease or systolic blood pressure (pleiotropy)
Alzheimer's disease or waist-hip ratio (pleiotropy)
wg lh intensity-contrast inferiorparietal
wg lh intensity-contrast inferiortemporal
wg lh intensity-contrast isthmuscingulate
Cerebral glucose metabolic decline (left angular gyrus)
Cerebral glucose metabolic decline (right temporal gyrus)
Cerebral glucose metabolic decline (left temporal gyrus)
Cerebral glucose metabolic decline (right angular gyrus)
Cerebral glucose metabolic decline (posterior cingulate cortex)
Tumor necrosis factor receptor superfamily member 5 levels
Tissue-type plasminogen activator levels
Proheparin-binding EGF-like growth factor levels
Endothelial cell-specific molecule 1 levels
Matrix metalloproteinase-12 levels
CCR2 on granulocyte
CD14 on CD33+ HLA DR+ CD14dim
CD14 on CD33dim HLA DR+ CD11b+
CD4 on CD4+ T cell
CD4 on Central Memory CD4+ T cell
CD4 on naive CD4+ T cell
CD4 on Effector Memory CD4+ T cell
CD4 on CD45RA+ CD4+ T cell
CD19 on B cell
CD39 on CD39+ CD8+ T cell
CD39 on CD39+ activated CD4 regulatory T cell
aparc-Desikan rh area fusiform
aparc-Desikan rh area inferiorparietal
aparc-Desikan rh area isthmuscingulate
aparc-Desikan rh area lateraloccipital
aparc-Desikan rh area lingual
aparc-Desikan rh area parsopercularis
aparc-Desikan rh area parstriangularis
aparc-Desikan rh area pericalcarine
aparc-Desikan rh area postcentral
aparc-Desikan rh area precentral
aparc-Desikan rh area precuneus
Sensitive skin
Body fat percentage and type 2 diabetes (pairwise)
Body mass index and HDL-C (pairwise)
Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder
Body mass index and LDL-C (pairwise)
Body mass index and triglycerides (pairwise)
Episodic memory (pairs-matching)
Executive function (trail making test B)
Information processing speed (symbol digit substitution)
aparc-DKTatlas lh area supramarginal
aparc-DKTatlas rh area caudalmiddlefrontal
aparc-DKTatlas rh area cuneus
aparc-DKTatlas rh area fusiform
aparc-DKTatlas rh area inferiorparietal
IDP dMRI TBSS ICVF Anterior corona radiata R
IDP dMRI TBSS ICVF Anterior corona radiata L
Body mass index and fasting insulin (pairwise)
Body mass index and fasting glucose (pairwise)
Response to immune checkpoint inhibitors in melanoma (immune-related adverse events)
Resistin levels in overweight individuals
Resistin levels in type 2 diabetes
Visfatin levels
Visfatin levels in lean individuals
Visfatin levels in overweight individuals
Visfatin levels in type 2 diabetes
ghrelin levels in type 2 diabetes
Leptin levels in lean individuals
Leptin levels in overweight individuals
Leptin levels in type 2 diabetes
Leptin levels
Plasminogen activator inhibitor type 1 levels (PAI-1) in lean individuals
Plasminogen activator inhibitor type 1 levels (PAI-1) in overweight individuals
Plasminogen activator inhibitor type 1 levels (PAI-1) in type 2 diabetes
Resistin levels in lean individuals
Glucose-dependent insulinotropic peptide levels
Glucose-dependent insulinotropic peptide levels in lean individuals
Glucose-dependent insulinotropic peptide levels in overweight individuals
Glucose-dependent insulinotropic peptide levels in type 2 diabetes
IDP dMRI TBSS ICVF Uncinate fasciculus R
IDP dMRI TBSS ICVF Uncinate fasciculus L
IDP dMRI TBSS ICVF Tapetum R
IDP dMRI TBSS ICVF Tapetum L
IDP dMRI ProbtrackX ICVF ar l
IDP dMRI ProbtrackX ICVF ar r
IDP dMRI ProbtrackX ICVF atr l
Insulin levels in overweight individuals
Tuberculosis susceptibility in HIV infection
Lacunar stroke
Stool frequency
IDP dMRI ProbtrackX OD slf r
IDP dMRI ProbtrackX OD str l
IDP dMRI ProbtrackX OD str r
IDP dMRI TBSS ISOVF Genu of corpus callosum
IDP dMRI TBSS ISOVF Fornix
IDP dMRI TBSS ISOVF Corticospinal tract R
IDP dMRI TBSS ISOVF Superior cerebellar peduncle L
IDP dMRI TBSS ISOVF Anterior corona radiata R
IDP dMRI TBSS ISOVF Anterior corona radiata L
IDP dMRI TBSS ISOVF Superior corona radiata R
IDP dMRI TBSS ISOVF Posterior corona radiata R
IDP dMRI TBSS ISOVF Posterior corona radiata L
IDP dMRI TBSS ISOVF Posterior thalamic radiation R
IDP dMRI TBSS ISOVF Posterior thalamic radiation L
IDP dMRI TBSS ISOVF Sagittal stratum R
IDP dMRI TBSS ISOVF Sagittal stratum L
IDP dMRI TBSS ISOVF External capsule R
IDP dMRI TBSS ISOVF External capsule L
IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R
IDP dMRI TBSS ISOVF Superior longitudinal fasciculus R
IDP dMRI TBSS ISOVF Superior longitudinal fasciculus L
IDP dMRI ProbtrackX ISOVF ar r
Gut microbiota presence (genus Turicibacter id.2162)
Gut microbiota presence (genus Ruminiclostridium6 id.11356)
Gut microbiota presence (genus Odoribacter id.952)
wg lh intensity-contrast rostralanteriorcingulate
wg lh intensity-contrast rostralmiddlefrontal
wg lh intensity-contrast superiorfrontal
Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer
Obstructive sleep apnea (BMI adjusted)
CD39+ resting CD4 regulatory T cell %resting CD4 regulatory T cell
CD39+ resting CD4 regulatory T cell %CD4 regulatory T cell
Activated CD4 regulatory T cell Absolute Count
Activated CD4 regulatory T cell %CD4 regulatory T cell
CD39+ activated CD4 regulatory T cell Absolute Count
CD39+ activated CD4 regulatory T cell %activated CD4 regulatory T cell
CD39+ activated CD4 regulatory T cell %CD4 regulatory T cell
Secreting CD4 regulatory T cell Absolute Count
Secreting CD4 regulatory T cell %CD4 regulatory T cell
Secreting CD4 regulatory T cell %CD4+ T cell
CD39+ secreting CD4 regulatory T cell Absolute Count
wg rh intensity-contrast frontalpole
wg rh intensity-contrast temporalpole
wg rh intensity-contrast transversetemporal
wg rh intensity-contrast insula
IDP T2 FLAIR BIANCA WMH volume
IDP SWI T2star left thalamus
IDP SWI T2star right thalamus
IDP SWI T2star left caudate
wg rh intensity-contrast superiorfrontal
wg rh intensity-contrast superiorparietal
wg rh intensity-contrast superiortemporal
wg rh intensity-contrast supramarginal
Facial morphology traits (63 three-dimensional facial segments)
Obstructive sleep apnea trait (average oxyhemoglobin desaturation per event)
Obstructive sleep apnea trait (average oxyhemoglobin saturation across sleep episode)
Obstructive sleep apnea trait (minimum oxyhemoglobin saturation across sleep episode)
Obstructive sleep apnea trait (percentage sleep with oxyhemoglobin saturation less than 90%)
BAFF-R on transitional B cell
CD19 on CD20- CD38- B cell
CD19 on CD24+ CD27+ B cell
CD19 on IgD+ CD24+ B cell
CD19 on IgD+ CD24- B cell
CD19 on IgD+ CD38- B cell
CD19 on IgD+ CD38+ B cell
CD19 on IgD+ CD38dim B cell
CD19 on IgD- CD27- B cell
CD19 on IgD- CD38- B cell
CD19 on IgD- CD38dim B cell
CD19 on memory B cell
CD19 on naive-mature B cell
BAFF-R on IgD+ CD24- B cell
BAFF-R on IgD+ CD38- B cell
BAFF-R on IgD+ CD38+ B cell
BAFF-R on IgD+ CD38dim B cell
BAFF-R on IgD- CD24- B cell
BAFF-R on IgD- CD27- B cell
BAFF-R on IgD- CD38- B cell
BAFF-R on IgD- CD38+ B cell
BAFF-R on IgD- CD38dim B cell
BAFF-R on memory B cell
BAFF-R on naive-mature B cell
BAFF-R on unswitched memory B cell
BAFF-R on switched memory B cell
BAFF-R on IgD+ B cell
IDP dMRI TBSS MO Body of corpus callosum
IDP dMRI TBSS MO Fornix
IDP dMRI TBSS MO Medial lemniscus R
IDP dMRI TBSS MO Medial lemniscus L
rfMRI connectivity (ICA100 edge 383)
rfMRI connectivity (ICA100 edge 387)
rfMRI connectivity (ICA100 edge 391)
rfMRI connectivity (ICA100 edge 399)
rfMRI connectivity (ICA100 edge 414)
rfMRI connectivity (ICA100 edge 429)
aparc-Desikan rh volume fusiform
aparc-Desikan rh volume lateraloccipital
aparc-Desikan rh volume lingual
aparc-Desikan rh volume parahippocampal
aparc-Desikan rh volume parsopercularis
aparc-Desikan rh volume parstriangularis
aparc-Desikan rh volume pericalcarine
BA-exvivo rh volume BA3a
BA-exvivo rh volume BA3b
BA-exvivo rh volume BA4a
BA-exvivo rh volume BA4p
BA-exvivo rh volume BA6
BA-exvivo rh volume BA45
BA-exvivo rh volume V1
BA-exvivo rh volume V2
BA-exvivo rh volume MT
aparc-DKTatlas lh volume caudalanteriorcingulate
aparc-DKTatlas lh volume caudalmiddlefrontal
aparc-DKTatlas lh volume cuneus
aparc-DKTatlas lh volume lateraloccipital
aparc-DKTatlas lh volume lingual
aparc-DKTatlas lh volume parsopercularis
aparc-DKTatlas lh volume parstriangularis
aparc-Desikan rh volume postcentral
aparc-Desikan rh volume precentral
aparc-Desikan rh volume precuneus
aparc-Desikan rh volume superiorparietal
aparc-Desikan rh volume supramarginal
aparc-Desikan rh volume insula
BA-exvivo lh volume BA1
BA-exvivo lh volume BA2
BA-exvivo lh volume BA3a
BA-exvivo lh volume BA3b
BA-exvivo lh volume BA4p
BA-exvivo lh volume BA6
BA-exvivo lh volume V1
BA-exvivo lh volume V2
BA-exvivo lh volume entorhinal
BA-exvivo rh volume BA1
BA-exvivo rh volume BA2
Effector Memory CD8+ T cell %T cell
Terminally Differentiated CD8+ T cell Absolute Count
Terminally Differentiated CD8+ T cell %CD8+ T cell
Terminally Differentiated CD8+ T cell %T cell
CD45RA+ CD8+ T cell Absolute Count
CD45RA+ CD8+ T cell %CD8+ T cell
CD45RA+ CD8+ T cell %T cell
Naive CD4-CD8- T cell %T cell
Effector Memory CD4-CD8- T cell Absolute Count
Effector Memory CD4-CD8- T cell %CD4-CD8- T cell
Effector Memory CD4-CD8- T cell %T cell
Terminally Differentiated CD4+ T cell %T cell
Naive CD8+ T cell Absolute Count
Naive CD8+ T cell %CD8+ T cell
Naive CD8+ T cell %T cell
Effector Memory CD8+ T cell Absolute Count
Effector Memory CD8+ T cell %CD8+ T cell
ThalamNuclei rh volume VAmc
ThalamNuclei rh volume MDl
ThalamNuclei rh volume CeM
ThalamNuclei rh volume VLp
ThalamNuclei lh volume Whole-thalamus
Brainstem global volume Medulla
Brainstem global volume Pons
Brainstem global volume Midbrain
Beta blocker survival benefit in heart failure with reduced ejection fraction (time to all cause mortality x beta blocker interaction)
Pentraxin-related protein PTX3 levels
Renin levels
CD3 on Terminally Differentiated CD4+ T cell
CD3 on CD45RA- CD4+ T cell
CD3 on Central Memory CD8+ T cell
CD3 on HLA DR+ T cell
CD3 on Natural Killer T
CD3 on HLA DR+ CD4+ T cell
CD3 on HLA DR+ CD8+ T cell
CD3 on CD39+ resting CD4 regulatory T cell
CD3 on activated CD4 regulatory T cell
CD3 on CD39+ activated CD4 regulatory T cell
CD3 on secreting CD4 regulatory T cell
CD3 on CD39+ secreting CD4 regulatory T cell
CD3 on activated & secreting CD4 regulatory T cell
CD3 on CD45RA+ CD4+ T cell
CD3 on CD8+ T cell
CD3 on CD39+ CD4+ T cell
CD3 on CD28+ CD4+ T cell
CD3 on CD28+ CD45RA- CD8+ T cell
CD3 on CD28+ CD45RA+ CD8+ T cell
CD3 on CD28- CD8+ T cell
CD3 on CD39+ CD8+ T cell
CD3 on CD4+ T cell
aparc-a2009s rh volume G-precentral
aparc-a2009s rh volume G-precuneus
aparc-a2009s rh volume Lat-Fis-ant-Vertical
aparc-a2009s rh volume Pole-occipital
aparc-a2009s rh volume S-calcarine
aparc-a2009s rh volume S-central
aparc-a2009s rh volume S-collat-transv-ant
aparc-a2009s rh volume S-front-inf
aparc-a2009s rh volume S-intrapariet+P-trans
aparc-a2009s rh volume S-oc-middle+Lunatus
aparc-a2009s rh volume S-oc-temp-med+Lingual
aparc-a2009s rh volume S-orbital-H-Shaped
aparc-a2009s rh volume S-parieto-occipital
aparc-a2009s rh volume S-postcentral
aparc-a2009s rh volume S-precentral-sup-part
aparc-a2009s rh volume S-subparietal
aparc-Desikan lh area TotalSurface
aparc-Desikan lh area caudalmiddlefrontal
aparc-Desikan lh area cuneus
IDP dMRI TBSS L2 Anterior corona radiata L
IDP dMRI TBSS L2 Superior corona radiata R
IDP dMRI TBSS L2 Superior corona radiata L
IDP dMRI TBSS L2 Posterior corona radiata R
IDP dMRI TBSS L2 Posterior corona radiata L
IDP dMRI TBSS L2 Posterior thalamic radiation R
IDP dMRI TBSS L2 Posterior thalamic radiation L
IDP dMRI TBSS L2 Sagittal stratum R
IDP dMRI TBSS L2 Sagittal stratum L
IDP dMRI TBSS L2 External capsule R
IDP dMRI TBSS L2 External capsule L
aparc-a2009s rh volume G+S-subcentral
aparc-a2009s rh volume G-cingul-Post-ventral
aparc-a2009s rh volume G-cuneus
aparc-a2009s rh volume G-front-inf-Triangul
aparc-a2009s rh volume G-occipital-sup
aparc-a2009s rh volume G-pariet-inf-Supramar
aparc-a2009s rh volume G-parietal-sup
aparc-a2009s rh volume G-postcentral
IDP dMRI TBSS L2 Superior cerebellar peduncle R
IDP dMRI TBSS L2 Superior cerebellar peduncle L
IDP dMRI TBSS L2 Cerebral peduncle R
IDP dMRI TBSS L2 Anterior limb of internal capsule R
IDP dMRI TBSS L2 Anterior limb of internal capsule L
IDP dMRI TBSS L2 Posterior limb of internal capsule R
IDP dMRI TBSS L2 Posterior limb of internal capsule L
IDP dMRI TBSS L2 Retrolenticular part of internal capsule R
IDP dMRI TBSS L2 Retrolenticular part of internal capsule L
IDP dMRI TBSS L2 Anterior corona radiata R
Glucagon levels
Glucagon levels in lean individuals
Glucagon levels in overweight individuals
Interleukin-6 levels in overweight individuals
Insulin levels in lean individuals
IDP dMRI TBSS ICVF Superior longitudinal fasciculus L
IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R
IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L
aparc-a2009s lh area S-collat-transv-ant
aparc-a2009s lh area S-intrapariet+P-trans
aparc-a2009s lh area S-oc-middle+Lunatus
aparc-a2009s lh area S-orbital-med-olfact
aparc-a2009s lh area S-orbital-H-Shaped
aparc-a2009s lh area S-postcentral
aparc-a2009s lh area S-precentral-sup-part
aparc-a2009s lh area S-subparietal
aparc-a2009s lh area S-temporal-sup
IDP dMRI TBSS OD Superior fronto-occipital fasciculus R
IDP dMRI TBSS OD Superior fronto-occipital fasciculus L
IDP dMRI TBSS OD Tapetum R
IDP dMRI ProbtrackX OD fma
IDP dMRI ProbtrackX OD fmi
IDP dMRI ProbtrackX OD ilf r
IDP dMRI ProbtrackX OD slf l
Beta 1 electroencephalogram power
Beta 2 electroencephalogram power
Delta electroencephalogram power
Theta electroencephalogram power
Alpha electroencephalogram power
Kleine-Levin syndrome
aseg lh intensity Accumbens-area
aseg lh intensity VentralDC
aseg rh intensity Lateral-Ventricle
aseg rh intensity Cerebellum-Cortex
aseg rh intensity Thalamus-Proper
aseg rh intensity Caudate
aseg rh intensity Putamen
wg lh intensity-contrast cuneus
wg lh intensity-contrast entorhinal
wg lh intensity-contrast fusiform
aseg rh intensity Pallidum
aseg rh intensity Accumbens-area
wg lh intensity-contrast bankssts
wg lh intensity-contrast caudalmiddlefrontal
aseg rh volume Hippocampus
aseg rh volume Amygdala
aseg rh volume Accumbens-area
aseg rh volume VentralDC
aseg rh volume choroid-plexus
aseg rh number HolesBeforeFixing
AmygNuclei lh volume Lateral-nucleus
AmygNuclei lh volume Accessory-Basal-nucleus
AmygNuclei lh volume Central-nucleus
AmygNuclei lh volume Medial-nucleus
AmygNuclei lh volume Cortical-nucleus
AmygNuclei lh volume Whole-amygdala
AmygNuclei rh volume Lateral-nucleus
AmygNuclei rh volume Basal-nucleus
aseg rh volume Lateral-Ventricle
aseg rh volume Cerebellum-White-Matter
aseg rh volume Cerebellum-Cortex
aseg rh volume Caudate
aseg rh volume Putamen
aseg rh volume Pallidum
IgD+ CD24+ B cell %lymphocyte
IgD+ CD24- B cell %lymphocyte
CD24+ CD27+ B cell %lymphocyte
IgD- CD38- B cell Absolute Count
IgD+ CD38+ B cell %B cell
CD4 regulatory T cell %CD4+ T cell
CD4 regulatory T cell %T cell
Resting CD4 regulatory T cell Absolute Count
Resting CD4 regulatory T cell %CD4 regulatory T cell
Resting CD4 regulatory T cell %CD4+ T cell
CD39+ resting CD4 regulatory T cell Absolute Count
IgD- CD38- B cell %lymphocyte
IgD+ CD38+ B cell %lymphocyte
IgD+ CD38dim B cell %lymphocyte
IgD+ CD38- B cell %lymphocyte
Unswitched memory B cell %lymphocyte
IgD- CD27- B cell %lymphocyte
Switched memory B cell %lymphocyte
Plasma Blast-Plasma Cell %lymphocyte
Memory B cell %lymphocyte
Naive-mature B cell %lymphocyte
HippSubfield rh volume Whole-hippocampal-head
HippSubfield rh volume Whole-hippocampus
ThalamNuclei lh volume PuI
ThalamNuclei lh volume L-Sg
ThalamNuclei lh volume VPL
ThalamNuclei lh volume CM
wg rh intensity-contrast posteriorcingulate
wg rh intensity-contrast precentral
wg rh intensity-contrast precuneus
wg rh intensity-contrast rostralanteriorcingulate
wg rh intensity-contrast rostralmiddlefrontal
HippSubfield lh volume Whole-hippocampus
HippSubfield rh volume Hippocampal-tail
HippSubfield rh volume subiculum-body
HippSubfield rh volume CA1-body
HippSubfield rh volume subiculum-head
HippSubfield rh volume hippocampal-fissure
HippSubfield rh volume presubiculum-head
HippSubfield rh volume CA1-head
HippSubfield rh volume presubiculum-body
HippSubfield rh volume molecular-layer-HP-head
HippSubfield rh volume GC-ML-DG-head
HippSubfield rh volume CA3-body
HippSubfield rh volume GC-ML-DG-body
HippSubfield rh volume CA4-head
HippSubfield rh volume CA4-body
HippSubfield rh volume CA3-head
HippSubfield rh volume Whole-hippocampal-body
Myeloperoxidase-DNA complexes
CD25 on CD24+ CD27+ B cell
CD25 on IgD+ CD24+ B cell
CD25 on IgD+ CD24- B cell
CD25 on IgD+ CD38- B cell
CD25 on IgD+ CD38+ B cell
CD25 on IgD+ CD38dim B cell
CD25 on IgD- CD24- B cell
CD25 on IgD- CD27- B cell
CD25 on IgD- CD38- B cell
CD25 on IgD- CD38dim B cell
CD25 on memory B cell
CD25 on naive-mature B cell
CD25 on unswitched memory B cell
CD25 on switched memory B cell
CD25 on IgD+ B cell
CD25 on transitional B cell
CD27 on CD24+ CD27+ B cell
CD27 on IgD+ CD24+ B cell
CD27 on IgD- CD38- B cell
CD27 on IgD- CD38+ B cell
aparc-DKTatlas rh volume parstriangularis
aparc-DKTatlas rh volume pericalcarine
aparc-DKTatlas rh volume postcentral
aparc-DKTatlas rh volume precentral
aparc-DKTatlas rh volume precuneus
aparc-DKTatlas rh volume superiorparietal
aparc-DKTatlas rh volume supramarginal
aparc-a2009s lh volume G+S-subcentral
aparc-a2009s lh volume G-cingul-Post-ventral
aparc-a2009s lh volume G-cuneus
aparc-a2009s lh volume G-front-inf-Opercular
aparc-a2009s lh volume G-front-inf-Triangul
aparc-a2009s lh volume G-oc-temp-med-Lingual
aparc-a2009s lh volume G-pariet-inf-Supramar
Fatty acid-binding protein, adipocyte levels
C-C motif chemokine 20 levels
Ovarian cancer-related tumor marker CA 125 levels
Follistatin levels
Platelet endothelial cell adhesion molecule levels
N-terminal prohormone brain natriuretic peptide levels
CD8 on CD8+ T cell
CD8 on Natural Killer T
CD8 on HLA DR+ CD8+ T cell
CD4 on CD39+ CD4+ T cell
CD4 on CD28+ CD4+ T cell
CD4 on CD4 regulatory T cell
CD4 on resting CD4 regulatory T cell
CD4 on activated CD4 regulatory T cell
CD4 on CD39+ activated CD4 regulatory T cell
CD4 on secreting CD4 regulatory T cell
CD4 on CD39+ secreting CD4 regulatory T cell
CD4 on activated & secreting CD4 regulatory T cell
SSC-A on myeloid Dendritic Cell
IDP dMRI ProbtrackX L1 unc r
IDP dMRI ProbtrackX L2 ar l
IDP dMRI ProbtrackX L2 ar r
IDP dMRI ProbtrackX L2 atr l
IDP dMRI ProbtrackX L2 atr r
IDP dMRI ProbtrackX L2 cgc l
IDP dMRI ProbtrackX L2 cgc r
IDP dMRI ProbtrackX L2 cst l
IDP dMRI ProbtrackX L2 cst r
IDP dMRI ProbtrackX L2 fma
IDP dMRI ProbtrackX L2 fmi
IDP dMRI ProbtrackX L2 ifo l
IDP dMRI ProbtrackX L2 ifo r
IDP dMRI ProbtrackX L2 ilf l
IDP dMRI ProbtrackX L2 ilf r
IDP dMRI ProbtrackX L2 ptr l
IDP dMRI ProbtrackX L2 ptr r
IDP dMRI ProbtrackX L2 slf l
IDP dMRI ProbtrackX L2 slf r
IDP dMRI ProbtrackX L2 str r
IDP dMRI ProbtrackX L2 unc l
IDP dMRI ProbtrackX L2 unc r
IDP dMRI ProbtrackX L3 ar l
IDP dMRI ProbtrackX L3 ar r
IDP dMRI ProbtrackX L3 atr l
IDP dMRI ProbtrackX L3 atr r
IDP dMRI ProbtrackX L3 cgc l
IDP dMRI ProbtrackX L3 cgc r
IDP dMRI ProbtrackX L3 cst l
IDP dMRI ProbtrackX L3 cst r
IDP dMRI ProbtrackX L3 fma
Extranodal natural killer T-cell lymphoma (nasal type)
Body mass index and type 2 diabetes (pairwise)
Waist-hip ratio and HDL-C (pairwise)
Waist-hip ratio and LDL-C (pairwise)
Waist-hip ratio and triglycerides (pairwise)
Waist-hip ratio and fasting insulin (pairwise)
Waist-hip ratio and fasting glucose (pairwise)
Waist-hip ratio and systolic blood pressure (pairwise)
Waist-hip ratio and coronary artery disease (pairwise)
Body mass index and systole blood pressure (pairwise)
Body mass index and coronary artery disease (pairwise)
HDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
LDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
Total cholesterol levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
Triglyceride levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder
BMI x SSRI levels interaction in schizophrenia or bipolar disorder
Waist-hip ratio and type 2 diabetes (pairwise)
Rocuronium dose requirement in breast cancer surgery
IDP dMRI TBSS OD Anterior limb of internal capsule R
IDP dMRI TBSS OD Anterior limb of internal capsule L
IDP dMRI TBSS OD Posterior limb of internal capsule R
IDP dMRI TBSS OD Posterior limb of internal capsule L
IDP dMRI TBSS OD Superior corona radiata R
IDP dMRI TBSS OD Superior corona radiata L
IDP dMRI TBSS OD Posterior corona radiata R
IDP dMRI TBSS OD Posterior corona radiata L
IDP dMRI TBSS OD External capsule R
IDP dMRI TBSS OD External capsule L
aparc-DKTatlas rh area lateraloccipital
aparc-DKTatlas rh area insula
aparc-a2009s lh area G+S-subcentral
aparc-a2009s lh area G-cingul-Post-ventral
aparc-a2009s lh area G-cuneus
aparc-a2009s lh area G-front-inf-Triangul
aparc-a2009s lh area G-oc-temp-med-Lingual
aparc-a2009s lh area G-pariet-inf-Supramar
aparc-a2009s lh area G-parietal-sup
aparc-a2009s lh area G-postcentral
aparc-a2009s lh area G-precentral
aparc-a2009s lh area G-precuneus
aparc-a2009s lh area Pole-temporal
aparc-a2009s lh area S-calcarine
aparc-a2009s lh area S-central
aparc-DKTatlas rh area lingual
aparc-DKTatlas rh area parsopercularis
aparc-DKTatlas rh area parstriangularis
aparc-DKTatlas rh area pericalcarine
aparc-DKTatlas rh area postcentral
aparc-DKTatlas rh area precentral
aparc-DKTatlas rh area precuneus
aparc-DKTatlas rh area superiorparietal
aparc-DKTatlas rh area supramarginal
Mitochondrial heteroplasmy measurement
IDP dMRI ProbtrackX ISOVF slf l
IDP dMRI ProbtrackX ISOVF slf r
IDP dMRI ProbtrackX ISOVF str l
IDP dMRI ProbtrackX ISOVF str r
IDP dMRI ProbtrackX ISOVF unc l
IDP dMRI ProbtrackX ISOVF unc r
rfMRI amplitudes (ICA25 node 12)
rfMRI amplitudes (ICA25 node 14)
rfMRI amplitudes (ICA100 node 2)
rfMRI amplitudes (ICA100 node 7)
rfMRI amplitudes (ICA100 node 11)
Tinnitus
Tinnitus (severest)
rfMRI amplitudes (ICA100 node 12)
rfMRI amplitudes (ICA100 node 15)
rfMRI amplitudes (ICA100 node 26)
rfMRI amplitudes (ICA100 node 27)
aparc-Desikan lh thickness precentral
aparc-Desikan lh thickness precuneus
aparc-Desikan rh thickness GlobalMeanThickness
aparc-Desikan rh thickness cuneus
aparc-Desikan rh thickness lateraloccipital
aparc-Desikan rh thickness lingual
aparc-Desikan rh thickness paracentral
aparc-Desikan rh thickness pericalcarine
aparc-Desikan rh thickness postcentral
aparc-Desikan rh thickness transversetemporal
BA-exvivo lh thickness BA1
BA-exvivo lh thickness BA2
BA-exvivo lh thickness BA3b
BA-exvivo lh thickness BA4a
BA-exvivo lh thickness BA4p
BA-exvivo lh thickness V2
BA-exvivo lh thickness MT
BA-exvivo rh thickness BA1
BA-exvivo rh thickness BA2
Epidermal growth factor levels
Adrenomedullin levels
Placenta growth factor levels
Cystatin-B levels
TNF-related apoptosis-inducing ligand levels
Angiopoietin-1 receptor levels
Kallikrein-6 levels
Galectin-3 levels
Proteinase-activated receptor 1 levels
CD27 on IgD- CD38dim B cell
CD27 on memory B cell
CD27 on unswitched memory B cell
CD27 on Plasma Blast-Plasma Cell
CD27 on switched memory B cell
CD38 on IgD+ CD24- B cell
aparc-a2009s lh volume G-parietal-sup
aparc-a2009s lh volume G-postcentral
aparc-a2009s lh volume G-precentral
aparc-a2009s lh volume G-precuneus
aparc-a2009s lh volume S-calcarine
aparc-a2009s lh volume S-central
aparc-a2009s lh volume S-circular-insula-sup
aparc-a2009s lh volume S-intrapariet+P-trans
aparc-a2009s lh volume S-postcentral
aparc-a2009s lh volume S-precentral-sup-part
aparc-a2009s lh volume S-subparietal
IDP dMRI TBSS MD Cingulum cingulate gyrus R
IDP dMRI TBSS MD Cingulum cingulate gyrus L
IDP dMRI TBSS MD Cingulum hippocampus R
IDP dMRI TBSS MD Cingulum hippocampus L
IDP dMRI TBSS MD Superior longitudinal fasciculus R
IDP dMRI TBSS MD Superior longitudinal fasciculus L
IDP dMRI TBSS MD Superior fronto-occipital fasciculus R
IDP dMRI TBSS MD Superior fronto-occipital fasciculus L
IDP dMRI TBSS MD Uncinate fasciculus R
IDP dMRI TBSS MD Uncinate fasciculus L
IDP dMRI TBSS L1 Genu of corpus callosum
IDP dMRI TBSS L1 Body of corpus callosum
IDP dMRI TBSS L1 Splenium of corpus callosum
Spondin-1 levels
Caspase 8 levels
Cathepsin L1 levels
CX3CL1 levels
CD80 on granulocyte
CD45 on lymphocyte
CD45 on CD33+ HLA DR+ CD14-
CD45 on CD33- HLA DR-
CD45 on CD33- HLA DR+
CD45 on CD33dim HLA DR-
CD45 on Immature Myeloid-Derived Suppressor Cells
CD8 on Central Memory CD8+ T cell
CD8 on naive CD8+ T cell
CD8 on Effector Memory CD8+ T cell
CD39 on CD39+ secreting CD4 regulatory T cell
CD39 on CD39+ CD4+ T cell
CD39 on granulocyte
CD39 on monocyte
CD80 on myeloid Dendritic Cell
CD80 on CD62L+ myeloid Dendritic Cell
CD80 on plasmacytoid Dendritic Cell
CD80 on CD62L+ plasmacytoid Dendritic Cell
CD80 on monocyte
aparc-pial lh area supramarginal
aparc-pial rh area TotalSurface
aparc-pial rh area caudalmiddlefrontal
aparc-pial rh area cuneus
aparc-pial rh area fusiform
aparc-pial rh area inferiorparietal
aparc-pial rh area lateraloccipital
aparc-pial rh area lateralorbitofrontal
aparc-pial rh area lingual
aparc-pial rh area parsopercularis
aparc-pial rh area parstriangularis
IDP dMRI ProbtrackX L1 fmi
aparc-Desikan rh area superiorparietal
aparc-Desikan rh area supramarginal
aparc-pial lh area TotalSurface
aparc-pial lh area caudalmiddlefrontal
aparc-pial lh area cuneus
aparc-pial lh area lateraloccipital
aparc-pial lh area lateralorbitofrontal
aparc-pial lh area lingual
aparc-pial lh area parstriangularis
aparc-pial lh area pericalcarine
aparc-pial lh area postcentral
aparc-pial lh area precentral
aparc-pial lh area precuneus
aparc-pial lh area rostralmiddlefrontal
aparc-pial lh area superiorparietal
IDP dMRI ProbtrackX L1 ifo l
IDP dMRI ProbtrackX L1 ifo r
IDP dMRI ProbtrackX L1 ilf l
IDP dMRI ProbtrackX L1 ilf r
IDP dMRI ProbtrackX L1 ptr l
IDP dMRI ProbtrackX L1 slf l
IDP dMRI ProbtrackX L1 slf r
IDP dMRI ProbtrackX L1 str l
IDP dMRI ProbtrackX L1 str r
IDP dMRI ProbtrackX L1 unc l
Eosinophil cationic protein levels
Odorant perception
Body fat percentage and triglycerides (pairwise)
Body fat percentage and HDL-C (pairwise)
Body fat percentage and fasting insulin (pairwise)
Body fat percentage and LDL-C (pairwise)
Body fat percentage and fasting glucose (pairwise)
Body fat percentage and systolic blood pressure (pairwise)
Body fat percentage and coronary artery disease (pairwise)
Glucagon-like peptide-1 levels in lean individuals
Glucagon-like peptide-1 levels
Glucagon-like peptide-1 levels in overweight individuals
Adipsin levels in overweight individuals
Adipsin levels in lean individuals
IDP dMRI ProbtrackX ICVF atr r
IDP dMRI ProbtrackX ICVF cgc l
IDP dMRI ProbtrackX ICVF cgc r
IDP dMRI ProbtrackX ICVF cgh l
IDP dMRI ProbtrackX ICVF cgh r
IDP T1 SIENAX brain-unnormalised volume
IDP T1 FIRST left caudate volume
IDP T1 FIRST right caudate volume
IDP T1 FIRST left putamen volume
IDP T1 FIRST right putamen volume
IDP T1 FIRST left pallidum volume
IDP T1 FIRST right pallidum volume
IDP T1 FIRST left hippocampus volume
IDP T1 FIRST brain stem+4th ventricle volume
IDP T1 FAST ROIs R mid front gyrus
IDP T1 FAST ROIs R inf front gyrus parstri
IDP T1 FAST ROIs L precentral gyrus
IDP T1 FAST ROIs R precentral gyrus
IDP T1 FAST ROIs L temporal pole
IDP T1 FAST ROIs R temporal pole
IDP T1 FAST ROIs R sup temp gyrus ant
IDP T1 SIENAX peripheral grey normalised volume
IDP T1 SIENAX peripheral grey unnormalised volume
IDP T1 SIENAX CSF normalised volume
IDP T1 SIENAX CSF unnormalised volume
IDP T1 SIENAX grey normalised volume
IDP T1 SIENAX grey unnormalised volume
IDP T1 SIENAX white normalised volume
IDP T1 SIENAX white unnormalised volume
IDP T1 SIENAX brain-normalised volume
Gut microbiota alpha diversity (Simpson index)
Gut microbiota abundance (genus Bifidobacterium id.436)
rfMRI connectivity ICA-features 2
rfMRI connectivity ICA-features 3
rfMRI connectivity ICA-features 4
rfMRI connectivity ICA-features 6
QC T1-to-standard linear alignment discrepancy
QC T1-to-standard nonlinear alignment discrepancy
QC T1 inverse SNR
QC T2 FLAIR-to-T1 linear alignment discrepancy
QC dMRI-to-T1 linear alignment discrepancy
QC SWI-to-T1 linear alignment discrepancy
QC rfMRI-to-T1 linear alignment discrepancy
QC tfMRI-to-T1 linear alignment discrepancy
QC rfMRI cleaned inverse tSNR
rfMRI connectivity (ICA100 edge 614)
rfMRI connectivity (ICA100 edge 619)
Brain shape (segment 1)
aseg lh volume Caudate
aseg lh volume Putamen
aseg lh volume Pallidum
aseg lh volume Hippocampus
aseg lh volume Accumbens-area
aseg lh volume VentralDC
aseg lh volume choroid-plexus
aseg lh number HolesBeforeFixing
aseg rh volume CerebralWhiteMatter
aseg global volume-ratio BrainSegVol-to-eTIV
aseg global volume-ratio MaskVol-to-eTIV
aseg lh volume CerebralWhiteMatter
aseg lh volume Lateral-Ventricle
aseg lh volume Inf-Lat-Vent
aseg lh volume Cerebellum-White-Matter
aseg lh volume Cerebellum-Cortex
rfMRI connectivity (ICA100 edge 659)
rfMRI connectivity (ICA100 edge 567)
rfMRI connectivity (ICA100 edge 810)
rfMRI connectivity (ICA100 edge 912)
rfMRI connectivity (ICA100 edge 931)
rfMRI connectivity (ICA100 edge 951)
rfMRI connectivity (ICA100 edge 957)
rfMRI connectivity (ICA100 edge 961)
rfMRI connectivity (ICA100 edge 974)
rfMRI connectivity (ICA100 edge 995)
rfMRI connectivity (ICA100 edge 1001)
rfMRI connectivity (ICA100 edge 605)
rfMRI connectivity (ICA100 edge 1011)
rfMRI connectivity (ICA100 edge 1066)
rfMRI connectivity (ICA100 edge 1083)
rfMRI connectivity (ICA100 edge 1090)
rfMRI connectivity (ICA100 edge 1091)
rfMRI connectivity (ICA100 edge 1099)
rfMRI connectivity ICA-features 1
Brain shape (segment 2)
Low myopia vs hyperopia
Hand grip strength right (UKB data field 47)
Hand grip strength left (UKB data field 46)
Smoking status - Current (UKB data field 20116)
Current tobacco smoking on most or all days (UKB data field 1239)
Use of sun UV protection - Always (UKB data field 2267)
Use of sun UV protection - Sometimes (UKB data field 2267)
Hip circumference (UKB data field 49)
Standing height (UKB data field 50)
Seated height (UKB data field 51)
Sitting height (UKB data field 20015)
Hair colour natural before greying - Blonde (UKB data field 1747)
Direct bilirubin levels (UKB data field 30660)
Type 2 diabetes New Strict
Interpolated Age of participant when operation took place (UKB data field 20011)
Eczema or dermatitis
High cholesterol
Hypothyroidism or myxoedema
Lipoprotein A levels (UKB data field 30790)
Asthma vs allergic disease
ICD10 L30: Eczema or dermatitis
ICD10 H40: Glaucoma
ICD10 E78: high cholesterol
ICD10 L40: Psoriasis
Childhood asthma vs allergic disease
Hearing aid user (UKB data field 3393)
Birth weight (UKB data field 20022)
Ankle spacing width (UKB data field 3143)
Heel bone mineral density T score automated (UKB data field 78)
Heel quantitative ultrasound index direct entry (UKB data field 3147)
Speed of sound through heel (UKB data field 3146)
Heel Broadband ultrasound attenuation direct entry (UKB data field 3144)
Heel bone mineral density (UKB data field 3148)
Medication for pain relief constipation heartburn - Aspirin (UKB data field 6154)
Started wearing glasses or contacts before 40
ICD10 J45: Asthma
ICD10 I10: hypertension
Airways medication use
Anticoagulant medicine use
Lipid lowering medication use
Treatment or medication use - allopurinol
Treatment or medication use - aspirin
Started wearing glasses or contacts after 40
Treatment or medication use - atorvastatin
Treatment or medication use - ezetimibe
ICD10 E78.0: Pure hypercholesterolemia
Total protein levels (UKB data field 30860)
Glucose levels (UKB data field 30740)
Asthma strict
Apolipoprotein A levels (UKB data field 30630)
Sex hormone binding globulin levels (UKB data field 30830)
Glasses or contact lenses use (age of onset) (UKB data field 2217)
ICD10 E78: Disorders of lipoprotein metabolism and other lipidemias
Allergic disease
Pulse rate (UKB data field 4194)
Heel bone mineral density T score automated right (UKB data field 4125)
Heel quantitative ultrasound index direct entry right (UKB data field 4123)
Speed of sound through heel right (UKB data field 4122)
Heel broadband ultrasound attenuation right (UKB data field 4120)
Heel bone mineral density T score automated left (UKB data field 4106)
Heel quantitative ultrasound index direct entry left (UKB data field 4104)
Speed of sound through heel left (UKB data field 4103)
Heel broadband ultrasound attenuation left (UKB data field 4101)
Heel bone mineral density right (UKB data field 4124)
Heel bone mineral density left (UKB data field 4105)
Chronic obstructive pulmonary disease x current smoker interaction (2df)
Chronic obstructive pulmonary disease x current smoker interaction (main effect)
Gut microbiota presence (unknown genus id.1000005479)
Gut microbiota alpha diversity (Inverse Simpson index)
Complement C3 levels
Complement C4 levels
Brain shape (segment 155)
Brain shape (segment 157)
Brain shape (segment 159)
Brain shape (segment 164)
Brain shape (segment 177)
Brain shape (segment 188)
Brain shape (segment 190)
Brain shape (segment 196)
Brain shape (segment 197)
Brain shape (segment 198)
Brain shape (segment 199)
Brain shape (segment 202)
Brain shape (segment 203)
Brain shape (segment 204)
Brain shape (segment 205)
Brain shape (segment 206)
IDP T1 FAST ROIs R cerebellum IX
IDP T1 FAST ROIs L cerebellum X
IDP T1 FAST ROIs V cerebellum X
IDP T1 FAST ROIs R cerebellum X
aseg global volume BrainSeg
aseg global volume BrainSegNotVent
aseg global volume BrainSegNotVentSurf
aseg global volume TotalGray
aseg global volume SupraTentorial
aseg global volume SupraTentorialNotVent
aseg global volume EstimatedTotalIntraCranial
Response to resistance training (vastus lateralis fiber area change)
Achilles tendon injury
Total amyloid (SNP x SNP interaction)
Brain shape (segment 10)
Brain shape (segment 11)
Brain shape (segment 12)
Brain shape (segment 14)
Brain shape (segment 15)
Brain shape (segment 19)
Brain shape (segment 20)
Brain shape (segment 21)
Brain shape (segment 22)
Brain shape (segment 26)
Brain shape (segment 7)
Impedance of leg right (UKB data field 23107)
Impedance of leg left (UKB data field 23108)
Impedance of whole body (UKB data field 23106)
Impedance of arm left (UKB data field 23110)
Impedance of arm right (UKB data field 23109)
Weight (UKB data field 23098)
Basal metabolic rate (UKB data field 23105)
Leg fat percentage right (UKB data field 23111)
Leg fat mass right (UKB data field 23112)
Leg fat free mass right (UKB data field 23113)
Weight (UKB data field 21002)
Diabetes mellitus (UKB data field 2443)
Skin colour - Dark olive (UKB data field 1717)
Skin colour - Fair (UKB data field 1717)
Skin colour - Light olive (UKB data field 1717)
Skin colour - Very fair (UKB data field 1717)
Hair colour natural before greying - Dark brown (UKB data field 1747)
Hair colour natural before greying - Light brown (UKB data field 1747)
Hair colour natural before greying - Red (UKB data field 1747)
Hair colour natural before greying - Black (UKB data field 1747)
Neurofibrillary tangles (SNP x SNP interaction)
Orofacial cleft x maternal periconceptional smoking interaction (1df)
Orofacial cleft x maternal periconceptional alcohol use interaction (1df)
Orofacial cleft x maternal periconceptional multivitamin use interaction (1df)
Orofacial cleft x maternal periconceptional smoking interaction (2df)
Orofacial cleft x maternal periconceptional alcohol use interaction (2df)
Orofacial cleft x maternal periconceptional multivitamin use interaction (2df)
Biological sex
Gout vs asymptomatic hyperuricemia
Cerebrospinal fluid progranulin levels
Alkaline phosphatase levels (UKB data field 30610)
Cystatin C levels (UKB data field 30720)
Glycated haemoglobin HbA1c levels (UKB data field 30750)
Alanine aminotransferase levels (UKB data field 30620)
Creatinine levels (UKB data field 30700)
Triglyceride levels (UKB data field 30870)
Urate levels (UKB data field 30880)
Direct low density lipoprotein levels (UKB data field 30780)
Aspartate aminotransferase levels (UKB data field 30650)
Total bilirubin levels (UKB data field 30840)
High light scatter reticulocyte percentage (UKB data field 30290)
Mean sphered cell volume (UKB data field 30270)
Immature reticulocyte fraction (UKB data field 30280)
Cholesterol levels (UKB data field 30690)
Abdominal fat cell number
Endometriosis or depression (pleiotropy)
Brain shape (segment 208)
Brain shape (segment 209)
Brain shape (segment 213)
Brain shape (segment 215)
Brain shape (segment 217)
Brain shape (segment 219)
Brain shape (segment 220)
Brain shape (segment 230)
Brain shape (segment 231)
Brain shape (segment 232)
Brain shape (segment 233)
Brain shape (segment 237)
Brain shape (segment 238)
Brain shape (segment 255)
aseg global volume VentricleChoroid
aseg global volume 3rd-Ventricle
aseg global volume 4th-Ventricle
aseg global volume Brain-Stem
aseg global volume CSF
aseg global volume WM-hypointensities
aseg global volume CC-Posterior
aseg global volume CC-Central
aseg global volume CC-Anterior
Acute lymphoblastic leukemia
Acute lymphoblastic leukemia (adult)
Acute lymphoblastic leukemia (adult vs childhood)
Brain shape (segment 3)
Brain shape (segment 5)
Brain shape (segment 6)
Mean corpuscular volume (UKB data field 30040)
Red blood cell erythrocyte distribution width (UKB data field 30070)
Platelet count (UKB data field 30080)
Mean corpuscular haemoglobin concentration (UKB data field 30060)
White blood cell leukocyte count (UKB data field 30000)
Ease of skin tanning - Never tan only burn (UKB data field 1727)
Long standing illness disability or infirmity (UKB data field 2188)
Haematocrit percentage (UKB data field 30030)
Red blood cell erythrocyte count (UKB data field 30010)
Haemoglobin concentration (UKB data field 30020)
Mean corpuscular haemoglobin (UKB data field 30050)
Trunk predicted mass (UKB data field 23130)
Hearing difficulty problems background noise (UKB data field 2257)
Ease of skin tanning - Get mildly or occasionally tanned (UKB data field 1727)
Ease of skin tanning - Get moderately tanned (UKB data field 1727)
Ease of skin tanning - Get very tanned (UKB data field 1727)
Mean platelet thrombocyte volume (UKB data field 30100)
Illnesses of father - Diabetes (UKB data field 20107)
Ganglion cell inner plexiform layer (GCIPL) thickness
Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG)
Chronic obstructive pulmonary disease x current smoker interaction (1df)
Chronic obstructive pulmonary disease in current smokers
Chronic obstructive pulmonary disease in non-current smokers
Gut microbiota presence (genus Coprococcus1 id.11301)
Gut microbiota presence (family Pseudomonadaceae id.3718)
IDP T1 FAST ROIs V cerebellum VI
IDP T1 FAST ROIs R cerebellum VI
IDP T1 FAST ROIs L cerebellum crus I
IDP T1 FAST ROIs R cerebellum crus I
IDP T1 FAST ROIs L cerebellum crus II
IDP T1 FAST ROIs V cerebellum crus II
IDP T1 FAST ROIs R cerebellum crus II
IDP T1 FAST ROIs L hippocampus
IDP T1 FAST ROIs R hippocampus
IDP T1 FAST ROIs L ventral striatum
IDP T1 FAST ROIs R ventral striatum
IDP T1 FAST ROIs brain stem
IDP T1 FAST ROIs L cerebellum I-IV
IDP T1 FAST ROIs L cerebellum V
IDP T1 FAST ROIs R cerebellum V
IDP T1 FAST ROIs L cerebellum VI
IDP T1 FAST ROIs L cerebellum VIIb
IDP T1 FAST ROIs V cerebellum VIIb
IDP T1 FAST ROIs R cerebellum VIIb
IDP T1 FAST ROIs L cerebellum VIIIa
IDP T1 FAST ROIs V cerebellum VIIIa
Platelet distribution width (UKB data field 30110)
Eosinophill percentage (UKB data field 30210)
Lymphocyte percentage (UKB data field 30180)
Monocyte percentage (UKB data field 30190)
Neutrophill percentage (UKB data field 30200)
Eosinophill count (UKB data field 30150)
Lymphocyte count (UKB data field 30120)
Monocyte count (UKB data field 30130)
Neutrophill count (UKB data field 30140)
Tea intake (UKB data field 1488)
Illnesses of father - Lung cancer (UKB data field 20107)
Platelet crit (UKB data field 30090)
High light scatter reticulocyte count (UKB data field 30300)
Severe skin toxicity response to cetuximab in stage 3 colon cancer
Suicide attempt severity in mood disorders
Suicidality in mood disorders
Retinitis pigmentosa
QT dynamics during exercise
QT dynamics during recovery from exercise
Arterial stiffness index
wg rh intensity-contrast inferiortemporal
wg rh intensity-contrast isthmuscingulate
wg rh intensity-contrast lateraloccipital
wg rh intensity-contrast lateralorbitofrontal
wg rh intensity-contrast lingual
wg lh intensity-contrast frontalpole
wg lh intensity-contrast temporalpole
wg lh intensity-contrast transversetemporal
wg lh intensity-contrast insula
wg rh intensity-contrast bankssts
wg rh intensity-contrast caudalmiddlefrontal
wg rh intensity-contrast cuneus
wg rh intensity-contrast entorhinal
wg rh intensity-contrast fusiform
wg rh intensity-contrast inferiorparietal
Computer vision syndrome
Opioid use disorder vs exposed controls
ICD10 C91: Lymphoid leukemia
ICD10 Z51.3: Blood transfusion without reported diagnosis
ICD10 R16.1: Splenomegaly, not elsewhere classified
ICD10 Q61: Cystic kidney disease
ICD10 R16: Hepatomegaly and splenomegaly, not elsewhere classified
ICD10 D47: Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
Liverfc
ICD10 D75: Other and unspecified diseases of blood and blood-forming organs
ICD10 D69: Purpura and other hemorrhagic conditions
ICD10 R31: Hematuria
Calcium levels (UKB data field 30680)
High density lipoprotein cholesterol levels (UKB data field 30760)
Pulse rate automated reading (UKB data field 102)
Apolipoprotein B levels (UKB data field 30640)
IGF 1 (UKB data field 30770)
Peak expiratory flow (UKB data field 3064)
Chronic obstructive pulmonary disease x ever smoker interaction (2df)
Chronic obstructive pulmonary disease x ever smoker interaction (main effect)
Childhood body fatness
wg rh intensity-contrast paracentral
wg rh intensity-contrast parsopercularis
wg rh intensity-contrast parsorbitalis
wg rh intensity-contrast parstriangularis
wg rh intensity-contrast pericalcarine
wg rh intensity-contrast postcentral
IDP T1 FAST ROIs R postcent gyrus
IDP T1 FAST ROIs L supramarg gyrus ant
IDP T1 FAST ROIs L intracalc cortex
wg rh intensity-contrast medialorbitofrontal
wg rh intensity-contrast middletemporal
wg rh intensity-contrast parahippocampal
Neck circumference
Neck circumference (BMI adjusted)
Longevity (100 years and older)
Hearing difficulty problems (UKB data field 2247)
ICD10 D63.165.8: Anemia in chronic kidney disease
ICD10 C92: Myeloid leukemia
Mean reticulocyte volume (UKB data field 30260)
Chronic obstructive pulmonary disease x ever smoker interaction (1df)
Chronic obstructive pulmonary disease in ever smokers
Chronic obstructive pulmonary disease in never smokers
Surgical recurrence in Crohn's disease
Gut microbiota presence (genus Lachnospiraceae UCG 010 id.11330)
Gut microbiota presence (genus Anaerostipes id.1991)
Brain shape (segment 122)
Brain shape (segment 105)
Brain shape (segment 113)
Brain shape (segment 116)
Brain shape (segment 132)
Brain shape (segment 117)
Brain shape (segment 133)
Brain shape (segment 138)
Brain shape (segment 119)
Brain shape (segment 120)
Brain shape (segment 140)
Brain shape (segment 144)
Brain shape (segment 121)
Brain shape (segment 151)
Brain shape (segment 102)
Brain shape (segment 106)
Brain shape (segment 131)
Brain shape (segment 134)
Brain shape (segment 139)
Brain shape (segment 150)
IDP T1 FAST ROIs R cerebellum VIIIa
IDP T1 FAST ROIs L cerebellum VIIIb
IDP T1 FAST ROIs V cerebellum VIIIb
IDP T1 FAST ROIs R cerebellum VIIIb
IDP T1 FAST ROIs L cerebellum IX
IDP T1 FAST ROIs V cerebellum IX
Brain shape (segment 61)
Brain shape (segment 62)
Brain shape (segment 63)
Brain shape (segment 76)
Brain shape (segment 77)
Brain shape (segment 79)
Brain shape (segment 80)
Brain shape (segment 81)
Brain shape (segment 83)
Brain shape (segment 86)
Brain shape (segment 89)
Brain shape (segment 270)
Brain shape (segment 271)
Brain shape (segment 273)
Brain shape (segment 276)
Brain shape (segment 277)
Brain shape (segment 280)
Brain shape (segment 281)
Brain shape (segment 283)
Brain shape (segment 285)
Spherical power left (UKB data field 5085)
Spherical equivalent left
Mean spherical equivalent
Corneal hysteresis left (UKB data field 5264)
Corneal resistance factor left (UKB data field 5265)
Intraocular pressure corneal compensated left (UKB data field 5262)
Eye measure - 3mm strong meridian left (UKB data field 5135)
Eye measure - 3mm weak meridian left (UKB data field 5096)
Corneal power
Eye measure - 3mm strong meridian right (UKB data field 5132)
Eye measure - 3mm weak meridian right (UKB data field 5099)
Visual acuity - mean spherical equivalent (UKB data field 20261)
Spherical equivalent right (first instance)
Spherical equivalent left (first instance)
Mean spherical equivalent (first instance)
Eye measure - 6mm strong meridian right (UKB data field 5133)
Eye measure - 6mm weak meridian right (UKB data field 5098)
Eye measure - 6mm strong meridian left (UKB data field 5134)
Eye measure - 6mm weak meridian left (UKB data field 5097)
Hay fever rhinitis or eczema (age of onset) (UKB data field 3761)
Chronic lymphocytic leukemia of B-cell type (UKB data field 40006)
Malignant melanoma of skin (UKB data field 40006)
Lymphoid leukemia (UKB data field 40006)
Prostate cancer (UKB data field 20001)
Glaucoma (UKB data field 6148)
Malignant neoplasm of prostate (UKB data field 40006)
ICD10 C91.1: Chronic lymphocytic leukemia of B-cell type
Arm fat free mass right (UKB data field 23121)
Arm predicted mass right (UKB data field 23122)
Arm fat free mass left (UKB data field 23125)
Arm predicted mass left (UKB data field 23126)
Comparative height size at age 10 - Taller (UKB data field 1697)
Trunk fat free mass (UKB data field 23129)
Leg predicted mass right (UKB data field 23114)
Leg fat mass left (UKB data field 23116)
Leg fat free mass left (UKB data field 23117)
Leg predicted mass left (UKB data field 23118)
Spherical equivalent right - started wearing glasses contacts before 40
Spherical equivalent left - started wearing glasses contacts before 40
Mean spherical equivalent - started wearing glasses or contacts before 40
Microalbumin in urine (UKB data field 30500)
Spherical power right (UKB data field 5084)
Spherical equivalent right
Retinal nerve fibre layer (RNFL) thickness
Early-onset schizophrenia
Gut microbiota presence (family Bacteroidales S24 7group id.11173)
Gut microbiota abundance (genus Candidatus Soleaferrea id.11350)
Gut microbiota abundance (genus Enterorhabdus id.820)
Gut microbiota abundance (genus Erysipelatoclostridium id.11381)
Gut microbiota abundance (genus Eubacterium coprostanoligenes group id.11375)
Gut microbiota abundance (genus Faecalibacterium id.2057)
Clostridioides difficle infection
Clostridioides difficle infection in antibiotics-users
IDP T1 FAST ROIs R intracalc cortex
IDP T1 FAST ROIs L subcallosal cortex
IDP T1 FAST ROIs R subcallosal cortex
IDP T1 FAST ROIs L cuneal cortex
IDP T1 FAST ROIs L parahipp gyrus post
IDP T1 FAST ROIs R lingual gyrus
IDP T1 FAST ROIs L front operc cortex
IDP T1 FAST ROIs R front operc cortex
IDP T1 FAST ROIs R parietal operc cortex
IDP T1 FAST ROIs L planum temporale
rfMRI connectivity (ICA100 edge 237)
IDP T1 FAST ROIs R planum temporale
IDP T1 FAST ROIs L supracalc cortex
IDP T1 FAST ROIs L occ pole
IDP T1 FAST ROIs R occ pole
IDP T1 FAST ROIs L thalamus
IDP T1 FAST ROIs R thalamus
IDP T1 FAST ROIs L caudate
IDP T1 FAST ROIs R caudate
IDP T1 FAST ROIs L putamen
IDP T1 FAST ROIs R putamen
IDP T1 FAST ROIs L pallidum
Brain shape (segment 42)
Brain shape (segment 43)
Brain shape (segment 45)
Brain shape (segment 47)
Brain shape (segment 48)
Brain shape (segment 50)
Brain shape (segment 51)
Brain shape (segment 52)
Brain shape (segment 53)
Brain shape (segment 56)
Brain shape (segment 58)
Brain shape (segment 60)
Brain shape (segment 27)
Brain shape (segment 30)
Brain shape (segment 31)
Brain shape (segment 39)
Brain shape (segment 40)
Brain shape (segment 41)
COVID-19 severity
COVID-19
Urine 6-hydroxymelatonin sulfate-to-creatinine ratio
Low myopia
Severe exacerbations in childhood asthma
Facial wrinkles (forehead)
Facial wrinkles (frown lines)
Facial wrinkles (crow's feet)
Facial wrinkles (principal components analysis)
Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
Crohn's disease vs ulcerative colitis (ordinary least squares (OLS))
Schizophrenia vs ADHD (ordinary least squares (OLS))
Schizophrenia vs anorexia nervosa (ordinary least squares (OLS))
Serum levels of protein AMY2B
Serum levels of protein ANAPC7
Serum levels of protein ANG
Serum levels of protein ANGPT1
Serum levels of protein ANGPTL1
Serum levels of protein ANGPTL3
Serum levels of protein ANGPTL4
Serum levels of protein ANGPTL7
Serum levels of protein ANKRD27
Serum levels of protein ANKRD46
Serum levels of protein ANP32B
Metastatic colorectal cancer survival in treatment with chemotherapy plus biologics
Serum levels of protein PTK6
Serum levels of protein PTN
Serum levels of protein PTPN1
Serum levels of protein PTPN4
Serum levels of protein PTPRH
Serum levels of protein PTPRN2
Serum levels of protein PTPRR
Serum levels of protein PTPRU
Serum levels of protein PUF60
Serum levels of protein PVRIG
Serum levels of protein PXDN
Serum levels of protein PXYLP1
Serum levels of protein PYY
Serum levels of protein PZP
Serum levels of protein QDPR
Serum levels of protein QPCT
Serum levels of protein QPCTL
Serum levels of protein QSOX1
Serum levels of protein QSOX2
Serum levels of protein RAB14
Serum levels of protein RAB17
Serum levels of protein RAB18
Serum levels of protein RAB26
Serum levels of protein RAB27A
Serum levels of protein EPHA2
Serum levels of protein EPHA4
Serum levels of protein EPHA5
Serum levels of protein EPHB2
Serum levels of protein EPHB3
Serum levels of protein EPHB4
Serum levels of protein EPHB6
Serum levels of protein EPO
Serum levels of protein EPYC
Serum levels of protein EQTN
Serum levels of protein ERAP1
Serum levels of protein ERCC4
Serum levels of protein ERLIN1
Serum levels of protein ERMAP
Serum levels of protein ERO1A
Serum levels of protein ERO1B
Serum levels of protein ERP29
Serum levels of protein ERP44
Serum levels of protein ESAM
Asthma and cardiovascular disease
Serum levels of protein NPTX1
Serum levels of protein NPTX2
Serum levels of protein NPTXR
Serum levels of protein NPW
Serum levels of protein NQO1
Serum levels of protein NQO2
Serum levels of protein NR1H2
Serum levels of protein NR3C2
Serum levels of protein NRAS
Serum levels of protein NRG4
Serum levels of protein NRP1
Serum levels of protein NRSN1
Serum levels of protein NRXN3
Serum levels of protein RNF165
Serum levels of protein RNF41
Serum levels of protein RNF43
Serum levels of protein RNF8
Serum levels of protein RNPEP
Serum levels of protein ROBO4
Serum levels of protein ROCK2
Serum levels of protein ROR1
Serum levels of protein RPIA
Serum levels of protein RPL30
Serum levels of protein RPLP2
Serum levels of protein RPN1
Serum levels of protein RPS10
Serum levels of protein RPS6KB1
Methazolamide-induced Stevens-Johnson syndrome / toxic epidermal necrolysis
Noncognitive aspects of educational attainment
Cognitive aspects of educational attainment
Serum levels of protein FLRT2
Serum levels of protein FLRT3
Serum levels of protein FLT3
Serum levels of protein FLT4
Serum levels of protein PDK1
Serum levels of protein PDLIM4
Serum levels of protein PDXK
Serum levels of protein PEAR1
Serum levels of protein PEBP1
Serum levels of protein PENK
Serum levels of protein PF4V1
Serum levels of protein PFDN5
Serum levels of protein PFKFB3
Serum levels of protein PFN2
Serum levels of protein PGK1
Serum levels of protein PGLYRP1
Gout (age >=50)
Gout (age <50)
Asymptomatic hyperuricaemia (age >=50)
Asymptomatic hyperuricaemia (age <50)
Serum levels of protein ADAM22
Serum levels of protein ADAM23
Serum levels of protein ADAM7
Serum levels of protein ADAMDEC1
Serum levels of protein ADAMTS13
Serum levels of protein ADAMTS6
Serum levels of protein ADCYAP1
Serum levels of protein ADGRE2
Serum levels of protein ADGRE5
Serum levels of protein ADGRF5
Serum levels of protein ADH4
Serum levels of protein ADH5
Serum levels of protein ADH7
Serum levels of protein ADI1
Serum levels of protein ADIPOQ
Serum levels of protein ADM
Serum levels of protein ADRM1
Serum levels of protein ADSL
Serum levels of protein AFM
Serum levels of protein AGA
Serum levels of protein AGER
Serum levels of protein AGGF1
Serum levels of protein AGRP
Serum levels of protein AGT
Serum levels of protein AHSA1
Serum levels of protein AHSG
Serum levels of protein AHSP
Serum levels of protein AIF1
Serum levels of protein AIFM1
Serum levels of protein AIMP1
Serum levels of protein AKR1A1
Serum levels of protein AKR1B1
Serum levels of protein AKR7A2
Serum levels of protein AKT2
Serum levels of protein AKT3
Serum levels of protein ALB
Serum levels of protein ALDH1A3
Serum levels of protein ACBD7
Serum levels of protein ACE
Serum levels of protein ACE2
Serum levels of protein ACHE
Serum levels of protein ACP2
Serum levels of protein ACP5
Serum levels of protein ACP6
Serum levels of protein ACP7
Serum levels of protein ACY1
Serum levels of protein ACYP2
Serum levels of protein ADAM11
Serum levels of protein ADAM12
Serum levels of protein ADAM19
Serum levels of protein ICAM5
Serum levels of protein ICOS
Serum levels of protein ICOSLG
Serum levels of protein PSMD1
Serum levels of protein PSMD11
Serum levels of protein PSMD7
Serum levels of protein PSMD9
Serum levels of protein PSME1
Serum levels of protein PSME3
Serum levels of protein PTGDS
Serum levels of protein PTGFRN
Serum levels of protein PTGR1
Serum levels of protein PTHLH
Serum levels of protein ESD
Serum levels of protein ESRP1
Serum levels of protein ETHE1
Serum levels of protein ETNK1
Serum levels of protein EVA1B
Serum levels of protein EVA1C
Serum levels of protein EVI2B
Serum levels of protein EVPL
Serum levels of protein EXOSC1
Serum levels of protein EZR
Serum levels of protein F10
Serum levels of protein F11
Serum levels of protein F13B
Serum levels of protein F3
Serum levels of protein F5
Serum levels of protein ID2
Serum levels of protein NTN1
Serum levels of protein NTN4
Serum levels of protein NTNG1
Serum levels of protein NTRK1
Serum levels of protein NUCB1
Serum levels of protein NUDT12
Serum levels of protein NUDT16L1
Serum levels of protein NUDT9
Serum levels of protein NUP210
Common neurobiological substrate measurement (PC1)
Excessive alcohol consumption
Serum levels of protein RPSA
Serum levels of protein RRAS2
Serum levels of protein RRBP1
Serum levels of protein RRM1
Serum levels of protein RRM2B
Serum levels of protein RSPO3
Serum levels of protein RSPO4
Serum levels of protein RSRP1
Serum levels of protein RTN4
Serum levels of protein RTN4R
Serum levels of protein RUFY1
Serum levels of protein RYK
Serum levels of protein S100A12
Serum levels of protein S100A13
Serum levels of protein APOE
Serum levels of protein APOH
8-isoprostaglandin-F2alpha x bisphenol A interaction
8-isoprostaglandin-F2alpha x triclosan interaction
8-hydroxydeoxyguanosine x triclosan interaction
Serum levels of protein PLA2G12B
Serum levels of protein PLA2G2A
Serum levels of protein PLA2G7
Serum levels of protein PLA2R1
Serum levels of protein PLAT
Serum levels of protein IDS
Serum levels of protein IDUA
Serum levels of protein IFI16
Serum levels of protein IFIT2
Serum levels of protein IFNA10
Serum levels of protein IFNA2
Serum levels of protein IFNA7
Serum levels of protein IFNAR1
Serum levels of protein IFNGR1
Major depressive disorder vs ADHD (ordinary least squares (OLS))
Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS))
Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS))
Obsessive compulsive disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))
HOMA-B (corrected for HOMA-IR)
Serum levels of protein NCF2
Serum levels of protein NCK1
Serum levels of protein NCMAP
Serum levels of protein NCOA2
Serum levels of protein NCR1
Serum levels of protein NCR2
Serum levels of protein NCR3
Serum levels of protein NDC80
Serum levels of protein NDE1
Serum levels of protein NDNF
Serum levels of protein NDUFAF8
Serum levels of protein NDUFB4
Serum levels of protein NDUFS4
Serum levels of protein NEFL
Serum levels of protein NEGR1
Serum levels of protein NELL1
Hair curvature (quantitative)
Hair curvature (observational)
Serum levels of protein NSDHL
Serum levels of protein NSF
Serum levels of protein NT5C
Serum levels of protein NTM
Serum levels of protein F7
Serum levels of protein F8
Serum levels of protein F9
Serum levels of protein FABP1
Serum levels of protein FAH
Serum levels of protein FAIM
Serum levels of protein FAM151A
Serum levels of protein FAM159B
Serum levels of protein FAM163A
Response to tolvaptan in hepatic ascites (body weight gain)
Serum levels of protein PCBD1
Serum levels of protein PCDH10
Serum levels of protein PCDH9
Serum levels of protein PCDHA4
Serum levels of protein PCDHA7
Serum levels of protein PCDHAC1
Serum levels of protein PCDHB14
Serum levels of protein PCDHB4
Serum levels of protein PCDHGA1
Serum levels of protein PCDHGA11
Serum levels of protein PCDHGB4
Serum levels of protein PCOLCE
Bilateral cleft lip
Unilateral cleft lip
Serum levels of protein FGF10
Serum levels of protein FGF19
Serum levels of protein FGF7
Serum levels of protein FGFBP1
Serum levels of protein FGFBP3
Serum levels of protein FGFR3
Serum levels of protein FGFRL1
Serum levels of protein FGL1
Serum levels of protein FJX1
Serum levels of protein FKBP2
Serum levels of protein FKBP7
Serum levels of protein FLNA
Serum levels of protein FLRT1
Complement factor H levels
Complement factor H-related protein 1 levels
Complement factor H-related protein 2 levels
Complement factor H-related protein 3 levels
Complement factor H-related protein 4A levels
Complement factor H-related protein 5 levels
Serum levels of protein RAB31
Serum levels of protein RAB35
Serum levels of protein RAB39B
Serum levels of protein RAB5C
Serum levels of protein RAB6B
Serum levels of protein RABEPK
Serum levels of protein RACGAP1
Serum levels of protein RAD51
Serum levels of protein MYZAP
Serum levels of protein NAAA
Serum levels of protein NAALAD2
Serum levels of protein NXPH1
Serum levels of protein NXPH2
Serum levels of protein NXPH3
Serum levels of protein NXT1
Serum levels of protein OAF
Serum levels of protein OBP2B
Serum levels of protein OCIAD1
Serum levels of protein OCRL
Serum levels of protein OLA1
Serum levels of protein OLFM2
Serum levels of protein OLFM3
Serum levels of protein OLR1
Serum levels of protein OMD
Serum levels of protein NOG
Serum levels of protein NOTCH2
Serum levels of protein NOTUM
Serum levels of protein NOV
Serum levels of protein NPIPB3
Serum levels of protein NPNT
Serum levels of protein NPPA
Serum levels of protein NPPB
Bilateral cleft lip and palate
Unilateral cleft lip and palate
Cleft lip with or without cleft palate (bilateral vs unilateral)
Serum levels of protein PDGFD
Serum levels of protein PDGFRA
Serum levels of protein PDGFRL
Serum levels of protein PDIA3
Serum levels of protein PDIA4
Serum levels of protein PDIA5
Serum levels of protein PDILT
Serum levels of protein RNASE3
Serum levels of protein RNASE4
Serum levels of protein RNASE6
Serum levels of protein RNF122
Serum levels of protein RNF13
Serum levels of protein RNF146
Serum levels of protein RNF149
End-stage knee osteoarthritis
Serum levels of protein PGLYRP2
Serum levels of protein PGM1
Serum levels of protein PI3
Serum levels of protein PIGA
Serum levels of protein PIGR
Serum levels of protein PIK3CG
Serum levels of protein PIK3R1
Serum levels of protein PILRA
Serum levels of protein PIM1
Serum levels of protein PIP
Serum levels of protein PIR
Serum levels of protein PKD2
Serum levels of protein PKDCC
Serum levels of protein PKLR
Serum levels of protein PKN1
Serum levels of protein APOA1
Serum levels of protein APOA2
Serum levels of protein APOA5
Serum levels of protein APOB
Serum levels of protein APOC3
Serum levels of protein A1CF
Serum levels of protein A4GALT
Serum levels of protein A4GNT
Serum levels of protein AAGAB
Serum levels of protein ABL2
Serum levels of protein ABO
Serum levels of protein ACAP2
Serum levels of protein APOF
Serum levels of protein ANXA2
Serum levels of protein ANXA6
Serum levels of protein AOC1
Serum levels of protein AP1G2
Serum levels of protein AP4M1
Serum levels of protein APBB1
Serum levels of protein APBB2
Serum levels of protein APBB3
Serum levels of protein APCS
Serum levels of protein APLN
Serum levels of protein APLP2
Serum levels of protein APMAP
Schizophrenia vs bipolar disorder (ordinary least squares (OLS))
Schizophrenia vs major depressive disorder (ordinary least squares (OLS))
Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
Congenital heart disease (transposition of the great arteries)
Congenital right-sided heart lesions
Congenital heart disease (septal defects)
Congenital heart disease (anomalies of thoracic arteries and veins)
Serum levels of protein HPGDS
Serum levels of protein HPSE
Serum levels of protein HPX
Serum levels of protein HRC
Serum levels of protein HRG
Serum levels of protein HS3ST1
Serum levels of protein HS6ST1
Serum levels of protein HSD17B1
Serum levels of protein HSD17B14
Serum levels of protein HSP90AA1;HSP90AB1
Serum levels of protein HSP90B1
Serum levels of protein HSPA1A
Serum levels of protein HSPA1L
Serum levels of protein HSPA6
Serum levels of protein NAB1
Serum levels of protein NAB2
Serum levels of protein NADK
Serum levels of protein NAGK
Serum levels of protein NAGPA
Serum levels of protein NAGS
Serum levels of protein NAP1L1
Serum levels of protein NAPB
Serum levels of protein NAT1
Serum levels of protein NBL1
Serum levels of protein NBR1
Serum levels of protein NCAM1
Serum levels of protein NCAM2
Serum levels of protein OOSP2
Serum levels of protein OPCML
Serum levels of protein OSCAR
Serum levels of protein OSM
Serum levels of protein OXT
Serum levels of protein P4HB
Serum levels of protein PA2G4
Serum levels of protein PACSIN1
Serum levels of protein PAK3
Serum levels of protein PAM
Severe coronary stenosis (family history of CAD interaction)
Severe coronary stenosis (young age of onset interaction)
Severe coronary stenosis
Spleen iron concentration
Survival in progressive supranuclear palsy
Skin and soft tissue infections
Serum levels of protein PCOLCE2
Serum levels of protein PCSK7
Serum levels of protein PCSK9
Serum levels of protein PCYOX1
Serum levels of protein PCYOX1L
Serum levels of protein PDCD1LG2
Serum levels of protein PDCD5
Serum levels of protein PDCL2
Serum levels of protein PDE11A
Serum levels of protein PDE2A
Serum levels of protein PDE3A
Serum levels of protein PDGFA
Serum levels of protein PDGFB
Serum levels of protein ASIP
Serum levels of protein ASL
Serum levels of protein ASPH
Serum levels of protein ASPN
Serum levels of protein ASPRV1
Serum levels of protein ASTL
Serum levels of protein ATF6
Serum levels of protein ATF6B
Serum levels of protein ATG5
Serum levels of protein ATP13A1
Serum levels of protein ATP1A1
Serum levels of protein ATP1B1
Serum levels of protein ATP1B2
Serum levels of protein FCER2
Serum levels of protein FCGR2B
Serum levels of protein FCGR3B
Asymmetrical dimethylarginine levels in osteoarthritis
Serum levels of protein ALDH3A1
Serum levels of protein ALDOC
Serum levels of protein ALOX15B
Serum levels of protein ALPI
Serum levels of protein ALPL
Serum levels of protein ALPPL2
Serum levels of protein AMBN
Serum levels of protein AMELX
Serum levels of protein AMH
Serum levels of protein AMY1A
Sun-seeking behavior
Serum levels of protein HSPB1
Serum levels of protein HTATIP2
Serum levels of protein HTN1
Serum levels of protein HTN3
Serum levels of protein HTR2A
Serum levels of protein HTR7
Serum levels of protein IAPP
Serum levels of protein IBSP
Serum levels of protein ICAM1
Serum levels of protein ICAM2
Serum levels of protein ICAM4
SAPHO syndrome
Serum levels of protein RAD51D
Serum levels of protein RAET1E
Serum levels of protein RAET1L
Serum levels of protein RALA
Serum levels of protein RAP1GDS1
Serum levels of protein RARRES1
Serum levels of protein RARRES2
Serum levels of protein RASA1
Serum levels of protein RBBP9
Serum levels of protein RBL2
Serum levels of protein RBM19
Serum levels of protein RBM24
Serum levels of protein RBM28
Serum levels of protein RBP7
Serum levels of protein RCAN1
Serum levels of protein RCN2
Serum levels of protein RDH16
Serum levels of protein RECQL
Serum levels of protein REG1A
Periodontitis (stage III/IV grade C)
Brain asymmetrical skew (horizontal)
Brain asymmetrical skew (vertical)
Serum levels of protein FAM163B
Serum levels of protein FAM171B
Serum levels of protein FAM174A
Serum levels of protein FAM174B
Serum levels of protein FAM177A1
Serum levels of protein FAM189A2
Serum levels of protein FAM19A3
Serum levels of protein FAM209B
Serum levels of protein FAM20A
Serum levels of protein FAM210A
Serum levels of protein FAM213A
Serum levels of protein FAM3B
Serum levels of protein FAM3D
Serum levels of protein APOL1
Serum levels of protein APOM
Serum levels of protein AQP4
Serum levels of protein ARF6
Serum levels of protein ARFGAP1
Serum levels of protein ARFIP1
Serum levels of protein ARFIP2
Serum levels of protein ARG1
Serum levels of protein ARHGAP1
Serum levels of protein ARHGAP30
Serum levels of protein ARHGAP45
Serum levels of protein ARHGEF7
Serum levels of protein ARL1
Serum levels of protein ARL11
Serum levels of protein ARL2
Serum levels of protein ARL3
Serum levels of protein ARMC5
Serum levels of protein ARPC3
Serum levels of protein ARRB1
Serum levels of protein ARSA
Serum levels of protein ART3
Serum levels of protein ASAH2
Serum levels of protein ASGR1
Serum levels of protein ASGR2
Serum levels of protein ASH2L
ADHD vs anorexia nervosa (ordinary least squares (OLS))
ADHD vs autism spectrum disorder (ordinary least squares (OLS))
ADHD vs obsessive compulsive disorder (ordinary least squares (OLS))
ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Anorexia nervosa vs autism spectrum disorder (ordinary least squares (OLS))
Anorexia nervosa vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Autism spectrum disorder vs obsessive compulsive disorder (ordinary least squares (OLS))
Autism spectrum disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Bipolar disorder vs ADHD (ordinary least squares (OLS))
Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS))
Serum levels of protein ANTXR1
Serum levels of protein ANXA10
Serum levels of protein HMGB3
Serum levels of protein HMGCS1
Serum levels of protein HMGN1
Serum levels of protein HMP19
Serum levels of protein HNF1A
Serum levels of protein HNF4A
Serum levels of protein HNRNPAB
Serum levels of protein HNRNPC
Serum levels of protein HNRNPH1
Serum levels of protein HNRNPM
Serum levels of protein HP
Serum levels of protein HPGD
Serum levels of protein REG3G
Serum levels of protein RELB
Serum levels of protein RELT
Serum levels of protein RET
Serum levels of protein REXO2
Serum levels of protein RFESD
Serum levels of protein RFFL
Serum levels of protein RFXAP
Serum levels of protein RGMA
Serum levels of protein RGS8
Serum levels of protein RHOD
Serum levels of protein RIC3
Serum levels of protein RIDA
Serum levels of protein RIPK2
Serum levels of protein FCN1
Serum levels of protein FCN2
Serum levels of protein FCN3
Serum levels of protein FCRL1
Serum levels of protein FCRL2
Serum levels of protein FCRL4
Serum levels of protein FETUB
Migraine age at onset (before 12 years vs after 12 years)
Migraine (age at onset)
Migraine with aura (age at onset)
Migraine without aura (age at onset)
Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS))
Bipolar disorder vs major depressive disorder (ordinary least squares (OLS))
Bipolar disorder vs obsessive compulsive disorder (ordinary least squares (OLS))
Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))
Serum levels of protein NEO1
Serum levels of protein NEURL4
Serum levels of protein NFASC
Serum levels of protein NFKB1
Serum levels of protein NFU1
Serum levels of protein NGFR
Serum levels of protein NHLRC3
Serum levels of protein NID1
Serum levels of protein NID2
Serum levels of protein ENO2
Serum levels of protein ENOX2
Serum levels of protein ENPP5
Serum levels of protein ENTPD1
Serum levels of protein ENTPD3
Serum levels of protein ENTPD5
Serum levels of protein ENTPD6
Serum levels of protein EPHA1
Serum levels of protein RLN1
Serum levels of protein RLN2
Serum levels of protein RMDN3
Serum levels of protein RMI1
Serum levels of protein RNASE1
Serum levels of protein RNASE2
Serum levels of protein NLGN2
Serum levels of protein NLGN3
Serum levels of protein NLGN4X
Serum levels of protein NMB
Serum levels of protein NME1
Serum levels of protein NME2
Serum levels of protein NMRAL1
Antisaccade tracking error rate
Overall startle response
Aversive difference startle modulation
Pleasant difference startle modulation
Skin conductance response amplitude
Beta electroencephalogram power
Alpha electroencephalogram frequency O1O2
Serum levels of protein FAP
Serum levels of protein FARS2
Serum levels of protein FAS
Serum levels of protein FASLG
Serum levels of protein FBLN1
Serum levels of protein FBN3
Serum levels of protein FBXL4
Serum levels of protein FCER1A
Serum levels of protein PAPLN
Serum levels of protein PAPPA
Serum levels of protein PAPSS1
Serum levels of protein PARP11
Serum levels of protein PAXIP1
Childhood aggressive behavior
Serum levels of protein BACH1
Serum levels of protein BACH2
Serum levels of protein BAG4
Serum levels of protein BAG5
Serum levels of protein BAGE3
Serum levels of protein BAMBI
Serum levels of protein BCAM
Serum levels of protein BCAN
Serum levels of protein BCAR3
Serum levels of protein BCHE
Serum levels of protein BCL2L1
Serum levels of protein BCL2L10
Serum levels of protein BCL2L2
Serum levels of protein BDNF
Direct low density lipoprotein cholesterol levels
Psoriasis or type 2 diabetes (trans-disease meta-analysis)
Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
Serum levels of protein CA10
Serum levels of protein CA11
Serum levels of protein CA2
Serum levels of protein CA4
Serum levels of protein CA6
Serum levels of protein CA8
Serum levels of protein CABP7
Serum levels of protein CACNA2D3
Serum levels of protein CADM3
Serum levels of protein CALB1
Serum levels of protein CALCOCO2
Serum levels of protein CAMK1
Serum levels of protein CAMK1D
Serum levels of protein CAMP
Serum levels of protein CCL8
Serum levels of protein CCM2
Serum levels of protein CCNB1IP1
Serum levels of protein CCNC
Serum levels of protein CD109
Serum levels of protein CD14
Serum levels of protein CD163
Serum levels of protein CD177
Serum levels of protein CD200
Body mass index and bone mineral density (pleiotropy)
Tinnitus in noise exposure
Coronary artery disease in dyslipidemia
Ischemic stroke in dyslipidemia
Clinical depression
Mean reticulocyte volume
Mean sphered cell volume
Serum levels of protein KDR
Serum levels of protein KERA
Serum levels of protein KIAA0040
Serum levels of protein KIAA1024
Serum levels of protein KIAA1324L
Serum levels of protein KIAA1549L
Serum levels of protein KIAA2013
Serum levels of protein KIF1C
Serum levels of protein KIF22
Serum levels of protein KIF3A
Serum levels of protein KIN
Serum levels of protein KIR2DL2
Serum levels of protein KIR2DS2
Serum levels of protein KIT
Serum levels of protein KITLG
Serum levels of protein KLHL12
Serum levels of protein KLHL13
Haemorrhoidal disease
Serum levels of protein IGFLR1
Serum levels of protein IGHG1;IGHG2;IGHG3;IGHG4;IGL;IGK
Serum levels of protein IGLL1
Serum levels of protein IGSF9B
Serum levels of protein IL10RA
Serum levels of protein IL10RB
Serum levels of protein IL11RA
Serum levels of protein ATP2A3
Serum levels of protein AURKB
Serum levels of protein AXIN2
Serum levels of protein AXL
Serum levels of protein AZGP1
Serum levels of protein IFNLR1
Serum levels of protein IGDCC4
Serum levels of protein IGF1
Serum levels of protein IGF1R
Serum levels of protein IGF2R
Serum levels of protein IGFALS
Serum levels of protein IGFBP1
Serum levels of protein IGFBP3
Serum levels of protein IGFBP5
Serum levels of protein IGFBP6
Serum levels of protein IGFBP7
Serum levels of protein IGFBPL1
Serum levels of protein IGFL1
Serum levels of protein IGFL3
Serum levels of protein IGFL4
Serum phosphate levels
N-formylanthranilic acid levels
N-acetylarginine levels
X-18921 levels
N-acetylglutamine levels
X-24518 levels
N-acetylcitrulline levels
X-16946 levels
S-1-pyrroline-5-carboxylate levels
Alliin levels
4-acetamidobutanoate levels
X-23590 levels
N6-methyllysine levels
X-23314 levels
N2-acetyl,N6,N6-dimethyllysine levels
N2-acetyl,N6-methyllysine levels
Dopamine 3-o-sulfate levels
N-acetyl-aspartyl-glutamate (naag) levels
Methylsuccinate levels
X-12822 levels
1-methyl-4-imidazoleacetate levels
X-23659 levels
5-hydroxylysine levels
5-acetylamino-6-amino-3-methyluracil levels
Cysteinylglycine disulfide levels
N6-acetyllysine levels
N-acetyl-1-methylhistidine levels
Glutaroylcarnitine (C5DC) levels
N-acetylasparagine levels
X-23680 levels
N-delta-acetylornithine levels
X-16570 levels
N-acetylglucosaminylasparagine levels
Biliverdin levels
6-oxopiperidine-2-carboxylate levels
X-11787 levels
N-acetylputrescine levels
Methyl glucopyranoside (alpha + beta) levels
N6,N6-dimethyllysine levels
X-19141 levels
X-24947 levels
X-12117 levels
X-24544 levels
X-12798 levels
X-13866 levels
Ethylmalonate levels
X-11470 levels
Dopamine 4-sulfate levels
Metabolonic lactone sulfate levels
Cys-gly, oxidized levels
5-acetylamino-6-formylamino-3-methyluracil levels
Survival time in esophageal squamous cell carcinoma
Ultradistal forearm bone mineral density
Cardio-cerebrovascular disease in hypertension
Coronary artery disease in hypertension
Ischemic stroke in hypertension
Lung function (FEV1) and body mass index
Lung function (FEV1) and waist to hip ratio adjusted for BMI
Lung function (FEV1) and waist circumference adjusted for BMI
Lung function (FVC) and body mass index
Lung function (FVC) and waist to hip ratio adjusted for BMI
Lung function (FVC) and waist circumference adjusted for BMI
Serum levels of protein IL6ST
Serum levels of protein IL7
Serum levels of protein IL7R
Serum levels of protein IL9
Serum levels of protein IMPAD1
Serum levels of protein INHBB
Serum levels of protein INPP5B
Serum levels of protein INPP5E
Serum levels of protein INSR
Serum levels of protein IRF6
Serum levels of protein ISG15
Serum levels of protein ISLR2
Cervical intraepithelial neoplasia grade 3
Invasive cervical cancer
Cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
Externalizing behaviour (multivariate analysis)
Serum levels of protein CLEC12A
Serum levels of protein CLEC12B
Serum levels of protein CLEC1B
Serum levels of protein JAM2
Serum levels of protein JAM3
Serum levels of protein JARID2
Serum levels of protein KAZALD1
Serum levels of protein KCNA10
Serum levels of protein KCNE2
Serum levels of protein KCNG4
Serum levels of protein KCNIP1
Serum levels of protein KCNMB3
Serum levels of protein KDELC2
Heel bone mineral density T score
Direct bilirubin levels
Serum levels of protein CNDP1
Serum levels of protein CNDP2
Serum levels of protein CNGA2
Serum levels of protein CNP
Serum levels of protein CNTFR
Serum levels of protein CNTN1
Serum levels of protein CNTN2
Serum levels of protein CNTN4
Serum levels of protein CNTN5
Serum levels of protein CNTNAP2
Serum levels of protein CNTNAP5
Serum levels of protein COCH
Serum levels of protein COL11A2
Serum levels of protein COL15A1
Serum levels of protein COL18A1
Serum levels of protein COL1A1
Serum levels of protein COL20A1
Serum levels of protein COL26A1
Serum levels of protein COL4A3BP
Serum levels of protein COL6A1
Serum levels of protein COL9A2
Serum levels of protein COLEC11
Serum levels of protein COLEC12
Serum levels of protein COLGALT1
Serum levels of protein COLQ
Acute myeloid leukemia or myelodysplastic syndrome (pleiotropy)
Therapy-related myelodysplastic syndrome
Sleepwalking
Breast cancer-specific survival (ER negative)
Idiopathic achalasia
Breast cancer-specific survival (ER positive)
Serum levels of protein COMP
Serum levels of protein KLK6
Serum levels of protein KLK7
Serum levels of protein KLK8
Serum levels of protein KLKB1
Serum levels of protein KLRB1
Serum levels of protein KLRC3
Serum levels of protein KLRG1
Serum levels of protein KLRG2
Serum levels of protein KMT2C
Serum levels of protein KMT2D
Serum levels of protein KNG1
Serum levels of protein KPNA2
Serum levels of protein KPNA4
Serum levels of protein KRT23
Serum levels of protein KRT5
Serum levels of protein KRT7
Serum levels of protein KRTDAP
Serum levels of protein KYNU
Serum levels of protein L1CAM
Serum levels of protein LAG3
Serum levels of protein LAIR2
Serum levels of protein LAMA1;LAMB1;LAMC1
Serum levels of protein LAMC2
Serum levels of protein LAMTOR3
Serum levels of protein LANCL1
Serum levels of protein LARGE1
Serum levels of protein LAYN
Serum levels of protein LBP
Serum levels of protein LCT
Serum levels of protein LDHB
Serum levels of protein LDLRAD4
Serum levels of protein LDOC1
Serum levels of protein LEAP2
Serum levels of protein LECT2
Serum levels of protein LEMD1
Serum levels of protein COPS2
Serum levels of protein COPS7B
Serum levels of protein COTL1
Serum levels of protein COX7A1
Serum levels of protein COX7A2L
Serum levels of protein CPB1
Serum levels of protein CPB2
Serum levels of protein CPE
Serum levels of protein CPM
Serum levels of protein CPN2
Serum levels of protein CPNE1
Serum levels of protein CPQ
Serum levels of protein CPT1B
Serum levels of protein CPVL
Serum levels of protein CPXM1
Serum levels of protein CRABP1
Serum levels of protein CRABP2
Serum levels of protein CRAT
Serum levels of protein CREB3L4
Serum levels of protein CREBBP
Serum levels of protein AZU1
Serum levels of protein B2M
Serum levels of protein B3GALT2
Serum levels of protein B3GALT6
Serum levels of protein B3GAT3
Serum levels of protein B3GLCT
Serum levels of protein B3GNT2
Serum levels of protein B4GALT1
Serum levels of protein B4GALT2
Serum levels of protein B4GALT3
Serum levels of protein B4GALT6
Serum levels of protein B4GALT7
Serum levels of protein FMOD
Angioedema in response to angiotensin-converting enzyme inhibitor
Vascular endothelial growth factor A levels
Serum levels of protein C1R
Serum levels of protein C1RL
Serum levels of protein C1S
Serum levels of protein C2
Serum levels of protein C20orf173
Serum levels of protein C2orf40
Serum levels of protein C2orf66
Serum levels of protein C3
Serum levels of protein C3orf18
Serum levels of protein C4A;C4B
Serum levels of protein C15orf48
Serum levels of protein C17orf78
Serum levels of protein C19orf18
Serum levels of protein C1GALT1C1
Serum levels of protein C1orf185
Serum levels of protein C1orf56
Serum levels of protein C1QBP
Serum levels of protein C1QC
Serum levels of protein C1QL1
Serum levels of protein C1QL2
Serum levels of protein C1QTNF1
Serum levels of protein C1QTNF5
Serum levels of protein C1QTNF9
Serum levels of protein CBR3
Serum levels of protein CCDC126
Serum levels of protein CCDC50
Serum levels of protein CCK
Serum levels of protein CCL1
Serum levels of protein CCL11
Serum levels of protein CCL13
Serum levels of protein CCL14
Serum levels of protein CCL15
Serum levels of protein CCL17
Anti-N-methyl-D-aspartate receptor encephalitis
Serum levels of protein CD200R1
Serum levels of protein CD200R1L
Serum levels of protein CD209
Serum levels of protein CD244
Serum levels of protein CD27
Serum levels of protein CD274
Serum levels of protein CD300A
Serum levels of protein CD300C
Serum levels of protein CD300E
Serum levels of protein CD33
Serum levels of protein CD34
Serum levels of protein CD36
Serum levels of protein CDH7
Serum levels of protein CDHR1
Serum levels of protein CDHR3
Serum levels of protein CDK2AP1
Serum levels of protein CDK5;CDK5R1
Serum levels of protein CDK8;CCNC
Serum levels of protein CDKN2B
Serum levels of protein CDNF
Serum levels of protein CDON
Serum levels of protein CDSN
Serum levels of protein CDYL2
Serum levels of protein CEACAM1
Change in high-sensitivity cardiac troponin I concentration
High-sensitivity cardiac troponin I concentration
Serum levels of protein CHMP3
Serum levels of protein CHRDL1
Serum levels of protein CHRDL2
Serum levels of protein CHST11
Serum levels of protein CHST12
Serum levels of protein CHST15
Serum levels of protein CHST9
Serum levels of protein CKAP2
Serum levels of protein CKAP4
Serum levels of protein CKB;CKM
Serum levels of protein CKM
Serum levels of protein CLC
Serum levels of protein CLCA1
Serum levels of protein CLCA2
Serum levels of protein CLCNKB
Serum levels of protein CLEC11A
Fibrinopeptide B (1-12) levels
Fibrinopeptide B (1-13) levels
Threonylphenylalanine levels
3-aminoisobutyrate levels
5-oxoproline levels
5-methyluridine (ribothymidine) levels
Succinylcarnitine (C4DC) levels
N-acetyltyrosine levels
Cis-4-decenoate (10:1n6) levels
N-linoleoylglycine levels
N-linoleoyltaurine levels
N-palmitoylglycine levels
10-undecenoate (11:1n1) levels
Hexanoylcarnitine (C6) levels
Cis-4-decenoylcarnitine (C10:1) levels
Nonanoylcarnitine (C9) levels
Octanoylcarnitine (c8) levels
Methylmalonate (mma) levels
N-acetyl-2-aminooctanoate levels
2-aminooctanoate levels
Cholic acid glucuronide levels
Deoxycholic acid glucuronide levels
5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels
5alpha-pregnan-diol disulfate levels
Arachidonoylcarnitine (C20:4) levels
X-12410 levels
X-12112 levels
N-methylpipecolate levels
Butyric acid levels
X-25435 levels
X-21607 levels
Carotene diol (1) levels
Carotene diol (2) levels
X-12411 levels
X-24736 levels
X-21851 levels
X-21785 levels
3-formylindole levels
X-22162 levels
Asparagine levels
Orotate levels
Dimethylglycine levels
3-methylcytidine levels
2'-o-methyluridine levels
2'-o-methylcytidine levels
Gamma-glutamylglycine levels
Fibrinopeptide A (2-15) levels
Fibrinopeptide A (3-15) levels
Glu-gly-asn-val levels
Etiocholanolone glucuronide levels
Butyrylcarnitine (C4) levels
Butyrylglycine (C4) levels
1-linoleoyl-GPG (18:2) levels
1-oleoyl-GPG (18:1) levels
Glycochenodeoxycholate glucuronide (1) levels
Taurodeoxycholic acid 3-sulfate levels
Hexadecanedioate (C16) levels
Hexadecenedioate (C16:1-DC) levels
Octadecenedioate (C18:1-DC) levels
Octadecadienedioate (C18:2-DC) levels
Deoxycarnitine levels
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels
Decadienedioic acid (C10:2-DC) levels
Tetradecadienedioate (C14:2-DC) levels
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) levels
1-palmitoyl-GPE (16:0) levels
Androstenediol (3beta,17beta) disulfate (1) levels
Pregnen-diol disulfate levels
Pregnenetriol disulfate levels
Androstenediol (3alpha, 17alpha) monosulfate (2) levels
5alpha-androstan-3beta,17beta-diol monosulfate (1) levels
Cardio-cerebrovascular disease in dyslipidemia
Ischemic stroke in diabetes mellitus
Serum levels of protein CD8B
Serum levels of protein CD96
Serum levels of protein CD99L2
Serum levels of protein CDC25B
Serum levels of protein CDC34
Serum levels of protein CDC42BPA
Serum levels of protein CDC42BPB
Serum levels of protein CDCP1
Serum levels of protein CDH11
Serum levels of protein CDH12
Serum levels of protein CDH15
Serum levels of protein CDH2
Serum levels of protein CDH3
Serum levels of protein CDH5
Serum levels of protein CDH6
Intestinal permeability measurement
Serum levels of protein CETN2
Serum levels of protein CETP
Serum levels of protein CFB
Serum levels of protein CFC1
Serum levels of protein CFD
Serum levels of protein CFH
Serum levels of protein CFHR4
Serum levels of protein CFHR5
Serum levels of protein CFI
Serum levels of protein BGLAP
Serum levels of protein BGN
Serum levels of protein BID
Serum levels of protein BIN1
Serum levels of protein BIRC2
Serum levels of protein BLVRA
Serum levels of protein BMP10
Serum levels of protein BMP15
Serum levels of protein BMP4
Serum levels of protein BMP6
Serum levels of protein BMP7
Serum levels of protein BNIP3
Serum levels of protein BOC
Serum levels of protein BPI
Serum levels of protein BPIFA2
Serum levels of protein BPIFB1
Serum levels of protein C7
Serum levels of protein C7orf73
Serum levels of protein C8A;C8B;C8G
Serum levels of protein C8G
Serum levels of protein C9
Serum levels of protein CA1
Bilirubin (z,z) levels
1-ribosyl-imidazoleacetate levels
2-hydroxyadipate levels
3-ureidopropionate levels
Betaine levels
Guanosine levels
Methionine sulfone levels
N-acetyl-beta-alanine levels
N-acetylglutamate levels
N-acetylhistidine levels
Oxalate (ethanedioate) levels
Tryptophan betaine levels
Serum levels of protein CCL25
Serum levels of protein CCL27
Serum levels of protein CCL28
Serum levels of protein CCL3
Serum levels of protein CCL3L3
Serum levels of protein CCL4L1
Serum levels of protein CCL5
Serum levels of protein CCL7
Serum levels of protein IL36A
Serum levels of protein IL36G
Serum levels of protein IL3RA
Serum levels of protein IL5
Serum levels of protein CD5
Serum levels of protein CD55
Serum levels of protein CD58
Serum levels of protein CD59
Serum levels of protein CD5L
Serum levels of protein CD63
Serum levels of protein CD7
Serum levels of protein CD70
Serum levels of protein CD74
Serum levels of protein CD84
Serum levels of protein CD8A
International normalisation ratio
Gut bacterial pathway abundance (PWY.6151..S.adenosyl.L.methionine.cycle.I)
Gut bacterial pathway abundance (PWY.6353..purine.nucleotides.degradation.II..aerobic.)
Gut bacterial pathway abundance (PWY.6612..superpathway.of.tetrahydrofolate.biosynthesis)
Gut bacterial pathway abundance (PWY.6708..ubiquinol.8.biosynthesis..prokaryotic.)
Gut bacterial pathway abundance (PWY.7209..superpathway.of.pyrimidine.ribonucleosides.degradation)
Gut bacterial pathway abundance (PWY.7234..inosine.5..phosphate.biosynthesis.III)
Gut bacterial pathway abundance (PWY.841..superpathway.of.purine.nucleotides.de.novo.biosynthesis.I)
Gut bacterial pathway abundance (PWY_REDCITCYC..TCA.cycle.VIII..helicobacter.)
Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)
Gut bacterial pathway abundance (TRPSYN.PWY..L.tryptophan.biosynthesis)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria)
Gut microbiota abundance (k_Bacteria.p_Firmicutes.c_Negativicutes)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales.f_Coriobacteriaceae)
Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium)
Gut bacterial pathway abundance (ASPASN.PWY..superpathway.of.L.aspartate.and.L.asparagine.biosynthesis)
Gut bacterial pathway abundance (ENTBACSYN.PWY..enterobactin.biosynthesis)
Gut bacterial pathway abundance (GLYCOCAT.PWY..glycogen.degradation.I..bacterial.)
Gut bacterial pathway abundance (HISDEG.PWY..L.histidine.degradation.I)
Gut bacterial pathway abundance (HISTSYN.PWY..L.histidine.biosynthesis)
Gut bacterial pathway abundance (LACTOSECAT.PWY..lactose.and.galactose.degradation.I)
Gut bacterial pathway abundance (P105.PWY..TCA.cycle.IV..2.oxoglutarate.decarboxylase.)
Gut bacterial pathway abundance (PWY.5088..L.glutamate.degradation.VIII..to.propanoate.)
Gut bacterial pathway abundance (PWY.6147..6.hydroxymethyl.dihydropterin.diphosphate.biosynthesis.I)
Plasma ethanolamine levels in alcohol use disorder treated with acamprosate
Plasma alpha-amino-N-butyric acid levels in alcohol use disorder treated with acamprosate
Plasma asparagine levels in alcohol use disorder treated with acamprosate
Plasma lysine levels in alcohol use disorder treated with acamprosate
Plasma taurine levels in alcohol use disorder treated with acamprosate
Plasma tyrosine levels in alcohol use disorder treated with acamprosate
Body mass index in childhood asthma
Phosphatidylcholine(36:5)_[M+OAc]1-/Phosphatidylserine(40:4)_[M-H]1- levels
Hyperlipidemia
Schizophrenia x sex interaction
Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:4)_[M+H]1+/Phosphatidate(42:5)_[M+NH4]1+ levels
Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:3)_[M+H]1+ levels
Serum levels of protein THRA
Serum levels of protein THSD1
Serum levels of protein THSD7A
Serum levels of protein THYN1
Serum levels of protein TIE1
Serum levels of protein TIGAR
Serum levels of protein TIMP2
Serum levels of protein TIMP3
Serum levels of protein TIMP4
Serum levels of protein TINF2
Serum levels of protein TIRAP
Serum levels of protein TKT
Serum levels of protein TLL1
Serum levels of protein TLR2
Serum levels of protein TMCC3
Schizophrenia, bipolar disorder or major depressive disorder x sex interaction
Schizophrenia, bipolar disorder or major depressive disorder
Schizophrenia, bipolar disorder or major depressive disorder x sex interaction (3df)
Recurrent major depressive disorder x sex interaction
Corneal resistance factor (MTAG)
Weight loss in chronic obstructive pulmonary disease
Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction
Cerebral amyloid angiopathy in APOEe4 carrier Alzheimer’s disease
Cerebral amyloid angiopathy in APOEe4 non-carrier Alzheimer’s disease
Cerebral amyloid angiopathy x sex interaction in Alzheimer’s disease
Cerebral amyloid angiopathy x APOEe4 status interaction in Alzheimer’s disease
Cerebral amyloid angiopathy in Alzheimer’s disease
Phosphatidylcholine(38:3)_[M+H]1+/Phosphatidylethanolamine(41:3)_[M+H]1+/Phosphatidate(43:4)_[M+NH4]1+ levels
Serum levels of protein TPSB2
Serum levels of protein TPSB2;TPSAB1
Serum levels of protein TPST1
Serum levels of protein TPST2
Serum levels of protein TPT1
Serum levels of protein TRABD
Serum levels of protein TRADD
Serum levels of protein TRAT1
Serum levels of protein TRDMT1
Serum levels of protein TREM1
Serum levels of protein TREM2
Serum levels of protein UGT1A6
Serum levels of protein UGT2A2
Serum levels of protein ULBP2
Serum levels of protein UMOD
Serum levels of protein UNC5C
Serum levels of protein UPK3BL
Serum levels of protein UQCC3
Serum levels of protein UROS
Serum levels of protein USP21
Serum levels of protein USP25
Serum levels of protein UST
Serum levels of protein UTS2
Serum levels of protein UXS1
Serum levels of protein VAPB
Serum levels of protein VCAN
Serum levels of protein VCY
Phosphatidylcholine(38:3)_[M+OAc]1-/Phosphatidylserine(42:2)_[M-H]1- levels
Facial morphology (segment 1)
Facial morphology (segment 3)
Facial morphology (segment 4)
Facial morphology (segment 11)
Facial morphology (segment 14)
Facial morphology (segment 18)
Facial morphology (segment 21)
Facial morphology (segment 27)
Facial morphology (segment 28)
Facial morphology (segment 30)
Facial morphology (segment 40)
Facial morphology (segment 41)
Facial morphology (segment 43)
Facial morphology (segment 48)
Facial morphology (segment 52)
Facial morphology (segment 53)
Facial morphology (segment 54)
Facial morphology (segment 59)
Phosphatidylcholine(38:4)_[M+H]1+/Phosphatidylethanolamine(41:4)_[M+H]1+ levels
Phosphatidylcholine(38:4)_[M+OAc]1-/Phosphatidylserine(42:3)_[M-H]1- levels
Serum levels of protein WARS
Serum levels of protein WDR1
Serum levels of protein WFDC1
Serum levels of protein WFDC10B
Serum levels of protein WFDC13
Serum levels of protein WFDC3
Serum levels of protein WFDC5
Serum levels of protein WFIKKN1
Serum levels of protein WFIKKN2
Serum levels of protein WIF1
Serum levels of protein WISP1
Serum levels of protein WISP2
Serum levels of protein WISP3
Serum levels of protein WNT3A
Serum levels of protein WNT5A
Hearing function (left/right asymmetry)
Serum levels of protein SYNCRIP
Serum levels of protein SYNGR3
Serum levels of protein SYT11
Serum levels of protein SYT17
Serum levels of protein SYTL4
Serum levels of protein TAB1;MAP3K7
Serum levels of protein TAC3
Serum levels of protein TAGLN2
Serum levels of protein TAPBP
Serum levels of protein TAPBPL
Serum levels of protein TARDBP
Serum levels of protein TAX1BP3
Serum levels of protein TBCA
Serum levels of protein TBCE
Serum levels of protein TBL2
Serum levels of protein TBX22
Serum levels of protein TCEA2
Serum levels of protein TCN1
Serum levels of protein TCN2
Serum levels of protein TCP11
Serum levels of protein TCTN2
Serum levels of protein TDO2
Serum levels of protein TEC
Serum levels of protein TEK
Serum levels of protein TENM3
Serum levels of protein TENM4
Serum levels of protein TESC
Serum levels of protein TEX29
Plasma amyloid beta peptide concentration (ABx-40/ABx-42 ratio)
Bipolar disorder x sex interaction
Serum levels of protein TMED10
Serum levels of protein TMEM106A
Serum levels of protein TMEM106B
Serum levels of protein TMEM132A
Serum levels of protein TMEM132B
Serum levels of protein TMEM132C
Serum levels of protein TMEM132D
Serum levels of protein TMEM185A
Serum levels of protein TMEM230
Serum levels of protein TMEM52B
Phosphatidylcholine(37:6)_[M+H]1+/Phosphatidylethanolamine(40:6)_[M+H]1+/Phosphatidate(42:7)_[M+NH4]1+ levels
Phosphatidylcholine(38:2)_[M+H]1+/Phosphatidylethanolamine(41:2)_[M+H]1+ levels
Serum levels of protein TNFRSF10B
Serum levels of protein TNFRSF11A
Serum levels of protein TNFRSF11B
Serum levels of protein TNFRSF12A
Serum levels of protein TNFRSF13B
Serum levels of protein TNFRSF14
Serum levels of protein TNFRSF18
Serum levels of protein TNFRSF19
Serum levels of protein TNFRSF1A
Serum levels of protein TNFRSF1B
Serum levels of protein TNFRSF8
Serum levels of protein TNFSF11
Serum levels of protein TNFSF12
Serum levels of protein TNFSF14
Serum levels of protein TNFSF18
Serum levels of protein TNNI3
Serum levels of protein TNNT2
Serum levels of protein TNS2
Serum levels of protein TNXB
Schizophrenia, bipolar disorder or recurrent major depressive disorder
Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction (3df)
Serum levels of protein TREML1
Serum levels of protein TREML4
Serum levels of protein TRH
Serum levels of protein TRIB2
Serum levels of protein TRIL
Serum levels of protein TSNARE1
Serum levels of protein TST
Serum levels of protein TUFT1
Serum levels of protein TWF1
Serum levels of protein TXNDC11
Serum levels of protein TXNDC12
Serum levels of protein TXNDC15
Serum levels of protein VDR
Serum levels of protein VEGFA
Serum levels of protein VEGFB
Serum levels of protein VEGFC
Serum levels of protein VEGFD
Serum levels of protein VIMP
Serum levels of protein VIT
Fibrosis-4 index in high alcohol intake
Aspartate transaminase levels in high alcohol intake
Alanine transaminase levels in high alcohol intake
Aspartate aminotransferase platelet ratio index in high alcohol intake
Metamizole-induced agranulocytosis or neutropenia
Metamizole-induced agranulocytosis
CCR7 on naive CD8+ T cell
CD127 on CD28+ CD45RA+ CD8+ T cell
CD45 on CD14+ monocyte
CD45 on B cell
CD45 on Natural Killer
CD45 on granulocyte
CD127 on CD45RA+ CD4+ T cell
CD45 on CD8+ T cell
CD25 on CD45RA- CD4 not regulatory T cell
CD45 on Natural Killer T
CD25 on CD45RA+ CD4 not regulatory T cell
CD127 on CD45RA- CD4 not regulatory T cell
CD25 on CD39+ CD4 regulatory T cell
CD127 on CD28+ CD4+ T cell
CD25 on CD39+ resting CD4 regulatory T cell
CD127 on CD28+ CD4-CD8- T cell
CD25 on CD39+ activated CD4 regulatory T cell
CD127 on granulocyte
CD25 on secreting CD4 regulatory T cell
CD127 on CD8+ T cell
CD123 on CD62L+ plasmacytoid Dendritic Cell
CD127 on CD28- CD8+ T cell
CD127 on CD4+ T cell
CD45 on CD4+ T cell
CD45 on HLA DR+ T cell
CD45 on HLA DR+ CD4+ T cell
CD25 on resting CD4 regulatory T cell
CD25 on activated CD4 regulatory T cell
CD25 on CD39+ secreting CD4 regulatory T cell
CD123 on plasmacytoid Dendritic Cell
CD127 on CD28+ CD45RA- CD8+ T cell
Childhood asthma exacerbations in long-acting beta2-agonist treatment
Drug-induced liver injury (isoniazid-containing anti-tuberculosis drugs)
Plasmacytoid Dendritic Cell %Dendritic Cell
HLA DR++ monocyte %monocyte
HLA DR++ monocyte %leukocyte
HLA DR++ monocyte Absolute Count
T/B cell
CD4+/CD8+ T cell
CD4+ T cell Absolute Count
CD4+ T cell %T cell
CD8+ T cell Absolute Count
CD8+ T cell %T cell
CD4+CD8+ T cell Absolute Count
CD4+CD8+ T cell %T cell
CD8dim T cell Absolute Count
CD8dim T cell %T cell
CD4-CD8- T cell Absolute Count
CD4-CD8- T cell %T cell
Keratoconus
CD25 on CD39+ CD4+ T cell
CD25 on CD28+ CD4+ T cell
FSC-A on myeloid Dendritic Cell
FSC-A on plasmacytoid Dendritic Cell
FSC-A on monocyte
FSC-A on granulocyte
FSC-A on CD14+ monocyte
FSC-A on Natural Killer
FSC-A on HLA DR+ Natural Killer
FSC-A on CD4+ T cell
FSC-A on CD8+ T cell
FSC-A on Natural Killer T
CD33 on CD33dim HLA DR-
CD33 on basophil
CD33 on Immature Myeloid-Derived Suppressor Cells
CD33 on CD33+ HLA DR+
CD33 on CD33+ HLA DR+ CD14-
CD4 on monocyte
CD4 on HLA DR+ CD4+ T cell
CD25 on CD4+ T cell
CD16 on CD14- CD16+ monocyte
CD62L- monocyte Absolute Count
CD62L- monocyte %monocyte
CD11c+ CD62L- monocyte Absolute Count
CD11c+ HLA DR++ monocyte Absolute Count
CD11c+ HLA DR++ monocyte %monocyte
Myeloid Dendritic Cell Absolute Count
Myeloid Dendritic Cell %Dendritic Cell
Plasmacytoid Dendritic Cell Absolute Count
Dendritic Cell Absolute Count
CD62L- Dendritic Cell Absolute Count
CD62L- Dendritic Cell %Dendritic Cell
CD33 on CD14+ monocyte
CD33 on CD33+ HLA DR+ CD14dim
CD33 on CD33dim HLA DR+ CD11b+
CD33 on CD33dim HLA DR+ CD11b-
CD33 on Granulocytic Myeloid-Derived Suppressor Cells
CD33 on CD66b++ myeloid cell
CD33 on Monocytic Myeloid-Derived Suppressor Cells
Skeletal muscle index
Leukocyte Absolute Count
Lymphocyte Absolute Count
Lymphocyte %leukocyte
T cell Absolute Count
T cell %lymphocyte
T cell %leukocyte
CD4+ T cell %leukocyte
CD8+ T cell %leukocyte
CD4+CD8+ T cell %leukocyte
CD4+ CD8dim T cell Absolute Count
CD4+ CD8dim T cell %lymphocyte
CD4+ CD8dim T cell %leukocyte
CD8dim T cell %leukocyte
CD4-CD8- T cell %leukocyte
CD8+ and CD8dim T cell %leukocyte
TCRgd T cell Absolute Count
TCRgd T cell %lymphocyte
HLA DR+ T cell Absolute Count
HLA DR+ T cell%T cell
HLA DR+ T cell%lymphocyte
Natural Killer T Absolute Count
Natural Killer T %T cell
CD86+ myeloid Dendritic Cell Absolute Count
CD86+ myeloid Dendritic Cell %Dendritic Cell
CD86+ plasmacytoid Dendritic Cell %Dendritic Cell
CD62L- myeloid Dendritic Cell Absolute Count
CD62L- myeloid Dendritic Cell %Dendritic Cell
CD62L- plasmacytoid Dendritic Cell Absolute Count
CD62L- plasmacytoid Dendritic Cell %Dendritic Cell
CD62L- CD86+ myeloid Dendritic Cell Absolute Count
CD62L- CD86+ myeloid Dendritic Cell %Dendritic Cell
Dilated cardiomyopathy
Natural Killer T %lymphocyte
HLA DR+ CD4+ T cell Absolute Count
HLA DR+ CD4+ T cell %T cell
HLA DR+ CD4+ T cell %lymphocyte
HLA DR+ CD8+ T cell Absolute Count
HLA DR+ CD8+ T cell %T cell
HLA DR+ CD8+ T cell %lymphocyte
CD8+ Natural Killer T Absolute Count
CD8+ Natural Killer T %T cell
CD8+ Natural Killer T %lymphocyte
CD8dim Natural Killer T Absolute Count
CD8dim Natural Killer T %T cell
CD8dim Natural Killer T %lymphocyte
CD4-CD8- Natural Killer T Absolute Count
CD4-CD8- Natural Killer T %T cell
CD4-CD8- Natural Killer T %lymphocyte
CD3- lymphocyte %lymphocyte
CD3- lymphocyte %leukocyte
B cell Absolute Count
Serum levels of protein TF
Serum levels of protein TFF1
Serum levels of protein TFF3
Serum levels of protein TFPI
Serum levels of protein TFPI2
Serum levels of protein TFRC
Serum levels of protein TGFB1
Serum levels of protein TGFB3
Serum levels of protein TGFBI
Serum levels of protein TGM1
Serum levels of protein TGM3
Serum levels of protein THBS1
Serum levels of protein THBS2
Serum levels of protein THBS4
Serum levels of protein THPO
Major depressive disorder x sex interaction
Serum levels of protein TMEM57
Serum levels of protein TMEM87B
Serum levels of protein TMEM9
Serum levels of protein TMIE
Serum levels of protein TMOD3
Serum levels of protein TMPRSS11D
Serum levels of protein TMX3
Serum levels of protein TNC
Serum levels of protein TNF
Serum levels of protein TNFAIP6
Serum levels of protein TNFAIP8
Serum levels of protein TNFRSF10A
Serum levels of protein TOM1L1
Serum levels of protein TOR1AIP1
Serum levels of protein TP53
Serum levels of protein TP53I11
Serum levels of protein TP53I13
Serum levels of protein TPI1
Serum levels of protein TPM2
Serum levels of protein TPM3
Serum levels of protein TPMT
Serum levels of protein TPPP2
Serum levels of protein TXNDC5
Serum levels of protein TXNIP
Serum levels of protein TXNRD1
Serum levels of protein TYK2
Serum levels of protein TYMP
Serum levels of protein TYMSOS
Serum levels of protein UBA2
Serum levels of protein UBASH3B
Serum levels of protein UBC
Serum levels of protein UBE2D4
Serum levels of protein UBE2G2
Serum levels of protein UBE3A
Serum levels of protein UBXN4
Serum levels of protein UCHL1
Serum levels of protein UCMA
Serum levels of protein UFC1
Serum levels of protein UFM1
Serum levels of protein UGP2
Plasma p-tau181 levels
Serum levels of protein VNN2
Serum levels of protein VOPP1
Serum levels of protein VPS29
Serum levels of protein VRK1
Serum levels of protein VSNL1
Serum levels of protein VSTM5
Serum levels of protein VTN
Serum levels of protein VWA1
Serum levels of protein VWA2
Serum levels of protein VWC2
Serum levels of protein VWF
Soluble CD14 levels
Serum levels of protein WNT7A
Serum levels of protein XCL1
Serum levels of protein XG
Serum levels of protein XXYLT1
Serum levels of protein YBX1
Serum levels of protein YBX2
Serum levels of protein YWHAB
Serum levels of protein YWHAE
Serum levels of protein YWHAQ
Serum levels of protein YWHAQ;SFN;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ
Serum levels of protein ZAP70
Serum levels of protein ZBTB33
Serum levels of protein ZFYVE27
Serum levels of protein ZG16B
Serum levels of protein ZNF10
Serum levels of protein ZNF275
Diastolic blood pressure change trajectory
Systolic blood pressure (baseline)
Academic attainment (English)
Academic attainment (maths)
Anthropometric traits (multi-trait analysis)
Disorders of lipid metabolism
Cotinine levels in smokers with chronic obstructive pulmonary disease
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease
Academic attainment (science)
Brain imaging measurements
Well-being spectrum (multivariate analysis)
Cerebral microbleeds (lobar)
Cholesteryl ester transfer protein levels
Delirium
Eudaimonic well-being
Hedonic well-being
Major depressive disorder (probable)
Major depressive disorder (ICD-10 coded)
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Cutaneous leishmaniasis
Paediatric migraine
Hypospadias (moderate to severe)
Diastolic blood pressure (baseline)
Disruptive behavior disorder and attention deficit hyperactivity disorder
Left ventricular end-systolic volume (MTAG)
Left ventricular global circumferential strain (MTAG)
Left ventricular global radial strain (MTAG)
Left ventricular global longitudinal strain (MTAG)
Hypertrophic cardiomyopathy
Lateral ventricular volume in normal aging
Fish consumption
Skin pigmentation traits
Endometrial cancer (endometrioid histology)
Endometrial cancer (Non-endometrioid histology)
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)
Relative amplitude of rest-activity cycles
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)
Urinary albumin excretion (no hypertensive medication)
Initial alcohol sensitivity
Extremely high intelligence
Response to lurasidone in schizophrenia
Remission after SSRI treatment in major depression
Triiodothyronine levels and thyroxine levels
Early age-related macular degeneration
joint destruction in rheumatoid arthritis (rapid vs slow)
Severe depressive disorders in coronary artery disease
Latent autoimmune diabetes
Latent autoimmune diabetes vs. type 2 diabetes
Latent autoimmune diabetes vs. type 1 diabetes
HDL cholesterol and triglyceride levels (pleiotropy)
Change in HbA1c levels in response to metformin treatment in type 2 diabetes
Chronic back pain
Seasonality and depression
Cortical amyloid beta load
Alzheimer's disease progression score
Type 2 diabetes and end-stage kidney disease
Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals
Postoperative survival time in hepatocellular carcinoma
Cholesterol efflux capacity
Heart rate in heart failure with reduced ejection fraction
Geographic atrophy lesion growth rate in age-related macular degeneration
Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)
Carotid plaque maximum area
Sum of carotid plaque area
Mean area of carotid plaque
Maximum stenosis
Mean degree of stenosis
Sum of stenosis
Medication use (calcium channel blockers)
Medication use (agents acting on the renin-angiotensin system)
Aerodigestive squamous cell cancer (pleiotropy)
Systolic blood pressure (education interaction)
Diastolic blood pressure (education interaction)
Adult hearing difficulty
Adult hearing aid use
Autoimmune traits (pleiotropy)
Diabetic peripheral neuropathy in type 2 diabetes
BMI x environmental factors (including physical activity) interaction
BMI x  environmental factors (excluding physical activity) interaction
Medication use (HMG CoA reductase inhibitors)
Visceral fat, circulating phospholipid PC(16:0/2:0) and white matter microstructure (shared variance)
Medication use (thyroid preparations)
Low susceptibility to hepatitis C infection
Medication use (immunosuppressants)
Medication use (anti-inflammatory and antirheumatic products, non-steroids)
Medication use (drugs affecting bone structure and mineralization)
Medication use (antimigraine preparations)
Medication use (antidepressants)
Medication use (adrenergics, inhalants)
Fulminant type 1 diabetes
Plasma norclozapine levels in treatment-resistant schizophrenia
Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia
Plasma clozapine levels in treatment-resistant schizophrenia
Pre-treatment viral load in HIV-1 infection
Response to SSRI in MDD or conscientiouness
Remission after SSRI treatment in MDD or neuroticism
Remission after SSRI treatment in MDD or openness
Response to SSRI in MDD or openness
Idiopathic intracranial hypertension
Velopharyngeal dysfunction
Number of twin births
Health literacy
Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)
Medication use (drugs used in diabetes)
Brain-derived neurotrophic factor levels
Suicide attempt severity
Ambidextrousness
Left-handedness
Cardiovascular disease in type 2 diabetes
Age-related macular degeneration (MTAG)
Glycemic traits (pleiotropy)
Asthma exacerbations in inhaled corticosteroid treatment
Diarrhea in mesalamine-treated irritable bowel disease
Fever in mesalamine-treated irritable bowel disease
Fever and diarrhea in mesalamine-treated irritable bowel disease
Medication use (opioids)
Medication use (salicylic acid and derivatives)
Medication use (anilides)
Medication use (glucocorticoids)
Medication use (antihistamines for systemic use)
Medication use (antiglaucoma preparations and miotics)
Serum levels of protein DNAJC10
Serum levels of protein DNAJC11
Serum levels of protein DNAJC15
Serum levels of protein DNAJC4
Serum levels of protein DNER
Serum levels of protein DPEP1
Serum levels of protein DPEP2
Serum levels of protein DPP7
Serum levels of protein DPT
Serum levels of protein DPYSL2
Serum levels of protein DRAXIN
Serum levels of protein DRGX
Serum levels of protein DSC1
Serum levels of protein DSG1
Phosphatidylcholine-O(36:5)_[M+H]1+/Phosphatidylcholine-P(36:4)_[M+H]1+ levels
Phosphatidylcholine-O(38:4)_[M+H]1+/Phosphatidylcholine-P(38:3)_[M+H]1+ levels
Anxiety and stress-related disorders
Major depressive disorder or stress-related disorder
Phosphatidylcholine-O(40:5)_[M+H]1+/Phosphatidylcholine-P(40:4)_[M+H]1+ levels
Serum levels of protein HFE2
Serum levels of protein HGF
Serum levels of protein HGFAC
Serum levels of protein HHIP
Serum levels of protein HHLA2
Serum levels of protein HIBCH
Serum levels of protein HIF1A
Serum levels of protein HIKESHI
Serum levels of protein HINT2
Serum levels of protein HIST2H2BE
Serum levels of protein HIST3H2A
Serum levels of protein HLA-DRB3
Serum levels of protein PRDX6
Serum levels of protein PRELP
Serum levels of protein PREP
Serum levels of protein PRG2
Serum p2 prostate specific antigen levels
Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+NH4]1+ levels
Serum levels of protein PSG5
Serum levels of protein PSG6
Serum levels of protein PSG9
Serum levels of protein PSMA1
Serum levels of protein PSMA7
Serum levels of protein PSMB1
Serum levels of protein MMP7
Serum levels of protein MMP8
Serum levels of protein MMP9
Serum levels of protein MMRN2
Serum levels of protein EDDM3B
Serum levels of protein EDIL3
Serum levels of protein EDN2
Serum levels of protein EEF2K
Serum levels of protein EFCAB14
Serum levels of protein EFEMP1
Serum levels of protein EFNA2
Serum levels of protein EFNB1
Serum levels of protein EFNB2
Serum levels of protein EGF
Serum levels of protein EGFLAM
Serum levels of protein EHBP1
Serum levels of protein EHD4
Serum levels of protein EHMT2
Serum levels of protein EID3
Serum levels of protein EIF1AD
Serum levels of protein EIF4EBP2
Serum levels of protein EIF5A2
Serum levels of protein ELANE
Serum levels of protein ELF5
Serum levels of protein ELK1
Serum levels of protein ELL
Serum levels of protein EMC1
Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels
Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels
Serum levels of protein MUL1
Serum levels of protein MUSK
Serum levels of protein MXRA7
Serum levels of protein MYC
Serum levels of protein MYCT1
Serum levels of protein MYNN
Serum levels of protein MYOM3
Serum levels of protein MYRF
Serum levels of protein DYRK3
Serum levels of protein EBI3
Serum levels of protein EBI3;IL27
Serum levels of protein ECE1
Serum levels of protein ECH1
Serum levels of protein ECI2
Serum levels of protein ECM1
Serum levels of protein EDA
Serum levels of protein EDAR
Serum levels of protein EDDM3A
Serum levels of protein SECTM1
Serum levels of protein SEL1L2
Serum levels of protein SELE
Serum levels of protein SELL
Serum levels of protein SELP
Serum levels of protein SELPLG
Serum levels of protein SEMA3A
Serum levels of protein SEMA3E
Serum levels of protein SEMA3G
Serum levels of protein SEMA4C
Serum levels of protein SEMA5A
Serum levels of protein SEMA6A
Serum levels of protein SEMA6B
Serum levels of protein SEMA6C
Phosphatidylcholine(35:3)_[M+H]1+/Phosphatidylethanolamine(38:3)_[M+H]1+/Phosphatidate(40:4)_[M+NH4]1+ levels
Phosphatidylcholine(36:2)_[M+H]1+/Phosphatidylethanolamine(39:2)_[M+H]1+/Phosphatidate(41:3)_[M+NH4]1+ levels
Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+NH4]1+ levels
Serum levels of protein SIGLEC6
Serum levels of protein SIGLEC7
Serum levels of protein SIGLEC8
Serum levels of protein SIRPB1
Serum levels of protein SIRPG
Serum levels of protein SIRT2
Serum levels of protein SIRT5
Serum levels of protein SKIL
Serum levels of protein SLAMF7
Serum levels of protein SLC14A2
Serum levels of protein SLC22A16
Serum levels of protein SLC25A18
Serum levels of protein SLC26A11
Serum levels of protein SLC30A3
Serum levels of protein SLC35G2
Serum levels of protein SLC3A1
Serum levels of protein SLC3A2
Serum levels of protein SLC5A5
Serum levels of protein SLC5A8
Serum levels of protein SLC6A14
Serum levels of protein SLITRK1
Serum levels of protein SLITRK3
Serum levels of protein SLITRK4
Serum levels of protein SLPI
Serum levels of protein SLURP1
Serum levels of protein SMAD3
Serum levels of protein SMDT1
Serum levels of protein SMIM10
Serum levels of protein SMIM13
Serum levels of protein SMIM9
Serum levels of protein SMOC1
Serum levels of protein SMPD1
Serum levels of protein SMPDL3A
Phosphatidylcholine(36:3)_[M+OAc]1-/Phosphatidylserine(40:2)_[M-H]1- levels
Serum levels of protein STAT3
Serum levels of protein STAT6
Serum levels of protein STAU2
Serum levels of protein STIM1
Serum levels of protein STIP1
Serum levels of protein STK16
Serum levels of protein STK17B
Serum levels of protein STOML2
Serum levels of protein STX1A
Serum levels of protein STX1B
Serum levels of protein STX2
Serum levels of protein STX3
Serum levels of protein STX6
Serum levels of protein STX7
Serum levels of protein STX8
Serum levels of protein SULF2
Serum levels of protein SULT1B1
Serum levels of protein SULT1E1
Serum levels of protein SULT2A1
Serum levels of protein SULT4A1
Serum levels of protein SPOCK3
Serum levels of protein SPON1
Serum levels of protein SPON2
Serum levels of protein SPP1
Serum levels of protein SPRN
Serum levels of protein SPSB1
Serum levels of protein SPTLC2
Serum levels of protein SRL
Serum levels of protein SRXN1
Serum levels of protein SSR1
Serum levels of protein ST14
Serum levels of protein ST3GAL1
Serum levels of protein ST3GAL6
Serum levels of protein ST6GALNAC1
Serum levels of protein ST6GALNAC2
Serum levels of protein ST6GALNAC6
Serum levels of protein STAP1
Free triiodothyronine (T3) levels
Serum levels of protein DKK2
Serum levels of protein DKK3
Serum levels of protein DKK4
Serum levels of protein DKKL1
Serum levels of protein DLG3
Serum levels of protein DLK1
Serum levels of protein DLK2
Serum levels of protein DLL3
Serum levels of protein DMKN
Serum levels of protein DNAJB11
Serum levels of protein DNAJB12
Serum levels of protein DNAJB14
Serum levels of protein DNAJB2
Serum levels of protein DNAJB9
Serum levels of protein GXYLT1
Serum levels of protein GZMA
Serum levels of protein GZMB
Serum levels of protein GZMK
Serum levels of protein H2AFZ
Serum levels of protein H6PD
Serum levels of protein HAAO
Serum levels of protein HAT1
Serum levels of protein HAVCR1
Serum levels of protein HAVCR2
Serum levels of protein HBD
Phosphatidylcholine-O(38:5)_[M+H]1+/Phosphatidylcholine-P(38:4)_[M+H]1+ levels
Vertigo
Major adverse cardiovascular events in response to aspirin and clopidogrel treatment
Serum levels of protein PRG3
Serum levels of protein PRH2
Serum levels of protein PRDX3
Serum levels of protein PRKCSH
Serum levels of protein PRLR
Serum levels of protein PROC
Serum levels of protein PROK2
Serum levels of protein PRPF6
Serum levels of protein PRRG1
Serum levels of protein PRRG4
Serum levels of protein PRSS2
Serum levels of protein PRSS22
Serum levels of protein PRSS27
Serum levels of protein PRSS57
Serum levels of protein PRSS8
Phosphatidylcholine-O(40:6)_[M+H]1+/Phosphatidylcholine-P(40:5)_[M+H]1+ levels
Total cerebellar volume (excluding Crus I vermis)
Bile acid(DCA)_[M-H]1- levels
Ceramide_40:1_[M-H]1- levels
Ceramide_41:1_[M-H]1- levels
Ceramide_42:1_[M+H-H2O]1+ levels
Warfarin dose variability
Intraocular pressure in individuals with narrow occludable anterior chamber angle
Serum levels of protein MRPL33
Serum levels of protein MRPL55
Serum levels of protein MRPL58
Serum levels of protein MSN
Serum levels of protein MSR1
Serum levels of protein MST1
Serum levels of protein MST1R
Serum levels of protein MSTN
Serum levels of protein MT1F
Serum levels of protein MTHFS
Serum levels of protein MTPAP
Serum levels of protein MUC1
Finger osteoarthritis
Thumb osteoarthritis
Early-onset osteoarthritis
ICD10 Z72.0: Tobacco use
Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes
Phosphatidylcholine(34:2)_[M+H]1+/Phosphatidylethanolamine(37:2)_[M+H]1+/Phosphatidate(39:3)_[M+NH4]1+ levels
Serum levels of protein EMC4
Serum levels of protein EMID1
Serum levels of protein EMILIN3
Serum levels of protein ENAH
Serum levels of protein ENDOU
Serum levels of protein ENG
Serum levels of protein S100A4
Serum levels of protein S100A5
Serum levels of protein S100A6
Serum levels of protein SAA1
Serum levels of protein SAT2
Serum levels of protein SCARA5
Serum levels of protein SCARF1
Serum levels of protein SCARF2
Serum levels of protein SCG2
Serum levels of protein SCG3
Serum levels of protein SCGB1A1
Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels
Serum levels of protein SERPINA11
Serum levels of protein SERPINA12
Serum levels of protein SERPINA3
Serum levels of protein SERPINA4
Serum levels of protein SERPINA5
Serum levels of protein SERPINA7
Serum levels of protein SERPINA9
Serum levels of protein SERPINB1
Serum levels of protein SERPIND1
Serum levels of protein SERPINE1
Serum levels of protein SERPINE2
Plasma PCSK9 levels
Serum levels of protein SH2D3C
Serum levels of protein SHANK3
Serum levels of protein SHBG
Serum levels of protein SHISA3
Serum levels of protein SHMT1
Serum levels of protein SHMT2
Serum levels of protein SIAE
Serum levels of protein SIGIRR
Serum levels of protein SIGLEC10
Serum levels of protein SIGLEC12
Serum levels of protein SIGLEC14
Serum levels of protein SPARC
Serum levels of protein SPARCL1
Serum levels of protein SPATA20
Serum levels of protein SPHK2
Serum levels of protein SPINK1
Serum levels of protein SPINK2
Serum levels of protein SPINK5
Serum levels of protein SPINK6
Serum levels of protein SPINK9
Serum levels of protein SPINT1
Serum levels of protein SPINT2
Serum levels of protein SPINT3
Serum levels of protein SPOCK2
Serum lipopolysaccharide activity
Disease-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor effect)
Mortality after unrelated donor allogeneic hematopoietic cell transplantation (recipient effect)
Mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor-recipient mismatch)
Transplant-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (recipient effect)
Transplant-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor-recipient mismatch)
Phosphatidylcholine_36:1_[M+H]1+/Phosphatidylethanolamine_39:1_[M+H]1+/Phosphatidate_41:2_[M+NH4]1+ levels
Phosphatidylcholine_36:2_[M+OAc]1-/Phosphatidylserine_40:1_[M-H]1- levels
Phosphatidylcholine_36:3_[M+H]1+/Phosphatidylethanolamine_39:3_[M+H]1+/Phosphatidate_41:4_[M+NH4]1+ levels
Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levels
Phosphatidylcholine_37:3_[M+OAc]1-/Phosphatidylserine_41:2_[M-H]1- levels
Serum levels of protein CRTAC1
Serum levels of protein CRTAM
Serum levels of protein CRYBB2
Serum levels of protein CRYZ
Serum levels of protein CRYZL1
Serum levels of protein CSF2RA
Serum levels of protein CSF2RB
Serum levels of protein CSF3
Serum levels of protein CSGALNACT2
Serum levels of protein CSH1;CSH2
Serum levels of protein CSMD2
Serum levels of protein CSN1S1
Serum levels of protein CSNK2A1;CSNK2B
Serum levels of protein FRS2
Serum levels of protein FRZB
Serum levels of protein CREG1
Serum levels of protein CRELD1
Serum levels of protein CRHBP
Serum levels of protein CRIM1
Serum levels of protein CRISP2
Serum levels of protein CRISPLD2
Serum levels of protein CRLF1
Serum levels of protein CRLF2
Serum levels of protein CROT
Serum levels of protein CRP
Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer
Phosphatidylcholine_38:6_[M+H]1+/Phosphatidylethanolamine_41:6_[M+H]1+ levels
Phosphatidylcholine_39:6_[M+OAc]1- levels
Phosphatidylcholine_40:4_[M+H]1+/Phosphatidylethanolamine_43:4_[M+H]1+ levels
Mucositis (moderate to severe) in head and neck cancer treated with radiotherapy
Childhood gender nonconformity
Serum levels of protein CXCL2;CXCL3
Serum levels of protein CXCL5
Serum levels of protein CXCL6
Serum levels of protein CXCL8
Serum levels of protein CXCL9
Serum levels of protein CYB5D2
Serum levels of protein FTCD
Serum levels of protein FTH1;FTL
Serum levels of protein FTMT
Serum levels of protein FUT10
Serum levels of protein FUT3
Phosphatidylcholine-O_18:1_[M+H]1+/Phosphatidylcholine-P_18:0_[M+H]1+ levels
Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels
Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels
Phosphatidylcholine-2O_32:0_[M+H]1+ levels
Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ levels
Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels
Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels
Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels
Serum levels of protein GCSH
Serum levels of protein GDA
Serum levels of protein GDF15
Serum levels of protein GDF9
Serum levels of protein GDI2
Serum levels of protein GFRA1
Serum levels of protein GFRA2
Serum levels of protein GFRAL
Serum levels of protein GGH
Serum levels of protein GGT2
Serum levels of protein GHR
Serum levels of protein GHRL
Serum levels of protein GIP
Serum levels of protein PLAU
Serum levels of protein PLAUR
Serum levels of protein PLBD1
Serum levels of protein PLCG1
Serum levels of protein PLG
Serum levels of protein LRTM2
Serum levels of protein LSAMP
Serum levels of protein LST1
Serum levels of protein LTA;LTB
Serum levels of protein LTF
Serum levels of protein LUM
Serum levels of protein LY6G6C
Serum levels of protein LY9
Serum levels of protein LY96;TLR4
Serum levels of protein DDX46
Serum levels of protein DEAF1
Serum levels of protein DEF6
Serum levels of protein DEFA1
Serum levels of protein DEFA5
Serum levels of protein DEFB1
Serum levels of protein DEFB105B
Serum levels of protein DEFB113
Serum levels of protein DEFB118
Serum levels of protein DEFB119
Serum levels of protein DEFB121
Serum levels of protein DEFB129
Serum levels of protein DEFB131
Serum levels of protein DEFB132
Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levels
Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels
Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levels
Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ levels
Phosphatidylcholine-O(36:3)_M+H]1+/Phosphatidylcholine-P(36:2)_M+H]1+ levels
Serum levels of protein GRAMD1C
Serum levels of protein GRAP
Serum levels of protein GRAP2
Serum levels of protein GRB14
Serum levels of protein GRB7
Serum levels of protein GREM2
Serum levels of protein GRIA4
Serum levels of protein GRID2
Serum levels of protein GRN
Serum levels of protein GRP
Serum levels of protein GSK3A;GSK3B
Serum levels of protein GSKIP
Serum levels of protein PLIN3
Serum levels of protein PLOD3
Serum levels of protein PLXDC1
Serum levels of protein PLXDC2
Serum levels of protein PLXNA1
Serum levels of protein PLXNB2
Serum levels of protein PLXNC1
Serum levels of protein PMEL
Serum levels of protein PMEPA1
Serum levels of protein PMVK
Serum levels of protein PNLIPRP1
Serum levels of protein PNLIPRP2
Serum levels of protein PNP
Serum levels of protein PNPLA2
Serum levels of protein POFUT1
Serum levels of protein POFUT2
Serum levels of protein POGLUT1
Tinnitus (chronic, bothersome)
Body fat percentage or coronary artery disease (MTAG)
Body fat percentage or heart failure (MTAG)
Serum levels of protein DSG2
Serum levels of protein DTX1
Serum levels of protein DUSP13
Serum levels of protein DUSP26
Serum levels of protein DUSP4
Serum levels of protein DUT
Serum levels of protein DVL2
Serum levels of protein DYNAP
Serum levels of protein DYNLL2
Serum levels of protein DYNLRB1
Serum levels of protein GSN
Serum levels of protein GSTA1
Serum levels of protein GSTM1
Serum levels of protein GSTM3
Serum levels of protein GSTO1
Serum levels of protein GSTT2
Serum levels of protein GUCA1A
Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels
Serum levels of protein HBE1
Serum levels of protein HBEGF
Serum levels of protein HBQ1
Serum levels of protein HBZ
Serum levels of protein HCAR2
Serum levels of protein HDAC8
Serum levels of protein HDGF
Serum levels of protein HDHD2
Serum levels of protein HDLBP
Serum levels of protein HERC1
Serum levels of protein HERC5
Bevacizumab-induced hypertension
Bevacizumab-induced proteinuria
Bevacizumab-induced composite toxicity (either hypertension or proteinuria)
Serum levels of protein PRTN3
Serum levels of protein PSAP
Serum levels of protein PSAPL1
Serum levels of protein PSD
Serum levels of protein PSD2
Serum levels of protein PSG2
Serum levels of protein PSG3
Serum levels of protein PSG4
Osteoarthritis (with total knee replacement)
Serum levels of protein MNX1
Serum levels of protein MOB1A
Serum levels of protein MOCS3
Serum levels of protein MPG
Serum levels of protein MPO
Serum levels of protein MPP6
Serum levels of protein MPZ
Serum levels of protein MPZL2
Serum levels of protein MRAP
Serum levels of protein MRPL14
Phosphatidylcholine(35:1)_[M+H]1+/Phosphatidylethanolamine(38:1)_[M+H]1+/Phosphatidate(40:2)_[M+NH4]1+ levels
Serum levels of protein SCGB1C2
Serum levels of protein SCGB2A1
Serum levels of protein SCGB3A1
Serum levels of protein SCGN
Serum levels of protein SCIN
Serum levels of protein SCMH1
Serum levels of protein SCO1
Serum levels of protein SCP2D1
Serum levels of protein SCUBE1
Serum levels of protein SEC11C
Serum levels of protein SEC13
Serum levels of protein SEMG1
Serum levels of protein SEMG2
Serum levels of protein SENP7
Serum levels of protein SEPT10
Serum levels of protein SERPINA1
Serum levels of protein SERPINA10
Serum levels of protein SERPINF1
Serum levels of protein SERPINF2
Serum levels of protein SERPINI2
Serum levels of protein SET
Serum levels of protein SETD2
Serum levels of protein SF1
Serum levels of protein SF3B4
Serum levels of protein SFN
Serum levels of protein SFRP1
Serum levels of protein SFRP2
Serum levels of protein SFRP4
Serum levels of protein SFTPB
Serum levels of protein SFTPC
Serum levels of protein SFXN5
Serum levels of protein SGK3
Serum levels of protein SH2D1A
Developmental stuttering
Serum levels of protein SMR3A
Serum levels of protein SMURF1
Serum levels of protein SNCA
Serum levels of protein SNRPF
Serum levels of protein SNU13
Serum levels of protein SNX7
Serum levels of protein SOCS3
Serum levels of protein SOD2
Serum levels of protein SORCS2
Serum levels of protein SOST
Serum levels of protein SPACA3
Serum levels of protein SPACA7
Serum levels of protein SPAG11B
Phosphatidylcholine(36:4)_[M+H]1+/Phosphatidylethanolamine(39:4)_[M+H]1+/Phosphatidate(41:5)_[M+NH4]1+ levels
Serum levels of protein SUMF1
Serum levels of protein SUN3
Serum levels of protein SUN5
Serum levels of protein SURF1
Serum levels of protein SUSD2
Serum levels of protein SVEP1
Serum levels of protein SWAP70
Serum levels of protein SYK
Human papilloma virus 16 positive oropharyngeal cancer
Human papilloma virus 16 negative oropharyngeal cancer
Serum levels of protein LRIT3
Serum levels of protein LRP1
Serum levels of protein LRP11
Serum levels of protein LRP12
Serum levels of protein LRP1B
Serum levels of protein LRP2
Serum levels of protein LRP8
Serum levels of protein LRPAP1
Serum levels of protein LRPPRC
Serum levels of protein LRRC15
Serum levels of protein LRRC19
Serum levels of protein LRRC24
Serum levels of protein LRRC25
Phosphatidylcholine_38:3_[M+H]1+/Phosphatidylethanolamine_41:3_[M+H]1+/Phosphatidate_43:4_[M+NH4]1+ levels
Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels
Response to paclitaxel
Response to vinblastine
Response to vinorelbine
Response to cladaribine
Response to fluoro-deoxyuridine
Response to arsenic trioxide
Response to oxaliplatin
Response to dovitinib
Response to erlotinib
Response to nintedanib
Response to tivantinib
Response to trametinib
Response to vandetanib
Response to vemurafenib
Response to hydroxyurea
Response to paclitaxel and epirubicin
Response to epirubicin
Depression x vitamin D PRS interaction (COJO adjusted)
Anxiety x vitamin D PRS interaction (COJO adjusted)
Depression score x vitamin D interaction
Anxiety score x vitamin D interaction
Anxiety score x vitamin D PRS interaction (COJO adjusted)
Anxiety score x vitamin D PRS interaction
Serum levels of protein FUT5
Serum levels of protein FUT9
Serum levels of protein FXYD4
Serum levels of protein FZD10
Serum levels of protein GAA
Serum levels of protein GABARAPL2
Serum levels of protein GABBR1
Serum levels of protein GABBR2
Serum levels of protein GAL3ST1
Serum levels of protein GAL3ST2
Serum levels of protein GALK1
Serum levels of protein GALNT10
Bisphosphonate-related osteonecrosis of the jaw in cancer (i.v. bisphosphonate)
Bisphosphonate-related osteonecrosis of the jaw in osteoporosis (oral bisphosphonate)
Bisphosphonate-related osteonecrosis of the jaw
Phosphatidylcholine-O_35:4_[M+OAc]1-/Phosphatidylcholine-P_35:3_[M+OAc]1- levels
Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels
Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels
Serum levels of protein LYPD3
Serum levels of protein LYVE1
Serum levels of protein LYZ
Serum levels of protein M6PR
Serum levels of protein MADCAM1
Serum levels of protein MAGEA10
Serum levels of protein MAGEA3
Serum levels of protein MAN1A2
Serum levels of protein MAN1B1
Serum levels of protein MAN1C1
Serum levels of protein MAN2B2
Serum levels of protein MANBA
Serum levels of protein MANEA
Serum levels of protein MANF
Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels
Phosphatidylcholine-O(32:0)_[M+H]1+/Phosphatidylethanolamine-O(35:0)_[M+H]1+ levels
Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels
Suicide attempt
Vitamin C levels
Colorectal polyp
Colorectal polyp and colorectal cancer (MTAG)
Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+NH4]1+ levels
Phosphatidylcholine_37:5_[M+H]1+/Phosphatidylethanolamine_40:5_[M+H]1+/Phosphatidate_42:6_[M+NH4]1+ levels
Serum levels of protein FST
Serum levels of protein FSTL1
Serum levels of protein LGALS2
Serum levels of protein LGALS3
Serum levels of protein LGALS3BP
Serum levels of protein LGALS4
Serum levels of protein LGALS7
Serum levels of protein LGALS7B
Serum levels of protein LGALS9
Serum levels of protein LGMN
Neonatal total 25-hydroxyvitamin D levels (cord blood)
Midgestational total 25-hydroxyvitamin D levels (antenatal blood)
Serum levels of protein LRRC32
Serum levels of protein LRRC4B
Serum levels of protein LRRC74A
Serum levels of protein CSNK2B
Serum levels of protein CST1
Serum levels of protein CST2
Serum levels of protein CST4
Serum levels of protein CST5
Serum levels of protein CST6
Serum levels of protein CST7
Serum levels of protein LRRC37A2
Serum levels of protein LRRC4C
Serum levels of protein LRRC52
Serum levels of protein CST3
Phosphatidylcholine_40:5_[M+H]1+ levels
Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels
Phosphatidylcholine_40:6_[M+OAc]1-/Phosphatidylserine_44:5_[M-H]1- levels
Alanine aminotransferase level after methotrexate initiation in rheumatoid arthritis
Serum levels of protein CTSS
Serum levels of protein CTSV
Serum levels of protein CTSZ
Serum levels of protein CTXN3
Serum levels of protein CUEDC2
Serum levels of protein CUZD1
Serum levels of protein CX3CL1
Serum levels of protein CXADR
Serum levels of protein CXCL1
Serum levels of protein CXCL11
Serum levels of protein CXCL12
Serum levels of protein CXCL16
Phosphatidylcholine_44:5_[M+OAc]1- levels
Phosphatidylcholine_52:4_[M+OAc]1- levels
Phosphatidylcholine_42:4_[M+OAc]1- levels
Language functional connectivity
Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels
Early onset periodontitis x sex interaction
15-year breast cancer-specific survival (grade 3 tumor)
15-year breast cancer-specific survival (ER positive treated with endocrine therapy)
15-year breast cancer-specific survival (ER negative treated with chemotherapy)
15-year breast cancer-specific survival (ER positive, PR positive, and HER2 negative)
15-year breast cancer-specific survival (ER positive or PR positive, and HER2 negative treated with chemotherapy)
15-year breast cancer-specific survival (treated with anthracyclines)
5-year breast cancer-specific survival (ER negative treated with chemotherapy)
5-year breast cancer-specific survival (treated with tamoxifen)
Serum levels of protein DEFB4A
Serum levels of protein DERL1
Serum levels of protein DES
Serum levels of protein DGKB
Serum levels of protein DHFR
Serum levels of protein DHX8
Serum levels of protein DIABLO
Serum levels of protein DKK1
Serum levels of protein GKN2
Serum levels of protein GLCE
Serum levels of protein GLO1
Serum levels of protein GLT8D1
Serum levels of protein GLTPD2
Serum levels of protein GNLY
Phosphatidylcholine-O_42:6_[M+OAc]1-/Phosphatidylcholine-P_42:5_[M+OAc]1- levels
Phosphatidylcholine-O(36:4)_[M+H]1+/Phosphatidylcholine-P(36:3)_[M+H]1+ levels
Urinary creatinine levels
Urinary potassium levels
Urinary sodium levels
Serum levels of protein MAVS
Serum levels of protein MAX
Serum levels of protein MAZ
Serum levels of protein MB
Serum levels of protein MBD4
Serum levels of protein MBL2
Serum levels of protein MCEE
Serum levels of protein MCEMP1
Serum levels of protein MCF2L
Serum levels of protein MCFD2
Serum levels of protein MCL1
Serum levels of protein MCTS1
Serum levels of protein PPBP
Serum levels of protein PPIB
Serum levels of protein PPID
Serum levels of protein PPIE
Serum levels of protein PPIL1
Serum levels of protein PPIL2
Serum levels of protein PPP1R14B
Serum levels of protein PPP1R3B
Serum levels of protein PPP2R3A
Serum levels of protein PPP3R1
Serum levels of protein PPT1
Serum levels of protein PPY
Serum levels of protein PRB4
Serum levels of protein PRCP
Serum levels of protein PRDM1
Serum levels of protein MATN3
Serum levels of protein MATN4
Serum levels of protein LILRB4
Serum levels of protein LILRB5
Serum levels of protein LIPA
Serum levels of protein LIPN
Serum levels of protein LMAN2
Serum levels of protein LMAN2L
Serum levels of protein LMCD1
Serum levels of protein LMNB1
Serum levels of protein LOC652493
Serum levels of protein LPO
Serum levels of protein LRFN1
Serum levels of protein LRIG3
Serum levels of protein LRIT2
Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ levels
Phosphatidylcholine_40:7_[M+H]1+ levels
Serum levels of protein CST8
Serum levels of protein CSTL1
Serum levels of protein CTAG1A
Serum levels of protein CTBS
Serum levels of protein CTF1
Serum levels of protein CTGF
Serum levels of protein CTNNB1
Serum levels of protein CTRB2
Serum levels of protein CTRL
Serum levels of protein CTSA
Serum levels of protein GALNT11
Serum levels of protein GALNT16
Serum levels of protein GALNT2
Serum levels of protein GALNT3
Serum levels of protein GBP6
Serum levels of protein GC
Serum levels of protein GCA
Serum levels of protein GCH1
Serum levels of protein GCK
Serum levels of protein GCNT2
Serum levels of protein GCNT4
Phosphatidylcholine-O_36:3_[M+H]1+/Phosphatidylcholine-P_36:2_[M+H]1+ levels
Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels
Phosphatidylcholine-O_38:4_[M+H]1+/Phosphatidylcholine-P_38:3_[M+H]1+ levels
Serum levels of protein MANSC1
Serum levels of protein MAP2K2
Serum levels of protein MAP2K3
Serum levels of protein MAP2K4
Serum levels of protein MAPK12
Serum levels of protein MAPK13
Serum levels of protein MAPK14
Serum levels of protein MAPK3
Serum levels of protein MAPK8
Serum levels of protein MAPK9
Serum levels of protein MAPKAPK5
Serum levels of protein MARCO
Serum levels of protein MASP1
Physical activity (Total log acceleration)
Physical activity (Total log acceleration 12am-2am)
Physical activity (Total log acceleration 2am-4am)
Physical activity (Total log acceleration 6am-8am)
Physical activity (Total log acceleration 8am-10am)
Physical activity (Total log acceleration 6pm-8pm)
Physical activity (Total log acceleration 8pm-10pm)
Physical activity (Total log acceleration 10pm-12am)
Light-intensity physical activity duration
Moderate to vigorous physical activity duration
Physical activity (Principal component 2)
Active to sedentary transition probability
Average log acceleration during the five least active hours of the day
Physical activity (Relative amplitude)
Mid-point of the five least active hours of the day
Serum levels of protein GNMT
Serum levels of protein GNPNAT1
Serum levels of protein GNPTG
Serum levels of protein GNRH1
Serum levels of protein GNS
Serum levels of protein GOLM1
Serum levels of protein GOSR2
Serum levels of protein GOT1
Serum levels of protein GP1BA
Serum levels of protein GP6
Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ levels
Serum levels of protein POLR1C
Serum levels of protein POMC
Serum levels of protein POMGNT2
Serum levels of protein PON1
Serum levels of protein POSTN
Serum levels of protein PPARA
Serum levels of protein LHB
Serum levels of protein LHCGR
Serum levels of protein LIF
Serum levels of protein LIFR
Serum levels of protein LILRA3
Serum levels of protein LILRA4
Serum levels of protein LILRA5
Serum levels of protein LILRA6
Serum levels of protein LILRB1
Serum levels of protein LILRB2
Serum levels of protein LILRB3
Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels
Risky substance use
Psychiatric symptomatology
Psychiatric symptomatology and risky substance use
Phosphatidylcholine_40:7_[M+OAc]1-/Phosphatidylserine_44:6_[M-H]1- levels
Serum levels of protein CTSB
Serum levels of protein CTSC
Serum levels of protein CTSD
Serum levels of protein CTSF
Serum levels of protein CTSH
Serum levels of protein CTSL
Serum levels of protein CTSO
Cardiorespiratory fitness (vo2 max)
Cardiorespiratory fitness slope
Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels
Physical activity
Disease free survival in colorectal cancer
Serum levels of protein CYTL1
Serum levels of protein DAPK2
Serum levels of protein DBNL
Serum levels of protein DCBLD2
Serum levels of protein DCK
Serum levels of protein DCN
Serum levels of protein DCP1A
Serum levels of protein DCP1B
Serum levels of protein DCUN1D5
Serum levels of protein DDR1
Serum levels of protein DDR2
Serum levels of protein DDX23
High Gleason score in radical prostatectomy
Phosphatidylcholine-O(34:3)_[M+H]1+/Phosphatidylethanolamine-P(37:2)_[M+H]1+ levels
Serum levels of protein GPC1
Serum levels of protein GPC3
Serum levels of protein GPC5
Serum levels of protein GPD1L
Serum levels of protein GPHB5
Serum levels of protein GPI
Serum levels of protein GPLD1
Serum levels of protein GPNMB
Serum levels of protein GPR101
Serum levels of protein GPR135
Serum levels of protein GPR68
Serum levels of protein GPX7
Sleep disturbance (changes in sleep) in depressive disorders
Sleep disturbance (increased sleep) in depressive disorders
Sleep disturbance (decreased sleep) in depressive disorders
Serum levels of protein MGAT4B
Serum levels of protein MGP
Serum levels of protein MIA
Serum levels of protein MICA
Serum levels of protein MICALL2
Serum levels of protein MICB
Serum levels of protein MIF
Serum levels of protein MILR1
Serum levels of protein MINPP1
Serum levels of protein MIOX
Serum levels of protein MLEC
Serum levels of protein MDH1
Serum levels of protein MDM2
Serum levels of protein MDM4
Serum levels of protein MED1
Serum levels of protein MET
Serum levels of protein METTL1
Serum levels of protein METTL24
Serum levels of protein MFAP2
Serum levels of protein MFAP3L
Serum levels of protein MFAP4
Serum levels of protein MFF
Serum levels of protein MFGE8
Serum levels of protein MFN1
Serum levels of protein MGA
Serum levels of protein MGAT2
Serum levels of protein MGAT4A
Atorvastatin-induced myalgia
Response to influenza vaccine
Serum levels of protein MLN
Serum levels of protein MMEL1
Serum levels of protein MMP1
Serum levels of protein MMP10
Serum levels of protein MMP12
Serum levels of protein MMP13
Serum levels of protein MMP14
Serum levels of protein MMP19
Serum levels of protein MMP3
Morning person
High IL-1beta levels in gingival crevicular fluid
Pemphigus foliaceus
Femoral neck length
Narrowest width of the femoral neck
Femoral neck section modulus
Glomerular filtration rate change in heart transplantation
Gemcitabine-induced early high-grade neutropenia in pancreatic cancer
Anorexia nervosa or obsessive-compulsive disorder
Response to opioid analgesics in cancer (pain decrease)
General factor of neuroticism
Response to dolutegravir (body weight gain)
Response to tenofovir alafenamide (body weight gain)
Response to tenofovir disoproxil fumarate (body weight gain)
Glioblastoma (age-stratified)
Post bronchodilator percent predicted FEV1 in smoking
Post bronchodilator FEV1/FVC ratio in smoking
Postburn scar height
Postburn scar pliability
cognitive impairment (MMSE score) in Parkinson’s disease
cognitive impairment (MoCA score) in Parkinson’s disease
Anxiety/tension (special factor of neuroticism)
Energy expenditure
Energy intake
Remission after antidepressant treatment in major depression
Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer
tricyclic pyrone compound response (IC50)
Worry/vulnerability (special factor of neuroticism)
Rumination (response to stress)
Brooding (response to stress)
Reflection (response to stress)
Warfarin maintenance dose (adjusted for clinical factors)
Voxel-wise structural brain imaging measurements
Total hippocampal volume
Presubiculum volume (corrected for total hippocampal volume)
Subiculum volume (corrected for total hippocampal volume)
Hippocampal subfield CA1 volume (corrected for total hippocampal volume)
Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)
Hippocampal tail volume (corrected for total hippocampal volume)
Presubiculum volume
Subiculum volume
Hippocampal subfield CA1 volume
Hippocampal subfield CA3 volume
Hippocampal subfield CA4 volume
Dentate gyrus granule cell layer volume
Dentate gyrus molecular layer volume
Hippocampal fissure volume
Hippocampal tail volume
Breast cancer specific mortality in estrogen receptor positive breast cancer
Confectionary intake
Eye movement (horizontal position gain)
Eye movement in schizophrenia (horizontal position gain)
perceptual and visual search speed (trail making test A) (age interaction)
Perceptual and visual search speed (trail making test A)
Cortical brain region measurements (area, volume and thickness)
Cognitive flexibility
C-peptide levels
HATA volume
Breast cancer specific mortality in breast cancer
Breast cancer specific mortality in estrogen receptor negative breast cancer
Thrombocytopenia in coronary artery bypass surgery
Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer
Handedness (Right-handed vs. non-right-handed)
Shoulder impingement or rotator cuff tear
Shoulder impingement
Osteolysis in total hip arthroplasty
Osteolysis in total hip arthroplasty (time to prosthesis revision)
3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)
3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)
Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)
Tinnitus in cisplatin-treated testicular cancer
Calcaneus stiffness index
Diarrhoea-associated Entamoeba histolytica infection
Sero-negative rheumatoid arthritis
Sub-foveal choroidal thickness
Cognitive empathy
Medication use (beta blocking agents)
Medication use (diuretics)
Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy
Breast cancer and/or colorectal cancer
Soluble VCAM-1 levels
Percent glycated albumin
Total glycated albumin levels
Fructosamine levels
Response to long-term oxygen therapy in chronic obstructive pulmonary disease
Psychological wellbeing index (total score)
Placental abruption
Carotid plaque
Femoral neck size
Trochanter size
Intertrochanteric region size
Medication use (antithrombotic agents)
Medication use (vasodilators used in cardiac diseases)
Medication use (antihypertensives)
Sural nerve amplitude potential
Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP
Candidemia
Macular thickness
Breast cancer somatic mutation signature APOBEC C>T
Breast cancer somatic mutation signature APOBEC C>G
Resistance to Mycobacterium tuberculosis infection
Hypo-HDL-cholesterolemia
Hypertrophic cardiomyopathy (sarcomere positive)
Hypertrophic cardiomyopathy (sarcomere negative)
Lipid traits (pleiotropy) (HIPO component 2)
Social science traits (pleiotropy) (HIPO component 1)
Psychiatric diseases (pleiotropy) (HIPO component 1)
Cannabis smoking or cigarette smoking or schizophrenia
Childhood onset ulcerative colitis
Central serous retinopathy
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)
Relapse in treatment-naive multiple sclerosis (time to event)
Sensitivity to environmental stress and adversity
Soluble gp130 levels
Response to cognitive-behavioural therapy in anxiety and major depressive disorders
Response to cognitive-behavioural therapy in major depressive disorder
Cognitive performance in schizophrenia or bipolar disorder
Oxidized LDL cholesterol levels
Forns index in high alcohol intake
Age-related hearing impairment (MTAG)
Cardiovascular event in colchicine-treated recent myocardial infarction (time to event)
Gastrointestinal event in colchicine-treated recent myocardial infarction (time to event)
Renal cell carcinoma x sex interaction
Strabismus
Lipid traits (pleiotropy) (HIPO component 1)
Estrone-3-glucuronide levels
Fragile X syndrome
Stress-related disorders
Anxiety and stress-related disorders (excluding adjustment disorder)
Anxiety and stress-related disorders (excluding co-morbid schizophrenia)
Anxiety and stress-related disorders (including obsessive-compulsive disorder)
Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)
Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)
smoking initiation in schizophrenia
Cigarettes smoked per day in Schizophrenia
Cervical high-risk human papilloma virus infection (persistent)
Cervical high-risk human papilloma virus infection
Chronic pain
Postherpetic neuralgia
Response to opiods (pain relief efficacy)
Response to antidepressants (pain relief efficacy)
Response to anticonvulsants (pain relief efficacy)
Response to non-steroidal anti-inflammatory drugs (pain relief efficacy)
Response to gamma-aminobutyric acid receptor agonists (pain relief efficacy)
Shigella-associated diarrhea
Low hand grip strength (60 years and older) (EWGSOP)
Low hand grip strength (60 years and older) (FNIH)
Depression in multiple sclerosis (pre-diagnosis)
Depression in multiple sclerosis (post-diagnosis)
Depression in multiple sclerosis
Generalized anxiety disorder (mental health questionnaire or predicted)
Post-traumatic stress disorder (mental health questionnaire or predicted)
COVID-19 or psoriasis (trans-disease meta-analysis)
COVID-19 or atopic dermatitis (trans-disease meta-analysis)
Generalized anxiety disorder (phenotype risk score)
Post-traumatic stress disorder (phenotype risk score)
Adverse response to benznidazole in Chagas disease
Aromatic antiseizure medication-induced Stevens-Johnson syndrome or toxic epidermal necrolysis
Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Aromatic antiseizure medication-induced Stevens-Johnson syndrome or toxic epidermal necrolysis in HLA-B*15:02 non-carriers
Podoconiosis
Adiponectin levels in type 2 diabetes
Adiponectin levels x Mediterranean diet adherence interaction
T-Cell Immunoglobulin and Mucin domain 1 levels
Fasting glucose in pregnancy (gestational week 14-16)
Two-hour glucose in pregnancy (gestational week 30-32)
General glucose level in pregnancy (gestational week 30-32)
Hypertrophic cardiomyopathy (MTAG)
Dilated cardiomyopathy (MTAG)
Left ventricular ejection fraction (MTAG)
Left ventricular mass to end-diastolic volume ratio (MTAG)
Left ventricular mass (MTAG)
Left ventricular end-diastolic volume (MTAG)
Sleep duration (short sleep)
Sleep duration (long sleep)
Hair morphology traits
Metabolic syndrome (multivariate analysis)
Myopic maculopathy
Diastolic blood pressure x alcohol consumption interaction (1df test)
Left ventricular global radial strain
Left ventricular global longitudinal strain
Left ventricular mass to end-diastolic volume ratio
Left ventricular global circumferential strain
Serum galactose-deficient IgA1 levels in IgA nephropathy
Triglyceride levels (parental genotype effect)
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)
Facial wrinkles
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma
Radiation-induced brain injury in nasopharyngeal carcinoma
Lumbar spine bone mineral density (trabecular)
Lumbar spine bone mineral density (integral)
Infection persistence (>18 months) in genital human papillomavirus 16 infection
Depression in smokers
Urinary potassium to creatinine ratio
Urinary sodium to creatinine ratio
Urinary sodium to potassium ratio
Albuminuria
Response to intravenous immunoglobulin treatment in Kawasaki disease
Resting-state electroencephalogram vigilance
Perceptual rivalry (voluntary modulation strength)
Sleep (number of episodes)
Adverse response to antithyroid drugs in Graves disease
Alpha synuclein levels (MTAG)
Endometriosis or endometrial cancer (pleiotropy)
Psychological wellbeing index 1 (lack of subjective wellbeing and health)
Psychological wellbeing index 3 (fatigue and loss of appetite)
Psychological wellbeing index 12 (lack of enjoying daily life)
Psychological wellbeing (social role performance and self-confidence)
Psychological wellbeing (depressiveness)
Psychological wellbeing (health and vitality)
Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age
Infliximab-induced mucosal healing in Crohn's disease
Primary central nervous system lymphoma
Cellular nuclear factor (erythroid-derived 2)-like 2 levels
visceral adipose tissue/total adipose tissue ratio
Bicuspid aortic valve
Global electrical heterogeneity phenotypes
Cholesterol efflux capacity (cAMP stimulated assay)
Cholesterol efflux capacity (ABCA-1 dependent assay)
Cholesterol efflux capacity (BHK stimulated assay)
BMI at birth
BMI at 3 months old
BMI at 6 months old
BMI at 8 months old
BMI at 1 year old
BMI at 1.5 years old
BMI at 2 years old
BMI at 3 years old
BMI at 5 years old
BMI at 7 years old
BMI at 8 years old
KANNO antigen negativity
Alcohol dependence (tolerance)
Alcohol dependence (drinking more than intended)
Alcohol dependence (desire to cut drinking)
Alcohol dependence (time spent drinking)
Emotional lability in attention deficit hyperactivity disorder
Alzheimer's disease with memory domain impairment
Alzheimer's disease with language domain impairment
Alzheimer's disease with visuospatial domain impairment
Alzheimer's disease with multiple cognitive domain impairments
Obesity (extreme) (SNP x SNP interaction)
Alzheimer's disease with no specific cognitive domain impairment
Aortic coarctation
Sphingomyelin(42:4)_[M+H]1+ levels
Sphingomyelin(43:2)_[M-CH3]1- levels
Retinal vascular fractal density
Chronic elevation of alanine aminotransferase (cALT) levels
Multiple coagulation factor deficiency protein 2 levels (MCFD2.10476.23.3)
Multiple inositol polyphosphate phosphatase 1 levels (MINPP1.5586.66.3)
Myc target protein 1 levels (MYCT1.13541.1.3)
Myelin protein P0 levels (MPZ.10615.18.3)
Myeloblastin levels (PRTN3.3514.49.2)
Myeloid cell surface antigen CD33 levels (CD33.3166.92.1)
Myeloperoxidase levels (MPO.2580.83.2)
Myotonin-protein kinase levels (DMPK.9010.3.3)
N-acetyl-D-glucosamine kinase levels (NAGK.3894.15.2)
N-acetylated-alpha-linked acidic dipeptidase 2 levels (NAALAD2.7986.98.3)
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase levels (NAGPA.11208.15.3)
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 levels (B3GNT2.7980.72.3)
Alzheimer's disease or educational attainment (pleiotropy)
Total cholines levels
Ratio of docosahexaenoic acid to total fatty acid levels
N-acetylserotonin O-methyltransferase-like protein levels (ASMTL.10089.7.3)
N-acetyltransferase 14 levels (NAT14.11120.49.3)
N-acylethanolamine-hydrolyzing acid amidase levels (NAAA.3173.49.2)
N-terminal pro-BNP levels (NPPB.7655.11.3)
N-terminal Xaa-Pro-Lys N-methyltransferase 1 levels (NTMT1.12454.105.3)
NAD kinase levels (NADK.13624.17.3)
NAD-dependent protein deacetylase sirtuin-2 levels (SIRT2.5030.52.1)
NAD-dependent protein deacylase sirtuin-5, mitochondrial levels (SIRT5.12461.8.3)
NAD(P)H dehydrogenase [quinone] 1 levels (NQO1.9837.60.3)
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 levels (NDUFB4.10677.9.3)
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial levels (NDUFS4.10584.7.3)
Natural cytotoxicity triggering receptor 1 levels (NCR1.8360.169.3)
Natural cytotoxicity triggering receptor 3 levels (NCR3.3003.29.2)
Cholesteryl ester levels in HDL
Neuroendocrine convertase 1 levels (PCSK1.13388.57.3)
Neurofascin levels (NFASC.7179.69.3)
Neurogenic locus notch homolog protein 1 levels (NOTCH1.5107.7.2)
Neuron-specific protein family member 2 levels (NSG2.13409.9.3)
Neuronal pentraxin-1 levels (NPTX1.9256.78.3)
Neuronal pentraxin-2 levels (NPTX2.6521.35.3)
Neuropeptide W levels (NPW.9986.14.3)
Neuropilin-1 levels (NRP1.3214.3.2)
Neuropilin-2 levels (NRP2.6590.54.3)
Neutral ceramidase levels (ASAH2.3212.30.3)
Neutrophil collagenase levels (MMP8.2954.56.2)
Conversion from active surveillance to active treatment in prostate cancer
Normal mucosa of esophagus-specific gene 1 protein levels (NMES1.6406.3.3)
NTF2-related export protein 1 levels (NXT1.9942.2.3)
Nuclear factor erythroid 2-related factor 1 levels (NFE2L1.11154.3.3)
Nuclear migration protein nudC levels (NUDC.8887.21.3)
Nuclear pore complex-interacting protein family member B3 levels (NPIPB3.9954.2.3)
Nuclear protein localization protein 4 homolog levels (NPLOC4.12993.21.3)
Nuclear receptor coactivator 2 levels (NCOA2.14045.12.3)
Nuclear receptor subfamily 1 group D member 2 levels (NR1D2.12885.42.3)
Nuclear receptor-binding protein levels (NRBP1.12616.45.3)
Nuclear RNA export factor 1 levels (NXF1.12453.161.3)
Nucleolin levels (NCL.13655.34.3)
Nucleoside diphosphate kinase A levels (NME1.5909.51.3)
Nucleoside diphosphate kinase B levels (NME2.4249.64.2)
Nucleosome assembly protein 1-like 2 levels (NAP1L2.13529.39.3)
Nutritionally-regulated adipose and cardiac enriched protein homolog levels (NRAC.13464.8.3)
Obg-like ATPase 1 levels (OLA1.12659.13.3)
Odorant-binding protein 2b levels (OBP2B.5680.54.3)
Oncostatin-M levels (OSM.2693.20.3)
Parathyroid hormone-related protein levels (PTHLH.2962.50.2)
PAX-interacting protein 1 levels (PAXIP1.12894.3.3)
PDZK1-interacting protein 1 levels (PDZK1IP1.8260.13.3)
Peptide chain release factor 1-like, mitochondrial levels (MTRF1L.11134.30.3)
Peptidoglycan recognition protein 1 levels (PGLYRP1.3329.14.2)
Peptidyl-glycine alpha-amidating monooxygenase levels (PAM.5620.13.3)
Peptidyl-prolyl cis-trans isomerase A levels (PPIA.5247.17.4)
Peptidyl-prolyl cis-trans isomerase E levels (PPIE.5238.26.3)
Peptidyl-prolyl cis-trans isomerase FKBP14 levels (FKBP14.9340.17.3)
Peptidyl-prolyl cis-trans isomerase FKBP7 levels (FKBP7.9288.7.3)
Peptidyl-prolyl cis-trans isomerase H levels (PPIH.12449.16.3)
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 levels (PIN4.12718.43.3)
Peptidyl-prolyl cis-trans isomerase-like 1 levels (PPIL1.9884.8.3)
Peptidyl-prolyl cis-trans isomerase-like 2 levels (PPIL2.14314.6.3)
Periostin levels (POSTN.6650.20.3)
Free cholesterol levels in HDL
Triacylglycerol_46:5_[M+NH4]1+ levels
Triacylglycerol_47:4_[M+NH4]1+ levels
Triacylglycerol_48:3_[M+NH4]1+ levels
Triacylglycerol_48:4_[M+NH4]1+ levels
Triacylglycerol_49:3_[M+NH4]1+ levels
Triacylglycerol_49:4_[M+NH4]1+ levels
Triacylglycerol_45:4_[M+NH4]1+ levels
Triacylglycerol_49:5_[M+NH4]1+ levels
Triacylglycerol_50:2_[M+NH4]1+ levels
Triacylglycerol_50:3_[M+NH4]1+ levels
Triacylglycerol_50:4_[M+NH4]1+ levels
Triacylglycerol_50:5_[M+NH4]1+ levels
Triacylglycerol_51:2_[M+NH4]1+ levels
Triacylglycerol_51:3_[M+NH4]1+ levels
Pigment epithelium-derived factor levels (SERPINF1.9211.19.3)
PILR alpha-associated neural protein levels (PIANP.9599.6.3)
Pirin levels (PIR.13634.209.3)
Plasma protease C1 inhibitor levels (SERPING1.4479.14.2)
Plasmin levels (PLG.4150.75.2)
Plasminogen activator inhibitor 1 levels (SERPINE1.2925.9.1)
Plastin-2 levels (LCP1.9749.190.3)
Platelet endothelial aggregation receptor 1 levels (PEAR1.8275.31.3)
Platelet endothelial cell adhesion molecule levels (PECAM1.2695.25.1)
Platelet factor 4 variant levels (PF4V1.5663.18.3)
Platelet glycoprotein 4 levels (CD36.2973.15.2)
Platelet glycoprotein Ib alpha chain levels (GP1BA.4990.87.1)
Platelet receptor Gi24 levels (C10orf54.14123.34.3)
Platelet-activating factor acetylhydrolase IB subunit beta levels (PAFAH1B2.2642.4.1)
Platelet-derived growth factor D levels (PDGFD.9341.1.3)
Platelet-derived growth factor receptor alpha levels (PDGFRA.10366.11.3)
Platelet-derived growth factor receptor beta levels (PDGFRB.3459.49.2)
Platelet-derived growth factor receptor-like protein levels (PDGFRL.9713.67.3)
Triacylglycerol_56:4_[M+NH4]1+ levels
Triacylglycerol_56:5_[M+NH4]1+ levels
Testosterone levels in postmenopausal women
Triacylglycerol_54:5_[M+NH4]1+ levels
Triacylglycerol_54:7_[M+NH4]1+ levels
Triacylglycerol_52:6_[M+NH4]1+ levels
Triacylglycerol_53:2_[M+NH4]1+ levels
Triacylglycerol_53:3_[M+NH4]1+ levels
Triacylglycerol_53:4_[M+NH4]1+ levels
Triacylglycerol_53:5_[M+NH4]1+ levels
Triacylglycerol_54:3_[M+NH4]1+ levels
Triacylglycerol_54:4_[M+NH4]1+ levels
Programmed cell death protein 5 levels (PDCD5.12517.52.3)
Prolactin receptor levels (PRLR.5114.65.3)
Prolargin levels (PRELP.5675.6.3)
Prolow-density lipoprotein receptor-related protein 1 levels (LRP1.10699.52.3)
Promotilin levels (MLN.5631.83.3)
Properdin levels (CFP.2960.66.2)
Proprotein convertase subtilisin/kexin type 7 levels (PCSK7.4459.68.2)
Prostaglandin F2 receptor negative regulator levels (PTGFRN.12727.7.3)
Prostaglandin reductase 1 levels (PTGR1.13543.7.3)
Prostaglandin-H2 D-isomerase levels (PTGDS.10514.5.3)
Prostate and testis expressed protein 4 levels (PATE4.8065.245.3)
Protachykinin-1 levels (TAC1.9337.43.3)
Proteasome activator complex subunit 1 levels (PSME1.5918.5.3)
Proteasome subunit alpha type-1 levels (PSMA1.7880.9.3)
Protein C-ets-2 levels (ETS2.12350.86.3)
Total lipid levels in HDL
Triacylglycerol(50:3)_[M+NH4]1+ levels
Triacylglycerol(50:4)_[M+NH4]1+ levels
Triacylglycerol(51:2)_[M+NH4]1+ levels
Triacylglycerol(51:3)_[M+NH4]1+ levels
Sex hormone-binding globulin levels in postmenopausal women
Methotrexate-related central neurotoxicity in children treated for acute lymphoblastic leukemia
Protein CEI levels (C5orf38.6378.2.3)
Protein CREG1 levels (CREG1.9357.4.3)
Protein deglycase DJ-1 levels (PARK7.5016.61.2)
Protein delta homolog 1 levels (DLK1.6496.60.3)
Protein DEPP levels (DEPP.7178.59.3)
Protein DGCR14 levels (DGCR14.11356.19.3)
Protein disulfide-isomerase A5 levels (PDIA5.5593.11.3)
Protein eva-1 homolog C levels (EVA1C.7008.13.3)
Protein EVI2B levels (EVI2B.13028.2.3)
Protein FAM107A levels (FAM107A.2760.2.2)
Protein FAM150B levels (FAM150B.6284.7.3)
Protein FAM151A levels (FAM151A.7856.51.3)
Protein FAM163A levels (FAM163A.6260.14.3)
Protein FAM171B levels (FAM171B.8851.42.3)
Protein FAM177A1 levels (FAM177A1.8039.41.3)
Protein FAM189A2 levels (FAM189A2.5699.19.3)
Protein FAM3B levels (FAM3B.9177.6.3)
Protein FAM3D levels (FAM3D.13102.1.3)
Protein jagged-1 levels (JAG1.5092.51.3)
Protein kinase C beta type (splice variant beta-II) levels (PRKCB.5475.10.3)
Protein kinase C iota type levels (PRKCI.3379.29.1)
Protein kinase C-binding protein NELL1 levels (NELL1.6544.33.3)
Protein LDOC1 levels (LDOC1.8378.3.4)
Triacylglycerol(52:2)_[M+NH4]1+ levels
Triacylglycerol(52:3)_[M+NH4]1+ levels
Triacylglycerol(52:1)_[M+NH4]1+ levels
Triacylglycerol(51:4)_[M+NH4]1+ levels
Protein MENT levels (MENT.5744.12.3)
Protein MRVI1 levels (MRVI1.8255.34.3)
Protein NDRG4 levels (NDRG4.7934.11.3)
Protein NOV homolog levels (NOV.2737.22.2)
Protein O-glucosyltransferase 1 levels (POGLUT1.6467.65.3)
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 levels (POMGNT2.6359.50.3)
Protein RIC-3 levels (RIC3.11228.37.3)
Protein S100-A11 levels (S100A11.14011.17.3)
Protein S100-A12 levels (S100A12.5852.6.3)
Protein S100-A13 levels (S100A13.7223.60.3)
Protein S100-A4 levels (S100A4.14116.129.3)
Protein S100-A5 levels (S100A5.14222.68.3)
Protein S100-A6 levels (S100A6.13090.17.3)
Protein S100-A9 levels (S100A9.5339.49.3)
Protein SEC13 homolog levels (SEC13.14689.3.3)
Protein sel-1 homolog 2 levels (SEL1L2.9082.25.3)
Protein SERAC1 levels (SERAC1.8985.13.3)
Protein shisa-3 homolog levels (SHISA3.7057.18.3)
Concentration of HDL particles
Triacylglycerol(52:4)_[M+NH4]1+ levels
Triacylglycerol(52:5)_[M+NH4]1+ levels
Triacylglycerol(53:2)_[M+NH4]1+ levels
Triacylglycerol(53:3)_[M+NH4]1+ levels
Protein SPACA7 levels (SPACA7.6466.7.3)
Protein syndesmos levels (NUDT16L1.12497.29.3)
Protein TMEPAI levels (PMEPA1.6936.7.3)
Protein unc-93 homolog B1 levels (UNC93B1.13487.24.3)
Protein Z-dependent protease inhibitor levels (SERPINA10.13119.26.3)
Protein-tyrosine kinase 2-beta levels (PTK2B.8918.64.3)
Protein-tyrosine kinase 6 levels (PTK6.3832.51.1)
Protein-tyrosine sulfotransferase 1 levels (TPST1.7928.183.3)
Protein-tyrosine sulfotransferase 2 levels (TPST2.8024.64.3)
Triacylglycerol(53:4)_[M+NH4]1+ levels
Triacylglycerol(54:2)_[M+NH4]1+ levels
Triacylglycerol(54:3)_[M+NH4]1+ levels
Peripheral artery disease in diabetes
Peripheral artery disease in non diabetes
Peripheral artery disease x diabetes status interaction
Educational attainment (MTAG)
Peripheral artery disease in ever smokers
Proto-oncogene tyrosine-protein kinase receptor Ret levels (RET.3220.40.2)
Protocadherin alpha-4 levels (PCDHA4.7157.22.3)
Protocadherin alpha-7 levels (PCDHA7.8758.2.3)
Protocadherin beta-10 levels (PCDHB10.9963.19.3)
Protocadherin beta-2 levels (PCDHB2.10748.216.3)
Protocadherin beta-4 levels (PCDHB4.10522.167.3)
Protocadherin gamma-C5 levels (PCDHGC5.7983.1.3)
Protocadherin-10 levels (PCDH10.8780.2.3)
Pseudokinase FAM20A levels (FAM20A.6433.57.3)
Pulmonary surfactant-associated protein C levels (SFTPC.5738.25.3)
Pulmonary surfactant-associated protein D levels (SFTPD.4414.69.2)
Purine nucleoside phosphorylase levels (PNP.10039.32.3)
Pyridoxal kinase levels (PDXK.11098.1.3)
Pyruvate kinase PKLR levels (PKLR.11203.97.3)
Low skeletal muscle mass index
Low gait speed
Low hand grip strength
Triacylglycerol(54:4)_[M+NH4]1+ levels
Triacylglycerol(54:5)_[M+NH4]1+ levels
Triacylglycerol(56:4)_[M+NH4]1+ levels
Quinone oxidoreductase-like protein 1 levels (CRYZL1.9207.60.3)
R-spondin-3 levels (RSPO3.13094.75.3)
RAB6-interacting golgin levels (GORAB.7247.1.3)
Rab9 effector protein with kelch motifs levels (RABEPK.13599.15.3)
Rac GTPase-activating protein 1 levels (RACGAP1.13587.10.3)
RAC-alpha/beta/gamma serine/threonine-protein kinase levels (AKT1.AKT2.AKT3.3392.68.2)
RAC-beta serine/threonine-protein kinase levels (AKT2.14685.17.3)
Ragulator complex protein LAMTOR3 levels (LAMTOR3.12490.92.3)
Rap1 GTPase-activating protein 1 levels (RAP1GAP.13735.1.3)
Ras GTPase-activating protein 1 levels (RASA1.5481.16.3)
Ras-related C3 botulinum toxin substrate 3 levels (RAC3.5271.5.1)
Ras-related protein Rab-14 levels (RAB14.14283.12.3)
Ras-related protein Rab-26 levels (RAB26.6997.32.3)
Ras-related protein Rab-35 levels (RAB35.13514.121.3)
Receptor-type tyrosine-protein kinase FLT3 levels (FLT3.3437.80.3)
Receptor-type tyrosine-protein phosphatase H levels (PTPRH.11222.62.3)
RecQ-mediated genome instability protein 1 levels (RMI1.13926.1.3)
Redox-regulatory protein FAM213A levels (FAM213A.13423.94.3)
Regenerating islet-derived protein 4 levels (REG4.11102.22.3)
Regulation of nuclear pre-mRNA domain-containing protein 1A levels (RPRD1A.13515.8.3)
Regulator of G-protein signaling 18 levels (RGS18.13982.33.3)
Regulator of G-protein signaling 19 levels (RGS19.12713.365.3)
Regulator of G-protein signaling 8 levels (RGS8.11666.72.3)
Regulator of microtubule dynamics protein 1 levels (RMDN1.7096.30.3)
Regulatory factor X-associated protein levels (RFXAP.12726.3.3)
RELT-like protein 1 levels (RELL1.13399.33.3)
Renin levels (REN.3396.54.2)
Replication initiator 1 levels (REPIN1.13554.78.3)
Repulsive guidance molecule A levels (RGMA.5483.1.3)
Resistin levels (RETN.3046.31.1)
Reticulon-4 receptor levels (RTN4R.5105.2.3)
Phospholipid levels in HDL
Testosterone levels in premenopausal women
Triacylglycerol(56:5)_[M+NH4]1+ levels
Estradiol levels in premenopausal women
Detectable estradiol levels in premenopausal women
Sex hormone-binding globulin levels in premenopausal women
Pediatric dental caries (decayed, missing and filled teeth >5)
Liver fat
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta levels (PDE6D.13491.40.3)
Retinaldehyde-binding protein 1 levels (RLBP1.12936.38.3)
Retinoic acid receptor responder protein 1 levels (RARRES1.8398.277.3)
Retinoic acid receptor responder protein 3 levels (RARRES3.10961.15.3)
Retinoid-binding protein 7 levels (RBP7.14208.3.3)
Retinol dehydrogenase 16 levels (RDH16.12881.17.3)
Retroviral-like aspartic protease 1 levels (ASPRV1.13023.8.3)
RGM domain family member B levels (RGMB.3331.8.1)
Rho GDP-dissociation inhibitor 1 levels (ARHGDIA.6454.38.3)
Rho GDP-dissociation inhibitor 2 levels (ARHGDIB.9846.32.3)
Rho GTPase-activating protein 25 levels (ARHGAP25.11333.82.3)
Rho GTPase-activating protein 30 levels (ARHGAP30.12807.89.3)
Rho guanine nucleotide exchange factor 1 levels (ARHGEF1.13976.9.3)
Rho guanine nucleotide exchange factor 10 levels (ARHGEF10.9061.3.3)
Rhophilin-2 levels (RHPN2.11439.88.3)
Detectable estradiol levels
Pulmonary tuberculosis resistance
RING finger protein 165 levels (RNF165.11561.32.3)
RNA polymerase II elongation factor ELL levels (ELL.11459.81.3)
RNA polymerase II subunit A C-terminal domain phosphatase SSU72 levels (SSU72.13566.2.3)
RNA-binding protein 24 levels (RBM24.11380.84.3)
RNA-binding protein 3 levels (RBM3.12747.89.3)
RNA-binding protein 39 levels (RBM39.4284.18.3)
RNA-binding protein EWS levels (EWSR1.12988.49.3)
rRNA methyltransferase 3, mitochondrial levels (RNMTL1.9584.105.3)
Runt-related transcription factor 3 levels (RUNX3.11138.16.3)
S-formylglutathione hydrolase levels (ESD.4984.83.1)
Salivary acidic proline-rich phosphoprotein 1/2 levels (PRH1.10502.15.3)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 levels (ATP2A3.13510.7.3)
Scavenger receptor class A member 5 levels (SCARA5.10419.1.3)
Scavenger receptor class F member 2 levels (SCARF2.8956.96.3)
Scavenger receptor cysteine-rich type 1 protein M130 levels (CD163.5028.59.1)
SCP2 sterol-binding domain-containing protein 1 levels (SCP2D1.14175.78.3)
Riboflavin kinase levels (RFK.13059.33.3)
Ribonuclease 4 levels (RNASE4.5644.60.3)
Ribonuclease K6 levels (RNASE6.5646.20.3)
Ribonuclease pancreatic levels (RNASE1.7211.2.3)
Ribonuclease UK114 levels (HRSP12.14636.25.3)
Ribonucleoside-diphosphate reductase large subunit levels (RRM1.11360.39.3)
Ribonucleoside-diphosphate reductase subunit M2 B levels (RRM2B.8925.25.3)
Ribose-5-phosphate isomerase levels (RPIA.12333.87.3)
Ribosomal protein S6 kinase alpha-6 levels (RPS6KA6.12688.115.3)
Ribosyldihydronicotinamide dehydrogenase [quinone] levels (NQO2.9754.33.3)
Ribulose-phosphate 3-epimerase levels (RPE.12646.2.3)
Rieske domain-containing protein levels (RFESD.13603.7.3)
Average diameter for HDL particles
Triacylglycerol(56:6)_[M+NH4]1+ levels
Secreted and transmembrane protein 1 levels (SECTM1.13093.6.3)
Secreted frizzled-related protein 1 levels (SFRP1.3221.54.1)
Secreted frizzled-related protein 2 levels (SFRP2.7751.121.3)
Secreted frizzled-related protein 3 levels (FRZB.13740.51.3)
Secreted Ly-6/uPAR-related protein 1 levels (SLURP1.6401.73.3)
Secretoglobin family 1C member 1 levels (SCGB1C1.5960.49.3)
Secretogranin-3 levels (SCG3.7957.2.3)
Secretory phospholipase A2 receptor levels (PLA2R1.10916.44.3)
Segment polarity protein dishevelled homolog DVL-2 levels (DVL2.13575.40.3)
Ameloblastin levels (AMBN.6522.57.3)
Amelogenin, X isoform levels (AMELX.8578.45.3)
Amyloid beta A4 precursor protein-binding family B member 2 levels (APBB2.12753.6.3)
Amyloid-like protein 2 levels (APLP2.10627.87.3)
Anaphase-promoting complex subunit 7 levels (ANAPC7.11690.47.3)
Angiopoietin-1 levels (ANGPT1.2811.27.1)
Angiopoietin-1 receptor, soluble levels (TEK.3773.15.4)
Angiopoietin-related protein 1 levels (ANGPTL1.9092.33.3)
Angiostatin levels (PLG.3710.49.2)
Ankyrin-2 levels (ANK2.7624.19.3)
Annexin A1 levels (ANXA1.4960.72.1)
ATP-dependent RNA helicase DHX8 levels (DHX8.11601.26.3)
Carotid intima media thickness (minimum)
Carotid Intima-media thickness (mean of the maximum cIMT)
Calcium/calmodulin-dependent protein kinase type 1D levels (CAMK1D.3418.12.2)
Chondroitin sulfate N-acetylgalactosaminyltransferase 2 levels (CSGALNACT2.10772.21.3)
Chordin-like protein 2 levels (CHRDL2.6086.15.3)
Chromobox protein homolog 5 levels (CBX5.4540.11.2)
Chromobox protein homolog 7 levels (CBX7.13027.20.3)
Chromogranin-A levels (CHGA.8476.11.3)
Chymotrypsin-like protease CTRL-1 levels (CTRL.9229.9.3)
Chymotrypsinogen B levels (CTRB1.5671.1.3)
Ciliary neurotrophic factor receptor subunit alpha levels (CNTFR.14101.2.3)
Ck-beta-8-1 levels (CCL23.3028.36.2)
Clathrin interactor 1 levels (CLINT1.11659.31.3)
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 levels (ST3GAL1.5657.28.3)
CMRF35-like molecule 6 levels (CD300C.5066.134.3)
CMRF35-like molecule 8 levels (CD300A.5630.48.3)
Coagulation Factor VIII levels (F8.13499.30.3)
Sphingomyelin(32:1)_[M+H]1+ levels
Sphingomyelin(33:1)_[M-CH3]1- levels
Sphingomyelin(34:0)_[M-CH3]1- levels
Sphingomyelin(34:0)_[M+H]1+ levels
Sphingomyelin(34:1)_[M-CH3]1- levels
Sphingomyelin(34:1)_[M+H]1+ levels
Dementia with Lewy bodies in APOE e4- carriers
Dementia with Lewy bodies in APOE e4+ carriers
Apolipoprotein M levels (APOM.10445.20.3)
Apoptosis-inducing factor 1, mitochondrial levels (AIFM1.13424.51.3)
Apoptotic protease-activating factor 1 levels (APAF1.13583.19.3)
Calcium/calmodulin-dependent protein kinase type II subunit alpha levels (CAMK2A.3350.53.2)
Calcium/calmodulin-dependent protein kinase type II subunit beta levels (CAMK2B.3351.1.1)
Calcyclin-binding protein levels (CACYBP.12432.23.3)
Calnexin levels (CANX.8834.58.3)
Calpain-2 catalytic subunit levels (CAPN2.14684.17.3)
Calpastatin levels (CAST.3026.5.2)
cAMP-dependent protein kinase catalytic subunit alpha levels (PRKACA.3466.8.2)
cAMP-dependent protein kinase type I-beta regulatory subunit levels (PRKAR1B.12479.50.3)
cAMP-regulated phosphoprotein 19 levels (ARPP19.4963.19.1)
cAMP-specific 3',5'-cyclic phosphodiesterase 4D levels (PDE4D.5255.22.3)
Carbohydrate sulfotransferase 1 levels (CHST1.7803.4.3)
Carbohydrate sulfotransferase 11 levels (CHST11.7779.86.3)
Carbohydrate sulfotransferase 15 levels (CHST15.4469.78.2)
Carbohydrate sulfotransferase 9 levels (CHST9.11646.4.3)
Sphingomyelin(36:2)_[M+H]1+ levels
Sphingomyelin(37:1)_[M-CH3]1- levels
Dipeptidyl peptidase 2 levels (DPP7.8346.9.3)
Discoidin, CUB and LCCL domain-containing protein 2 levels (DCBLD2.9338.2.3)
Disintegrin and metalloproteinase domain-containing protein 11 levels (ADAM11.6586.19.3)
Disintegrin and metalloproteinase domain-containing protein 23 levels (ADAM23.7049.2.3)
DNA repair protein RAD51 homolog 1 levels (RAD51.2871.73.2)
DNA repair protein RAD51 homolog 4 levels (RAD51L3.12554.10.3)
DNA repair protein XRCC4 levels (XRCC4.9886.28.3)
DNA-(apurinic or apyrimidinic site) lyase levels (APEX1.9849.13.3)
DNA-3-methyladenine glycosylase levels (MPG.12438.127.3)
DNA-directed RNA polymerases I and III subunit RPAC1 levels (POLR1C.12939.1.3)
DNA/RNA-binding protein KIN17 levels (KIN.14643.27.3)
DnaJ homolog subfamily B member 11 levels (DNAJB11.7110.2.3)
DnaJ homolog subfamily B member 14 levels (DNAJB14.8053.16.3)
DnaJ homolog subfamily B member 2 levels (DNAJB2.11438.6.3)
Sphingomyelin(37:1)_[M+H]1+ levels
Sphingomyelin(38:0)_[M+H]1+ levels
Lifetime smoking
Cysteine-rich secretory protein 2 levels (CRISP2.9282.12.3)
Cysteine-rich secretory protein 3 levels (CRISP3.3187.52.2)
Cysteine-rich secretory protein LCCL domain-containing 2 levels (CRISPLD2.5691.2.3)
Cysteine-rich with EGF-like domain protein 1 levels (CRELD1.7628.40.3)
Cytochrome c oxidase assembly factor 3 homolog, mitochondrial levels (COA3.7888.58.3)
Cytochrome c oxidase subunit 4 isoform 2, mitochondrial levels (COX4I2.7850.1.3)
Cytochrome c oxidase subunit 6C levels (COX6C.8903.1.3)
Cytochrome c oxidase subunit 8A, mitochondrial levels (COX8A.10497.242.3)
Cytohesin-2 levels (CYTH2.12533.135.3)
Cytokine receptor common subunit beta levels (CSF2RB.10512.13.3)
Cytoskeleton-associated protein 2 levels (CKAP2.5345.51.3)
D-glucuronyl C5-epimerase levels (GLCE.7808.5.3)
DCN1-like protein 5 levels (DCUN1D5.8760.10.3)
Death-associated protein kinase 2 levels (DAPK2.4355.13.1)
Familial combined hyperlipidemia defined by Consensus criteria
radiation-induced toxicity (patient-rated acute xerostomia)
radiation-induced toxicity (physician-rated acute xerostomia)
radiation-induced toxicity (physician-rated acute dysphagia)
radiation-induced toxicity (patient-rated acute sticky saliva)
radiation-induced toxicity (physician-rated acute sticky saliva)
radiation-induced toxicity (physician-rated acute mucositis)
radiation-induced toxicity (standardized total average toxicity_physician)
radiation-induced toxicity (standardized total average toxicity_patient)
Sphingomyelin(39:1)_[M-CH3]1- levels
Complement C4 levels (C4A.C4B.4481.34.2)
Complement component 1 Q subcomponent-binding protein, mitochondrial levels (C1QBP.4967.1.1)
Complement component C8 levels (C8A.C8B.C8G.2429.27.4)
Complement component C9 levels (C9.3060.43.2)
Complement decay-accelerating factor levels (CD55.5069.9.3)
Complement factor B levels (CFB.4129.72.1)
Complement factor H levels (CFH.4159.130.1)
Complement factor H-related protein 5 levels (CFHR5.3666.17.4)
Anxiety severity x playing computer games interaction
Depression severity  x playing computer games interaction
Sphingomyelin(39:1)_[M+H]1+ levels
Vascular endothelial growth factor receptor 3 levels (FLT4.2358.19.2)
Very long-chain acyl-CoA synthetase levels (SLC27A2.9045.3.3)
Vesicle transport through interaction with t-SNAREs homolog 1B levels (VTI1B.8963.8.3)
Vesicle-associated membrane protein-associated protein A levels (VAPA.7167.102.3)
Vesicle-fusing ATPase levels (NSF.13992.12.3)
Vigilin levels (HDLBP.13570.43.3)
VIP36-like protein levels (LMAN2L.8013.9.3)
Vitamin D-binding protein levels (GC.6581.50.3)
Vitrin levels (VIT.6234.74.3)
Vitronectin levels (VTN.8280.238.3)
Voltage-dependent calcium channel subunit alpha-2/delta-3 levels (CACNA2D3.8885.6.3)
Voltage-gated potassium channel subunit beta-2 levels (KCNAB2.10015.119.3)
WAP four-disulfide core domain protein 3 levels (WFDC3.6384.19.3)
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels (WFIKKN2.13408.23.3)
Ratio of apolipoprotein B to apolipoprotein A1 levels
Retinal vascular fractal dimension
Sphingomyelin(41:2)_[M+H]1+ levels
Sphingomyelin(42:0)_[M+OAc]1- levels
Sphingomyelin(42:2)_[M+OAc]1- levels
Sphingomyelin(42:3)_[M+H]1+ levels
Mannose-binding protein C levels (MBL2.3000.66.1)
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB levels (MAN1A2.9077.10.3)
MANSC domain-containing protein 1 levels (MANSC1.9557.5.3)
MANSC domain-containing protein 4 levels (MANSC4.9578.263.3)
MAP kinase-activated protein kinase 2 levels (MAPKAPK2.3820.68.2)
MAP kinase-activated protein kinase 3 levels (MAPKAPK3.3822.54.2)
MAP kinase-activated protein kinase 5 levels (MAPKAPK5.8382.47.3)
Maspardin levels (SPG21.11122.97.3)
Mast cell-expressed membrane protein 1 levels (MCEMP1.6283.60.3)
Matrilin-4 levels (MATN4.7083.74.3)
Matrix metalloproteinase-9 levels (MMP9.2579.17.5)
Matrix-remodeling-associated protein 7 levels (MXRA7.8005.1.3)
MAX gene-associated protein levels (MGA.11587.5.3)
Mediator of RNA polymerase II transcription subunit 1 levels (MED1.5470.69.2)
Mediator of RNA polymerase II transcription subunit 4 levels (MED4.14021.81.3)
Melanocyte protein PMEL levels (PMEL.6472.40.3)
Melanoma-associated antigen 10 levels (MAGEA10.13610.9.3)
Melanoma-associated antigen 3 levels (MAGEA3.12576.21.3)
Alcohol consumption x hours spent watching television interaction
Anxiety severity x hours spent using computers interaction
Nonalcoholic fatty liver disease (imputed)
Septin-10 levels (SEPT10.12690.33.3)
E3 ubiquitin-protein ligase CBL levels (CBL.12016.60.3)
E3 ubiquitin-protein ligase DTX3L levels (DTX3L.11643.73.3)
E3 ubiquitin-protein ligase NEURL1 levels (NEURL1.13604.27.3)
E3 ubiquitin-protein ligase RNF128 levels (RNF128.6510.56.3)
E3 ubiquitin-protein ligase RNF13 levels (RNF13.8087.250.3)
E3 ubiquitin-protein ligase RNF8 levels (RNF8.14663.44.3)
Ecto-ADP-ribosyltransferase 3 levels (ART3.10970.3.3)
Ecto-ADP-ribosyltransferase 4 levels (ART4.6576.1.3)
Ectonucleoside triphosphate diphosphohydrolase 1 levels (ENTPD1.7999.23.3)
Ectonucleoside triphosphate diphosphohydrolase 5 levels (ENTPD5.4437.56.3)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 levels (ENPP5.6556.5.3)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels (ENPP7.4435.66.2)
Selenide, water dikinase 1 levels (SEPHS1.14083.25.3)
Selenoprotein S levels (VIMP.11286.78.3)
Semaphorin-3A levels (SEMA3A.3222.11.2)
Semaphorin-3B levels (SEMA3B.5667.3.3)
Semaphorin-3C levels (SEMA3C.6448.36.3)
Semaphorin-3E levels (SEMA3E.5363.51.3)
Semaphorin-3G levels (SEMA3G.5628.21.3)
Semaphorin-4D levels (SEMA4D.5737.61.3)
Semaphorin-5A levels (SEMA5A.13132.14.3)
Semaphorin-6A levels (SEMA6A.7945.10.3)
Semenogelin-1 levels (SEMG1.7115.5.3)
Semenogelin-2 levels (SEMG2.6373.54.3)
Triacylglycerol(56:7)_[M+NH4]1+ levels
Whole brain restricted isotropic diffusion (multivariate analysis)
Lesional skin FLG expression levels in childhood atopic dermatitis
Non(never)-lesional skin FLG expression levels in childhood atopic dermatitis
Augurin levels (C2orf40.6362.6.3)
Aurora kinase B levels (AURKB.3346.72.2)
Axin-2 levels (AXIN2.8429.16.3)
B melanoma antigen 2 levels (BAGE2.6294.11.3)
B-cell antigen receptor complex-associated protein alpha chain levels (CD79A.7796.10.3)
B-cell lymphoma/leukemia 10 levels (BCL10.8768.4.3)
B-cell receptor CD22 levels (CD22.2891.1.3)
Bactericidal permeability-increasing protein levels (BPI.4126.22.1)
Baculoviral IAP repeat-containing protein 5 levels (BIRC5.3472.40.2)
Basal Cell Adhesion Molecule levels (BCAM.2816.50.2)
Basic leucine zipper transcriptional factor ATF-like 3 levels (BATF3.8858.21.3)
Basic salivary proline-rich protein 4 levels (PRB4.12590.67.3)
Cell growth regulator with EF hand domain protein 1 levels (CGREF1.6257.56.3)
Sphingomyelin(36:0)_[M+H]1+ levels
Sphingomyelin(36:1)_[M-CH3]1- levels
Sphingomyelin(36:0)_[M-CH3]1- levels
Carcinoembryonic antigen-related cell adhesion molecule 1 levels (CEACAM1.8031.11.3)
Cardiotrophin-1 levels (CTF1.13732.79.3)
Cartilage intermediate layer protein 1 levels (CILP.5717.2.3)
Casein kinase I isoform gamma-2 levels (CSNK1G2.12653.13.3)
Caspase-10 levels (CASP10.5340.24.3)
Caspase-3 levels (CASP3.3593.72.3)
Catalase levels (CAT.3488.64.2)
Cathepsin B levels (CTSB.3061.61.2)
Cathepsin F levels (CTSF.9212.22.3)
Cathepsin H levels (CTSH.8465.52.3)
Cathepsin S levels (CTSS.3181.50.2)
Cathepsin Z levels (CTSZ.4971.1.1)
Cation-dependent mannose-6-phosphate receptor levels (M6PR.10491.21.3)
Cation-independent mannose-6-phosphate receptor levels (IGF2R.3676.15.3)
Type ii diabetes
DnaJ homolog subfamily B member 9 levels (DNAJB9.11214.40.3)
DnaJ homolog subfamily C member 17 levels (DNAJC17.14655.1.3)
DnaJ homolog subfamily C member 30 levels (DNAJC30.7866.11.3)
Docking protein 2 levels (DOK2.14246.50.3)
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 levels (RPN1.6458.6.3)
Dorsal root ganglia homeobox protein levels (DRGX.8034.6.3)
Double-stranded RNA-binding protein Staufen homolog 1 levels (STAU1.12471.47.3)
Double-stranded RNA-binding protein Staufen homolog 2 levels (STAU2.12970.35.3)
Drebrin-like protein levels (DBNL.4978.54.2)
Dual specificity mitogen-activated protein kinase kinase 1 levels (MAP2K1.2864.2.3)
Dual specificity mitogen-activated protein kinase kinase 3 levels (MAP2K3.6151.18.3)
Dual specificity mitogen-activated protein kinase kinase 4 levels (MAP2K4.5242.37.3)
Familial combined hyperlipidemia defined by Dutch criteria
Sphingomyelin(38:1)_[M+CH3]1- levels
Sphingomyelin(38:1)_[M+H]1+ levels
Complement C1q subcomponent subunit C levels (C1QC.14100.63.3)
Complement C1q tumor necrosis factor-related protein 1 levels (C1QTNF1.6304.8.3)
Complement C1q tumor necrosis factor-related protein 5 levels (C1QTNF5.7810.20.3)
Complement C1r subcomponent-like protein levels (C1RL.9348.1.3)
Cigarette consumption x hours spent using computers interaction
Alcohol consumption x hours spent using computers interaction
Familial combined hyperlipidemia defined by Mexico criteria
Sphingomyelin(40:0)_[M+OAc]1- levels
Sphingomyelin(40:1)_[M-CH3]1- levels
Sphingomyelin(40:2)_[M-CH3]1- levels
Sphingomyelin(41:1)_[M+H]1+ levels
Depression severity  x hours spent watching television interaction
Cell surface glycoprotein CD200 receptor 1 levels (CD200R1.5103.30.3)
Cell surface glycoprotein CD200 receptor 2 levels (CD200R1L.8980.19.3)
Cellular retinoic acid-binding protein 1 levels (CRABP1.11967.23.3)
Cellular tumor antigen p53 levels (TP53.6152.111.3)
Centrin-2 levels (CETN2.13078.3.3)
Centrosomal protein of 57 kDa levels (CEP57.11276.1.3)
Cerebellin-1 levels (CBLN1.9313.27.3)
Cerebellin-4 levels (CBLN4.5688.65.3)
Cerebral dopamine neurotrophic factor levels (CDNF.4962.52.1)
cGMP-dependent protein kinase 1, beta isozyme levels (PRKG1.13067.5.3)
Charged multivesicular body protein 3 levels (VPS24.12508.9.3)
Chitinase-3-like protein 1 levels (CHI3L1.11104.13.3)
Chitinase-3-like protein 2 levels (CHI3L2.9383.24.3)
Chitotriosidase-1 levels (CHIT1.3600.2.3)
Chloride intracellular channel protein 5 levels (CLIC5.12475.48.3)
Choline/ethanolamine kinase levels (CHKB.13117.232.3)
Annexin A2 levels (ANXA2.13700.10.3)
AP-4 complex accessory subunit tepsin levels (ENTHD2.7947.19.3)
AP-4 complex subunit mu-1 levels (AP4M1.10076.1.3)
APOBEC1 complementation factor levels (A1CF.12423.38.3)
Apolipoprotein A-V levels (APOA5.12908.15.3)
Apolipoprotein B levels (APOB.2797.56.2)
Apolipoprotein D levels (APOD.4712.28.2)
Apolipoprotein E (isoform E2) levels (APOE.5312.49.3)
Apolipoprotein E (isoform E3) levels (APOE.2937.10.2)
Apolipoprotein F levels (APOF.12370.30.3)
Apolipoprotein L1 levels (APOL1.9506.10.3)
Sphingomyelin(36:1)_[M+H]1+ levels
CD109 antigen levels (CD109.3290.50.2)
CD166 antigen levels (ALCAM.5451.1.3)
CD177 antigen levels (CD177.13116.25.3)
CD209 antigen levels (CD209.3029.52.2)
CD226 antigen levels (CD226.5721.1.3)
CD48 antigen levels (CD48.3292.75.1)
CD59 glycoprotein levels (CD59.11514.196.3)
CD63 antigen levels (CD63.9190.7.3)
CD97 antigen levels (CD97.2822.56.2)
CDGSH iron-sulfur domain-containing protein 1 levels (CISD1.7745.3.3)
Cell adhesion molecule-related/down-regulated by oncogenes levels (CDON.4541.49.2)
Collagen alpha-1(VI) chain levels (COL6A1.11150.3.3)
Familial combined hyperlipidemia defined by Brunzell criteria
Familial combined hyperlipidemia defined by Goldstein criteria
Cyclic AMP-responsive element-binding protein 3-like protein 4 levels (CREB3L4.11308.8.3)
Cyclin-C levels (CCNC.7817.36.3)
Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex levels (CDK5.CDK5R1.3358.51.2)
Cyclin-dependent kinase 8:Cyclin-C complex levels (CDK8.CCNC.3359.11.2)
Cyclin-dependent kinase inhibitor 1B levels (CDKN1B.3719.2.2)
Cyclin-H levels (CCNH.9848.22.3)
Cystatin-8 levels (CST8.10572.65.3)
Cystatin-F levels (CST7.3302.58.1)
Cystatin-M levels (CST6.3303.23.2)
Cysteine-rich hydrophobic domain-containing protein 2 levels (CHIC2.10914.4.3)
Esophageal atresia with or without tracheoesophageal fistula
Complement factor I levels (CFI.2567.5.6)
Contactin-2 levels (CNTN2.3296.92.2)
Contactin-4 levels (CNTN4.3298.52.2)
Contactin-5 levels (CNTN5.3299.29.2)
Contactin-associated protein-like 2 levels (CNTNAP2.6965.19.3)
COP9 signalosome complex subunit 2 levels (COPS2.14029.42.3)
Copine-1 levels (CPNE1.5346.24.3)
Core-binding factor subunit beta levels (CBFB.10048.7.3)
Corneodesmosin levels (CDSN.7085.81.3)
Urea transporter 2 levels (SLC14A2.12818.159.3)
Cigarette consumption x playing computer games interaction
Alcohol consumption x playing computer games interaction
Salicylic acid levels
Lysosomal Pro-X carboxypeptidase levels (PRCP.5722.78.3)
Lysosomal protective protein levels (CTSA.3179.51.2)
Lysozyme C levels (LYZ.4920.10.1)
Lysozyme g-like protein 1 levels (LYG1.9243.10.3)
Lysozyme-like protein 2 levels (LYZL2.6377.54.3)
M-phase inducer phosphatase 2 levels (CDC25B.12427.8.3)
Macrophage mannose receptor 1 levels (MRC1.2637.77.2)
Macrophage metalloelastase levels (MMP12.4496.60.2)
Macrophage migration inhibitory factor levels (MIF.5356.2.3)
MAGUK p55 subfamily member 6 levels (MPP6.13490.1.3)
Malate dehydrogenase, cytoplasmic levels (MDH1.3853.56.1)
Malignant T-cell-amplified sequence 1 levels (MCTS1.12488.9.3)
Mannan-binding lectin serine protease 1 levels (MASP1.3605.77.4)
Cigarette consumption x hours spent watching television interaction
COVID-19 severity (moderate-severe vs mild)
Coagulation Factor X levels (F10.4878.3.1)
Coagulation factor Xa levels (F10.3077.66.2)
Cochlin levels (COCH.7227.75.3)
Cofilin-1 levels (CFL1.4203.50.2)
Coiled-coil domain-containing protein 126 levels (CCDC126.6388.21.3)
Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial levels (CHCHD10.11270.17.3)
Cold-inducible RNA-binding protein levels (CIRBP.12724.81.3)
Colipase levels (CLPS.5749.53.3)
Collagen alpha-1(I) chain levels (COL1A1.11140.56.3)
Annexin A10 levels (ANXA10.13605.16.3)
Sphingomyelin(34:2)_[M+H]1+ levels
Waist-hip index
Carbonic anhydrase 3 levels (CA3.3799.11.2)
Carbonic anhydrase 4 levels (CA4.3177.49.2)
Carbonic anhydrase 5A, mitochondrial levels (CA5A.8791.151.3)
Carbonic anhydrase 6 levels (CA6.3352.80.3)
Carbonic anhydrase-related protein 10 levels (CA10.13666.222.3)
Carbonyl reductase [NADPH] 1 levels (CBR1.12381.26.3)
Carbonyl reductase [NADPH] 3 levels (CBR3.14091.42.3)
Carboxypeptidase A2 levels (CPA2.9276.7.3)
Carboxypeptidase A4 levels (CPA4.9267.2.3)
Carboxypeptidase B levels (CPB1.6356.3.3)
Carboxypeptidase M levels (CPM.7768.10.3)
Carboxypeptidase Z levels (CPZ.6493.9.3)
Deoxycytidine kinase levels (DCK.9836.20.3)
Dermatopontin levels (DPT.4979.34.2)
Desmocollin-2 levels (DSC2.13126.52.3)
Desmoglein-1 levels (DSG1.2976.58.2)
Desmoglein-2 levels (DSG2.9484.75.3)
Di-N-acetylchitobiase levels (CTBS.6115.40.3)
Diacylglycerol kinase beta levels (DGKB.12895.28.3)
Dickkopf-like protein 1 levels (DKKL1.3644.5.4)
Dickkopf-related protein 1 levels (DKK1.3535.84.1)
Dickkopf-related protein 3 levels (DKK3.3607.71.6)
Dickkopf-related protein 4 levels (DKK4.3365.7.2)
Dihydrofolate reductase levels (DHFR.9823.2.3)
Dihydropteridine reductase levels (QDPR.11257.1.3)
Dipeptidase 2 levels (DPEP2.8327.26.3)
Medication use (estrogens and progestogens)
Dual specificity protein kinase CLK2 levels (CLK2.11327.56.3)
Dual specificity protein phosphatase 13 isoform A levels (DUSP13.6525.17.3)
Dual specificity protein phosphatase 4 levels (DUSP4.10035.6.3)
Dynactin-associated protein levels (DYNAP.10692.48.3)
Dynein light chain 1, cytoplasmic levels (DYNLL1.3881.49.2)
E-selectin levels (SELE.3470.1.2)
Cortexin-3 levels (CTXN3.10467.58.3)
Corticotropin-releasing factor-binding protein levels (CRHBP.6039.24.3)
Creatine kinase M-type levels (CKM.2670.67.4)
CREB-binding protein levels (CREBBP.13614.6.3)
Crk-like protein levels (CRKL.9877.28.3)
Cryptic protein levels (CFC1.3294.55.2)
CUB and sushi domain-containing protein 1 levels (CSMD1.9598.23.3)
CUB and sushi domain-containing protein 2 levels (CSMD2.9971.5.3)
CUB and zona pellucida-like domain-containing protein 1 levels (CUZD1.7943.16.3)
CXADR-like membrane protein levels (CLMP.10440.26.3)
Cyclic AMP-dependent transcription factor ATF-6 alpha levels (ATF6.11277.23.3)
Dedicator of cytokinesis protein 9 levels (DOCK9.14002.18.3)
Deformed epidermal autoregulatory factor 1 homolog levels (DEAF1.6369.82.3)
Delta-like protein 1 levels (DLL1.5349.69.3)
Collagen alpha-1(XV) chain levels (COL15A1.8974.172.3)
Collagen alpha-2(IX) chain levels (COL9A2.9804.11.3)
Collagen alpha-2(XI) chain levels (COL11A2.11278.4.3)
Collectin-10 levels (COLEC10.6558.5.3)
Collectin-11 levels (COLEC11.4430.44.3)
Collectin-12 levels (COLEC12.5457.5.2)
COMM domain-containing protein 7 levels (COMMD7.2823.7.1)
Complement C1q and tumor necrosis factor-related protein 9A levels (C1QTNF9.6019.12.3)
Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
Steroid induced osteonecrosis of the femoral head in systemic lupus erythematosus
Depression severity  x hours spent using computers interaction
Urokinase-type plasminogen activator levels (PLAU.4158.54.2)
Uroplakin-3b-like protein levels (UPK3BL.6633.43.3)
Uroporphyrinogen-III synthase levels (UROS.11248.43.3)
UV excision repair protein RAD23 homolog B levels (RAD23B.12522.6.3)
V-set and immunoglobulin domain-containing protein 2 levels (VSIG2.8018.43.3)
Vacuolar protein sorting-associated protein 29 levels (VPS29.14318.1.3)
Vacuolar protein sorting-associated protein 4A levels (VPS4A.11476.43.3)
Vacuolar protein sorting-associated protein 4B levels (VPS4B.12668.7.3)
Valine--tRNA ligase levels (VARS.13083.18.3)
Vascular cell adhesion protein 1 levels (VCAM1.2967.8.1)
Vascular endothelial growth factor A levels (VEGFA.2597.8.3)
Vascular endothelial growth factor A, isoform 121 levels (VEGFA.14032.2.3)
Vascular endothelial growth factor C levels (VEGFC.3132.1.1)
Vascular endothelial growth factor D levels (FIGF.13098.93.3)
Vascular endothelial growth factor receptor 2 levels (KDR.3651.50.5)
Sphingomyelin(41:2)_[M-CH3]1- levels
Anxiety severity x hours spent watching television interaction
WD repeat-containing protein 1 levels (WDR1.10723.41.3)
WNT1-inducible-signaling pathway protein 1 levels (WISP1.13692.154.3)
WNT1-inducible-signaling pathway protein 3 levels (WISP3.5927.4.3)
WSC domain-containing protein 2 levels (WSCD2.6274.15.3)
Xyloside xylosyltransferase 1 levels (XXYLT1.6375.75.3)
Y-box-binding protein 2 levels (YBX2.6372.7.3)
Zinc finger protein 175 levels (ZNF175.12716.3.3)
Zinc finger protein 18 levels (ZNF18.11372.2.3)
Zinc finger protein 276 levels (ZNF276.14692.3.3)
Zinc fingers and homeoboxes protein 3 levels (ZHX3.10036.201.3)
Zinc-alpha-2-glycoprotein levels (AZGP1.9312.8.3)
Zona pellucida sperm-binding protein 4 levels (ZP4.7766.25.3)
Lymphotactin levels (XCL1.14078.69.3)
Lysophosphatidylcholine acyltransferase 2 levels (LPCAT2.11175.45.3)
Lysosomal acid phosphatase levels (ACP2.9237.54.3)
Melanoma-derived growth regulatory protein levels (MIA.2687.2.1)
Membrane protein FAM174A levels (FAM174A.6597.24.3)
Membrane-associated progesterone receptor component 2 levels (PGRMC2.10631.9.3)
Mesothelin levels (MSLN.3893.55.2)
Metalloproteinase inhibitor 4 levels (TIMP4.6462.12.3)
Metallothionein-1F levels (MT1F.10416.79.3)
MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)
MICAL-like protein 2 levels (MICALL2.12891.1.3)
MICOS complex subunit MIC10 levels (MINOS1.7956.11.3)
Microfibrillar-associated protein 2 levels (MFAP2.9294.45.3)
Mineralocorticoid receptor levels (NR3C2.12931.16.3)
Mitochondrial import inner membrane translocase subunit TIM14 levels (DNAJC19.4545.53.3)
Peripheral vascular disease
Acute reaction to stress
Metabolic biomarkers (multivariate analysis)
Phosphatidylinositol(36:2)_[M-H]1- levels
Phosphatidylinositol(36:3)_[M-H]1- levels
Phosphatidylinositol(36:4)_[M-H]1- levels
Cisplatin-induced nephrotoxicity (increased serum creatinine AKI-CTCAE)
Cisplatin-induced nephrotoxicity (decreased eGFR)
Phosphatidylinositol(38:4)_[M-H]1- levels
Neonatal abstinence syndrome
Femur bone mineral density x serum urate levels interaction
Gestational diabetes mellitus
Carotid artery intima-media thickness in type 2 diabetes
Coronary artery calcification in type 2 diabetes
Coronary artery calcification in type 2 diabetes (excluding prevalent cardiovascular disease)
Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+NH4]1+ levels
Phosphatidylserine-O_42:6_[M+H]1+ levels
Phosphatidylserine-P_42:1_[M+H]1+/Phosphatidylglycerol-P_42:6_[M+NH4]1+ levels
Phosphatidylserine(35:2)_[M+OAc]1- levels
Phosphatidylserine(42:5)_[M+OAc]1- levels
Crohn's disease or Leprosy
Crohn's disease or Leprosy (opposite effect)
body mass index x carrot consumption interaction
body mass index x broccoli consumption interaction
body mass index x other green vegetables (green pepper and green beans) consumption interaction
body mass index x pumpkin consumption interaction
body mass index x cabbage consumption interaction
Sphingomyelin_34:2_[M+H]1+ levels
Sphingomyelin_35:1_[M+H]1+ levels
Sphingomyelin_36:0_[M+H]1+ levels
Sphingomyelin_36:1_[M+H]1+ levels
Sphingomyelin_34:1_[M+H]1+ levels
Cancer code, self-reported: breast cancer (UKB data field 20001_1002)
Treatment or medication use - vitamin e product (UKB data field 20003_1140871112)
Coffee type: Instant coffee (UKB data field 1508_2)
Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3)
Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)
Treatment or medication use - glyceryl trinitrate (UKB data field 20003_1140860834)
Treatment or medication use - peppermint oil product (UKB data field 20003_1140865414)
Melanomas of skin (PheCode 172.11)
Malignant neoplasm of female breast (PheCode 174.11)
Hair colour (natural, before greying): Blonde (UKB data field 1747_1)
Symptom severity in clozapine treated schizophrenia spectrum disorders (quantitative)
Symptom severity in clozapine treated schizophrenia spectrum disorders (binary)
Xerostomia  (moderate to severe) in oropharyngeal cancer
Hair colour (natural, before greying): Light brown (UKB data field 1747_3)
Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)
Serine to glycine ratio
Phosphatidylinositol(40:6)_[M-H]1- levels
Phosphatidylinositol(40:5)_[M-H]1- levels
Ocular disease
Stimulant dependence
Sphingomyelin_32:1_[M+H]1+ levels
Sphingomyelin_33:1_[M+H]1+ levels
Sphingomyelin_34:0_[M+H]1+ levels
Sphingomyelin_40:2_[M+H]1+ levels
Sphingomyelin_40:3_[M+H]1+ levels
Sphingomyelin_41:0_[M+H]1+ levels
Sphingomyelin_41:2_[M+H]1+ levels
Sphingomyelin_42:1_[M+H]1+ levels
Sphingomyelin_42:2_[M+H]1+ levels
Sphingomyelin_42:2_[M+OAc]1- levels
Sphingomyelin_42:3_[M+H]1+ levels
Sphingomyelin_43_2_[M+H]1+ levels
Cardiovascular disease
Dyslipidemia
Phosphatidylserine_40:3_[M+H]1+/Phosphatidylglycerol_40:5_[M+NH4]1+ levels
Phosphatidylserine(44:6)_[M+OAc]1- levels
Immunoglobulin N-glycan 1 levels
Immunoglobulin N-glycan 2 levels
Immunoglobulin N-glycan 6 levels
Immunoglobulin N-glycan 7 levels
Immunoglobulin N-glycan 8 levels
Immunoglobulin N-glycan 10 levels
Immunoglobulin N-glycan 11 levels
Immunoglobulin N-glycan 12 levels
Immunoglobulin N-glycan 16 levels
Immunoglobulin N-glycan 17 levels
Immunoglobulin N-glycan 19 levels
Immunoglobulin N-glycan 20 levels
Immunoglobulin N-glycan 21 levels
Sphingomyelin_37:1_[M+H]1+ levels
Sphingomyelin_38:1_[M+H]1+ levels
Bone mineral density T score in postmenopausal osteoporosis
Immunoglobulin N-glycan 22 levels
Immunoglobulin N-glycan 23 levels
Immunoglobulin N-glycan 24 levels
Transferrin N-glycan 3 levels
Transferrin N-glycan 8 levels
Transferrin N-glycan 9 levels
Transferrin N-glycan 11 levels
Transferrin N-glycan 14 levels
Transferrin N-glycan 17 levels
Transferrin N-glycan 19 levels
Transferrin N-glycan 20 levels
Transferrin N-glycan 21 levels
Transferrin N-glycan 22 levels
Transferrin N-glycan 23 levels
Transferrin N-glycan 24 levels
Transferrin N-glycan 25 levels
Transferrin N-glycan 26 levels
Transferrin N-glycan 27 levels
Transferrin N-glycan 28 levels
Transferrin N-glycan 29 levels
Transferrin N-glycan 30 levels
Transferrin N-glycan 31 levels
Transferrin N-glycan 32 levels
Transferrin N-glycan 33 levels
Transferrin N-glycan 34 levels
Transferrin N-glycan 35 levels
Relative brain age
Sphingomyelin(32:1)_[M-CH3]1- levels
Hair colour (natural, before greying): Black (UKB data field 1747_5)
Cancer of prostate (PheCode 185)
Wheeze or whistling in the chest in last year (UKB data field 2316)
Hair/balding pattern: Pattern 1 (UKB data field 2395_1)
Hair/balding pattern: Pattern 4 (UKB data field 2395_4)
Cancer (UKB data field 2453)
Treatment or medication use - epanutin 25mg capsule (UKB data field 20003_1140872112)
COVID-19 (hospitalized vs population)
Free brassicasterol to free lanosterol
Total campesterol
Total sitosterol
Esterified stigmasterol
Gallbladder polyp
Tubulin-specific chaperone A levels (TBCA.12501.10.3)
Tubulin-specific chaperone E levels (TBCE.11211.7.3)
Tumor necrosis factor ligand superfamily member 12 levels (TNFSF12.5939.42.3)
Tumor necrosis factor ligand superfamily member 14 levels (TNFSF14.5355.69.3)
Tumor necrosis factor ligand superfamily member 6, soluble form levels (FASLG.3052.8.2)
Tumor necrosis factor ligand superfamily member 8 levels (TNFSF8.3421.54.2)
Tumor necrosis factor receptor superfamily member 11A levels (TNFRSF11A.8316.36.3)
Tumor necrosis factor receptor superfamily member 11B levels (TNFRSF11B.2526.53.3)
Tumor necrosis factor receptor superfamily member 16 levels (NGFR.8949.3.3)
Tumor necrosis factor receptor superfamily member 19L levels (RELT.5115.31.3)
Tumor necrosis factor receptor superfamily member 1B levels (TNFRSF1B.8368.102.3)
Tumor necrosis factor receptor superfamily member 3 levels (LTBR.2636.10.2)
Tumor necrosis factor receptor superfamily member 6 levels (FAS.9459.7.3)
Phospholipid levels in IDL
Whole brain restricted directional diffusion (multivariate analysis)
Gastric polyp
Gastric ulcer
Hepatic cancer
Coronary artery disease or factor VII levels (pleiotropy)
Interleukin-23 levels (IL12B.IL23A.10365.132.3)
Interleukin-23 receptor levels (IL23R.5088.175.3)
Interleukin-25 levels (IL25.4137.57.2)
Interleukin-27 levels (IL27.EBI3.2829.19.2)
Interleukin-27 receptor subunit alpha levels (IL27RA.5132.71.3)
Interleukin-3 receptor subunit alpha levels (IL3RA.13744.37.3)
Interleukin-31 levels (IL31.10455.196.3)
Interleukin-34 levels (IL34.4556.10.2)
Interleukin-36 alpha levels (IL36A.10928.7.3)
Interleukin-37 levels (IL37.2723.9.2)
Interleukin-5 levels (IL5.3741.4.3)
Interleukin-5 receptor subunit alpha levels (IL5RA.4491.4.2)
Interleukin-6 receptor subunit alpha levels (IL6R.4139.71.2)
Interleukin-6 receptor subunit beta levels (IL6ST.2620.4.2)
Phospholipids to total lipids ratio in IDL
acne vulgaris
Killer cell immunoglobulin-like receptor 2DL5A levels (KIR2DL5A.8000.17.3)
Killer cell immunoglobulin-like receptor 2DS2 levels (KIR2DS2.10428.1.3)
Killer cell lectin-like receptor subfamily F member 1 levels (KLRF1.5098.79.3)
Kinesin-like protein KIF16B levels (KIF16B.11672.17.3)
Kinetochore protein NDC80 homolog levels (NDC80.12730.3.3)
Tumor necrosis factor receptor superfamily member 6B levels (TNFRSF6B.5070.76.3)
Tumor necrosis factor receptor superfamily member EDAR levels (EDAR.2977.7.2)
Tumor necrosis factor-inducible gene 6 protein levels (TNFAIP6.5036.50.1)
Tumor protein p53-inducible protein 11 levels (TP53I11.13022.20.3)
Coronary artery disease or factor VIII levels (pleiotropy)
Malignant lymphoma
Meniere's disease
Nephrotic syndrome
Neuropathic bladder
Pulmonary tuberculosis
Pollinosis
Tyrosine-protein phosphatase non-receptor type 4 levels (PTPN4.14254.27.3)
Tyrosine-protein phosphatase non-receptor type 7 levels (PTPN7.14688.6.3)
Tyrosine-protein phosphatase non-receptor type 9 levels (PTPN9.12633.3.3)
Tyrosine-protein phosphatase non-receptor type substrate 1 levels (SIRPA.5430.66.3)
U1 small nuclear ribonucleoprotein A levels (SNRPA.12678.66.3)
Ubiquilin-4 levels (UBQLN4.12720.71.3)
Ubiquitin levels (RPS27A.4474.19.2)
Ubiquitin carboxyl-terminal hydrolase 21 levels (USP21.12681.63.3)
Ubiquitin carboxyl-terminal hydrolase 25 levels (USP25.9215.117.3)
Aspartate aminotransferase to alanine aminotransferase ratio
Whole brain free water diffusion (multivariate analysis)
Uncharacterized protein C6orf226 levels (C6orf226.8078.15.3)
Uncharacterized protein C7orf69 levels (C7orf69.9544.24.3)
Uncharacterized protein KIAA0040 levels (KIAA0040.14603.51.3)
Uncharacterized protein KIAA2013 levels (KIAA2013.6538.90.3)
Unique cartilage matrix-associated protein levels (UCMA.10977.55.3)
UPF0454 protein C12orf49 levels (C12orf49.9387.13.3)
UPF0488 protein C8orf33 levels (C8orf33.9613.16.3)
UPF0577 protein KIAA1324-like levels (KIAA1324L.8363.18.3)
UPF0696 protein C11orf68 levels (C11orf68.8307.47.3)
Kit ligand levels (KITLG.9377.25.3)
Kremen protein 1 levels (KREMEN1.6512.68.3)
Kunitz-type protease inhibitor 1 levels (SPINT1.2828.82.2)
Kunitz-type protease inhibitor 2 levels (SPINT2.2843.13.2)
Kunitz-type protease inhibitor 3 levels (SPINT3.7926.13.3)
Kv channel-interacting protein 1 levels (KCNIP1.13650.11.3)
Kynureninase levels (KYNU.4559.64.2)
Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)
L-lactate dehydrogenase B chain levels (LDHB.3890.8.2)
L-Selectin levels (SELL.4831.4.2)
Lactadherin levels (MFGE8.4455.89.2)
Stable angina pectoris
Triglycerides to total lipids ratio in IDL
Coronary artery disease or factor XI levels (pleiotropy)
Leucine-rich PPR motif-containing protein, mitochondrial levels (LRPPRC.9046.46.3)
Leucine-rich repeat and transmembrane domain-containing protein 2 levels (LRTM2.8906.60.3)
Leucine-rich repeat neuronal protein 1 levels (LRRN1.11293.14.3)
Leucine-rich repeat serine/threonine-protein kinase 2 levels (LRRK2.10990.21.3)
Leucine-rich repeat transmembrane protein FLRT2 levels (FLRT2.13122.19.3)
Leucine-rich repeat transmembrane protein FLRT3 levels (FLRT3.13123.3.3)
Leucine-rich repeat-containing protein 15 levels (LRRC15.6557.50.3)
Leucine-rich repeat-containing protein 19 levels (LRRC19.7014.27.3)
Leucine-rich repeat-containing protein 74A levels (LRRC74A.8389.8.3)
Leucine-rich repeats and immunoglobulin-like domains protein 3 levels (LRIG3.3322.52.2)
Leukemia inhibitory factor levels (LIF.7790.21.3)
Leukemia inhibitory factor receptor levels (LIFR.5837.49.3)
Leukocyte immunoglobulin-like receptor subfamily A member 4 levels (LILRA4.8299.66.3)
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels (LILRA5.7787.25.3)
Leukocyte immunoglobulin-like receptor subfamily A member 6 levels (LILRA6.7059.14.3)
Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)
Low-density lipoprotein receptor-related protein 1, soluble levels (LRP1.8601.167.3)
Low-density lipoprotein receptor-related protein 1B levels (LRP1B.11275.94.3)
Luteinizing hormone levels (CGA.LHB.2953.31.2)
Lutropin subunit beta levels (LHB.8376.25.4)
Lymphocyte antigen 6 complex locus protein G6c levels (LY6G6C.6256.9.3)
Interleukin-17 receptor A levels (IL17RA.2992.59.2)
Interleukin-17 receptor B levels (IL17RB.5084.154.3)
Interleukin-17 receptor D levels (IL17RD.3376.49.2)
Interleukin-18 receptor 1 levels (IL18R1.3446.7.2)
Interleukin-19 levels (IL19.3035.80.2)
Interleukin-2 levels (IL2.3070.1.2)
Interleukin-21 levels (IL21.7124.18.3)
Interleukin-22 receptor subunit alpha-1 levels (IL22RA1.3620.67.2)
Galectin-1 levels
Iritis
Iron deficiency anemia
Interleukin-7 receptor subunit alpha levels (IL7R.5089.11.3)
Intersectin-1 levels (ITSN1.14070.56.3)
Intestinal-type alkaline phosphatase levels (ALPI.10463.23.3)
Isochorismatase domain-containing protein 1 levels (ISOC1.9816.37.3)
IST1 homolog levels (IST1.12434.25.3)
Isthmin-1 levels (ISM1.8355.80.3)
Janus kinase and microtubule-interacting protein 3 levels (JAKMIP3.9068.17.3)
Junctional adhesion molecule B levels (JAM2.2997.8.1)
Junctional adhesion molecule-like levels (AMICA1.8232.90.3)
Kallikrein-11 levels (KLK11.2831.29.1)
Kallikrein-12 levels (KLK12.3199.54.2)
Kallikrein-14 levels (KLK14.8620.56.3)
Kallikrein-6 levels (KLK6.3450.4.2)
Melanoma x citrus consumption interaction (2df)
Idiopathic polyneuropathy
Kallikrein-7 levels (KLK7.3378.49.2)
Kallikrein-8 levels (KLK8.13708.56.3)
Kallistatin levels (SERPINA4.3449.58.2)
KDEL motif-containing protein 2 levels (KDELC2.8296.117.3)
Kelch-like protein 13 levels (KLHL13.12463.7.3)
Keratin-associated protein 2-4 levels (KRTAP2.4.14615.46.3)
Keratinocyte differentiation-associated protein levels (KRTDAP.5739.75.3)
Killer cell immunoglobulin-like receptor 2DL2 levels (KIR2DL2.7773.20.3)
Coronary artery disease or von Willebrand factor levels (pleiotropy)
Type 2 lactosamine alpha-2,3-sialyltransferase levels (ST3GAL6.6947.4.3)
Tyrosine-protein kinase BTK levels (BTK.3416.2.2)
Tyrosine-protein kinase CSK levels (CSK.3363.31.4)
Tyrosine-protein kinase Fgr levels (FGR.3810.50.2)
Tyrosine-protein kinase FRK levels (FRK.10034.16.3)
Tyrosine-protein kinase Fyn levels (FYN.4550.3.2)
Tyrosine-protein kinase JAK2 levels (JAK2.4998.50.2)
Tyrosine-protein kinase Lck levels (LCK.4560.34.2)
Tyrosine-protein kinase Lyn levels (LYN.3453.87.2)
Tyrosine-protein kinase Lyn, isoform B levels (LYN.3381.24.2)
Tyrosine-protein kinase receptor Tie-1, soluble levels (TIE1.2844.53.2)
Tyrosine-protein kinase transmembrane receptor ROR1 levels (ROR1.2590.69.4)
Tyrosine-protein kinase ZAP-70 levels (ZAP70.4476.22.2)
Tyrosine-protein phosphatase non-receptor type 1 levels (PTPN1.3005.5.2)
Tyrosine-protein phosphatase non-receptor type 11 levels (PTPN11.3397.7.4)
Skeletal age
Pulmonary fibrosis
Pyelonephritis
Ringworm
Ubiquitin carboxyl-terminal hydrolase 8 levels (USP8.13450.49.3)
Ubiquitin domain-containing protein 2 levels (UBTD2.12875.28.3)
Ubiquitin-conjugating enzyme E2 D4 levels (UBE2D4.13475.10.3)
Ubiquitin-conjugating enzyme E2 N levels (UBE2N.3905.62.1)
Ubiquitin-conjugating enzyme E2 variant 1 levels (UBE2V1.11626.7.3)
Ubiquitin-fold modifier 1 levels (UFM1.3836.51.2)
Ubiquitin-fold modifier-conjugating enzyme 1 levels (UFC1.3405.6.2)
Ubiquitin-like protein 4A levels (UBL4A.11490.42.3)
Ubiquitin-like protein ISG15 levels (ISG15.14151.4.3)
Ubiquitin+1, truncated mutation for UbB levels (RPS27A.2846.24.2)
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 levels (B3GNT8.9297.12.3)
UDP-glucuronosyltransferase 1-6 levels (UGT1A6.7891.45.3)
UDP-glucuronosyltransferase 2A1 levels (UGT2A1.8907.11.3)
UDP-N-acetylhexosamine pyrophosphorylase levels (UAP1.13580.2.3)
Uncharacterized family 31 glucosidase KIAA1161 levels (KIAA1161.8068.43.3)
Uncharacterized protein C10orf35 levels (C10orf35.8220.15.3)
Uncharacterized protein C14orf93 levels (C14orf93.6439.59.3)
Uncharacterized protein C17orf78 levels (C17orf78.8545.14.3)
Uncharacterized protein C2orf66 levels (C2orf66.5677.15.3)
Uncharacterized protein C3orf18 levels (C3orf18.6994.19.3)
Skin cancer
Subarachnoid hemorrhage
Lactase-phlorizin hydrolase levels (LCT.9017.58.3)
Lactoperoxidase levels (LPO.4801.13.3)
Lactotransferrin levels (LTF.2780.35.2)
Lamin-B1 levels (LMNB1.3889.64.2)
Lamina-associated polypeptide 2, isoforms beta/gamma levels (TMPO.8265.225.3)
Laminin levels (LAMA1.LAMB1.LAMC1.2728.62.2)
Laminin subunit alpha-4 levels (LAMA4.6577.64.3)
Laminin subunit gamma-2 levels (LAMC2.9580.5.3)
LEM domain-containing protein 1 levels (LEMD1.8040.9.3)
Leptin receptor levels (LEPR.5400.52.3)
Leukocyte immunoglobulin-like receptor subfamily B member 1 levels (LILRB1.5090.49.2)
Leukocyte immunoglobulin-like receptor subfamily B member 2 levels (LILRB2.5633.65.3)
Leukocyte immunoglobulin-like receptor subfamily B member 4 levels (LILRB4.6453.70.3)
Leukocyte immunoglobulin-like receptor subfamily B member 5 levels (LILRB5.7015.8.3)
Limbic system-associated membrane protein levels (LSAMP.2999.6.2)
Lipase member N levels (LIPN.8097.77.3)
Lon protease homolog, mitochondrial levels (LONP1.6398.12.3)
Low affinity immunoglobulin epsilon Fc receptor levels (FCER2.3291.30.2)
Low affinity immunoglobulin gamma Fc region receptor II-a levels (FCGR2A.3309.2.2)
Low affinity immunoglobulin gamma Fc region receptor II-b levels (FCGR2B.3310.62.1)
Low affinity immunoglobulin gamma Fc region receptor III-B levels (FCGR3B.3311.27.1)
Stevens-Johnson syndrome
Unstable angina pectoris
Cholesterol levels in large HDL
Serum levels of protein ZNF276
Serum levels of protein ZNF334
Serum levels of protein ZNRF3
Serum levels of protein ZNRF4
Serum levels of protein ZP4
Serum levels of protein ZPBP
Serum levels of protein ZPBP2
Serum levels of protein ZPLD1
Kawasaki disease or immunoglobulin A vasculitis (pleiotropy)
Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ levels
Phosphatidylcholine(39:6)_[M+OAc]1-/Phosphatidylserine(43:5)_[M-H]1- levels
Phosphatidylcholine(40:4)_[M+OAc]1-/Phosphatidylserine(44:3)_[M-H]1- levels
Aldosterone levels
Testosterone to estradiol ratio
Left unilateral cleft lip and palate
Left unilateral cleft lip
Right unilateral cleft lip
Phosphatidylcholine(40:5)_[M+H]1+ levels
Wheat-dependent exercise-induced anaphylaxis
Phosphatidylcholine(40:5)_[M+OAc]1-/Phosphatidylserine(44:4)_[M-H]1- levels
Alanine aminotransferase levels x BMI interaction
Aspartate aminotransferase levels x BMI interaction
Phosphatidylcholine(40:6)_[M+H]1+/Phosphatidylethanolamine(43:6)_[M+H]1+ levels
Phosphatidylcholine(40:6)_[M+OAc]1-/Phosphatidylserine(44:5)_[M-H]1- levels
Ceramide(41:2)_[M-H]1- levels
Ceramide(42:0)_[M-H]1- levels
Cholesterol_[M+H-H2O]1+ levels
Lymphocyte-to-monocyte ratio
Arm bone mineral content
Android fat/gynoid fat ratio
Cholesteryl ester_14:0_[M+NH4]1+ levels
SARS-CoV-2 infection
Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection
Cholesteryl ester_15:0_[M+NH4]1+ levels
Cholesteryl ester_16:0_[M+NH4]1+ levels
Cholesteryl ester_16:1_[M+NH4]1+ levels
Cholesteryl ester_18:2_[M+NH4]1+ levels
Cholesteryl ester_18:3_[M+NH4]1+ levels
Cholesteryl ester_17:0_[M+NH4]1+ levels
Cholesteryl ester_17:1_[M+NH4]1+ levels
Cholesteryl ester_18:0_[M+NH4]1+ levels
Cholesteryl ester_18:1_[M+NH4]1+ levels
Recurrence-free survival in non-muscle-invasive bladder cancer
Progression-free survival in non-muscle-invasive bladder cancer
Cholesteryl ester_20:3_[M+NH4]1+ levels
Cholesteryl ester_20:5_[M+NH4]1+ levels
Cholesteryl ester_22:6_[M+NH4]1+ levels
Cholesteryl ester(14:0)_[M+NH4]1+ levels
Cholesteryl ester_22:5_[M+NH4]1+ levels
Cholesteryl ester(16:0)_[M+NH4]1+ levels
Central corneal thickness (MTAG)
Depression x maternal smoking during pregnancy interaction
Anxiety x maternal smoking during pregnancy interaction
Cholesteryl ester(16:1)_[M+NH4]1+ levels
Cocaine dependence (time to event)
Opioid dependence (time to event)
Triacylglycerol(58:9)_[M+NH4]1+ levels
Eukaryotic translation initiation factor 3 subunit G levels (EIF3G.11454.87.3)
Eukaryotic translation initiation factor 3 subunit J levels (EIF3J.13497.34.3)
Eukaryotic translation initiation factor 4B levels (EIF4B.14675.20.3)
Eukaryotic translation initiation factor 4E type 2 levels (EIF4E2.9745.20.3)
Eukaryotic translation initiation factor 5 levels (EIF5.2612.5.2)
Eukaryotic translation initiation factor 5A-1 levels (EIF5A.5888.29.3)
Exosome complex component RRP40 levels (EXOSC3.12605.1.3)
Exostosin-like 2 levels (EXTL2.6528.95.3)
Extracellular sulfatase Sulf-2 levels (SULF2.8305.18.3)
Extracellular superoxide dismutase [Cu-Zn] levels (SOD3.8463.2.3)
Ezrin levels (EZR.9753.17.3)
Fatty acid-binding protein, liver levels (FABP1.11516.7.3)
Fc receptor-like protein 1 levels (FCRL1.5728.60.3)
Fc receptor-like protein 3 levels (FCRL3.4440.15.2)
Fc receptor-like protein 4 levels (FCRL4.8973.23.3)
Fc receptor-like protein 6 levels (FCRL6.6617.12.3)
Ferritin levels (FTH1.FTL.3031.66.1)
Fibroblast growth factor 16 levels (FGF16.13725.3.3)
Fibroblast growth factor 19 levels (FGF19.2762.30.2)
Triglyceride levels in HDL
Intracranial artery stenosis
GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)
GDNF family receptor alpha-1 levels (GFRA1.3314.74.2)
GDNF family receptor alpha-2 levels (GFRA2.2515.14.3)
GDNF family receptor alpha-like levels (GFRAL.6920.1.3)
GDP-fucose protein O-fucosyltransferase 1 levels (POFUT1.5634.39.3)
GDP-fucose protein O-fucosyltransferase 2 levels (POFUT2.6042.52.3)
Signal transducer and activator of transcription 3 levels (STAT3.10346.5.3)
Signal transducer and activator of transcription 6 levels (STAT6.10372.18.3)
Signal-regulatory protein beta-1 levels (SIRPB1.6247.9.3)
Cholesterol levels in IDL
Facial morphology (segment 31)
Facial morphology (segment 32)
Facial morphology (segment 34)
Facial morphology (segment 45)
Facial morphology (segment 49)
Facial morphology (segment 51)
Facial morphology (segment 56)
Facial morphology (segment 57)
Facial morphology (segment 60)
Facial morphology (segment 62)
Facial morphology (segment 2)
Facial morphology (segment 5)
Facial morphology (segment 6)
Facial morphology (segment 7)
Facial morphology (segment 9)
Facial morphology (segment 10)
Facial morphology (segment 12)
Facial morphology (segment 22)
Facial morphology (segment 23)
Facial morphology (segment 24)
Facial morphology (segment 25)
Facial morphology (segment 26)
Facial morphology (segment 29)
Facial morphology (segment 35)
Facial morphology (segment 36)
Facial morphology (segment 38)
Facial morphology (segment 44)
Facial morphology (segment 15)
Facial morphology (segment 17)
Facial morphology (segment 20)
Facial morphology (segment 46)
Facial morphology (segment 58)
Facial morphology (segment 61)
Facial morphology (segment 63)
Serum amyloid A-1 protein levels (SAA1.4336.2.1)
Serum amyloid P-component levels (APCS.2474.54.5)
SH2 domain-containing protein 1A levels (SH2D1A.4567.82.2)
SH3 domain-binding protein 2 levels (SH3BP2.7769.29.3)
SHC-transforming protein 1 levels (SHC1.5272.55.2)
Sialic acid-binding Ig-like lectin 10 levels (SIGLEC10.6048.4.3)
Sialic acid-binding Ig-like lectin 11 levels (SIGLEC11.8913.22.3)
Sialic acid-binding Ig-like lectin 12 levels (SIGLEC12.8352.26.3)
Sialic acid-binding Ig-like lectin 14 levels (SIGLEC14.8248.222.3)
Signal-regulatory protein beta-2 levels (SIRPB2.5669.26.3)
Signal-regulatory protein gamma levels (SIRPG.9241.40.3)
Serine protease inhibitor Kazal-type 2 levels (SPINK2.13405.61.3)
Serine protease inhibitor Kazal-type 6 levels (SPINK6.5731.1.3)
Serine-rich single-pass membrane protein 1 levels (SSMEM1.8298.8.3)
Serine/arginine-rich splicing factor 7 levels (SRSF7.12987.12.3)
Serine/threonine-protein kinase 16 levels (STK16.3471.49.1)
Serine/threonine-protein kinase 17B levels (STK17B.5249.31.3)
Serine/threonine-protein kinase MRCK alpha levels (CDC42BPA.12706.2.3)
Serine/threonine-protein kinase PAK 4 levels (PAK4.13719.19.3)
Serine/threonine-protein kinase pim-1 levels (PIM1.5359.65.3)
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha levels (PPP2R3A.13665.35.3)
Serpin A12 levels (SERPINA12.6551.94.3)
Serpin A9 levels (SERPINA9.7266.4.3)
Glucoside xylosyltransferase 1 levels (GXYLT1.8229.1.3)
Glutamate carboxypeptidase 2 levels (FOLH1.3218.8.2)
Glutamate receptor 4 levels (GRIA4.10760.107.3)
Glutamate receptor ionotropic, delta-2 levels (GRID2.12758.47.3)
Glutaminyl-peptide cyclotransferase-like protein levels (QPCTL.8866.53.3)
Glutaredoxin-2, mitochondrial levels (GLRX2.12486.8.3)
Glutaredoxin-like protein C5orf63 levels (C5orf63.13378.80.3)
Glutathione peroxidase 7 levels (GPX7.8345.27.3)
Glutathione S-transferase A1 levels (GSTA1.12446.49.3)
Glutathione S-transferase A4 levels (GSTA4.14645.253.3)
Glutathione S-transferase Mu 1 levels (GSTM1.7239.9.3)
Glutathione S-transferase omega-1 levels (GSTO1.12436.84.3)
Glutathione S-transferase P levels (GSTP1.4911.49.2)
Glycerol-3-phosphate dehydrogenase 1-like protein levels (GPD1L.12420.10.3)
Glycine N-methyltransferase levels (GNMT.14006.36.3)
Glycogen phosphorylase, liver form levels (PYGL.11441.11.3)
Cholesterol to total lipids ratio in IDL
GRAM domain-containing protein 1C levels (GRAMD1C.8842.16.3)
Grancalcin levels (GCA.12594.5.3)
Granulins levels (GRN.4992.49.1)
Granulysin levels (GNLY.3195.50.2)
Granzyme A levels (GZMA.3440.7.2)
Granzyme B levels (GZMB.4133.54.2)
Granzyme K levels (GZMK.9545.156.3)
Granzyme M levels (GZMM.5704.74.3)
Gremlin-1 levels (GREM1.4449.67.3)
Gremlin-2 levels (GREM2.5598.3.3)
Group XIIB secretory phospholipase A2-like protein levels (PLA2G12B.9380.2.3)
Growth arrest and DNA damage-inducible proteins-interacting protein 1 levels (GADD45GIP1.9302.90.3)
Growth factor receptor-bound protein 14 levels (GRB14.13628.58.3)
Growth factor receptor-bound protein 2 levels (GRB2.5464.52.3)
Growth factor receptor-bound protein 7 levels (GRB7.11281.6.3)
Growth hormone receptor levels (GHR.2948.58.2)
Growth-regulated alpha protein levels (CXCL1.2985.35.1)
Cholesteryl ester levels in IDL
Sulfiredoxin-1 levels (SRXN1.14268.4.3)
SUMO-conjugating enzyme UBC9 levels (UBE2I.2877.3.1)
SUN domain-containing protein 3 levels (SUN3.8852.10.3)
SUN domain-containing protein 5 levels (SUN5.11260.47.3)
Superoxide dismutase [Mn], mitochondrial levels (SOD2.5008.51.1)
Suppressor of cytokine signaling 3 levels (SOCS3.11440.58.3)
Surfeit locus protein 1 levels (SURF1.8009.121.3)
Sushi domain-containing protein 2 levels (SUSD2.10021.1.3)
Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 levels (SVEP1.11178.21.3)
Switch-associated protein 70 levels (SWAP70.13552.7.3)
Synaptosomal-associated protein 25 levels (SNAP25.13105.7.3)
Stathmin-3 levels (STMN3.8019.73.3)
Stathmin-4 levels (STMN4.6267.51.3)
Stem Cell Growth Factor-beta levels (CLEC11A.2966.65.2)
Steroidogenic acute regulatory protein, mitochondrial levels (STAR.10085.25.3)
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating levels (NSDHL.8038.41.3)
Stromal cell-derived factor 1 levels (CXCL12.3516.60.2)
Stromal interaction molecule 1 levels (STIM1.9271.101.3)
Stromal membrane-associated protein 1 levels (SMAP1.11649.3.3)
Stromelysin-2 levels (MMP10.8479.4.3)
Structural maintenance of chromosomes protein 3 levels (SMC3.14324.52.3)
Submaxillary gland androgen-regulated protein 3A levels (SMR3A.7838.27.3)
Sulfatase-modifying factor 1 levels (SUMF1.6941.11.3)
Sulfhydryl oxidase 1 levels (QSOX1.6217.23.3)
Sulfhydryl oxidase 2 levels (QSOX2.8397.147.3)
Cholesteryl esters to total lipids ratio in IDL
Ascending aorta minimum area
Ascending aorta distensibility
Tonsillitis
Hemojuvelin levels (HFE2.3332.57.1)
Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 levels (HS3ST3A1.8268.98.3)
Heparan-sulfate 6-O-sulfotransferase 1 levels (HS6ST1.5465.32.3)
Heparin-binding EGF-like growth factor levels (HBEGF.14094.29.3)
Hepatitis A virus cellular receptor 1 levels (HAVCR1.9021.1.3)
Hepatitis A virus cellular receptor 2 levels (HAVCR2.5134.52.2)
Hepatocyte growth factor levels (HGF.2681.23.2)
Hepatocyte growth factor receptor levels (MET.2837.3.2)
Hepatocyte nuclear factor 4-alpha levels (HNF4A.10041.3.3)
Heterogeneous nuclear ribonucleoprotein A/B levels (HNRNPAB.4450.26.2)
Heterogeneous nuclear ribonucleoprotein D-like levels (HNRNPDL.10852.114.3)
Heterogeneous nuclear ribonucleoprotein M levels (HNRNPM.12783.29.3)
Heterogeneous nuclear ribonucleoprotein Q levels (SYNCRIP.4224.7.2)
Heterogeneous nuclear ribonucleoproteins A2/B1 levels (HNRNPA2B1.5351.52.3)
COVID-19 symptoms (loss of smell or taste vs no loss of smell or taste)
HLA class II histocompatibility antigen, DP beta 1 chain levels (HLA.DPB1.8755.202.3)
HLA class II histocompatibility antigen, DQ alpha 2 chain levels (HLA.DQA2.7757.5.3)
Human Chorionic Gonadotropin levels (CGA.CGB.4914.10.1)
ICOS ligand levels (ICOSLG.9303.9.3)
IGF-like family receptor 1 levels (IGFLR1.7244.16.3)
Immunoglobulin lambda-like polypeptide 1 levels (IGLL1.6485.59.3)
Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels (ISLR2.13124.20.3)
Immunoglobulin superfamily DCC subclass member 3 levels (IGDCC3.11952.1.3)
Immunoglobulin superfamily DCC subclass member 4 levels (IGDCC4.9793.145.3)
Heterogeneous nuclear ribonucleoproteins C1/C2 levels (HNRNPC.11429.80.3)
Hexokinase-1 levels (HK1.13131.5.3)
Hexokinase-2 levels (HK2.13130.150.3)
High mobility group protein B1 levels (HMGB1.2524.56.3)
High mobility group protein B2 levels (HMGB2.6913.189.3)
High mobility group protein B3 levels (HMGB3.12775.6.3)
Histatin-1 levels (HTN1.10608.9.3)
Histidine triad nucleotide-binding protein 1 levels (HINT1.5900.11.2)
Histo-blood group ABO system transferase levels (ABO.9253.52.3)
Histone acetyltransferase KAT6A levels (KAT6A.2865.77.2)
Histone deacetylase complex subunit SAP18 levels (SAP18.12830.4.3)
Histone H1x levels (H1FX.12709.63.3)
Histone-lysine N-methyltransferase 2C levels (KMT2C.11402.17.3)
Histone-lysine N-methyltransferase 2D levels (MLL2.13623.4.3)
Histone-lysine N-methyltransferase EHMT2 levels (EHMT2.5843.60.3)
HLA class II histocompatibility antigen, DM alpha chain levels (HLA.DMA.10639.1.3)
Epidermal growth factor levels (EGF.5509.7.3)
Epididymal secretory protein E1 levels (NPC2.6259.60.3)
Epididymal-specific lipocalin-10 levels (LCN10.13007.66.3)
Epididymis-specific alpha-mannosidase levels (MAN2B2.9251.28.3)
Epiphycan levels (EPYC.9278.9.3)
ER membrane protein complex subunit 1 levels (EMC1.11989.35.3)
ER membrane protein complex subunit 4 levels (EMC4.13516.46.3)
Erlin-1 levels (ERLIN1.8776.10.3)
ERO1-like protein alpha levels (ERO1L.7060.2.3)
ERO1-like protein beta levels (ERO1LB.7994.41.3)
Erythrocyte band 7 integral membrane protein levels (STOM.8261.51.3)
Erythroid membrane-associated protein levels (ERMAP.8631.13.3)
Estrogen sulfotransferase levels (SULT1E1.9878.3.3)
ETS domain-containing protein Elk-1 levels (ELK1.10006.25.3)
ETS domain-containing protein Elk-3 levels (ELK3.5707.55.3)
Eukaryotic initiation factor 4A-III levels (EIF4A3.4997.19.1)
Eukaryotic translation initiation factor 1A, X-chromosomal levels (EIF1AX.9850.38.3)
Endostatin levels (COL18A1.2201.17.6)
Endothelial cell-selective adhesion molecule levels (ESAM.7841.84.3)
Endothelial differentiation-related factor 1 levels (EDF1.12415.122.3)
Endothelial monocyte-activating polypeptide 2 levels (AIMP1.2714.78.2)
Endothelin-2 levels (EDN2.12574.36.3)
Endothelin-converting enzyme 1 levels (ECE1.3611.70.4)
Enhancer of rudimentary homolog levels (ERH.11614.29.3)
Eotaxin levels (CCL11.5301.7.3)
Ephrin type-A receptor 1 levels (EPHA1.3431.54.2)
Ephrin type-A receptor 5 levels (EPHA5.14089.41.3)
Ephrin type-B receptor 2 levels (EPHB2.8225.86.3)
Ephrin type-B receptor 3 levels (EPHB3.9220.7.3)
Ephrin type-B receptor 6 levels (EPHB6.5078.82.3)
Ephrin-B1 levels (EFNB1.5746.37.3)
Ephrin-B3 levels (EFNB3.7785.1.3)
EH domain-binding protein 1 levels (EHBP1.12813.18.3)
Elafin levels (PI3.4982.54.1)
ELAV-like protein 1 levels (ELAVL1.11592.1.3)
EMILIN-3 levels (EMILIN3.8773.172.3)
Ena/VASP-like protein levels (EVL.11656.110.3)
Endogenous retrovirus group V member 1 Env polyprotein levels (ERVV.1.12531.5.3)
Endoglin levels (ENG.4908.6.1)
Endoplasmic reticulum aminopeptidase 1 levels (ERAP1.4964.67.1)
Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)
Endoplasmic reticulum lectin 1 levels (ERLEC1.8957.72.3)
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase levels (MAN1B1.7071.23.4)
Endoplasmic reticulum resident protein 44 levels (ERP44.6064.4.3)
Endoplasmin levels (HSP90B1.6393.63.3)
Triacylglyceroloxid(53:3)_[M+NH4]1+ levels
Plasma ANGPTL8 levels
Fibroblast growth factor 7 levels (FGF7.14031.18.3)
Fibroblast growth factor 8 isoform A levels (FGF8.4394.71.2)
Fibronectin type III domain-containing protein 5 levels (FNDC5.8041.5.3)
Ficolin-1 levels (FCN1.3613.62.5)
Ficolin-2 levels (FCN2.3313.21.2)
Filamin-A levels (FLNA.11124.9.3)
Follistatin-related protein 1 levels (FSTL1.13112.179.3)
Follistatin-related protein 4 levels (FSTL4.9350.3.3)
Forkhead box protein J2 levels (FOXJ2.14204.55.3)
Four-jointed box protein 1 levels (FJX1.7921.65.3)
Fractalkine levels (CX3CL1.2827.23.2)
Fructose-1,6-bisphosphatase 1 levels (FBP1.7206.20.3)
Fructose-2,6-bisphosphatase TIGAR levels (TIGAR.12476.50.3)
Fructose-bisphosphate aldolase A levels (ALDOA.5864.10.3)
Fumarylacetoacetase levels (FAH.11424.4.3)
Furin levels (FURIN.6276.16.3)
Galactoside 3(4)-L-fucosyltransferase levels (FUT3.4548.4.2)
Anthracycline-induced cardiotoxicity in breast cancer
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 levels (B3GAT3.6897.38.3)
Galanin peptides levels (GAL.13389.8.3)
Galanin-like peptide levels (GALP.9398.30.3)
Galectin-2 levels (LGALS2.3033.57.1)
Galectin-7 levels (LGALS7.9196.8.3)
Galectin-9 levels (LGALS9.9197.4.3)
Gamma-aminobutyric acid receptor-associated protein-like 1 levels (GABARAPL1.12661.44.3)
Gamma-aminobutyric acid receptor-associated protein-like 2 levels (GABARAPL2.12494.99.3)
Gamma-aminobutyric acid type B receptor subunit 2 levels (GABBR2.13948.50.3)
Gamma-enolase levels (ENO2.11083.23.3)
Gamma-glutamyl hydrolase levels (GGH.9370.69.3)
Gamma-interferon-inducible protein 16 levels (IFI16.12893.159.3)
Gap junction alpha-1 protein levels (GJA1.9937.7.3)
Gastrin-releasing peptide levels (GRP.8339.72.3)
Facial morphology (segment 13)
Facial morphology (segment 19)
Sialic acid-binding Ig-like lectin 7 levels (SIGLEC7.2742.68.2)
Sialic acid-binding Ig-like lectin 8 levels (SIGLEC8.7864.3.3)
Sialic acid-binding Ig-like lectin 9 levels (SIGLEC9.3007.7.2)
Signal peptidase complex catalytic subunit SEC11C levels (SEC11C.10658.28.3)
Signal transducer and activator of transcription 1-alpha/beta levels (STAT1.12351.25.3)
Single Ig IL-1-related receptor levels (SIGIRR.8326.63.3)
Ski-like protein levels (SKIL.14670.1.3)
SLAM family member 5 levels (CD84.8770.136.3)
General transcription factor II-I levels (GTF2I.13609.11.3)
Glia maturation factor gamma levels (GMFG.13062.4.3)
Glia-derived nexin levels (SERPINE2.3217.74.2)
Glucagon levels (GCG.4891.50.1)
Glucokinase levels (GCK.12960.9.3)
Glucosamine 6-phosphate N-acetyltransferase levels (GNPNAT1.13954.9.3)
Glucosamine-6-phosphate isomerase 1 levels (GNPDA1.8909.77.3)
Glucose-6-phosphate isomerase levels (GPI.4272.46.2)
Glucosidase 2 subunit beta levels (PRKCSH.5687.5.3)
Atopic dermatitis (moderate to severe)
Glycolipid transfer protein domain-containing protein 2 levels (GLTPD2.7948.129.3)
Glycoprotein endo-alpha-1,2-mannosidase levels (MANEA.8014.359.3)
Glycoprotein hormone alpha-2 levels (GPHA2.6395.58.3)
Glycoprotein Xg levels (XG.8044.90.3)
Glycosaminoglycan xylosylkinase levels (FAM20B.7198.197.3)
Glycosyltransferase 8 domain-containing protein 1 levels (GLT8D1.8955.60.3)
Glycylpeptide N-tetradecanoyltransferase 1 levels (NMT1.5196.7.3)
Glypican-1 levels (GPC1.8697.38.3)
Glypican-5 levels (GPC5.4991.12.1)
Glypican-6 levels (GPC6.5350.14.2)
Golgi membrane protein 1 levels (GOLM1.8983.7.3)
Golgi SNAP receptor complex member 1 levels (GOSR1.7805.52.3)
Soluble E-selectin levels (adjusted for ABO rs2519093 genotypes)
Postoperative venous thromboembolism
Growth/differentiation factor 11/8 levels (GDF11.MSTN.2765.4.3)
Growth/differentiation factor 15 levels (GDF15.4374.45.2)
Growth/differentiation factor 5 levels (GDF5.2752.62.2)
GTP-binding protein GEM levels (GEM.12817.1.3)
Guanine nucleotide-binding protein G(k) subunit alpha levels (GNAI3.12650.43.3)
Guanylate-binding protein 6 levels (GBP6.7818.101.3)
SLAM family member 6 levels (SLAMF6.5128.53.3)
SLAM family member 7 levels (SLAMF7.5487.7.3)
SLIT and NTRK-like protein 3 levels (SLITRK3.10565.19.3)
Small integral membrane protein 9 levels (SMIM9.8888.33.3)
Small ubiquitin-related modifier 3 levels (SUMO3.14623.26.3)
Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) levels (SLC6A14.13053.6.3)
Ascending aorta maximum area
Soluble urokinase plasminogen activator receptor levels
Sodium-coupled monocarboxylate transporter 1 levels (SLC5A8.13691.10.3)
Sodium/potassium-transporting ATPase subunit alpha-1 levels (ATP1A1.11993.227.3)
Sodium/potassium-transporting ATPase subunit beta-2 levels (ATP1B2.7218.87.3)
Solute carrier family 22 member 16 levels (SLC22A16.9969.8.3)
Solute carrier family 35 member G2 levels (SLC35G2.13501.10.3)
SPARC levels (SPARC.3043.49.2)
SPARC-like protein 1 levels (SPARCL1.4467.49.2)
SPARC-related modular calcium-binding protein 1 levels (SMOC1.13118.5.3)
Spectrin alpha chain, non-erythrocytic 1 levels (SPTAN1.5031.10.1)
Sperm acrosome membrane-associated protein 3 levels (SPACA3.8076.4.3)
Sperm-associated antigen 11A levels (SPAG11A.5726.49.3)
Spermatogenesis-associated protein 20 levels (SPATA20.11117.2.3)
Spliceosome RNA helicase DDX39B levels (DDX39B.9742.59.3)
Splicing factor 1 levels (SF1.12777.11.3)
Spondin-1 levels (SPON1.4297.62.3)
Stabilin-1 levels (STAB1.14599.18.3)
Stabilin-2 levels (STAB2.3399.31.2)
Stathmin-2 levels (STMN2.10900.272.3)
Synaptotagmin-11 levels (SYT11.7089.42.3)
Synaptotagmin-like protein 4 levels (SYTL4.11563.51.3)
Syntaxin-10 levels (STX10.12842.43.3)
Guanylyl cyclase-activating protein 1 levels (GUCA1A.10008.43.3)
Haloacid dehalogenase-like hydrolase domain-containing protein 2 levels (HDHD2.13472.35.3)
Haptoglobin levels (HP.3054.3.2)
Heat shock 70 kDa protein 1-like levels (HSPA1L.12041.33.3)
Heat shock 70 kDa protein 6 levels (HSPA6.13672.3.3)
Hematopoietic progenitor cell antigen CD34 levels (CD34.9023.9.3)
Hematopoietic prostaglandin D synthase levels (HPGDS.12549.33.3)
Heme oxygenase 2 levels (HMOX2.2622.18.1)
HemK methyltransferase family member 2 levels (N6AMT1.11096.57.3)
Hemoglobin subunit theta-1 levels (HBQ1.7965.25.3)
Hemoglobin subunit zeta levels (HBZ.6919.3.3)
Meat consumption
Syntaxin-1A levels (STX1A.3766.51.4)
Syntaxin-2 levels (STX2.7738.299.3)
Syntaxin-7 levels (STX7.8274.64.3)
Syntaxin-8 levels (STX8.10903.50.3)
T-cell surface glycoprotein CD3 epsilon chain levels (CD3E.8069.85.3)
T-cell surface protein tactile levels (CD96.9735.44.3)
T-lymphocyte surface antigen Ly-9 levels (LY9.3324.51.1)
t-SNARE domain-containing protein 1 levels (TSNARE1.7069.9.4)
Talin-2 levels (TLN2.14082.56.3)
Tapasin levels (TAPBP.12378.71.3)
Tapasin-related protein levels (TAPBPL.6364.7.3)
Tartrate-resistant acid phosphatase type 5 levels (ACP5.3232.28.2)
Tax1-binding protein 3 levels (TAX1BP3.12498.12.3)
Tenascin levels (TNC.4155.3.2)
Serum calcium levels
Serum cadmium levels
Serum aluminum levels
Serum arsenic levels
Serum barium levels
COVID-19 (hospitalized vs not hospitalized)
Free cholesterol to total lipids ratio in IDL
Serum iron levels
Serum manganese levels
Serum molybdenum levels
Serum chromium levels
Serum copper levels
Phosphatidylcholine(38:5)_[M+H]1+/Phosphatidylethanolamine(41:5)_[M+H]1+/Phosphatidate(43:6)_[M+NH4]1+ levels
Right unilateral cleft lip and palate
Ceramide_42:2_[M-H]1- levels
Ceramide_42:2_[M+H-H2O]1+ levels
Ceramide(40:0)_[M-H]1- levels
Ceramide(40:1)_[M-H]1- levels
Ceramide(40:2)_[M-H]1- levels
Ceramide(41:0)_[M-H]1- levels
Ceramide(41:1)_[M-H]1- levels
Suicide related phenotype (feeling that the life was not worth living) in bipolar disorder
Sortilin levels (ELISA)
Sortilin levels (OLINK)
Hypertensive renal disease
Android fat mass
Visceral adipose tissue mass
Visceral adipose tissue volume
Gynoid lean mass
Trunk fat/peripheral fat ratio
Android total mass
Trunk total mass
Arm fat mass
Gynoid bone mass
Trunk bone mineral content
Arm total mass
Leg total mass
Gynoid fat mass
Leg fat mass
Android bone mass
Serum levels of protein BRF1
Serum levels of protein BRICD5
Serum levels of protein BRPF1
Serum levels of protein BST2
Serum levels of protein BTC
Serum levels of protein BTD
Serum levels of protein BTNL8
Serum levels of protein C10orf105
Serum levels of protein C10orf35
Serum levels of protein C10orf54
Serum levels of protein C11orf87
Serum levels of protein C14orf180
Serum levels of protein C4BPA
Serum levels of protein C4orf32
Serum levels of protein C5
Serum levels of protein C5;C6
Serum levels of protein C5orf38
Serum levels of protein C5orf46
Serum levels of protein C5orf63
Serum levels of protein C6orf226
Serum levels of protein C6orf25
Serum levels of protein C6orf58
Dihomo-linolenoylcarnitine (C20:3n3 or 6) levels
Dihomo-linoleoylcarnitine (C20:2) levels
Azelaoyltaurine levels
Hexanoylglutamine levels
5alpha-androstan-3alpha,17alpha-diol monosulfate levels
5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels
5alpha-androstan-3beta,17beta-diol monosulfate (2) levels
Androsterone sulfate levels
Epiandrosterone sulfate levels
Carnitine levels
1-oleoyl-2-linoleoyl-GPE (18:1/18:2) levels
1,2-dilinoleoyl-GPC (18:2/18:2) levels
Docosatrienoate (22:3n6) levels
Stearoyl-arachidonoyl-glycerol (18:0/20:4) [1] levels
1-linoleoyl-GPE (18:2) levels
1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels
1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels
1-arachidonoyl-GPC (20:4) levels
1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels
1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] levels
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels
1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) levels
17alpha-hydroxypregnanolone glucuronide levels
Androsterone glucuronide levels
Superior frontal cortical thickness
Middle temporal cortical thickness
Inferior parietal cortical thickness
5alpha-androstan-3alpha,17beta-diol monosulfate (2) levels
Bilirubin (E,E) levels
Bilirubin (E,Z or Z,E) levels
4-guanidinobutanoate levels
Imidazole lactate levels
3-methylglutaconate levels
3-methylglutarylcarnitine (2) levels
N-acetylkynurenine (2) levels
N-acetylleucine levels
N-acetylphenylalanine levels
Serum levels of protein CCL18
Serum levels of protein CCL19
Serum levels of protein CCL2
Serum levels of protein CCL21
Serum levels of protein CCL22
Serum levels of protein CCL23
Response to antioxidants and zinc in age-related macular degeneration (disease progression)
Serum levels of protein IL17RA
Serum levels of protein IL17RB
Serum levels of protein IL17RD
Serum levels of protein IL18R1
Serum levels of protein IL18RAP
Serum levels of protein IL19
Serum levels of protein IL1B
Serum levels of protein IL1R1
Serum levels of protein IL1R2
Serum levels of protein IL1RAP
Serum levels of protein CD3G
Serum levels of protein CD4
Serum levels of protein CD40
Serum levels of protein CD40LG
Serum levels of protein CD47
Serum levels of protein CD48
Serum levels of protein IL12B
Serum levels of protein IL12B;IL23A
Serum levels of protein IL12RB2
Serum levels of protein IL13RA1
Serum levels of protein IL15
Serum levels of protein IL15RA
Serum levels of protein IL16
Serum levels of protein CEACAM7
Serum levels of protein CEL
Serum levels of protein CELA1
Serum levels of protein CEND1
Serum levels of protein IL5RA
Serum levels of protein IL6R
Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes.s_Alistipes_sp_AP11)
Gut microbiota abundance (k_Bacteria.p_Proteobacteria.c_Gammaproteobacteria.o_Enterobacteriales.f_Enterobacteriaceae.g_Escherichia.s_Escherichia_unclassified)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales.f_Coriobacteriaceae.g_Collinsella)
Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales)
Gut microbiota abundance (k_Bacteria.p_Firmicutes.c_Negativicutes.o_Selenomonadales)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium.s_Bifidobacterium_adolescentis)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium.s_Bifidobacterium_bifidum)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Bifidobacteriales.f_Bifidobacteriaceae.g_Bifidobacterium.s_Bifidobacterium_longum)
Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales.f_Coriobacteriaceae.g_Collinsella.s_Collinsella_aerofaciens)
Thoracic aortic aneurysms
Serum levels of protein CFL1
Serum levels of protein CFP
Serum levels of protein CFTR
Serum levels of protein CGA;FSHB
Serum levels of protein CGA;TSHB
Serum levels of protein CGREF1
Serum levels of protein CHGA
Serum levels of protein CHI3L2
Serum levels of protein CHIC2
Serum levels of protein CHIT1
Serum levels of protein CHKB
Serum levels of protein CHL1
Multiple myeloma or monoclonal gammopathy of undetermined significance
Erythropoietin levels
S100 calcium-binding protein levels
Thymus and reactivation regulated chemokine levels
Serum levels of protein FMR1
Serum levels of protein FN1
Serum levels of protein FNDC5
Serum levels of protein FOLH1
Serum levels of protein FOLR3
Serum levels of protein FOXJ2
Serum levels of protein FOXRED1
Serum levels of protein B4GAT1
Serum levels of protein CAPG
Serum levels of protein CAPN1;CAPNS1
Serum levels of protein CAPN2
Serum levels of protein CASC4
Serum levels of protein CASP2
Serum levels of protein CASQ1
Serum levels of protein CAST
Serum levels of protein CAT
Serum levels of protein CBLN1
Serum levels of protein CBLN4
Serum levels of protein CBR1
Cardio-cerebrovascular disease in diabetes mellitus
Serum levels of protein IL1RL1
Serum levels of protein IL1RL2
Serum levels of protein IL21
Serum levels of protein IL22
Serum levels of protein IL22RA1
Serum levels of protein IL22RA2
Serum levels of protein IL23R
Serum levels of protein IL27RA
Serum levels of protein IL32
Serum levels of protein IL34
Serum levels of protein ISM2
Serum levels of protein ISOC1
Serum levels of protein ITGB2
Serum levels of protein ITGB6
Serum levels of protein ITIH1
Serum levels of protein ITIH2
Serum levels of protein ITIH3
Serum levels of protein ITIH4
Serum levels of protein ITSN1
Serum levels of protein JAG1
Serum levels of protein JAK2
Serum levels of protein JAKMIP3
Serum levels of protein CEP57
Serum levels of protein KLK1
Serum levels of protein KLK10
Serum levels of protein KLK11
Serum levels of protein KLK12
Serum levels of protein KLK13
Serum levels of protein KLK14
Serum levels of protein KLK15
Serum levels of protein CLEC2D
Serum levels of protein CLEC2L
Serum levels of protein CLEC3B
Serum levels of protein CLEC4A
Serum levels of protein CLEC4E
Serum levels of protein CLEC4G
Serum levels of protein CLEC5A
Serum levels of protein CLEC6A
Serum levels of protein CLEC7A
Serum levels of protein CLGN
Serum levels of protein CLIC1
Serum levels of protein CLIC5
Serum levels of protein CLK2
Serum levels of protein CLMP
Serum levels of protein CLPS
Serum levels of protein CLPSL1
Serum levels of protein CMPK1
Coronary artery disease or fibrinogen levels (pleiotropy)
Urticaria
Ventricular arrhythmia
Zoster infection
Response to ustekinumab in psoriasis (improvement)
High-sensitivity cardiac troponin T levels (MTAG)
High-sensitivity cardiac troponin I concentration (MTAG)
Plasma amyloid beta 40 levels
Plasma amyloid beta 42 levels
Plasma glial fibrillary acidic protein levels
Plasma amyloid beta 42 to 40 ratio
Coronary artery disease or tissue plasminogen activator levels (pleiotropy)
Plasma amyloid beta 42 levels in Alzheimer disease
Plasma neurofilament light levels in Alzheimer disease
Plasma glial fibrillary acidic protein levels in Alzheimer disease
Plasma p-tau181 levels in Alzheimer disease
Plasma amyloid beta 42 to 40 ratio in Alzheimer disease
Cholesterol to total lipids ratio in large HDL
Acute myeloid leukemia (all cytogenetic sub-types)
Acute myeloid leukemia (normal cytogenetics)
Familial colorectal cancer
Non-familial colorectal cancer
Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy)
Myeloid cell surface antigen CD33 levels
Plexin-C1 levels
Polymeric immunoglobulin receptor levels
Programmed cell death 1 ligand 2 levels
Properdin levels
N-acylethanolamine-hydrolyzing acid amidase levels
Proprotein convertase subtilisin/kexin type 7 levels
NAD-dependent protein deacetylase sirtuin-2 levels
NADPH--cytochrome P450 reductase levels
Proto-oncogene tyrosine-protein kinase receptor Ret levels
Repulsive guidance molecule A levels
OCIA domain-containing protein 1 levels
Neurexophilin-1 levels
P-selectin levels
Peptidyl-prolyl cis-trans isomerase D levels
Peptidyl-prolyl cis-trans isomerase E levels
Persulfide dioxygenase ETHE1, mitochondrial levels
Neutral ceramidase levels
Plasma kallikrein levels
Neutrophil collagenase levels
Nidogen-1 levels
NKG2-D type II integral membrane protein levels
Serine/threonine-protein kinase 17B levels
Serum amyloid A-1 protein levels
Serum amyloid P-component levels
Sialic acid-binding Ig-like lectin 14 levels
Sialic acid-binding Ig-like lectin 6 levels
Sialic acid-binding Ig-like lectin 9 levels
SLAM family member 7 levels
Complement C4b levels
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial levels
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels
Non-receptor tyrosine-protein kinase TYK2 levels
N-acetyl-D-glucosamine kinase levels
Protein jagged-1 levels
Natural cytotoxicity triggering receptor 3 levels
OX-2 membrane glycoprotein levels
Neurogenic locus notch homolog protein 1 levels
Phospholipase A2, membrane associated levels
Plasma protease C1 inhibitor levels
Plasminogen activator inhibitor 1 levels
Platelet glycoprotein 4 levels
Platelet glycoprotein VI levels
Platelet-derived growth factor receptor beta levels
Retinoic acid receptor responder protein 2 levels
S-formylglutathione hydrolase levels
Scavenger receptor class F member 1 levels
Secreted frizzled-related protein 3 levels
Semaphorin-3A levels
Semaphorin-3E levels
Serine protease 27 levels
Small nuclear ribonucleoprotein F levels
SPARC-like protein 1 levels
Superoxide dismutase [Mn], mitochondrial levels
T-lymphocyte surface antigen Ly-9 levels
Tenascin levels
Teratocarcinoma-derived growth factor 1 levels
Thioredoxin domain-containing protein 12 levels
Thrombospondin-2 levels
Toll-like receptor 4:Lymphocyte antigen 96 complex levels
Transforming growth factor-beta-induced protein ig-h3 levels
A disintegrin and metalloproteinase with thrombospondin motifs 5 levels
Abelson tyrosine-protein kinase 2 levels
Acid sphingomyelinase-like phosphodiesterase 3a levels
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 levels
Afamin levels
Alcohol dehydrogenase [NADP(+)] levels
Alkaline phosphatase, tissue-nonspecific isozyme levels
alpha-1-antichymotrypsin complex levels
Alpha-1-antitrypsin levels
Alpha-2-HS-glycoprotein levels
Angiogenin levels
Cholesteryl ester(20:5)_[M+NH4]1+ levels
Phosphatidylcholine(40:8)_[M+H]1+ levels
Type 1 diabetes with low genetic risk score
Phosphatidylethanolamine_38:5_[M-H]1- levels
Symptoms in placebo-treated COVID-19 outpatients at risk of severe disease (time to remission)
Symptoms in COVID-19 outpatients at risk of severe disease (time to remission)
Phosphatidylethanolamine-O(38:4)_[M-H]1-/Phosphatidylcholine-O(35:4)_[M-H]1-/Phosphatidylcholine-P(35:3)_[M-H]1- levels
Diacylglycerol_38:5_[M+H-H2O]1+ levels
Trypanosoma cruzi infection
Candida albicans stimulated MCP-2 levels
Candida albicans stimulated CCL3 levels
Candida albicans stimulated MMP-1 levels
Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)
Candida albicans stimulated IL-8 levels
Platelet-to-lymphocyte ratio
Diacylglycerol(34:0)_[M+H-H2O]1+ levels
Diacylglycerol(34:1)_[M+H-H2O]1+ levels
Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)
Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)
Diacylglycerol(36:2)_[M+H-H2O]1+ levels
Diacylglycerol(36:2)_[M+NH4]1+ levels
Human milk oligosaccharide concentration (2'-fucosyllactose)
Human milk oligosaccharide concentration (3'-fucosyllactose) in secretors
Human milk oligosaccharide concentration (difucosyllacto-N-hexaose) in non-secretors
Human milk oligosaccharide concentration (difucosyllacto-N-tetrose)
Human milk oligosaccharide concentration (difucosyllacto-N-tetrose) in secretors
Human milk oligosaccharide concentration (difucosyllactose)
Human milk oligosaccharide concentration (fucodisialyllacto-N-hexaose)
Human milk oligosaccharide concentration (fucosyllacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I) in secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose II)
Human milk oligosaccharide concentration (lacto-N-fucopentaose II) in secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose III)
Phosphatidylethanolamine(36:4)_[M-H]1- levels
Phosphatidylcholine(45:0)_[M-H]1- levels
Phosphatidylethanolamine_25:0_[M-H]1- levels
Phosphatidylethanolamine_34:0_[M-H]1- levels
Phosphatidylethanolamine_34:1_[M-H]1- levels
Phosphatidylcholine(42:4)_[M+OAc]1- levels
Phosphatidylethanolamine-O_34:3_[M-H]1-/Phosphatidylethanolamine-P_34:2_[M-H]1- levels
Phosphatidylethanolamine-O_36:3_[M-H]1-/Phosphatidylethanolamine-P_36:2_[M-H]1- levels
Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- levels
Phosphatidylethanolamine-O_38:3_[M-H]1-/Phosphatidylethanolamine-P_38:2_[M-H]1- levels
Phosphatidylethanolamine-O_36:4_[M-H]1-/Phosphatidylethanolamine-P_36:3_[M-H]1- levels
Phosphatidylethanolamine-O(38:6)_[M+H]1+/Phosphatidylcholine-P(35:5)_[M+H]1+ levels
JC polyomavirus VP1 antibody levels
Human polyomavirus 6 VP1 antibody levels
Anti-JC polyomavirus IgG seropositivity
WU polyomavirus VP1 antibody levels
Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)
Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)
Brain functional connectivity measurement (global efficiency)
Brain functional connectivity measurement (characteristic path length)
Brain functional connectivity measurement (louvain modularity)
Brain functional connectivity measurement (local efficiency default)
Brain functional connectivity measurement (local efficiency somatomotor)
Brain functional connectivity measurement (strength default)
Brain functional connectivity measurement (strength limbic)
Brain functional connectivity measurement (strength salience)
Brain functional connectivity measurement (strength somatomotor)
Neutrophil-to-lymphocyte ratio
Phosphatidylethanolamine(34:2)_[M+H]1+ levels
Phosphatidylethanolamine(38:5)_[M-H]1- levels
Phosphatidylethanolamine(40:2)_[M-H]1- levels
Phosphatidylethanolamine_37:3_[M-H]1- levels
Phosphatidylethanolamine_38:2_[M-H]1- levels
Phosphatidylethanolamine_38:3_[M-H]1- levels
Hemoglobin levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Total antioxidant status in non-alcoholic fatty liver disease x mastiha supplementation interaction
Interleukin-6 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Interleukin-6 gene expression levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
TNF-alpha gene expression levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Interleukin-10 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction
Glutathione peroxidase in non-alcoholic fatty liver disease x mastiha supplementation interaction
Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- levels
Phosphatidylethanolamine-O_40:4_[M-H]1-/Phosphatidylethanolamine-P_40:3_[M-H]1- levels
Phosphatidylethanolamine-O_40:5_[M-H]1-/Phosphatidylethanolamine-P_40:4_[M-H]1- levels
Diacylglycerol_34:1_[M+H-H2O]1+ levels
Diacylglycerol_34:2_[M+H-H2O]1+ levels
Diacylglycerol_44:7_[M+H-H2O]1+ levels
Diacylglycerol(32:2)_[M+H-H2O]1+ levels
Diacylglycerol(36:1)_[M+H-H2O]1+ levels
Ventral thalamic nuclei volume
Intralaminar thalamic nuclei volume
Medial thalamic nuclei volume
Posterior thalamic nuclei volume
Anterior thalamic nuclei volume
Lateral thalamic nuclei volume
Diacylglycerol(36:4)_[M+H-H2O]1+ levels
Diacylglycerol(36:4)_[M+NH4]1+ levels
Late-onset Alzheimer’s disease in APOEe4 non-carriers
Phosphatidylethanolamine(36:4)_[M+H]1+ levels
Complement factor H-related protein 4 levels
Cholesteryl ester(20:4)_[M+NH4]1+ levels
Phosphatidylethanolamine_38:4_[M-H]1- levels
Serum vitamin D-binding protein levels in type 2 diabetes
Bioavailable vitamin D levels in type 2 diabetes
Phosphatidylethanolamine-O_40:6_[M-H]1-/Phosphatidylethanolamine-P_40:5_[M-H]1- levels
Non-hodgkin's lymphoma in HIV infection
HTLV-1 associated myelopathy
hemolysis of donated blood (osmotic)
hemolysis of donated blood (oxidative)
hemolysis of donated blood (cold-storage)
Complement factor H-like 1 protein levels
Complement factor H measurement
Serum urate levels
Peritoneal solute transfer rates in kidney failure treated with peritoneal dialysis
Thrombin generation parameter (lagtime)
Thrombomodulin modified thrombin generation parameter (lagtime)
Thrombin generation parameter (time to peak thrombin generation)
Thrombin generation parameter (peak thrombin generation)
Thrombin generation parameter (endogenous thrombin potential)
Thrombomodulin modified thrombin generation parameter (endogenous thrombin potential)
Thrombomodulin sensitivity ratio (normalized endogenous thrombin potential to thrombomodulin)
Thrombomodulin sensitivity ratio (normalized peak thrombin generation to thrombomodulin)
Nausea incidence in varenicline-treated smokers
Bipolar disorder (early vs late onset)
Age at menopause
Phosphatidylethanolamine-O_38:5_[M-H]1-/Phosphatidylethanolamine-P_38:4_[M-H]1- levels
Diacylglycerol_34:3_[M+H-H2O]1+ levels
Diacylglycerol_36:1_[M+H-H2O]1+ levels
Diacylglycerol_36:2_[M+H-H2O]1+ levels
Diacylglycerol_38:6_[M+H-H2O]1+ levels
Diacylglycerol_42:7_[M+H-H2O]1+ levels
Diacylglycerol(34:3)_[M+H-H2O]1+ levels
Diacylglycerol(34:2)_[M+H-H2O]1+ levels
Diacylglycerol(34:2)_[M+NH4]1+ levels
Frozen shoulder
Phosphatidylethanolamine_35:2_[M-H]1- levels
Phosphatidylethanolamine_36:2_[M-H]1- levels
Phosphatidylethanolamine_34:2_[M-H]1- levels
Diacylglycerol_38:3_[M+H-H2O]1+ levels
Diacylglycerol_36:4_[M+H-H2O]1+ levels
Diacylglycerol_36:5_[M+H-H2O]1+ levels
Facial skin colour (CIELAB index L* value)
Facial skin colour (CIELAB index b* value)
Idiopathic central precocious puberty
Phosphatidylethanolamine_38:6_[M-H]1- levels
Phosphatidylethanolamine_39:4_[M-H]1- levels
Alcohol consumption x experiences in childhood (felt loved by family member) interaction
Diacylglycerol_38:4_[M+H-H2O]1+ levels
Pulmonary mycobacterium avium complex disease
Diacylglycerol(36:3)_[M+H-H2O]1+ levels
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors
Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis)
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors
Human milk oligosaccharide concentration (lacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-tetrose)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose b)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose c) in non-secretors
Sociability score
Frequency of friend / family visits
Attending social / leisure activities
Bullous pemphigoid
Triglyceride levels in large HDL
Vaginal microbiome MetaCyc pathway (ALL-CHORISMATE-PWY|superpathway of chorismate metabolism)
Vaginal microbiome MetaCyc pathway (ANAEROFRUCAT-PWY|homolactic fermentation)
Vaginal microbiome MetaCyc pathway (ANAGLYCOLYSIS-PWY|glycolysis III (from glucose))
Vaginal microbiome MetaCyc pathway (ARG+POLYAMINE-SYN|superpathway of arginine and polyamine biosynthesis)
Vaginal microbiome MetaCyc pathway (ARGORNPROST-PWY|arginine, ornithine and proline interconversion)
Vaginal microbiome MetaCyc pathway (ARGSYN-PWY|L-arginine biosynthesis I (via L-ornithine))
Vaginal microbiome MetaCyc pathway (ARO-PWY|chorismate biosynthesis I)
Poly(ADP-ribose) glycohydrolase ARH3 level in Chronic kidney disease with hypertension and no diabetes (17332_3)
Charged multivesicular body protein 2b level in Chronic kidney disease with hypertension and no diabetes (17350_13)
Eukaryotic translation initiation factor 4E-binding protein 1 level in Chronic kidney disease with hypertension and no diabetes (17372_5)
ADP-ribosylation factor-like protein 5B level in Chronic kidney disease with hypertension and no diabetes (17404_5)
Electron transfer flavoprotein subunit alpha, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (17435_43)
Intestinal-type alkaline phosphatase level in Chronic kidney disease with hypertension and no diabetes (17441_4)
Folate receptor alpha level in Chronic kidney disease with hypertension and no diabetes (17455_42)
Dehydrogenase/reductase SDR family member 9 level in Chronic kidney disease with hypertension and no diabetes (17467_1)
NAD-dependent protein deacetylase sirtuin-3, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (17495_141)
Signal recognition particle 14 kDa protein level in Chronic kidney disease with hypertension and no diabetes (17510_7)
N-myc-interactor level in Chronic kidney disease with hypertension and no diabetes (17512_2)
Inhibitor of growth protein 4 level in Chronic kidney disease with hypertension and no diabetes (17671_58)
Butyrophilin subfamily 3 member A3 level in Chronic kidney disease with hypertension and no diabetes (17692_2)
Paraoxonase 2 level in Chronic kidney disease with hypertension and no diabetes (22003_4)
Protein phosphatase 1B level in Chronic kidney disease with hypertension and no diabetes (22009_1)
Interferon-inducible double-stranded RNA-dependent protein kinase activator A level in Chronic kidney disease with hypertension and no diabetes (22010_36)
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (22023_3)
Dual specificity mitogen-activated protein kinase kinase 5 level in Chronic kidney disease with hypertension and no diabetes (22041_26)
Forkhead box protein O1A level in Chronic kidney disease with hypertension and no diabetes (22055_31)
Palmdelphin level in Chronic kidney disease with hypertension and no diabetes (22059_56)
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform level in Chronic kidney disease with hypertension and no diabetes (22068_5)
Beta-ureidopropionase level in Chronic kidney disease with hypertension and no diabetes (22091_14)
DDB1- and CUL4-associated factor 11 level in Chronic kidney disease with hypertension and no diabetes (22120_4)
Triglycerides to total lipids ratio in large HDL
Vaginal microbiome MetaCyc pathway (DTDPRHAMSYN-PWY|dTDP-L-rhamnose biosynthesis I)
Vaginal microbiome MetaCyc pathway (ENTBACSYN-PWY|enterobactin biosynthesis)
Vertex-wise sulcal depth
Disintegrin and metalloproteinase domain-containing protein 15 level in Chronic kidney disease with hypertension and no diabetes (9956_7)
Solute carrier family 22 member 16 level in Chronic kidney disease with hypertension and no diabetes (9969_8)
Delta-like protein 3 level in Chronic kidney disease with hypertension and no diabetes (9974_8)
Probable E3 ubiquitin-protein ligase HERC4 level in Chronic kidney disease with hypertension and no diabetes (7860_9)
DnaJ homolog subfamily C member 30 level in Chronic kidney disease with hypertension and no diabetes (7866_11)
Transmembrane protein 132A level in Chronic kidney disease with hypertension and no diabetes (7871_16)
Haptoglobin isoform 2 level in Chronic kidney disease with hypertension and no diabetes (7905_30)
Kunitz-type protease inhibitor 3 level in Chronic kidney disease with hypertension and no diabetes (7926_13)
Glycolipid transfer protein domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (7948_129)
Inter-alpha-trypsin inhibitor heavy chain H1 level in Chronic kidney disease with hypertension and no diabetes (7955_195)
MICOS complex subunit MIC10 level in Chronic kidney disease with hypertension and no diabetes (7956_11)
Hemoglobin subunit theta-1 level in Chronic kidney disease with hypertension and no diabetes (7965_25)
Cytotoxic and regulatory T-cell molecule level in Chronic kidney disease with hypertension and no diabetes (7968_15)
Ecto-ADP-ribosyltransferase 3 level in Chronic kidney disease with hypertension and no diabetes (7970_315)
Killer cell immunoglobulin-like receptor 2DL5A level in Chronic kidney disease with hypertension and no diabetes (8000_17)
Matrix-remodeling-associated protein 7 level in Chronic kidney disease with hypertension and no diabetes (8005_1)
Cathepsin B level in Chronic kidney disease with hypertension and no diabetes (8007_19)
Surfeit locus protein 1 level in Chronic kidney disease with hypertension and no diabetes (8009_121)
Glycoprotein endo-alpha-1,2-mannosidase level in Chronic kidney disease with hypertension and no diabetes (8014_359)
DnaJ homolog subfamily C member 4 level in Chronic kidney disease with hypertension and no diabetes (8016_19)
Serine protease inhibitor Kazal-type 5 level in Chronic kidney disease with hypertension and no diabetes (8028_22)
DnaJ homolog subfamily B member 14 level in Chronic kidney disease with hypertension and no diabetes (8037_53)
Protein FAM177A1 level in Chronic kidney disease with hypertension and no diabetes (8039_41)
Ferritin, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (8048_9)
Interleukin-6 receptor subunit alpha level in Chronic kidney disease with hypertension and no diabetes (8092_29)
Bacillus AY abundance in stool
Bacillus C abundance in stool
Bacillus abundance in stool
Bacillus U abundance in stool
Bacillus velezensis abundance in stool
Bacteroides A plebeius A abundance in stool
Bacteroides A plebeius abundance in stool
Bacteroides A abundance in stool
Bacteroides clarus abundance in stool
Bacteroides eggerthii abundance in stool
Bacteroides faecis abundance in stool
Bacteroides intestinalis A abundance in stool
Bacteroides sp002160055 abundance in stool
Bacteroides stercoris abundance in stool
Bacteroides thetaiotaomicron abundance in stool
Barnesiellaceae abundance in stool
Barnesiella abundance in stool
Bifidobacteriaceae abundance in stool
Bifidobacterium adolescentis abundance in stool
Bifidobacterium angulatum abundance in stool
Vaginal microbiome MetaCyc pathway (FUCCAT-PWY|fucose degradation)
Vaginal microbiome MetaCyc pathway (GALACT-GLUCUROCAT-PWY|superpathway of hexuronide and hexuronate degradation)
Vaginal microbiome MetaCyc pathway (GALACTUROCAT-PWY|D-galacturonate degradation I)
S-1-pyrroline-5-carboxylate levels in elite athletes
S-methylcysteine sulfoxide levels in elite athletes
S-methylcysteine levels in elite athletes
S-methylmethionine levels in elite athletes
1,3,7-trimethylurate levels in elite athletes
1,5-anhydroglucitol (1,5-AG) levels in elite athletes
1,7-dimethylurate levels in elite athletes
Entorhinal cortical volume (6 month visit)
Middle temporal gyrus volume (6 month visit)
Fusiform volume (6 month visit)
Hippocampal volume (6 month visit)
Alzheimer's disease assessment scale (12 month visit)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (12 month visit)
Rey auditory verbal learning test (12 month visit)
Mini-mental state examination / Folstein test (12 month visit)
Functional activities questionnaire (12 month visit)
Fluorodeoxyglucose (PET imaging) (12 month visit)
CAG-884 abundance in stool
CAG-977 abundance in stool
Caloranaerobacteraceae abundance in stool
Caloranaerobacter abundance in stool
Campylobacter D abundance in stool
Cetobacterium A abundance in stool
CHKCI006 sp900018345 abundance in stool
Chloroflexales abundance in stool
Chromatiales abundance in stool
Chromobacteriaceae abundance in stool
Citrobacter A abundance in stool
Clostridia abundance in stool
Clostridium E sporosphaeroides abundance in stool
Clostridium I abundance in stool
Clostridium M clostridioforme abundance in stool
Clostridium M sp001304855 abundance in stool
Clostridium P abundance in stool
Clostridium saudiense abundance in stool
Clostridium S felsineum abundance in stool
Clostridium tertium abundance in stool
Collinsella abundance in stool
Cholesteryl esters to total lipids ratio in large LDL
GCA-900066755 abundance in stool
GCA-900199385 sp900320755 abundance in stool
Geminocystis abundance in stool
Gemmatimonadaceae abundance in stool
Geobacteraceae abundance in stool
Geobacter C abundance in stool
Gillisia abundance in stool
Gluconobacter abundance in stool
Gordonibacter pamelaeae abundance in stool
Gordonibacter abundance in stool
Gramella abundance in stool
Haemophilus D sp001679485 abundance in stool
Halarcobacter abundance in stool
Halomonadaceae abundance in stool
Haloplasmatales abundance in stool
Helicobacter abundance in stool
Herbidospora abundance in stool
Herbinix abundance in stool
Holdemania massiliensis abundance in stool
Holdemania sp900120005 abundance in stool
Holdemania abundance in stool
Hungatella sp900155545 abundance in stool
Vaginal microbiome MetaCyc pathway (METH-ACETATE-PWY|methanogenesis from acetate)
Vaginal microbiome MetaCyc pathway (NAD-BIOSYNTHESIS-II|NAD salvage pathway II)
Free cholesterol to total lipids ratio in large LDL
Vaginal microbiome MetaCyc pathway (P125-PWY|superpathway of (R,R)-butanediol biosynthesis)
Vaginal microbiome MetaCyc pathway (P161-PWY|acetylene degradation)
Vaginal microbiome MetaCyc pathway (P162-PWY|L-glutamate degradation V (via hydroxyglutarate))
Vaginal microbiome MetaCyc pathway (P163-PWY|L-lysine fermentation to acetate and butanoate)
1-lignoceroyl-GPC (24:0) levels in elite athletes
1-linolenoyl-GPC (18:3) levels in elite athletes
1-linolenoylglycerol (18:3) levels in elite athletes
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) levels in elite athletes
1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) levels in elite athletes
1-linoleoyl-GPC (18:2) levels in elite athletes
3-phenylpropionate (hydrocinnamate) levels in elite athletes
3-ureidopropionate levels in elite athletes
1-myristoylglycerol (14:0) levels in elite athletes
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) levels in elite athletes
1-oleoyl-2-linoleoyl-GPE (18:1/18:2) levels in elite athletes
1-oleoyl-GPA (18:1) levels in elite athletes
4-acetamidobutanoate levels in elite athletes
1-oleoyl-GPC (18:1) levels in elite athletes
Vaginal microbiome MetaCyc pathway (P562-PWY|myo-inositol degradation I)
Vaginal microbiome MetaCyc pathway (PANTO-PWY|phosphopantothenate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PANTOSYN-PWY|pantothenate and coenzyme A biosynthesis I)
Vaginal microbiome MetaCyc pathway (PENTOSE-P-PWY|pentose phosphate pathway)
Vaginal microbiome MetaCyc pathway (PEPTIDOGLYCANSYN-PWY|peptidoglycan biosynthesis I (meso-diaminopimelate containing))
Vaginal microbiome MetaCyc pathway (PHOSLIPSYN-PWY|superpathway of phospholipid biosynthesis I (bacteria))
Phosphatidylcholine (20:0_20:4) levels
Phosphatidylcholine (28:0) levels
Phosphatidylcholine (31:0) (a) levels
Phosphatidylcholine (32:2) levels
Phosphatidylcholine (33:0) (b) levels
Phosphatidylcholine (33:1) levels
Phosphatidylcholine (33:2) levels
Phosphatidylcholine (34:5) levels
Phosphatidylcholine (35:5) levels
Phosphatidylcholine (36:0) levels
Phosphatidylcholine (36:6) (a) levels
Phosphatidylcholine (18:1_20:3) levels
Phosphatidylcholine (18:1_22:6) (a) levels
Phosphatidylcholine (18:2_18:2) levels
Phosphatidylcholine (18:2_20:5) levels
Total lipid levels in large LDL
Vaginal microbiome MetaCyc pathway (PROTOCATECHUATE-ORTHO-CLEAVAGE-PWY|protocatechuate degradation II (ortho-cleavage pathway))
Vaginal microbiome MetaCyc pathway (PRPP-PWY|superpathway of histidine, purine, and pyrimidine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-1269|CMP-3-deoxy-D-manno-octulosonate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-1622|formaldehyde assimilation I (serine pathway))
Amiloride-sensitive amine oxidase [copper-containing] level in Chronic kidney disease with hypertension and no diabetes (15486_126)
Endosialin level in Chronic kidney disease with hypertension and no diabetes (15491_20)
Folate receptor gamma level in Chronic kidney disease with hypertension and no diabetes (15495_9)
Left-right determination factor 2 level in Chronic kidney disease with hypertension and no diabetes (15503_20)
Alpha-N-acetylglucosaminidase level in Chronic kidney disease with hypertension and no diabetes (15509_2)
Neuronal pentraxin receptor level in Chronic kidney disease with hypertension and no diabetes (15511_37)
Serum amyloid A-1 protein level in Chronic kidney disease with hypertension and no diabetes (15515_2)
Serum amyloid A-4 protein level in Chronic kidney disease with hypertension and no diabetes (15516_12)
Serine protease 27 level in Chronic kidney disease with hypertension and no diabetes (15535_3)
D-3-phosphoglycerate dehydrogenase level in Chronic kidney disease with hypertension and no diabetes (15548_35)
Glutamyl aminopeptidase level in Chronic kidney disease with hypertension and no diabetes (15558_63)
Transmembrane protein 190 level in Chronic kidney disease with hypertension and no diabetes (10442_1)
Apolipoprotein M level in Chronic kidney disease with hypertension and no diabetes (10445_20)
Protein shisa-2 homolog level in Chronic kidney disease with hypertension and no diabetes (10449_31)
Interleukin-31 level in Chronic kidney disease with hypertension and no diabetes (10455_196)
Chitotriosidase-1 level in Chronic kidney disease with hypertension and no diabetes (10460_1)
Cytokine receptor common subunit beta level in Chronic kidney disease with hypertension and no diabetes (10512_13)
Protocadherin-9 level in Chronic kidney disease with hypertension and no diabetes (10558_26)
Cystatin-8 level in Chronic kidney disease with hypertension and no diabetes (10572_65)
Beta-2-microglobulin level in Chronic kidney disease with hypertension and no diabetes (10574_10)
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (10584_7)
Protein CASC4 level in Chronic kidney disease with hypertension and no diabetes (10613_33)
Beta-microseminoprotein level in Chronic kidney disease with hypertension and no diabetes (10620_21)
N-(2-furoyl)glycine levels in elite athletes
Tyrosine levels in elite athletes
N-methylpipecolate levels in elite athletes
O-cresol sulfate levels in elite athletes
Urate levels in elite athletes
Perfluorooctanesulfonic acid (PFOS) levels in elite athletes
Uridine levels in elite athletes
Ursodeoxycholate levels in elite athletes
Valerate levels in elite athletes
Valine levels in elite athletes
Prevotella sp000434975 abundance in stool
Prevotella sp002437285 abundance in stool
Prevotella sp002437565 abundance in stool
Prevotella sp002933775 abundance in stool
Prevotella sp900317685 abundance in stool
Prevotella sp900318625 abundance in stool
Propionibacterium freudenreichii abundance in stool
Proteus abundance in stool
Provencibacterium massiliense abundance in stool
Provencibacterium abundance in stool
Providencia abundance in stool
Pseudomonadales abundance in stool
Pseudomonas aeruginosa abundance in stool
Psychroserpens abundance in stool
Raoultella abundance in stool
RC9 sp900317925 abundance in stool
Rhodanobacter abundance in stool
Rhodococcus abundance in stool
Romboutsia ilealis abundance in stool
Roseibacillus abundance in stool
Rubneribacter sp002159915 abundance in stool
RUG013 sp001486445 abundance in stool
RUG147 sp900315495 abundance in stool
Streptococcus sanguinis abundance in stool
Succiniclasticum abundance in stool
Succinivibrionaceae abundance in stool
Succinivibrio abundance in stool
Syntrophomonadia abundance in stool
Syntrophorhabdaceae abundance in stool
Syntrophorhabdia abundance in stool
Tannerellaceae abundance in stool
Tepidanaerobacteraceae abundance in stool
Terrisporobacter othiniensis abundance in stool
Terrisporobacter abundance in stool
Thermococcaceae abundance in stool
Thermococci abundance in stool
Thermoplasmatota abundance in stool
Thermoprotei abundance in stool
Thioalkalivibrionaceae abundance in stool
TMED109 abundance in stool
Treponema D abundance in stool
RUG147 abundance in stool
RUG420 sp900317985 abundance in stool
RUG472 sp900319345 abundance in stool
RUG472 abundance in stool
Ruminococcus A sp000432335 abundance in stool
Ruminococcus C sp000437255 abundance in stool
Ruminococcus D bicirculans abundance in stool
Ruminococcus D abundance in stool
Ruminococcus E sp003521625 abundance in stool
Ruminococcus E sp900100595 abundance in stool
Ruminococcus E sp900314705 abundance in stool
Ruminococcus abundance in stool
Saccharofermentanaceae abundance in stool
Saccharomonospora abundance in stool
SAR324 abundance in stool
SM23-33 abundance in stool
Sorangium abundance in stool
Spirillospora abundance in stool
Spirochaetia abundance in stool
Sporomusales abundance in stool
Staphylococcus A fleurettii abundance in stool
Staphylococcus aureus abundance in stool
Stappia abundance in stool
Streptacidiphilus abundance in stool
Vaginal microbiome MetaCyc pathway (FAO-PWY|fatty acid &beta;-oxidation I)
Vaginal microbiome MetaCyc pathway (FASYN-ELONG-PWY|fatty acid elongation -- saturated)
Vaginal microbiome MetaCyc pathway (FASYN-INITIAL-PWY|superpathway of fatty acid biosynthesis initiation (E. coli))
Vaginal microbiome MetaCyc pathway (FERMENTATION-PWY|mixed acid fermentation)
Vaginal microbiome MetaCyc pathway (FOLSYN-PWY|superpathway of tetrahydrofolate biosynthesis and salvage)
N-acetylputrescine levels in elite athletes
N-acetylserine levels in elite athletes
N-acetylthreonine levels in elite athletes
N-acetyltryptophan levels in elite athletes
N-acetylvaline levels in elite athletes
N-alpha-acetylornithine levels in elite athletes
N-delta-acetylornithine levels in elite athletes
Sexual orientation
Urinary uromodulin levels (raw)
Urinary uromodulin levels (indexed to creatinine)
Acidobacteriales abundance in stool
Actinobacteria abundance in stool
Actinobacteriota abundance in stool
Actinomycetales abundance in stool
Agathobacter sp000434275 abundance in stool
Akkermansia muciniphila B abundance in stool
Aliivibrio abundance in stool
Alistipes shahii abundance in stool
Alistipes abundance in stool
Alloprevotella abundance in stool
Alteromonadaceae abundance in stool
An181 abundance in stool
An7 abundance in stool
Anaeromassilibacillus sp001305115 abundance in stool
Aneurinibacillaceae abundance in stool
Aneurinibacillales abundance in stool
AR31 abundance in stool
Atopobiaceae abundance in stool
Aureimonas abundance in stool
Azorhizobium abundance in stool
Bacillaceae A abundance in stool
Bacillales A abundance in stool
Bacilli A abundance in stool
Whole-brain volume (baseline)
Entorhinal cortical volume (baseline)
Middle temporal gyrus volume (baseline)
Fusiform volume (baseline)
Hippocampal volume (baseline)
Alzheimer's disease assessment scale (6 month visit)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (6 month visit)
Rey auditory verbal learning test (6 month visit)
Mini-mental state examination / Folstein test (6 month visit)
Functional activities questionnaire (6 month visit)
Alzheimer's disease assessment scale (baseline)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (baseline)
Rey auditory verbal learning test (baseline)
Mini-mental state examination / Folstein test (baseline)
Functional activities questionnaire (baseline)
Fluorodeoxyglucose (PET imaging) (baseline)
Amyloid (PET imaging) (baseline)
Cerebrospinal fluid amyloid beta 42 levels (baseline)
Cerebrospinal fluid t-tau levels (baseline)
Cerebrospinal fluid p-tau levels (baseline)
ER4 sp002437735 abundance in stool
Eremiobacterota abundance in stool
Erysipelatoclostridiaceae abundance in stool
Escherichia flexneri abundance in stool
Escherichia abundance in stool
Eubacterium F sp000434115 abundance in stool
Eubacterium I ramulus A abundance in stool
Eubacterium Q abundance in stool
Eubacterium R coprostanoligenes abundance in stool
Eubacterium R sp000431535 abundance in stool
Ezakiellaceae abundance in stool
F0428 abundance in stool
Faecalibacterium prausnitzii E abundance in stool
Faecalibacterium sp002160895 abundance in stool
Faecalicatena glycyrrhizinilyticum abundance in stool
Faecalicatena lactaris abundance in stool
Faecalicatena sp000364245 abundance in stool
Faecalicatena sp001517425 abundance in stool
Faecalicatena sp002161355 abundance in stool
Faecalicatena sp002397985 abundance in stool
Faecalicatena torques abundance in stool
Faecalicoccus pleomorphus abundance in stool
Faecalicoccus abundance in stool
1-oleoyl-GPE (18:1) levels in elite athletes
1-oleoyl-GPG (18:1) levels in elite athletes
4-ethylphenylsulfate levels in elite athletes
1-oleoyl-GPI (18:1) levels in elite athletes
Bladder cancer adjusted for industrial classification factors
Bladder cancer in selected industrial classification factors (Information and communications, Scientific research, professional and technical services, Government, except elsewhere classified)
Bladder cancer adjusted for occupational classification factors
Bladder cancer in selected occupational classification factor (security workers)
Bladder cancer in selected industrial classification factors within Construction, Manufacturing, and Transport and Postal Services
Proteasome subunit beta type-10 level in Chronic kidney disease with hypertension and no diabetes (21861_8)
Cytosolic Fe-S cluster assembly factor NUBP2 level in Chronic kidney disease with hypertension and no diabetes (21863_11)
Cerebellin-2 level in Chronic kidney disease with hypertension and no diabetes (21887_2)
Fibulin-7 level in Chronic kidney disease with hypertension and no diabetes (21891_31)
Interferon lambda-4 level in Chronic kidney disease with hypertension and no diabetes (21895_36)
IL-17/ IL-17F level in Chronic kidney disease with hypertension and no diabetes (21897_4)
Coagulation Factor XI level in Chronic kidney disease with hypertension and no diabetes (2190_55)
Ubiquitin thioesterase otulin level in Chronic kidney disease with hypertension and no diabetes (21916_82)
Ubiquitin-like modifier-activating enzyme 7 level in Chronic kidney disease with hypertension and no diabetes (21933_7)
C-C motif chemokine 14 level in Chronic kidney disease with hypertension and no diabetes (2900_53)
C-C motif chemokine 23 level in Chronic kidney disease with hypertension and no diabetes (2913_1)
Cytochrome P450 3A4 level in Chronic kidney disease with hypertension and no diabetes (2943_5)
Luteinizing hormone level in Chronic kidney disease with hypertension and no diabetes (2953_31)
Neutrophil collagenase level in Chronic kidney disease with hypertension and no diabetes (2954_56)
Vascular cell adhesion protein 1 level in Chronic kidney disease with hypertension and no diabetes (2967_8)
Serine/threonine-protein kinase receptor R3 level in Chronic kidney disease with hypertension and no diabetes (2969_11)
Platelet glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (2973_15)
C-X-C motif chemokine 5 level in Chronic kidney disease with hypertension and no diabetes (2979_8)
Growth-regulated alpha protein level in Chronic kidney disease with hypertension and no diabetes (2985_35)
Gro-gamma level in Chronic kidney disease with hypertension and no diabetes (2986_49)
Methyl glucopyranoside (alpha + beta) levels in elite athletes
Methyl-4-hydroxybenzoate sulfate levels in elite athletes
Tryptophan betaine levels in elite athletes
Tryptophan levels in elite athletes
Phospholipids to total lipids ratio in large HDL
Collagen alpha-1(VI) chain level in Chronic kidney disease with hypertension and no diabetes (16828_8)
Maleylacetoacetate isomerase level in Chronic kidney disease with hypertension and no diabetes (16872_248)
MAM domain-containing glycosylphosphatidylinositol anchor protein 1 level in Chronic kidney disease with hypertension and no diabetes (16900_29)
Monocyte differentiation antigen CD14, soluble level in Chronic kidney disease with hypertension and no diabetes (16914_104)
Toll-like receptor 3 level in Chronic kidney disease with hypertension and no diabetes (16918_198)
Hemoglobin subunit beta level in Chronic kidney disease with hypertension and no diabetes (17137_160)
Interferon regulatory factor 3 level in Chronic kidney disease with hypertension and no diabetes (17151_84)
Killer cell immunoglobulin-like receptor 2DL3 level in Chronic kidney disease with hypertension and no diabetes (17153_46)
Prostaglandin E synthase 3 level in Chronic kidney disease with hypertension and no diabetes (17154_2)
Ubiquitin-conjugating enzyme E2 G1 level in Chronic kidney disease with hypertension and no diabetes (17158_17)
Annexin A4 level in Chronic kidney disease with hypertension and no diabetes (17164_15)
Fibroblast growth factor 8 isoform F level in Chronic kidney disease with hypertension and no diabetes (17166_4)
Protein Wnt-10b level in Chronic kidney disease with hypertension and no diabetes (21940_12)
Aryl hydrocarbon receptor nuclear translocator level in Chronic kidney disease with hypertension and no diabetes (21951_32)
CD109 antigen level in Chronic kidney disease with hypertension and no diabetes (3290_50)
Contactin-2 level in Chronic kidney disease with hypertension and no diabetes (3296_92)
Cystatin-F level in Chronic kidney disease with hypertension and no diabetes (3302_58)
Delta-like protein 4 level in Chronic kidney disease with hypertension and no diabetes (3305_6)
Low affinity immunoglobulin gamma Fc region receptor II-a level in Chronic kidney disease with hypertension and no diabetes (3309_2)
Low affinity immunoglobulin gamma Fc region receptor II-b level in Chronic kidney disease with hypertension and no diabetes (3310_62)
Heparin cofactor 2 level in Chronic kidney disease with hypertension and no diabetes (3316_58)
Leucine-rich repeats and immunoglobulin-like domains protein 3 level in Chronic kidney disease with hypertension and no diabetes (3322_52)
T-lymphocyte surface antigen Ly-9 level in Chronic kidney disease with hypertension and no diabetes (3324_51)
Carbonic anhydrase 6 level in Chronic kidney disease with hypertension and no diabetes (3352_80)
Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex level in Chronic kidney disease with hypertension and no diabetes (3358_51)
Vaginal microbiome MetaCyc pathway (CATECHOL-ORTHO-CLEAVAGE-PWY|catechol degradation to &beta;-ketoadipate)
Vaginal microbiome MetaCyc pathway (CENTFERM-PWY|pyruvate fermentation to butanoate)
Vaginal microbiome MetaCyc pathway (COA-PWY|coenzyme A biosynthesis I)
Vaginal microbiome MetaCyc pathway (CODH-PWY|reductive acetyl coenzyme A pathway)
Methionine sulfone levels in elite athletes
Methylsuccinate levels in elite athletes
N-acetyl-1-methylhistidine levels in elite athletes
N-acetyl-3-methylhistidine levels in elite athletes
N-acetyl-aspartyl-glutamate (NAAG) levels in elite athletes
Survival in colon cancer (proximal)
Survival in colon cancer (distal)
Mini-mental state examination / Folstein test (24 month visit)
Functional activities questionnaire (24 month visit)
Fluorodeoxyglucose (PET imaging) (24 month visit)
Amyloid (PET imaging) (24 month visit)
Cerebrospinal fluid amyloid beta 42 levels (24 month visit)
Cerebrospinal fluid t-tau levels (24 month visit)
Cerebrospinal fluid p-tau levels (24 month visit)
Whole-brain volume (24 month visit)
Entorhinal cortical volume (24 month visit)
Total ventricular volume (24 month visit)
Middle temporal gyrus volume (24 month visit)
Fusiform volume (24 month visit)
Hippocampal volume (24 month visit)
Alzheimer's disease assessment scale (baseline)(adjusted for APOE e4 dosage)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (baseline)(adjusted for APOE e4 dosage)
CAG-269 sp001916065 abundance in stool
CAG-269 sp002372935 abundance in stool
CAG-273 sp003507395 abundance in stool
CAG-273 sp003534295 abundance in stool
CAG-274 sp000432155 abundance in stool
CAG-302 abundance in stool
CAG-345 sp000433315 abundance in stool
CAG-349 abundance in stool
CAG-390 sp003523225 abundance in stool
CAG-433 abundance in stool
CAG-448 sp000433415 abundance in stool
CAG-448 sp003150135 abundance in stool
CAG-448 abundance in stool
CAG-449 abundance in stool
CAG-452 sp000434035 abundance in stool
CAG-452 abundance in stool
CAG-465 sp000433135 abundance in stool
CAG-475 abundance in stool
CAG-485 sp002362485 abundance in stool
CAG-485 sp002404675 abundance in stool
CAG-488 sp000434055 abundance in stool
CAG-488 abundance in stool
Trans-urocanate levels in elite athletes
Tyramine O-sulfate levels in elite athletes
Urea levels in elite athletes
Vanillactate levels in elite athletes
Vanillic alcohol sulfate levels in elite athletes
Vanillylmandelate (VMA) levels in elite athletes
Arabitol/xylitol levels in elite athletes
Vaginal microbiome MetaCyc pathway (LEU-DEG2-PWY|L-leucine degradation I)
Vaginal microbiome MetaCyc pathway (MET-SAM-PWY|superpathway of S-adenosyl-L-methionine biosynthesis)
Trigonelline (N'-methylnicotinate) levels in elite athletes
2-methylcitrate/homocitrate levels in elite athletes
Aconitate [cis or trans] levels in elite athletes
Alpha-ketoglutarate levels in elite athletes
Citraconate/glutaconate levels in elite athletes
1-(1-enyl-oleoyl)-GPE (P-18:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) levels in elite athletes
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) levels in elite athletes
DNA methylation-estimated granulocyte proportions
DNA methylation GrimAge acceleration
DNA methylation Hannum age acceleration
DNA methylation-estimated plasminogen activator inhibitor-1 levels
Vaginal microbiome MetaCyc pathway (P221-PWY|octane oxidation)
Vaginal microbiome MetaCyc pathway (P23-PWY|reductive TCA cycle I)
Vaginal microbiome MetaCyc pathway (P381-PWY|adenosylcobalamin biosynthesis II (late cobalt incorporation))
Phosphatidylcholine (17:0_22:6) levels
Phosphatidylcholine (17:1_18:2) levels
Phosphatidylcholine (18:0_18:1) levels
Phosphatidylcholine (18:0_18:2) levels
Phosphatidylcholine (18:0_20:3) levels
Phosphatidylcholine (18:0_20:4) levels
1-oleoylglycerol (18:1) levels in elite athletes
1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3) levels in elite athletes
1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2) levels in elite athletes
1-palmitoleoyl-GPA (16:1) levels in elite athletes
4-hydroxyhippurate levels in elite athletes
1-palmitoleoyl-GPC (16:1) levels in elite athletes
1-palmitoleoylglycerol (16:1) levels in elite athletes
1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) levels in elite athletes
Hydroxysphingomyeline C22:2 levels
Sphingomyeline C16:0 levels
Sphingomyeline C16:1 levels
Sphingomyeline C18:0 levels
Dimethyl sulfone levels in elite athletes
Taurodeoxycholate levels in elite athletes
Taurolithocholate 3-sulfate levels in elite athletes
Ectoine levels in elite athletes
Tetradecanedioate levels in elite athletes
Theobromine levels in elite athletes
Theophylline levels in elite athletes
Eugenol sulfate levels in elite athletes
Threonate levels in elite athletes
Threonine levels in elite athletes
Ferulic acid 4-sulfate levels in elite athletes
Thymol sulfate levels in elite athletes
Glutamate receptor 4 level in Chronic kidney disease with hypertension and no diabetes (10760_107)
G-protein coupled receptor 64 level in Chronic kidney disease with hypertension and no diabetes (10767_52)
Sphingomyelin phosphodiesterase level in Chronic kidney disease with hypertension and no diabetes (10818_36)
V-set and immunoglobulin domain-containing protein 10 level in Chronic kidney disease with hypertension and no diabetes (10825_12)
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 level in Chronic kidney disease with hypertension and no diabetes (10842_7)
Sialic acid-binding Ig-like lectin 15 level in Chronic kidney disease with hypertension and no diabetes (10847_1)
Interleukin-27 subunit beta level in Chronic kidney disease with hypertension and no diabetes (10851_77)
Plexin-B2 level in Chronic kidney disease with hypertension and no diabetes (10855_55)
Desmocollin-1 level in Chronic kidney disease with hypertension and no diabetes (10882_12)
Secretory phospholipase A2 receptor level in Chronic kidney disease with hypertension and no diabetes (10916_44)
Lymphocyte function-associated antigen 3 level in Chronic kidney disease with hypertension and no diabetes (10938_13)
Alpha-2-HS-glycoprotein level in Chronic kidney disease with hypertension and no diabetes (10966_1)
Ecto-ADP-ribosyltransferase 3 level in Chronic kidney disease with hypertension and no diabetes (10970_3)
Serine protease inhibitor Kazal-type 7 level in Chronic kidney disease with hypertension and no diabetes (10974_20)
Acetylcholinesterase level in Chronic kidney disease with hypertension and no diabetes (10980_11)
Leucine-rich repeat serine/threonine-protein kinase 2 level in Chronic kidney disease with hypertension and no diabetes (10990_21)
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (11081_1)
Chitinase-3-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (11104_13)
Cadherin-17 level in Chronic kidney disease with hypertension and no diabetes (16613_3)
Lymphocyte antigen 75 level in Chronic kidney disease with hypertension and no diabetes (16620_26)
NAD(P)H-hydrate epimerase level in Chronic kidney disease with hypertension and no diabetes (16621_77)
Leukocyte cell-derived chemotaxin-2 level in Chronic kidney disease with hypertension and no diabetes (16763_11)
Ataxin-3 level in Chronic kidney disease with hypertension and no diabetes (16825_20)
Xanthosine levels in elite athletes
Xanthurenate levels in elite athletes
Thioproline levels in elite athletes
Umbelliferone sulfate levels in elite athletes
1-(1-enyl-palmitoyl)-GPE (P-16:0) levels in elite athletes
Peptidyl-prolyl cis-trans isomerase FKBP7 level in Chronic kidney disease with hypertension and no diabetes (9288_7)
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 level in Chronic kidney disease with hypertension and no diabetes (9297_12)
T-cell surface glycoprotein CD8 beta chain level in Chronic kidney disease with hypertension and no diabetes (9310_2)
Cerebellin-1 level in Chronic kidney disease with hypertension and no diabetes (9313_27)
WAP four-disulfide core domain protein 1 level in Chronic kidney disease with hypertension and no diabetes (9316_67)
Inter-alpha-trypsin inhibitor heavy chain H2 level in Chronic kidney disease with hypertension and no diabetes (9326_33)
Platelet-derived growth factor D level in Chronic kidney disease with hypertension and no diabetes (9341_1)
Small integral membrane protein 10 level in Chronic kidney disease with hypertension and no diabetes (9379_248)
Carboxypeptidase Q level in Chronic kidney disease with hypertension and no diabetes (9394_19)
Uromodulin level in Chronic kidney disease with hypertension and no diabetes (9451_20)
ADP-ribose pyrophosphatase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (9482_110)
Apolipoprotein L1 level in Chronic kidney disease with hypertension and no diabetes (9506_10)
Trimeric intracellular cation channel type B level in Chronic kidney disease with hypertension and no diabetes (9509_4)
Colipase-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (9526_3)
CUB and sushi domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (9598_23)
Cadherin-11 level in Chronic kidney disease with hypertension and no diabetes (9604_14)
Platelet-derived growth factor receptor-like protein level in Chronic kidney disease with hypertension and no diabetes (9713_67)
T-cell surface protein tactile level in Chronic kidney disease with hypertension and no diabetes (9735_44)
Patatin-like phospholipase domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (9802_27)
Dihydrofolate reductase level in Chronic kidney disease with hypertension and no diabetes (9823_2)
NAD(P)H dehydrogenase [quinone] 1 level in Chronic kidney disease with hypertension and no diabetes (9837_60)
Nuclear factor NF-kappa-B p105 subunit level in Chronic kidney disease with hypertension and no diabetes (9869_28)
Testican-3 level in Chronic kidney disease with hypertension and no diabetes (9906_21)
F-box/LRR-repeat protein 4 level in Chronic kidney disease with hypertension and no diabetes (9951_36)
Cholesterol levels in large LDL
Cholesterol to total lipids ratio in large LDL
UBA7182 abundance in stool
UBA737 sp002451855 abundance in stool
UBA737 abundance in stool
UBA7703 abundance in stool
UBA7748 sp900314535 abundance in stool
UBA8517 abundance in stool
UBA8621 abundance in stool
UBA8904 abundance in stool
UBA9475 sp002161235 abundance in stool
UBA9475 sp002161675 abundance in stool
UBP9 abundance in stool
UCG-010 sp003150215 abundance in stool
UNC496MF abundance in stool
V9D3004 abundance in stool
Veillonellaceae abundance in stool
Veillonella rogosae abundance in stool
Veillonella abundance in stool
Victivallis sp002998355 abundance in stool
Absiella dolichum abundance in stool
Acetobacteraceae abundance in stool
Acetobacterales abundance in stool
Achromobacter abundance in stool
Acidaminococcus fermentans abundance in stool
Acidaminococcus sp900315205 abundance in stool
Vaginal microbiome MetaCyc pathway (FUC-RHAMCAT-PWY|superpathway of fucose and rhamnose degradation)
N2-acetyllysine levels in elite athletes
N2,N5-diacetylornithine levels in elite athletes
N6-acetyllysine levels in elite athletes
N6,N6,N6-trimethyllysine levels in elite athletes
Cholesteryl ester levels in large LDL
CAG-495 abundance in stool
CAG-510 sp002432425 abundance in stool
CAG-552 abundance in stool
CAG-590 sp000431135 abundance in stool
CAG-632 abundance in stool
CAG-776 sp000438195 abundance in stool
CAG-776 abundance in stool
CAG-81 sp000435795 abundance in stool
CAG-822 sp000432855 abundance in stool
CAG-822 abundance in stool
CAG-826 abundance in stool
CAG-83 sp000435555 abundance in stool
CAG-83 sp002392625 abundance in stool
CAG-841 sp002479075 abundance in stool
CAG-873 sp001701165 abundance in stool
CAG-877 sp000433455 abundance in stool
CAG-877 abundance in stool
CAG-882 sp003486385 abundance in stool
CAG-884 sp000433875 abundance in stool
Fusiform volume (6 month visit)(adjusted for APOE e4 dosage)
Alzheimer's disease assessment scale (12 month visit)(adjusted for APOE e4 dosage)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (12 month visit)(adjusted for APOE e4 dosage)
Mini-mental state examination / Folstein test (12 month visit)(adjusted for APOE e4 dosage)
Functional activities questionnaire (12 month visit)(adjusted for APOE e4 dosage)
Cerebrospinal fluid amyloid beta 42 levels (12 month visit)(adjusted for APOE e4 dosage)
Whole-brain volume (12 month visit)(adjusted for APOE e4 dosage)
Entorhinal cortical volume (12 month visit)(adjusted for APOE e4 dosage)
Middle temporal gyrus volume (12 month visit)(adjusted for APOE e4 dosage)
Fusiform volume (12 month visit)(adjusted for APOE e4 dosage)
Hippocampal volume (12 month visit)(adjusted for APOE e4 dosage)
Alzheimer's disease assessment scale (24 month visit)(adjusted for APOE e4 dosage)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (24 month visit)(adjusted for APOE e4 dosage)
Rey auditory verbal learning test (24 month visit)(adjusted for APOE e4 dosage)
Mini-mental state examination / Folstein test (24 month visit)(adjusted for APOE e4 dosage)
Functional activities questionnaire (24 month visit)(adjusted for APOE e4 dosage)
Amyloid (PET imaging) (24 month visit)(adjusted for APOE e4 dosage)
Cerebrospinal fluid p-tau levels (24 month visit)(adjusted for APOE e4 dosage)
Whole-brain volume (24 month visit)(adjusted for APOE e4 dosage)
Total ventricular volume (24 month visit)(adjusted for APOE e4 dosage)
Vaginal microbiome MetaCyc pathway (HEXITOLDEGSUPER-PWY|superpathway of hexitol degradation (bacteria))
Vaginal microbiome MetaCyc pathway (HISDEG-PWY|L-histidine degradation I)
Vaginal microbiome MetaCyc pathway (HISTSYN-PWY|L-histidine biosynthesis)
Vaginal microbiome MetaCyc pathway (HOMOSER-METSYN-PWY|L-methionine biosynthesis I)
Vaginal microbiome MetaCyc pathway (HSERMETANA-PWY|L-methionine biosynthesis III)
Vaginal microbiome MetaCyc pathway (ILEUSYN-PWY|L-isoleucine biosynthesis I (from threonine))
Vaginal microbiome MetaCyc pathway (KDO-NAGLIPASYN-PWY|superpathway of (Kdo)2-lipid A biosynthesis)
N6-carboxymethyllysine levels in elite athletes
Ribitol levels in elite athletes
Ribonate levels in elite athletes
Sedoheptulose levels in elite athletes
Xylose levels in elite athletes
1-methylnicotinamide levels in elite athletes
Alpha-CEHC sulfate levels in elite athletes
2-hydroxyglutarate levels in elite athletes
Bilirubin (Z,Z) levels in elite athletes
Hydrogenophaga abundance in stool
Hyphomonas abundance in stool
Intestinimonas massiliensis abundance in stool
Jiangellaceae abundance in stool
Johnsonella ignava abundance in stool
K10 sp001941205 abundance in stool
K10 abundance in stool
Kandleria vitulina abundance in stool
Kineothrix abundance in stool
KLE1615 sp900066985 abundance in stool
KLE1615 abundance in stool
Klebsiella A abundance in stool
Klebsiella pneumoniae abundance in stool
Klebsiella abundance in stool
koll11 abundance in stool
Lachnoanaerobaculum saburreum abundance in stool
Lachnospiraceae abundance in stool
Lachnospirales abundance in stool
Lachnospira rogosae abundance in stool
Lachnospira sp000437735 abundance in stool
Lactobacillus B ruminis abundance in stool
Lactobacillus B salivarius abundance in stool
Vaginal microbiome MetaCyc pathway (NAGLIPASYN-PWY|lipid IVA biosynthesis)
Vaginal microbiome MetaCyc pathway (NONMEVIPP-PWY|methylerythritol phosphate pathway I)
Vaginal microbiome MetaCyc pathway (NONOXIPENT-PWY|pentose phosphate pathway (non-oxidative branch))
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels in elite athletes
1-(1-enyl-palmitoyl)-GPC (P-16:0) levels in elite athletes
1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4) levels in elite athletes
3-(4-hydroxyphenyl)lactate levels in elite athletes
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2) levels in elite athletes
3-aminoisobutyrate levels in elite athletes
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF) levels in elite athletes
Peripheral blood CD34+ cell levels
Methanobrevibacter B abundance in stool
Microvirga abundance in stool
Monoglobaceae abundance in stool
Monoglobus pectinilyticus abundance in stool
Monoglobus abundance in stool
Morganella abundance in stool
Mycobacteriaceae abundance in stool
Mycoplasmataceae abundance in stool
Mycoplasmatales abundance in stool
Mycoplasmoidaceae abundance in stool
Negativibacillus massiliensis abundance in stool
Negativibacillus sp000435195 abundance in stool
Negativibacillus abundance in stool
NK4A144 abundance in stool
Odoribacter laneus abundance in stool
Olsenella C abundance in stool
Omnitrophota abundance in stool
Paceibacteria abundance in stool
Paenibacillales abundance in stool
Paenibacillus J abundance in stool
Pandoraea abundance in stool
Parabacteroides johnsonii abundance in stool
Parabacteroides sp000436495 abundance in stool
Parabacteroides abundance in stool
Diablo homolog, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (3122_6)
Gro-beta level in Chronic kidney disease with hypertension and no diabetes (3148_49)
Myeloid cell surface antigen CD33 level in Chronic kidney disease with hypertension and no diabetes (3166_92)
Arylsulfatase B level in Chronic kidney disease with hypertension and no diabetes (3172_28)
N-acylethanolamine-hydrolyzing acid amidase level in Chronic kidney disease with hypertension and no diabetes (3173_49)
A disintegrin and metalloproteinase with thrombospondin motifs 13 level in Chronic kidney disease with hypertension and no diabetes (3175_51)
Coagulation factor VII level in Chronic kidney disease with hypertension and no diabetes (3184_25)
Platelet glycoprotein VI level in Chronic kidney disease with hypertension and no diabetes (3194_36)
Granulysin level in Chronic kidney disease with hypertension and no diabetes (3195_50)
Kallikrein-12 level in Chronic kidney disease with hypertension and no diabetes (3199_54)
Neutral ceramidase level in Chronic kidney disease with hypertension and no diabetes (3212_30)
Nidogen-1 level in Chronic kidney disease with hypertension and no diabetes (3213_65)
Semaphorin-3A level in Chronic kidney disease with hypertension and no diabetes (3222_11)
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (3235_50)
Angiotensin-converting enzyme level in Chronic kidney disease with hypertension and no diabetes (10714_7)
Heparan sulfate glucosamine 3-O-sulfotransferase 5 level in Chronic kidney disease with hypertension and no diabetes (10731_10)
SLIT and NTRK-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (10743_13)
Chromodomain Y-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (10752_8)
Prokineticin-2 level in Chronic kidney disease with hypertension and no diabetes (10754_113)
Ficolin-1 level in Chronic kidney disease with hypertension and no diabetes (15582_25)
Complement factor H-related protein 2 level in Chronic kidney disease with hypertension and no diabetes (15584_9)
Vitamin D-binding protein level in Chronic kidney disease with hypertension and no diabetes (15589_1)
Interleukin-6 receptor subunit alpha level in Chronic kidney disease with hypertension and no diabetes (15602_43)
Leukocyte immunoglobulin-like receptor subfamily A member 2 level in Chronic kidney disease with hypertension and no diabetes (15614_168)
Pregnancy-specific beta-1-glycoprotein 1 level in Chronic kidney disease with hypertension and no diabetes (15631_18)
Tomoregulin-1 level in Chronic kidney disease with hypertension and no diabetes (15641_20)
Biotinidase level in Chronic kidney disease with hypertension and no diabetes (15644_1)
Collagen alpha-1(X) chain level in Chronic kidney disease with hypertension and no diabetes (15653_9)
Complement C1q-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (15670_15)
Inhibin beta C chain level in Chronic kidney disease with hypertension and no diabetes (15686_49)
Complement factor H-related protein 5 level in Chronic kidney disease with hypertension and no diabetes (16055_3)
Cation-independent mannose-6-phosphate receptor level in Chronic kidney disease with hypertension and no diabetes (16057_6)
Nidogen-2 level in Chronic kidney disease with hypertension and no diabetes (16060_99)
Ephrin type-A receptor 4 level in Chronic kidney disease with hypertension and no diabetes (16288_17)
Triggering receptor expressed on myeloid cells 2 level in Chronic kidney disease with hypertension and no diabetes (16300_4)
Cadherin-11 level in Chronic kidney disease with hypertension and no diabetes (16305_10)
B- and T-lymphocyte attenuator level in Chronic kidney disease with hypertension and no diabetes (16308_14)
Dickkopf-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (16309_30)
Myocilin level in Chronic kidney disease with hypertension and no diabetes (16558_2)
Alpha-1B-glycoprotein level in Chronic kidney disease with hypertension and no diabetes (16561_9)
Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] level in Chronic kidney disease with hypertension and no diabetes (16583_8)
Fas apoptotic inhibitory molecule 1 level in Chronic kidney disease with hypertension and no diabetes (16594_44)
Complement C1q and tumor necrosis factor-related protein 9A level in Chronic kidney disease with hypertension and no diabetes (16605_2)
Interleukin-18-binding protein level in Chronic kidney disease with hypertension and no diabetes (3073_51)
Vaginal microbiome MetaCyc pathway (ASPASN-PWY|superpathway of L-aspartate and L-asparagine biosynthesis)
Vaginal microbiome MetaCyc pathway (BIOTIN-BIOSYNTHESIS-PWY|biotin biosynthesis I)
Vaginal microbiome MetaCyc pathway (BRANCHED-CHAIN-AA-SYN-PWY|superpathway of branched amino acid biosynthesis)
Vaginal microbiome MetaCyc pathway (CALVIN-PWY|Calvin-Benson-Bassham cycle)
Pyrraline levels in elite athletes
Retinal levels in elite athletes
Succinimide levels in elite athletes
Sulfate levels in elite athletes
Tartarate levels in elite athletes
Tartronate (hydroxymalonate) levels in elite athletes
IGF-1 and IGFBP-3 levels (bivariate analysis)
Proteoglycan 3 level in Chronic kidney disease with hypertension and no diabetes (9015_1)
Oxysterols receptor LXR-beta level in Chronic kidney disease with hypertension and no diabetes (9016_12)
Lactase-phlorizin hydrolase level in Chronic kidney disease with hypertension and no diabetes (9017_58)
Butyrophilin-like protein 8 level in Chronic kidney disease with hypertension and no diabetes (9026_40)
Torsin-1A-interacting protein 1 level in Chronic kidney disease with hypertension and no diabetes (9039_47)
Janus kinase and microtubule-interacting protein 3 level in Chronic kidney disease with hypertension and no diabetes (9068_17)
UPF0258 protein KIAA1024 level in Chronic kidney disease with hypertension and no diabetes (9075_121)
C-type lectin domain family 4 member C level in Chronic kidney disease with hypertension and no diabetes (9094_5)
Uncharacterized protein C5orf46 level in Chronic kidney disease with hypertension and no diabetes (9100_32)
Protein FAM3B level in Chronic kidney disease with hypertension and no diabetes (9177_6)
Interferon alpha/beta receptor 1 level in Chronic kidney disease with hypertension and no diabetes (9183_7)
Trefoil factor 2 level in Chronic kidney disease with hypertension and no diabetes (9191_8)
Prolactin receptor level in Chronic kidney disease with hypertension and no diabetes (9224_20)
Roundabout homolog 4 level in Chronic kidney disease with hypertension and no diabetes (9232_1)
Palmitoyl-protein thioesterase 1 level in Chronic kidney disease with hypertension and no diabetes (9244_27)
Epididymis-specific alpha-mannosidase level in Chronic kidney disease with hypertension and no diabetes (9251_28)
Histo-blood group ABO system transferase level in Chronic kidney disease with hypertension and no diabetes (9253_52)
Triggering receptor expressed on myeloid cells 1 level in Chronic kidney disease with hypertension and no diabetes (9266_1)
Carboxypeptidase A4 level in Chronic kidney disease with hypertension and no diabetes (9267_2)
Biotinidase level in Chronic kidney disease with hypertension and no diabetes (9269_7)
Cysteine-rich secretory protein 2 level in Chronic kidney disease with hypertension and no diabetes (9282_12)
UBA1448 abundance in stool
UBA1611 abundance in stool
UBA1777 sp002320035 abundance in stool
UBA1777 sp900316255 abundance in stool
UBA1777 sp900319275 abundance in stool
UBA1777 sp900319835 abundance in stool
UBA2658 sp002841545 abundance in stool
UBA2821 abundance in stool
UBA2922 sp900313925 abundance in stool
UBA3282 sp002493835 abundance in stool
UBA3792 abundance in stool
UBA3855 sp900316885 abundance in stool
UBA5394 sp002409725 abundance in stool
UBA6382 abundance in stool
UBA6398 sp002451695 abundance in stool
UBA6398 abundance in stool
UBA644 abundance in stool
UBA6960 abundance in stool
UBA7102 sp002315655 abundance in stool
UBA7177 sp002491225 abundance in stool
UBA7177 abundance in stool
UBA7182 sp002491115 abundance in stool
Treponemataceae abundance in stool
Turicibacteraceae abundance in stool
Turicibacter sp001543345 abundance in stool
Turicibacter abundance in stool
UBA1033 sp001695555 abundance in stool
UBA1066 sp900317515 abundance in stool
UBA1066 abundance in stool
UBA11471 sp000434215 abundance in stool
UBA11471 abundance in stool
UBA1191 abundance in stool
UBA11963 sp002362595 abundance in stool
UBA11963 abundance in stool
UBA1206 sp000433115 abundance in stool
UBA1375 sp002305795 abundance in stool
UBA1407 abundance in stool
UBA1409 abundance in stool
UBA1417 sp003531055 abundance in stool
UBA1446 sp002329245 abundance in stool
UBA1448 sp002329405 abundance in stool
N-formylanthranilic acid levels in elite athletes
N-formylmethionine levels in elite athletes
N-formylphenylalanine levels in elite athletes
N-methylproline levels in elite athletes
N-trimethyl 5-aminovalerate levels in elite athletes
Mini-mental state examination / Folstein test (baseline)(adjusted for APOE e4 dosage)
Functional activities questionnaire (baseline)(adjusted for APOE e4 dosage)
Amyloid (PET imaging) (baseline)(adjusted for APOE e4 dosage)
Whole-brain volume (baseline)(adjusted for APOE e4 dosage)
Entorhinal cortical volume (baseline)(adjusted for APOE e4 dosage)
Middle temporal gyrus volume (baseline)(adjusted for APOE e4 dosage)
Fusiform volume (baseline)(adjusted for APOE e4 dosage)
Alzheimer's disease assessment scale (6 month visit)(adjusted for APOE e4 dosage)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (6 month visit)(adjusted for APOE e4 dosage)
Mini-mental state examination / Folstein test (6 month visit)(adjusted for APOE e4 dosage)
Functional activities questionnaire (6 month visit)(adjusted for APOE e4 dosage)
Whole-brain volume (6 month visit)(adjusted for APOE e4 dosage)
Entorhinal cortical volume (6 month visit)(adjusted for APOE e4 dosage)
Middle temporal gyrus volume (6 month visit)(adjusted for APOE e4 dosage)
Vaginal microbiome MetaCyc pathway (GLYOXYLATE-BYPASS|glyoxylate cycle)
Vaginal microbiome MetaCyc pathway (GOLPDLCAT-PWY|superpathway of glycerol degradation to 1,3-propanediol)
Vaginal microbiome MetaCyc pathway (HEME-BIOSYNTHESIS-II|heme biosynthesis I (aerobic))
Vaginal microbiome MetaCyc pathway (HEMESYN2-PWY|heme biosynthesis II (anaerobic))
Arabonate/xylonate levels in elite athletes
Galactonate levels in elite athletes
Mannitol/sorbitol levels in elite athletes
2-aminobutyrate levels in elite athletes
N-acetylglucosamine/N-acetylgalactosamine levels in elite athletes
Middle temporal gyrus volume (24 month visit)(adjusted for APOE e4 dosage)
Fusiform volume (24 month visit)(adjusted for APOE e4 dosage)
Elusimicrobia abundance in stool
Elusimicrobiota abundance in stool
Emergencia abundance in stool
Endozoicomonadaceae abundance in stool
Enorma massiliensis abundance in stool
Ensifer abundance in stool
Enterobacteriaceae abundance in stool
Enterococcaceae abundance in stool
Enterococcus A abundance in stool
Enterococcus B abundance in stool
Enterococcus faecalis abundance in stool
Enterococcus abundance in stool
Enteroscipio abundance in stool
Vaginal microbiome MetaCyc pathway (LACTOSECAT-PWY|lactose and galactose degradation I)
N1-Methyl-2-pyridone-5-carboxamide levels in elite athletes
N1-Methyl-4-pyridone-3-carboxamide levels in elite athletes
Nicotinamide levels in elite athletes
Pyridoxal levels in elite athletes
Quinolinate levels in elite athletes
Retinol (Vitamin A) levels in elite athletes
Lactobacillus B abundance in stool
Lactococcus lactis abundance in stool
Lawsonibacter sp000492175 abundance in stool
Lawsonibacter sp002161175 abundance in stool
Lawsonibacter sp900066645 abundance in stool
Leclercia abundance in stool
Lentimicrobiaceae abundance in stool
Leptospirae abundance in stool
Leptospirales abundance in stool
Leuconostoc mesenteroides abundance in stool
Leuconostoc abundance in stool
Magnetospirillum A abundance in stool
Marinilabiliaceae abundance in stool
Massiliomicrobiota sp002160815 abundance in stool
Massiliomicrobiota abundance in stool
Megamonas funiformis abundance in stool
Megamonas abundance in stool
Megasphaera elsdenii abundance in stool
Megasphaera sp900066485 abundance in stool
Megasphaera abundance in stool
Merdibacter massiliensis abundance in stool
Methanobacterium B abundance in stool
Vaginal microbiome MetaCyc pathway (OANTIGEN-PWY|O-antigen building blocks biosynthesis (E. coli))
Vaginal microbiome MetaCyc pathway (P105-PWY|TCA cycle IV (2-oxoglutarate decarboxylase))
Vaginal microbiome MetaCyc pathway (P108-PWY|pyruvate fermentation to propanoate I)
Vaginal microbiome MetaCyc pathway (P122-PWY|heterolactic fermentation)
Vaginal microbiome MetaCyc pathway (P124-PWY|Bifidobacterium shunt)
1-(1-enyl-stearoyl)-2-oleoyl-GPE (P-18:0/18:1) levels in elite athletes
1-(1-enyl-stearoyl)-GPE (P-18:0) levels in elite athletes
1-arachidonoyl-GPA (20:4) levels in elite athletes
1-arachidonoyl-GPC (20:4n6) levels in elite athletes
1-arachidonoyl-GPE (20:4n6) levels in elite athletes
Vaginal microbiome MetaCyc pathway (P42-PWY|incomplete reductive TCA cycle)
Vaginal microbiome MetaCyc pathway (P441-PWY|superpathway of N-acetylneuraminate degradation)
Vaginal microbiome MetaCyc pathway (P461-PWY|hexitol fermentation to lactate, formate, ethanol and acetate)
3-methyl-2-oxobutyrate levels in elite athletes
3-methyl-2-oxovalerate levels in elite athletes
1-linoleoyl-GPI (18:2) levels in elite athletes
1-linoleoylglycerol (18:2) levels in elite athletes
1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) levels in elite athletes
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) levels in elite athletes
3-methylhistidine levels in elite athletes
3-methylxanthine levels in elite athletes
Phosphatidylcholine (18:0_22:4) levels
Phosphatidylcholine (18:0_22:5) (n3) levels/Phosphatidylcholine (20:1_20:4) levels
Phosphatidylcholine (18:0_22:5) (n6) levels
Phosphatidylcholine (18:0_22:6) levels
Phosphatidylcholine (18:1_18:1) levels
Phosphatidylcholine (18:1_18:2) levels
Vaginal microbiome MetaCyc pathway (PPGPPMET-PWY|ppGpp biosynthesis)
4-methyl-2-oxopentanoate levels in elite athletes
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels in elite athletes
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) levels in elite athletes
4-vinylphenol sulfate levels in elite athletes
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) levels in elite athletes
Interleukin-17 receptor A level in Chronic kidney disease with hypertension and no diabetes (2992_59)
Mannose-binding protein C level in Chronic kidney disease with hypertension and no diabetes (3000_66)
Sialic acid-binding Ig-like lectin 9 level in Chronic kidney disease with hypertension and no diabetes (3007_7)
Ck-beta-8-1 level in Chronic kidney disease with hypertension and no diabetes (3028_36)
CD209 antigen level in Chronic kidney disease with hypertension and no diabetes (3029_52)
Interleukin-19 level in Chronic kidney disease with hypertension and no diabetes (3035_80)
C-X-C motif chemokine 11 level in Chronic kidney disease with hypertension and no diabetes (3038_9)
C-type mannose receptor 2 level in Chronic kidney disease with hypertension and no diabetes (3041_55)
C-C motif chemokine 18 level in Chronic kidney disease with hypertension and no diabetes (3044_3)
Resistin level in Chronic kidney disease with hypertension and no diabetes (3046_31)
Haptoglobin level in Chronic kidney disease with hypertension and no diabetes (3054_3)
Complement component C9 level in Chronic kidney disease with hypertension and no diabetes (3060_43)
Growth/differentiation factor 9 level in Chronic kidney disease with hypertension and no diabetes (3067_67)
Pro-FMRFamide-related neuropeptide FF level in Chronic kidney disease with hypertension and no diabetes (5617_41)
CMRF35-like molecule 8 level in Chronic kidney disease with hypertension and no diabetes (5630_48)
Cartilage acidic protein 1 level in Chronic kidney disease with hypertension and no diabetes (5632_6)
GDP-fucose protein O-fucosyltransferase 1 level in Chronic kidney disease with hypertension and no diabetes (5634_39)
Ribonuclease 4 level in Chronic kidney disease with hypertension and no diabetes (5644_60)
Ribonuclease K6 level in Chronic kidney disease with hypertension and no diabetes (5646_20)
Chymotrypsinogen B2 level in Chronic kidney disease with hypertension and no diabetes (5648_28)
Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)
Protein disulfide-isomerase TMX3 level in Chronic kidney disease with hypertension and no diabetes (5654_70)
Sphingomyeline C18:1 levels
Sphingomyeline C20:2 levels
Sphingomyeline C24:0 levels
Sphingomyeline C24:1 levels
Spermidine levels
Symmetric dimethylarginine levels
Tetradecadienylcarnitine levels
Tetradecanoylcarnitine levels
Tetradecenoylcarnitine levels
Threonine levels
trans-Hydroxyproline levels
Tryptophan levels
Valerylcarnitine levels
Valine levels
Thyroxine levels in elite athletes
Gluconate levels in elite athletes
Indolin-2-one levels in elite athletes
Isoeugenol sulfate levels in elite athletes
Lanthionine levels in elite athletes
Fetuin-B level in Chronic kidney disease with hypertension and no diabetes (3367_8)
Interleukin-17 receptor D level in Chronic kidney disease with hypertension and no diabetes (3376_49)
Tryptase beta-2 level in Chronic kidney disease with hypertension and no diabetes (3403_1)
Calcium/calmodulin-dependent protein kinase type 1D level in Chronic kidney disease with hypertension and no diabetes (3418_12)
Ephrin type-A receptor 1 level in Chronic kidney disease with hypertension and no diabetes (3431_54)
Interleukin-18 receptor 1 level in Chronic kidney disease with hypertension and no diabetes (3446_7)
Kallistatin level in Chronic kidney disease with hypertension and no diabetes (3449_58)
Kallikrein-6 level in Chronic kidney disease with hypertension and no diabetes (3450_4)
Spermatogenesis-associated protein 20 level in Chronic kidney disease with hypertension and no diabetes (11117_2)
Ras-related protein Rab-17 level in Chronic kidney disease with hypertension and no diabetes (11118_107)
Noelin-3 level in Chronic kidney disease with hypertension and no diabetes (11143_32)
UPF0606 protein KIAA1549L level in Chronic kidney disease with hypertension and no diabetes (11145_72)
Heat shock 70 kDa protein 1A level in Chronic kidney disease with hypertension and no diabetes (11157_35)
C-type lectin domain family 12 member A level in Chronic kidney disease with hypertension and no diabetes (11187_11)
T-box transcription factor TBX5 level in Chronic kidney disease with hypertension and no diabetes (11202_70)
Fibroblast growth factor-binding protein 3 level in Chronic kidney disease with hypertension and no diabetes (11219_95)
Transcobalamin-1 level in Chronic kidney disease with hypertension and no diabetes (11232_46)
Transmembrane protease serine 6 level in Chronic kidney disease with hypertension and no diabetes (11239_49)
Adhesion G-protein coupled receptor F1 level in Chronic kidney disease with hypertension and no diabetes (11243_90)
Filamin-A level in Chronic kidney disease with hypertension and no diabetes (11245_43)
Calsequestrin-1 level in Chronic kidney disease with hypertension and no diabetes (11263_57)
Kremen protein 1 level in Chronic kidney disease with hypertension and no diabetes (17331_138)
Vaginal microbiome MetaCyc pathway (COLANSYN-PWY|colanic acid building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (COMPLETE-ARO-PWY|superpathway of aromatic amino acid biosynthesis)
Vaginal microbiome MetaCyc pathway (DENOVOPURINE2-PWY|superpathway of purine nucleotides de novo biosynthesis II)
N-acetyl-cadaverine levels in elite athletes
N-acetylalanine levels in elite athletes
N-acetylasparagine levels in elite athletes
N-acetylaspartate (NAA) levels in elite athletes
N-acetylcitrulline levels in elite athletes
N-acetylglutamate levels in elite athletes
N-acetylglutamine levels in elite athletes
Cytomegalovirus reactivation after ﻿allogeneic hematopoietic cell transplantation (﻿recipients)
Cytomegalovirus high-level reactivation after ﻿allogeneic hematopoietic cell transplantation (﻿recipients)
Cytomegalovirus infection after ﻿allogeneic hematopoietic cell transplantation (﻿recipients)
Cytomegalovirus reactivation after ﻿allogeneic hematopoietic cell transplantation (﻿donors)
Cytomegalovirus high-level reactivation after ﻿allogeneic hematopoietic cell transplantation (﻿donors)
Cytomegalovirus infection after ﻿allogeneic hematopoietic cell transplantation (﻿donors)
Bifidobacterium bifidum abundance in stool
Bifidobacterium breve abundance in stool
Bifidobacterium catenulatum abundance in stool
Bifidobacterium infantis abundance in stool
Bifidobacterium kashiwanohense abundance in stool
Bifidobacterium longum abundance in stool
Bifidobacterium pseudocatenulatum abundance in stool
Bifidobacterium ruminantium abundance in stool
Bifidobacterium abundance in stool
Bin127 abundance in stool
Blautia A sp000285855 abundance in stool
Blautia A sp002159835 abundance in stool
Blautia A sp900066145 abundance in stool
Blautia A sp900066355 abundance in stool
Blautia hansenii abundance in stool
Blautia sp000436935 abundance in stool
Blautia sp001304935 abundance in stool
Borreliaceae abundance in stool
Borreliales abundance in stool
Brachyspiraceae abundance in stool
Brachyspirae abundance in stool
Brachyspirales abundance in stool
Brachyspira abundance in stool
Brevibacillaceae abundance in stool
Vaginal microbiome MetaCyc pathway (GLCMANNANAUT-PWY|superpathway of N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminate degradation)
Vaginal microbiome MetaCyc pathway (GLUCOSE1PMETAB-PWY|glucose and glucose-1-phosphate degradation)
Vaginal microbiome MetaCyc pathway (GLUCUROCAT-PWY|superpathway of &beta;-D-glucuronide and D-glucuronate degradation)
Vaginal microbiome MetaCyc pathway (GLUTORN-PWY|L-ornithine biosynthesis)
Cathepsin H level in Chronic kidney disease with hypertension and no diabetes (8465_52)
Inactive tyrosine-protein kinase transmembrane receptor ROR1 level in Chronic kidney disease with hypertension and no diabetes (8474_6)
Faecalitalea cylindroides abundance in stool
Fervidobacteriaceae abundance in stool
Fibrobacteraceae abundance in stool
Fibrobacterales abundance in stool
Fibrobacteria abundance in stool
Fimbriimonadia abundance in stool
Firmicutes A abundance in stool
Firmicutes E abundance in stool
Firmicutes I abundance in stool
Flavobacteriales abundance in stool
Flavonifractor sp002159265 abundance in stool
Flavonifractor sp900199495 abundance in stool
Fournierella massiliensis abundance in stool
Francisellaceae abundance in stool
Francisellales abundance in stool
Fusobacteriaceae abundance in stool
Fusobacterium A abundance in stool
GCA-900066135 sp900066135 abundance in stool
GCA-900066495 sp900066495 abundance in stool
GCA-900066495 abundance in stool
GCA-900066575 sp900066385 abundance in stool
GCA-900066755 sp900066755 abundance in stool
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2) levels in elite athletes
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2) levels in elite athletes
1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-oleoyl-GPE (P-16:0/18:1) levels in elite athletes
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels in elite athletes
1-arachidonoyl-GPI (20:4) levels in elite athletes
1-arachidonylglycerol (20:4) levels in elite athletes
1-dihomo-linolenylglycerol (20:3) levels in elite athletes
3-hydroxyisobutyrate levels in elite athletes
1-dihomo-linoleoylglycerol (20:2) levels in elite athletes
Parachlamydiales abundance in stool
Paraglaciecola abundance in stool
Paramuribaculum sp001689565 abundance in stool
Pararhizobium abundance in stool
Pauljensenia sp000411415 abundance in stool
Peptococcia abundance in stool
Phascolarctobacterium sp003150755 abundance in stool
Phocea massiliensis abundance in stool
Phocea abundance in stool
Photobacterium abundance in stool
Planococcaceae abundance in stool
Poseidoniaceae abundance in stool
Prevotella bivia abundance in stool
Prevotella buccae abundance in stool
Prevotellamassilia sp000437675 abundance in stool
Prevotellamassilia abundance in stool
Primary dysmenorrhea
Vaginal microbiome MetaCyc pathway (POLYAMINSYN3-PWY|superpathway of polyamine biosynthesis II)
Vaginal microbiome MetaCyc pathway (POLYAMSYN-PWY|superpathway of polyamine biosynthesis I)
Vaginal microbiome MetaCyc pathway (POLYISOPRENSYN-PWY|polyisoprenoid biosynthesis (E. coli))
Phosphatidylcholine (38:2) levels
Phosphatidylcholine (38:4) (b) levels
Phosphatidylcholine (38:5) (a) levels
Phosphatidylcholine (38:5) (b) levels
Endometriosis or asthma (pleiotropy)
Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer
Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer
Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer
Bcl-2-like protein 1 levels (BCL2L1.4423.77.2)
Beta-defensin 119 levels (DEFB119.13455.10.3)
Bcl10-interacting CARD protein levels (C9orf89.7778.104.3)
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 levels (GCNT4.10854.15.3)
Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels (RFNG.7203.125.3)
Beta-1,4-galactosyltransferase 1 levels (B4GALT1.13381.49.3)
Beta-endorphin levels (POMC.2558.51.3)
Beta-1,4-galactosyltransferase 2 levels (B4GALT2.9595.11.3)
Beta-mannosidase levels (MANBA.6382.17.3)
Beta-microseminoprotein levels (MSMB.10620.21.3)
beta-adrenergic receptor kinase 1 levels (ADRBK1.3347.9.2)
Beta-crystallin B2 levels (CRYBB2.10000.28.3)
Beta-sarcoglycan levels (SGCB.7034.4.3)
Beta-defensin 1 levels (DEFB1.6629.3.3)
Beta-soluble NSF attachment protein levels (NAPB.12655.30.3)
Beta-defensin 105 levels (DEFB105A.10962.46.3)
Beta-defensin 112 levels (DEFB112.5689.1.3)
Bifunctional polynucleotide phosphatase/kinase levels (PNKP.13657.2.3)
Biglycan levels (BGN.13690.26.3)
Beta-defensin 128 levels (DEFB128.6360.7.3)
Beta-1,4-galactosyltransferase 6 levels (B4GALT6.10832.24.3)
Beta-1,4-glucuronyltransferase 1 levels (B3GNT1.8259.25.3)
Beta-arrestin-1 levels (ARRB1.12643.4.3)
Beta-defensin 104 levels (DEFB104A.5763.67.3)
Bile salt-activated lipase levels (CEL.9796.4.3)
Neuropathic pain
5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)
5'(3')-deoxyribonucleotidase, cytosolic type levels (NT5C.12560.9.3)
60S ribosomal protein L30 levels (RPL30.12478.15.3)
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels (ADAMTS13.3175.51.5)
A disintegrin and metalloproteinase with thrombospondin motifs 4 levels (ADAMTS4.2809.25.2)
A disintegrin and metalloproteinase with thrombospondin motifs 5 levels (ADAMTS5.3168.8.2)
A disintegrin and metalloproteinase with thrombospondin motifs 6 levels (ADAMTS6.6441.62.3)
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial levels (PDK1.5227.60.3)
Abelson tyrosine-protein kinase 2 levels (ABL2.5261.13.3)
Acid ceramidase levels (ASAH1.5748.20.3)
Arachidonate 15-lipoxygenase B levels (ALOX15B.12422.143.3)
Arf-GAP domain and FG repeat-containing protein 1 levels (AGFG1.11681.8.3)
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 levels (ACAP2.12343.14.3)
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 levels (ASAP2.13518.5.3)
Arfaptin-1 levels (ARFIP1.13488.3.3)
C-C motif chemokine 25 levels (CCL25.2705.5.2)
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 levels (PLCG1.4563.61.2)
14-3-3 protein family levels (YWHAB.YWHAE.YWHAG.YWHAH.YWHAQ.YWHAZ.SFN.4707.50.2)
14-3-3 protein zeta/delta levels (YWHAZ.5858.6.5)
15-hydroxyprostaglandin dehydrogenase [NAD(+)] levels (HPGD.4995.16.1)
2-phosphoxylose phosphatase 1 levels (ACPL2.6079.59.3)
2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)
26S proteasome non-ATPase regulatory subunit 5 levels (PSMD5.10716.35.3)
3-hydroxyanthranilate 3,4-dioxygenase levels (HAAO.5861.78.3)
39S ribosomal protein L33, mitochondrial levels (MRPL33.13453.2.3)
40S ribosomal protein S3 levels (RPS3.5026.66.1)
40S ribosomal protein S3a levels (RPS3A.5484.63.3)
40S ribosomal protein S4, X isoform levels (RPS4X.9758.17.3)
40S ribosomal protein S7 levels (RPS7.3864.5.2)
40S ribosomal protein SA levels (RPSA.4957.1.2)
Biliverdin reductase A levels (BLVRA.11382.5.3)
Bis(5'-adenosyl)-triphosphatase levels (FHIT.9826.135.3)
Bombesin receptor-activated protein C6orf89 levels (C6orf89.10885.36.3)
Bone morphogenetic protein 6 levels (BMP6.8459.10.3)
Bone morphogenetic protein 7 levels (BMP7.2972.57.2)
Bone sialoprotein 2 levels (IBSP.14023.84.3)
BPI fold-containing family B member 1 levels (BPIFB1.11246.3.3)
Brain-derived neurotrophic factor levels (BDNF.2421.7.3)
Brain-specific serine protease 4 levels (PRSS22.4534.10.2)
Breast cancer anti-estrogen resistance protein 3 levels (BCAR3.12634.79.3)
Brevican core protein levels (BCAN.3461.58.1)
BRICHOS domain-containing protein 5 levels (BRICD5.6612.90.3)
Bromodomain-containing protein 1 levels (BRD1.11607.15.3)
Brorin levels (VWC2.11121.56.3)
C-C motif chemokine 14 levels (CCL14.2900.53.3)
C-C motif chemokine 15 levels (CCL15.14109.15.3)
C-C motif chemokine 16 levels (CCL16.4913.78.1)
C-C motif chemokine 17 levels (CCL17.3519.3.2)
C-C motif chemokine 19 levels (CCL19.4922.13.1)
C-C motif chemokine 21 levels (CCL21.2516.57.3)
C-C motif chemokine 22 levels (CCL22.3508.78.3)
C-C motif chemokine 23 levels (CCL23.2913.1.2)
C-type lectin domain family 4 member M levels (CLEC4M.3030.3.2)
C-type lectin domain family 5 member A levels (CLEC5A.8282.15.3)
C-type mannose receptor 2 levels (MRC2.3041.55.2)
C-X-C motif chemokine 10 levels (CXCL10.4141.79.1)
C-X-C motif chemokine 11 levels (CXCL11.3038.9.2)
C-X-C motif chemokine 16 levels (CXCL16.2436.49.4)
C-X-C motif chemokine 5 levels (CXCL5.2979.8.2)
C1GALT1-specific chaperone 1 levels (C1GALT1C1.5735.54.3)
Cadherin-12 levels (CDH12.10701.30.3)
Cadherin-15 levels (CDH15.11215.6.3)
Cadherin-3 levels (CDH3.2643.57.2)
Cadherin-5 levels (CDH5.2819.23.2)
Cadherin-7 levels (CDH7.7959.34.3)
Cadherin-related family member 1 levels (CDHR1.8372.29.3)
Cadherin-related family member 5 levels (CDHR5.9962.1.3)
Calbindin levels (CALB1.9918.23.3)
Calcipressin-1 levels (RCAN1.13465.5.3)
Calcium/calmodulin-dependent protein kinase type 1 levels (CAMK1.3592.4.3)
Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)
Acidic leucine-rich nuclear phosphoprotein 32 family member B levels (ANP32B.4194.26.3)
Activating signal cointegrator 1 complex subunit 1 levels (ASCC1.10647.18.3)
Activator of 90 kDa heat shock protein ATPase homolog 1 levels (AHSA1.11633.89.3)
Acyl-CoA-binding domain-containing protein 6 levels (ACBD6.10075.75.3)
Acyl-CoA-binding domain-containing protein 7 levels (ACBD7.13563.259.3)
Acylphosphatase-2 levels (ACYP2.12812.25.3)
Adenosine deaminase CECR1 levels (CECR1.6077.63.3)
Adenylosuccinate synthetase isozyme 2 levels (ADSS.12644.63.3)
Adhesion G protein-coupled receptor F5 levels (ADGRF5.6409.57.3)
Adhesion G-protein coupled receptor F1 levels (ADGRF1.11243.90.3)
Adipocyte plasma membrane-associated protein levels (APMAP.10605.22.3)
Medium chain acylcarnitines levels (additive genetic model)
Medium chain acylcarnitines levels (dominant genetic model)
Long-chain dicarboxylacylcarnitines levels (additive genetic model)
Long-chain dicarboxylacylcarnitines levels (dominant genetic model)
Agouti-signaling protein levels (ASIP.5676.54.3)
Alanine--tRNA ligase, cytoplasmic levels (AARS.12340.17.3)
Alcohol dehydrogenase [NADP(+)] levels (AKR1A1.4192.10.2)
Alcohol dehydrogenase 1B levels (ADH1B.9834.62.3)
Aldehyde dehydrogenase family 3 member B1 levels (ALDH3B1.12940.35.3)
Aldehyde dehydrogenase, dimeric NADP-preferring levels (ALDH3A1.11480.1.3)
Aldo-keto reductase family 1 member C1 levels (AKR1C1.12618.50.3)
Aldose reductase levels (AKR1B1.9854.36.3)
Allergin-1 levels (MILR1.11173.29.3)
Allograft inflammatory factor 1 levels (AIF1.2849.49.1)
Alpha-(1,3)-fucosyltransferase 10 levels (FUT10.7156.2.3)
Alpha-(1,3)-fucosyltransferase 5 levels (FUT5.4549.78.2)
Alpha-(1,3)-fucosyltransferase 9 levels (FUT9.6991.24.3)
Alpha-(1,6)-fucosyltransferase levels (FUT8.8244.16.3)
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B levels (MGAT4B.7141.21.3)
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels (MGAT2.6909.40.3)
Alpha-2-antiplasmin levels (SERPINF2.3024.18.2)
Alpha-2-HS-glycoprotein levels (AHSG.3581.53.3)
Progression free survival in serous epithelial ovarian cancer
Hypoalbuminemia
Phosphatidylcholine_35:3_[M+H]1+/Phosphatidylethanolamine_38:3_[M+H]1+/Phosphatidate_40:4_[M+NH4]1+ levels
Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels
Lung cancer prognosis in former smokers
Alcohol drinking status (current drinker vs non-current drinker)
Age related hearing loss-related regional glucose metabolism (Cochlear nucleus)
Phosphatidylinositol(32:1)_[M-H]1- levels
Phosphatidylinositol(34:0)_[M-H]1- levels
Phosphatidylinositol(34:1)_[M-H]1- levels
Age related hearing loss-related regional glucose metabolism (Bilateral Heschl’s gyrus)
Age related hearing loss-related regional glucose metabolism (Inferior colliculus)
Phosphatidylinositol-O(36:0)_[M-H]1-/Phosphatidylglycerol(37:0)_[M+OAc]1- levels
Epigenetic age acceleration (Hannum) in childhood cancer survivors
Epigenetic age acceleration (Horvath) in childhood cancer survivors
Alzheimer's disease or gastroesophageal reflux disease
Fatigue in primary Sjögren's syndrome
Severe autoimmune type 2 diabetes
Severe insulin-deficient type 2 diabetes
Severe insulin-resistant type 2 diabetes
Mild obesity-related type 2 diabetes
Mild age-related type 2 diabetes
Hemorrhoids
Hernia abdominopelvic cavity
Phosphatidylinositol(38:6)_[M-H]1- levels
Lysophosphatidylcholine(15:0) levels
Phosphatidylserine(42:7)_[M+OAc]1- levels
Sphingomyelin_36:2_[M+H]1+ levels
Sphingomyelin_39:1_[M+H]1+ levels
Sphingomyelin_38:2_[M+H]1+ levels
Sphingomyelin_39:2_[M+H]1+ levels
Sphingomyelin_40:0_[M+H]1+ levels
Sphingomyelin_40:1_[M+H]1+ levels
Upper facial depth
Morphological facial height
Outercanthal width
Nasal width
Nasal protrusion
Nasal ala length
Nasal height
Lower lip height
Hair colour (natural, before greying): Red (UKB data field 1747_2)
Job coding: building or civil engineering technician, structural engineering technician, survey technician (UKB data field 22601_31143051)
Job coding: it operations technician, computer operator or technician, database manager, network or web technician, web master, systems administrator or officer (UKB data field 22601_31313060)
Job SOC coding: Travel agency managers (UKB data field 22617_1226)
Job SOC coding: Electrical engineers (UKB data field 22617_2123)
Job SOC coding: Building and civil engineering technicians (UKB data field 22617_3114)
Job SOC coding: IT operations technicians (UKB data field 22617_3131)
Job SOC coding: Travel and tour guides (UKB data field 22617_6213)
Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211)
Myopathy (PheCode 359.2)
Glaucoma (PheCode 365)
Cataract (PheCode 366)
Epiphora (PheCode 375.2)
ICD10 C50.9: Malignant neoplasm of breast of unspecified site
ICD10 C61: Malignant neoplasm of prostate
ICD10 D04.7: Carcinoma in situ of skin of lower limb, including hip
Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3)
Myocardial infarction (PheCode 411.2)
Coronary atherosclerosis (PheCode 411.4)
Atrial fibrillation and flutter (PheCode 427.2)
Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)
Esophagitis, GERD and related diseases (PheCode 530.1)
Ulcerative colitis (PheCode 555.2)
Celiac disease (PheCode 557.1)
Treatment or medication use - amlodipine (UKB data field 20003_1140879802)
Gout (PheCode 274.1)
Disorders of iron metabolism (PheCode 275.1)
Treatment or medication use - insulin product (UKB data field 20003_1140883066)
Treatment or medication use - codeine (UKB data field 20003_1140884444)
Treatment or medication use - metformin (UKB data field 20003_1140884600)
Treatment or medication use - sulfasalazine (UKB data field 20003_1140909702)
Treatment or medication use - ginkgo forte tablet (UKB data field 20003_1140911734)
Treatment or medication use - menophase tablet (UKB data field 20003_1140912212)
Treatment or medication use - venlafaxine (UKB data field 20003_1140916282)
Treatment or medication use - terbinafine (UKB data field 20003_1140927328)
Treatment or medication use - atorvastatin (UKB data field 20003_1141146234)
Treatment or medication use - elleste duet conti tablet (UKB data field 20003_1141156644)
Treatment or medication use - maxalt 5mg tablet (UKB data field 20003_1141167940)
Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)
Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410)
Treatment or medication use - ezetimibe (UKB data field 20003_1141192736)
Treatment or medication use - ezetrol 10mg tablet (UKB data field 20003_1141192740)
Treatment or medication use - saw palmetto product (UKB data field 20003_1205)
Illnesses of father: PHESANT recoding (UKB data field 20107_101)
Illnesses of father: Prostate cancer (UKB data field 20107_13)
Illnesses of father: Lung cancer (UKB data field 20107_3)
Illnesses of father: Diabetes (UKB data field 20107_9)
Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)
Illnesses of mother: Breast cancer (UKB data field 20110_5)
Wears glasses or contact lenses (UKB data field 2207)
Hearing difficulty/problems: No (UKB data field 2247_0)
Hearing difficulty/problems: Yes (UKB data field 2247_1)
Hearing difficulty/problems: I am completely deaf (UKB data field 2247_99)
Platelet response to aspirin
X-24809 levels
X-24983 levels
N2-acetyllysine levels
X-11491 levels
X-21792 levels
X-11530 levels
1-arachidonoyl-gpc (20:4n6) levels
X-24849 levels
X-11522 levels
X-21448 levels
Hexadecanedioate levels
X-11593 levels
Glycodeoxycholate glucuronide (1) levels
X-24747 levels
X-13431 levels
Sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0) levels
X-21441 levels
5alpha-pregnan-3beta,20alpha-diol monosulfate (1) levels
Fexofenadine levels
Glycocholenate sulfate levels
Taurochenodeoxycholic acid 3-sulfate levels
Valsartan levels
Naringenin levels
Childhood asthma x sex interaction
Childhood asthma
Acute appendicitis
Major depressive disorder or stroke (pleiotropy)
Treprostinil dose in pulmonary arterial hypertension
Arfaptin-2 levels (ARFIP2.12630.8.3)
Arylamine N-acetyltransferase 1 levels (NAT1.12632.14.3)
Arylsulfatase B levels (ARSB.3172.28.2)
Arylsulfatase K levels (ARSK.8269.327.3)
Aspartate aminotransferase, cytoplasmic levels (GOT1.4912.17.1)
Aspartyl/asparaginyl beta-hydroxylase levels (ASPH.6998.106.3)
Asporin levels (ASPN.6451.64.3)
C-C motif chemokine 28 levels (CCL28.2890.59.2)
C-C motif chemokine 3 levels (CCL3.3040.59.1)
C-C motif chemokine 3-like 1 levels (CCL3L1.2783.18.2)
C-C motif chemokine 7 levels (CCL7.4886.3.1)
C-C motif chemokine 8 levels (CCL8.2785.15.2)
C-reactive protein levels (CRP.4337.49.2)
C-type lectin domain family 12 member A levels (CLEC12A.11187.11.3)
C-type lectin domain family 2 member D levels (CLEC2D.7054.87.3)
C-type lectin domain family 4 member E levels (CLEC4E.7077.9.4)
C-type lectin domain family 4 member K levels (CD207.3361.26.2)
Polycystic ovary syndrome (adjusted for age)
Polycystic ovary syndrome (adjusted for age and BMI)
ABO blood group (O vs non-O)
ABO blood group (A vs non-A)
ABO blood group (B vs non-B)
ABO blood group (AB vs non-AB)
ABO blood group (A vs O)
ABO blood group (B vs O)
ABO blood group (AB vs O)
ADP-ribose pyrophosphatase, mitochondrial levels (NUDT9.9482.110.3)
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 levels (BST1.4535.50.2)
ADP-ribosylation factor 6 levels (ARF6.12425.104.3)
ADP-ribosylation factor GTPase-activating protein 2 levels (ARFGAP2.11664.32.3)
ADP-ribosylation factor-binding protein GGA1 levels (GGA1.13594.158.3)
ADP-ribosylation factor-binding protein GGA3 levels (GGA3.11683.19.3)
ADP-ribosylation factor-like protein 1 levels (ARL1.12392.30.3)
ADP-ribosylation factor-like protein 11 levels (ARL11.12433.8.3)
ADP-ribosylation factor-like protein 3 levels (ARL3.12571.14.3)
Adrenomedullin levels (ADM.14115.34.3)
Adseverin levels (SCIN.12684.5.3)
Advanced glycosylation end product-specific receptor, soluble levels (AGER.4125.52.2)
Agouti-related protein levels (AGRP.2813.11.2)
Short-chain dicarboxylacylcarnitine levels (additive genetic model)
Short-chain dicarboxylacylcarnitine levels (dominant genetic model)
alpha-2-macroglobulin receptor-associated protein levels (LRPAP1.3640.14.3)
Alpha-amylase 1 levels (AMY1A.7918.114.3)
Alpha-L-iduronidase levels (IDUA.3169.70.2)
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 levels (ST6GALNAC1.7867.154.3)
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 levels (ST6GALNAC2.7823.22.3)
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 levels (ST6GALNAC3.10626.116.3)
Alpha-synuclein levels (SNCA.8458.111.3)
Alpha-taxilin levels (TXLNA.9065.28.3)
Alpha/beta hydrolase domain-containing protein 14A levels (ABHD14A.5715.4.3)
Phosphatidylcholine (39:5) (a) levels
Phosphatidylcholine (39:5) (b) levels
Phosphatidylcholine (40:7) (a) levels
Phosphatidylcholine (40:8) levels
Alkylphosphatidylcholine (O-16:0/16:0) levels
Alkylphosphatidylcholine (O-16:0/20:3) levels
Alkylphosphatidylcholine (O-18:0/22:6) levels
Alkylphosphatidylcholine (O-18:1/18:1) levels
Alkylphosphatidylcholine (O-18:1/18:2) levels
Alkylphosphatidylcholine (O-32:1) levels
Alkylphosphatidylcholine (O-32:2) levels
Alkylphosphatidylcholine (O-34:1) levels
Alkylphosphatidylcholine (O-34:2) levels
Alkylphosphatidylcholine (O-34:4) levels
Alkylphosphatidylcholine (O-38:5) levels
Alkylphosphatidylcholine (O-40:5) levels
Alkylphosphatidylcholine (O-16:0/20:4) levels
Alkylphosphatidylcholine (O-16:0/22:6) levels
Alkylphosphatidylcholine (O-18:0/18:1) levels
Alkylphosphatidylcholine (O-18:0/18:2) levels
Alkylphosphatidylcholine (O-18:0/20:4) levels
Vaginal microbiome MetaCyc pathway (PWY-1861|formaldehyde assimilation II (RuMP Cycle))
Vaginal microbiome MetaCyc pathway (PWY-2941|L-lysine biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-2942|L-lysine biosynthesis III)
Vaginal microbiome MetaCyc pathway (PWY-3001|superpathway of L-isoleucine biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-3781|aerobic respiration I (cytochrome c))
Vaginal microbiome MetaCyc pathway (PWY-4984|urea cycle)
5-oxoproline levels in elite athletes
1-palmitoyl-2-stearoyl-GPC (16:0/18:0) levels in elite athletes
1-palmitoyl-GPA (16:0) levels in elite athletes
1-palmitoyl-GPC (16:0) levels in elite athletes
1-palmitoyl-GPE (16:0) levels in elite athletes
1-palmitoyl-GPG (16:0) levels in elite athletes
Alkenylphosphatidylcholine (P-38:5) (a) levels
Alkenylphosphatidylcholine (P-38:5) (b) levels
Phosphatidylethanolamine (15-MHDA_18:1) levels
Phosphatidylethanolamine (15-MHDA_18:2) levels
Phospholipid levels in large LDL
Phospholipids to total lipids ratio in large LDL
Vaginal microbiome MetaCyc pathway (PWY-5180|toluene degradation I (aerobic) (via o-cresol))
1-stearoyl-GPE (18:0) levels in elite athletes
1-stearoyl-GPG (18:0) levels in elite athletes
Adenine levels in elite athletes
1-stearoyl-GPI (18:0) levels in elite athletes
Adrenate (22:4n6) levels in elite athletes
1-stearoyl-GPS (18:0) levels in elite athletes
Alanine levels in elite athletes
Allantoin levels in elite athletes
1,2-dilinoleoyl-GPC (18:2/18:2) levels in elite athletes
Cutaneous melanoma (MTAG)
Phosphatidylethanolamine (16:0_22:6) levels
Phosphatidylethanolamine (16:1_18:2) levels
Phosphatidylethanolamine (16:1_20:4) levels
Phosphatidylethanolamine (17:0_18:1) levels
Triglycerides to total lipids ratio in large LDL
Phosphatidylethanolamine (38:5) (b) levels
Alkylphosphatidylethanolamine (O-16:0/18:2) levels
Alkylphosphatidylethanolamine (O-16:0/20:3) levels
Alkylphosphatidylethanolamine (O-16:0/22:6) levels
Alkylphosphatidylethanolamine (O-18:0/20:4) levels
Alkylphosphatidylethanolamine (O-18:0/22:5) levels
Alkylphosphatidylethanolamine (O-18:0/22:6) levels
Alkylphosphatidylethanolamine (O-18:1/18:2) levels
Alkylphosphatidylethanolamine (O-34:1) levels
Alkylphosphatidylethanolamine (O-38:5) (a) levels
Alkylphosphatidylethanolamine (O-38:5) (b) levels
Alkenylphosphatidylethanolamine (P-15:0/20:4) levels
Alkenylphosphatidylethanolamine (P-15:0/22:6) (a) levels
Alkenylphosphatidylethanolamine (P-15:0/22:6) (b) levels
Alkenylphosphatidylethanolamine (P-16:0/18:1) levels
Alkenylphosphatidylethanolamine (P-16:0/18:2) levels
Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)
3-hydroxybutyrate (BHBA) levels in elite athletes
3-hydroxybutyrylcarnitine (1) levels in elite athletes
3-hydroxydecanoate levels in elite athletes
Catechol sulfate levels in elite athletes
3-hydroxyhexanoate levels in elite athletes
3-hydroxylaurate levels in elite athletes
3-hydroxymyristate levels in elite athletes
3-hydroxyoctanoate levels in elite athletes
Alkenylphosphatidylethanolamine (P-16:0/20:3) (a) levels
Alkenylphosphatidylethanolamine (P-16:0/20:3) (b) levels
Alkenylphosphatidylethanolamine (P-16:0/20:4) levels
Alkenylphosphatidylethanolamine (P-16:0/20:5) levels
Alkenylphosphatidylethanolamine (P-16:0/22:5) (n3) levels
Alkenylphosphatidylethanolamine (P-16:0/22:5) (n6) levels
Alkenylphosphatidylethanolamine (P-16:0/22:6) levels
Alkenylphosphatidylethanolamine (P-17:0/20:4) (a) levels
Alkenylphosphatidylethanolamine (P-17:0/20:4) (b) levels
Alkenylphosphatidylethanolamine (P-17:0/22:6) (a) levels
Alkenylphosphatidylethanolamine (P-17:0/22:6) (b) levels
Alkenylphosphatidylethanolamine (P-18:0/18:1) levels
Cholesterol levels in large VLDL
Vaginal microbiome MetaCyc pathway (PWY-5837|1,4-dihydroxy-2-naphthoate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5838|superpathway of menaquinol-8 biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5840|superpathway of menaquinol-7 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5845|superpathway of menaquinol-9 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5747|2-methylcitrate cycle II)
Cholate levels in elite athletes
3-methylglutarate/2-methylglutarate levels in elite athletes
3b-hydroxy-5-cholenoic acid levels in elite athletes
Choline levels in elite athletes
3beta-hydroxy-5-cholestenoate levels in elite athletes
3beta,7alpha-dihydroxy-5-cholestenoate levels in elite athletes
Phosphatidylinositol (16:0_16:1) levels
Phosphatidylinositol (16:0_20:3) (a) levels
Phosphatidylinositol (16:0_20:3) (b) levels
Phosphatidylinositol (16:0_20:4) levels
Phosphatidylinositol (15-MHDA_18:1) levels/Phosphatidylinositol (17:0_18:1) levels
Phosphatidylinositol (15-MHDA_18:2) levels/Phosphatidylinositol (17:0_18:2) levels
Cholesterol to total lipids ratio in large VLDL
Vaginal microbiome MetaCyc pathway (PWY-5896|superpathway of menaquinol-10 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5897|superpathway of menaquinol-11 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5898|superpathway of menaquinol-12 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5899|superpathway of menaquinol-13 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5910|superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate))
Vaginal microbiome MetaCyc pathway (PWY-5863|superpathway of phylloquinol biosynthesis)
5alpha-androstan-3alpha,17beta-diol monosulfate (2) levels in elite athletes
5alpha-androstan-3beta,17alpha-diol disulfate levels in elite athletes
5alpha-androstan-3beta,17beta-diol monosulfate (2) levels in elite athletes
5alpha-pregnan-3(alpha or beta),20beta-diol disulfate levels in elite athletes
5alpha-pregnan-3beta-ol,20-one sulfate levels in elite athletes
5alpha-pregnan-3beta,20alpha-diol disulfate levels in elite athletes
Phosphatidylinositol (36:2) levels
Phosphatidylinositol (37:6) levels
Phosphatidylinositol (38:5) (a) levels
Phosphatidylinositol (38:5) (b) levels
Phosphatidylinositol (38:6) levels
Acylcarnitine (12:0) levels
Acylcarnitine (13:0) levels
Acylcarnitine (14:0) levels
Cholesteryl ester levels in large VLDL
Vaginal microbiome MetaCyc pathway (PWY-6269|adenosylcobalamin salvage from cobinamide II)
Vaginal microbiome MetaCyc pathway (PWY-6277|superpathway of 5-aminoimidazole ribonucleotide biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6282|palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate))
Vaginal microbiome MetaCyc pathway (PWY-6317|galactose degradation I (Leloir pathway))
Vaginal microbiome MetaCyc pathway (PWY-6353|purine nucleotides degradation II (aerobic))
Vaginal microbiome MetaCyc pathway (PWY-6383|mono-trans, poly-cis decaprenyl phosphate biosynthesis)
Serum uromodulin concentration
Cholesteryl esters to total lipids ratio in large VLDL
Acylcarnitine (17:0) (a) levels
Acylcarnitine (17:0) (b) levels
Acylcarnitine (18:0) levels
Vaginal microbiome MetaCyc pathway (PWY-6397|mycolyl-arabinogalactan-peptidoglycan complex biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6467|Kdo transfer to lipid IVA III (Chlamydia))
Vaginal microbiome MetaCyc pathway (PWY-6470|peptidoglycan biosynthesis V (&beta;-lactam resistance))
Vaginal microbiome MetaCyc pathway (PWY-6471|peptidoglycan biosynthesis IV (Enterococcus faecium))
Vaginal microbiome MetaCyc pathway (PWY-6478|GDP-D-glycero-&alpha;-D-manno-heptose biosynthesis)
Epiandrosterone sulfate levels in elite athletes
Ergothioneine levels in elite athletes
Arachidate (20:0) levels in elite athletes
Erythritol levels in elite athletes
Erythronate levels in elite athletes
Ethylmalonate levels in elite athletes
Concentration of large LDL particles
Alkenylphosphatidylcholine (P-16:0/18:2) levels
Alkenylphosphatidylcholine (P-16:0/18:3) levels
Alkenylphosphatidylcholine (P-16:0/20:4) levels
Alkenylphosphatidylcholine (P-16:0/20:5) levels
Alkenylphosphatidylcholine (P-16:0/22:6) levels
Alkenylphosphatidylcholine (P-17:0/20:4) (a) levels
Alkenylphosphatidylcholine (P-15:0/20:4) (a) levels
Alkenylphosphatidylcholine (P-15:0/20:4) (b) levels
Alkenylphosphatidylcholine (P-16:0/14:0) levels
Alkenylphosphatidylcholine (P-16:0/16:0) levels
Alkenylphosphatidylcholine (P-16:0/16:1) levels
Alkenylphosphatidylcholine (P-16:0/18:0) levels
Alkenylphosphatidylcholine (P-16:0/18:1) levels
Vaginal microbiome MetaCyc pathway (PWY-5005|biotin biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-5022|4-aminobutanoate degradation V)
Vaginal microbiome MetaCyc pathway (PWY-5100|pyruvate fermentation to acetate and lactate II)
Vaginal microbiome MetaCyc pathway (PWY-5101|L-isoleucine biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-5103|L-isoleucine biosynthesis III)
Phosphatidylethanolamine (15-MHDA_20:4) levels
Phosphatidylethanolamine (15-MHDA_22:6) levels
Phosphatidylethanolamine (16:0_16:0) levels
Phosphatidylethanolamine (16:0_16:1) levels
Vaginal microbiome MetaCyc pathway (PWY-5182|toluene degradation II (aerobic) (via 4-methylcatechol))
1,2-dipalmitoyl-GPC (16:0/16:0) levels in elite athletes
1,2-dipalmitoyl-GPE (16:0/16:0) levels in elite athletes
10-heptadecenoate (17:1n7) levels in elite athletes
Alpha-tocopherol levels in elite athletes
Phosphatidylethanolamine (18:0_18:2) levels
Phosphatidylethanolamine (18:0_20:3) (a) levels
Phosphatidylethanolamine (17:0_20:4) levels
Phosphatidylethanolamine (17:0_22:6) levels
Phosphatidylethanolamine (18:0_18:1) levels
Triglyceride levels in large LDL
Vaginal microbiome MetaCyc pathway (PWY-5484|glycolysis II (from fructose 6-phosphate))
Vaginal microbiome MetaCyc pathway (PWY-5505|L-glutamate and L-glutamine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5507|adenosylcobalamin biosynthesis I (early cobalt insertion))
Vaginal microbiome MetaCyc pathway (PWY-5509|adenosylcobalamin biosynthesis from cobyrinate a,c-diamide I)
Vaginal microbiome MetaCyc pathway (PWY-5659|GDP-mannose biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5667|CDP-diacylglycerol biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5676|acetyl-CoA fermentation to butanoate II)
Vaginal microbiome MetaCyc pathway (PWY-5677|succinate fermentation to butanoate)
Vaginal microbiome MetaCyc pathway (PWY-5686|UMP biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5695|urate biosynthesis/inosine 5'-phosphate degradation)
2-aminooctanoate levels in elite athletes
2-arachidonoylglycerol (20:4) levels in elite athletes
Arginine levels in elite athletes
Asparagine levels in elite athletes
Aspartate levels in elite athletes
2-hydroxyadipate levels in elite athletes
2-hydroxydecanoate levels in elite athletes
2-hydroxylaurate levels in elite athletes
Phosphatidylethanolamine (18:1_22:6) (b) levels
Phosphatidylethanolamine (36:0) levels
Phosphatidylethanolamine (38:5) (a) levels
Vaginal microbiome MetaCyc pathway (PWY-5705|allantoin degradation to glyoxylate III)
Bone mineral density (pelvis)
Bone mineral density (trunk)
Caffeic acid sulfate levels in elite athletes
Caffeine levels in elite athletes
Campesterol levels in elite athletes
21-hydroxypregnenolone disulfate levels in elite athletes
3-hydroxy-3-methylglutarate levels in elite athletes
Alkenylphosphatidylethanolamine (P-18:0/22:6) levels
Alkenylphosphatidylethanolamine (P-18:1/18:1) levels
Alkenylphosphatidylethanolamine (P-18:1/18:1) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/18:1) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/18:2) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/18:2) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/18:3) levels
Alkenylphosphatidylethanolamine (P-18:1/20:3) (a) levels
Alkenylphosphatidylethanolamine (P-18:0/20:3) (a) levels
Alkenylphosphatidylethanolamine (P-18:0/20:3) (b) levels
Alkenylphosphatidylethanolamine (P-18:0/20:4) levels
Alkenylphosphatidylethanolamine (P-18:0/20:5) levels
Alkenylphosphatidylethanolamine (P-18:0/22:5) (n3) levels
Alkenylphosphatidylethanolamine (P-18:0/22:5) (n6) levels
Vaginal microbiome MetaCyc pathway (PWY-5850|superpathway of menaquinol-6 biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-5855|ubiquinol-7 biosynthesis (prokaryotic))
4-cholesten-3-one levels in elite athletes
4-HDoHE levels in elite athletes
Citrate levels in elite athletes
Cortisol levels in elite athletes
Cortisone levels in elite athletes
Creatine levels in elite athletes
Alkenylphosphatidylethanolamine (P-20:0/18:2) levels
Alkenylphosphatidylethanolamine (P-20:0/20:4) levels
Alkenylphosphatidylethanolamine (P-20:0/22:6) levels
Alkenylphosphatidylethanolamine (P-20:1/20:4) levels
Alkenylphosphatidylethanolamine (P-20:1/22:6) levels
Phosphatidylglycerol (34:1) levels
Dehydroisoandrosterone sulfate (DHEA-S) levels in elite athletes
5alpha-androstan-3alpha,17alpha-diol monosulfate levels in elite athletes
Deoxycholate levels in elite athletes
5alpha-androstan-3alpha,17beta-diol disulfate levels in elite athletes
5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels in elite athletes
Dihomo-linoleate (20:2n6) levels in elite athletes
Vaginal microbiome MetaCyc pathway (PWY-5861|superpathway of demethylmenaquinol-8 biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5862|superpathway of demethylmenaquinol-9 biosynthesis)
Fasting plasma glucose in prediabetes
Postprandial glucose in prediabetes
Glycated hemoglobin levels in prediabetes
Body mass index in prediabetes
Phosphatidylinositol (18:0_22:5) (n3) levels
Phosphatidylinositol (18:0_22:5) (n6) levels
Phosphatidylinositol (18:0_22:6) levels
Phosphatidylinositol (18:1_18:2) levels
Phosphatidylinositol (20:0_20:4) levels
Phosphatidylinositol (34:1) levels
Vaginal microbiome MetaCyc pathway (PWY-6126|superpathway of adenosine nucleotides de novo biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6147|6-hydroxymethyl-dihydropterin diphosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6151|S-adenosyl-L-methionine cycle I)
Vaginal microbiome MetaCyc pathway (PWY-6163|chorismate biosynthesis from 3-dehydroquinate)
Vaginal microbiome MetaCyc pathway (PWY-621|sucrose degradation III (sucrose invertase))
Vaginal microbiome MetaCyc pathway (PWY-6263|superpathway of menaquinol-8 biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6396|superpathway of 2,3-butanediol biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-181|photorespiration)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) levels in elite athletes
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels in elite athletes
1-palmitoyl-2-oleoyl-GPI (16:0/18:1) levels in elite athletes
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1) levels in elite athletes
5-methyluridine (ribothymidine) levels in elite athletes
Alkenylphosphatidylcholine (P-18:0/22:6) levels
Alkenylphosphatidylcholine (P-18:1/22:6) levels
Alkenylphosphatidylcholine (P-20:0/20:4) levels
Alkenylphosphatidylcholine (P-36:3) levels
Early-onset myasthenia gravis
7-methylguanine levels in elite athletes
7-methylxanthine levels in elite athletes
9,10-DiHOME levels in elite athletes
1-stearoyl-GPA (18:0) levels in elite athletes
1-stearoyl-GPC (18:0) levels in elite athletes
Estimated glomerular filtration rate (creatinine)
Phosphatidylethanolamine (16:0_20:3) levels
Phosphatidylethanolamine (16:0_20:4) levels
Phosphatidylethanolamine (16:0_20:5) levels
Vaginal microbiome MetaCyc pathway (PWY-5345|superpathway of L-methionine biosynthesis (by sulfhydrylation))
Vaginal microbiome MetaCyc pathway (PWY-5347|superpathway of L-methionine biosynthesis (transsulfuration))
Vaginal microbiome MetaCyc pathway (PWY-5384|sucrose degradation IV (sucrose phosphorylase))
Vaginal microbiome MetaCyc pathway (PWY-5415|catechol degradation I (meta-cleavage pathway))
Vaginal microbiome MetaCyc pathway (PWY-5188|tetrapyrrole biosynthesis I (from glutamate))
Vaginal microbiome MetaCyc pathway (PWY-5189|tetrapyrrole biosynthesis II (from glycine))
Vaginal microbiome MetaCyc pathway (PWY-5265|peptidoglycan biosynthesis II (staphylococci))
Vaginal microbiome MetaCyc pathway (PWY-5304|superpathway of sulfur oxidation (Acidianus ambivalens))
Predicted developmental stuttering
12,13-DiHOME levels in elite athletes
13-HODE + 9-HODE levels in elite athletes
14-HDoHE/17-HDoHE levels in elite athletes
15-methylpalmitate levels in elite athletes
Androsterone sulfate levels in elite athletes
COVID-19 (critical illness vs population or mild symptoms)
COVID-19 (critical illness vs mild symptoms)
Phosphatidylethanolamine (18:1_18:2) levels
Phosphatidylethanolamine (18:1_22:6) (a) levels
Alkenylphosphatidylethanolamine (P-18:0/18:2) levels
Alkenylphosphatidylethanolamine (P-18:0/18:3) levels
Pseudouridine levels
Phosphatidylglycerol (34:2) levels
Phosphatidylglycerol (36:1) levels
Phosphatidylglycerol (36:2) levels
Phosphatidylinositol (15-MHDA_20:4) levels/Phosphatidylinositol (17:0_20:4) levels
Phosphatidylinositol (16:0/16:0) levels
Adipoylcarnitine (C6-DC) levels in elite athletes
Adrenoylcarnitine (C22:4) levels in elite athletes
Andro steroid monosulfate C19H28O6S (1) levels in elite athletes
Androstenediol (3alpha, 17alpha) monosulfate (2) levels in elite athletes
Acylcarnitine (18:2) levels
Cholesteryl ester (14:0) levels
Cholesteryl ester (15:0) levels
Cholesteryl ester (16:0) levels
Cholesteryl ester (16:1) levels
Cholesteryl ester (16:2) levels
Cholesteryl ester (17:0) levels
Cholesteryl ester (17:1) levels
Cholesteryl ester (18:0) levels
Acylcarnitine (18:1) levels
Vaginal microbiome MetaCyc pathway (PWY-6507|4-deoxy-L-threo-hex-4-enopyranuronate degradation)
Vaginal microbiome MetaCyc pathway (PWY-6519|8-amino-7-oxononanoate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6545|pyrimidine deoxyribonucleotides de novo biosynthesis III)
Vaginal microbiome MetaCyc pathway (PWY-6562|norspermidine biosynthesis)
Arachidonate (20:4n6) levels in elite athletes
Arachidonoylcarnitine (C20:4) levels in elite athletes
Arachidonoylcholine levels in elite athletes
Fructose levels in elite athletes
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) levels in elite athletes
1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) levels in elite athletes
1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) levels in elite athletes
1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) levels in elite athletes
Cervical dystonia (age at onset)
Alkenylphosphatidylcholine (P-17:0/20:4) (b) levels
Alkenylphosphatidylcholine (P-18:0/18:2) levels
Alkenylphosphatidylcholine (P-18:0/20:4) levels
Alkenylphosphatidylcholine (P-18:0/22:5) levels
Vaginal microbiome MetaCyc pathway (PWY-5104|L-isoleucine biosynthesis IV)
Vaginal microbiome MetaCyc pathway (PWY-5121|superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP))
Vaginal microbiome MetaCyc pathway (PWY-5154|L-arginine biosynthesis III (via N-acetyl-L-citrulline))
Vaginal microbiome MetaCyc pathway (PWY-5177|glutaryl-CoA degradation)
1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels in elite athletes
1-stearoyl-2-linoleoyl-GPC (18:0/18:2) levels in elite athletes
1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels in elite athletes
1-stearoyl-2-oleoyl-GPC (18:0/18:1) levels in elite athletes
1-stearoyl-2-oleoyl-GPI (18:0/18:1) levels in elite athletes
1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels in elite athletes
Phosphatidylethanolamine (16:0_18:3) (a) levels
Phosphatidylethanolamine (16:0_18:3) (b) levels
10-undecenoate (11:1n1) levels in elite athletes
12-HETE levels in elite athletes
12-HHTrE levels in elite athletes
Phosphatidylethanolamine (18:0_20:3) (b) levels
Phosphatidylethanolamine (18:0_20:4) levels
Phosphatidylethanolamine (18:0_22:4) levels
Phosphatidylethanolamine (18:0_22:5) (n3) levels
2-hydroxyoctanoate levels in elite athletes
Benzoate levels in elite athletes
2-linoleoylglycerol (18:2) levels in elite athletes
2-myristoylglycerol (14:0) levels in elite athletes
2-oleoylglycerol (18:1) levels in elite athletes
2-palmitoleoyl-GPC (16:1) levels in elite athletes
2-palmitoleoylglycerol (16:1) levels in elite athletes
Carnitine levels in elite athletes
Alkenylphosphatidylethanolamine (P-18:1/20:3) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/20:4) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/20:4) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/20:5) (b) levels
Alkenylphosphatidylethanolamine (P-18:1/22:5) (a) levels
Alkenylphosphatidylethanolamine (P-18:1/22:5) (b) levels
Creatinine levels in elite athletes
Cystathionine levels in elite athletes
5-dodecenoate (12:1n7) levels in elite athletes
5-HEPE levels in elite athletes
Cysteine-glutathione disulfide levels in elite athletes
Vaginal microbiome MetaCyc pathway (PWY-5856|ubiquinol-9 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-5857|ubiquinol-10 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-5860|superpathway of demethylmenaquinol-6 biosynthesis I)
Phosphatidylinositol (18:0_18:1) levels
Phosphatidylinositol (18:0_20:2) levels
Vaginal microbiome MetaCyc pathway (PWY-5913|TCA cycle VI (obligate autotrophs))
Vaginal microbiome MetaCyc pathway (PWY-5918|superpathay of heme biosynthesis from glutamate)
Vaginal microbiome MetaCyc pathway (PWY-5920|superpathway of heme biosynthesis from glycine)
Vaginal microbiome MetaCyc pathway (PWY-5971|palmitate biosynthesis II (bacteria and plants))
Vaginal microbiome MetaCyc pathway (PWY-5973|cis-vaccenate biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-5989|stearate biosynthesis II (bacteria and plants))
5alpha-pregnan-3beta,20alpha-diol monosulfate (2) levels in elite athletes
Dimethylguanidino valeric acid levels
Triacylglycerol 56:9 levels
Phosphatidylcholine 38:2 levels
Oleoyl glycine levels
C8 carnitine levels
Triacylglycerol 56:10 levels
Phosphatidylcholine 34:4 levels
Phophatidylethanolamine 38:6 levels
Triacylglycerol 54:9 levels
Phosphatidylcholine plasmalogen 36:5 levels
C6 carnitine levels
Phosphatidylcholine 36:3 levels
Sphingomyelin 18:0 levels
Lysophosphatidylcholine 20:4 levels
Carnosine levels
Phosphatidylethanolamine 36:4 levels
Ribothymidine levels
N-acetylornithine levels
N-alpha-acetylarginine levels
Guanine levels
C9 carnitine levels
2-aminoisobutyric acid levels
5-methylcytidine levels
Phosphatidylcholine 36:4 levels
Cholesteryl ester 20:4 levels
Phosphatidylcholine 38:4 levels
Diacylglycerol 38:5 levels
C4 carnitine levels
Diacylglycerol 38:4 levels
PS plasmalogen 36:3 levels
Cholesteryl ester 22:4 levels
Acylcarnitine (14:1) levels
Acylcarnitine (14:2) levels
Acylcarnitine (15:0) (a) levels
Acylcarnitine (15:0) (b) levels
Vaginal microbiome MetaCyc pathway (PWY-6385|peptidoglycan biosynthesis III (mycobacteria))
Vaginal microbiome MetaCyc pathway (PWY-6386|UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing))
Vaginal microbiome MetaCyc pathway (PWY-6387|UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing))
Dodecanedioate levels in elite athletes
Androstenediol (3alpha, 17alpha) monosulfate (3) levels in elite athletes
DSGEGDFXAEGGGVR levels in elite athletes
Androstenediol (3beta,17beta) disulfate (1) levels in elite athletes
Androstenediol (3beta,17beta) disulfate (2) levels in elite athletes
Phosphatidylcholine (38:6) (a) levels
Phosphatidylcholine (38:7) (c) levels
1-palmitoyl-GPI (16:0) levels in elite athletes
1-palmitoylglycerol (16:0) levels in elite athletes
5alpha-androstan-3beta,17beta-diol disulfate levels in elite athletes
1-pentadecanoylglycerol (15:0) levels in elite athletes
1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) levels in elite athletes
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels in elite athletes
Phosphatidylethanolamine (16:0_18:1) levels
Phosphatidylethanolamine (16:0_18:2) levels
Phosphatidylethanolamine (17:0_18:2) levels
Arabinose levels in elite athletes
16-hydroxypalmitate levels in elite athletes
16a-hydroxy DHEA 3-sulfate levels in elite athletes
17-methylstearate levels in elite athletes
17alpha-hydroxypregnenolone 3-sulfate levels in elite athletes
2-aminoheptanoate levels in elite athletes
Phosphatidylethanolamine (18:0_22:5) (n6) levels
Phosphatidylethanolamine (18:0_22:6) levels
Phosphatidylethanolamine (18:1_18:1) levels
3-hydroxybutyrylcarnitine (2) levels in elite athletes
2-palmitoyl-GPC (16:0) levels in elite athletes
2-palmitoylglycerol (16:0) levels in elite athletes
2-stearoyl-GPE (18:0) levels in elite athletes
Biliverdin levels in elite athletes
C-glycosyltryptophan levels in elite athletes
Alkenylphosphatidylethanolamine (P-16:0/18:3) levels
3-hydroxysebacate levels in elite athletes
Chenodeoxycholate levels in elite athletes
3-methyladipate levels in elite athletes
Alkenylphosphatidylethanolamine (P-18:1/22:6) (b) levels
Alkenylphosphatidylethanolamine (P-19:0/20:4) (a) levels
Alkenylphosphatidylethanolamine (P-19:0/20:4) (b) levels
Alkenylphosphatidylethanolamine (P-20:0/18:1) levels
Cysteine levels in elite athletes
5-HETE levels in elite athletes
5-HETrE levels in elite athletes
5alpha-androstan-3alpha,17alpha-diol disulfate levels in elite athletes
Overall survival in advanced colorectal cancer
Phosphatidylinositol (18:0_20:3) (a) levels
Phosphatidylinositol (18:0_20:3) (b) levels
Phosphatidylinositol (18:0_20:4) levels
Phosphatidylinositol (18:0_22:4) levels
Low-carbohydrate diet (LCD) score
Vaginal microbiome MetaCyc pathway (PWY-6121|5-aminoimidazole ribonucleotide biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6122|5-aminoimidazole ribonucleotide biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6123|inosine-5'-phosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-6125|superpathway of guanosine nucleotides de novo biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6700|queuosine biosynthesis)
5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels in elite athletes
Dimethylglycine levels in elite athletes
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca) levels in elite athletes
Acetylcarnitine (C2) levels in elite athletes
Acylcarnitine (16:0) levels
Acylcarnitine (16:1) levels
Eicosapentaenoate (EPA; 20:5n3) levels in elite athletes
Androstenediol (3beta,17beta) monosulfate (1) levels in elite athletes
Androstenediol (3beta,17beta) monosulfate (2) levels in elite athletes
Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels
Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels
Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels
Amyloid beta positivity
Phosphatidylinositol-O(33:0)_[M-H]1- levels
Random glucose levels
High-sensitivity C-reactive protein levels
Albumin levels
Alkaline phosphatase (UKB data field 30610)
Phosphatidylinositol(36:0)_[M+OAc]1- levels
Hearing function (0.5 kHz)
Hearing function (1 kHz)
Hearing function (2 kHz)
Phosphatidylcholine_34:2_[M+OAc]1-/Phosphatidylserine_38:1_[M-H]1- levels
Phosphatidylinositol(34:2)_[M-H]1- levels
Phosphatidylinositol(35:2)_[M-H]1- levels
Hearing function (4 kHz)
Hearing function (8 kHz)
Wellbeing index
Alzheimer's disease or gastroesophageal reflux disease and/or peptic ulcer disease
Alzheimer's disease or peptic ulcer disease
Cystatin C plasma levels
Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels
Phosphatidylcholine_32:2_[M+H]1+/Phosphatidylethanolamine_35:2_[M+H]1+/Phosphatidate_37:3_[M+NH4]1+ levels
Phosphatidylcholine_32:0_[M+OAc]1- levels
Phosphatidylcholine_33:2_[M+OAc]1-/Phosphatidylserine_37:1_[M-H]1- levels
Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels
Disability level (impaired activities of daily living)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes)
Cognitive impairment level
Circulating plasma alpha-Klotho levels
Amyloid beta positivity in normal cognition
Cognitive function (processing speed) x major depressive disorder interaction (1df)
Cognitive function (processing speed) x major depressive disorder interaction (2df)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node2)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node3)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node4)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node5)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node7)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node10)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node11)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node12)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node13)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node15)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node17)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node18)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node19)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node21)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node22)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node24)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node7)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node9)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node11)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node13)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node14)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node16)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node17)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node18)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node20)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node21)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node1)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node42)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node44)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node46)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node48)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node49)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node51)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node55)
Decaffeinated coffee consumption and/or neuroticism
Decaffeinated coffee consumption and/or insomnia
Alcohol-related hepatocellular carcinoma
Primary dental caries (decayed and filled teeth)
Permanent dental caries (decayed and filled teeth)
Kidney injury 5 years post-surgery in obstructive uropathies
PCSK9 levels
NSAID-induced peptic ulcer disease
Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels
Phosphatidate(44:6)_[M+OAc]1-/Phosphatidylglycerol(43:6)_[M-H]1- levels
Phosphatidate(45:6)_[M-H]1- levels
Phosphatidylcholine_30:0_[M+H]1+/Phosphatidylethanolamine_33:0_[M+H]1+/Phosphatidate_35:1_[M+NH4]1+ levels
Phosphatidate(43:4)_[M-H]1- levels
Phosphatidate(43:6)_[M-H]1- levels
Coprococcus comes
Chronic widespread musculoskeletal pain
Phosphatidylcholine_35:5_[M+OAc]1-/Phosphatidylserine_39:4_[M-H]1- levels
Childhood acute lymphoblastic leukemia (TCF3-PBX1 fusion)
TCF3-PBX1 fusion in childhood acute lymphoblastic leukemia
Phosphatidylinositol(36:1)_[M+OAc]1- levels
Age at menarche
Cognitive function (executive function)
Cognitive function (executive function) x major depressive disorder interaction (1df)
Cognitive function (executive function) x major depressive disorder interaction (2df)
Cognitive function (global cognition) x major depressive disorder interaction (1df)
Cognitive function (global cognition) x major depressive disorder interaction (2df)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node25)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node26)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node27)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node28)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node29)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node30)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node31)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node35)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node37)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node38)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node39)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node40)
Response to levetiracetam in focal epilepsy
Response to carbamazepine in focal epilepsy
Response to oxcarbazepine in focal epilepsy
Response to phenytoin in focal epilepsy
Response to calcium-channel-Active anticonvulsants in focal epilepsy
Response to valproic acid in focal epilepsy
Response to sodium channel-Active anticonvulsant in focal epilepsy
Response to lamotrigine in focal epilepsy
Ascending aorta diameter
Response to levetiracetam in epilepsy
Response to lamotrigine in epilepsy
Response to calcium-channel-Active anticonvulsants in epilepsy
Response to valproic acid in epilepsy
Occupational attainment
Progression free survival in epithelial ovarian cancer
Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels
Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels
Cognitive function (delayed memory)
Cognitive function (delayed memory) x major depressive disorder interaction (2df)
Cognitive function (processing speed)
Systemic vasculitis
Extrahepatic cholangiocarcinoma
Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels
Urinary incontinence
Phosphatidylcholine_35:6_[M+H]1+/Phosphatidylethanolamine_38:6_[M+H]1+/Phosphatidate_40:7_[M+NH4]1+ levels
Phosphatidylcholine_36:0_[M+OAc]1- levels
Phosphatidylinositol-O_36:0_[M-H]1- levels
Phosphatidylinositol-O_36:1_[M+H]1+ levels
Cleft lip with or without cleft palate or cleft palate (pleiotropy)
Cleft lip or cleft palate (pleiotropy)
Cleft lip with cleft palate or cleft palate (pleiotropy)
Cleft lip or cleft lip with cleft palate (pleiotropy)
Asthma and eczema
Brain rsFMRI measurement (functional connectivity) (Net25_Pair11_12)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA2)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair9_29)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA3)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair7_11)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair9_44)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair24_44)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA6)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair29_44)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair30_41)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node1)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair5_21)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node3)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair5_48)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair5_47)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node5)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair21_49)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair2_29)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair13_29)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair27_38)
Brain rsFMRI measurement (functional connectivity) (Net_Edge_ICA4)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair28_44)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair2_15)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair11_45)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair15_45)
Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node2)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair11_42)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair34_48)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair12_47)
Brain rsFMRI measurement (functional connectivity) (Net100_Pair28_47)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair10_11)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair10_12)
Brain rsFMRI measurement (functional connectivity) (Net25_Pair12_17)
Bisoprolol clearance in non-ST elevation acute coronary syndrome
Type 2 diabetes or polycystic ovary syndrome (pleiotropy)
Type 2 diabetes (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)
Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)
Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)
HbA1c or polycystic ovary syndrome (pleiotropy)
Decaffeinated coffee consumption and/or alcohol use disorder score
Decaffeinated coffee consumption and/or alcohol consumption score
Decaffeinated coffee consumption and/or alcohol dependence and hazardous-use score
Decaffeinated coffee consumption and/or lifetime cannabis use
Decaffeinated coffee consumption or major depression disorder
Left inferior frontal gyrus (orbital part) cortical thickness
Left parahippocampal gyrus cortical thickness
Acute encephalopathy with biphasic seizures and late reduced diffusion
Tenascin-X levels (TNXB.5698.60.3)
Tensin-2 levels (TNS2.11667.29.3)
Tensin-4 levels (TNS4.9927.96.3)
Teratocarcinoma-derived growth factor 1 levels (TDGF1.5810.25.3)
Testican-1 levels (SPOCK1.5490.53.3)
Testican-2 levels (SPOCK2.5491.12.3)
Testican-3 levels (SPOCK3.9906.21.3)
Testis-expressed sequence 29 protein levels (TEX29.10557.6.3)
Testis-specific basic protein Y 1 levels (VCY.6295.67.3)
Serum lead levels
Serum rubidium levels
Serum nickel levels
Serum cobalt levels
Periodontal pocket (adjusted for age and sex)
Periodontal pocket (adjusted for age, sex and smoking status)
Periodontal pocket (adjusted for age, sex, smoking status  and plaque)
Viral variant GAG242N carrier status in HIV infection
Testis-specific chromodomain protein Y 1 levels (CDY1.7097.8.3)
Thioredoxin domain-containing protein 12 levels (TXNDC12.4815.25.3)
Thioredoxin domain-containing protein 5 levels (TXNDC5.11212.7.3)
Thioredoxin reductase 1, cytoplasmic levels (TXNRD1.13967.14.3)
Thiosulfate sulfurtransferase levels (TST.12663.1.3)
Thrombopoietin Receptor levels (MPL.3473.78.2)
Thrombospondin type-1 domain-containing protein 1 levels (THSD1.5621.64.3)
Thrombospondin-2 levels (THBS2.3339.33.1)
Thymocyte nuclear protein 1 levels (THYN1.12424.107.3)
Tissue factor pathway inhibitor levels (TFPI.3336.50.1)
Toll-interacting protein levels (TOLLIP.13963.7.3)
L1-L4 bone mineral density x ﻿gut microbiota (genus Escherichia Shigella) interaction
Total bone mineral density x gut microbiota (﻿genus Dialister) interaction
Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction
Serum tin levels
Serum strontium levels
Serum titanium levels
General population vs COVID-19 exposed negative controls
COVID-19 (symptomatic vs paucisymptomatic)
COVID-19 in household exposure to COVID-19
Toll-like receptor 4:Lymphocyte antigen 96 complex levels (TLR4.LY96.3647.49.4)
Toll/interleukin-1 receptor domain-containing adapter protein levels (TIRAP.9839.148.3)
Tolloid-like protein 1 levels (TLL1.6383.90.3)
TOM1-like protein 1 levels (TOM1L1.13652.2.3)
Torsin-1A-interacting protein 1 levels (TOR1AIP1.9039.47.3)
Transcobalamin-1 levels (TCN1.11232.46.3)
Transcobalamin-2 levels (TCN2.5584.21.3)
Transcription factor RelB levels (RELB.11464.9.3)
Transcription regulator protein BACH1 levels (BACH1.12451.62.3)
Transferrin receptor protein 1 levels (TFRC.8795.48.3)
Total lipid levels in IDL
Serum vanadium levels
Serum zinc levels
Number of clonal hematopoiesis mutations
Femur total bone mineral density x gut microbiota (﻿genus Escherichia Shigella) interaction
Plasma aluminum levels
Plasma arsenic levels
Plasma barium levels
Transformer-2 protein homolog beta levels (TRA2B.12373.73.3)
Transforming growth factor beta-3 levels (TGFB3.3520.58.1)
Transforming growth factor-beta-induced protein ig-h3 levels (TGFBI.3283.21.1)
Immunoglobulin-binding protein 1 levels (IGBP1.12358.6.3)
Inactive gamma-glutamyltranspeptidase 2 levels (GGT2.6334.9.3)
Inactive pancreatic lipase-related protein 1 levels (PNLIPRP1.6627.25.3)
Inactive peptidyl-prolyl cis-trans isomerase FKBP6 levels (FKBP6.12529.32.3)
Indoleamine 2,3-dioxygenase 1 levels (IDO1.9759.13.3)
Inducible T-cell costimulator levels (ICOS.14084.191.3)
Inhibin beta C chain levels (INHBC.6408.2.3)
Inhibitor of growth protein 1 levels (ING1.3888.8.1)
Inosine-5'-monophosphate dehydrogenase 1 levels (IMPDH1.5229.90.3)
Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1 levels (ITPRIPL1.9221.6.3)
Inositol monophosphatase 3 levels (IMPAD1.9231.23.3)
Inositol polyphosphate 5-phosphatase OCRL-1 levels (OCRL.10011.65.3)
Insulin growth factor-like family member 3 levels (IGFL3.6961.14.3)
COVID-19 severity score
COVID-19 (covid vs negative)
Insulin growth factor-like family member 4 levels (IGFL4.6353.60.3)
Insulin receptor levels (INSR.3448.13.2)
Insulin-like growth factor 1 receptor levels (IGF1R.4232.19.2)
Insulin-like growth factor I levels (IGF1.2952.75.2)
Insulin-like growth factor-binding protein 3 levels (IGFBP3.2571.12.3)
Insulin-like growth factor-binding protein 7 levels (IGFBP7.3320.49.2)
Integral membrane protein 2A levels (ITM2A.7765.15.3)
Integrin alpha-I: beta-1 complex levels (ITGA1.ITGB1.3503.4.2)
Inter-alpha-trypsin inhibitor heavy chain H1 levels (ITIH1.7955.195.3)
Inter-alpha-trypsin inhibitor heavy chain H5 levels (ITIH5.8233.2.3)
Intercellular adhesion molecule 1 levels (ICAM1.4342.10.3)
Intercellular adhesion molecule 2 levels (ICAM2.5486.73.3)
Intercellular adhesion molecule 4 levels (ICAM4.6550.4.3)
Plasma calcium levels
Plasma cadmium levels
Plasma cobalt levels
Intercellular adhesion molecule 5 levels (ICAM5.8245.27.3)
Interferon alpha/beta receptor 1 levels (IFNAR1.9183.7.3)
Interferon gamma receptor 1 levels (IFNGR1.5825.49.3)
Interferon regulatory factor 2 levels (IRF2.12801.33.3)
Interferon-induced protein with tetratricopeptide repeats 3 levels (IFIT3.13642.90.3)
Interleukin-1 beta levels (IL1B.3037.62.1)
Interleukin-1 Receptor accessory protein levels (IL1RAP.2630.12.2)
Interleukin-1 receptor antagonist protein levels (IL1RN.5353.89.2)
Interleukin-1 receptor type 2 levels (IL1R2.14133.93.3)
Interleukin-1 receptor-like 1 levels (IL1RL1.4234.8.2)
Interleukin-1 receptor-like 2 levels (IL1RL2.2994.71.2)
Interleukin-11 receptor subunit alpha levels (IL11RA.3814.63.1)
Interleukin-12 receptor subunit beta-1 levels (IL12RB1.2632.5.2)
Interleukin-12 receptor subunit beta-2 levels (IL12RB2.3815.14.1)
Venous thromboembolism or factor VIII levels (pleiotropy)
Venous thromboembolism or von Willebrand factor levels (pleiotropy)
New onset hypertension
New onset hypertension (low renin group)
New onset hypertension (high renin group)
Plasma chromium levels
Plasma copper levels
Plasma iron levels
Concentration of IDL particles
Venous thromboembolism or factor XI levels (pleiotropy)
Plasma magnesium levels
Plasma manganese levels
Plasma molybdenum levels
Plasma nickel levels
Venous thromboembolism or fibrinogen levels (pleiotropy)
Interleukin-13 receptor subunit alpha-1 levels (IL13RA1.2633.52.2)
Interleukin-15 receptor subunit alpha levels (IL15RA.14054.17.3)
Interleukin-16 levels (IL16.2774.10.3)
Transforming protein RhoA levels (RHOA.9855.10.3)
Transketolase levels (TKT.4306.4.2)
Translation initiation factor eIF-2B subunit alpha levels (EIF2B1.10080.9.3)
Translationally-controlled tumor protein levels (TPT1.3872.2.1)
Transmembrane emp24 domain-containing protein 10 levels (TMED10.6506.54.3)
Transmembrane gamma-carboxyglutamic acid protein 1 levels (PRRG1.9008.6.3)
Transmembrane glycoprotein NMB levels (GPNMB.8606.39.3)
Transmembrane inner ear expressed protein levels (TMIE.7992.3.3)
Transmembrane protease serine 11D levels (TMPRSS11D.6547.83.3)
Plasma lead levels
Plasma rubidium levels
Venous thromboembolism or tissue plasminogen activator levels (pleiotropy)
Plasma selenium levels
Plasma tin levels
Plasma strontium levels
Plasma titanium levels
Physiological aging rate
Chronic sinusitis
Chronic bronchitis
Colon polyp
Back pain
Bronchiectasis
Bronchitis
Chronic heart failure
Autoimmune hepatitis
Acute pancreatitis
Angina pectoris
Aplastic anemia
Venous thromboembolism or plasminogen activator inhibitor 1 levels (pleiotropy)
Transmembrane protein 132A levels (TMEM132A.7871.16.3)
Transmembrane protein 132B levels (TMEM132B.8890.9.3)
Transmembrane protein 132C levels (TMEM132C.7173.141.3)
Transmembrane protein 132D levels (TMEM132D.13416.8.3)
Transmembrane protein 190 levels (TMEM190.10442.1.3)
Transmembrane protein 2 levels (TMEM2.8992.1.3)
Transmembrane protein 230 levels (TMEM230.11542.11.3)
Transmembrane protein 59-like levels (TMEM59L.9959.60.3)
Transmembrane protein 87B levels (TMEM87B.13485.20.3)
Trefoil factor 1 levels (TFF1.9185.15.3)
Trefoil factor 3 levels (TFF3.4721.54.2)
Trem-like transcript 2 protein levels (TREML2.5736.1.3)
Trem-like transcript 4 protein levels (TREML4.11139.4.3)
Triggering receptor expressed on myeloid cells 1 levels (TREM1.9266.1.3)
Plasma vanadium levels
Plasma zinc levels
Mitochondrial sodium/hydrogen exchanger 9B2 levels (SLC9B2.9088.20.3)
Mitochondrial ubiquitin ligase activator of NFKB 1 levels (MUL1.9315.16.3)
Mitogen-activated protein kinase 1 levels (MAPK1.3115.64.2)
Mitogen-activated protein kinase 13 levels (MAPK13.5006.71.1)
Mitogen-activated protein kinase 14 levels (MAPK14.5007.1.1)
Mitogen-activated protein kinase 3 levels (MAPK3.2855.49.2)
Mitogen-activated protein kinase 8 levels (MAPK8.3825.18.2)
Mitogen-activated protein kinase kinase kinase 3 levels (MAP3K3.12990.39.3)
Mitotic checkpoint serine/threonine-protein kinase BUB1 levels (BUB1.12033.3.3)
Mitotic spindle assembly checkpoint protein MAD1 levels (MAD1L1.13618.15.3)
Mono [ADP-ribose] polymerase PARP16 levels (PARP16.7881.244.3)
Mothers against decapentaplegic homolog 2 levels (SMAD2.10364.6.3)
Mothers against decapentaplegic homolog 4 levels (SMAD4.12022.12.3)
Mucin-1 levels (MUC1.9176.3.3)
Muellerian-inhibiting factor levels (AMH.4923.79.1)
Multimerin-2 levels (MMRN2.11895.21.3)
Mitral valve prolapse after mitral valve surgery
Sphingomyelin(44:9)_[M+H]1- levels
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; all treatment preparations)
Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1b subcutaneous)
Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1a subcutaneous and intramuscular)
Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1a subcutaneous)
Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1b subcutaneous)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a subcutaneous and intramuscular)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a subcutaneous)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; all treatment preparations)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1b subcutaneous)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1a subcutaneous and intramuscular)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1a subcutaneous)
Neogenin levels (NEO1.8900.28.3)
Nesprin-2 levels (SYNE2.9789.52.3)
Netrin receptor UNC5C levels (UNC5C.5139.32.3)
Netrin-1 levels (NTN1.6649.51.3)
Netrin-4 levels (NTN4.3327.27.1)
Netrin-G1 levels (NTNG1.5637.81.3)
Neural cell adhesion molecule 1 levels (NCAM1.7746.230.3)
Neural cell adhesion molecule 1, 120 kDa isoform levels (NCAM1.4498.62.2)
Neural cell adhesion molecule 2 levels (NCAM2.6507.16.3)
Neural cell adhesion molecule L1-like protein levels (CHL1.3601.54.3)
Neurensin-1 levels (NRSN1.11654.77.3)
Neurexin-1 levels (NRXN1.8971.9.3)
Neurexin-3-beta levels (NRXN3.7093.20.3)
Neurexophilin-1 levels (NXPH1.4562.1.2)
Neutrophil cytosol factor 2 levels (NCF2.10047.12.3)
Neutrophil-activating peptide 2 levels (PPBP.2790.54.2)
Next to BRCA1 gene 1 protein levels (NBR1.7696.104.3)
NHL repeat-containing protein 3 levels (NHLRC3.9087.8.3)
NHP2-like protein 1 levels (NHP2L1.13602.6.3)
Nicotinamide phosphoribosyltransferase levels (NAMPT.5011.11.1)
Nidogen-2 levels (NID2.3633.70.5)
Nischarin levels (NISCH.12738.43.3)
NKG2-E type II integral membrane protein levels (KLRC3.7795.14.3)
NKG2D ligand 4 levels (RAET1E.7800.85.3)
NmrA-like family domain-containing protein 1 levels (NMRAL1.13988.67.3)
Noggin levels (NOG.5846.24.3)
Non-histone chromosomal protein HMG-14 levels (HMGN1.9187.2.3)
Non-secretory ribonuclease levels (RNASE2.8394.56.3)
Oncostatin-M-specific receptor subunit beta levels (OSMR.10892.8.3)
Opalin levels (OPALIN.7736.28.3)
Osteocalcin levels (BGLAP.11067.13.3)
Out at first protein homolog levels (OAF.6414.8.3)
Oxidoreductase HTATIP2 levels (HTATIP2.7753.21.3)
Oxysterol-binding protein-related protein 11 levels (OSBPL11.12878.60.3)
Oxysterols receptor LXR-beta levels (NR1H2.9016.12.3)
P-selectin levels (SELP.4154.57.2)
p53 and DNA damage-regulated protein 1 levels (PDRG1.12593.33.3)
Paired immunoglobulin-like type 2 receptor alpha levels (PILRA.8683.119.3)
Palmitoyl-protein thioesterase 1 levels (PPT1.9244.27.3)
Pancreatic hormone levels (PPY.4588.1.2)
Triacylglycerol_46:4_[M+NH4]1+ levels
Peroxisomal NADH pyrophosphatase NUDT12 levels (NUDT12.13947.371.3)
Persulfide dioxygenase ETHE1, mitochondrial levels (ETHE1.3847.56.2)
PH and SEC7 domain-containing protein 1 levels (PSD.13055.53.3)
PH and SEC7 domain-containing protein 2 levels (PSD2.9118.7.3)
Phenylalanine--tRNA ligase, mitochondrial levels (FARS2.13941.82.3)
Phosducin-like protein 2 levels (PDCL2.14192.31.3)
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN levels (PTEN.3831.21.1)
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha levels (PIK3C2A.14028.22.3)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform levels (PIK3CG.3391.10.2)
Phosphatidylinositol-glycan-specific phospholipase D levels (GPLD1.11939.11.3)
Phosphoglucomutase-1 levels (PGM1.9173.21.3)
Phosphoglycerate kinase 1 levels (PGK1.5020.50.1)
Phospholipase A2, membrane associated levels (PLA2G2A.2692.74.2)
Phosphomevalonate kinase levels (PMVK.12450.42.3)
Triacylglycerol_52:3_[M+NH4]1+ levels
Triacylglycerol_52:4_[M+NH4]1+ levels
Triacylglycerol_52:5_[M+NH4]1+ levels
Triacylglycerol_51:4_[M+NH4]1+ levels
Triacylglycerol_52:1_[M+NH4]1+ levels
Triacylglycerol_52:2_[M+NH4]1+ levels
Detectable estradiol levels in postmenopausal women
CD4+ T cell-associated HIV-1 DNA levels in long-term suppressive antiretroviral treated HIV-1 (adjusted for cell-associated HIV-1 RNA)
CD4+ T cell-associated HIV-1 RNA-to-DNA ratio in long-term suppressive antiretroviral treated HIV-1
Platelet-derived growth factor subunit A levels (PDGFA.4499.21.1)
Platelet-derived growth factor subunit B levels (PDGFB.4149.8.2)
Pleckstrin homology domain-containing family A member 7 levels (PLEKHA7.12731.12.3)
Pleiotrophin levels (PTN.3045.72.2)
Plexin-A1 levels (PLXNA1.9005.16.3)
Plexin-B2 levels (PLXNB2.9216.100.3)
Plexin-C1 levels (PLXNC1.4564.2.2)
Poly(A) RNA polymerase, mitochondrial levels (MTPAP.9028.5.3)
Poly(rC)-binding protein 1 levels (PCBP1.11458.30.3)
Poly(U)-binding-splicing factor PUF60 levels (PUF60.10575.31.3)
Polyadenylate-binding protein 3 levels (PABPC3.10447.18.3)
Polyadenylate-binding protein 4 levels (PABPC4.12603.87.3)
Polycomb protein SCMH1 levels (SCMH1.12604.16.3)
Polymeric immunoglobulin receptor levels (PIGR.3216.2.2)
Polypeptide N-acetylgalactosaminyltransferase 1 levels (GALNT1.7090.17.3)
Polypeptide N-acetylgalactosaminyltransferase 16 levels (GALNT16.8923.94.3)
PolyUbiquitin K48-linked levels (UBB.6651.74.3)
Potassium voltage-gated channel subfamily E member 2 levels (KCNE2.10427.2.3)
Triacylglycerol_56:7_[M+NH4]1+ levels
Triacylglycerol_56:8_[M+NH4]1+ levels
Triacylglycerol_56:6_[M+NH4]1+ levels
Lifetime smoking (without educational attainment)
Potassium voltage-gated channel subfamily E regulatory beta subunit 5 levels (KCNE5.8908.14.3)
Potassium-transporting ATPase subunit beta levels (ATP4B.9994.217.3)
PR domain zinc finger protein 1 levels (PRDM1.14197.2.3)
Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 levels (DHX38.13645.14.3)
Prefoldin subunit 5 levels (PFDN5.4271.75.2)
Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)
Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)
Pregnancy-specific beta-1-glycoprotein 5 levels (PSG5.9314.9.3)
Pregnancy-specific beta-1-glycoprotein 9 levels (PSG9.9335.28.3)
Prenylcysteine oxidase-like levels (PCYOX1L.5599.88.3)
Pro-FMRFamide-related neuropeptide FF levels (NPFF.5617.41.3)
Proactivator polypeptide-like 1 levels (PSAPL1.8814.33.3)
Probable ATP-dependent RNA helicase DDX58 levels (DDX58.12382.2.3)
Probable carboxypeptidase X1 levels (CPXM1.6255.74.3)
Triacylglycerol_58:10_[M+NH4]1+ levels
Triacylglycerol_58:7_[M+NH4]1+ levels
High general stress
High physical stress
High activity stress
Probable dimethyladenosine transferase levels (DIMT1.12694.28.3)
Probable G-protein coupled receptor 135 levels (GPR135.11465.4.3)
Probable RNA-binding protein 23 levels (RBM23.11590.5.3)
Probable RNA-binding protein EIF1AD levels (EIF1AD.13545.97.3)
Probable serine carboxypeptidase CPVL levels (CPVL.8891.7.3)
Procollagen C-endopeptidase enhancer 1 levels (PCOLCE.11237.49.3)
Procollagen C-endopeptidase enhancer 2 levels (PCOLCE2.6081.52.3)
Procollagen galactosyltransferase 1 levels (COLGALT1.5638.23.3)
Proenkephalin-A levels (PENK.9076.25.3)
Progonadoliberin-1 levels (GNRH1.5627.53.3)
Progonadoliberin-2 levels (GNRH2.10708.3.3)
Programmed cell death 1 ligand 2 levels (PDCD1LG2.3004.67.2)
Programmed cell death protein 1 levels (PDCD1.9227.15.3)
Triacylglycerol_58:8_[M+NH4]1+ levels
Triacylglycerol_58:9_[M+NH4]1+ levels
Triacylglycerol(48:3)_[M+NH4]1+ levels
Triacylglycerol(50:2)_[M+NH4]1+ levels
Congenital Zika syndrome
Triosephosphate isomerase levels (TPI1.4309.59.3)
tRNA (guanine-N(7)-)-methyltransferase levels (METTL1.12514.16.3)
Tropomyosin beta chain levels (TPM2.4472.5.2)
Troponin I, cardiac muscle levels (TNNI3.5930.54.3)
Trypsin-2 levels (PRSS2.5034.79.1)
Trypsin-3 levels (PRSS3.3479.71.2)
Tryptase beta-2 levels (TPSB2.3403.1.2)
Tryptase gamma levels (TPSG1.14103.12.3)
Tuberoinfundibular peptide of 39 residues levels (PTH2.7257.18.3)
Tubulin polymerization-promoting protein family member 2 levels (TPPP2.12800.5.3)
Tubulin--tyrosine ligase levels (TTL.13973.62.3)
Cholesteryl ester(17:1)_[M+NH4]1+ levels
Cholesteryl ester(18:0)_[M+NH4]1+ levels
Frailty index
Cholesteryl ester(18:1)_[M+NH4]1+ levels
Cholesteryl ester(18:2)_[M+NH4]1+ levels
Cholesteryl ester(18:3)_[M+NH4]1+ levels
Parenchymal hematoma in thrombolytic-treated acute ischaemic stroke
Cholesteryl ester(20:3)_[M+NH4]1+ levels
Emphysema
Emphysema in chronic obstructive pulmonary disease
Unruptured cerebral aneurysm
Cholelithiasis
Chronic pancreatitis
Dysentery
Cognitive function (immediate memory) (longitudinal)
Global cognition (Mini Mental State Examination)
Monohexosylceramide (d18:1/20:0) levels
Monohexosylceramide (d18:1/22:0) levels
Monohexosylceramide (d18:1/24:0) levels
F-small fish liking (derived food-liking factor)
Smoked fish liking
Vaginal microbiome MetaCyc pathway (PWY0-42|2-methylcitrate cycle I)
Vaginal microbiome MetaCyc pathway (PWY0-781|aspartate superpathway)
Vaginal microbiome MetaCyc pathway (PWY0-845|superpathway of pyridoxal 5'-phosphate biosynthesis and salvage)
Lignoceroylcarnitine (C24) levels in elite athletes
Linoleate (18:2n6) levels in elite athletes
Linolenate [alpha or gamma; (18:3n3 or 6)] levels in elite athletes
Linolenoylcarnitine (C18:3) levels in elite athletes
Linoleoyl ethanolamide levels in elite athletes
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels in elite athletes
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels in elite athletes
Cardiac valvular disease
Monohexosylceramide (d18:1/24:1) levels
Monohexosylceramide (d18:2/18:0) levels
Monohexosylceramide (d18:2/20:0) levels
Monohexosylceramide (d18:2/22:0) levels
Monohexosylceramide (d18:2/24:0) levels
Vaginal microbiome MetaCyc pathway (PWY1G-0|mycothiol biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY490-3|nitrate reduction VI (assimilatory))
Vaginal microbiome MetaCyc pathway (PWY4FS-7|phosphatidylglycerol biosynthesis I (plastidic))
Vaginal microbiome MetaCyc pathway (PWY4FS-8|phosphatidylglycerol biosynthesis II (non-plastidic))
Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2] levels in elite athletes
Linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] levels in elite athletes
Lysine levels in elite athletes
Malate levels in elite athletes
Maleate levels in elite athletes
Maltose levels in elite athletes
Linoleoylcarnitine (C18:2) levels in elite athletes
Mannose levels in elite athletes
Lysophosphatidylcholine (15-MHDA) [sn1] levels /Lysophosphatidylcholine (17:0) [sn2] levels
Lysophosphatidylcholine (15-MHDA) [sn2] levels
Lysophosphatidylcholine (16:0) [sn1] levels
Lysophosphatidylcholine (16:0) [sn2] levels
Lysophosphatidylcholine (16:1) [sn1] levels
Lysophosphatidylcholine (16:1) [sn2] levels
Lysophosphatidylcholine (17:0) [sn1] levels
Lysophosphatidylcholine (17:1) (a) [sn1] [104_sn1] levels
Lysophosphatidylcholine (17:1) [sn1] (a) levels/ Lysophosphatidylcholine (17:1) [sn2] (b) levels
Lysophosphatidylcholine (18:0) [sn1] levels
Lysophosphatidylcholine (18:0) [sn2] levels
Lysophosphatidylcholine (18:2) [sn1] levels
Global cognition (Mini Mental State Examination) (longitudinal)
Right hippocampal volume
Cholecystitis
Vaginal microbiome MetaCyc pathway (RUMP-PWY|formaldehyde oxidation I)
Vaginal microbiome MetaCyc pathway (SALVADEHYPOX-PWY|adenosine nucleotides degradation II)
Vaginal microbiome MetaCyc pathway (SER-GLYSYN-PWY|superpathway of L-serine and glycine biosynthesis I)
Vaginal microbiome MetaCyc pathway (SO4ASSIM-PWY|sulfate reduction I (assimilatory))
Vaginal microbiome MetaCyc pathway (SULFATE-CYS-PWY|superpathway of sulfate assimilation and cysteine biosynthesis)
Vaginal microbiome MetaCyc pathway (TCA|TCA cycle I (prokaryotic))
Vaginal microbiome MetaCyc pathway (TCA-GLYOX-BYPASS|superpathway of glyoxylate bypass and TCA)
F-strong vegetable liking (derived food-liking factor)
F-sweetened coffee drink liking (derived food-liking factor)
F-sweet food liking (derived food-liking factor)
Osmotic hemolysis of cold stored red blood cells
Lysophosphatidylcholine (20:4) [sn2] levels
Lysophosphatidylcholine (20:5) [sn1] levels
Lysophosphatidylcholine (20:5) [sn2] levels
N-acetyl-beta-alanine levels in elite athletes
N-palmitoylserine levels in elite athletes
N-palmitoyltaurine levels in elite athletes
N-acetylarginine levels in elite athletes
N-stearoyl-sphingosine (d18:1/18:0) levels in elite athletes
N-stearoyltaurine levels in elite athletes
Vaginal microbiome MetaCyc pathway (TRPSYN-PWY|L-tryptophan biosynthesis)
Vaginal microbiome MetaCyc pathway (TYRFUMCAT-PWY|L-tyrosine degradation I)
Lysophosphatidylcholine (22:5) [sn1] (n6) levels
Lysophosphatidylcholine (22:5) [sn2] (n3) levels
Lysophosphatidylcholine (22:6) [sn1] levels
Lysophosphatidylcholine (22:6) [sn2] levels
Lysophosphatidylcholine (24:0) [sn1] levels
Lysophosphatidylcholine (24:0) [sn2] levels
Lysophosphatidylcholine (26:0) [sn1] levels
Lysophosphatidylcholine (26:0) [sn2] levels
Lysoalkylphosphatidylcholine (O-16:0) levels
Lysoalkylphosphatidylcholine (O-18:0) levels
Lysoalkylphosphatidylcholine (O-18:1) levels
Lysoalkylphosphatidylcholine (O-20:0) levels
Triglycerides to total lipids ratio in large VLDL
Vaginal microbiome MetaCyc pathway (UBISYN-PWY|superpathway of ubiquinol-8 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (UDPNAGSYN-PWY|UDP-N-acetyl-D-glucosamine biosynthesis I)
Vaginal microbiome MetaCyc pathway (VALSYN-PWY|L-valine biosynthesis)
Vaginal microbiome presence (c_Actinobacteria)
F-wine liking (derived food-liking factor)
Whiskey liking
Alcohol liking
Aniseed liking
Apple juice liking
Nervonoylcarnitine (C24:1) levels in elite athletes
Octanoylcarnitine (C8) levels in elite athletes
Oleate/vaccenate (18:1) levels in elite athletes
Oleoyl ethanolamide levels in elite athletes
Chronic glomerulonephritis
Chronic renal failure
Vaginal microbiome presence (g_Megasphaera)
Vaginal microbiome presence (g_Prevotella)
Vaginal microbiome presence (g_Streptococcus)
Vaginal microbiome presence (o_Bacteroidales)
Vaginal microbiome presence (o_Campylobacterales)
Vaginal microbiome presence (o_Fusobacteriales)
Vaginal microbiome presence (o_Peptostreptococcales-Tissierellales)
Vaginal microbiome presence (p_Actinobacteriota)
Vaginal microbiome presence (p_Proteobacteria)
Vaginal microbiome presence (s_Aerococcus christensenii)
Vaginal microbiome presence (s_Dialister micraerophilus)
Apples liking
Avocado liking
Baked/steamed fish liking
BBQ/grilled meat liking
Beans liking
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] levels in elite athletes
N-acetylglycine levels in elite athletes
Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels in elite athletes
Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels in elite athletes
Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels in elite athletes
Lysophosphatidylethanolamine (18:0) [sn2] levels
Lysophosphatidylethanolamine (18:1) [sn1] levels
Lysophosphatidylethanolamine (18:1) [sn2] levels
Lysophosphatidylethanolamine (18:2) [sn1] levels
Lysophosphatidylethanolamine (17:0) [sn1] levels
Lysophosphatidylethanolamine (17:0) [sn2] levels
Lysophosphatidylethanolamine (18:0) [sn1] levels
Beef/steak liking
Beetroot liking
Bell pepper liking
Bitter ale liking
F-bitter food liking (derived food-liking factor)
Ratio of linoleic acid to total fatty acids
Vaginal microbiome presence (s_Dialister propionicifaciens)
Vaginal microbiome presence (s_Finegoldia magna)
Vaginal microbiome presence (s_Gardnerella vaginalis)
Vaginal microbiome presence (s_Lactobacillus jensenii)
Vaginal microbiome presence (s_Lactobacillus mulieris)
Vaginal microbiome presence (s_Lactobacillus paragasseri/gasseri)
Vaginal microbiome presence (s_Peptoniphilus vaginalis)
Vaginal microbiome presence (s_Prevotella bivia)
Vaginal microbiome presence (s_Prevotella timonensis)
Vaginal microbiome relative abundance (c_Actinobacteria)
Nociceptive flexion reflex threshold
Cholesteryl ester (20:3) levels
Cholesteryl ester (20:4) levels
Free cholesterol levels in large VLDL
Caprate (10:0) levels in elite athletes
Gamma-glutamylglutamate levels in elite athletes
Gamma-glutamylglutamine levels in elite athletes
Caproate (6:0) levels in elite athletes
Caprylate (8:0) levels in elite athletes
Vaginal microbiome MetaCyc pathway (PWY-6608|guanosine nucleotides degradation III)
Vaginal microbiome MetaCyc pathway (PWY-6609|adenine and adenosine salvage III)
Free cholesterol to total lipids ratio in large VLDL
Ceramide (d16:1/24:0) levels
Ceramide (d16:1/24:1) levels
Ceramide (d17:1/16:0) levels
Ceramide (d17:1/18:0) levels
Sib-shared facial trait 159; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 180; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 183; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 192; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 232; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 234; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 247; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 250; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 253; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 194; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 208; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 209; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 210; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 220; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 224; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 229; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 263; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 267; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 271; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 280; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 283; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 290; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 320; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 322; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 327; Facial segment 7; 3D morphology of the upper face
Sib-shared facial trait 339; Facial segment 8; 3D morphology of the upper lip
Sib-shared facial trait 347; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 348; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 349; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 350; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 354; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 356; Facial segment 9; 3D morphology of the upper lip
Sib-shared facial trait 368; Facial segment 10; 3D morphology of the nose sides
Sib-shared facial trait 372; Facial segment 10; 3D morphology of the nose sides
Sib-shared facial trait 378; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 379; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 381; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 388; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 393; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 397; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 399; Facial segment 11; 3D morphology of the nose
Sib-shared facial trait 412; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 422; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 2; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 4; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 14; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 15; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 21; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 24; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 25; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 26; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 31; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 32; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 40; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 42; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 47; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 49; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 84; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 90; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 93; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 103; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 117; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 119; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 121; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 126; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 132; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Sib-shared facial trait 154; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose
Vaginal microbiome MetaCyc pathway (PWY-6969|TCA cycle V (2-oxoglutarate:ferredoxin oxidoreductase))
Vaginal microbiome MetaCyc pathway (PWY-7007|methyl ketone biosynthesis)
Ceramide (d18:1/20:0) levels
Ceramide (d18:1/22:0) levels
Ceramide (d18:1/24:0) levels
Ceramide (d18:1/24:1) levels
Ceramide (d18:1/26:0) levels
Ceramide (d18:2/14:0) levels
Ceramide (d18:2/16:0) levels
Ceramide (d18:2/18:0) levels
F-highly palatable foods liking (derived food-liking factor)
Kiwi liking
Lager liking
Lamb liking
Glycerophosphorylcholine (GPC) levels in elite athletes
Glycine levels in elite athletes
Cis-4-decenoylcarnitine (C10:1) levels in elite athletes
Decanoylcarnitine (C10) levels in elite athletes
Maximum indexed left atrial volume
Longitudinal peak diastolic strain rate
Radial peak diastolic strain rate
Depression (age of onset)
Ceramide (d19:1/24:0) levels
Ceramide (d19:1/24:1) levels
Total lipid levels in large VLDL
Vaginal microbiome MetaCyc pathway (PWY-7219|adenosine ribonucleotides de novo biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7220|adenosine deoxyribonucleotides de novo biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-7221|guanosine ribonucleotides de novo biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7222|guanosine deoxyribonucleotides de novo biosynthesis II)
Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)
Ceramide (d20:1/24:1) levels
Dehydrocholesteryl ester (16:0) levels
Dehydrocholesteryl ester (18:1) levels
Dehydrocholesteryl ester (18:2) levels
Dehydrocholesteryl ester (20:4) levels
Cognitive performance (attention)
Executive function
Concentration of large VLDL particles
Vaginal microbiome MetaCyc pathway (PWY-7323|superpathway of GDP-mannose-derived O-antigen building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7328|superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7332|superpathway of UDP-N-acetylglucosamine-derived O-antigen building blocks biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7371|1,4-dihydroxy-6-naphthoate biosynthesis II)
Eicosenoylcarnitine (C20:1) levels in elite athletes
Guanosine levels in elite athletes
Erucate (22:1n9) levels in elite athletes
Etiocholanolone glucuronide levels in elite athletes
Heptanoate (7:0) levels in elite athletes
Glutarate (pentanedioate) levels in elite athletes
GM3 ganglioside (d18:1/24:0) levels
GM3 ganglioside (d18:1/24:1) levels
Dihexosylceramide (d16:1/16:0) levels
Dihexosylceramide (d16:1/24:1) levels
Dihexosylceramide (d18:1/16:0) levels
Cognitive performance (language ability)
Cognitive performance (language ability) (longitudinal)
Vaginal microbiome MetaCyc pathway (PWY-7456|mannan degradation)
Vaginal microbiome MetaCyc pathway (PWY-7539|6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia))
Vaginal microbiome MetaCyc pathway (PWY-7560|methylerythritol phosphate pathway II)
Vaginal microbiome MetaCyc pathway (PWY-7663|gondoate biosynthesis (anaerobic))
Vaginal microbiome MetaCyc pathway (PWY-7664|oleate biosynthesis IV (anaerobic))
Vaginal microbiome MetaCyc pathway (PWY-841|superpathway of purine nucleotides de novo biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-922|mevalonate pathway I)
Vaginal microbiome MetaCyc pathway (PWY0-1061|superpathway of L-alanine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-7431|aromatic biogenic amine degradation (bacteria))
Glycolithocholate levels in elite athletes
Indoleacetate levels in elite athletes
Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels in elite athletes
Indolelactate levels in elite athletes
Indolepropionate levels in elite athletes
Glycosyl ceramide (d18:1/23:1, d17:1/24:1) levels in elite athletes
Inosine levels in elite athletes
Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels in elite athletes
Facial skin elasticity
Cognitive function (delayed memory) (longitudinal)
F-savoury food liking (derived food-liking factor)
Savoury biscuit liking
F-savour/caloric food liking (derived food-liking factor)
F-seafood liking (derived food-liking factor)
Vaginal microbiome MetaCyc pathway (PWY0-1298|superpathway of pyrimidine deoxyribonucleosides degradation)
Vaginal microbiome MetaCyc pathway (PWY0-1319|CDP-diacylglycerol biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY0-1415|superpathway of heme biosynthesis from uroporphyrinogen-III)
Isovalerate levels in elite athletes
Glycosyl-N-stearoyl-sphingosine (d18:1/18:0) levels in elite athletes
Glycoursodeoxycholate levels in elite athletes
Hexadecadienoate (16:2n6) levels in elite athletes
Kynurenine levels in elite athletes
Hexanoylcarnitine (C6) levels in elite athletes
Hexanoylglutamine levels in elite athletes
Brain tumor
Hepatic bile duct cancer
Phospholipids to total lipids ratio in large VLDL
Cognitive function (immediate memory)
F-sharp flavour liking (derived food-liking factor)
Shellfish liking
Leucine levels in elite athletes
Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels in elite athletes
Lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels in elite athletes
Laurate (12:0) levels in elite athletes
Monohexosylceramide (d16:1/24:0) levels
Monohexosylceramide (d18:1/16:0) levels
Monohexosylceramide (d18:1/18:0) levels
Vaginal microbiome MetaCyc pathway (PWY0-321|phenylacetate degradation I (aerobic))
Laurylcarnitine (C12) levels in elite athletes
Leukotriene B4 levels in elite athletes
Leukotriene B5 levels in elite athletes
Lignoceroyl sphingomyelin (d18:1/24:0) levels in elite athletes
F-sodas liking (derived food-liking factor)
Soft cheese liking
Soy sauce liking
Soya milk liking
Spicy food liking
Vaginal microbiome MetaCyc pathway (PWY0-862|(5Z)-dodec-5-enoate biosynthesis)
Lysophosphatidylcholine (15:0) [sn1] levels
Lysophosphatidylcholine (15:0) [sn2] levels
Lysophosphatidylcholine (15-MHDA) [sn1]  [104_sn1] levels
Vaginal microbiome MetaCyc pathway (PWYG-321|mycolate biosynthesis)
Vaginal microbiome MetaCyc pathway (PYRIDNUCSAL-PWY|NAD salvage pathway I)
Vaginal microbiome MetaCyc pathway (PYRIDNUCSYN-PWY|NAD biosynthesis I (from aspartate))
Vaginal microbiome MetaCyc pathway (PYRIDOXSYN-PWY|pyridoxal 5'-phosphate biosynthesis I)
Spirits liking
Strawberries liking
F-strong alcohol liking (derived food-liking factor)
F-strong flavour liking (derived food-liking factor)
Margarate (17:0) levels in elite athletes
Linoleoylcholine levels in elite athletes
Margaroylcarnitine levels in elite athletes
Methionine sulfoxide levels in elite athletes
Germline telomere length in neuroblastoma
Lysophosphatidylcholine (18:2) [sn2] levels
Lysophosphatidylcholine (18:3) [sn1] (a) levels/Lysophosphatidylcholine (18:3) [sn2] (b) levels
Lysophosphatidylcholine (18:3) [sn1] levels (b)
Lysophosphatidylcholine (18:3) [sn2] levels (a)
Lysophosphatidylcholine (19:0) (a) [sn1] [104_sn1] levels
Lysophosphatidylcholine (19:0) [sn2] levels (a)
Lysophosphatidylcholine (20:0) [sn2] levels
Lysophosphatidylcholine (20:1) [sn1] levels
Lysophosphatidylcholine (20:1) [sn2] levels
Lysophosphatidylcholine (20:2) [sn1] levels
Lysophosphatidylcholine (20:2) [sn2] levels
Vaginal microbiome MetaCyc pathway (REDCITCYC|TCA cycle VIII (helicobacter))
Vaginal microbiome MetaCyc pathway (RHAMCAT-PWY|L-rhamnose degradation I)
Vaginal microbiome MetaCyc pathway (RIBOSYN2-PWY|flavin biosynthesis I (bacteria and plants))
Methionine levels in elite athletes
Myo-inositol levels in elite athletes
Myristate (14:0) levels in elite athletes
Myristoleate (14:1n5) levels in elite athletes
Myristoleoylcarnitine (C14:1) levels in elite athletes
Myristoyl dihydrosphingomyelin (d18:0/14:0) levels in elite athletes
Myristoylcarnitine (C14) levels in elite athletes
A body shape index
Lysophosphatidylcholine (20:3) [sn1] levels
Lysophosphatidylcholine (20:3) [sn2] levels
Lysophosphatidylcholine (20:4) [sn1] levels
Left hippocampal volume
White matter lesions (Fazekas score)
Tea difference liking
Tea with sugar liking
Tea without sugar liking
Turnip liking
Vegetables liking
Vaginal microbiome MetaCyc pathway (TEICHOICACID-PWY|teichoic acid (poly-glycerol) biosynthesis)
Vaginal microbiome MetaCyc pathway (THISYN-PWY|superpathway of thiamin diphosphate biosynthesis I)
Vaginal microbiome MetaCyc pathway (THRESYN-PWY|superpathway of L-threonine biosynthesis)
Vaginal microbiome MetaCyc pathway (TRNA-CHARGING-PWY|tRNA charging)
N-behenoyl-sphingadienine (d18:2/22:0) levels in elite athletes
N-oleoylserine levels in elite athletes
N-oleoyltaurine levels in elite athletes
N-palmitoyl-sphingadienine (d18:2/16:0) levels in elite athletes
N-palmitoyl-sphinganine (d18:0/16:0) levels in elite athletes
N-palmitoyl-sphingosine (d18:1/16:0) levels in elite athletes
N-palmitoylglycine levels in elite athletes
Lysophosphatidylcholine (22:0) [sn1] levels
Lysophosphatidylcholine (22:0) [sn2] levels
Lysophosphatidylcholine (22:1) [sn1] levels
Lysophosphatidylcholine (22:1) [sn2] levels
Lysophosphatidylcholine (22:4) [sn1] levels
Lysophosphatidylcholine (22:4) [sn2] levels
Lysophosphatidylcholine (22:5) [sn1] (n3) levels/Lysophosphatidylcholine (22:5) [sn2] (n6) levels
Oral corticosteroid burst in asthma
F-vegetarian liking (derived food-liking factor)
White bread liking
F-whole food liking (derived food-liking factor)
Whole grain cereal liking
Lysoalkylphosphatidylcholine (O-20:1) levels
Lysoalkylphosphatidylcholine (O-22:0) levels
Lysoalkylphosphatidylcholine (O-22:1) levels
Lysoalkylphosphatidylcholine (O-24:0) levels
Lysoalkylphosphatidylcholine (O-24:1) levels
Lysoalkylphosphatidylcholine (O-24:2) levels
Lysoalkenylphosphatidylcholine (P-16:0) levels
Lysoalkenylphosphatidylcholine (P-18:0) levels
Lysoalkenylphosphatidylcholine (P-18:1) levels
Lysoalkenylphosphatidylcholine (P-20:0) levels
Lysophosphatidylethanolamine (16:0) [sn1] levels
Vaginal microbiome presence (c_Clostridia)
Vaginal microbiome presence (c_Gammaproteobacteria)
Vaginal microbiome presence (f_Aerococcaceae)
Vaginal microbiome presence (f_Bifidobacteriaceae)
Vaginal microbiome presence (f_Lachnospiraceae)
Vaginal microbiome presence (f_Mycoplasmataceae)
Vaginal microbiome presence (f_Peptostreptococcales-Tissierellales)
Vaginal microbiome presence (f_Veillonellaceae)
Vaginal microbiome presence (g_Anaerococcus)
Vaginal microbiome presence (g_Dialister)
Lysophosphatidylethanolamine (16:0) [sn2] levels
Oleoyl-oleoyl-glycerol (18:1/18:1)  [1] levels in elite athletes
N-acetylmethionine levels in elite athletes
N-acetylneuraminate levels in elite athletes
Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels in elite athletes
Constipation
Contact dermatitis
Cystitis
Diabetic nephropathy
Lysophosphatidylethanolamine (18:2) [sn2] levels
Lysophosphatidylethanolamine (20:4) [sn1] levels
Lysophosphatidylethanolamine (20:4) [sn2] levels
Lysophosphatidylethanolamine (22:6) [sn1] levels
Lysophosphatidylethanolamine (22:6) [sn2] levels
Vaginal microbiome relative abundance (c_Clostridia)
Vaginal microbiome relative abundance (c_Gammaproteobacteria)
Juvenile rheumatoid arthritis
Sphingomyelin (d18:0/22:0) levels
Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels
Sphingomyelin (d18:1/16:0) levels
Sphingomyelin (d18:1/17:0) levels/Sphingomyelin (d17:1/18:0) levels
Sphingomyelin (d18:1/18:0) levels/Sphingomyelin (d16:1/20:0) levels
Sphingomyelin (d18:1/20:0) levels/Sphingomyelin (d16:1/22:0) levels
Sphingomyelin (d18:1/23:0) levels/Sphingomyelin (d17:1/24:0) levels
Vaginal microbiome relative abundance (s_Lactobacillus jensenii)
Vaginal microbiome relative abundance (s_Lactobacillus mulieris)
Vaginal microbiome relative abundance (s_Lactobacillus paragasseri/gasseri)
Phenylacetate levels in elite athletes
2'-deoxyinosine levels in elite athletes
Phenylacetylglutamine levels in elite athletes
Phenylalanine levels in elite athletes
Phenyllactate (PLA) levels in elite athletes
Sphingomyelin (d18:1/24:0) levels
Sphingomyelin (d18:1/24:1) levels
Sphingomyelin (d18:2/14:0) levels
Sphingomyelin (d18:2/16:0) levels
Sphingomyelin (d18:2/17:0) levels
Sphingomyelin (d18:2/18:0) levels
Sphingomyelin (d18:2/20:0) levels
Sphingomyelin (d18:2/22:0) levels
Sphingomyelin (d18:2/23:0) levels
Sphingomyelin (d18:2/24:0) levels
Sphingomyelin (d19:1/24:1) levels
Phospholipid levels in LDL
Vaginal microbiome relative abundance (s_Lactobacillus reuteri)
Vaginal microbiome relative abundance (s_Megasphaera genomosp type 1)
Phosphate levels in elite athletes
2'-deoxyuridine levels in elite athletes
Pipecolate levels in elite athletes
2'-O-methyluridine levels in elite athletes
Adult onset asthma and/or waist-to-hip ratio adjusted for BMI
Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
Adult onset asthma or type 2 diabetes
Nonatopic asthma or type 2 diabetes
Adult onset asthma and/or BMI
Nonatopic asthma and/or BMI
Average diameter for LDL particles
Sulfatide (d18:1/16:0) levels
Sulfatide (d18:1/16:0(OH) levels) levels
Vaginal microbiome relative abundance (s_Peptoniphilus vaginalis)
Sulfatide (d18:1/24:0) levels
Sulfatide (d18:1/24:0(OH) levels) levels
Sulfatide (d18:1/24:1) levels
Sulfatide (d18:1/24:1(OH) levels) levels
Triacylglycerol (48:3) [NL-16:1] levels
Triacylglycerol (49:1) [NL-15:0] levels
Triacylglycerol (49:1) [NL-16:0] levels
Triacylglycerol (49:1) [NL-18:1] levels
Triacylglycerol (50:0) [NL-18:0] levels
Triacylglycerol (50:1) [NL-14:0] levels
Triacylglycerol (50:1) [NL-18:1] levels
COVID-19 (covid vs negative or unknown)
COVID-19 (not hospitalized vs negative or unknown)
COVID-19 (hospitalized vs negative or unknown)
COVID-19 (severe vs negative or unknown)
Vaginal microbiome relative abundance (s_Prevotella bivia)
5,6-dihydrothymine levels in elite athletes
Beta-alanine levels in elite athletes
Cytidine levels in elite athletes
Dihydroorotate levels in elite athletes
Pro-hydroxy-pro levels in elite athletes
Proline levels in elite athletes
N1-methylinosine levels in elite athletes
Adult onset asthma or fasting glucose levels
Nonatopic asthma or fasting glucose levels
Phosphatidylcholine (16:0_18:2) levels
Phosphatidylcholine (16:0_18:3) (a) levels
Phosphatidylcholine (16:0_20:3) (a) levels
Phosphatidylcholine (16:0_20:3) (b) levels
Phosphatidylcholine (16:0_20:4) levels
Phosphatidylcholine (16:0_20:5) levels
Phosphatidylcholine (16:1_18:2) levels
Phosphatidylcholine (16:1_20:4) levels
Phosphatidylcholine (17:0_20:4) levels
Vaginal microbiome relative abundance (s_Prevotella timonensis)
Vaginal microbiome relative abundance (Lactobacillus crispatus or Lactobacillus iners or Gardnerella vaginalis) (pleiotropy)
N6-carbamoylthreonyladenosine levels in elite athletes
Orotate levels in elite athletes
Pseudouridine levels in elite athletes
Orotidine levels in elite athletes
Pyridoxate levels in elite athletes
Pyroglutamine levels in elite athletes
Uracil levels in elite athletes
Vaginal microbiome relative abundance (pleiotropy)
Mastopathy
Metal allergy
Triacylglycerol (50:2) [NL-18:2] levels
Triglyceride levels in LDL
Hormone-sensitive cancer
Incident hormone-sensitive cancer
Tenascin level in Chronic kidney disease with hypertension and no diabetes (5675_6)
Agouti-signaling protein level in Chronic kidney disease with hypertension and no diabetes (5676_54)
Uncharacterized protein C2orf66 level in Chronic kidney disease with hypertension and no diabetes (5677_15)
Odorant-binding protein 2b level in Chronic kidney disease with hypertension and no diabetes (5680_54)
Cerebellin-4 level in Chronic kidney disease with hypertension and no diabetes (5688_65)
BPI fold-containing family A member 2 level in Chronic kidney disease with hypertension and no diabetes (5695_5)
Tenascin-X level in Chronic kidney disease with hypertension and no diabetes (5698_60)
Serine protease inhibitor Kazal-type 6 level in Chronic kidney disease with hypertension and no diabetes (5731_1)
Eosinophil cationic protein level in Chronic kidney disease with hypertension and no diabetes (5741_55)
Lysophosphatidic acid phosphatase type 6 level in Chronic kidney disease with hypertension and no diabetes (5742_14)
Low affinity immunoglobulin gamma Fc region receptor III-A level in Chronic kidney disease with hypertension and no diabetes (15388_24)
Glutathione S-transferase Mu 1 level in Chronic kidney disease with hypertension and no diabetes (15395_15)
Sialidase-1 level in Chronic kidney disease with hypertension and no diabetes (15426_5)
Otoraplin level in Chronic kidney disease with hypertension and no diabetes (15432_1)
Neuregulin-1, sensory and motor neuron-derived factor isoform level in Chronic kidney disease with hypertension and no diabetes (15446_25)
Sequestosome-1 level in Chronic kidney disease with hypertension and no diabetes (15448_47)
5'-Nucleotidase level in Chronic kidney disease with hypertension and no diabetes (15452_5)
T-cell surface glycoprotein CD8 alpha chain level in Chronic kidney disease with hypertension and no diabetes (15462_28)
Complement factor H-related protein 1 level in Chronic kidney disease with hypertension and no diabetes (15468_14)
Pancreatic lipase-related protein 2 level in Chronic kidney disease with hypertension and no diabetes (15471_29)
Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (15472_16)
Phospholipid transfer protein level in Chronic kidney disease with hypertension and no diabetes (15475_4)
Regenerating islet-derived protein 3-gamma level in Chronic kidney disease with hypertension and no diabetes (15476_6)
Vascular non-inflammatory molecule 2 level in Chronic kidney disease with hypertension and no diabetes (15480_2)
Alpha-2-macroglobulin-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (15482_12)
Vaginal microbiome beta diversity (Unweighted Unifrac)
Vaginal microbiome beta diversity (Weighted Unifrac)
Vaginal microbiome dominance (g_Lactobacillus)
Vaginal microbiome dominance (s_Lactobacillus iners)
Vaginal microbiome MetaCyc pathway (1CMET2-PWY|N10-formyl-tetrahydrofolate biosynthesis)
Vaginal microbiome alpha diversity (Faith phylogenetic diversity)
Vaginal microbiome alpha diversity (Pielou Evenness)
Vaginal microbiome alpha diversity (Shannon Index)
Vaginal microbiome beta diversity (Bray-curtis Dissimilarity)
Putative protein N-methyltransferase FAM86B1 level in Chronic kidney disease with hypertension and no diabetes (22142_4)
GATA zinc finger domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (22154_37)
Gem-associated protein 7 level in Chronic kidney disease with hypertension and no diabetes (22155_44)
Immunoglobulin superfamily containing leucine-rich repeat protein 2 level in Chronic kidney disease with hypertension and no diabetes (8528_74)
Transmembrane glycoprotein NMB level in Chronic kidney disease with hypertension and no diabetes (8606_39)
Cathepsin H level in Chronic kidney disease with hypertension and no diabetes (8644_46)
Olfactomedin-like protein 3 level in Chronic kidney disease with hypertension and no diabetes (8660_5)
Glypican-1 level in Chronic kidney disease with hypertension and no diabetes (8697_38)
DCN1-like protein 5 level in Chronic kidney disease with hypertension and no diabetes (8760_10)
Leukocyte immunoglobulin-like receptor subfamily A member 5 level in Chronic kidney disease with hypertension and no diabetes (8766_29)
EMILIN-3 level in Chronic kidney disease with hypertension and no diabetes (8773_172)
Protocadherin-10 level in Chronic kidney disease with hypertension and no diabetes (8780_2)
Dipeptidase 1 level in Chronic kidney disease with hypertension and no diabetes (8794_13)
Microfibrillar-associated protein 3-like level in Chronic kidney disease with hypertension and no diabetes (8837_8)
Complement C1s subcomponent level in Chronic kidney disease with hypertension and no diabetes (8840_61)
Glutaminyl-peptide cyclotransferase-like protein level in Chronic kidney disease with hypertension and no diabetes (8866_53)
Probable serine carboxypeptidase CPVL level in Chronic kidney disease with hypertension and no diabetes (8891_7)
UDP-glucuronosyltransferase 2A1 level in Chronic kidney disease with hypertension and no diabetes (8907_11)
Stromal interaction molecule 1 level in Chronic kidney disease with hypertension and no diabetes (8916_32)
Transmembrane and coiled-coil domains protein 3 level in Chronic kidney disease with hypertension and no diabetes (8922_4)
Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)
Monocyte differentiation antigen CD14 level in Chronic kidney disease with hypertension and no diabetes (8969_49)
Neurexin-1 level in Chronic kidney disease with hypertension and no diabetes (8971_9)
Neuronal pentraxin receptor level in Chronic kidney disease with hypertension and no diabetes (8997_4)
N-acetylisoleucine levels in elite athletes
N-acetylkynurenine (2) levels in elite athletes
N-acetylleucine levels in elite athletes
N-acetylmethionine sulfoxide levels in elite athletes
N-acetylphenylalanine levels in elite athletes
N-acetylproline levels in elite athletes
Lipase member N level in Chronic kidney disease with hypertension and no diabetes (8097_77)
Translocon-associated protein subunit alpha level in Chronic kidney disease with hypertension and no diabetes (8106_15)
Zymogen granule membrane protein 16 level in Chronic kidney disease with hypertension and no diabetes (8219_14)
Glucoside xylosyltransferase 1 level in Chronic kidney disease with hypertension and no diabetes (8229_1)
Junctional adhesion molecule-like level in Chronic kidney disease with hypertension and no diabetes (8232_90)
Alpha-(1,6)-fucosyltransferase level in Chronic kidney disease with hypertension and no diabetes (8244_16)
Intercellular adhesion molecule 5 level in Chronic kidney disease with hypertension and no diabetes (8245_27)
Proprotein convertase subtilisin/kexin type 9 level in Chronic kidney disease with hypertension and no diabetes (8246_9)
Receptor-type tyrosine-protein phosphatase eta level in Chronic kidney disease with hypertension and no diabetes (8250_2)
Noelin-2 level in Chronic kidney disease with hypertension and no diabetes (8295_16)
Single Ig IL-1-related receptor level in Chronic kidney disease with hypertension and no diabetes (8326_63)
Dipeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8327_26)
Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)
Sialic acid-binding Ig-like lectin 12 level in Chronic kidney disease with hypertension and no diabetes (8352_26)
Oxytocin-neurophysin 1 level in Chronic kidney disease with hypertension and no diabetes (8356_88)
Protein LDOC1 level in Chronic kidney disease with hypertension and no diabetes (8378_3)
Hepatocyte growth factor activator level in Chronic kidney disease with hypertension and no diabetes (8385_248)
Spastin level in Chronic kidney disease with hypertension and no diabetes (8388_24)
Sulfhydryl oxidase 2 level in Chronic kidney disease with hypertension and no diabetes (8397_147)
Retinoic acid receptor responder protein 1 level in Chronic kidney disease with hypertension and no diabetes (8398_277)
Gastrin-releasing peptide level in Chronic kidney disease with hypertension and no diabetes (8400_74)
Neurogenic locus notch homolog protein 2 level in Chronic kidney disease with hypertension and no diabetes (8407_84)
Catenin beta-1 level in Chronic kidney disease with hypertension and no diabetes (8424_269)
Axin-2 level in Chronic kidney disease with hypertension and no diabetes (8429_16)
Cerebrospinal fluid amyloid beta 42 levels (12 month visit)
Cerebrospinal fluid p-tau levels (12 month visit)
Whole-brain volume (12 month visit)
Entorhinal cortical volume (12 month visit)
Middle temporal gyrus volume (12 month visit)
Fusiform volume (12 month visit)
Hippocampal volume (12 month visit)
Alzheimer's disease assessment scale (24 month visit)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes) (24 month visit)
Rey auditory verbal learning test (24 month visit)
Brevibacillales abundance in stool
Brevibacillus B abundance in stool
Butyricimonas sp900258545 abundance in stool
CAG-1000 sp000434555 abundance in stool
CAG-1000 abundance in stool
CAG-1031 abundance in stool
CAG-110 abundance in stool
CAG-145 sp000435615 abundance in stool
CAG-145 sp002320005 abundance in stool
CAG-145 abundance in stool
CAG-170 sp003516765 abundance in stool
CAG-177 sp002438685 abundance in stool
CAG-177 sp002451755 abundance in stool
CAG-177 sp003514385 abundance in stool
CAG-177 sp003538135 abundance in stool
CAG-177 abundance in stool
CAG-180 sp000432435 abundance in stool
CAG-194 sp002441865 abundance in stool
CAG-245 sp000435175 abundance in stool
CAG-245 abundance in stool
CAG-269 sp001915995 abundance in stool
Vaginal microbiome MetaCyc pathway (GLYCOGENSYNTH-PWY|glycogen biosynthesis I (from ADP-D-Glucose))
Vaginal microbiome MetaCyc pathway (GLYCOLYSIS|glycolysis I (from glucose 6-phosphate))
Vaginal microbiome MetaCyc pathway (GLYCOLYSIS-E-D|superpathway of glycolysis and Entner-Doudoroff)
Vaginal microbiome MetaCyc pathway (GLYCOLYSIS-TCA-GLYOX-BYPASS|superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass)
Spermidine levels in elite athletes
10-nonadecenoate (19:1n9) levels in elite athletes
Tiglylcarnitine (C5:1-DC) levels in elite athletes
Trans-4-hydroxyproline levels in elite athletes
Comamonas B abundance in stool
Comamonas abundance in stool
Coprobacillus cateniformis abundance in stool
Coprobacillus abundance in stool
Coprobacter secundus abundance in stool
Corynebacterium abundance in stool
Cyanobacteria abundance in stool
Demequinaceae abundance in stool
Demequina abundance in stool
Desulfobacterota A abundance in stool
Desulfovibrionaceae abundance in stool
Desulfovibrionales abundance in stool
Desulfovibrionia abundance in stool
Desulfovibrio piger abundance in stool
Dialister sp000434475 abundance in stool
Dokdonella abundance in stool
Dorea phocaeense abundance in stool
Dorea abundance in stool
DTU024 sp002411105 abundance in stool
Dysgonomonadaceae abundance in stool
Eisenbergiella sp900066775 abundance in stool
Elusimicrobiaceae abundance in stool
Gamma-CEHC levels in elite athletes
Gamma-tocopherol/beta-tocopherol levels in elite athletes
2-hydroxypalmitate levels in elite athletes
Gulonate levels in elite athletes
2-hydroxystearate levels in elite athletes
Heme levels in elite athletes
Vaginal microbiome MetaCyc pathway (P164-PWY|purine nucleobases degradation I (anaerobic))
3-methoxytyrosine levels in elite athletes
1-linoleoyl-GPE (18:2) levels in elite athletes
1-linoleoyl-GPG (18:2) levels in elite athletes
Triacylglycerol (50:3) [NL-14:1] levels
Triacylglycerol (50:3) [NL-16:1] levels
Triacylglycerol (50:3) [NL-18:1] levels
Triacylglycerol (50:4) [NL-14:0] levels
Triacylglycerol (51:0) [NL-16:0] levels
Triacylglycerol (51:1) [NL-18:1] levels
Triacylglycerol (52:2) [NL-16:0] levels
Triacylglycerol (52:3) [NL-16:1] levels
Triacylglycerol (52:4) [NL-16:0] levels
Triacylglycerol (53:2) [NL-17:0] levels
Triacylglycerol (54:1) [NL-18:1] levels
Triacylglycerol (54:2) [NL-18:0] levels
Triacylglycerol (54:3) [NL-18:1] levels
Pyruvate levels in elite athletes
Quinate levels in elite athletes
4-hydroxyphenylacetylglutamine levels in elite athletes
Gamma-glutamyl-2-aminobutyrate levels in elite athletes
Gamma-glutamyl-alpha-lysine levels in elite athletes
Cholesteryl ester (22:5) (n6) levels
Cholesteryl ester (22:6) levels
Cholesteryl ester (24:0) levels
Cholesteryl ester (24:1) levels
Cholesteryl ester (24:4) levels
Cholesteryl ester (24:5) levels
Actinic keratosis
Vaginal microbiome MetaCyc pathway (PWY-6708|ubiquinol-8 biosynthesis (prokaryotic))
Vaginal microbiome MetaCyc pathway (PWY-6737|starch degradation V)
Vaginal microbiome MetaCyc pathway (PWY-6749|CMP-legionaminate biosynthesis I)
Ceramide (d17:1/20:0) levels
Ceramide (d17:1/22:0) levels
Ceramide (d17:1/24:0) levels
Ceramide (d17:1/24:1) levels
Sib-shared facial trait 425; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 426; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 447; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 450; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 468; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 476; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 485; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 486; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 487; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 490; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 519; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 520; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 522; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 524; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 528; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 529; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 531; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 532; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 536; Facial segment 20; 3D morphology of the nose sides
Sib-shared facial trait 537; Facial segment 20; 3D morphology of the nose sides
Sib-shared facial trait 539; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 541; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 543; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 545; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 546; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 548; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 554; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 559; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 560; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 563; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 564; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 568; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 572; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 590; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 608; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 609; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 619; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 622; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 626; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 628; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 630; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 633; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 643; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 661; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 676; Facial segment 30; 3D morphology of the eyes
Vaginal microbiome MetaCyc pathway (PWY-7013|L-1,2-propanediol degradation)
Glutamine levels in elite athletes
Ceramide (d18:2/24:1, d18:1/24:2) levels in elite athletes
Cerotoylcarnitine (C26) levels in elite athletes
Glycerate levels in elite athletes
Aortic aneurysm
Ceramide (d18:2/20:0) levels
Ceramide (d18:2/22:0) levels
Ceramide (d18:2/24:0) levels
Ceramide (d18:2/24:1) levels
Ceramide (d18:2/26:0) levels
Ceramide (d19:1/16:0) levels
Sib-shared facial trait 881; Facial segment 51; 3D morphology of the cheeks
Sib-shared facial trait 889; Facial segment 52; 3D morphology of the outer cheeks
Sib-shared facial trait 891; Facial segment 52; 3D morphology of the outer cheeks
Sib-shared facial trait 897; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 898; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 902; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 903; Facial segment 53; 3D morphology of the chin
Sib-shared facial trait 906; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 908; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 912; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 913; Facial segment 54; 3D morphology of the lower chin
Sib-shared facial trait 917; Facial segment 55; 3D morphology of the inner jaw
Sib-shared facial trait 919; Facial segment 55; 3D morphology of the inner jaw
Sib-shared facial trait 920; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 923; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 924; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 927; Facial segment 56; 3D morphology of the middle forehead
Sib-shared facial trait 929; Facial segment 56; 3D morphology of the middle forehead
Vaginal microbiome MetaCyc pathway (PWY-7159|chlorophyllide a biosynthesis III (aerobic, light independent))
F-acquired taste liking (derived food-liking factor)
Ceramide (d19:1/26:0) levels
Ceramide (d20:1/22:0) levels
Vaginal microbiome MetaCyc pathway (PWY-7228|superpathway of guanosine nucleotides de novo biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-7229|superpathway of adenosine nucleotides de novo biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-7234|inosine-5'-phosphate biosynthesis III)
Vaginal microbiome MetaCyc pathway (PWY-7237|myo-, chiro- and scillo-inositol degradation)
Docosadioate levels in elite athletes
Docosahexaenoylcarnitine (C22:6) levels in elite athletes
Docosahexaenoylcholine levels in elite athletes
Docosapentaenoate (n3 DPA; 22:5n3) levels in elite athletes
Docosapentaenoate (n6 DPA; 22:5n6) levels in elite athletes
Eicosanodioate levels in elite athletes
Glycylvaline levels in elite athletes
Eicosenoate (20:1) levels in elite athletes
F-meat liking (derived food-liking factor)
Milk chocolate liking
Milky sweets liking
F-oily fish liking (derived food-liking factor)
Diacylglycerol (16:0_20:4) levels
Diacylglycerol (16:0_22:5) levels
Diacylglycerol (16:0_22:6) levels
Diacylglycerol (16:1_18:1) levels
Diacylglycerol (18:0_18:1) levels
Diacylglycerol (18:0_18:2) levels
Diacylglycerol (18:0_20:4) levels
Diacylglycerol (18:1_18:3) levels
Diacylglycerol (18:1_20:3) levels
Executive function (longitudinal)
Cognitive performance (visuoconstruction)
Vaginal microbiome MetaCyc pathway (PWY-7373|superpathway of demethylmenaquinol-6 biosynthesis II)
Dihexosylceramide (d18:1/18:0) levels
Dihexosylceramide (d18:1/20:0) levels
Dihexosylceramide (d18:1/22:0) levels
Dihexosylceramide (d18:1/24:0) levels
Sardines liking
F-sauces liking (derived food-liking factor)
Overall survival in breast cancer
Overall survival in breast cancer treated with Par-4 dependent chemotherapy
Overall survival in breast cancer treated with chemotherapy (excluding Par-4 dependent chemotherapy)
Overall survival in ER positive breast cancer
Overall survival in ER negative breast cancer
Dihexosylceramide (d18:2/16:0) levels
Dihexosylceramide (d18:2/24:1) levels
Trihexosylcermide (d18:1/16:0) levels
Trihexosylcermide (d18:1/18:0) levels
Biological age (BioAge)
Biological age (PhenoAge)
Cholesteryl ester (18:2) levels
Cholesteryl ester (18:3) levels
Cholesteryl ester (20:0) levels
Cholesteryl ester (20:1) levels
Cholesteryl ester (20:2) levels
Cholesteryl ester (20:5) levels
Cholesteryl ester (22:0) levels
Cholesteryl ester (22:1) levels
Cholesteryl ester (22:4) levels
Cholesteryl ester (22:5) (n3) levels
Gamma-glutamylisoleucine levels in elite athletes
Gamma-glutamylleucine levels in elite athletes
Gamma-glutamylmethionine levels in elite athletes
Gamma-glutamylphenylalanine levels in elite athletes
Gamma-glutamylthreonine levels in elite athletes
Vaginal microbiome MetaCyc pathway (PWY-6612|superpathway of tetrahydrofolate biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6628|superpathway of L-phenylalanine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6630|superpathway of L-tyrosine biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6703|preQ0 biosynthesis)
Ceramide (d16:1/20:0) levels
Ceramide (d16:1/22:0) levels
Ceramide (d18:1/14:0, d16:1/16:0) levels in elite athletes
Ceramide (d18:1/20:0, d16:1/22:0, d20:1/18:0) levels in elite athletes
Glucose levels in elite athletes
Glucuronate levels in elite athletes
Glutamate levels in elite athletes
Sib-shared facial trait 804; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 806; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 807; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 809; Facial segment 43; 3D morphology of the nose sides
Sib-shared facial trait 821; Facial segment 44; 3D morphology of the nose apex
Sib-shared facial trait 822; Facial segment 44; 3D morphology of the nose apex
Sib-shared facial trait 823; Facial segment 44; 3D morphology of the nose apex
Sib-shared facial trait 828; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 832; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 833; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 835; Facial segment 45; 3D morphology of the nose alae
Sib-shared facial trait 841; Facial segment 46; 3D morphology of the nose bridge
Sib-shared facial trait 848; Facial segment 47; 3D morphology of the nose bridge
Sib-shared facial trait 851; Facial segment 48; 3D morphology of the cheeks
Sib-shared facial trait 854; Facial segment 48; 3D morphology of the cheeks
Sib-shared facial trait 855; Facial segment 48; 3D morphology of the cheeks
Sib-shared facial trait 860; Facial segment 49; 3D morphology of the cheeks
Sib-shared facial trait 869; Facial segment 50; 3D morphology of the cheeks
Herring liking
Honey liking
Horseradish liking
Vaginal microbiome MetaCyc pathway (PWY-7094|fatty acid salvage)
Vaginal microbiome MetaCyc pathway (PWY-7111|pyruvate fermentation to isobutanol (engineered))
Chiro-inositol levels in elite athletes
Glycerol levels in elite athletes
Cholesterol levels in elite athletes
Choline phosphate levels in elite athletes
Ceramide (d19:1/18:0) levels
Ceramide (d19:1/20:0) levels
Vaginal microbiome MetaCyc pathway (PWY-7184|pyrimidine deoxyribonucleotides de novo biosynthesis I)
Vaginal microbiome MetaCyc pathway (PWY-7187|pyrimidine deoxyribonucleotides de novo biosynthesis II)
F-lentils/beans liking (derived food-liking factor)
Liver liking
F-low caloric food liking (derived food-liking factor)
Glycochenodeoxycholate levels in elite athletes
Glycocholate levels in elite athletes
Deoxycarnitine levels in elite athletes
Diacylglycerol (16:1/18:2 [2], 16:0/18:3 [1]) levels in elite athletes
Sib-shared facial trait 941; Facial segment 58; 3D morphology of the temple lines
Sib-shared facial trait 950; Facial segment 58; 3D morphology of the temple lines
Sib-shared facial trait 951; Facial segment 58; 3D morphology of the temple lines
Sib-shared facial trait 961; Facial segment 59; 3D morphology of the temple lines
Sib-shared facial trait 963; Facial segment 59; 3D morphology of the temple lines
Sib-shared facial trait 976; Facial segment 60; 3D morphology of the eye sockets
Sib-shared facial trait 995; Facial segment 60; 3D morphology of the eye sockets
Sib-shared facial trait 1000; Facial segment 60; 3D morphology of the eye sockets
Sib-shared facial trait 1002; Facial segment 60; 3D morphology of the eye sockets
Sib-shared facial trait 1015; Facial segment 61; 3D morphology of the under eyes
Sib-shared facial trait 1030; Facial segment 62; 3D morphology of the temples
Sib-shared facial trait 1035; Facial segment 63; 3D morphology of the cheekbones
Sib-shared facial trait 1036; Facial segment 63; 3D morphology of the cheekbones
Sib-shared facial trait 1039; Facial segment 63; 3D morphology of the cheekbones
Sib-shared facial trait 1044; Facial segment 63; 3D morphology of the cheekbones
Sib-shared facial trait 1045; Facial segment 63; 3D morphology of the cheekbones
Ceramide (d20:1/24:0) levels
Obstructive heart defect
Obstructive heart defect (maternal genotype effect)
Dehydrocholesteryl ester (20:5) levels
Dehydrocholesteryl ester (22:6) levels
Diacylglycerol (14:0_16:0) levels
Diacylglycerol (16:0_16:0) levels
Diacylglycerol (16:0_16:1) levels
Diacylglycerol (16:0_18:2) levels
Cognitive performance (attention) (longitudinal)
Hexadecanedioate levels in elite athletes
Glycerol 3-phosphate levels in elite athletes
Glycerophosphoethanolamine levels in elite athletes
Glycerophosphoinositol levels in elite athletes
Hippurate levels in elite athletes
Histidine levels in elite athletes
Glycochenodeoxycholate glucuronide (1) levels in elite athletes
Porridge liking
Potatoes liking
Raw carrot liking
Red meat liking
Roast chicken liking
Cognitive performance (visuoconstruction) (longitudinal)
Diacylglycerol (18:1_20:4) levels
Diacylglycerol (18:2_20:4) levels
GM3 ganglioside (d18:1/16:0) levels
GM3 ganglioside (d18:1/20:0) levels
GM3 ganglioside (d18:1/22:0) levels
GM1 ganglioside (d18:1/16:0) levels
GM3 ganglioside (d18:1/18:0) levels
Vaginal microbiome MetaCyc pathway (PWY-7376|cob(II)yrinate a,c-diamide biosynthesis II (late cobalt incorporation))
Vaginal microbiome MetaCyc pathway (PWY-7377|cob(II)yrinate a,c-diamide biosynthesis I (early cobalt insertion))
Vaginal microbiome MetaCyc pathway (PWY-7392|taxadiene biosynthesis (engineered))
Vaginal microbiome MetaCyc pathway (PWY-7400|L-arginine biosynthesis IV (archaebacteria))
HWESASXX levels in elite athletes
Glycochenodeoxycholate sulfate levels in elite athletes
Hydroquinone sulfate levels in elite athletes
Glycocholenate sulfate levels in elite athletes
Glycodeoxycholate sulfate levels in elite athletes
Hypoxanthine levels in elite athletes
Glycohyocholate levels in elite athletes
Glycolithocholate sulfate levels in elite athletes
Salami liking
Salmon liking
F-salty food liking (derived food-liking factor)
Salty food liking
Facial skin gloss
Facial skin hydration
Facial skin melanin
Trihexosylcermide (d18:1/24:0) levels
Trihexosylcermide (d18:1/24:1) levels
Monohexosylceramide (d16:1/18:0) levels
Vaginal microbiome MetaCyc pathway (PWY0-1533|methylphosphonate degradation I)
Vaginal microbiome MetaCyc pathway (PWY0-1586|peptidoglycan maturation (meso-diaminopimelate containing))
Vaginal microbiome MetaCyc pathway (PWY0-162|superpathway of pyrimidine ribonucleotides de novo biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY0-166|superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli))
QTc interval
Vaginal microbiome MetaCyc pathway (PWY-6588|pyruvate fermentation to acetone)
Vaginal microbiome MetaCyc pathway (PWY-6590|superpathway of Clostridium acetobutylicum acidogenic fermentation)
Fumarate levels in elite athletes
Azelate (nonanedioate) levels in elite athletes
Behenoyl dihydrosphingomyelin (d18:0/22:0) levels in elite athletes
Behenoyl sphingomyelin (d18:1/22:0) levels in elite athletes
Behenoylcarnitine (C22) levels in elite athletes
Beta-sitosterol levels in elite athletes
High-density lipoprotein 3 cholesterol levels
Pigment dispersion syndrome or pigmentary glaucoma
Cholesteryl ester (24:6) levels
Ceramide (d16:1/16:0) levels
Ceramide (d16:1/18:0) levels
Vaginal microbiome MetaCyc pathway (PWY-6892|thiazole biosynthesis I (E. coli))
Vaginal microbiome MetaCyc pathway (PWY-6895|superpathway of thiamin diphosphate biosynthesis II)
Vaginal microbiome MetaCyc pathway (PWY-6897|thiamin salvage II)
Vaginal microbiome MetaCyc pathway (PWY-6901|superpathway of glucose and xylose degradation)
Vaginal microbiome MetaCyc pathway (PWY-6876|isopropanol biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY-6891|thiazole biosynthesis II (Bacillus))
Ceramide (d16:1/24:1, d18:1/22:1) levels in elite athletes
Gamma-glutamyltyrosine levels in elite athletes
Gamma-glutamylvaline levels in elite athletes
Dihydroceramide (d18:0/18:0) levels
Dihydroceramide (d18:0/20:0) levels
Dihydroceramide (d18:0/22:0) levels
Dihydroceramide (d18:0/24:0) levels
Dihydroceramide (d18:0/24:1) levels
Ceramide (d18:1/18:0) levels
Sib-shared facial trait 685; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 702; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 707; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 712; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 720; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 722; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 740; Facial segment 34; 3D morphology of the upper lip
Sib-shared facial trait 752; Facial segment 36; 3D morphology of the philtrium
Sib-shared facial trait 753; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 754; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 756; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 757; Facial segment 37; 3D morphology of the philtrium
Sib-shared facial trait 763; Facial segment 38; 3D morphology of the upper vermillion
Sib-shared facial trait 765; Facial segment 38; 3D morphology of the upper vermillion
Sib-shared facial trait 766; Facial segment 39; 3D morphology of the upper vermillion
Sib-shared facial trait 772; Facial segment 39; 3D morphology of the upper vermillion
Sib-shared facial trait 780; Facial segment 40; 3D morphology of the nose sides
Sib-shared facial trait 782; Facial segment 40; 3D morphology of the nose sides
Sib-shared facial trait 784; Facial segment 41; 3D morphology of the nose sides
Sib-shared facial trait 788; Facial segment 42; 3D morphology of the nose sides
Sib-shared facial trait 796; Facial segment 42; 3D morphology of the nose sides
Haddock liking
Hard cheese liking
F-healthy food liking (derived food-liking factor)
F-healthy breakfast food liking (derived food-liking factor)
F-glutamate liking (derived food-liking factor)
Goat cheese liking
Grapefruit liking
Acute glomerulonephritis
Ceramide (d19:1/22:0) levels
Vaginal microbiome MetaCyc pathway (PWY-7196|superpathway of pyrimidine ribonucleosides salvage)
Vaginal microbiome MetaCyc pathway (PWY-7197|pyrimidine deoxyribonucleotide phosphorylation)
Vaginal microbiome MetaCyc pathway (PWY-7199|pyrimidine deoxyribonucleosides salvage)
Vaginal microbiome MetaCyc pathway (PWY-7200|superpathway of pyrimidine deoxyribonucleoside salvage)
Vaginal microbiome MetaCyc pathway (PWY-7208|superpathway of pyrimidine nucleobases salvage)
Vaginal microbiome MetaCyc pathway (PWY-7211|superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis)
Mackerel liking
Marzipan liking
Dihomo-linolenate (20:3n3 or n6) levels in elite athletes
Dihomo-linolenoyl-choline levels in elite athletes
Dihomo-linolenoylcarnitine (20:3n3 or 6) levels in elite athletes
Dihomo-linoleoylcarnitine (C20:2) levels in elite athletes
Docosadienoate (22:2n6) levels in elite athletes
Vaginal microbiome MetaCyc pathway (PWY-7242|D-fructuronate degradation)
Vaginal microbiome MetaCyc pathway (PWY-7254|TCA cycle VII (acetate-producers))
Vaginal microbiome MetaCyc pathway (PWY-7315|dTDP-N-acetylthomosamine biosynthesis)
Orange juice liking
Oranges liking
Pizza liking
Plum liking
Pollock liking
Homoarginine levels in elite athletes
Homocitrulline levels in elite athletes
Homostachydrine levels in elite athletes
Salad dressing liking
Salad leaves liking
F-salad vegetables liking (derived food-liking factor)
Dihexosylceramide (d18:1/24:1) levels
Vaginal microbiome MetaCyc pathway (PWY0-1241|ADP-L-glycero-&beta;-D-manno-heptose biosynthesis)
Vaginal microbiome MetaCyc pathway (PWY0-1261|anhydromuropeptides recycling)
Vaginal microbiome MetaCyc pathway (PWY0-1296|purine ribonucleosides degradation)
Vaginal microbiome MetaCyc pathway (PWY0-1297|superpathway of purine deoxyribonucleosides degradation)
Glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) levels in elite athletes
Glycosyl-N-behenoyl-sphingosine (d18:1/22:0) levels in elite athletes
Isoleucine levels in elite athletes
Glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels in elite athletes
Trihexosylcermide (d18:1/20:0) levels
Trihexosylcermide (d18:1/22:0) levels
Vaginal microbiome MetaCyc pathway (PWY0-1479|tRNA processing)
Hexanoylglycine levels in elite athletes
Hyocholate levels in elite athletes
Isoursodeoxycholate levels in elite athletes
Lactosyl-N-behenoyl-sphingosine (d18:1/22:0) levels in elite athletes
High-density lipoprotein mediated cholesterol efflux capacity
Monohexosylceramide (d16:1/20:0) levels
Monohexosylceramide (d16:1/22:0) levels
Lysoalkenylphosphatidylethanolamine (P-16:0) levels
Lysoalkenylphosphatidylethanolamine (P-18:0) levels
Lysoalkenylphosphatidylethanolamine (P-20:0) levels
Lysophosphatidylinositol (18:0) [sn1] levels
Lysophosphatidylinositol (18:0) [sn2] levels
Lysophosphatidylinositol (18:1) [sn1] levels
Lysophosphatidylinositol (18:1) [sn2] levels
Lysophosphatidylinositol (18:2) [sn1] levels
Lysophosphatidylinositol (18:2) [sn2] levels
Lysophosphatidylinositol (20:4) [sn1] levels
Lysophosphatidylinositol (20:4) [sn2] levels
Cholesteryl ester levels in LDL
Broad bean liking
Brussel sprout liking
Burger liking
F-burn/spicy liking (derived food-liking factor)
Vaginal microbiome relative abundance (f_Aerococcaceae)
Oleoylcholine levels in elite athletes
Palmitate (16:0) levels in elite athletes
Palmitoleoyl-arachidonoyl-glycerol (16:1/20:4) [2] levels in elite athletes
N-acetyltaurine levels in elite athletes
Palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] levels in elite athletes
Palmitoleoylcarnitine (C16:1) levels in elite athletes
Palmitoloelycholine levels in elite athletes
Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels in elite athletes
Palmitoyl ethanolamide levels in elite athletes
Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [1] levels in elite athletes
Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1] levels in elite athletes
Palmitoyl-linoleoyl-glycerol (16:0/18:2) [2] levels in elite athletes
Palmitoyl-oleoyl-glycerol (16:0/18:1) [1] levels in elite athletes
Phosphatidylcholine (15:0_20:4) levels
Phosphatidylcholine (15:0_22:6) levels
Phosphatidylcholine (15-MHDA_18:1) levels
Phosphatidylcholine (15-MHDA_18:2) levels
Phosphatidylcholine (15-MHDA_20:4) levels
F-caffeinated/sweet liking (derived food-liking factor)
F-cake/biscuits liking (derived food-liking factor)
Cake icing liking
Vaginal microbiome relative abundance (f_Mycoplasmataceae)
Vaginal microbiome relative abundance (f_Peptostreptococcales-Tissierellales)
Vaginal microbiome relative abundance (f_Veillonellaceae)
Vaginal microbiome relative abundance (g_Anaerococcus)
Pregnanediol-3-glucuronide levels in elite athletes
Pregnanolone/allopregnanolone sulfate levels in elite athletes
Pregnen-diol disulfate C21H34O8S2 levels in elite athletes
Pregnenolone sulfate levels in elite athletes
Propionylcarnitine (C3) levels in elite athletes
Capers liking
F-carbohydrate liking (derived food-liking factor)
F-capsicum liking (derived food-liking factor)
Vaginal microbiome relative abundance (g_Dialister)
Vaginal microbiome relative abundance (g_Lactobacillus)
Vaginal microbiome relative abundance (g_Megasphaera)
Propionylglycine levels in elite athletes
Sebacate (decanedioate) levels in elite athletes
Sphinganine-1-phosphate levels in elite athletes
Sphinganine levels in elite athletes
Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels in elite athletes
N1-methyladenosine levels in elite athletes
Sphingomyelin (d17:2/16:0, d18:2/15:0) levels in elite athletes
Sphingomyelin (d18:0/18:0, d19:0/17:0) levels in elite athletes
N2,N2-dimethylguanosine levels in elite athletes
Sphingomyelin (d18:0/20:0, d16:0/22:0) levels in elite athletes
Cauliflower liking
Cereal bar liking
F-cheese liking (derived food-liking factor)
Cheesecake liking
Facial wrinkles (under eye)
Goiter
Phosphatidylcholine (16:1_22:6) levels
Phosphatidylcholine (17:0_18:2) levels
Ascending thoracic aortic diameter
Chicken liking
F-chocolate/coffee liking (derived food-liking factor)
Cod liking
F-coffee/alcohol liking (derived food-liking factor)
Descending thoracic aortic diameter
Vaginal microbiome relative abundance (o_Campylobacterales)
Vaginal microbiome relative abundance (o_Fusobacteriales)
Diacylglycerol (18:1_18:1) levels
Diacylglycerol (18:1_18:2) levels
Diacylglycerol (18:2_18:2) levels
Vaginal microbiome relative abundance (o_Peptostreptococcales-Tissierellales)
Vaginal microbiome relative abundance (p_Actinobacteriota)
F-cooking vegetables liking (derived food-liking factor)
Coriander liking
Cream liking
Crisps liking
Sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0) levels in elite athletes
Sphingomyelin (d18:2/14:0, d18:1/14:1) levels in elite athletes
Sphingomyelin (d18:2/16:0, d18:1/16:1) levels in elite athletes
Sphingomyelin (d18:2/18:1) levels in elite athletes
Sphingomyelin (d18:2/21:0, d16:2/23:0) levels in elite athletes
Statin intolerance or statin-associated muscle symptoms
Maximum creatine kinase levels in statin users
Total lipid levels in LDL
Concentration of LDL particles
Vaginal microbiome relative abundance (p_Proteobacteria)
Vaginal microbiome relative abundance (s_Aerococcus christensenii)
Croissant liking
Cucumber liking
Curry liking
F-dairy liking (derived food-liking factor)
F-deep fried food liking (derived food-liking factor)
F-dessert liking (derived food-liking factor)
Oleoylcarnitine (C18:1) levels in elite athletes
Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels in elite athletes
Ornithine levels in elite athletes
Sphingomyelin (d18:2/23:1) levels in elite athletes
Sphingomyelin (d18:2/24:1, d18:1/24:2) levels in elite athletes
Oxalate (ethanedioate) levels in elite athletes
Invasive bacterial infection
Stearate (18:0) levels in elite athletes
Stearoyl sphingomyelin (d18:1/18:0) levels in elite athletes
Stearoyl-arachidonoyl-glycerol (18:0/20:4) [2] levels in elite athletes
Stearoylcholine levels in elite athletes
Suberate (octanedioate) levels in elite athletes
Stearoyl-arachidonoyl-glycerol (18:0/20:4) [1] levels in elite athletes
Phosphatidylserine (36:2) levels
Phosphatidylserine (38:3) levels
Phosphatidylserine (38:4) levels
Phosphatidylserine (38:5) levels
Phosphatidylserine (40:6) levels
Sphingomyelin (34:3) levels
Sphingomyelin (37:2) levels
Sphingomyelin (41:0) levels
Sphingomyelin (41:1) (a) levels
Sphingomyelin (43:1) levels
Sphingomyelin (43:2) (b) levels
Sphingomyelin (43:2) (c) levels
Sphingomyelin (d16:1/19:0) levels
Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levels
Sphingomyelin (d16:1/24:1) levels
Vaginal microbiome relative abundance (s_Finegoldia magna)
Vaginal microbiome relative abundance (s_Gardnerella vaginalis)
Vaginal microbiome relative abundance (s_Lactobacillus crispatus)
Vaginal microbiome relative abundance (s_Dialister propionicifaciens)
F-fish liking (derived food-liking factor)
Fruit liking
Tauro-beta-muricholate levels in elite athletes
Taurocholenate sulfate levels in elite athletes
Tauroursodeoxycholate levels in elite athletes
Palmitoylcarnitine (C16) levels in elite athletes
Tricosanoyl sphingomyelin (d18:1/23:0) levels in elite athletes
Esophageal varix
Oxidized cholesteryl ester (18:2) [+2O] levels
Oxidized cholesteryl ester (18:2) [+O] levels
Phosphatidylcholine (14:0_20:4) levels
Phosphatidylcholine (14:0_22:6) levels
Phosphatidylcholine (15:0_20:3) levels
Vaginal microbiome relative abundance (f_Bifidobacteriaceae)
Vaginal microbiome relative abundance (f_Lachnospiraceae)
Butternut squash liking
Cabbage liking
Palmitoyl-oleoyl-glycerol (16:0/18:1) [2] levels in elite athletes
Palmitoylcholine levels in elite athletes
Pentadecanoate (15:0) levels in elite athletes
Pimelate (heptanedioate) levels in elite athletes
Pregn steroid monosulfate C21H34O5S levels in elite athletes
Phosphatidylcholine (15-MHDA_22:6) levels
Phosphatidylcholine (16:0_16:0) levels
Phosphatidylcholine (16:0_18:0) levels
Free cholesterol levels in LDL
Vaginal microbiome relative abundance (g_Atopobium)
Phosphatidylcholine (16:0_22:6) levels
Vaginal microbiome relative abundance (g_Peptoniphilus)
Vaginal microbiome relative abundance (g_Prevotella)
Vaginal microbiome relative abundance (g_Streptococcus)
Sphingomyelin (d18:1/14:0, d16:1/16:0) levels in elite athletes
Sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0) levels in elite athletes
Sphingomyelin (d18:1/18:1, d18:2/18:0) levels in elite athletes
Sphingomyelin (d18:1/19:0, d19:1/18:0) levels in elite athletes
Sphingomyelin (d18:1/20:0, d16:1/22:0) levels in elite athletes
Vaginal microbiome relative abundance (o_Bacteroidales)
Sphingomyelin (d18:1/20:1, d18:2/20:0) levels in elite athletes
Nonadecanoate (19:0) levels in elite athletes
Sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2) levels in elite athletes
O-sulfo-L-tyrosine levels in elite athletes
Octadecanedioate levels in elite athletes
Hearing loss, difficulty in hearing
Coffee difference liking
Coffee max liking
F-cooking flavour liking (derived food-liking factor)
Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) levels in elite athletes
Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels in elite athletes
Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes
Sphingomyelin (d18:1/24:1, d18:2/24:0) levels in elite athletes
Vaginal microbiome relative abundance (p_Firmicutes)
Vaginal microbiome relative abundance (s_Atopobium vaginae)
Vaginal microbiome relative abundance (s_Dialister micraerophilus)
P-cresol sulfate levels in elite athletes
Sphingomyelin (d18:2/24:2) levels in elite athletes
Palmitoleate (16:1n7) levels in elite athletes
Sphingosine 1-phosphate levels in elite athletes
Sphingosine levels in elite athletes
Dried fruit liking
F-fatty/salty food liking (derived food-liking factor)
Phosphatidylinositol (39:6) levels
F-fatty/dairy food liking (derived food-liking factor)
F-fatty food liking (derived food-liking factor)
Midgestational selenium levels
Sphingomyelin (d17:1/14:0) levels
Sphingomyelin (d17:1/16:0) levels
Sphingomyelin (d17:1/24:1) levels
Sphingomyelin (d18:0/14:0) levels
Sphingomyelin (d18:0/16:0) levels
Pantothenate levels in elite athletes
Paraxanthine levels in elite athletes
Trimethylamine N-oxide levels in elite athletes
Ximenoylcarnitine (C26:1) levels in elite athletes
Phenol sulfate levels in elite athletes
Vaginal microbiome relative abundance (s_Lactobacillus iners)
F-fruit liking (derived food-liking factor)
Fruit juice liking
Globe artichoke liking
Spinal canal stenosis
Verbal learning
Mean spheric corpuscular volume
Metabolite peak levels (QI890)
Metabolite peak levels (QI8919)
Metabolite peak levels (QI8963)
Metabolite peak levels (QI8972)
Metabolite peak levels (QI8977)
Metabolite peak levels (QI8984)
Metabolite peak levels (QI904)
Metabolite peak levels (QI14931)
Metabolite peak levels (QI15249)
Metabolite peak levels (QI15290)
Metabolite peak levels (QI9110)
Metabolite peak levels (QI9111)
Metabolite peak levels (QI9112)
Metabolite peak levels (QI9113)
Metabolite peak levels (QI9119)
Metabolite peak levels (QI9202)
Metabolite peak levels (QI9211)
Metabolite peak levels (QI9297)
Metabolite peak levels (QI9368)
Metabolite peak levels (QI9376)
Metabolite peak levels (QI9385)
Descending aorta maximum area
Descending aorta distensibility
N-terminal pro-BNP levels
Basal Cell Adhesion Molecule levels
Intercellular adhesion molecule 1 levels
Metalloproteinase inhibitor 3 levels
Pigment epithelium-derived factor levels
C-C motif chemokine 27 levels
Receptor tyrosine-protein kinase erbB-3 levels
Complement C2 levels
Leptin receptor levels
C-C motif chemokine 22 levels
C-C motif chemokine 15 levels
Coagulation Factor XI levels
C-C motif chemokine 17 levels
Low affinity immunoglobulin epsilon Fc receptor levels
Tyrosine-protein kinase receptor Tie-1, soluble levels
Angiopoietin-1 receptor, soluble levels
Vascular endothelial growth factor receptor 2 levels
Kunitz-type protease inhibitor 2 levels
Interleukin-1 receptor antagonist protein levels
Tissue factor pathway inhibitor levels
Cadherin-5 levels
Ficolin-3 levels
Growth-regulated alpha protein levels
Intercellular adhesion molecule 2 levels
Tumor necrosis factor ligand superfamily member 11 levels
GTPase KRas levels
Parathyroid hormone-related protein levels
Trefoil factor 2 levels
C-C motif chemokine 21 levels
Pleiotrophin levels
C-C motif chemokine 25 levels
Kallikrein-14 levels
Myeloblastin levels
Carboxypeptidase B2 levels
Endothelin-converting enzyme 1 levels
Bone morphogenetic protein 7 levels
Tartrate-resistant acid phosphatase type 5 levels
Insulin receptor levels
CD27 antigen levels
Ephrin type-A receptor 1 levels
GDNF family receptor alpha-2 levels
Interleukin-1 receptor-like 1 levels
Interleukin-10 receptor subunit beta levels
Interleukin-12 receptor subunit beta-1 levels
Interleukin-15 receptor subunit alpha levels
Cadherin-3 levels
Granzyme A levels
Growth/differentiation factor 5 levels
Interleukin-25 levels
Interleukin-19 levels
C-C motif chemokine 3-like 1 levels
C-C motif chemokine 4-like levels
Stem Cell Growth Factor-beta levels
C-C motif chemokine 16 levels
Ck-beta-8-1 levels
C-C motif chemokine 23 levels
Insulin-like growth factor 1 receptor levels
Vascular endothelial growth factor receptor 3 levels
C-C motif chemokine 18 levels
Coagulation factor Xa levels
C-X-C motif chemokine 11 levels
Complement factor I levels
C-C motif chemokine 14 levels
Endothelial monocyte-activating polypeptide 2 levels
Aflatoxin B1 aldehyde reductase member 2 levels
Extracellular superoxide dismutase [Cu-Zn] levels
Cation-independent mannose-6-phosphate receptor levels
Neural cell adhesion molecule 1, 120 kDa isoform levels
Growth/differentiation factor 15 levels
Interleukin-6 receptor subunit beta levels
Kallikrein-8 levels
Kallikrein-12 levels
Verbal short term memory (paragraph recall test)
Metabolite peak levels (QI2242)
Metabolite peak levels (QI2435)
Metabolite peak levels (QI244)
Serine levels
Stearic acid levels
Succinic acid/Methylmalonic acid levels
UDP-GlcNAc levels
Urocanic acid levels
Metabolite peak levels (QI176)
Xanthosine levels
Metabolite peak levels (QI250)
Metabolite peak levels (QI254)
Metabolite peak levels (QI2551)
Metabolite peak levels (QI256)
Metabolite peak levels (QI261)
Metabolite peak levels (QI2689)
Metabolite peak levels (QI2691)
Metabolite peak levels (QI2694)
Metabolite peak levels (QI2718)
Total Phosphatidylethanolamine levels
Total Phosphatidylglycerol levels
Total Phosphatidylinositol levels
Total Sphingomyelin levels
Total Sulfatide levels
Total Triacylglycerol levels
Total Trihexosylcermide levels
Total Ubiquinone levels
Ubiquinone levels
Ascending aorta maximum area (MTAG)
Descending aorta maximum area (MTAG)
Total lipid levels in medium HDL
Endothelial cell-selective adhesion molecule levels
Galectin-2 levels
Galectin-4 levels
Growth hormone receptor levels
Intercellular adhesion molecule 5 levels
interleukin-17 receptor B levels
Interleukin-36 alpha levels
Interleukin-22 receptor subunit alpha-2 levels
Interleukin-23 levels
Interleukin-23 receptor levels
Interleukin-5 receptor subunit alpha levels
Interleukin-7 receptor subunit alpha levels
Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
Limbic system-associated membrane protein levels
MHC class I polypeptide-related sequence B levels
Muellerian-inhibiting factor levels
Natural cytotoxicity triggering receptor 1 levels
Reticulon-4 receptor levels
Tumor necrosis factor receptor superfamily member 19L levels
Semaphorin-6A levels
Sialic acid-binding Ig-like lectin 7 levels
Phospholipids to total lipids ratio in medium HDL
Ceramide (d18:1/16:0) levels
Metabolite peak levels (QI648)
Metabolite peak levels (QI6523)
Metabolite peak levels (QI6558)
Metabolite peak levels (QI6685)
Metabolite peak levels (QI6688)
Metabolite peak levels (QI6691)
Metabolite peak levels (QI6693)
Metabolite peak levels (QI6701)
Metabolite peak levels (QI6703)
Metabolite peak levels (QI6721)
Metabolite peak levels (QI13749)
Metabolite peak levels (QI1377)
Metabolite peak levels (QI13770)
Metabolite peak levels (QI13773)
Metabolite peak levels (QI13785)
Metabolite peak levels (QI1379)
Metabolite peak levels (QI13938)
Metabolite peak levels (QI13939)
Metabolite peak levels (QI13969)
Metabolite peak levels (QI13988)
Cholesteryl ester levels in medium HDL
Verbal learning (oral presentation)
Verbal learning (visual presentation)
Metabolite peak levels (QI2727)
Metabolite peak levels (QI2799)
Metabolite peak levels (QI2815)
Metabolite peak levels (QI2974)
Metabolite peak levels (QI3018)
Metabolite peak levels (QI3060)
Metabolite peak levels (QI3067)
Metabolite peak levels (QI3127)
Metabolite peak levels (QI3139)
Metabolite peak levels (QI3403)
Metabolite peak levels (QI3426)
Metabolite peak levels (QI3436)
Metabolite peak levels (QI3442)
Metabolite peak levels (QI3453)
Metabolite peak levels (QI3504)
Metabolite peak levels (QI3513)
Metabolite peak levels (QI3710)
Metabolite peak levels (QI3722)
Metabolite peak levels (QI3754)
Metabolite peak levels (QI3783)
Elafin levels
Heparin cofactor 2 levels
Protein Z-dependent protease inhibitor levels
Interferon alpha/beta receptor 1 levels
Bactericidal permeability-increasing protein levels
Peptidoglycan recognition protein 1 levels
Mannose-binding protein C levels
Complement decay-accelerating factor levels
Macrophage mannose receptor 1 levels
Interleukin-1 Receptor accessory protein levels
Low-density lipoprotein receptor-related protein 8 levels
Tumor necrosis factor ligand superfamily member 8 levels
Kunitz-type protease inhibitor 1 levels
Layilin levels
Apolipoprotein E (isoform E3) levels
Apolipoprotein E (isoform E4) levels
Tumor necrosis factor receptor superfamily member 13C levels
Cathepsin S levels
WNT1-inducible-signaling pathway protein 1 levels
Leukemia inhibitory factor receptor levels
Uterine prolapse
Uveitis
Histidine-rich glycoprotein levels
Hepatocyte growth factor activator levels
Lactadherin levels
Prolyl endopeptidase FAP levels
Ficolin-2 levels
Extracellular matrix protein 1 levels
Cytoskeleton-associated protein 2 levels
Beta-Ala-His dipeptidase levels
Collectin-11 levels
Fetuin-B levels
Gremlin-1 levels
Cystatin-F levels
Lactoperoxidase levels
Granulins levels
Ephrin type-B receptor 2 levels
Triglyceride levels in medium HDL
Verbal short term memory
Metabolite peak levels (QI7085)
Metabolite peak levels (QI7086)
Metabolite peak levels (QI7089)
Metabolite peak levels (QI7090)
Metabolite peak levels (QI7106)
Metabolite peak levels (QI14127)
Metabolite peak levels (QI1417)
Metabolite peak levels (QI14216)
Metabolite peak levels (QI14245)
Metabolite peak levels (QI14354)
Metabolite peak levels (QI1451)
Metabolite peak levels (QI14556)
Metabolite peak levels (QI14562)
Metabolite peak levels (QI14564)
Metabolite peak levels (QI14569)
Metabolite peak levels (QI7137)
Metabolite peak levels (QI7191)
Metabolite peak levels (QI7214)
Metabolite peak levels (QI722)
Metabolite peak levels (QI7228)
Metabolite peak levels (QI7232)
Metabolite peak levels (QI7312)
Diacylglycerol (14:0_18:2) levels
Cerebral venous thrombosis
Metabolite peak levels (QI14793)
Metabolite peak levels (QI14798)
Metabolite peak levels (QI1480)
Metabolite peak levels (QI1481)
Metabolite peak levels (QI14818)
Metabolite peak levels (QI1483)
Metabolite peak levels (QI8421)
Metabolite peak levels (QI8422)
Metabolite peak levels (QI843)
Metabolite peak levels (QI8492)
Metabolite peak levels (QI8556)
Metabolite peak levels (QI8596)
Metabolite peak levels (QI8703)
Metabolite peak levels (QI8774)
Metabolite peak levels (QI8814)
Metabolite peak levels (QI8853)
Metabolite peak levels (QI8858)
Cholesteryl esters to total lipids ratio in medium HDL
Total cholesterol levels in very large HDL
Alanine levels
Citrate levels
Concentration of small HDL particles
Glucose levels
Glutamine levels
Phospholipid levels in very large HDL
Total lipid levels in small HDL
Triglyceride levels in chylomicrons and extremely large VLDL
Glycoprotein acetyls (mainly a1-acid glycoprotein)
Histidine levels
Other polyunsaturated fatty acid levels than 18:2
Phenylalanine levels
Pyruvate levels
Ratio of bis-allylic bonds to double bonds in lipids
Descending aorta minimum area
Apolipoprotein M levels
MAP kinase-activated protein kinase 3 levels
Tumor necrosis factor-inducible gene 6 protein levels
Interleukin-17 receptor A levels
Serine/threonine-protein kinase receptor R3 levels
Programmed cell death 1 ligand 1 levels
Contactin-1 levels
GDNF family receptor alpha-1 levels
Interleukin-18 receptor accessory protein levels
Carbonic anhydrase 1 levels
Tumor necrosis factor receptor superfamily member EDAR levels
Interleukin-1 receptor-like 2 levels
Kallistatin levels
Tropomyosin beta chain levels
Insulin-like growth factor-binding protein 7 levels
CD209 antigen levels
Phosphatidylethanolamine (38:6) levels
Phosphatidylethanolamine plasmalogen C38:6 levels
Phosphatidylcholine plasmalogen C38:7 levels
Carnitine C4 levels
Phosphatidylethanolamine plasmalogen C40:7 levels
Carnitine C6 levels
Carnitine C8 levels
Carnitine C9 levels
Creatine levels
Diacetylspermine levels
DMGV levels
GABA levels
Glycochenodeoxycholic acid levels
Glycodeoxycholate/glycochenodeoxycholate levels
Indole-3-lactic acid levels
Kynurenine levels
Linoleoyl ethanolamide levels
Methionine sulfoxide levels
N-acetyl-L-glutamic acid levels
N-acetyl-L-glutamine levels
N-acetylalanine levels
N-acetylaspartic acid levels
N-acetylserine levels
N-acetyltryptophan levels
N-carbamoyl-beta-alanine levels
N-oleoyltaurine levels
N1-acetylspermidine levels
N1-methyl-2-pyridone-5-carboxamide levels
N4-acetylcytidine levels
N6,n6,n6-trimethyllysine levels
DG(36:4) levels
DG(38:5) levels
NMMA levels
Oleoyl leucine levels
Oleoyl phenylalanine levels
Oleoyl serine levels
Orotic acid levels
Oxaloacetic acid levels
Metabolite peak levels (QI6160)
Metabolite peak levels (QI618)
Metabolite peak levels (QI619)
Metabolite peak levels (QI6203)
Metabolite peak levels (QI6204)
Metabolite peak levels (QI6252)
Metabolite peak levels (QI6270)
Metabolite peak levels (QI6305)
Triacylglycerol (52:3) [NL-18:2] levels
Triacylglycerol (52:4) [NL-18:1] levels
Metabolite peak levels (QI9680)
Metabolite peak levels (QI9708)
Metabolite peak levels (QI9710)
Metabolite peak levels (QI9738)
Metabolite peak levels (QI15587)
Metabolite peak levels (QI15625)
Metabolite peak levels (QI15628)
Metabolite peak levels (QI15633)
Metabolite peak levels (QI1565)
Metabolite peak levels (QI1568)
Metabolite peak levels (QI15739)
Metabolite peak levels (QI15785)
Metabolite peak levels (QI1839)
Metabolite peak levels (QI1841)
Metabolite peak levels (QI190)
Metabolite peak levels (QI9774)
Metabolite peak levels (QI9777)
Metabolite peak levels (QI9778)
Metabolite peak levels (QI9810)
Metabolite peak levels (QI9811)
Metabolite peak levels (QI9845)
Metabolite peak levels (QI9862)
Metabolite peak levels (QI9873)
Metabolite peak levels (QI9878)
Total Cholesteryl ester levels
Total Dihexosylceramide levels
Total GM3 ganglioside levels
Total Lysophosphatidylethanolamine levels
Total Phosphatidylcholine levels
Total Phosphatidylserine levels
Total Alkyldiacylglycerol levels
Free cholesterol to total lipids ratio in medium HDL
Ascending aorta distensibility (MTAG)
Descending aorta distensibility (MTAG)
Interleukin-27 receptor subunit alpha levels
alpha-2-macroglobulin receptor-associated protein levels
Apolipoprotein D levels
Secreted and transmembrane protein 1 levels
Gelsolin levels
Galactoside 3(4)-L-fucosyltransferase levels
Apolipoprotein L1 levels
Scavenger receptor cysteine-rich type 1 protein M130 levels
Chitotriosidase-1 levels
Tyrosine-protein kinase transmembrane receptor ROR1 levels
Trefoil factor 3 levels
Fatty acid-binding protein, liver levels
Sleep apnea syndrome
Metabolite peak levels (QI14010)
Metabolite peak levels (QI14012)
Metabolite peak levels (QI14032)
Metabolite peak levels (QI14045)
Metabolite peak levels (QI14055)
Metabolite peak levels (QI6762)
Metabolite peak levels (QI68)
Metabolite peak levels (QI6816)
Metabolite peak levels (QI6823)
Metabolite peak levels (QI6840)
Metabolite peak levels (QI6879)
Metabolite peak levels (QI692)
Metabolite peak levels (QI694)
Metabolite peak levels (QI6976)
Metabolite peak levels (QI6983)
Metabolite peak levels (QI6984)
Metabolite peak levels (QI6985)
Metabolite peak levels (QI6991)
Metabolite peak levels (QI7003)
Metabolite peak levels (QI7019)
Metabolite peak levels (QI7072)
Metabolite peak levels (QI7079)
Metabolite peak levels (QI7080)
Triacylglycerol (54:5) [NL-18:1] levels
Triacylglycerol (56:6) [NL-20:4] levels
Triacylglycerol (56:8) [NL-20:4] levels
Alkyldiacylglycerol (O-52:2) [NL-16:0] levels
Total Ceramide levels
Total free cholesterol levels
Total Diacylglycerol levels
Total Dihydroceramide levels
Total Lysoalkylphosphatidylcholine levels
Total Lysoalkenylphosphatidylcholine levels
Total Monohexosylceramide levels
Total Alkylphosphatidylcholine levels
Total Alkenylphosphatidylcholine levels
Metabolite peak levels (QI9885)
Metabolite peak levels (QI9912)
Metabolite peak levels (QI9963)
Metabolite peak levels (QI9993)
Metabolite peak levels (QI15802)
Metabolite peak levels (QI15804)
Metabolite peak levels (QI15805)
Metabolite peak levels (QI15932)
Metabolite peak levels (QI15952)
Metabolite peak levels (QI15953)
Metabolite peak levels (QI15962)
Metabolite peak levels (QI15965)
Metabolite peak levels (QI2044)
Metabolite peak levels (QI2146)
Metabolite peak levels (QI2179)
Metabolite peak levels (QI2180)
Metabolite peak levels (QI2187)
Metabolite peak levels (QI2188)
Metabolite peak levels (QI2190)
Metabolite peak levels (QI2222)
Metabolite peak levels (QI2236)
Metabolite peak levels (QI2240)
Sphingomyelin (35:2) (b) levels
Triacylglycerol (48:2) [NL-16:0] levels
Triacylglycerol (54:0) [NL-18:0] levels
Triacylglycerol (54:4) [NL-18:2] levels
Metabolite peak levels (QI6095)
Metabolite peak levels (QI12070)
Metabolite peak levels (QI12128)
Metabolite peak levels (QI12147)
Metabolite peak levels (QI1234)
Metabolite peak levels (QI12380)
Metabolite peak levels (QI12439)
Metabolite peak levels (QI12470)
Metabolite peak levels (QI12472)
Metabolite peak levels (QI12488)
Metabolite peak levels (QI1249)
Metabolite peak levels (QI12497)
Metabolite peak levels (QI12506)
Metabolite peak levels (QI12663)
Metabolite peak levels (QI12680)
Metabolite peak levels (QI11307)
Metabolite peak levels (QI11418)
Metabolite peak levels (QI11461)
Metabolite peak levels (QI11516)
Metabolite peak levels (QI11537)
Metabolite peak levels (QI11581)
Metabolite peak levels (QI11633)
Metabolite peak levels (QI11739)
Metabolite peak levels (QI11833)
Metabolite peak levels (QI12000)
1-methylguanosine levels
2-hydroxyglutaric acid levels
ADMA levels
Arecaidine levels
Arginine levels
Cholesterol to total lipids ratio in medium HDL
Mortality in Parkinson's disease
Metabolite peak levels (QI3785)
Metabolite peak levels (QI3819)
Metabolite peak levels (QI3870)
Metabolite peak levels (QI4060)
Metabolite peak levels (QI409)
Metabolite peak levels (QI4123)
Metabolite peak levels (QI4130)
Metabolite peak levels (QI4144)
Metabolite peak levels (QI422)
Metabolite peak levels (QI4246)
Metabolite peak levels (QI4247)
Metabolite peak levels (QI4288)
Metabolite peak levels (QI4307)
Metabolite peak levels (QI4378)
Metabolite peak levels (QI445)
Metabolite peak levels (QI4508)
Metabolite peak levels (QI4560)
Metabolite peak levels (QI4584)
Metabolite peak levels (QI4667)
Metabolite peak levels (QI4680)
Metabolite peak levels (QI4687)
Metabolite peak levels (QI4689)
Alkylphosphatidylethanolamine (O-16:0/22:4) levels
Typhoid fever
Butyrobetaine levels
Carnitine C10 levels
Carnitine C12 levels
Sphingomyelin C14:0 levels
Carnitine C14:1 levels
Carnitine C14:2 levels
Acetylcarnitine (c2) levels
Cerotoylcarnitine (C26) levels
Propionylcarnitine (c3) levels
CAR DC3:0;2Me levels
Phosphatidylethanolamine (34:2) levels
Phosphatidylethanolamine (36:2) levels
Phosphatidylserine plasmalogen C36:3 levels
Phosphatidylethanolamine C38:4 levels
Phosphatidylcholine plasmalogen C38:6 levels
Metabolite peak levels (QI6333)
Metabolite peak levels (QI6365)
Metabolite peak levels (QI6383)
Metabolite peak levels (QI6455)
Metabolite peak levels (QI12743)
Metabolite peak levels (QI12750)
Metabolite peak levels (QI12764)
Metabolite peak levels (QI12768)
Metabolite peak levels (QI12890)
Metabolite peak levels (QI12942)
Metabolite peak levels (QI13066)
Metabolite peak levels (QI13235)
Metabolite peak levels (QI13326)
Metabolite peak levels (QI13343)
Metabolite peak levels (QI13360)
Metabolite peak levels (QI13375)
Metabolite peak levels (QI13392)
Metabolite peak levels (QI13448)
Metabolite peak levels (QI13613)
Metabolite peak levels (QI13644)
Metabolite peak levels (QI6471)
Metabolite peak levels (QI7338)
Metabolite peak levels (QI7372)
Metabolite peak levels (QI7379)
Metabolite peak levels (QI7380)
Metabolite peak levels (QI7389)
Metabolite peak levels (QI7417)
Metabolite peak levels (QI7471)
Metabolite peak levels (QI750)
Metabolite peak levels (QI7549)
Metabolite peak levels (QI7601)
Metabolite peak levels (QI7638)
Metabolite peak levels (QI7703)
Metabolite peak levels (QI1459)
Metabolite peak levels (QI14615)
Metabolite peak levels (QI14717)
Metabolite peak levels (QI14719)
Metabolite peak levels (QI14741)
Metabolite peak levels (QI14769)
Metabolite peak levels (QI1478)
Metabolite peak levels (QI4690)
Metabolite peak levels (QI4708)
Metabolite peak levels (QI4755)
Metabolite peak levels (QI4773)
Metabolite peak levels (QI4775)
Metabolite peak levels (QI4887)
Metabolite peak levels (QI4952)
Metabolite peak levels (QI4974)
Metabolite peak levels (QI5099)
Metabolite peak levels (QI510)
Metabolite peak levels (QI5101)
Metabolite peak levels (QI5169)
Metabolite peak levels (QI5171)
Metabolite peak levels (QI5469)
Metabolite peak levels (QI5541)
Metabolite peak levels (QI565)
Metabolite peak levels (QI5684)
Metabolite peak levels (QI5745)
Metabolite peak levels (QI5780)
Metabolite peak levels (QI588)
Metabolite peak levels (QI5884)
Metabolite peak levels (QI6080)
Survival in melanoma
Post-traumatic stress disorder (MTAG)
Spelling
L1-L4 bone mineral density x serum urate levels interaction
Liver iron content
Pancreas fat
Pancreas iron content
COVID-19 (hospitalized covid vs population)
COVID-19 (covid pneumonia vs population)
Total bilirubin levels x insomnia interaction
Phosphatidylglycerol(32:1)_[M+OAc]1- levels
COVID-19 (covid respiratory support vs population)
COVID-19 (severe respiratory symptoms vs population)
Phosphatidylglycerol(35:3)_[M-H]1- levels
Phosphatidylglycerol(36:0)_[M-H]1- levels
Phosphatidylglycerol(34:0)_[M-H]1- levels
Fatty acid(20:4)_[M-H]1- levels
sarcopenia
Total protein levels x insomnia interaction
Lysophosphatidylcholine-O_16:1_[M+H]1+/Lysophosphatidylcholine-P_16:0_[M+H]1+ levels
Lysophosphatidylcholine(16:1)_[M+H]1+/Lysophosphatidylethanolamine(19:1)_[M+H]1+ levels
Lysophosphatidylcholine(20:4)_[M+H]1+ levels
Lysophosphatidylcholine_20:4_[M+H]1+ levels
Lysophosphatidylcholine_22:6_[M+H]1+ levels
Lysophosphatidylcholine-2O_18:0_[M+H]1+ levels
Hip index
Acute respiratory distress syndrome
Phosphatidate(40:5)_[M+OAc]1-/Phosphatidylglycerol(39:5)_[M-H]1- levels
Phosphatidate(41:2)_[M+H]1+ levels
Conotruncal heart defects with normally related great vessels in 22q.11.2 deletion syndrome
Conotruncal heart defects with normally related great vessels (without 22q.11.2 deletion syndrome)
Conotruncal heart defects with normally related great vessels
Phosphatidylglycerol_36:0_[M-H]1- levels
Phosphatidylglycerol-O_34:0_[M-H]1- levels
Phosphatidylglycerol-O_38:0_[M-H]1- levels
Phosphatidylglycerol-O_40:0_[M-H]1- levels
Heel bone mineral density x serum urate levels interaction
Low testosterone levels
Curly vs straight hair
Sunburn type
Pigment spots (darkness)
Skin flushing frequency
Rough skin frequency
Response to cosmetics (uncomfortable frequency)
Direct bilirubin levels x insomnia interaction
Cisplatin-induced hearing loss in childhood cancer
Phosphatidylinositol_34:0_[M+H]1+ levels
Phosphatidylinositol_34:1_[M-H]1- levels
Phosphatidylinositol_38:4_[M-H]1- levels
Phosphatidylinositol_40:6_[M-H]1- levels
Diacylglycerol(44:6)_[M+H-H2O]1+ levels
Fatty acid(16:1)_[M-H]1- levels
Fatty acid(18:4)_[M-H]1- levels
Fatty acid(20:3)_[M-H]1- levels
DNA methylation PhenoAge acceleration
Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels
Lysophosphatidylcholine_18:2_[M+OAc]1-/Lysophosphatidylserine_22:1_[M-H]1- levels
Fatty acid(22:6)_[M-H]1- levels
Hydroxycholesterol_[M+H-2H2O]1+ levels
Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ levels
Response to buprenorphine in opioid use disorder
Phosphatidylinositol_36:4_[M-H]1- levels
Phosphatidylinositol_38:0_[M-H]1- levels
Phosphatidylinositol_36:2_[M+H]1+ levels
Phosphatidylinositol_36:3_[M-H]1- levels
Anxious temperament
Cyclothymic temperament
Depressive temperament
Irritable temperament
Hyperthymic temperament
Arthritis (oligoarticular juvenile idiopathic)
Fatty acid(22:5)_[M-H]1- levels
Phosphatidate(39:1)_[M+H]1+ levels
Leucine-rich alpha-2-glycoprotein 1 levels in type 2 diabetes
Phosphatidylethanolamine_36:4_[M-H]1- levels
Phosphatidylethanolamine_37:2_[M-H]1- levels
Phosphatidylethanolamine_40:6_[M-H]1- levels
Phosphatidylethanolamine-O_34:1_[M-H]1-/Phosphatidylethanolamine-P_34:0_[M-H]1- levels
Smoking x experiences in childhood (felt loved by family member) interaction
Smoking x traumatic event in childhood (felt hated by family member) interaction
Smoking x traumatic event in childhood (sexually molested) interaction
Diacylglycerol_36:3_[M+H-H2O]1+ levels
Diacylglycerol_44:6_[M+H-H2O]1+ levels
Diacylglycerol(36:3)_[M+NH4]1+ levels
Phosphatidylethanolamine_36:3_[M-H]1- levels
Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction
Diacylglycerol_32:2_[M+H-H2O]1+ levels
Diacylglycerol_33:1_[M+H-H2O]1+ levels
Diacylglycerol_34:0_[M+H-H2O]1+ levels
Switch to non-stimulant treatment in ADHD
Adverse cardiovascular outcome x beta blockers interaction in hypertension
Adverse cardiovascular outcome x calcium channel blockers interaction in hypertension
Adverse cardiovascular outcome x ACE inhibitors/ARBs interaction in hypertension
Adverse cardiovascular outcome x thiazide/thiazide-like diuretics interaction in hypertension
Subjective wellbeing conditioned on cognitive performance (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on educational attainment (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on highest math class (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on average household income before tax (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on self-rated math ability (multi-trait conditioning and joint analysis)
Phosphatidylethanolamine(40:7)_[M-H]1- levels
Phosphatidylglycerol_34:0_[M-H]1- levels
Phosphatidylglycerol_35:3_[M-H]1- levels
Phosphatidylglycerol-O_42:0_[M-H]1- levels
Age at peak height velocity
Peak height velocity
Phosphatidylinositol_36:2_[M-H]1- levels
Phosphatidylinositol_35:2_[M-H]1- levels
Fatty acid(22:4)_[M-H]1- levels
Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Nausea)
Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Diarrhoea)
Adverse response to chemotherapy in colorectal cancer (XELOX) (Lethargy)
Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Neutropenia)
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Hand foot syndrome)
Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty)
Parkinson's disease motor subtype (tremor to postural instability/gait difficulty score ratio)
Lysophosphatidylethanolamine_16:0_[M-H]1- levels
Lysophosphatidylethanolamine_18:0_[M-H]1- levels
Lysophosphatidylethanolamine_18:2_[M-H]1- levels
Hand osteoarthritis severity (hand Klsum)
Finger osteoarthritis severity (hand Klsum)
Thumb osteoarthritis severity (hand Klsum)
Lysophosphatidylethanolamine-O_18:1_[M-H]1-/Lysophosphatidylethanolamine-P_18:0_[M-H]1- levels
Lysophosphatidylethanolamine-P_20:0_[M-H]1- levels
Phosphatidate_34:2_[M-H]1- levels
Phosphatidate(34:2)_[M-H]1- levels
Phosphatidate(39:0)_[M+H]1+ levels
Left atrial maximum volume
Left atrial minimum volume
Left atrial active emptying fraction
Left atrial passive emptying fraction
Left atrial total emptying fraction
Pancreas volume
Kidney volume
Abdominal subcutaneous adipose tissue volume
Spleen volume
Lung volume
Liver volume
Motor coordination
Phosphatidylinositol_34:2_[M-H]1- levels
Phosphatidylinositol_35:0_[M-H]1- levels
Degenerative rotator cuff disease surgery
Lysophosphatidylethanolamine_22:4_[M-H]1- levels
Lysophosphatidylethanolamine_20:4_[M-H]1- levels
Lysophosphatidylethanolamine_20:0_[M-H]1- levels
Lysophosphatidylethanolamine_20:2_[M-H]1- levels
Lysophosphatidylethanolamine_22:6_[M-H]1- levels
Phospholipids to total lipids ratio in medium LDL
Tumor necrosis factor receptor superfamily member 11B levels
Beta-endorphin levels
Insulin-like growth factor-binding protein 3 levels
C-C motif chemokine 2 levels
Matrix metalloproteinase-9 levels
Cystatin-C levels
Tyrosine-protein kinase receptor TYRO3 levels
Apolipoprotein E levels
Complement component C8 levels
Mast/stem cell growth factor receptor Kit levels
Triglyceride levels in medium LDL
Triglycerides to total lipids ratio in medium LDL
Complement C1q subcomponent levels
Annexin A2 levels
Cerebral dopamine neurotrophic factor levels
Endoplasmic reticulum aminopeptidase 1 levels
Total cerebellar volume
Melanoma specific survival
Cholesterol levels in medium VLDL
Vertex-wise cortical surface area
Leucine-rich repeat transmembrane protein FLRT2 levels
Leucine-rich repeat transmembrane protein FLRT3 levels
Glycated haemoglobin HbA1c levels adjusted for BMI
Vitronectin levels
Desmocollin-2 levels
Hexokinase-1 levels
Semaphorin-5A levels
PILR alpha-associated neural protein levels
Platelet receptor Gi24 levels
Interleukin-1 receptor type 2 levels
Fasting glucose adjusted for BMI
Tumor necrosis factor ligand superfamily member 18 levels
Ciliary neurotrophic factor receptor subunit alpha levels
Interleukin-37 levels
Laminin levels
Glypican-5 levels
Galectin-3-binding protein levels
Intracranial germ cell tumors
Cytochrome c levels
Estrogen receptor levels
Complement factor D levels
Insulin-like growth factor I levels
Luteinizing hormone levels
Vitamin K-dependent protein C levels
Cholesterol to total lipids ratio in medium VLDL
Attention deficit hyperactivity disorder (late-diagnosed)
Cholesteryl ester levels in medium VLDL
Junctional adhesion molecule B levels
Cystatin-SA levels
Brother of CDO levels
C-type lectin domain family 1 member B levels
Macrophage-stimulating protein receptor levels
NT-3 growth factor receptor levels
Tumor necrosis factor receptor superfamily member 17 levels
Oncostatin-M levels
Vitamin K-dependent protein S levels
Colorectal cancer vs inflammatory bowel disease
Colorectal cancer vs inflammatory bowel disease or controls
Hemopexin levels
C-C motif chemokine 1 levels
Interleukin-17F levels
Lactotransferrin levels
Receptor tyrosine-protein kinase erbB-4 levels
Interleukin-13 receptor subunit alpha-1 levels
Tumor necrosis factor receptor superfamily member 3 levels
Macrophage colony-stimulating factor 1 receptor levels
ICD10 K44: Diaphragmatic hernia
Right colon cancer
Left colon cancer
Left colon cancer vs right colon cancer
Rectal cancer vs colon cancer
Mitogen-activated protein kinase 12 levels
Inorganic pyrophosphatase levels
Protein FAM107A levels
Fibroblast growth factor 19 levels
Growth/differentiation factor 11/8 levels
Interleukin-1 receptor type 1 levels
Homeobox protein NANOG levels
Natural cytotoxicity triggering receptor 2 levels
Immunoglobulin G levels
Apolipoprotein A-I levels
Cerebrospinal fluid amyloid beta 42 levels
Cerebrospinal fluid amyloid beta 42 levels in abnormal amyloid levels
Cerebrospinal fluid amyloid beta 42 levels in APOE e4 non-carriers
Cerebrospinal fluid amyloid beta 42 levels in APOE e4 carriers
Cerebrospinal fluid amyloid beta 42 levels in normal amyloid levels
Cerebrospinal fluid p-tau levels in abnormal amyloid levels
Cerebrospinal fluid p-tau levels in APOE e4 non-carriers
Cerebrospinal fluid p-tau levels in APOE e4 carriers
Cerebrospinal fluid p-tau levels in normal amyloid levels
Wnt inhibitory factor 1 levels
C5a anaphylatoxin levels
Mitogen-activated protein kinase 3 levels
DNA repair protein RAD51 homolog 1 levels
Alpha-1-antichymotrypsin levels
Complement component C7 levels
Desmoglein-1 levels
C-X-C motif chemokine 5 levels
Hazardous alcohol drinking
Concentration of medium LDL particles
Fasting insulin adjusted for BMI
Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
Endostatin levels
Complement C5 levels
C-C motif chemokine 8 levels
Stromelysin-1 levels
Matrilysin levels
Complement factor B levels
Contactin-2 levels
Contactin-5 levels
Copine-1 levels
Cystatin-D levels
Cholesteryl ester levels in large HDL
Circulating levels of total-tau
Fibrinogen levels or factor VII levels (pleiotropy)
Leucine carboxyl methyltransferase 1 levels
Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
Low affinity immunoglobulin gamma Fc region receptor II-a/b levels
Low affinity immunoglobulin gamma Fc region receptor III-B levels
Low molecular weight phosphotyrosine protein phosphatase levels
Lymphotactin levels
Lysosomal protective protein levels
Lysozyme C levels
Sialic acid-binding Ig-like lectin 12 level in Chronic kidney disease with hypertension and no diabetes (10037_98)
Baculoviral IAP repeat-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (10046_55)
Core-binding factor subunit beta level in Chronic kidney disease with hypertension and no diabetes (10048_7)
Gigaxonin level in Chronic kidney disease with hypertension and no diabetes (10054_3)
Mothers against decapentaplegic homolog 3 level in Chronic kidney disease with hypertension and no diabetes (10363_13)
E3 ubiquitin-protein ligase ZNRF3 level in Chronic kidney disease with hypertension and no diabetes (10390_21)
Scavenger receptor class A member 5 level in Chronic kidney disease with hypertension and no diabetes (10419_1)
Killer cell immunoglobulin-like receptor 2DS2 level in Chronic kidney disease with hypertension and no diabetes (10428_1)
Platelet-derived growth factor receptor beta level in Chronic kidney disease with hypertension and no diabetes (3459_49)
Brevican core protein level in Chronic kidney disease with hypertension and no diabetes (3461_58)
E-selectin level in Chronic kidney disease with hypertension and no diabetes (3470_1)
C-X-C motif chemokine 6 level in Chronic kidney disease with hypertension and no diabetes (3495_15)
Interferon alpha-2 level in Chronic kidney disease with hypertension and no diabetes (3497_13)
C-C motif chemokine 15 level in Chronic kidney disease with hypertension and no diabetes (3509_1)
Carboxypeptidase B2 level in Chronic kidney disease with hypertension and no diabetes (3518_54)
Dickkopf-related protein 1 level in Chronic kidney disease with hypertension and no diabetes (3535_84)
Alpha-1-antitrypsin level in Chronic kidney disease with hypertension and no diabetes (3580_25)
Alpha-2-HS-glycoprotein level in Chronic kidney disease with hypertension and no diabetes (3581_53)
Bone morphogenetic protein 10 level in Chronic kidney disease with hypertension and no diabetes (3587_53)
Cadherin-6 level in Chronic kidney disease with hypertension and no diabetes (3591_51)
Chitotriosidase-1 level in Chronic kidney disease with hypertension and no diabetes (3600_2)
Endothelin-converting enzyme 1 level in Chronic kidney disease with hypertension and no diabetes (3611_70)
N-acetylglucosamine-6-sulfatase level in Chronic kidney disease with hypertension and no diabetes (3616_3)
Hepatocyte growth factor activator level in Chronic kidney disease with hypertension and no diabetes (3617_80)
Nidogen-2 level in Chronic kidney disease with hypertension and no diabetes (3633_70)
alpha-2-macroglobulin receptor-associated protein level in Chronic kidney disease with hypertension and no diabetes (3640_14)
Complement factor H-related protein 5 level in Chronic kidney disease with hypertension and no diabetes (3666_17)
Cation-independent mannose-6-phosphate receptor level in Chronic kidney disease with hypertension and no diabetes (3676_15)
Interleukin-5 level in Chronic kidney disease with hypertension and no diabetes (3741_4)
Activated Protein C level in Chronic kidney disease with hypertension and no diabetes (3758_63)
Syntaxin-1A level in Chronic kidney disease with hypertension and no diabetes (3766_51)
Angiopoietin-1 receptor, soluble level in Chronic kidney disease with hypertension and no diabetes (3773_15)
Low-density lipoprotein receptor-related protein 1B level in Chronic kidney disease with hypertension and no diabetes (11275_94)
Leucine-rich repeat neuronal protein 1 level in Chronic kidney disease with hypertension and no diabetes (11293_14)
Cyclic AMP-responsive element-binding protein 3-like protein 4 level in Chronic kidney disease with hypertension and no diabetes (11308_8)
Leukocyte immunoglobulin-like receptor subfamily B member 3 level in Chronic kidney disease with hypertension and no diabetes (11334_7)
Prolyl 4-hydroxylase subunit alpha-2 level in Chronic kidney disease with hypertension and no diabetes (11348_132)
Teneurin-4 level in Chronic kidney disease with hypertension and no diabetes (11365_17)
Suppressor of cytokine signaling 3 level in Chronic kidney disease with hypertension and no diabetes (11440_58)
Cornulin level in Chronic kidney disease with hypertension and no diabetes (17738_7)
Quinone oxidoreductase PIG3 level in Chronic kidney disease with hypertension and no diabetes (17748_21)
DNA-directed RNA polymerase III subunit RPC9 level in Chronic kidney disease with hypertension and no diabetes (17771_35)
Succinate-semialdehyde dehydrogenase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (17792_158)
Inositol monophosphatase 1 level in Chronic kidney disease with hypertension and no diabetes (17796_15)
Androstenediol levels
Beta pregnolone levels
Ceramide (d32:1) levels
Ceramide (d33:1) levels
Ceramide (d34:0) levels
Ceramide (d34:1) levels
Ceramide (d34:2) levels
Ceramide (d36:1) levels
Ceramide (d39:1) levels
Ceramide (d42:2)A levels
Ceramide (d42:2)B levels
Ceramide (d43:1) levels
Sphingomyelin (d32:2) levels
Sphingomyelin (d40:0) levels
Acylcarnitine (10:0) levels
Acylcarnitine (10:1) levels
Plexin-D1 level in Chronic kidney disease with hypertension and no diabetes (19561_216)
Pulmonary surfactant-associated protein D level in Chronic kidney disease with hypertension and no diabetes (19590_46)
Indian hedgehog protein level in Chronic kidney disease with hypertension and no diabetes (19606_28)
Transcobalamin-1 level in Chronic kidney disease with hypertension and no diabetes (19614_8)
Dynorphin A (1-17) level in Chronic kidney disease with hypertension and no diabetes (19638_9)
V-set and transmembrane domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (19743_12)
Proto-oncogene tyrosine-protein kinase MER level in Chronic kidney disease with hypertension and no diabetes (19787_14)
Uridine diphosphate glucose pyrophosphatase level in Chronic kidney disease with hypertension and no diabetes (19794_10)
NAD-dependent protein deacetylase sirtuin-1 level in Chronic kidney disease with hypertension and no diabetes (19823_75)
Frizzled-10 level in Chronic kidney disease with hypertension and no diabetes (20056_7)
Phosphoenolpyruvate carboxykinase [GTP], mitochondrial level in Chronic kidney disease with hypertension and no diabetes (20079_6)
15 kDa selenoprotein level in Chronic kidney disease with hypertension and no diabetes (20087_3)
soluble Endothelial protein C receptor level in Chronic kidney disease with hypertension and no diabetes (24023_35)
Cleavage stimulation factor 50 kDa subunit level in Chronic kidney disease with hypertension and no diabetes (24055_44)
Elongation factor 1-gamma level in Chronic kidney disease with hypertension and no diabetes (24111_10)
Paired mesoderm homeobox protein 1 level in Chronic kidney disease with hypertension and no diabetes (24215_8)
Mth938 domain-containing protein level in Chronic kidney disease with hypertension and no diabetes (24216_30)
Myocyte-specific enhancer factor 2D level in Chronic kidney disease with hypertension and no diabetes (24266_2)
Complement component C8 level in Chronic kidney disease with hypertension and no diabetes (2429_27)
General transcription factor IIE subunit 1 level in Chronic kidney disease with hypertension and no diabetes (24322_1)
C-X-C motif chemokine 16 level in Chronic kidney disease with hypertension and no diabetes (2436_49)
Kinesin-like protein KIF3C level in Chronic kidney disease with hypertension and no diabetes (24407_31)
Cytochrome c-type heme lyase level in Chronic kidney disease with hypertension and no diabetes (24453_75)
Superoxide dismutase [Mn], mitochondrial level in Chronic kidney disease with hypertension and no diabetes (5008_51)
Lysophosphatidylcholines (20:5) levels
Lysophosphatidylcholines (22:5) levels
Lysophosphatidylcholines (22:6) levels
Phosphatidylcholines (32:0) levels
Phosphatidylcholines (34:0) levels
Phosphatidylcholines (34:2) levels
Phosphatidylcholines (34:4) levels
Phosphatidylcholines (35:2)B levels
Phosphatidylcholines (35:3) levels
Phosphatidylcholines (35:4) levels
Phosphatidylcholines (36:2) levels
Phosphatidylcholines (36:3)B levels
Phosphatidylcholines (36:3E) levels
Phosphatidylcholines (36:3E)1 levels
Phosphatidylcholines (36:4)B levels
lysoPhosphatidylcholine acyl C16:1 levels
lysoPhosphatidylcholine acyl C17:0 levels
lysoPhosphatidylcholine acyl C18:0 levels
lysoPhosphatidylcholine acyl C18:1 levels
lysoPhosphatidylcholine acyl C18:2 levels
lysoPhosphatidylcholine acyl C20:3 levels
lysoPhosphatidylcholine acyl C20:4 levels
lysoPhosphatidylcholine acyl C24:0 levels
lysoPhosphatidylcholine acyl C26:0 levels
lysoPhosphatidylcholine acyl C26:1 levels
lysoPhosphatidylcholine acyl C28:0 levels
Isoleucine levels
Leucine levels
lysoPhosphatidylcholine acyl C14:0 levels
lysoPhosphatidylcholine acyl C16:0 levels
40S ribosomal protein S14 level in Chronic kidney disease with hypertension and no diabetes (20964_13)
Mitochondrial-processing peptidase subunit alpha level in Chronic kidney disease with hypertension and no diabetes (24907_3)
Enhancer of zeste homolog 2 level in Chronic kidney disease with hypertension and no diabetes (24914_10)
Calpain-13 level in Chronic kidney disease with hypertension and no diabetes (24915_123)
Secernin-3 level in Chronic kidney disease with hypertension and no diabetes (24923_27)
Clustered mitochondria protein homolog level in Chronic kidney disease with hypertension and no diabetes (24941_14)
Nonspecific lipid-transfer protein level in Chronic kidney disease with hypertension and no diabetes (25049_8)
UDP-glucuronosyltransferase 2B15 level in Chronic kidney disease with hypertension and no diabetes (25080_16)
T-lymphocyte activation antigen CD86 level in Chronic kidney disease with hypertension and no diabetes (6232_54)
Vitrin level in Chronic kidney disease with hypertension and no diabetes (6234_74)
Signal-regulatory protein beta-1 level in Chronic kidney disease with hypertension and no diabetes (6247_9)
Probable carboxypeptidase X1 level in Chronic kidney disease with hypertension and no diabetes (6255_74)
Cell growth regulator with EF hand domain protein 1 level in Chronic kidney disease with hypertension and no diabetes (6257_56)
Nephronectin level in Chronic kidney disease with hypertension and no diabetes (6342_10)
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 level in Chronic kidney disease with hypertension and no diabetes (6359_50)
Receptor-type tyrosine-protein phosphatase R level in Chronic kidney disease with hypertension and no diabetes (6361_49)
Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)
fibromodulin level in Chronic kidney disease with hypertension and no diabetes (6367_66)
Lysozyme-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (6377_54)
Leukocyte immunoglobulin-like receptor subfamily A member 3 level in Chronic kidney disease with hypertension and no diabetes (6391_52)
Endoplasmin level in Chronic kidney disease with hypertension and no diabetes (6393_63)
Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM level in Chronic kidney disease with hypertension and no diabetes (6402_8)
Adhesion G protein-coupled receptor F5 level in Chronic kidney disease with hypertension and no diabetes (6409_57)
Out at first protein homolog level in Chronic kidney disease with hypertension and no diabetes (6414_8)
Concentration of large HDL particles
Dopamine 3-O-sulfate levels in elite athletes
Glutarylcarnitine (C5-DC) levels in elite athletes
Guanidinoacetate levels in elite athletes
Guanidinosuccinate levels in elite athletes
Hydantoin-5-propionic acid levels in elite athletes
Hypotaurine levels in elite athletes
Asthma-COPD overlap syndrome
Phosphatidylcholine acyl-alkyl C32:2 levels
Phosphatidylcholine acyl-alkyl C34:1 levels
Phosphatidylcholine acyl-alkyl C34:2 levels
Phosphatidylcholine acyl-alkyl C34:3 levels
Phosphatidylcholine acyl-alkyl C36:2 levels
Phosphatidylcholine acyl-alkyl C36:3 levels
Phosphatidylcholine acyl-alkyl C36:4 levels
Phosphatidylcholine acyl-alkyl C36:5 levels
Phosphatidylcholine acyl-alkyl C38:0 levels
BMI at 6 weeks old
Stearoylcarnitine (C18) levels in elite athletes
Beta-guanidinopropanoate levels in elite athletes
Betonicine levels in elite athletes
Succinate levels in elite athletes
Carotene diol (1) levels in elite athletes
Fibronectin levels
Ficolin-1 levels
gp41 C34 peptide, HIV levels
Granulocyte colony-stimulating factor levels
Granulysin levels
Fibrinogen levels or plasminogen activator inhibitor 1 levels (pleiotropy)
Fibrinogen levels or factor VII levels or factor XI levels or tissue plasminogen activator levels (pleiotropy)
Cholesteryl esters to total lipids ratio in large HDL
Choline/ethanolamine kinase level in Chronic kidney disease with hypertension and no diabetes (13117_232)
Protein Z-dependent protease inhibitor level in Chronic kidney disease with hypertension and no diabetes (13119_26)
Leucine-rich repeat transmembrane protein FLRT3 level in Chronic kidney disease with hypertension and no diabetes (13123_3)
Immunoglobulin superfamily containing leucine-rich repeat protein 2 level in Chronic kidney disease with hypertension and no diabetes (13124_20)
Vitronectin level in Chronic kidney disease with hypertension and no diabetes (13125_45)
Semaphorin-5A level in Chronic kidney disease with hypertension and no diabetes (13132_14)
Protein Mdm4 level in Chronic kidney disease with hypertension and no diabetes (13229_20)
Protein Wnt-3a level in Chronic kidney disease with hypertension and no diabetes (13236_25)
Beta-defensin 113 level in Chronic kidney disease with hypertension and no diabetes (13374_4)
Vascular cell adhesion protein 1 level in Chronic kidney disease with hypertension and no diabetes (20093_9)
Amphoterin-induced protein 1 level in Chronic kidney disease with hypertension and no diabetes (20120_101)
Macrophage receptor MARCO level in Chronic kidney disease with hypertension and no diabetes (20134_27)
mRNA-capping enzyme level in Chronic kidney disease with hypertension and no diabetes (20135_85)
Complement C1s subcomponent level in Chronic kidney disease with hypertension and no diabetes (20203_45)
Signal transducer and activator of transcription 5A level in Chronic kidney disease with hypertension and no diabetes (20225_119)
TM2 domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (20229_67)
Acylphosphatase-1 level in Chronic kidney disease with hypertension and no diabetes (20370_6)
Putative deoxyribonuclease TATDN1 level in Chronic kidney disease with hypertension and no diabetes (20376_64)
Probable RNA-binding protein 18 level in Chronic kidney disease with hypertension and no diabetes (20383_31)
Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 level in Chronic kidney disease with hypertension and no diabetes (20387_277)
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma level in Chronic kidney disease with hypertension and no diabetes (20393_10)
Tetratricopeptide repeat protein 33 level in Chronic kidney disease with hypertension and no diabetes (20411_52)
Mediator of RNA polymerase II transcription subunit 20 level in Chronic kidney disease with hypertension and no diabetes (20427_18)
Calcipressin-3 level in Chronic kidney disease with hypertension and no diabetes (20442_12)
SET-binding protein level in Chronic kidney disease with hypertension and no diabetes (24471_2)
alpha-Aminoadipic acid levels
Aspartate levels
Butyrylcarnitine levels
Phosphatidylcholine diacyl C42:1 levels
Acetylcarnitine levels
Acetylornithine levels
Phosphatidylinositol (38:4) levels
Sphingomyelin (d30:1) levels
Sphingomyelin (d32:0) levels
Sphingomyelin (d32:1) levels
Sphingomyelin (d33:1) levels
Sphingomyelin (d34:0) levels
Sphingomyelin (d34:2) levels
Sphingomyelin (d36:0) levels
Sphingomyelin (d36:1) levels
Sphingomyelin (d36:2) levels
Sphingomyelin (d37:1) levels
Sphingomyelin (d38:0) levels
Beta-hydroxyisovalerate levels in elite athletes
Betaine levels in elite athletes
Carboxyethyl-GABA levels in elite athletes
Cis-urocanate levels in elite athletes
1-methylhistidine levels in elite athletes
Octanoylcarnitine levels
Ornithine levels
Phosphatidylcholine diacyl C24:0 levels
Phosphatidylcholine diacyl C26:0 levels
Phosphatidylcholine diacyl C28:1 levels
Phosphatidylcholine diacyl C30:0 levels
Phosphatidylcholine diacyl C32:0 levels
Phosphatidylcholine diacyl C32:1 levels
Phosphatidylcholine diacyl C32:2 levels
Phosphatidylcholine diacyl C34:1 levels
Phosphatidylcholine diacyl C34:2 levels
Isobutyrylcarnitine (C4) levels in elite athletes
Isobutyrylglycine levels in elite athletes
Isovalerylcarnitine (C5) levels in elite athletes
Isovalerylglycine levels in elite athletes
Kynurenate levels in elite athletes
3-acetylphenol sulfate levels in elite athletes
3-hydroxyhippurate levels in elite athletes
Vascular endothelial growth factor D level in Chronic kidney disease with hypertension and no diabetes (14705_1)
Coiled-coil domain-containing protein 134 level in Chronic kidney disease with hypertension and no diabetes (15300_66)
Thioredoxin-like protein 4B level in Chronic kidney disease with hypertension and no diabetes (15316_262)
Stromal cell-derived factor 2 level in Chronic kidney disease with hypertension and no diabetes (15333_11)
Neuroendocrine protein 7B2 level in Chronic kidney disease with hypertension and no diabetes (15358_28)
Apolipoprotein C-I level in Chronic kidney disease with hypertension and no diabetes (15364_101)
BolA-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (15370_5)
Endothelin-3 level in Chronic kidney disease with hypertension and no diabetes (15383_200)
Fatty acid-binding protein, intestinal level in Chronic kidney disease with hypertension and no diabetes (15385_116)
Polypeptide N-acetylgalactosaminyltransferase 4 level in Chronic kidney disease with hypertension and no diabetes (21722_21)
Ubiquitin-conjugating enzyme E2 Q1 level in Chronic kidney disease with hypertension and no diabetes (21732_78)
Beta-galactoside alpha-2,6-sialyltransferase 2 level in Chronic kidney disease with hypertension and no diabetes (21737_20)
Ubiquitin carboxyl-terminal hydrolase 30 level in Chronic kidney disease with hypertension and no diabetes (21764_99)
Ubiquitin carboxyl-terminal hydrolase CYLD level in Chronic kidney disease with hypertension and no diabetes (21765_10)
N-sulphoglucosamine sulphohydrolase level in Chronic kidney disease with hypertension and no diabetes (21766_50)
Polypeptide N-acetylgalactosaminyltransferase 14 level in Chronic kidney disease with hypertension and no diabetes (21767_129)
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 level in Chronic kidney disease with hypertension and no diabetes (21770_18)
Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase level in Chronic kidney disease with hypertension and no diabetes (21771_47)
Aspartoacylase-2 level in Chronic kidney disease with hypertension and no diabetes (21781_9)
HLA-C level in Chronic kidney disease with hypertension and no diabetes (21797_4)
Nucleolar protein of 40 kDa level in Chronic kidney disease with hypertension and no diabetes (21811_20)
Protein phosphatase 1G level in Chronic kidney disease with hypertension and no diabetes (21823_5)
Complement C4b level in Chronic kidney disease with hypertension and no diabetes (2182_54)
Pimelylcarnitine levels
Proline levels
Propionylcarnitine levels
Sarcosine levels
Hydroxysphingomyeline C14:1 levels
Hydroxysphingomyeline C16:1 levels
Hydroxysphingomyeline C22:1 levels
Dihydroferulic acid levels in elite athletes
Taurochenodeoxycholate levels in elite athletes
Taurocholate levels in elite athletes
Angiostatin levels
Angiotensinogen levels
Annexin A1 levels
Apolipoprotein E (isoform E2) levels
Transmembrane glycoprotein NMB levels
Trypsin-2 levels
Tryptase beta-2 levels
Arylsulfatase B levels
Aspartate aminotransferase, cytoplasmic levels
Breast cancer anti-estrogen resistance protein 3 levels
Ischemic stroke or von Willebrand factor levels (pleiotropy)
Ischemic stroke or factor XI levels (pleiotropy)
Ischemic stroke or fibrinogen levels (pleiotropy)
Naive T-cell telomere length
Memory T-cell telomere length
B-cell telomere length
Pyridoxine-5'-phosphate oxidase level in Chronic kidney disease with hypertension and no diabetes (17804_102)
Myeloid leukemia factor 1 level in Chronic kidney disease with hypertension and no diabetes (17820_170)
UPF0705 protein C11orf49 level in Chronic kidney disease with hypertension and no diabetes (22367_17)
Homeobox protein Hox-C11 level in Chronic kidney disease with hypertension and no diabetes (22474_28)
Keratin, type I cytoskeletal 14 level in Chronic kidney disease with hypertension and no diabetes (22482_87)
Casein kinase I isoform alpha-like level in Chronic kidney disease with hypertension and no diabetes (22484_17)
Arginine-hydroxylase NDUFAF5, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (22509_9)
Serine/threonine-protein phosphatase 4 catalytic subunit level in Chronic kidney disease with hypertension and no diabetes (22534_14)
Regulator of G-protein signaling 13 level in Chronic kidney disease with hypertension and no diabetes (22548_18)
Desmoglein-4 level in Chronic kidney disease with hypertension and no diabetes (22568_7)
CD209 antigen level in Chronic kidney disease with hypertension and no diabetes (22576_1)
NKG2D ligand 2 level in Chronic kidney disease with hypertension and no diabetes (22583_47)
Butyrophilin subfamily 2 member A2 level in Chronic kidney disease with hypertension and no diabetes (22586_24)
MAP kinase-activated protein kinase 3 level in Chronic kidney disease with hypertension and no diabetes (3822_54)
Toll-like receptor 2 level in Chronic kidney disease with hypertension and no diabetes (3835_11)
Malate dehydrogenase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (3853_56)
Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)
Complement component C6 level in Chronic kidney disease with hypertension and no diabetes (4127_75)
Complement factor B level in Chronic kidney disease with hypertension and no diabetes (4129_72)
Interleukin-6 receptor subunit alpha level in Chronic kidney disease with hypertension and no diabetes (4139_71)
Pappalysin-1 level in Chronic kidney disease with hypertension and no diabetes (4148_49)
P-selectin level in Chronic kidney disease with hypertension and no diabetes (4154_57)
Tenascin level in Chronic kidney disease with hypertension and no diabetes (4155_3)
Aflatoxin B1 aldehyde reductase member 2 level in Chronic kidney disease with hypertension and no diabetes (4188_1)
RNA polymerase II elongation factor ELL2 level in Chronic kidney disease with hypertension and no diabetes (11494_4)
Transcription initiation factor TFIID subunit 12 level in Chronic kidney disease with hypertension and no diabetes (22797_20)
Translation machinery-associated protein 16 level in Chronic kidney disease with hypertension and no diabetes (22811_5)
TPT1-like protein level in Chronic kidney disease with hypertension and no diabetes (22813_5)
Uracil-DNA glycosylase level in Chronic kidney disease with hypertension and no diabetes (22821_50)
Zinc finger CCHC domain-containing protein 18 level in Chronic kidney disease with hypertension and no diabetes (22833_74)
Butyrophilin subfamily 3 member A3 level in Chronic kidney disease with hypertension and no diabetes (22950_6)
Low affinity immunoglobulin gamma Fc region receptor II-b level in Chronic kidney disease with hypertension and no diabetes (22960_8)
G antigen 2D level in Chronic kidney disease with hypertension and no diabetes (22968_9)
Gro-beta level in Chronic kidney disease with hypertension and no diabetes (22972_26)
Gro-gamma level in Chronic kidney disease with hypertension and no diabetes (22973_8)
Protein lin-7 homolog B level in Chronic kidney disease with hypertension and no diabetes (22990_20)
Interleukin-1 receptor-like 1 level in Chronic kidney disease with hypertension and no diabetes (4234_8)
Glucose-6-phosphate isomerase level in Chronic kidney disease with hypertension and no diabetes (4272_46)
C-type lectin domain family 1 member B level in Chronic kidney disease with hypertension and no diabetes (4332_6)
Serum amyloid A-1 protein level in Chronic kidney disease with hypertension and no diabetes (4336_2)
Intercellular adhesion molecule 1 level in Chronic kidney disease with hypertension and no diabetes (4342_10)
Apolipoprotein L1 level in Chronic kidney disease with hypertension and no diabetes (11510_31)
Apolipoprotein L1 level in Chronic kidney disease with hypertension and no diabetes (11510_51)
MAX gene-associated protein level in Chronic kidney disease with hypertension and no diabetes (11587_5)
Serine--tRNA ligase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (18178_13)
Oral cancer-overexpressed protein 1 level in Chronic kidney disease with hypertension and no diabetes (18195_3)
Gamma-crystallin C level in Chronic kidney disease with hypertension and no diabetes (18203_9)
G2/mitotic-specific cyclin-B2 level in Chronic kidney disease with hypertension and no diabetes (18208_3)
Glutamate--cysteine ligase regulatory subunit level in Chronic kidney disease with hypertension and no diabetes (18214_2)
Probable tRNA(His) guanylyltransferase level in Chronic kidney disease with hypertension and no diabetes (18215_5)
CB1 cannabinoid receptor-interacting protein 1 level in Chronic kidney disease with hypertension and no diabetes (18218_48)
Heme-binding protein 1 level in Chronic kidney disease with hypertension and no diabetes (18225_13)
Aspartate aminotransferase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (18233_10)
Cysteine-rich protein 1 level in Chronic kidney disease with hypertension and no diabetes (18275_5)
C-C motif chemokine 15 level in Chronic kidney disease with hypertension and no diabetes (18289_16)
Protein zwilch homolog level in Chronic kidney disease with hypertension and no diabetes (18302_204)
Frizzled-1 level in Chronic kidney disease with hypertension and no diabetes (22590_68)
Sterile alpha motif domain-containing protein 12 level in Chronic kidney disease with hypertension and no diabetes (22771_6)
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (22773_69)
S-phase kinase-associated protein 2 level in Chronic kidney disease with hypertension and no diabetes (22777_46)
Kinetochore protein Spc25 level in Chronic kidney disease with hypertension and no diabetes (22782_80)
Spermatogenesis-associated protein 46 level in Chronic kidney disease with hypertension and no diabetes (22786_57)
Transcription initiation factor IIA subunit 2 level in Chronic kidney disease with hypertension and no diabetes (22793_110)
Methionine aminopeptidase 2 levels
Hepatocyte growth factor-like protein level in Chronic kidney disease with hypertension and no diabetes (4407_10)
Bcl-2-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (4423_77)
Collectin-11 level in Chronic kidney disease with hypertension and no diabetes (4430_44)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 level in Chronic kidney disease with hypertension and no diabetes (4435_66)
Ectonucleoside triphosphate diphosphohydrolase 5 level in Chronic kidney disease with hypertension and no diabetes (4437_56)
Fc receptor-like protein 3 level in Chronic kidney disease with hypertension and no diabetes (4440_15)
Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)
SPARC-like protein 1 level in Chronic kidney disease with hypertension and no diabetes (4467_49)
Platelet-derived growth factor subunit A level in Chronic kidney disease with hypertension and no diabetes (4499_21)
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 level in Chronic kidney disease with hypertension and no diabetes (4535_50)
Cell adhesion molecule-related/down-regulated by oncogenes level in Chronic kidney disease with hypertension and no diabetes (4541_49)
Adhesion G protein-coupled receptor E2 level in Chronic kidney disease with hypertension and no diabetes (4546_27)
Interleukin-34 level in Chronic kidney disease with hypertension and no diabetes (4556_10)
Hepatocyte growth factor receptor level in Chronic kidney disease with hypertension and no diabetes (11814_29)
Ribosomal protein S6 kinase alpha-1 level in Chronic kidney disease with hypertension and no diabetes (12329_21)
Ribose-5-phosphate isomerase level in Chronic kidney disease with hypertension and no diabetes (12333_87)
Alanine--tRNA ligase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (12340_17)
Tribbles homolog 2 level in Chronic kidney disease with hypertension and no diabetes (12363_70)
Tapasin level in Chronic kidney disease with hypertension and no diabetes (12378_71)
COP9 signalosome complex subunit 7b level in Chronic kidney disease with hypertension and no diabetes (12384_92)
Aminopeptidase B level in Chronic kidney disease with hypertension and no diabetes (12386_11)
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (12396_19)
Syntaxin-binding protein 6 level in Chronic kidney disease with hypertension and no diabetes (18308_30)
Receptor-transporting protein 4 level in Chronic kidney disease with hypertension and no diabetes (18315_38)
Supranormal left ventricular ejection fraction
Glutathione S-transferase theta-1 level in Chronic kidney disease with hypertension and no diabetes (19230_12)
NTF2-related export protein 2 level in Chronic kidney disease with hypertension and no diabetes (19255_124)
Peflin level in Chronic kidney disease with hypertension and no diabetes (19272_9)
Glutathione reductase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (19273_3)
Myosin regulatory light chain 2, atrial isoform level in Chronic kidney disease with hypertension and no diabetes (19296_51)
Iron-sulfur cluster co-chaperone protein HscB, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (19316_2)
MOB-like protein phocein level in Chronic kidney disease with hypertension and no diabetes (19332_1)
Hematological and neurological expressed 1 protein level in Chronic kidney disease with hypertension and no diabetes (19335_2)
TOM1-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (19356_20)
Matrilin-3 level in Chronic kidney disease with hypertension and no diabetes (19361_78)
Coiled-coil domain-containing protein 94 level in Chronic kidney disease with hypertension and no diabetes (23571_93)
tRNA wybutosine-synthesizing protein 3 homolog level in Chronic kidney disease with hypertension and no diabetes (23572_186)
Hydroxysteroid dehydrogenase-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (23588_9)
Laccase domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (23595_6)
Acyl-coenzyme A thioesterase 12 level in Chronic kidney disease with hypertension and no diabetes (23601_43)
TRM112-like protein level in Chronic kidney disease with hypertension and no diabetes (23615_4)
SOSS complex subunit C level in Chronic kidney disease with hypertension and no diabetes (23622_128)
N-acetylgalactosamine kinase level in Chronic kidney disease with hypertension and no diabetes (23631_1)
2-hydroxyacyl-CoA lyase 1 level in Chronic kidney disease with hypertension and no diabetes (23645_49)
Bifunctional purine biosynthesis protein PURH level in Chronic kidney disease with hypertension and no diabetes (23666_35)
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 level in Chronic kidney disease with hypertension and no diabetes (23669_20)
PAXIP1-associated protein 1 level in Chronic kidney disease with hypertension and no diabetes (23967_8)
14-3-3 protein theta level in Chronic kidney disease with hypertension and no diabetes (7625_27)
Cysteine-rich with EGF-like domain protein 1 level in Chronic kidney disease with hypertension and no diabetes (7628_40)
Vesicular integral-membrane protein VIP36 level in Chronic kidney disease with hypertension and no diabetes (7638_30)
Acute graft-versus-host disease (gut) (recipient effect)
Chronic graft-versus-host disease (donor effect)
Chronic graft-versus-host disease (recipient effect)
Relapse after allogeneic hematopoietic cell transplantation (donor effect)
Relapse after allogeneic hematopoietic cell transplantation (recipient effect)
2-aminoadipate levels in elite athletes
2-hydroxy-3-methylvalerate levels in elite athletes
2-hydroxybutyrate/2-hydroxyisobutyrate levels in elite athletes
2-hydroxyphenylacetate levels in elite athletes
2-methylbutyrylcarnitine (C5) levels in elite athletes
2-methylbutyrylglycine levels in elite athletes
2-methylserine levels in elite athletes
2-oxoarginine levels in elite athletes
(N(1) + N(8))-acetylspermidine levels in elite athletes
1-methylguanidine levels in elite athletes
1-methylimidazoleacetate levels in elite athletes
Glycosphingolipids (d40:1) levels
Glycosphingolipids (d41:1) levels
Hexadecanoylcarnitine levels
Hexadecenoylcarnitine levels
Hexanoylcarnitine levels
Hexose levels
Serine protease inhibitor Kazal-type 2 level in Chronic kidney disease with hypertension and no diabetes (13405_61)
Protrudin level in Chronic kidney disease with hypertension and no diabetes (13432_9)
Shadow of prion protein level in Chronic kidney disease with hypertension and no diabetes (13447_42)
Protein FAM171A2 level in Chronic kidney disease with hypertension and no diabetes (13479_8)
Transmembrane protein 87B level in Chronic kidney disease with hypertension and no diabetes (13485_20)
Coagulation Factor VIII level in Chronic kidney disease with hypertension and no diabetes (13499_30)
Solute carrier family 35 member G2 level in Chronic kidney disease with hypertension and no diabetes (13501_10)
ER membrane protein complex subunit 4 level in Chronic kidney disease with hypertension and no diabetes (13516_46)
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 level in Chronic kidney disease with hypertension and no diabetes (13518_5)
Switch-associated protein 70 level in Chronic kidney disease with hypertension and no diabetes (13552_7)
5-hydroxytryptamine receptor 6 level in Chronic kidney disease with hypertension and no diabetes (13561_5)
BMP and activin membrane-bound inhibitor homolog level in Chronic kidney disease with hypertension and no diabetes (20514_8)
Sodium channel subunit beta-3 level in Chronic kidney disease with hypertension and no diabetes (20516_11)
Retinoic acid early transcript 1L protein level in Chronic kidney disease with hypertension and no diabetes (20526_3)
SLAM family member 9 level in Chronic kidney disease with hypertension and no diabetes (20531_5)
Interleukin-35 level in Chronic kidney disease with hypertension and no diabetes (20533_39)
Sialic acid-binding Ig-like lectin 11 level in Chronic kidney disease with hypertension and no diabetes (20538_71)
Izumo sperm-egg fusion protein 4 level in Chronic kidney disease with hypertension and no diabetes (20549_1)
Contactin-6 level in Chronic kidney disease with hypertension and no diabetes (20561_15)
FRAS1-related extracellular matrix protein 1 level in Chronic kidney disease with hypertension and no diabetes (20568_3)
V-set and transmembrane domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (20570_18)
Latrophilin-3 level in Chronic kidney disease with hypertension and no diabetes (20578_10)
Gliomedin level in Chronic kidney disease with hypertension and no diabetes (20591_48)
PDZ domain-containing protein GIPC2 level in Chronic kidney disease with hypertension and no diabetes (20921_1)
Magnesium-dependent phosphatase 1 level in Chronic kidney disease with hypertension and no diabetes (20923_10)
Triglycerides (46:2) levels
Triglycerides (46:3)A levels
Triglycerides (46:3)B levels
Triglycerides (48:1) levels
Triglycerides (48:2)A levels
Triglycerides (49:0) levels
Triglycerides (50:4) levels
Triglycerides (51:1) levels
Triglycerides (51:3) levels
Triglycerides (51:4) levels
Triglycerides (52:1) levels
Triglycerides (52:3) levels
Triglycerides (53:1) levels
Triglycerides (54:2)B levels
Triglycerides (54:7)B levels
Triglycerides (56:1) levels
Triglycerides (56:2) levels
Triglycerides (56:7)A levels
Triglycerides (56:9) levels
Triglycerides (58:1) levels
Total lipid levels in large HDL
1-methylurate levels in elite athletes
1-methylxanthine levels in elite athletes
Cystine levels in elite athletes
Dimethylarginine (SDMA + ADMA) levels in elite athletes
Triglycerides (58:10) levels
Triglycerides (58:5) levels
Triglycerides (58:9) levels
Phosphatidylcholine diacyl C38:6 levels
Phosphatidylcholine diacyl C40:2 levels
Phosphatidylcholine diacyl C40:3 levels
Phosphatidylcholine diacyl C40:4 levels
Phosphatidylcholine diacyl C40:5 levels
Phosphatidylcholine diacyl C40:6 levels
Phosphatidylcholine diacyl C42:0 levels
Phosphatidylcholine diacyl C42:4 levels
Phosphatidylcholine diacyl C42:5 levels
Phosphatidylcholine diacyl C42:6 levels
Phosphatidylcholine acyl-alkyl C30:1 levels
Phosphatidylcholine acyl-alkyl C30:2 levels
Phosphatidylcholine acyl-alkyl C32:1 levels
Platelet reactivity in response to ADP
Platelet reactivity in response to CRP-XL
Platelet reactivity in response to PAR-1
Platelet reactivity in response to PAR-4
Manic switch in bipolar I disorder with depressive episode
C-C motif chemokine 3-like 1 level in Chronic kidney disease with hypertension and no diabetes (2783_18)
Stromelysin-1 level in Chronic kidney disease with hypertension and no diabetes (2788_55)
Basal Cell Adhesion Molecule level in Chronic kidney disease with hypertension and no diabetes (2816_50)
Cadherin-5 level in Chronic kidney disease with hypertension and no diabetes (2819_23)
Kunitz-type protease inhibitor 1 level in Chronic kidney disease with hypertension and no diabetes (2828_82)
Hepatocyte growth factor receptor level in Chronic kidney disease with hypertension and no diabetes (2837_3)
Kunitz-type protease inhibitor 2 level in Chronic kidney disease with hypertension and no diabetes (2843_13)
Tyrosine-protein kinase receptor Tie-1, soluble level in Chronic kidney disease with hypertension and no diabetes (2844_53)
Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)
Leukocyte immunoglobulin-like receptor subfamily B member 4 level in Chronic kidney disease with hypertension and no diabetes (6453_70)
Protocadherin gamma-A1 level in Chronic kidney disease with hypertension and no diabetes (6457_50)
Complement factor H-related protein 4 level in Chronic kidney disease with hypertension and no diabetes (6471_53)
Neural cell adhesion molecule 2 level in Chronic kidney disease with hypertension and no diabetes (6507_16)
Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 level in Chronic kidney disease with hypertension and no diabetes (6556_5)
Ecto-ADP-ribosyltransferase 4 level in Chronic kidney disease with hypertension and no diabetes (6576_1)
Membrane protein FAM174A level in Chronic kidney disease with hypertension and no diabetes (6597_24)
Inactive pancreatic lipase-related protein 1 level in Chronic kidney disease with hypertension and no diabetes (6627_25)
Prolyl endopeptidase level in Chronic kidney disease with hypertension and no diabetes (14273_19)
Vacuolar protein sorting-associated protein 29 level in Chronic kidney disease with hypertension and no diabetes (14318_1)
Protein FAM210A level in Chronic kidney disease with hypertension and no diabetes (14593_152)
Lutropin-choriogonadotropic hormone receptor level in Chronic kidney disease with hypertension and no diabetes (14634_13)
E3 ubiquitin-protein ligase RNF8 level in Chronic kidney disease with hypertension and no diabetes (14663_44)
Zinc finger protein 276 level in Chronic kidney disease with hypertension and no diabetes (14692_3)
Tryptase beta-2 level in Chronic kidney disease with hypertension and no diabetes (14696_45)
CMRF35-like molecule 6 levels
Coagulation Factor V levels
Coagulation Factor VII levels
Complement C1r subcomponent levels
Complement C1s subcomponent levels
Pain sensitivity measurement (Pain Sensitivity Questionnaire)
Pain sensitivity measurement (Cold pressor test)
Interstitial collagenase levels
Kallikrein-7 levels
Killer cell immunoglobulin-like receptor 2DL4 levels
Kininogen-1 levels
Kynureninase levels
LIM domain only transcription factor protein 4 level in Chronic kidney disease with hypertension and no diabetes (23284_5)
Ribonuclease P protein subunit p25 level in Chronic kidney disease with hypertension and no diabetes (23311_19)
AN1-type zinc finger protein 2B level in Chronic kidney disease with hypertension and no diabetes (23319_6)
Multivesicular body subunit 12B level in Chronic kidney disease with hypertension and no diabetes (23320_11)
Plexin-C1 level in Chronic kidney disease with hypertension and no diabetes (4564_2)
Apolipoprotein D level in Chronic kidney disease with hypertension and no diabetes (4712_28)
Afamin level in Chronic kidney disease with hypertension and no diabetes (4763_31)
Acid sphingomyelinase-like phosphodiesterase 3a level in Chronic kidney disease with hypertension and no diabetes (4771_10)
Lactoperoxidase level in Chronic kidney disease with hypertension and no diabetes (4801_13)
Thioredoxin domain-containing protein 12 level in Chronic kidney disease with hypertension and no diabetes (4815_25)
L-Selectin level in Chronic kidney disease with hypertension and no diabetes (4831_4)
Vascular endothelial growth factor A, isoform 121 level in Chronic kidney disease with hypertension and no diabetes (4867_15)
C-C motif chemokine 7 level in Chronic kidney disease with hypertension and no diabetes (4886_3)
Coactosin-like protein level in Chronic kidney disease with hypertension and no diabetes (4905_63)
Endoglin level in Chronic kidney disease with hypertension and no diabetes (4908_6)
Glutathione S-transferase P level in Chronic kidney disease with hypertension and no diabetes (4911_49)
C-C motif chemokine 16 level in Chronic kidney disease with hypertension and no diabetes (4913_78)
Human Chorionic Gonadotropin level in Chronic kidney disease with hypertension and no diabetes (4914_10)
Muellerian-inhibiting factor level in Chronic kidney disease with hypertension and no diabetes (4923_79)
Endoplasmic reticulum aminopeptidase 1 level in Chronic kidney disease with hypertension and no diabetes (4964_67)
Dermatopontin level in Chronic kidney disease with hypertension and no diabetes (4979_34)
S-formylglutathione hydrolase level in Chronic kidney disease with hypertension and no diabetes (4984_83)
Glypican-5 level in Chronic kidney disease with hypertension and no diabetes (4991_12)
Granulins level in Chronic kidney disease with hypertension and no diabetes (4992_49)
Free cholesterol to total lipids ratio in large HDL
Glycosphingolipids (d42:2) levels
Sphingomyelin (d34:1) levels
Phosphatidylcholines (36:5)B levels
Phosphatidylcholines (36:5)C levels
Phosphatidylcholines (37:4) levels
Phosphatidylcholines (37:5) levels
Phosphatidylcholines (38:2) levels
Phosphatidylcholines (38:4)A levels
Phosphatidylcholines (38:4)B levels
Phosphatidylcholines (38:4)C levels
Phosphatidylcholines (38:5)A levels
Phosphatidylcholines (38:5)B levels
Phosphatidylcholines (38:6)A levels
Phosphatidylcholines (39:4) levels
Phosphatidylcholines (40:5)A levels
Phosphatidylcholines (40:6)A levels
Phosphatidylcholines (40:8) levels
Phosphatidylcholines (42:5) levels
4-imidazoleacetate levels in elite athletes
5-(galactosylhydroxy)-L-lysine levels in elite athletes
5-bromotryptophan levels in elite athletes
5-methylthioadenosine (MTA) levels in elite athletes
6-oxopiperidine-2-carboxylate levels in elite athletes
Acisoga levels in elite athletes
Alpha-hydroxyisocaproate levels in elite athletes
Alpha-hydroxyisovalerate levels in elite athletes
TBC1 domain family member 24 level in Chronic kidney disease with hypertension and no diabetes (25114_256)
Calgranulin A level in Chronic kidney disease with hypertension and no diabetes (25216_8)
C-C motif chemokine 5 level in Chronic kidney disease with hypertension and no diabetes (2523_31)
Ciliogenesis-associated TTC17-interacting protein level in Chronic kidney disease with hypertension and no diabetes (25242_12)
MTSS1-like protein level in Chronic kidney disease with hypertension and no diabetes (25252_29)
Carboxylesterase 3 level in Chronic kidney disease with hypertension and no diabetes (25292_6)
SH3 and PX domain-containing protein 2B level in Chronic kidney disease with hypertension and no diabetes (25297_11)
WD repeat-containing protein 18 level in Chronic kidney disease with hypertension and no diabetes (25307_8)
LIM domain kinase 1 level in Chronic kidney disease with hypertension and no diabetes (25308_8)
G antigen 2 level in Chronic kidney disease with hypertension and no diabetes (25413_80)
cAMP-specific 3',5'-cyclic phosphodiesterase 4D level in Chronic kidney disease with hypertension and no diabetes (5255_22)
Non-receptor tyrosine-protein kinase TYK2 level in Chronic kidney disease with hypertension and no diabetes (5260_80)
Eotaxin level in Chronic kidney disease with hypertension and no diabetes (5301_7)
Apolipoprotein E (isoform E2) level in Chronic kidney disease with hypertension and no diabetes (5312_49)
Copine-1 level in Chronic kidney disease with hypertension and no diabetes (5346_24)
RAC-beta serine/threonine-protein kinase level in Chronic kidney disease with hypertension and no diabetes (5360_9)
Semaphorin-3E level in Chronic kidney disease with hypertension and no diabetes (5363_51)
Transcription factor IIIB 90 kDa subunit level in Chronic kidney disease with hypertension and no diabetes (5384_67)
Leptin receptor, soluble level in Chronic kidney disease with hypertension and no diabetes (5400_52)
CD27 antigen level in Chronic kidney disease with hypertension and no diabetes (5412_53)
Methionine levels
Methioninesulfoxide levels
Methylglutarylcarnitine levels
Nonaylcarnitine levels
Octadecandienylcarnitine levels
Octadecanoylcarnitine levels
Octadecenoylcarnitine levels
Adhesion G-protein coupled receptor D1 level in Chronic kidney disease with hypertension and no diabetes (21546_20)
Gamma-glutamyltransferase 5 level in Chronic kidney disease with hypertension and no diabetes (21548_20)
Serine/threonine kinase 10 level in Chronic kidney disease with hypertension and no diabetes (21569_49)
Cyclin-dependent kinase 15; EC=2.7.11.22 level in Chronic kidney disease with hypertension and no diabetes (21581_87)
Smad nuclear-interacting protein 1 level in Chronic kidney disease with hypertension and no diabetes (21645_6)
Syntaxin-17 level in Chronic kidney disease with hypertension and no diabetes (21649_12)
Thioredoxin-like protein 4A level in Chronic kidney disease with hypertension and no diabetes (21651_9)
LisH domain-containing protein FOPNL level in Chronic kidney disease with hypertension and no diabetes (21655_18)
GTP-binding protein SAR1b level in Chronic kidney disease with hypertension and no diabetes (21660_4)
PAI-2 level in Chronic kidney disease with hypertension and no diabetes (21676_17)
Very Late Antigen-4 level in Chronic kidney disease with hypertension and no diabetes (21688_50)
Leucine-rich repeat and fibronectin type-III domain-containing protein 4 level in Chronic kidney disease with hypertension and no diabetes (21696_80)
Protocadherin-12 level in Chronic kidney disease with hypertension and no diabetes (21704_8)
Leukocyte immunoglobulin-like receptor subfamily A member 1 level in Chronic kidney disease with hypertension and no diabetes (21706_29)
IgG receptor FcRn large subunit p51 level in Chronic kidney disease with hypertension and no diabetes (21708_149)
Reelin level in Chronic kidney disease with hypertension and no diabetes (21713_11)
Cadherin-3 level in Chronic kidney disease with hypertension and no diabetes (2643_57)
Urokinase plasminogen activator surface receptor level in Chronic kidney disease with hypertension and no diabetes (2652_15)
Melanoma-derived growth regulatory protein level in Chronic kidney disease with hypertension and no diabetes (2687_2)
Tumor necrosis factor ligand superfamily member 18 level in Chronic kidney disease with hypertension and no diabetes (2708_54)
MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)
Sialic acid-binding Ig-like lectin 6 level in Chronic kidney disease with hypertension and no diabetes (2741_22)
Sialic acid-binding Ig-like lectin 7 level in Chronic kidney disease with hypertension and no diabetes (2742_68)
Hemopexin level in Chronic kidney disease with hypertension and no diabetes (2768_56)
Interleukin-16 level in Chronic kidney disease with hypertension and no diabetes (2774_10)
Phosphatidylcholine acyl-alkyl C38:1 levels
Phosphatidylcholine acyl-alkyl C38:2 levels
Phosphatidylcholine acyl-alkyl C38:3 levels
Phosphatidylcholine acyl-alkyl C38:4 levels
Phosphatidylcholine acyl-alkyl C38:5 levels
Phosphatidylcholine acyl-alkyl C38:6 levels
Phosphatidylcholine acyl-alkyl C40:1 levels
Phosphatidylcholine acyl-alkyl C40:3 levels
Phosphatidylcholine acyl-alkyl C40:4 levels
Phosphatidylcholine acyl-alkyl C40:5 levels
Phosphatidylcholine acyl-alkyl C40:6 levels
Phosphatidylcholine acyl-alkyl C42:1 levels
Cystatin-SN levels
Death-associated protein kinase 2 levels
Dermatopontin levels
Dickkopf-related protein 3 levels
Dickkopf-related protein 4 levels
Dual specificity mitogen-activated protein kinase kinase 2 levels
Dual specificity mitogen-activated protein kinase kinase 4 levels
Dynein light chain roadblock-type 1 levels
Ectonucleoside triphosphate diphosphohydrolase 5 levels
EGF-like module-containing mucin-like hormone receptor-like 2 levels
Fibrinogen levels or tissue plasminogen activator levels (pleiotropy)
Macrophage metalloelastase levels
Macrophage scavenger receptor types I and II levels
Mannan-binding lectin serine protease 1 levels
MAP kinase-activated protein kinase 2 levels
Mediator of RNA polymerase II transcription subunit 1 levels
Trichilemmal cysts
Apolipoprotein-L2 level in Chronic kidney disease with hypertension and no diabetes (23566_6)
Teratocarcinoma-derived growth factor 1 level in Chronic kidney disease with hypertension and no diabetes (5810_25)
3-hydroxyanthranilate 3,4-dioxygenase level in Chronic kidney disease with hypertension and no diabetes (5861_78)
Tumor necrosis factor level in Chronic kidney disease with hypertension and no diabetes (5936_53)
Dermokine level in Chronic kidney disease with hypertension and no diabetes (5963_9)
Complement factor H-related protein 1 level in Chronic kidney disease with hypertension and no diabetes (5982_50)
T-cell surface glycoprotein CD8 alpha chain level in Chronic kidney disease with hypertension and no diabetes (5992_50)
Urotensin-2 level in Chronic kidney disease with hypertension and no diabetes (6020_52)
Interferon alpha/beta receptor 1 level in Chronic kidney disease with hypertension and no diabetes (6055_53)
Adenosine deaminase CECR1 level in Chronic kidney disease with hypertension and no diabetes (6077_63)
2-phosphoxylose phosphatase 1 level in Chronic kidney disease with hypertension and no diabetes (6079_59)
Procollagen C-endopeptidase enhancer 2 level in Chronic kidney disease with hypertension and no diabetes (6081_52)
Chymotrypsin-like elastase family member 1 level in Chronic kidney disease with hypertension and no diabetes (6107_3)
Cellular tumor antigen p53 R175H mutant level in Chronic kidney disease with hypertension and no diabetes (6168_11)
Prosaposin level in Chronic kidney disease with hypertension and no diabetes (6207_10)
Amiloride-sensitive amine oxidase [copper-containing] level in Chronic kidney disease with hypertension and no diabetes (6209_2)
ADP-ribosylation factor-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (12587_65)
Kinesin light chain 1 level in Chronic kidney disease with hypertension and no diabetes (12656_1)
Thiosulfate sulfurtransferase level in Chronic kidney disease with hypertension and no diabetes (12663_1)
Prostaglandin F2 receptor negative regulator level in Chronic kidney disease with hypertension and no diabetes (12727_7)
Prefoldin subunit 3 level in Chronic kidney disease with hypertension and no diabetes (19193_18)
D-tyrosyl-tRNA(Tyr) deacylase 1 level in Chronic kidney disease with hypertension and no diabetes (19194_9)
Serine protease inhibitor Kazal-type 4 level in Chronic kidney disease with hypertension and no diabetes (19213_1)
Homer protein homolog 1 level in Chronic kidney disease with hypertension and no diabetes (19229_92)
Ceramide (d44:1) levels
Cortexone levels
Diglycerides (32:1) levels
Diglycerides (36:2) levels
Diglycerides (36:3) levels
Diglycerides (38:5) levels
Estriol levels
Fatty acids (14:0) levels
Fatty acids (15:0) levels
Fatty acids (20:3)W6 levels
Fatty acids (20:5) levels
Glycosphingolipids (d38:1) levels
Inorganic pyrophosphatase level in Chronic kidney disease with hypertension and no diabetes (5021_13)
Natural killer cell receptor 2B4 level in Chronic kidney disease with hypertension and no diabetes (5063_12)
CMRF35-like molecule 6 level in Chronic kidney disease with hypertension and no diabetes (5066_134)
Leukocyte immunoglobulin-like receptor subfamily B member 1 level in Chronic kidney disease with hypertension and no diabetes (5090_49)
Leukocyte immunoglobulin-like receptor subfamily B member 2 level in Chronic kidney disease with hypertension and no diabetes (5091_28)
MHC class I polypeptide-related sequence B level in Chronic kidney disease with hypertension and no diabetes (5102_55)
Semaphorin-6B level in Chronic kidney disease with hypertension and no diabetes (5121_3)
Intercellular adhesion molecule 5 level in Chronic kidney disease with hypertension and no diabetes (5124_62)
Intercellular adhesion molecule 5 level in Chronic kidney disease with hypertension and no diabetes (5124_69)
Scavenger receptor class F member 1 level in Chronic kidney disease with hypertension and no diabetes (5129_12)
Hepatitis A virus cellular receptor 2 level in Chronic kidney disease with hypertension and no diabetes (5134_52)
Proprotein convertase subtilisin/kexin type 9 level in Chronic kidney disease with hypertension and no diabetes (5231_79)
Dual specificity mitogen-activated protein kinase kinase 4 level in Chronic kidney disease with hypertension and no diabetes (5242_37)
Histone deacetylase complex subunit SAP30 level in Chronic kidney disease with hypertension and no diabetes (12888_18)
E3 ISG15--protein ligase HERC5 level in Chronic kidney disease with hypertension and no diabetes (12934_1)
Retinaldehyde-binding protein 1 level in Chronic kidney disease with hypertension and no diabetes (12936_38)
Peroxisome proliferator-activated receptor alpha level in Chronic kidney disease with hypertension and no diabetes (12954_71)
Tumor protein p53-inducible protein 11 level in Chronic kidney disease with hypertension and no diabetes (13022_20)
cGMP-dependent protein kinase 1, beta isozyme level in Chronic kidney disease with hypertension and no diabetes (13067_5)
Centrin-2 level in Chronic kidney disease with hypertension and no diabetes (13078_3)
Valine--tRNA ligase level in Chronic kidney disease with hypertension and no diabetes (13083_18)
Protein FAM3D level in Chronic kidney disease with hypertension and no diabetes (13102_1)
Lumican level in Chronic kidney disease with hypertension and no diabetes (13114_50)
Argininate levels in elite athletes
Beta-citrylglutamate levels in elite athletes
Tacrolimus trough level in transplant patients (heart, kidney, lung, and liver)
Thyroglobulin levels
Serine/threonine/tyrosine-interacting protein level in Chronic kidney disease with hypertension and no diabetes (21349_2)
Sperm antigen with calponin homology and coiled-coil domains 1 level in Chronic kidney disease with hypertension and no diabetes (21360_27)
Alpha-L-fucoside fucohydrolase level in Chronic kidney disease with hypertension and no diabetes (21384_2)
Protocadherin-17 level in Chronic kidney disease with hypertension and no diabetes (21395_23)
Butyrophilin subfamily 3 member A2 level in Chronic kidney disease with hypertension and no diabetes (21433_3)
Methylated-DNA--protein-cysteine methyltransferase level in Chronic kidney disease with hypertension and no diabetes (21437_77)
Dynamin-1-like protein level in Chronic kidney disease with hypertension and no diabetes (21452_3)
Ropporin-1B level in Chronic kidney disease with hypertension and no diabetes (25453_57)
O-acetyl-ADP-ribose deacetylase MACROD2 level in Chronic kidney disease with hypertension and no diabetes (25459_3)
Protein FAM221B level in Chronic kidney disease with hypertension and no diabetes (25493_11)
Caspase-5 level in Chronic kidney disease with hypertension and no diabetes (25895_29)
Inactive tyrosine-protein kinase transmembrane receptor ROR1 level in Chronic kidney disease with hypertension and no diabetes (2590_69)
HLA class I histocompatibility antigen, alpha chain E level in Chronic kidney disease with hypertension and no diabetes (25918_60)
Preferentially expressed antigen of melanoma level in Chronic kidney disease with hypertension and no diabetes (25951_17)
Exportin-5 level in Chronic kidney disease with hypertension and no diabetes (25963_2)
Vascular endothelial growth factor A level in Chronic kidney disease with hypertension and no diabetes (2597_8)
Interleukin-6 receptor subunit beta level in Chronic kidney disease with hypertension and no diabetes (2620_4)
Interleukin-1 Receptor accessory protein level in Chronic kidney disease with hypertension and no diabetes (2630_12)
Macrophage mannose receptor 1 level in Chronic kidney disease with hypertension and no diabetes (2637_77)
Semenogelin-1 level in Chronic kidney disease with hypertension and no diabetes (7115_5)
Interleukin-21 level in Chronic kidney disease with hypertension and no diabetes (7124_18)
Apolipoprotein A-II level in Chronic kidney disease with hypertension and no diabetes (7127_3)
Tenascin level in Chronic kidney disease with hypertension and no diabetes (7131_207)
Inter-alpha-trypsin inhibitor heavy chain H3 level in Chronic kidney disease with hypertension and no diabetes (7145_1)
Alpha-(1,3)-fucosyltransferase 10 level in Chronic kidney disease with hypertension and no diabetes (7156_2)
Phosphatidylcholine diacyl C36:5 levels
Phosphatidylcholine diacyl C36:6 levels
Phosphatidylcholine diacyl C38:0 levels
Phosphatidylcholine diacyl C38:3 levels
Phosphatidylcholine diacyl C38:4 levels
Phosphatidylcholine diacyl C38:5 levels
4-hydroxychlorothalonil levels in elite athletes
4-hydroxycoumarin levels in elite athletes
4-methylcatechol sulfate levels in elite athletes
4-vinylguaiacol sulfate levels in elite athletes
Stachydrine levels in elite athletes
5-acetylamino-6-amino-3-methyluracil levels in elite athletes
Ischemic stroke or tissue plasminogen activator levels (pleiotropy)
Ischemic stroke or plasminogen activator inhibitor 1 levels (pleiotropy)
Factor VIII levels or von Willebrand factor levels (pleiotropy)
Calcineurin levels
Calcium/calmodulin-dependent protein kinase type 1 levels
Calcium/calmodulin-dependent protein kinase type 1D levels
Calpain I levels
Calpastatin levels
Carbohydrate sulfotransferase 15 levels
Carbonic anhydrase 13 levels
Carbonic anhydrase 6 levels
Revision surgery after total joint arthroplasty
Revision surgery due to aseptic loosening after total hip arthroplasty
Revision surgery due to aseptic loosening after total joint arthroplasty
Granulocyte telomere length
Lymphocyte telomere length
NK-cell telomere length
Problematic opioid prescription use
C-C motif chemokine 19 levels
UMP-CMP kinase levels
von Willebrand factor levels
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
C-C motif chemokine 5 levels
C-C motif chemokine 7 levels
Revision surgery after total hip arthroplasty
Revision surgery due to aseptic loosening after total knee arthroplasty
Revision surgery after total knee arthroplasty
Venous thromboembolism in pregnancy
Endoglin levels
Fc receptor-like protein 3 levels
Fibroblast growth factor 2 levels
Fibronectin Fragment 3 levels
Fibronectin Fragment 4 levels
Phosphatidylcholines (o-32:0) levels
Phosphatidylcholines (o-34:0) levels
Phosphatidylethanolamine (34:1) levels
Phosphatidylethanolamine (36:1) levels
Phosphatidylethanolamine (36:3) levels
Phosphatidylethanolamine (36:4) levels
Phosphatidylethanolamine (38:2) levels
Phosphatidylethanolamine (38:4)A levels
Phosphatidylethanolamine (38:4)B levels
Orofacial cleft x maternal vitamin supplementation interaction (2df)
Carboxypeptidase N subunit 2 level in Chronic kidney disease with hypertension and no diabetes (6415_90)
Prenylcysteine oxidase 1 level in Chronic kidney disease with hypertension and no diabetes (6431_68)
A disintegrin and metalloproteinase with thrombospondin motifs 6 level in Chronic kidney disease with hypertension and no diabetes (6441_62)
Acyl-CoA-binding domain-containing protein 7 level in Chronic kidney disease with hypertension and no diabetes (13563_259)
Retinoblastoma-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (13565_2)
Segment polarity protein dishevelled homolog DVL-2 level in Chronic kidney disease with hypertension and no diabetes (13575_40)
Glutathione S-transferase P level in Chronic kidney disease with hypertension and no diabetes (13576_15)
CREB-binding protein level in Chronic kidney disease with hypertension and no diabetes (13614_6)
Pirin level in Chronic kidney disease with hypertension and no diabetes (13634_209)
Heat shock 70 kDa protein 6 level in Chronic kidney disease with hypertension and no diabetes (13672_3)
Ornithine decarboxylase level in Chronic kidney disease with hypertension and no diabetes (13689_2)
WNT1-inducible-signaling pathway protein 1 level in Chronic kidney disease with hypertension and no diabetes (13692_154)
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (13697_51)
Ficolin-2 level in Chronic kidney disease with hypertension and no diabetes (13717_15)
Homeobox protein SIX6 level in Chronic kidney disease with hypertension and no diabetes (20987_21)
Retinitis pigmentosa 9 protein level in Chronic kidney disease with hypertension and no diabetes (20988_63)
Uncharacterized metallophosphoesterase CSTP1 level in Chronic kidney disease with hypertension and no diabetes (21108_5)
Pre-miRNA 5'-monophosphate methyltransferase level in Chronic kidney disease with hypertension and no diabetes (21115_48)
Inositol-tetrakisphosphate 1-kinase level in Chronic kidney disease with hypertension and no diabetes (21130_82)
Fructosamine-3-kinase level in Chronic kidney disease with hypertension and no diabetes (21147_9)
GTP-binding protein SAR1b level in Chronic kidney disease with hypertension and no diabetes (21220_11)
Acetyl-coenzyme A synthetase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (25094_9)
Vacuolar protein sorting-associated protein 53 homolog level in Chronic kidney disease with hypertension and no diabetes (25103_45)
Arginyl-tRNA--protein transferase 1 level in Chronic kidney disease with hypertension and no diabetes (25108_6)
Imidazole lactate levels in elite athletes
Imidazole propionate levels in elite athletes
Indole-3-carboxylic acid levels in elite athletes
Indoleacetylglutamine levels in elite athletes
Phosphatidylcholine acyl-alkyl C42:2 levels
Phosphatidylcholine acyl-alkyl C42:3 levels
Phosphatidylcholine acyl-alkyl C42:4 levels
Phosphatidylcholine acyl-alkyl C42:5 levels
Phosphatidylcholine acyl-alkyl C44:5 levels
Phosphatidylcholine acyl-alkyl C44:6 levels
Succinylcarnitine (C4-DC) levels in elite athletes
Sucrose levels in elite athletes
Carotene diol (2) levels in elite athletes
Cinnamoylglycine levels in elite athletes
Diglycerol levels in elite athletes
Taurine levels in elite athletes
Ischemic stroke or factor VII levels (pleiotropy)
Caspase-3 levels
Catalase levels
Cathepsin B levels
Cathepsin Z levels
CD109 antigen levels
Cell adhesion molecule-related/down-regulated by oncogenes levels
cGMP-specific 3',5'-cyclic phosphodiesterase levels
Human Chorionic Gonadotropin levels
Inosine-5'-monophosphate dehydrogenase 1 levels
Inosine-5'-monophosphate dehydrogenase 2 levels
Integrin alpha-I: beta-1 complex levels
Interleukin-1 beta levels
Venous thromboembolism or factor VII levels (pleiotropy)
Interleukin-17 receptor D levels
Pyruvate dehydrogenase protein X component, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (18319_7)
Glucosylceramidase level in Chronic kidney disease with hypertension and no diabetes (18331_3)
Cytidine deaminase level in Chronic kidney disease with hypertension and no diabetes (18336_31)
Proteasome subunit beta type-4 level in Chronic kidney disease with hypertension and no diabetes (18340_2)
Interleukin-36 receptor antagonist protein level in Chronic kidney disease with hypertension and no diabetes (18375_28)
Catechol O-methyltransferase level in Chronic kidney disease with hypertension and no diabetes (18382_109)
Glutaredoxin-1 level in Chronic kidney disease with hypertension and no diabetes (18386_36)
[Protein ADP-ribosylarginine] hydrolase level in Chronic kidney disease with hypertension and no diabetes (18395_5)
ADP-ribosylation factor-like protein 15 level in Chronic kidney disease with hypertension and no diabetes (18411_83)
Peptidyl-prolyl cis-trans isomerase G level in Chronic kidney disease with hypertension and no diabetes (18449_33)
Peptidyl-prolyl cis-trans isomerase C level in Chronic kidney disease with hypertension and no diabetes (18819_21)
Intelectin-1 level in Chronic kidney disease with hypertension and no diabetes (18830_1)
Leucine-rich repeats and immunoglobulin-like domains protein 1 level in Chronic kidney disease with hypertension and no diabetes (18831_6)
Ubiquitin-conjugating enzyme E2 D2 level in Chronic kidney disease with hypertension and no diabetes (18842_24)
Chondrocalcin level in Chronic kidney disease with hypertension and no diabetes (18875_125)
Gremlin-1 level in Chronic kidney disease with hypertension and no diabetes (18878_15)
Endophilin-A3 level in Chronic kidney disease with hypertension and no diabetes (23029_3)
BTB/POZ domain-containing protein KCTD6 level in Chronic kidney disease with hypertension and no diabetes (23161_3)
Histamine N-methyltransferase level in Chronic kidney disease with hypertension and no diabetes (23178_95)
Uncharacterized protein C11orf70 level in Chronic kidney disease with hypertension and no diabetes (23213_21)
E3 ubiquitin-protein ligase TRIM62 level in Chronic kidney disease with hypertension and no diabetes (23225_26)
Speriolin-like protein level in Chronic kidney disease with hypertension and no diabetes (23245_5)
COMM domain-containing protein 10 level in Chronic kidney disease with hypertension and no diabetes (23257_14)
Ras-related protein Rab-43 level in Chronic kidney disease with hypertension and no diabetes (23283_9)
Acute graft-versus-host disease (stage 2 to 4) (donor effect)
Acute graft-versus-host disease (stage 2 to 4) (recipient effect)
Acute graft-versus-host disease (stage 2b to 4) (donor effect)
Acute graft-versus-host disease (stage 2b to 4) (recipient effect)
Acute graft-versus-host disease (stage 3 to 4) (donor effect)
Acute graft-versus-host disease (stage 3 to 4) (recipient effect)
Acute graft-versus-host disease (gut) (donor effect)
2-pyrrolidinone levels in elite athletes
2,3-dihydroxy-2-methylbutyrate levels in elite athletes
3-hydroxy-2-ethylpropionate levels in elite athletes
3-indoxyl sulfate levels in elite athletes
3-methylglutaconate levels in elite athletes
Sphingomyelin (d43:1) levels
Sphingomyelin (d43:2) levels
Sphingomyelin (d44:2) levels
Triglycerides (44:0) levels
Triglycerides (44:1) levels
Triglycerides (44:2) levels
Triglycerides (46:1) levels
GDH/6PGL endoplasmic bifunctional protein level in Chronic kidney disease with hypertension and no diabetes (7161_25)
Protein DEPP level in Chronic kidney disease with hypertension and no diabetes (7178_59)
Ephrin type-A receptor 4 level in Chronic kidney disease with hypertension and no diabetes (7190_50)
Beta-1,3-N-acetylglucosaminyltransferase radical fringe level in Chronic kidney disease with hypertension and no diabetes (7203_125)
Protein S100-A13 level in Chronic kidney disease with hypertension and no diabetes (7223_60)
Interleukin-1 Receptor accessory protein level in Chronic kidney disease with hypertension and no diabetes (14048_7)
Tumor necrosis factor ligand superfamily member 15 level in Chronic kidney disease with hypertension and no diabetes (14057_68)
Ficolin-3 level in Chronic kidney disease with hypertension and no diabetes (14077_6)
Carbonyl reductase [NADPH] 3 level in Chronic kidney disease with hypertension and no diabetes (14091_42)
Cysteine--tRNA ligase, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (14098_28)
Ciliary neurotrophic factor receptor subunit alpha level in Chronic kidney disease with hypertension and no diabetes (14101_2)
Granulysin level in Chronic kidney disease with hypertension and no diabetes (14102_6)
Kallistatin level in Chronic kidney disease with hypertension and no diabetes (14105_5)
5-formyltetrahydrofolate cyclo-ligase level in Chronic kidney disease with hypertension and no diabetes (14107_1)
C-C motif chemokine 15 level in Chronic kidney disease with hypertension and no diabetes (14109_15)
HERV-H LTR-associating protein 2 level in Chronic kidney disease with hypertension and no diabetes (14132_21)
Interleukin-1 receptor type 2 level in Chronic kidney disease with hypertension and no diabetes (14133_93)
Interleukin-36 alpha level in Chronic kidney disease with hypertension and no diabetes (14150_7)
SCP2 sterol-binding domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (14175_78)
Vascular adhesion protein-1 level in Chronic kidney disease with hypertension and no diabetes (21491_7)
Alpha-aminoadipic semialdehyde dehydrogenase level in Chronic kidney disease with hypertension and no diabetes (21498_3)
Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase level in Chronic kidney disease with hypertension and no diabetes (21508_7)
Tryptophan 5-hydroxylase 1 level in Chronic kidney disease with hypertension and no diabetes (21521_17)
Selenocysteine lyase level in Chronic kidney disease with hypertension and no diabetes (21537_33)
Musculoskeletal embryonic nuclear protein 1 level in Chronic kidney disease with hypertension and no diabetes (21545_51)
Stearidonate (18:4n3) levels in elite athletes
5-acetylamino-6-formylamino-3-methyluracil levels in elite athletes
6-hydroxyindole sulfate levels in elite athletes
Acesulfame levels in elite athletes
Ischemic stroke or factor VIII levels (pleiotropy)
Hemojuvelin levels
Hepatitis A virus cellular receptor 2 levels
Hepatocyte growth factor receptor levels
Hepatocyte growth factor-like protein levels
Glutathione S-transferase omega-1 level in Chronic kidney disease with hypertension and no diabetes (12436_84)
Phosphomevalonate kinase level in Chronic kidney disease with hypertension and no diabetes (12450_42)
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase level in Chronic kidney disease with hypertension and no diabetes (12457_10)
Proteasome subunit alpha type-7 level in Chronic kidney disease with hypertension and no diabetes (12460_18)
Tax1-binding protein 3 level in Chronic kidney disease with hypertension and no diabetes (12498_12)
Tubulin-specific chaperone A level in Chronic kidney disease with hypertension and no diabetes (12501_10)
Ovarian cancer G-protein coupled receptor 1 level in Chronic kidney disease with hypertension and no diabetes (12503_5)
Inactive peptidyl-prolyl cis-trans isomerase FKBP6 level in Chronic kidney disease with hypertension and no diabetes (12529_32)
Hematopoietic prostaglandin D synthase level in Chronic kidney disease with hypertension and no diabetes (12549_33)
Guanylate-binding protein 2 level in Chronic kidney disease with hypertension and no diabetes (18891_98)
Hepatoma-derived growth factor-related protein 3 level in Chronic kidney disease with hypertension and no diabetes (18899_82)
GTPase HRas level in Chronic kidney disease with hypertension and no diabetes (18900_37)
Inosine triphosphate pyrophosphatase level in Chronic kidney disease with hypertension and no diabetes (18916_25)
Death-associated protein 1 level in Chronic kidney disease with hypertension and no diabetes (19141_22)
NADH-cytochrome b5 reductase 2 level in Chronic kidney disease with hypertension and no diabetes (19143_38)
Glia-derived nexin level in Chronic kidney disease with hypertension and no diabetes (19154_41)
PCNA-associated factor level in Chronic kidney disease with hypertension and no diabetes (19158_1)
Meiotic recombination protein DMC1/LIM15 homolog level in Chronic kidney disease with hypertension and no diabetes (23341_16)
Coiled-coil domain-containing protein 24 level in Chronic kidney disease with hypertension and no diabetes (23356_32)
Voltage-gated potassium channel subunit beta-3 level in Chronic kidney disease with hypertension and no diabetes (23370_39)
Diphthine methyl ester synthase level in Chronic kidney disease with hypertension and no diabetes (23373_77)
Ermin level in Chronic kidney disease with hypertension and no diabetes (23425_19)
Variable charge X-linked protein 1 level in Chronic kidney disease with hypertension and no diabetes (23426_1)
Methyltransferase-like protein 2B level in Chronic kidney disease with hypertension and no diabetes (23558_33)
Oxidoreductase HTATIP2 level in Chronic kidney disease with hypertension and no diabetes (7753_21)
HLA class II histocompatibility antigen, DQ alpha 2 chain level in Chronic kidney disease with hypertension and no diabetes (7757_5)
Cadherin-11 level in Chronic kidney disease with hypertension and no diabetes (7763_25)
Carboxypeptidase M level in Chronic kidney disease with hypertension and no diabetes (7768_10)
Leukocyte immunoglobulin-like receptor subfamily A member 5 level in Chronic kidney disease with hypertension and no diabetes (7787_25)
Coiled-coil domain-containing protein 90B, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (7792_58)
NKG2-E type II integral membrane protein level in Chronic kidney disease with hypertension and no diabetes (7795_14)
D-glucuronyl C5-epimerase level in Chronic kidney disease with hypertension and no diabetes (7808_5)
Protocadherin gamma-C3 level in Chronic kidney disease with hypertension and no diabetes (7859_21)
Probable G-protein coupled receptor 142 level in Chronic kidney disease with hypertension and no diabetes (12766_33)
Heterogeneous nuclear ribonucleoprotein M level in Chronic kidney disease with hypertension and no diabetes (12783_29)
Amyloid beta A4 precursor protein-binding family B member 3 level in Chronic kidney disease with hypertension and no diabetes (12784_10)
EH domain-binding protein 1 level in Chronic kidney disease with hypertension and no diabetes (12813_18)
GTP-binding protein GEM level in Chronic kidney disease with hypertension and no diabetes (12817_1)
Amyloid beta A4 precursor protein-binding family B member 1 level in Chronic kidney disease with hypertension and no diabetes (12822_34)
Syntaxin-10 level in Chronic kidney disease with hypertension and no diabetes (12842_43)
Rho guanine nucleotide exchange factor 2 level in Chronic kidney disease with hypertension and no diabetes (12848_9)
Retinol dehydrogenase 16 level in Chronic kidney disease with hypertension and no diabetes (12881_17)
Heparan sulfate glucosamine 3-O-sulfotransferase 4 level in Chronic kidney disease with hypertension and no diabetes (19370_30)
Noelin-2 level in Chronic kidney disease with hypertension and no diabetes (19377_14)
Isoform L-VEGF165 level in Chronic kidney disease with hypertension and no diabetes (19437_61)
Pre-mRNA-splicing factor SYF2 level in Chronic kidney disease with hypertension and no diabetes (19438_68)
Complement receptor type 1 level in Chronic kidney disease with hypertension and no diabetes (19556_12)
Beta-klotho level in Chronic kidney disease with hypertension and no diabetes (19557_3)
Low-density lipoprotein receptor-related protein 4 level in Chronic kidney disease with hypertension and no diabetes (19558_10)
Glycosphingolipids (d42:1) levels
Lysophosphatidylcholines (20:1) levels
Lysophosphatidylcholines (20:4) levels
3-methylglutarylcarnitine (2) levels in elite athletes
4-guanidinobutanoate levels in elite athletes
4-hydroxyglutamate levels in elite athletes
4-hydroxyphenylpyruvate levels in elite athletes
Cysteine s-sulfate levels in elite athletes
Cysteine sulfinic acid levels in elite athletes
Decanoylcarnitine levels
Decenoylcarnitine levels
Dodecanoylcarnitine levels
Dodecenoylcarnitine levels
Glutamate levels
Citrulline levels
Activating signal cointegrator 1 complex subunit 2 level in Chronic kidney disease with hypertension and no diabetes (24476_18)
Myotubularin-related protein 7 level in Chronic kidney disease with hypertension and no diabetes (24493_10)
Katanin p60 ATPase-containing subunit A-like 1 level in Chronic kidney disease with hypertension and no diabetes (24494_67)
Lengsin level in Chronic kidney disease with hypertension and no diabetes (24499_36)
Protein ripply3 level in Chronic kidney disease with hypertension and no diabetes (24634_1)
Claudin-1 level in Chronic kidney disease with hypertension and no diabetes (24641_10)
Reticulon-1 level in Chronic kidney disease with hypertension and no diabetes (24651_1)
MAP6 domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (24661_4)
Transcription factor ETV7 level in Chronic kidney disease with hypertension and no diabetes (24679_35)
Sorting nexin-11 level in Chronic kidney disease with hypertension and no diabetes (24685_12)
Metalloproteinase inhibitor 3 level in Chronic kidney disease with hypertension and no diabetes (2480_58)
F-BAR and double SH3 domains protein 1 level in Chronic kidney disease with hypertension and no diabetes (24895_25)
Uroplakin-3b-like protein level in Chronic kidney disease with hypertension and no diabetes (6633_43)
Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)
Hemoglobin subunit zeta level in Chronic kidney disease with hypertension and no diabetes (6919_3)
39S ribosomal protein L34, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (6933_20)
Type 2 lactosamine alpha-2,3-sialyltransferase level in Chronic kidney disease with hypertension and no diabetes (6947_4)
Pancreatic lipase-related protein 2 level in Chronic kidney disease with hypertension and no diabetes (6957_14)
Alpha-(1,3)-fucosyltransferase 9 level in Chronic kidney disease with hypertension and no diabetes (6991_24)
Aspartyl/asparaginyl beta-hydroxylase level in Chronic kidney disease with hypertension and no diabetes (6998_106)
Leukocyte immunoglobulin-like receptor subfamily B member 5 level in Chronic kidney disease with hypertension and no diabetes (7015_8)
Leukocyte immunoglobulin-like receptor subfamily A member 6 level in Chronic kidney disease with hypertension and no diabetes (7059_14)
t-SNARE domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (7069_9)
Corneodesmosin level in Chronic kidney disease with hypertension and no diabetes (7085_81)
Neuroendocrine convertase 1 level in Chronic kidney disease with hypertension and no diabetes (13388_57)
Sphingomyelin (d38:1) levels
Sphingomyelin (d38:2) levels
Sphingomyelin (d39:1) levels
Sphingomyelin (d39:2) levels
Sphingomyelin (d40:1) levels
Sphingomyelin (d40:2)B levels
Sphingomyelin (d40:3) levels
Sphingomyelin (d41:1) levels
Sphingomyelin (d41:2)A levels
Sphingomyelin (d42:0) levels
Sphingomyelin (d42:1) levels
Sphingomyelin (d42:2) levels
Sphingomyelin (d42:2)A levels
Sphingomyelin (d42:2)B levels
Sphingomyelin (d42:3) levels
Tyrosine-protein phosphatase non-receptor type substrate 1 level in Chronic kidney disease with hypertension and no diabetes (5430_66)
Ficolin-3 level in Chronic kidney disease with hypertension and no diabetes (5462_62)
C-C motif chemokine 5 level in Chronic kidney disease with hypertension and no diabetes (5480_49)
SLAM family member 7 level in Chronic kidney disease with hypertension and no diabetes (5487_7)
Small nuclear ribonucleoprotein F level in Chronic kidney disease with hypertension and no diabetes (5494_52)
Holo-Transcobalamin-2 level in Chronic kidney disease with hypertension and no diabetes (5584_21)
Protein disulfide-isomerase A5 level in Chronic kidney disease with hypertension and no diabetes (5593_11)
T-cell surface glycoprotein CD5 level in Chronic kidney disease with hypertension and no diabetes (5596_75)
N-acetylmuramoyl-L-alanine amidase level in Chronic kidney disease with hypertension and no diabetes (5601_2)
Complement component C9 level in Chronic kidney disease with hypertension and no diabetes (13722_105)
Interleukin-3 receptor subunit alpha level in Chronic kidney disease with hypertension and no diabetes (13744_37)
Carbonic anhydrase 6 level in Chronic kidney disease with hypertension and no diabetes (13747_9)
C-C motif chemokine 8 level in Chronic kidney disease with hypertension and no diabetes (13748_4)
Rho guanine nucleotide exchange factor 7 level in Chronic kidney disease with hypertension and no diabetes (13932_45)
Kinesin-like protein KIF3A level in Chronic kidney disease with hypertension and no diabetes (13961_18)
Thioredoxin reductase 1, cytoplasmic level in Chronic kidney disease with hypertension and no diabetes (13967_14)
NmrA-like family domain-containing protein 1 level in Chronic kidney disease with hypertension and no diabetes (13988_67)
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha level in Chronic kidney disease with hypertension and no diabetes (14028_22)
COP9 signalosome complex subunit 2 level in Chronic kidney disease with hypertension and no diabetes (14029_42)
Vascular endothelial growth factor A, isoform 121 level in Chronic kidney disease with hypertension and no diabetes (14032_2)
Ankyrin repeat and SOCS box protein 13 level in Chronic kidney disease with hypertension and no diabetes (21234_7)
Transmembrane emp24 domain-containing protein 9 level in Chronic kidney disease with hypertension and no diabetes (21236_12)
Retinol dehydrogenase 12 level in Chronic kidney disease with hypertension and no diabetes (21345_93)
Phosphatidylcholine diacyl C34:3 levels
Phosphatidylcholine diacyl C34:4 levels
Phosphatidylcholine diacyl C36:0 levels
Phosphatidylcholine diacyl C36:2 levels
Phosphatidylcholine diacyl C36:3 levels
Phosphatidylcholine diacyl C36:4 levels
3-hydroxypyridine sulfate levels in elite athletes
3-methoxycatechol sulfate (2) levels in elite athletes
3-methyl catechol sulfate (1) levels in elite athletes
3-methyl catechol sulfate (2) levels in elite athletes
3,7-dimethylurate levels in elite athletes
4-acetylphenol sulfate levels in elite athletes
4-allylphenol sulfate levels in elite athletes
Serum uromodulin levels (antibody-based assay)
Serum uromodulin levels (aptamer-based assay)
Free cholesterol to total lipids ratio in medium VLDL
Candidiasis
Birth year infant mortality rates
Tumor necrosis factor ligand superfamily member 6, soluble form levels
C-type lectin domain family 4 member M levels
C-type mannose receptor 2 levels
Total lipid levels in medium VLDL
Tyrosine-protein kinase ZAP-70 levels
Alanine aminotransferase levels in low dose methotrexate treatment
Aspartate aminotransferase levels in low dose methotrexate treatment
High aspartate aminotransferase or alanine aminotransferase levels in low dose methotrexate treatment
Eosinophil-derived neurotoxin levels
Eosinophil cationic protein levels and Eosinophil-derived neurotoxin levels
HDL cholesterol levels in type 2 diabetes
Triglyceride levels in type 2 diabetes
Phospholipids to total lipids ratio in medium VLDL
Adhesion G protein-coupled receptor E2 levels
Alpha-(1,3)-fucosyltransferase 5 levels
Interleukin-34 levels
SH2 domain-containing protein 1A levels
SLIT and NTRK-like protein 5 levels
2,4,5-trichlorophenol-2 levels
2-palmitoylglycerophosphocholine levels (Metabolon platform)
1-palmitoylglycerophosphocholine levels (Metabolon platform)
2-stearoylglycerophosphocholine levels (Metabolon platform)
1-docosahexaenoylglycerophosphocholine levels (Metabolon platform)
1-arachidonoylglycerophosphocholine levels (Biocrates platform)
1-docosahexaenoylglycerophosphocholine levels (Biocrates platform)
Butyrylcarnitine levels (Biocrates platform)
Carnitine levels (Biocrates platform)
Decanoylcarnitine levels (Biocrates platform)
Acetylcarnitine levels (Biocrates platform)
Propionylcarnitine levels (Biocrates platform)
Isovalerylcarnitine levels (Biocrates platform)
Hexanoylcarnitine levels (Biocrates platform)
Octanoylcarnitine levels (Biocrates platform)
Glutamine levels (Biocrates platform)
Glycine levels (Biocrates platform)
Glucose levels (Biocrates platform)
Histidine levels (Biocrates platform)
Ornithine levels (Biocrates platform)
Tryptophan levels (Biocrates platform)
1-eicosatrienoylglycerophosphocholine levels (Biocrates platform)
1-heptadecanoylglycerophosphocholine levels (Biocrates platform)
Tyrosine levels (Biocrates platform)
Laurylcarnitine levels (Biocrates platform)
Threonine levels (Biocrates platform)
Plasminogen levels
Ratio of omega-6 fatty acids to total fatty acids
Age of onset of depression x felt loved as a child interaction
Methionine levels (Biocrates platform)
Phenylalanine levels (Biocrates platform)
Arginine levels (Biocrates platform)
Serine levels (Biocrates platform)
2-tetradecenoyl carnitine levels (Biocrates platform)
Oleoylcarnitine levels (Biocrates platform)
1-linoleoylglycerophosphocholine levels (Biocrates platform)
Glutaroyl carnitine levels (Biocrates platform)
1-myristoylglycerophosphocholine levels (Biocrates platform)
Hydroxyisovaleroyl carnitine levels (Biocrates platform)
1-oleoylglycerophosphocholine levels (Biocrates platform)
Aldrin levels
Azinphos methyl levels
Cadmium chloride levels
Phosphoglycerides levels
Chlorpyrifos levels
Atrial fibrillation (MTAG)
Time to colon cancer recurrence
Cholesteryl esters to total lipids ratio in medium VLDL
Fibroblast growth factor 8 isoform A levels
Pulmonary surfactant-associated protein D levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels
Alzheimer's disease in APOE E4 homozygosity
Cardioembolic stroke (MTAG)
Chondromalacia
Ephrin type-B receptor 6 levels
ICOS ligand levels
CD226 antigen levels
Natural killer cell receptor 2B4 levels
Asymptomatic COVID-19 infection
Concentration of medium VLDL particles
Alzheimer's disease (age of onset) (adjusted for APOE e4 carrier status)
Alzheimer's disease (age of onset) in APOE e4 non-carriers
Glia-derived nexin levels
Secreted frizzled-related protein 1 levels
Iduronate 2-sulfatase levels
Kallikrein-13 levels
Lymphatic vessel endothelial hyaluronic acid receptor 1 levels
Matrix extracellular phosphoglycoprotein levels
Type 2 diabetes or peripheral artery disease (MTAG)
Perinatal depression
Lithium clearance
Lithium clearance (adjusted for clinical predictors)
Serine/threonine-protein kinase PAK 3 levels
Plasma serine protease inhibitor levels
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform levels
Stabilin-2 levels
Cathepsin H levels
Chromogranin-A levels
Stromelysin-2 levels
Down syndrome cell adhesion molecule levels
Mucin-1 levels
Protein FAM3B levels
Total cholesterol minus HDL-C levels
Ribavirin-induced anemia in chronic hepatitis C
Non-histone chromosomal protein HMG-14 levels
Galectin-9 levels
Ubiquitin-conjugating enzyme E2 G2 levels
Quinone oxidoreductase-like protein 1 levels
Cathepsin F levels
Ubiquitin carboxyl-terminal hydrolase 25 levels
Plexin-B2 levels
Omega-3 fatty acid levels
Periostin levels
Brevican core protein levels
2,4,5-trichlorophenol levels
Aromatic-L-amino-acid decarboxylase levels
Arylsulfatase A levels
Basigin levels
Total omega-3 fatty acid levels
Linoleic acid levels
Ratio of omega-3 fatty acids to total fatty acids
Omega-6 fatty acid levels
Cadherin-6 levels
4,6-dinitro-o-cresol levels
Environmental pollutants exposure (AC50 high)
Total omega-6 fatty acid levels
Legumain levels
Attention deficit hyperactivity disorder or autism spectrum disorder (pleiotropy)
Environmental pollutants exposure (AC50 low)
Hypertrophic cardiomyopathy (ICD-10 coded)
Cyclin-dependent kinase inhibitor 1B levels
Disintegrin and metalloproteinase domain-containing protein 9 levels
Angiopoietin-related protein 4 levels
Carbonic anhydrase 3 levels
Ratio of omega-6 fatty acids to omega-3 fatty acids
Peak plasma concentration of rosuvastatin
Plasma concentration-time curve of rosuvastatin
Accelerated lung function decline (FVC) and worsened/persistent change in fatty liver (pleiotropy)
Accelerated lung function decline (FEV1) and worsened/persistent change in fatty liver (pleiotropy)
Ratio of polyunsaturated fatty acids to monounsaturated fatty acids
CD59 glycoprotein levels
Growth/differentiation factor 11 levels
Betacellulin levels
Hypoxia-inducible factor 1-alpha levels
R-spondin-3 levels
Lithostathine-1-alpha levels
Protein FAM3D levels
Neuronal growth regulator 1 levels
CD177 antigen levels
Choline/ethanolamine kinase levels
SPARC-related modular calcium-binding protein 1 levels
Ubiquitin-like protein ISG15 levels
14-3-3 protein beta/alpha levels
Growth/differentiation factor 8 levels
Complement component 1 Q subcomponent-binding protein, mitochondrial levels
Macrophage-capping protein levels
Endoplasmic reticulum resident protein 29 levels
Platelet glycoprotein Ib alpha chain levels
Log white blood cell count in acute lymphoblastic leukemia
Spline residuals of log white blood cell count in acute lymphoblastic leukemia
CD97 antigen levels
Fractalkine levels
Systolic blood pressure x depressive symptoms interaction (2df test)
Pulse pressure x depressive symptoms interaction (1df test)
Pulse pressure x low social support interaction (1df test)
Pulse pressure x depressive symptoms interaction (2df test)
Pulse pressure x low social support interaction (2df test)
Mean arterial pressure x depressive symptoms interaction (2df test)
Systolic blood pressure x depressive symptoms interaction (1df test)
Diastolic blood pressure x depressive symptoms interaction (2df test)
Systolic blood pressure x low social support interaction (1df test)
Diastolic blood pressure x low social support interaction (2df test)
Systolic blood pressure x low social support interaction (2df test)
Pulse pressure x anxiety symptoms interaction (2df test)
DDT metabolite (DDD p-p') levels
DDT metabolite (DDT o-p') levels
DDT metabolite (DDT p-p') levels
Ratio of polyunsaturated fatty acids to total fatty acids
Remnant cholesterol (non-HDL, non-LDL -cholesterol)
CFTR mutation F508del heterozygosity in cystic fibrosis
CFTR mutation F508del heterozygosity in cystic fibrosis (PC-adjusted model)
Cholesterol levels in small HDL
Di-n-butyl phthalate levels
Mean arterial pressure x depressive symptoms interaction (1df test)
Mean arterial pressure x low social support interaction (1df test)
Mean arterial pressure x low social support interaction (2df test)
Diastolic blood pressure x depressive symptoms interaction (1df test)
Diazinon levels
Hepatocellular carcinoma in alcohol related cirrhosis
Dicofol levels
Pulse pressure x anxiety symptoms interaction (1df test)
Opioid use disorder (MTAG)
Dietary macronutrient intake (multi-trait analysis)
Cholesterol to total lipids ratio in small HDL
Non-small cell lung cancer x BMI trajectory interaction
cGMP-dependent 3',5'-cyclic phosphodiesterase levels
Coagulation factor IXab levels
Prothrombin levels
Protein S100-A9 levels
Olfactomedin-4 levels
Inter-alpha-trypsin inhibitor heavy chain H4 levels
Age of onset of parkinson disease
Estimated glomerular filtration rate (cystatin c)
Tyrosine-protein phosphatase non-receptor type substrate 1 levels
Troponin I, fast skeletal muscle levels
Collectin-12 levels
Ideal cardiovascular health score (behavioral)
Ideal cardiovascular health (behavioral)
Monounsaturated fatty acid levels
Juvenile dermatomyositis
Cysteine-rich with EGF-like domain protein 1 levels
Proteasome activator complex subunit 1 levels
Somatostatin-28 levels
Netrin-1 levels
Ankyrin-2 levels
Vesicular integral-membrane protein VIP36 measurement
Low-density lipoprotein receptor-related protein 1B levels
CD48 antigen levels
CD5 antigen-like levels
Contactin-4 levels
Leucine-rich repeats and immunoglobulin-like domains protein 3 levels
Netrin-4 levels
Thrombospondin-4 levels
Low affinity immunoglobulin gamma Fc region receptor II-b levels
Heparan-sulfate 6-O-sulfotransferase 1 levels
Glutamate carboxypeptidase 2 levels
Ras GTPase-activating protein 1 levels
Triglycerides to total lipids ratio in medium VLDL
Testican-2 levels
Fibroblast growth factor receptor 1 levels
Tumor necrosis factor receptor superfamily member 1B levels
Neuropilin-1 levels
Complement C3d fragment levels
Circulating complement factor I levels
BMI-adjusted waist-hip ratio
Chronic spontaneous urticaria
Delta-like protein 4 levels
Low affinity immunoglobulin gamma Fc region receptor II-a levels
Ratio of monounsaturated fatty acids to total fatty acids
Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex levels
Cathepsin L2 levels
eGFR decline after treatment with platinum based chemotherapy
Acute kidney injury after treatment with platinum based chemotherapy
Lowest magnesium plasma levels after treatment with platinum based chemotherapy
Neuroligin-4, X-linked levels
RAC-beta serine/threonine-protein kinase levels
Ideal cardiovascular health score (clinical and behavioral)
Ideal cardiovascular health score (clinical)
Histone-lysine N-methyltransferase EHMT2 levels
3-hydroxyanthranilate 3,4-dioxygenase levels
Posterior urethral valves
Bcl-2-related protein A1 levels
Cytoplasmic tyrosine-protein kinase BMX levels
Ephrin type-A receptor 3 levels
Hydroxyvalerylcarnitine levels
Tumor necrosis factor receptor superfamily member 19 levels
Netrin receptor UNC5C levels
Netrin receptor UNC5D levels
Glucokinase regulatory protein levels
Semaphorin-6B levels
SLAM family member 6 levels
Systolic blood pressure variability
Diastolic blood pressure variability
Alpha-L-iduronidase levels
Carbonic anhydrase 4 levels
Cytosolic non-specific dipeptidase levels
Facial phenotypes (right palpebrale fissure height)
Facial phenotypes (philtrum height)
Facial phenotypes (labiale inferius to pogonion)
Facial phenotypes (midendocanthion to labiale superius )
Facial phenotypes (midendocanthion to subnasale)
Facial phenotypes (nasal bridge height)
Facial phenotypes (nasal height)
Complement C3b levels
Oxaliplatin-induced peripheral sensory neuropathy in colon cancer
Oxaliplatin-induced allergic reactions in colon cancer
Time to recovery from peripheral sensory neuropathy in colon cancer
Oxaliplatin-induced allergic reactions in colon cancer (extreme)
Oxaliplatin-induced peripheral sensory neuropathy in colon cancer (extreme)
Ectonucleoside triphosphate diphosphohydrolase 3 levels
Cell surface glycoprotein CD200 receptor 1 levels
Killer cell lectin-like receptor subfamily F member 1 levels
Large artery stroke (MTAG)
Lipopolysaccharide-binding protein levels
Complement component C9 levels
Facial phenotypes (outercanthal width)
Facial phenotypes (interpalpebral superius length)
Facial phenotypes (interpalpebral inferius length)
Facial phenotypes (left palpebral fissure length)
Facial phenotypes (right palpebral fissure length)
Facial phenotypes (mouth width)
Complement C5b-C6 complex levels
Stem Cell Growth Factor-alpha levels
A disintegrin and metalloproteinase with thrombospondin motifs 15 levels
Brain-specific serine protease 4 levels
Chromobox protein homolog 5 levels
Serotonin levels
Putrescine levels
Hydroxyhexadecanoylcarnitine levels
Alpha-2-antiplasmin levels
Cardioembolic stroke
Small vessel stroke (MTAG)
Facial phenotypes (midendocanthion to pogonion)
Facial phenotypes (nasion to pogonion)
Facial phenotypes (subnasale to pogonion)
Facial phenotypes (intercanthal width)
Facial phenotypes (nasal width)
Facial phenotypes (subnasale to left alare)
Facial phenotypes (subnasale to right alare)
Facial phenotypes (left palpebrale fissure height)
Coiled-coil domain-containing protein 80 levels
Coactosin-like protein levels
Vascular endothelial growth factor A, isoform 121 levels
Coagulation factor IX levels
Coagulation Factor X levels
Glypican-6 levels
Hypomagnesemia after treatment with platinum based chemotherapy
Cholesteryl ester levels in small HDL
Chlamydia trachomatis-related tubal factor infertility
Dieldrin levels
Disulfoton levels
Leisure screen time
Moderate-to-vigorous intensity physical activity during leisure time
Cholesteryl esters to total lipids ratio in small HDL
Free cholesterol levels in small HDL
Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)
Moderate-to-vigorous intensity physical activity during leisure time (MTAG)
Endosulfan levels
Concentration of medium HDL particles
Endrin levels
Ethion levels
Anti-Mullerian hormone levels
1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) levels
Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1] levels
Palmitoyl-linoleoyl-glycerol (16:0/18:2) [2] levels
1-palmitoyl-2-oleoyl-GPI (16:0/18:1) levels
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levels
1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2) levels
1-palmitoyl-2-alpha-linolenoyl-GPC (16:0/18:3n3) levels
1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) levels
1-pentadecanoyl-2-arachidonoyl-GPC (15:0/20:4) levels
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) levels
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) levels
1-myristoyl-2-linoleoyl-GPC (14:0/18:2) levels
1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) levels
1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels
1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (p-18:0/20:4) levels
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPE (p-16:0/22:6) levels
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (p-16:0/20:4) levels
1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (p-16:0/22:6) levels
1-palmityl-2-arachidonoyl-GPC (o-16:0/20:4) levels
Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) levels
Behenoyl dihydrosphingomyelin (d18:0/22:0) levels
Sphingomyelin (d18:0/18:0, d19:0/17:0) levels
Lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels
1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2) levels
1-margaroyl-2-oleoyl-GPC (17:0/18:1) levels
1-margaroyl-2-linoleoyl-GPC (17:0/18:2) levels
Myristoyl dihydrosphingomyelin (d18:0/14:0) levels
Vertex-wise cortical thickness
Fresh fruit consumption
Phosphatidylcholine (16:0/22:5n3, 18:1/20:4) levels
Phosphatidylcholine (18:0/20:5, 16:0/22:5n6) levels
1-stearoyl-2-oleoyl-GPI (18:0/18:1) levels
1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) levels
1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) levels
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (p-18:0/18:2) levels
(S)-3-hydroxybutyrylcarnitine levels
Glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) levels
Arachidonoylcholine levels
Eicosapentaenoylcholine levels
1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) levels
1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3) levels
1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) levels
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) levels
1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6) levels
1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9) levels
1-stearoyl-2-adrenoyl-GPC (18:0/22:4) levels
1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3) levels
1-oleoyl-2-eicosapentaenoyl-GPC (18:1/20:5) levels
1-stearoyl-2-meadoyl-GPC (18:0/20:3n9) levels
1-(1-enyl-palmitoyl)-2-myristoyl-GPC (p-16:0/14:0) levels
Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618)
Never eat eggs vs no eggs restrictions (UKB data field 6144)
Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)
Never eat wheat vs no wheat restrictions (UKB data field 6144)
Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)
Never eat sugar vs no sugar restrictions (UKB data field 6144)
Milk type used: Full cream (UKB data field 1418_1)
Milk type used: Soy milk vs never have milk (UKB data field 1418)
Spread type: Butter and margarine vs never use spread (UKB data field 1428)
Environmental pollutants exposure (Expo high)
1-oleoyl-2-docosapentaenoyl-GPC (18:1/22:5n3) levels
Phosphatidylcholine (18:0/20:2, 20:0/18:2) levels
1-myristoyl-2-eicosapentaenoyl-GPC (14:0/20:5) levels
Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels
Oleoyl-oleoyl-glycerol (18:1/18:1)  [1] levels
Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels
Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels
Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2] levels
Palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] levels
Diacylglycerol (16:1/18:2 [2], 16:0/18:3 [1]) levels
Linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] levels
Bread type: White (UKB data field 1448_1)
Bread type: Wholemeal or wholegrain (UKB data field 1448_3)
Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)
Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)
Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2)
Cereal type: Muesli (UKB data field 1468_4)
Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)
Spread type: Any oil based spread vs never use spread (UKB data field 1428)
Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)
Spread type: Butter vs never use spread (UKB data field 1428)
Spread type: Butter/spreadable butter (UKB data field 1428_1)
Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2)
Gestational age (fetal effect)
Gestational age (maternal effect)
Diastolic blood pressure in preeclampsia
Severity of diagnosis of preeclampsia
Proteinuria in preeclampsia
Systolic blood pressure in preeclampsia
Sedentary behavior at work
Leisure screen time (MTAG)
1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels
1-oleoyl-2-linoleoyl-GPC (18:1/18:2) levels
1-palmitoyl-2-palmitoleoyl-gpc (16:0/16:1) levels
1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) levels
1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) levels
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) levels
1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels
1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (p-18:0/20:4) levels
Sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0) levels
1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels
1-palmitoleoylglycerol (16:1) levels
Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels
Tricosanoyl sphingomyelin (d18:1/23:0) levels
Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels
Sphingomyelin (d18:2/24:1, d18:1/24:2) levels
Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1)
Ground coffee consumption
Cooked vegetables consumption
Dried fruit consumption
Alcohol drinker status: current or former vs never (UKB data field 20117)
Alcohol drinker status: current vs never (UKB data field 20117)
Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618)
1-palmityl-2-palmitoyl-GPC (O-16:0/16:0) levels
Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levels
Lactosyl-N-behenoyl-sphingosine (d18:1/22:0) levels
Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levels
N-stearoyl-sphingadienine (d18:2/18:0) levels
N-palmitoylserine levels
N-oleoylserine levels
Sphingadienine levels
Myristoyl-linoleoyl-glycerol (14:0/18:2) [1] levels
Myristoyl-linoleoyl-glycerol (14:0/18:2) [2] levels
Hexadecasphingosine (d16:1) levels
Ceramide (d16:1/24:1, d18:1/22:1) levels
Glycosyl ceramide (d16:1/24:1, d18:1/22:1) levels
N-palmitoyl-heptadecasphingosine (d17:1/16:0) levels
Free cholesterol to total lipids ratio in small HDL
Ceramide (d18:1/14:0, d16:1/16:0) levels
Ceramide (d18:2/24:1, d18:1/24:2) levels
Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels
Glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) levels
Ceramide (d18:1/20:0, d16:1/22:0, d20:1/18:0) levels
Nisinate (24:6n3) levels
Sphingomyelin (d18:0/20:0, d16:0/22:0) levels
Sphingomyelin (d18:1/19:0, d19:1/18:0) levels
Sphingomyelin (d18:2/21:0, d16:2/23:0) levels
Sphingomyelin (d18:2/23:1) levels
Environmental pollutants exposure (Expo low)
Sphingomyelin (d17:2/16:0, d18:2/15:0) levels
Linolenoylcarnitine (C18:3) levels
Behenoylcarnitine (C22) levels
Arachidoylcarnitine (C20) levels
Lignoceroylcarnitine (C24) levels
Ximenoylcarnitine (C26:1) levels
Cereal consumption (bowls per week) (UKB data field 1458)
Bread consumption (slices per week) (UKB data field 1438)
Impulse control disorders in Parkinson’s disease
Eicosenoylcarnitine (C20:1) levels
Docosahexaenoylcarnitine (C22:6) levels
Nervonoylcarnitine (C24:1) levels
High-density lipoprotein 2 cholesterol levels
Degree of unsaturation
Triglycerides to total lipids ratio in very small VLDL
Docosahexaenoic acid levels
Cholesterol to total lipids ratio in small LDL
Cholesteryl esters to total lipids ratio in small LDL
Healthy aging
Heptachlor levels
Cholesteryl ester levels in very large VLDL
Phospholipids to total lipids ratio in small LDL
Docosapentaenoylcarnitine (C22:5n3) levels
Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels
Cortolone glucuronide (1) levels
Phosphatidylcholine (O-18:1/20:4, O-16:0/22:5n3) levels
5-dodecenoylcarnitine (C12:1) levels
Hydroxy-cmpf levels
3-hydroxyoleate levels
Dodecenedioate (C12:1-DC) levels
3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) levels
3-hydroxybutyroylglycine levels
Glyco-beta-muricholate levels
Sphingomyelin (d17:1/14:0, d16:1/15:0) levels
Tetradecadienoate (14:2) levels
Dodecadienoate (12:2) levels
11beta-hydroxyandrosterone glucuronide levels
4-methylhexanoylglutamine levels
Lithocholate sulfate (1) levels
Tetrahydrocortisol sulfate (1) levels
Hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) levels
Pregnenetriol sulfate levels
Water consumption (glasses per day) (UKB data field 1528)
Undecenoylcarnitine (C11:1) levels
3-decenoylcarnitine levels
3-hydroxydecanoylcarnitine levels
Palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0) levels
Picolinoylglycine levels
(2 or 3)-decenoate (10:1n7 or n8) levels
Deoxycholic acid (12 or 24)-sulfate levels
Oleoyl ethanolamide levels
Estrone 3-sulfate levels
Choline levels
1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels
Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)
Red wine consumption (glasses per month) (UKB data field 1578, 4419)
Beer or cider consumption (glasses per month) (UKB data field 1578, 4420)
Alcohol consumption (drinks per month) (UKB data field 1578, 4424)
Heptachlor epoxide levels
1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) levels
1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels
Stearoyl sphingomyelin (d18:1/18:0) levels
N-stearoyl-sphingosine (d18:1/18:0) levels
9,10-DiHOME levels
Eicosapentaenoate (EPA; 20:5n3) levels
Arachidonate (20:4n6) levels
3-hydroxybutyrate (bhba) levels
Cholesterol levels
Choline phosphate levels
Sphingosine levels
Deoxycholate levels
Glutarate (C5-DC) levels
Cortisol levels
Bipolar disorder type I vs bipolar disorder type II
Triacylglycerol (54:4) [NL-18:0] levels
Gamma-glutamyl-epsilon-lysine levels in elite athletes
Gamma-glutamylalanine levels in elite athletes
Gamma-glutamylglycine levels in elite athletes
S-adenosylhomocysteine (SAH) levels in elite athletes
Gamma-glutamylhistidine levels in elite athletes
Longitudinal body mass index
Longitudinal waist-hip ratio
Ovarian cyst
Triacylglycerol (58:8) [NL-22:6] levels
Alkyldiacylglycerol (O-50:1) [NL-16:0] levels
Alkyldiacylglycerol (O-52:0) [NL-16:0] levels
Total Acylcarnitine levels
Gamma-glutamyltryptophan levels in elite athletes
Histidylalanine levels in elite athletes
Salicylate levels in elite athletes
Sarcosine levels in elite athletes
Total Dehydrocholesteryl ester levels
Total GM1 ganglioside levels
Cardiovascular death or hospitalisation in heart failure
Cardiovascular death or hospitalisation in heart failure treated with candesartan
Pediatric asthma
Total Lysophosphatidylcholine levels
Total Lysoalkenylphosphatidylethanolamine levels
Total Lysophosphatidylinositol levels
Leucylalanine levels in elite athletes
Leucylglycine levels in elite athletes
Serine levels in elite athletes
Serotonin levels in elite athletes
N-acetylcarnosine levels in elite athletes
Phenylacetylglutamate levels in elite athletes
Prolylglycine levels in elite athletes
Threonylphenylalanine levels in elite athletes
Valylglutamine levels in elite athletes
Valylglycine levels in elite athletes
Valylleucine levels in elite athletes
Pneumothorax
Total Oxidized sterol ester levels
Total Alkenylphosphatidylethanolamine levels
1,2,3-benzenetriol sulfate (2) levels in elite athletes
1,3-dimethylurate levels in elite athletes
2-aminophenol sulfate levels in elite athletes
2-hydroxyhippurate (salicylurate) levels in elite athletes
2-oxindole-3-acetate levels in elite athletes
2-piperidinone levels in elite athletes
2,3-dihydroxyisovalerate levels in elite athletes
3-(3-hydroxyphenyl)propionate sulfate levels in elite athletes
3-(3-hydroxyphenyl)propionate levels in elite athletes
Myalgic encephalomyelitis / chronic fatigue syndrome
Pyroglutamic acid levels
Metabolite peak levels (QI1001)
Metabolite peak levels (QI10057)
Metabolite peak levels (QI1027)
Metabolite peak levels (QI10291)
Metabolite peak levels (QI10309)
Metabolite peak levels (QI10524)
Metabolite peak levels (QI10664)
Metabolite peak levels (QI10705)
Metabolite peak levels (QI1071)
Metabolite peak levels (QI10761)
Metabolite peak levels (QI10834)
Metabolite peak levels (QI1087)
Metabolite peak levels (QI10958)
Metabolite peak levels (QI10969)
Metabolite peak levels (QI10980)
Metabolite peak levels (QI10992)
Metabolite peak levels (QI11083)
Metabolite peak levels (QI11242)
Triglycerides to total lipids ratio in medium HDL
Cholesterol levels in medium LDL
Cholesteryl ester levels in medium LDL
Triacylglycerol (51:2) [NL-15:0] levels
Metabolite peak levels (QI9389)
Metabolite peak levels (QI15385)
Metabolite peak levels (QI15436)
Metabolite peak levels (QI15464)
Metabolite peak levels (QI15493)
Metabolite peak levels (QI15502)
Metabolite peak levels (QI15517)
Metabolite peak levels (QI15536)
Metabolite peak levels (QI15545)
Metabolite peak levels (QI15563)
Metabolite peak levels (QI15571)
Metabolite peak levels (QI1631)
Metabolite peak levels (QI9489)
Metabolite peak levels (QI9499)
Metabolite peak levels (QI9508)
Metabolite peak levels (QI9509)
Metabolite peak levels (QI961)
Metabolite peak levels (QI9645)
Metabolite peak levels (QI9655)
Neuropeptide Y autoantibody levels in type 1 diabetes
Acidic leucine-rich nuclear phosphoprotein 32 family member B levels
Severe COVID-19 disease
Free cholesterol to total lipids ratio in medium LDL
Total lipid levels in medium LDL
White matter mean diffusivity x age interaction (2df)
Synaptosomal-associated protein 25 levels
Oxidized low-density lipoprotein receptor 1 levels
Interleukin-12 receptor subunit beta-2 levels
Phosphoglucomutase-1 levels
Malate dehydrogenase, cytoplasmic levels
Nidogen-2 levels
Performance intelligence quotient
Leucine-rich repeat serine/threonine-protein kinase 2 levels
Proprotein convertase subtilisin/kexin type 9 levels
Cholesteryl esters to total lipids ratio in medium LDL
Free cholesterol levels in medium LDL
Heat shock protein beta-1 levels
Cholesterol to total lipids ratio in medium LDL
Bone morphogenetic protein 10 levels
Insulin-like growth factor-binding protein 5 levels
Aminoacylase-1 levels
T-lymphocyte activation antigen CD86 levels
Connective tissue growth factor levels
Thrombin levels
Complement component C6 levels
C34 gp41 HIV Fragment levels
Transgelin-2 levels
Kidney disese (macroalbuminuria or end-stage renal disease) in diabetes
End-stage renal disease in diabetes
Kidney disease (end stage renal disease vs macroalbuminuria) in diabetes
Kidney disease (end stage renal disease or macroalbuminuria or microalbuminuria) in diabetes
Microalbuminuria in diabetes
Reduced eGFR in diabetes
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in diabetes
Glucose-6-phosphate isomerase levels
Urokinase-type plasminogen activator levels
Platelet-derived growth factor receptor alpha levels
Gamma-enolase levels
Osteocalcin levels
Interleukin-10 receptor subunit alpha levels
Signal transducer and activator of transcription 3 levels
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic levels
HemK methyltransferase family member 2 levels
Regenerating islet-derived protein 4 levels
Trefoil factor 1 levels
High affinity immunoglobulin gamma Fc receptor I levels
Mitogen-activated protein kinase 8 levels
Serine/threonine-protein kinase 16 levels
Complement component C1q receptor levels
Formimidoyltransferase-cyclodeaminase levels
Alpha-2-macroglobulin levels
Protein Wnt-7a levels
Toll-like receptor 2 levels
Mental disorders (time to event)
Depression (time to event)
Substance use disorders (time to event)
E3 ubiquitin-protein ligase RNF43 levels
Glial cell line-derived neurotrophic factor levels
Interleukin-18-binding protein levels
N-acetylglucosamine-6-sulfatase levels
Lumican levels
Phosphatidylethanolamine-binding protein 1 levels
dCTP pyrophosphatase 1 levels
72 kDa type IV collagenase levels
Protein disulfide-isomerase levels
Sonic hedgehog protein levels
Protein S100-A4 levels
White matter fractional anisotropy x age interaction (2df)
Cataract
Beta-2-microglobulin levels
Circulating docosahexaenoic acid levels
Neural cell adhesion molecule L1-like protein levels
Dipeptidyl peptidase 2 levels
Opioid-binding protein/cell adhesion molecule levels
SLAM family member 5 levels
Dickkopf-like protein 1 levels
Calcineurin subunit B type 1 levels
1-palmitoleoylglycerophosphocholine levels (Biocrates platform)
1-palmitoylglycerophosphocholine levels (Biocrates platform)
1-stearoylglycerophosphocholine levels (Biocrates platform)
2-linoleoylglycerophosphocholine levels (Biocrates platform)
Palmitoylcarnitine levels (Biocrates platform)
Stearoylcarnitine levels (Biocrates platform)
2-oleoylglycerophosphocholine levels (Biocrates platform)
2-palmitoylglycerophosphocholine levels (Biocrates platform)
2-stearoylglycerophosphocholine levels (Biocrates platform)
Proline levels (Biocrates platform)
Valine levels (Biocrates platform)
1-arachidonoylglycerophosphocholine levels (Metabolon platform)
1-linoleoylglycerophosphoethanolamine levels
1-methylurate levels
1-methylxanthine levels
1-palmitoylglycerophosphoinositol levels
1-stearoylglycerol (1-monostearin) levels
1-stearoylglycerophosphocholine levels (Metabolon platform)
1,3,7-trimethylurate levels
2-aminobutyrate levels
3-(cystein-S-yl)acetaminophen levels
Aspartylphenylalanine levels
Butyrylcarnitine levels (Metabolon platform)
Carnitine levels (Metabolon platform)
Decanoylcarnitine levels (Metabolon platform)
Acetylcarnitine levels (Metabolon platform)
Propionylcarnitine levels (Metabolon platform)
Isovalerylcarnitine levels (Metabolon platform)
Hexanoylcarnitine levels (Metabolon platform)
Octanoylcarnitine levels (Metabolon platform)
Gamma-glutamylglutamine levels
Glutamine levels (Metabolon platform)
Glycine levels (Metabolon platform)
Glycochenodeoxycholate levels
Glucose levels (Metabolon platform)
Histidine levels (Metabolon platform)
Tyrosine-protein kinase Fgr levels
Serine/threonine-protein kinase PAK 6 levels
Hydroxysphingomyeline C24:1 levels
Succinylcarnitine levels
Thymol sulfate levels
Tryptophan levels (Metabolon platform)
X-02249 levels
X-04498 levels
X-08988 levels
X-10510 levels
X-11244 levels
Advanced glycosylation end product-specific receptor, soluble levels
X-14632 levels
Xleu levels
Proline levels (Metabolon platform)
Valine levels (Metabolon platform)
Tyrosine levels (Metabolon platform)
Laurylcarnitine levels (Metabolon platform)
Threonine levels (Metabolon platform)
Methionine levels (Metabolon platform)
Phenylalanine levels (Metabolon platform)
Arginine levels (Metabolon platform)
Serine levels (Metabolon platform)
2-tetradecenoyl carnitine levels (Metabolon platform)
Oleoylcarnitine levels (Metabolon platform)
1-palmitoleoylglycerophosphocholine levels (Metabolon platform)
Glutaroyl carnitine levels (Metabolon platform)
1-myristoylglycerophosphocholine levels (Metabolon platform)
Hydroxyisovaleroyl carnitine levels (Metabolon platform)
2-linoleoylglycerophosphocholine levels (Metabolon platform)
1-linoleoylglycerophosphocholine levels (Metabolon platform)
1-eicosatrienoylglycerophosphocholine levels (Metabolon platform)
1-oleoylglycerophosphocholine levels (Metabolon platform)
2-oleoylglycerophosphocholine levels (Metabolon platform)
Palmitoylcarnitine levels (Metabolon platform)
Stearoylcarnitine levels (Metabolon platform)
1-heptadecanoylglycerophosphocholine levels (Metabolon platform)
X-11255 levels
X-11421 levels
X-11440 levels
X-11469 levels
X-11529 levels
X-11538 levels
X-11792 levels
X-11793 levels
X-11818 levels
X-12063 levels
X-12092 levels
X-12093 levels
X-12435 levels
X-12510 levels
X-12844 levels
X-13215 levels
X-13429 levels
X-13435 levels
X-14086 levels
X-14208 levels
Inosine levels
Isobutyrylcarnitine (c4) levels
Laurate (12:0) levels
Mannose levels
N-(2-furoyl)glycine levels
Ornithine levels (Metabolon platform)
Serotransferrin levels
Heterogeneous nuclear ribonucleoprotein Q levels
Eukaryotic translation initiation factor 4 gamma 2 levels
Nucleoside diphosphate kinase B levels
X-12125 levels
X-12127 levels
X-12216 levels
X-12456 levels
X-12689 levels
X-12707 levels
X-12713 levels
X-12816 levels
Added salt consumption
Drink temperature
Mercuric chloride-2 levels
Methoxychlor levels
Crohn's disease x smoking status (never vs ever smoking) interaction
Ulcerative colitis x smoking status (never vs ever smoking) interaction
Inflammatory bowel disease x smoking status (never vs ever smoking) interaction
Crohn's disease x smoking status (never vs current smoking) interaction
Ulcerative colitis x smoking status (never vs current smoking) interaction
Inflammatory bowel disease x smoking status (never vs current smoking) interaction
Crohn's disease x smoking status (never vs former smoking) interaction
Ulcerative colitis x smoking status (never vs former smoking) interaction
Inflammatory bowel disease x smoking status (never vs former smoking) interaction
3,7-dimethylurate levels
1,7-dimethylurate levels
Homostachydrine levels
3-(3-hydroxyphenyl)propionate levels
4-vinylphenol sulfate levels
4-ethylphenylsulfate levels
4-allylphenol sulfate levels
Ergothioneine levels
Sulfate levels
Solanidine levels
Mannonate levels
3-methyl catechol sulfate (1) levels
Indolin-2-one levels
Free testosterone levels
Environmental pollutants exposure (POD high)
Insomnia in migraine with aura
Insomnia in migraine without aura
Vanillactate levels
P-cresol glucuronide levels
Glucuronide of piperine metabolite C17H21NO3 (3) levels
Glucuronide of piperine metabolite C17H21NO3 (4) levels
Glucuronide of piperine metabolite C17H21NO3 (5) levels
Sulfate of piperine metabolite C18H21NO3 (1) levels
2-naphthol sulfate levels
4-allylcatechol sulfate levels
2-hydroxyfluorene sulfate levels
2,6-dihydroxybenzoic acid levels
3-ethylcatechol sulfate (1) levels
3,5-dichloro-2,6-dihydroxybenzoic acid levels
(S)-a-amino-omega-caprolactam levels
3-bromo-5-chloro-2,6-dihydroxybenzoic acid levels
N-acetyl-4-chlorophenylalanine levels
Gluconate levels
Salicylate levels
Caffeine levels
Cholesteryl ester levels in small LDL
Environmental pollutants exposure (RfD high)
Environmental pollutants exposure (RfD low)
2-hydroxypalmitate levels
Docosapentaenoate (n6 DPA; 22:5n6) levels
2-methylmalonylcarnitine (C4-DC) levels
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-hoca) levels
3beta,7alpha-dihydroxy-5-cholestenoate levels
Tetradecanedioate (C14-DC) levels
Hexadecanedioate (C16-DC) levels
Octadecanedioate (C18-DC) levels
1-myristoylglycerol (14:0) levels
2-palmitoyl-GPE (16:0) levels
1-arachidonoyl-GPI (20:4) levels
1-palmitoyl-GPI (16:0) levels
Glycolithocholate sulfate levels
2-arachidonoyl-GPE (20:4) levels
Total lipid levels in small LDL
Risk-taking behavior (multivariate analysis)
X-23636 levels
X-23639 levels
X-23641 levels
X-23644 levels
X-23666 levels
X-23739 levels
X-23780 levels
X-23782 levels
X-23787 levels
X-23974 levels
X-24295 levels
X-24309 levels
X-24328 levels
X-24337 levels
Parathion levels
Principal component-derived dietary pattern 3
Moderate physical activity
Accelerometer measured moderate to vigorous physical activity
Kynurenate levels
Maltotriose levels
Ribitol levels
1,5-anhydroglucitol (1,5-ag) levels
Ribonate levels
Galactonate levels
Erythronate levels
Mannitol/sorbitol levels
Arabonate/xylonate levels
Arabitol/xylitol levels
N-acetylglucosamine/n-acetylgalactosamine levels
Ribulonate/xylulonate/lyxonate levels
Glycerate levels
N-acetylneuraminate levels
Free cholesterol levels in small LDL
Free cholesterol to total lipids ratio in small LDL
2-linoleoyl-GPE (18:2) levels
1-oleoyl-GPI (18:1) levels
1-linoleoyl-GPI (18:2) levels
1-palmitoleoyl-GPI (16:1) levels
1-stearoyl-2-oleoyl-GPE (18:0/18:1) levels
Glycosyl-N-stearoyl-sphingosine (d18:1/18:0) levels
Hearing loss
Concentration of small LDL particles
ACE-inhibitor discontinuation
Cholesteryl esters to total lipids ratio in small VLDL
Sleep health score
Free cholesterol to total lipids ratio in small VLDL
Premature atrial contraction frequency
Urinary microalbumin levels
Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy)
Male infertility (Sertoli cell-only)
Unsuccessful sperm retrieval in biopsy
Late-onset Alzheimer's disease in high risk polygenic risk score
Total lipid levels in small VLDL
Concentration of small VLDL particles
1-linolenoyl-GPE (18:3) levels
1-palmitoyl-GPG (16:0) levels
Sphingomyelin (d18:1/24:1, d18:2/24:0) levels
Octadecenedioylcarnitine (C18:1-DC) levels
Cholesterol levels in small VLDL
Depression, cognition and memory (multivariate analysis)
Glycated hemoglobin HbA1c levels
Triglyceride levels in small LDL
Triglycerides to total lipids ratio in small LDL
Early neurological instability after acute ischemic stroke
FGF21 levels in alcohol use disorder
Cholesterol to total lipids ratio in small VLDL
Cholesteryl ester levels in small VLDL
Pulse rate
Angiopoietin-related protein 1 levels
Angiopoietin-related protein 7 levels
DNA-(apurinic or apyrimidinic site) lyase levels
Amyloid-like protein 1 levels
Aminopeptidase N levels
Tyrosine-protein kinase receptor UFO levels
Azurocidin levels
Bleomycin hydrolase levels
Bone morphogenetic protein 6 levels
Carbonic anhydrase 5A,mitochondrial levels
Lysophosphatidic acid phosphatase type 6 levels
Protein AMBP levels
Bone stiffness index
LDL cholesterol x thiazide diuretic use interaction
Opioid addiction
Ratio of triglycerides to phosphoglycerides
Osteocalcin level (CSF)
FCG2B level (CSF)
YKL-40 level (CSF)
ECM1 level (CSF)
Hemopexin level (CSF)
CAMK1 level (CSF)
MMEL2 level (CSF)
sTie-1 level (CSF)
complement factor H-related 5 level (CSF)
IL-6 sRa level (CSF)
Cathepsin S level (CSF)
P-Selectin level (CSF)
6-Phosphogluconate dehydrogenase level (CSF)
Nidogen level (CSF)
PIGR level (CSF)
CD5L level (CSF)
CNTN2 level (CSF)
AK1A1 level (CSF)
sL-Selectin level (CSF)
TFPI level (CSF)
IL-18 Ra level (CSF)
PPAC level (CSF)
NAGK level (CSF)
IL-1 R4 level (CSF)
SLPI level (CSF)
Collectin Kidney 1 level (CSF)
ASM3A level (CSF)
CAPG level (CSF)
TSG-6 level (CSF)
FAM3D level (CSF)
6Ckine level (CSF)
MCP-1 level (CSF)
IL-1 R AcP level (CSF)
LAG-1 level (CSF)
REG4 level (CSF)
LRP8 level (CSF)
LYNB level (CSF)
Chitotriosidase-1 level (CSF)
FLRT2 level (plasma)
ISLR2 level (plasma)
CD97 level (plasma)
DC-SIGN level (plasma)
ATS13 level (plasma)
FCN2 level (plasma)
sE-Selectin level (plasma)
TLR4:MD-2 complex level (plasma)
VEGF sR2 level (plasma)
complement factor H-related 5 level (plasma)
Tenascin level (plasma)
ASAH2 level (plasma)
LY86 level (plasma)
MYPC1 level (plasma)
b-Endorphin level (plasma)
P-Cadherin level (plasma)
Contactin-5 level (plasma)
ASAHL level (plasma)
RAP level (plasma)
MIC-1 level (plasma)
SPARCL1 level (plasma)
BST1 level (plasma)
MK11 level (plasma)
IL-23 level (plasma)
SEM5A level (plasma)
C7 level (plasma)
BGH3 level (plasma)
PDGF Rb level (plasma)
ARTS1 level (plasma)
TIMD3 level (plasma)
HGH level (plasma)
Calpain I level (plasma)
MICA level (plasma)
TSP2 level (plasma)
IGF-II receptor level (plasma)
CK-MB level (plasma)
B7-H1 level (plasma)
calreticulin level (plasma)
INGR2 level (plasma)
UBP25 level (plasma)
protein Z inhibitor level (plasma)
Coactosin-like protein level (plasma)
EphB6 level (plasma)
Semaphorin 3E level (plasma)
Lectin, mannose-binding 2 level (plasma)
FAM3D level (plasma)
Total lipid levels in lipoprotein particles
TXD12 level (plasma)
HRG level (plasma)
MP2K4 level (plasma)
CD27 level (plasma)
Cripto level (plasma)
CREL1 level (plasma)
HMGN1 level (plasma)
Gro-a level (plasma)
IDUA level (plasma)
Total fatty acid levels
Serum glutamic-oxaloacetic transaminase levels
Chymotrypsin C levels
Pro-cathepsin H levels
Cathepsin O levels
Protein delta homolog 1 levels
Cadherin-related family member 5 levels
Carcinoembryonic antigenrelated cell adhesion molecule 8 levels
Chordin-like protein 2 levels
C-type lectin domain family 5 member A levels
CXADR-like membrane protein levels
Calsyntenin-2 levels
Clusterin-like protein 1 levels
Carboxypeptidase A1 levels
Carboxypeptidase B levels
Angiotensin-converting enzyme 2 levels
Phospholipids to total lipids ratio in small VLDL
Paired immunoglobulin-like type 2 receptor beta levels
Perlecan levels
Paraoxonase levels
Prolargin levels
AFP levels
Triglycerides to total lipids ratio in small VLDL
Orbital telorism
Maximum habitual alcohol consumption (MTAG)
Opioid use disorder (broad)
Tongue microbiota abundance (Prevotella_buccalis_SGB_3005)
Tongue microbiota abundance (Prevotella_denticola_SGB_3531)
Tongue microbiota abundance (Prevotella_jejuni_SGB_2431)
Tongue microbiota abundance (Prevotella_sp000599605_SGB_134)
Tongue microbiota abundance (Prevotella_veroralis_SGB_161)
Tongue microbiota abundance (Prevotella_unclassified_SGB_144)
Tongue microbiota abundance (Solobacterium_unclassified_SGB_315)
Tongue microbiota abundance (Streptococcus_unclassified_SGB_2253)
Tongue microbiota abundance (Streptococcus_unclassified_SGB_3019)
Tongue microbiota abundance (Oribacterium_unclassified_SGB_1215)
Tongue microbiota abundance (Oribacterium_unclassified_SGB_3339)
Tongue microbiota abundance (Oribacterium_unclassified_SGB_489)
Tongue microbiota abundance (F0422_unclassified_SGB_392)
Tongue microbiota abundance (Veillonella_unclassified_SGB_1075)
Tongue microbiota abundance (Veillonella_unclassified_SGB_3585)
Tongue microbiota abundance (Fusobacterium_unclassified_SGB_1140)
Tongue microbiota abundance (Neisseria_flavescens_SGB_3307)
Tongue microbiota abundance (Neisseria_unclassified_SGB_1962)
Tongue microbiota abundance (Neisseria_unclassified_SGB_3316)
Saliva microbiota abundance (Eggerthia)
Saliva microbiota abundance (Saccharimonas_unclassified_SGB_271)
Saliva microbiota abundance (Oribacterium_unclassified_SGB_3339)
C4b level (CSF)
ULBP-3 level (CSF)
Siglec-3 level (CSF)
granzyme A level (CSF)
MDC level (CSF)
GNS level (CSF)
LY86 level (CSF)
SLAF5 level (CSF)
IGF-II receptor level (CSF)
MFRP level (CSF)
HPLN1 level (CSF)
TSP4 level (CSF)
PDGF Rb level (CSF)
Endocan level (CSF)
ARTS1 level (CSF)
TIMD3 level (CSF)
IL-9 level (CSF)
BCL6 level (CSF)
IL-1F6 level (CSF)
Total concentration of branched-chain amino acids (leucine + isoleucine + valine)
Meteorin-like protein levels
Matrix metalloproteinase-2 levels
Nectin-2 levels
Nodal modulator 1 levels
Neuronal pentraxin receptor levels
Platelet-derived growth factor subunit A levels
Kynurenine-oxoglutarate transaminase 1 levels
Low-density lipoprotein receptor levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels
Lipoprotein lipase levels
Leucine-rich repeats and immunoglobulin-like domains protein 1 levels
Low-density lipoprotein receptor-related protein 11 levels
Lymphotoxin-beta receptor levels
Macrophage receptor MARCO levels
Multiple coagulation factor deficiency protein 2 levels
Meprin A subunit beta levels
Tyrosine-protein kinase Mer levels
MSP plasma levels
NT proBNP plasma levels
Omentin plasma levels
PARC plasma levels
PECAM 1 plasma levels
PEDF plasma levels
PON 1 plasma levels
Progranulin plasma levels
PSP94 plasma levels
RANTES plasma levels
SAA plasma levels
SHBG plasma levels
SP D plasma levels
ST2 plasma levels
TAFI plasma levels
TATI plasma levels
TECK plasma levels
Tetranectin plasma levels
TFR1 plasma levels
THP plasma levels
TIE 2 plasma levels
TIMP 3 plasma levels
TN X plasma levels
TRAIL R3 plasma levels
Vaspin plasma levels
FAS plasma levels
Fetuin A plasma levels
Ficolin 3 plasma levels
Galectin 3 plasma levels
GDF 15 plasma levels
Haptoglobin plasma levels
HCC 4 plasma levels
IGFBP 3 plasma levels
IL 18 plasma levels
IL 1RI plasma levels
IL 1RII plasma levels
IL 2 receptor_alpha plasma levels
IL 6r plasma levels
Kallikrein 5 plasma levels
Lp a plasma levels
LRG1 plasma levels
MCP 2 plasma levels
MIF plasma levels
MIP 1_beta plasma levels
MMP 1 plasma levels
MMP 10 plasma levels
MMP 3 plasma levels
MMP 7 plasma levels
MPIF 1 plasma levels
MSLN plasma levels
ACE plasma levels
AGP 1 plasma levels
Angiogenin plasma levels
Apo C_I plasma levels
Apo E plasma levels
Apo H plasma levels
CA 15 3 plasma levels
Cathepsin D plasma levels
CD40 plasma levels
CD5L plasma levels
CEACAM6 plasma levels
CFH plasma levels
CFHR1 plasma levels
cFib plasma levels
CTSB plasma levels
Cystatin B plasma levels
DBH plasma levels
E Cad plasma levels
E Selectin plasma levels
EGF plasma levels
ENA 78 plasma levels
Endostatin plasma levels
Eotaxin 2 plasma levels
ErbB3 plasma levels
Saturated fatty acid levels
VDBP plasma levels
VEGF plasma levels
VEGFR 2 plasma levels
VEGFR 3 plasma levels
YKL 40 plasma levels
PSMA level (CSF)
PolyUbiquitin K63 level (CSF)
MMP-8 level (CSF)
CATF level (CSF)
IL-22 level (CSF)
vWF level (CSF)
Cathepsin A level (CSF)
CD39 level (CSF)
NET4 level (CSF)
CLC7A level (CSF)
OLR1 level (CSF)
PHI level (CSF)
PLXC1 level (CSF)
Lysozyme level (CSF)
GRN level (CSF)
CLM6 level (CSF)
Coagulation Factor VII level (CSF)
Periostin level (CSF)
Esterase D level (CSF)
GPC5 level (CSF)
Peroxiredoxin-6 level (CSF)
GPC6 level (CSF)
Galectin-3 level (CSF)
Heparin cofactor II level (CSF)
NID2 level (CSF)
Plasminogen level (CSF)
IL-16 level (CSF)
Cathepsin H level (CSF)
Glutathione S-transferase Pi level (CSF)
IMDH1 level (CSF)
Thioredoxin domain-containing protein 5 levels
Thymidine phosphorylase levels
Versican core protein levels
V-set and immunoglobulin domain-containing protein 2 levels
X-C motif chemokine ligand 1 levels
Ratio of saturated fatty acids to total fatty acids
Siglec-9 level (CSF)
DC-SIGN level (CSF)
GPVI level (CSF)
TrATPase level (CSF)
FSTL3 level (CSF)
14-3-3 level (CSF)
sICAM-1 level (CSF)
MIC-1 level (CSF)
EMR2 level (CSF)
FUT5 level (CSF)
HCG level (CSF)
phosphoglycerate kinase 1 level (CSF)
ILT-2 level (CSF)
SIG14 level (CSF)
Apo E2 level (CSF)
CKAP2 level (CSF)
RUXF level (CSF)
14-3-3 protein zeta/delta level (CSF)
PSME1 level (CSF)
UB2G2 level (CSF)
QORL1 level (CSF)
Vitronectin level (CSF)
MPIF-1 level (CSF)
Carbonic Anhydrase IV level (CSF)
WFKN2 level (CSF)
MIP-5 level (CSF)
HCC-4 level (CSF)
SREC-I level (CSF)
Keratin 18 level (CSF)
LEG9 level (CSF)
HEMK2 level (CSF)
SMOC1 level (CSF)
MIA level (CSF)
EMAP-2 level (CSF)
Siglec-7 level (CSF)
Kallikrein 11 level (CSF)
kallikrein 8 level (CSF)
Luteinizing hormone level (CSF)
AREG level (CSF)
PTP-1B level (CSF)
Protein C level (CSF)
VEGF sR3 level (CSF)
B7-H2 level (CSF)
TAJ level (CSF)
FAM3B level (CSF)
IFN-a/b R1 level (CSF)
Apo L1 level (CSF)
IL-17 sR level (CSF)
Arylsulfatase A level (CSF)
Protein disulfide isomerase A3 level (CSF)
PDGFRA level (plasma)
YKL-40 level (plasma)
NPS-PLA2 level (plasma)
FGF-19 level (plasma)
Hemopexin level (plasma)
Angiopoietin-1 level (plasma)
IL-1 sRII level (plasma)
C1QR1 level (plasma)
Hat1 level (plasma)
PPAC level (plasma)
IL-1 R4 level (plasma)
KYNU level (plasma)
Nogo Receptor level (plasma)
Coagulation Factor XI level (plasma)
VEGF sR3 level (plasma)
IL-1 R AcP level (plasma)
IL-17 RD level (plasma)
BASI level (plasma)
Endothelin-converting enzyme 1 level (plasma)
WIF-1 level (plasma)
amyloid precursor protein level (plasma)
Cathepsin S level (plasma)
GPC2 level (plasma)
TFPI level (plasma)
CAMK1 level (plasma)
Chitotriosidase-1 level (plasma)
IgE level (plasma)
IL-6 sRa level (plasma)
AK1A1 level (plasma)
FCRL3 level (plasma)
DERM level (plasma)
GRN level (plasma)
IFN-g level (CSF)
ART level (CSF)
Haptoglobin, Mixed Type level (CSF)
Nectin-like protein 2 level (CSF)
TPSB2 level (CSF)
MMP-2 level (CSF)
IL-34 level (CSF)
BMP-6 level (CSF)
Total concentration of lipoprotein particles
Drusen volume within a central 3 mm circle (model 2)
Ephrin type-B receptor 4 levels
Fatty acid-binding protein,intestinal levels
Fc receptor-like protein 1 levels
Fibroblast growth factor 21 levels
Growth/differentiation factor 2 levels
Gastric intrinsic factor levels
Lactoylglutathione lyase levels
Serum glutamic-pyruvic transaminase levels
Anxiety (GAD-7 score) x environmental factor score interaction
Anxiety x environmental factor score interaction
Depression (PHQ-9 score) x environmental factor score interaction
Depression x environmental factor score interaction
C-C motif chemokine 24 levels
Sialomucin core protein 24 levels
T-cell surface glycoprotein CD1c levels
CD2-associated protein levels
T-cell surface glycoprotein CD4 levels
Dihydropteridine reductase levels
Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels
Syndecan-4 levels
Serpin A12 levels
Peptic ulcers
Anti-measles virus IgG levels
Anti-Toxoplasma gondii IgG levels
Anti-beta-casein IgG levels
Anti-Epstein Barr IgG levels
Anti-feline herpes IgG levels
Anti-influenza subtype H1N1 IgG levels
Anti-influenza subtype H3N2 IgG levels
Anti-saccharomyces cerevisiae IgA levels
COVID-19 susceptibility
Opioid addiction (multi-trait analysis)
CD30 Ligand level (CSF)
sE-Selectin level (CSF)
DPP2 level (CSF)
TLR4:MD-2 complex level (CSF)
Tenascin level (CSF)
Gelsolin level (CSF)
B7-H1 level (CSF)
FSH level (CSF)
ASAH2 level (CSF)
ARMEL level (CSF)
Cyclophilin F level (CSF)
Fas, soluble level (CSF)
Testican-2 level (CSF)
NRP1 level (CSF)
MICB level (CSF)
DLL1 level (CSF)
ERBB1 level (CSF)
HGF level (CSF)
NADPH-P450 Oxidoreductase level (CSF)
BAFF level (CSF)
TIG2 level (CSF)
EphA1 level (CSF)
PYY level (CSF)
PUR8 level (CSF)
GPNMB level (CSF)
Semaphorin 3E level (CSF)
HSP 60 level (CSF)
Cathepsin B level (CSF)
TNFSF15 level (CSF)
ATS13 level (CSF)
3HAO level (CSF)
ERBB3 level (CSF)
Layilin level (CSF)
FGF-19 level (CSF)
Cystatin M level (CSF)
Spondin-1 level (CSF)
PCSK7 level (CSF)
C1-Esterase Inhibitor level (CSF)
CDON level (CSF)
Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)
Factor B level (CSF)
FGF7 level (CSF)
NCC27 level (CSF)
PAFAH level (CSF)
Drusen area within a central 3 mm circle (model 1)
Drusen volume within a central 3 mm circle (model 1)
Drusen area within a central 5 mm circle (model 2)
Drusen volume within a central 5 mm circle (model 2)
Drusen area within a central 3 mm circle (model 2)
Geographic atrophy within a central 5 mm circle (model 1)
Drusen area within a central 5 mm circle (model 1)
Drusen volume within a central 5 mm circle (model 1)
N-linoleoyl ethanolamide levels
N-palmitoyl ethanolamide levels
N-vaccinoyl ethanolamide levels
Total ethanolamine levels
Ceramide [N(22)S(19)] levels
Ceramide [N(23)S(20)] levels
Ceramide [N(24)DS(19)] levels
Ceramide [N(24)DS(20)] levels
Ceramide [N(24)S(16)] levels
Ceramide [N(24)S(19)] levels
Ceramide [N(24)S(20)] levels
Ceramide [N(26)S(19)] levels
Ceramide [N(24)S(19)] product-precursor ratio
Total Ceramide [S19] levels
Total Ceramide [S20] levels
N-docosahexaenoyl ethanolamide levels
Thimet oligopeptidase levels
Thrombopoietin levels
Metalloproteinase inhibitor 4 levels
Trem-like transcript 2 protein levels
Tumor necrosis factor receptor superfamily member 10A levels
Tumor necrosis factor receptor superfamily member 10C levels
Tumor necrosis factor receptor superfamily member 11A levels
Tumor necrosis factor receptor superfamily member 13B levels
Tumor necrosis factor receptor superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 13B levels
Transferrin receptor protein 1 levels
Serpin B6 levels
Serpin B8 levels
Sortilin levels
Sclerostin levels
Spondin-2 levels
Scavenger receptor cysteine-rich domain-containing group B protein levels
Sulfatase-modifying factor 2 levels
Cripto level (CSF)
CREL1 level (CSF)
Osteopontin level (CSF)
IDUA level (CSF)
ASAHL level (CSF)
BSP level (CSF)
HGFA level (CSF)
Prekallikrein level (CSF)
BST1 level (CSF)
CBPE level (CSF)
EGF level (CSF)
Growth hormone receptor level (CSF)
Coagulation Factor V level (CSF)
Galectin-8 level (CSF)
DERM level (CSF)
PCSK9 level (CSF)
Caspase-10 level (CSF)
sLeptin R level (CSF)
SLAF7 level (CSF)
N-terminal pro-BNP level (CSF)
IL-1 sRII level (CSF)
CXCL16, soluble level (CSF)
sFRP-3 level (CSF)
IL-1 sRI level (CSF)
Granulysin level (CSF)
Endothelin-converting enzyme 1 level (CSF)
MSP level (CSF)
TXD12 level (CSF)
Nr-CAM level (CSF)
Semaphorin 3A level (plasma)
WFKN2 level (plasma)
SREC-I level (plasma)
TGF-b R III level (plasma)
HEMK2 level (plasma)
MIA level (plasma)
TECK level (plasma)
Siglec-6 level (plasma)
SPINT2 level (plasma)
Luteinizing hormone level (plasma)
Siglec-3 level (plasma)
GPVI level (plasma)
sICAM-1 level (plasma)
Fucosyltransferase 3 level (plasma)
G-CSF level (plasma)
HCG level (plasma)
Moesin level (plasma)
ILT-2 level (plasma)
SIG14 level (plasma)
BAFF Receptor level (plasma)
PSME1 level (plasma)
QORL1 level (plasma)
FLRT3 level (plasma)
Protein C level (plasma)
C4b level (brain)
SMAD2 level (brain)
GPNMB level (brain)
Ferritin level (brain)
NXPH1 level (brain)
MED-1 level (brain)
LRIG3 level (brain)
Cystatin-S level (brain)
Fas, soluble level (brain)
S100A12 level (brain)
NET1 level (brain)
UFC1 level (brain)
SAA level (brain)
Glutathione S-transferase Pi level (brain)
OAS1 level (brain)
ILT-4 level (brain)
COLEC12 level (brain)
PSP level (brain)
CDK2/cyclin A level (brain)
ILT-2 level (brain)
SIG14 level (brain)
Apo E2 level (brain)
CPNE1 level (brain)
CNTN2 level (brain)
FCG2A level (brain)
KPCI level (brain)
DPP2 level (brain)
AK1A1 level (brain)
TXD12 level (brain)
sL-Selectin level (brain)
cGMP-stimulated PDE level (brain)
C3d level (brain)
PGM1 level (brain)
Cathepsin B level (brain)
IDE level (brain)
IL-18 Ra level (brain)
PPAC level (brain)
Histone H2A.z level (brain)
IL-1 R4 level (brain)
Collectin Kidney 1 level (brain)
FAM107B level (brain)
IGFBP-1 level (brain)
RAC1 level (brain)
MSP level (brain)
PDGF-CC level (plasma)
IL-17E level (plasma)
PCSK7 level (plasma)
C1-Esterase Inhibitor level (plasma)
MMP-12 level (plasma)
RXFP1 level (plasma)
Cathepsin A level (plasma)
PIK3CA/PIK3R1 level (plasma)
RSPO2 level (plasma)
Lysozyme level (plasma)
CLM6 level (plasma)
Prolactin Receptor level (plasma)
SUMO3 level (plasma)
Coagulation Factor VII level (plasma)
Vasoactive Intestinal Peptide level (plasma)
MP2K2 level (plasma)
MAPKAPK3 level (plasma)
ERP29 level (plasma)
Galectin-3 level (plasma)
HPLN1 level (plasma)
CYTF level (plasma)
CYTD level (plasma)
CYTT level (plasma)
Elafin level (plasma)
CPNE1 level (plasma)
ADAMTS-5 level (plasma)
14-3-3 level (plasma)
AFP level (plasma)
FAM3B level (plasma)
IL-17 sR level (plasma)
PLXB2 level (plasma)
IL-10 Ra level (brain)
c-Jun level (brain)
YKL-40 level (brain)
Cathepsin G level (brain)
TACI level (brain)
Hemopexin level (brain)
ER level (brain)
CFC1 level (brain)
Angiopoietin-1 level (brain)
Growth hormone receptor level (brain)
TNF sR-II level (brain)
IDUA level (brain)
ASAHL level (brain)
RET level (brain)
ANGL3 level (brain)
DLL4 level (brain)
IGFBP-7 level (brain)
JAK2 level (brain)
ARTS1 level (brain)
sICAM-5 level (brain)
ENTP5 level (plasma)
Angiogenin level (plasma)
Caspase-2 level (plasma)
S100A12 level (plasma)
Apo B level (plasma)
C3b level (plasma)
Apo L1 level (plasma)
Haptoglobin, Mixed Type level (plasma)
TPSB2 level (plasma)
H31 level (plasma)
BCMA level (brain)
Semaphorin 3A level (brain)
CYTF level (brain)
CD30 Ligand level (brain)
Arylsulfatase A level (brain)
pTEN level (brain)
Heme oxygenase 1 levels
Osteoclast-associated immunoglobulin-like receptor levels
Insulin-like growth factor-binding protein-like 1 levels
Interleukin-17D levels
Severe COVID-19 or systemic lupus erythematosus (inverse variance)
Severe COVID-19 or systemic lupus erythematosus
Interleukin-2 receptor subunit alpha levels
Interleukin-4 receptor subunit alpha levels
Integrin beta-7 levels
Kidney Injury Molecule levels
Kallikrein-10 levels
Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer
Body mass index (aged 40-50 years)
Body fat percentage (aged 40-50 years)
Waist-hip ratio (aged 40-50 years)
Waist circumference (aged 40-50 years)
Body mass index (aged 64-69 years)
Body fat percentage (aged 64-69 years)
Waist-hip ratio (aged 64-69 years)
Waist circumference (aged 64-69 years)
Hip circumference (aged 64-69 years)
HLA risk haplotype in IgA deficiency
HLA risk haplotype in IgA deficiency (homozygous HLA-DRB1*07:01 HLA-DQB1*02:02)
HLA risk haplotype in IgA deficiency (homozygous HLA-DRB1*01 HLA-DQB1*05:01)
Meconium Ileus in Cystic Fibrosis (adjusted for Cystic Fibrosis-Related Diabetes)
Cystic fibrosis-related diabetes in cystic fibrosis
Cystic Fibrosis-Related Diabetes in Cystic Fibrosis (adjusted for Meconium Ileus)
Phospholipid levels in small HDL
RR interval
Principal component-derived dietary pattern 4
Principal component-derived dietary pattern 5
Principal component-derived dietary pattern 7
X-24418 levels
X-24422 levels
X-24431 levels
X-24432 levels
X-24455 levels
X-24462 levels
X-24475 levels
X-24494 levels
X-24546 levels
X-24549 levels
X-24556 levels
Principal component-derived dietary pattern 8
Principal component-derived dietary pattern 9
Pentachlorophenol levels
1-methylhistidine levels
Indolepropionate levels
Pro-hydroxy-pro levels
3-hydroxy-2-ethylpropionate levels
Triglycerides to total lipids ratio in small HDL
Cholesterol levels in small LDL
Environmental pollutants exposure (POD low)
Chronic Chagas Cardiomyopathy in Chagas disease
Dental anomalies (Tooth Agenesis, impaction and Rotation)
Dental anomalies (Hypoplasia, displacement and rotation)
Dental anomalies (Displacement, Rotation and Mamelon)
Dental caries, Agenesis and Hypoplasia
Palmitoleate (16:1n7) levels
Caproate (6:0) levels
Caprylate (8:0) levels
Orotidine levels
5,6-dihydrouridine levels
3-(3-amino-3-carboxypropyl)uridine levels
7-methylguanine levels
N2-methylguanosine levels
N6-succinyladenosine levels
Pentose acid levels
Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid levels
GlcNAc sulfate conjugate of C21H34O2 steroid levels
Gamma-glutamylphenylalanine levels
Pyroglutamylglutamine levels
Gamma-glutamylvaline levels
Gamma-glutamyltryptophan levels
Gamma-glutamylmethionine levels
Gamma-glutamylthreonine levels
Gamma-glutamyl-2-aminobutyrate levels
Cyclo(leu-pro) levels
Phenylalanylphenylalanine levels
Isoleucylglycine levels
X-19438 levels
X-21285 levels
X-21286 levels
X-21319 levels
X-21339 levels
X-21353 levels
X-21364 levels
X-21410 levels
X-21442 levels
X-21467 levels
Principal component-derived dietary pattern 1
Widow's peak
Earlobe attachment
4-hydroxychlorothalonil levels
6-hydroxyindole sulfate levels
3,4-methyleneheptanoate levels
Thioproline levels
3-indoleglyoxylic acid levels
Ethyl beta-glucopyranoside levels
Phenylacetate levels
Xanthurenate levels
3-methyl-2-oxovalerate levels
Insomnia in migraine
Insomnia in episodic migraine
Insomnia in chronic migraine
Asthma exacerbations
Indoleacetoylcarnitine levels
N-acetyl-isoputreanine levels
2-ketocaprylate levels
2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels
Hydroxy-N6,N6,N6-trimethyllysine levels
2-hydroxy-4-(methylthio)butanoic acid levels
Picolinate levels
Pipecolate levels
N-acetylmethionine levels
Uterine leiomyoma or breast cancer (pleiotropy)
Multisyllabic word repetition
Nonsense word repetition
Diadochokinetic rates
Comprehensive listening
Word attack subtest
Expressive language ability
Written spelling
Percent phonemes correct for nonsense word repetition
Phonological awareness (Elision)
Disruptive behavior (multivariate analysis)
Uterine leiomyoma or ER negative breast cancer (pleiotropy)
Trans-urocanate levels
HDL cholesterol levels adjusted for adiponectin levels
Flavin adenine dinucleotide (FAD) levels
Retinol (Vitamin A) levels
1-methylnicotinamide levels
Succinylcarnitine (c4-dc) levels
Isocitric lactone levels
Alpha-ketoglutarate levels
2-arachidonoylglycerol (20:4) levels
1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels
1,2-dipalmitoyl-gpc (16:0/16:0) levels
5,6-dihydrothymine levels
Hypoxanthine levels
Beta-alanine levels
2'-deoxyuridine levels
Uracil levels
Cytidine levels
Adenine levels
Glucuronide of C19H28O4 (2) levels
Glycine conjugate of C10H14O2 (1) levels
Glutamine conjugate of C6H10O2 (1) levels
Glutamine conjugate of C6H10O2 (2) levels
1-aminocyclopropane-1-carboxylate levels
3-methyl-2-oxindole levels
Caprylic acid levels
D-gulonic acid gama-lactone levels
Hypotaurine levels
L-arabitol levels
Melanin levels
N-acetyl-d-tryptophan levels
Palmitoleic acid levels
Pyridoxamine levels
Rac-glycerol 1-myristate levels
Sorbate levels
Lamb or mutton consumption (UKB data field 1379)
Cheese consumption
Mercuric chloride levels
Alcohol usually taken with meals (UKB data field 1618)
Milk type: Skimmed, semi-skimmed or full cream (UKB data field 1418)
X-24574 levels
X-24588 levels
X-24669 levels
X-24699 levels
X-24811 levels
X-24949 levels
X-25371 levels
X-25419 levels
X-25422 levels
Principal component-derived dietary pattern 10
Principal component-derived dietary pattern 11
Principal component-derived dietary pattern 12
Principal component-derived dietary pattern 13
Principal component-derived dietary pattern 14
Principal component-derived dietary pattern 16
Principal component-derived dietary pattern 17
Principal component-derived dietary pattern 18
Principal component-derived dietary pattern 19
Principal component-derived dietary pattern 20
Tiglylcarnitine (C5:1-DC) levels
Indoleacetylglutamine levels
Dimethylarginine (sdma + adma) levels
N-methylproline levels
N-acetyl-3-methylhistidine levels
Alpha-ketoglutaramate levels
Potassium chromate levels
N,N,N-trimethyl-5-aminovalerate levels
(N(1) + N(8))-acetylspermidine levels
3-amino-2-piperidone levels
N,N-dimethylalanine levels
6-bromotryptophan levels
1-carboxyethylphenylalanine levels
1-carboxyethylvaline levels
1-carboxyethylleucine levels
1-carboxyethylisoleucine levels
COVID-19 related pneumonia
Cysteinylglycine levels
Cystine levels
Guanidinoacetate levels
Phospholipids to total lipids ratio in small HDL
X-21470 levels
X-21471 levels
X-21733 levels
X-21796 levels
X-22771 levels
X-23593 levels
Principal component-derived dietary pattern 2
Indolelactate levels
4-methyl-2-oxopentanoate levels
Phenyllactate (pla) levels
N-acetylaspartate (naa) levels
Cysteine s-sulfate levels
3-methyl-2-oxobutyrate levels
Homocitrulline levels
N-acetylglycine levels
N-acetylvaline levels
Vanillylmandelate (VMA) levels
4-hydroxyphenylpyruvate levels
Tigloylglycine levels
3-methoxytyrosine levels
Beta-hydroxyisovalerate levels
Lactate levels
Arabinose levels
Maltose levels
Threonate levels
Trigonelline (n'-methylnicotinate) levels
Gamma-CEHC levels
L-urobilin levels
2-o-methylascorbic acid levels
Gamma-CEHC glucuronide levels
Alpha-CMBHC glucuronide levels
Gamma-tocopherol/beta-tocopherol levels
Ascorbic acid 2-sulfate levels
Carotene diol (3) levels
Ascorbic acid 3-sulfate levels
Pantothenate levels
Alpha-tocopherol levels
Quinolinate levels
Antipsychotic-induced metabolic syndrome in schizophrenia
5alpha-androstan-3beta,17beta-diol disulfate levels
5alpha-pregnan-3beta,20alpha-diol disulfate levels
Taurocholenate sulfate levels
Pregnenediol disulfate (C21H34O8S2) levels
Androstenediol (3beta,17beta) disulfate (2) levels
Right ventricular end diastolic volume
Right ventricular end diastolic volume (MTAG)
Right ventricular stroke volume (MTAG)
Right ventricular ejection fraction (MTAG)
Phenylalanyltryptophan levels
Prolylproline levels
Phenylacetylglutamate levels
4-hydroxyphenylacetylglutamine levels
Gamma-glutamyl-alpha-lysine levels
Gamma-glutamyltyrosine levels
X-07765 levels
X-10458 levels
X-11261 levels
X-11308 levels
X-11315 levels
X-11372 levels
X-11378 levels
X-11381 levels
X-11441 levels
X-11442 levels
X-11444 levels
X-11478 levels
X-11795 levels
X-11880 levels
X-12007 levels
X-12026 levels
X-12100 levels
X-12101 levels
X-25433 levels
X-25790 levels
X-25937 levels
X-26054 levels
3-phenylpropionate (hydrocinnamate) levels
Tartarate levels
Theophylline levels
Theobromine levels
Paraxanthine levels
Tartronate (hydroxymalonate) levels
Erythritol levels
3-methylxanthine levels
Oral microbiota abundance (Lachnoanaerobaculum) in oral squamous cell carcinoma
Oral microbiota abundance (Kingella) in oral squamous cell carcinoma
Oral microbiota abundance (Parvimonas) in oral squamous cell carcinoma
Oral microbiome alpha diversity (Chao1 index) in oral squamous cell carcinoma
Oral microbiome alpha diversity (Shannon index) in oral squamous cell carcinoma
Oral microbiome beta diversity (Euclidian distance) in oral squamous cell carcinoma
Oral microbiome beta diversity (Bray-Curtis) in oral squamous cell carcinoma
Principal component-derived dietary pattern 21
Principal component-derived dietary pattern 23
Principal component-derived dietary pattern 24
Principal component-derived dietary pattern 26
Principal component-derived dietary pattern 27
Principal component-derived dietary pattern 28
Principal component-derived dietary pattern 29
Principal component-derived dietary pattern 30
Principal component-derived dietary pattern 31
Principal component-derived dietary pattern 32
Principal component-derived dietary pattern 33
Principal component-derived dietary pattern 35
Principal component-derived dietary pattern 36
Principal component-derived dietary pattern 39
Principal component-derived dietary pattern 40
Principal component-derived dietary pattern 42
Principal component-derived dietary pattern 43
Principal component-derived dietary pattern 44
Principal component-derived dietary pattern 45
Principal component-derived dietary pattern 46
Principal component-derived dietary pattern 52
Principal component-derived dietary pattern 54
Principal component-derived dietary pattern 58
Principal component-derived dietary pattern 81
Formiminoglutamate levels
Hydantoin-5-propionate levels
S-methylcysteine levels
Argininate levels
2-oxoarginine levels
1-methyl-5-imidazoleacetate levels
S-methylcysteine sulfoxide levels
Carboxyethyl-gaba levels
Beta-citrylglutamate levels
Imidazole propionate levels
N-acetylcarnosine levels
Acisoga levels
N2,N5-diacetylornithine levels
3-methoxytyramine sulfate levels
Fructosyllysine levels
N-acetyltaurine levels
N-formylmethionine levels
S-adenosylhomocysteine (SAH) levels
5-methylthioadenosine (mta) levels
2-hydroxyphenylacetate levels
Phenylpyruvate levels
Hexanoylglycine levels
Testosterone sulfate levels
1-dihomo-linolenoyl-GPC (20:3n3 or 6) levels
1-dihomo-linoleoyl-GPC (20:2) levels
2-arachidonoyl-GPC (20:4) levels
2-linoleoyl-GPC (18:2) levels
2-myristoyl-GPC (14:0) levels
1-oleoyl-GPE (18:1) levels
1-arachidonoyl-GPE (20:4n6) levels
Increased healthspan in old age
Increased healthspan
Beef consumption (UKB data field 1369)
Trans-cinnamaldehyde levels
X-12847 levels
X-12906 levels
X-13553 levels
X-13729 levels
X-13844 levels
X-14056 levels
X-14939 levels
X-15461 levels
X-15469 levels
X-15486 levels
X-15492 levels
X-15503 levels
N-acetylthreonine levels
N-acetylisoleucine levels
Alpha-hydroxyisovalerate levels
Isovalerylcarnitine (C5) levels
Cysteine-glutathione disulfide levels
Pyroglutamine levels
2-hydroxy-3-methylvalerate levels
Glutarylcarnitine (c5-dc) levels
Beta-hydroxyisovaleroylcarnitine levels
Decanoylcarnitine (C10) levels
Campesterol levels
1-myristoyl-GPC (14:0) levels
Stearoylcarnitine (C18) levels
Laurylcarnitine (C12) levels
1-linoleoyl-gpc (18:2) levels
1-arachidonylglycerol (20:4) levels
1-stearoyl-GPE (18:0) levels
1-stearoyl-GPG (18:0) levels
Oleoylcarnitine (C18:1) levels
1-palmitoleoyl-GPC (16:1) levels
3-hydroxylaurate levels
3-hydroxysebacate levels
Propionylglycine levels
Butyrylglycine levels
Docosapentaenoate (n3 DPA; 22:5n3) levels
Adrenate (22:4n6) levels
Myristoleate (14:1n5) levels
Stearidonate (18:4n3) levels
5-dodecenoate (12:1n7) levels
Tauro-beta-muricholate levels
Hip fracture
X-15666 levels
X-15674 levels
X-16087 levels
X-16397 levels
X-16576 levels
X-16935 levels
X-16964 levels
X-17325 levels
X-17340 levels
X-17357 levels
X-17612 levels
X-17653 levels
X-17654 levels
X-17676 levels
X-18886 levels
X-18888 levels
X-18899 levels
X-18913 levels
X-18922 levels
Uterine leiomyoma or ER positive breast cancer (pleiotropy)
Nonsense word reading
Maleate levels
2-hydroxyoctanoate levels
3-hydroxyoctanoate levels
Palmitoylcarnitine (C16) levels
Dehydroepiandrosterone sulfate (DHEA-S) levels
3-hydroxydecanoate levels
1-linoleoylglycerol (18:2) levels
Dodecanedioate (C12-DC) levels
COVID-19 (severe vs population) x cardiometabolic health status interaction (joint test)
COVID-19 (severe vs population) x cardiometabolic health status interaction
COVID-19 (severe vs population) x multiple deprivation index interaction (joint test)
COVID-19 (severe vs population) x multiple deprivation index interaction
Smoking initiation (ever vs never)
Smoking cessation (current vs former)
COVID-19 (severe vs population) x sex interaction (joint test)
COVID-19 (severe vs population) x sex interaction
Total phospholipid levels in lipoprotein particles
Cholesteryl ester levels in VLDL
Alanine aminotransferase elevation after methotrexate initiation in rheumatoid arthritis (>1.5 × ULN)
VLDL cholesterol levels
Heart failure (multivariate analysis)
Octadecadienylcarnitine levels
Phosphatidylcholine acyl-alkyl C40:2 levels
Concentration of VLDL particles
Visceral adipose tissue volumes (adjusted for BMI and height)
Abdominal adipose tissue volumes (adjusted for BMI and height)
Gluteofemoral adipose tissue volumes
Visceral adipose tissue volumes
Abdominal adipose tissue volumes
Gluteofemoral adipose tissue volumes (adjusted for BMI and height)
Free cholesterol levels in VLDL
Univariate microbial feature (genus: acinetobacter) at the antecubital fossa (moist skin)
Univariate microbial feature (asv: asv013) at the antecubital fossa (moist skin)
Univariate microbial feature (asv: asv006) at the antecubital fossa (moist skin)
Univariate microbial feature (asv: asv021) at the antecubital fossa (moist skin)
Univariate microbial feature (order: bacteroidales) at the dorsal forearm (dry skin)
Univariate microbial feature (genus: staphylococcus) at the forehead (sebaceous skin)
Univariate microbial feature (asv: asv002) at the forehead (sebaceous skin)
Univariate microbial feature (asv: asv004) at the forehead (sebaceous skin)
Univariate microbial feature (asv: asv093) at the forehead (sebaceous skin)
Univariate microbial feature (genus: anaerococcus) at the dorsal forearm (dry skin)
Univariate microbial feature (genus: micrococcus) at the dorsal forearm (dry skin)
Univariate microbial feature (genus: paracoccus) at the dorsal forearm (dry skin)
Univariate microbial feature (asv: asv013) at the dorsal forearm (dry skin)
Univariate microbial feature (asv: asv086) at the dorsal forearm (dry skin)
Univariate microbial feature (class: gammaproteobacteria) at the antecubital fossa (moist skin)
Univariate microbial feature (asv: asv070) at the antecubital fossa (moist skin)
Univariate microbial feature (order: burkholderiales) at the antecubital fossa (moist skin)
Univariate microbial feature (order: lactobacillales) at the antecubital fossa (moist skin)
Univariate microbial feature (family: rhodobacteraceae) at the antecubital fossa (moist skin)
Univariate microbial feature (family: clostridiales) at the incertae (moist skin)
Univariate microbial feature (family: streptococcaceae) at the antecubital fossa (moist skin)
Multivariate microbial feature (beta-diversity) at the dorsal forearm (dry skin)
Intrahepatic cholestasis of pregnancy
Subjective cognitive decline in migraine
Subjective cognitive decline in episodic migraine
Subjective cognitive decline in chronic migraine
Subjective cognitive decline in migraine without aura
Subjective cognitive decline
Visceral adipose tissue volumes to abdominal adipose tissue volumes ratio
Phospholipid levels in VLDL
Visceral adipose tissue volumes to gluteofemoral adipose tissue volumes ratio
Abdominal adipose tissue volumes to gluteofemoral adipose tissue volumes ratio
Sporadic vestibular schwannoma
Total lipid levels in VLDL
Colorectal cancer x estrogen hormone therapy interaction
Colorectal cancer x estrogen hormone therapy interaction (2df test)
Colorectal cancer x estrogen hormone therapy interaction (3df test)
Colorectal cancer x estrogen-progesterone hormone therapy interaction
Colorectal cancer x menopausal hormone therapy interaction
Colorectal cancer x menopausal hormone therapy interaction (2df test)
Colorectal cancer x menopausal hormone therapy interaction (3df test)
Triglyceride levels in VLDL
Nonsyndromic orofacial cleft x sex interaction
Nonsyndromic orofacial cleft x sex interaction (2df)
Common executive function
Cholesterol levels in very large HDL
Dementia in non-APOE e4 carriers
X-12556 levels
1-arachidonoylglycerophosphoinositol levels
X-12627 levels
X-12749 levels
Isovalerylcarnitine levels
1-stearoylglycerophosphoethanolamine levels
Bradykinin, des-arg 9 levels
X-12850 levels
X-12990--docosapentaenoic acid n6-DPA levels
Oleoylcarnitine levels
1-arachidonoylglycerophosphoethanolamine levels
X-12095--N1-methyl-3-pyridone-4-carboxamide levels
X-12100--hydroxytryptophan levels
X-12244--N-acetylcarnosine levels
ADpSGEGDFXAEGGGVR levels
1-eicosatrienoylglycerophosphocholine levels
X-12441--12-hydroxyeicosatetraenoate 12-HETE levels
X-12442--5,8-tetradecadienoate levels
Stearidonate 18:4n3 levels
X-12510--2-aminooctanoic acid levels
HWESASXX levels
X-11550 levels
X-11593--O-methylascorbate levels
Adrenate 22:4n6 levels
X-11786--methylcysteine levels
X-11793--oxidized bilirubin levels
X-11799 levels
1-arachidonoylglycerophosphocholine levels
X-12038 levels
Isobutyrylcarnitine levels
Palmitoleate 16:1n7 levels
Cholesterol to total lipids ratio in very large HDL
Self-reported depression (with anxiety score <5)
Depression (with anxiety score <5)
Self-reported depression (with non-self-reported anxiety)
Depression (with non-self-reported anxiety)
Average diameter for VLDL particles
Colorectal cancer x estrogen-progesterone hormone therapy interaction (2df test)
Colorectal cancer x estrogen-progesterone hormone therapy interaction (3df test)
Morbidity in COVID-19 (deceased vs asymptomatic)
Dementia
Alzheimer's disease in non-APOE e4 carriers
Linoleate 18:2n6-to-X-12442--5,8-tetradecadienoate ratio
Lysine-to-glutaroyl carnitine ratio
Myristate 14:0-to-myristoleate 14:1n5 ratio
N-acetylornithine-to-myo-inositol ratio
Octanoylcarnitine-to-X-13435 ratio
Phenyllactate-to-phenylalanine ratio
Phosphate-to-erythronate ratio
Propionylcarnitine-to-isovalerylcarnitine ratio
Urate-to-histidine ratio
Valine-to-isovalerylcarnitine ratio
Valine-to-proline ratio
X-04499--3,4-dihydroxybutyrate-to-C-glycosyltryptophan ratio
X-08402-to-cholesterol ratio
X-10510-to-palmitoyl sphingomyelin ratio
X-11315-to-pyroglutamine ratio
X-11440-to-4-androsten-3beta,17beta-diol disulfate 2 ratio
X-11444-to-X-11470 ratio
X-11444-to-X-12844 ratio
X-11820-to-cholesterol ratio
X-12038-to-bradykinin, des-arg 9 ratio
X-12095--N1-methyl-3-pyridone-4-carboxamide-to-X-12844 ratio
X-12798-to-phenylalanine ratio
X-13215-to-X-13671 ratio
Acetylcarnitine-to-hexanoylcarnitine ratio
ADpSGEGDFXAEGGGVR-to-X-14304--leucylalanine ratio
ADSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio
Androsterone sulfate-to-4-androsten-3beta,17beta-diol disulfate 2 ratio
Androsterone sulfate-to-epiandrosterone sulfate ratio
Arachidonate 20:4n6-to-1-arachidonoylglycerophosphoinositol ratio
Arachidonate 20:4n6-to-dihomo-linolenate 20:3n3 or n6 ratio
Aspartylphenylalanine-to-X-14450--phenylalanylleucine ratio
Betaine-to-pyroglutamine ratio
C-glycosyltryptophan-to-succinylcarnitine ratio
Carnitine-to-X-12798 ratio
DHEA-S-to-4-androsten-3beta,17beta-diol disulfate 2 ratio
Docosapentaenoate n3 DPA; 22:5n3-to-X-12627 ratio
DSGEGDFXAEGGGVR-to-ADpSGEGDFXAEGGGVR ratio
Glucose-to-mannose ratio
Glutamine-to-histidine ratio
Hexanoylcarnitine-to-octanoylcarnitine ratio
Indoleacetate-to-N2,N2-dimethylguanosine ratio
Isoleucine-to-X-11529 ratio
Linoleate 18:2n6-to-dihomo-linolenate 20:3n3 or n6 ratio
X-14205--alpha-glutamyltyrosine levels
X-14208--phenylalanylserine levels
X-14304--leucylalanine levels
X-14473 levels
X-14625 levels
X-14626 levels
Octadecanedioate levels
4-androsten-3beta,17beta-diol disulfate 1 levels
4-androsten-3beta,17beta-diol disulfate 2 levels
Cis-4-decenoyl carnitine levels
10-undecenoate 11:1n1-to-X-11438 ratio
3- 4-hydroxyphenyl lactate-to-alpha-hydroxyisovalerate ratio
4-acetamidobutanoate-to-N1-methyladenosine ratio
4-acetamidobutanoate-to-X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide ratio
X-13431--nonanoylcarnitine levels
X-13477 levels
X-13548 levels
Hydroxyisovaleroyl carnitine levels
Glutaroyl carnitine levels
X-13671 levels
1-palmitoylglycerophosphoethanolamine levels
Tetradecanedioate levels
Dihomo-linolenate 20:3n3 or n6 levels
X-14189--leucylalanine levels
Cholesteryl ester levels in very large HDL
Overall survival in ovarian cancer
Dementia in APOE e4+ carriers
COVID-19 (recovered vs asymptomatic)
Margarate 17:0 levels
Stearate 18:0 levels
X-03094 levels
3-phenylpropionate hydrocinnamate levels
X-04499--3,4-dihydroxybutyrate levels
X-18601 levels
Eicosapentaenoate EPA; 20:5n3 levels
Myo-inositol levels
Asthma or COVID-19 (pleiotropy)
3-dehydrocarnitine levels
X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levels
X-01911 levels
O-sulfo-l-tyrosine levels
X-09789 levels
X-11445--5-alpha-pregnan-3beta,20alpha-disulfate levels
X-08402 levels
2-hydroxyisobutyrate levels
Levulinate 4-oxovalerate levels
X-10395 levels
1-linoleoylglycerol 1-monolinolein levels
3-(4-hydroxyphenyl)lactate levels
Scyllo-inositol levels
Myristoleate 14:1n5 levels
Dehydroisoandrosterone sulfate DHEA-S levels
Docosapentaenoate n3 DPA; 22:5n3 levels
X-02269 levels
X-11247 levels
Crohn's disease vs ulcerative colitis
Adverse response to chemotherapy in breast cancer (grade 3/4 neutropenic or leukopenic events)
Phospholipid levels in small LDL
Androstenediol (3beta,17beta) monosulfate (2) levels
1-docosahexaenoyl-GPE (22:6) levels
2-docosahexaenoyl-GPE (22:6) levels
1-docosapentaenoyl-GPC (22:5n3) levels
Pregnenediol sulfate (C21H34O5S) levels
2-hydroxyglutarate levels
Sphingomyelin (d18:1/18:1, d18:2/18:0) levels
Palmitoyl sphingomyelin (d18:1/16:0) levels
16a-hydroxy DHEA 3-sulfate levels
21-hydroxypregnenolone disulfate levels
21-hydroxypregnenolone monosulfate (1) levels
5alpha-pregnan-3beta,20alpha-diol monosulfate (2) levels
5alpha-androstan-3alpha,17beta-diol disulfate levels
Abdominal aortic diameter
Cancer pain intensity
Body shape (principal component analysis)
17alpha-hydroxypregnenolone 3-sulfate levels
Pregnenolone sulfate levels
Andro steroid monosulfate C19H28O6S (1) levels
1-margaroyl-GPE (17:0) levels
2s,3R-dihydroxybutyrate levels
2R,3R-dihydroxybutyrate levels
4-hydroxy-2-oxoglutaric acid levels
Predicted heart recovery rate
Dihydrobiopterin levels
Platelet-activating factor levels
Ceramide (d18:0/12:0) levels
5alpha-androstan-3beta,17alpha-diol disulfate levels
Androstenediol (3alpha, 17alpha) monosulfate (3) levels
Androstenediol (3beta,17beta) monosulfate (1) levels
Right ventricular end systolic volume
Right ventricular stroke volume
Right ventricular ejection fraction
1-meadoyl-GPC (20:3n9) levels
1-adrenoyl-GPC (22:4) levels
1-(1-enyl-palmitoyl)-GPC (p-16:0) levels
1-(1-enyl-stearoyl)-GPC (p-18:0) levels
Eicosanedioate (C20-DC) levels
Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels
Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels
Linoleoylcarnitine (C18:2) levels
N-palmitoyltaurine levels
N-stearoyltaurine levels
Pregnanediol-3-glucuronide levels
2-stearoyl-GPE (18:0) levels
(R)-3-hydroxybutyrylcarnitine levels
3b-hydroxy-5-cholenoic acid levels
Sphingomyelin (d18:1/14:0, d16:1/16:0) levels
3-hydroxyadipate levels
1-eicosapentaenoyl-GPE (20:5) levels
1-eicosapentaenoyl-GPC (20:5) levels
1-dihomo-linolenoyl-GPE (20:3n3 or 6) levels
5alpha-androstan-3alpha,17beta-diol 17-glucuronide levels
COVID-19 or coronary artery disease (pleiotropy)
COVID-19 or type 2 diabetes (pleiotropy)
COVID-19 or hypertension (pleiotropy)
COVID-19 or obesity (pleiotropy)
Platelet factor 4/heparin antibody levels in heparin treatment
Neutrophil granulocyte count
Red blood cell distribution width coefficient of variation
Survival in coronary artery disease
Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels
Lignoceroyl sphingomyelin (d18:1/24:0) levels
Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels
3-hydroxyhexanoate levels
3beta-hydroxy-5-cholestenoate levels
Adipoylcarnitine (C6-DC) levels
Suberoylcarnitine (C8-DC) levels
Glycochenodeoxycholate 3-sulfate levels
Glycodeoxycholate 3-sulfate levels
Octadecanedioylcarnitine (C18-DC) levels
Myristoleoylcarnitine (C14:1) levels
Pregnanolone/allopregnanolone sulfate levels
Sphingomyelin (d18:1/20:0, d16:1/22:0) levels
Sphingomyelin (d18:1/20:1, d18:2/20:0) levels
Sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2) levels
Behenoyl sphingomyelin (d18:1/22:0) levels
Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels
COVID-19 (hospitalized vs tested, not hospitalized)
Phospholipids to total lipids ratio in very large HDL
S-warfarin levels
COVID-19 (severe vs population)
Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)
Cognitive performance (MTAG)
COVID-19 (severe vs tested, not severe)
1-palmityl-2-oleoyl-GPC (o-16:0/18:1) levels
1-palmityl-2-stearoyl-GPC (O-16:0/18:0) levels
1-pentadecanoyl-2-docosahexaenoyl-GPC (15:0/22:6) levels
1-ribosyl-imidazoleacetate (X-11334) levels
1-palmitoyl-2-eicosapentaenoyl-GPE (16:0/20:5) levels
1-palmityl-2-linoleoyl-GPC (O-16:0/18:2) levels
1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) levels
2-hydroxybutyrate/2-hydroxyisobutyrate levels
2-methylbutyrylcarnitine (C5) levels
3-(4-hydroxyphenyl) lactate levels
3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) (X-02249) levels
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (cmpf) levels
3-formylindole (X-16071) levels
3-hydroxy-5-cholestenoic acid levels
1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels
1-stearoyl-GPI (18:0) levels
2,3-dihydroxy-5-methylthio-4-pentenoate (DMTPA) (X-11564) levels
2,6-dihydroxybenzoic acid (X-09789) levels
2-aminoadipate levels
4-androsten-3alpha,17alpha-diol monosulfate (2) levels
4-androsten-3alpha,17alpha-diol monosulfate (3) levels
4-androsten-3beta,17beta-diol disulfate (1) levels
4-androsten-3beta,17beta-diol disulfate (2) levels
4-androsten-3beta,17beta-diol monosulfate (1) levels
4-androsten-3beta,17beta-diol monosulfate (2) levels
COVID-19 (severe vs non-severe with positive test)
9-hydroxystearate levels
Andro steroid monosulfate (1) levels
Androsterone glucuronide (X-22379) levels
5,6-dihydrouridine (X-11429) levels
5-bromotryptophan levels
R-warfarin levels
COVID-19 death (death vs population)
Ascorbic acid 3-sulfate (X-12206) levels
Decadienedioic acid (c10:2-dc) (X-21792) levels
COVID-19 death (death vs tested and survived)
Triglycerides to total lipids ratio in very large HDL
Dehydroisoandrosterone sulfate (dhea-s) levels
Deoxycholic acid glucuronide (X-11491) levels
Dihomo-linolenate (20:3n3 or n6) levels
Dodecadienoate (12:2) (X-21343) levels
Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid (X-22764) levels
Catechol sulfate levels
Cinnamoylglycine levels
Cis-4-decenoate (10:1n6) (X-23293) levels
Cortolone glucuronide (1) (X-17359) levels
Fumarate levels
Gamma-glutamylcitrulline (X-24449) levels
Gamma-glutamylisoleucine levels
Gamma-glutamylleucine levels
Dodecanedioate levels
Dopamine sulfate (2) levels
Eicosanodioate levels
Ethyl beta-glucopyranoside (X-23314) levels
Glucuronide of piperine metabolite c17h21no3 (4) (X-01911) levels
Glutamine conjugate of c6h10o2 (2) (X-12472) levels
Glycochenodeoxycholate sulfate levels
Glycodeoxycholate sulfate levels
Isoleucylleucine/leucylisoleucine levels
Laurylcarnitine levels
Hydantoin-5-propionic acid levels
Hydroxy-cmpf (X-02269) levels
Indoleacetate levels
Hexadecenedioate (c16:1-dc) (X-11905) levels
Cholesteryl esters to total lipids ratio in very large HDL
Free cholesterol to total lipids ratio in very large HDL
Follicle stimulating hormone levels in idiopathic male infertility
Opioid analgesic dose requirement in cancer pain treatment
Total lipid levels in very large HDL
AUC of simvastatin acid
Concentration of very large HDL particles
Response to antidepressants (symptom improvement) in major depressive disorder
Response to antidepressants in major depressive disorder
Response to dolutegravir in HIV infection (area under the concentration-time curve)
Bilirubin concentration in dolutegravir-treated HIV infection
Response to dolutegravir in HIV infection (clearance)
6-mercaptopurine dose in acute lymphoblastic leukaemia
Lifelong premature ejaculation
Body mass index (MTAG)
Highest math class taken
Triglyceride levels (MTAG)
Highest math class taken (MTAG)
Self-reported math ability (MTAG)
Mosaic chromosomal alteration of the Y chromosome
RS-10-hydroxywarfarin to RS-warfarin ratio
S-7-hydroxywarfarin to S-warfarin ratio
Total lipid levels in chylomicrons and extremely large VLDL
Concentration of chylomicrons and extremely large VLDL particles
C-reactive protein levels (MTAG)
Glycoprotein acetyls levels
Polyunsaturated fatty acid levels
Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL
Acetate levels
Acetoacetate levels
Acetone levels
Self-reported math ability
Cholesterol levels in chylomicrons and extremely large VLDL
Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL
Cholesteryl ester levels in chylomicrons and extremely large VLDL
Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL
Free cholesterol levels in chylomicrons and extremely large VLDL
Phospholipid levels in chylomicrons and extremely large VLDL
Cholesterol levels in medium HDL
Metabolonic lactone sulfate (X-12063) levels
Myristoylcarnitine levels
N,n-dimethylalanine (X-23585) levels
N1-methyladenosine levels
Linoleoylcarnitine levels
Lithocholate sulfate (1) (X-17469) levels
N-acetyl-2-aminooctanoate (X-12511) levels
N-acetyl-isoputreanine (X-12688) levels
Working memory x anxiety interaction
N-palmitoyl-sphinganine (d18:0/16:0) levels
Ayurvedic vata prakriti specific rheumatoid arthritis
Ayurvedic pitta prakriti specific rheumatoid arthritis
Ayurvedic kapha prakriti specific rheumatoid arthritis
Heparin-induced thrombocytopenia in PF4/heparin antibody positivity
Cholesterol levels in very large VLDL
N-trimethyl 5-aminovalerate (X-21365) levels
Octadecenedioate (c18:1-dc) (X-11538) levels
O-methylcatechol sulfate levels
Palmitoleoylcarnitine levels
Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [2] levels
Palmitoylcarnitine levels
Palmitoyl-oleoyl-glycerol (16:0/18:1) [2] levels
P-cresol-glucuronide levels
Phosphatidylcholine (18:0/20:2, 20:0/18:2, 18:1/20:1) levels
Picolinoylglycine (X-12170) levels
Pregn steroid monosulfate levels
Sphinganine levels
Sphingomyelin (d18:1/15:0, d16:1/17:0) levels
Pregnenetriol disulfate (X-11440) levels
Sulcal opening distance of the right calloso-marginal posterior fissure
Tiglylcarnitine levels
Tridecenedioate (c13:1-dc) (X-11438) levels
Tryptophan betaine  levels
Undecenoylcarnitine (c11:1) (X-17337) levels
Taurolithocholate 3-sulfate levels
Tetradecadienoate (14:2) (X-12442) levels
Stearoylcarnitine levels
Succinimide levels
Cholesterol to total lipids ratio in very large VLDL
X-11299 levels
X-12462 levels
X-13684 levels
X-17690 levels
X-21258 levels
X-21358 levels
X-21658 levels
X-23749 levels
X-23756 levels
X-24020 levels
X-24243 levels
X-24307 levels
Prostate cancer x metformin use interaction (complex model)
High grade prostate cancer x metformin use interaction (simple model)
Remission after antidepressant treatment in major depressive disorder
Total lipid levels in very large VLDL
Free cholesterol to total lipids ratio in very large VLDL
Concentration of very small VLDL particles
RS-6-hydroxywarfarin levels
S-7-hydroxywarfarin levels
Cholesteryl esters to total lipids ratio in very large VLDL
Free cholesterol levels in very large VLDL
RS-warfarin levels
Fibromuscular dysplasia
Concentration of very large VLDL particles
Triglycerides to total lipids ratio in very large VLDL
S-6-hydroxywarfarin levels
Cholesteryl esters to total lipids ratio in very small VLDL
Free cholesterol levels in very small VLDL
R-6-hydroxywarfarin levels
Mosaic chromosomal alteration of the autosomes
Mosaic chromosomal alteration of the X chromosome
R-6-hydroxywarfarin to R-warfarin ratio
Phospholipids to total lipids ratio in very large VLDL
S-warfarin to R-warfarin ratio
RS-10-hydroxywarfarin levels
Cholesterol levels in very small VLDL
Cholesterol to total lipids ratio in very small VLDL
S-6-hydroxywarfarin to S-warfarin ratio
Myocardial infraction risk reduction in statin users
Phospholipids to total lipids ratio in very small VLDL
REM sleep behavior disorder (probable or isolated)
1-margaroyl-2-arachidonoyl-GPC (17:0/20:4) levels
1-methyl-5-imidazoleacetate (X-14838) levels
1-methylimidazoleacetate levels
1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels
1-(1-enyl-stearoyl)-2-oleoyl-GPC (p-18:0/18:1) levels
1-(1-enyl-stearoyl)-GPC (P-18:0)  levels
11beta-hydroxyandrosterone glucuronide (X-12846) levels
1-arachidoyl-2-arachidonoyl-GPC (20:0/20:4) levels
1-docosahexaenoyl-GPC (22:6) levels
1-lignoceroyl-GPC (24:0) levels
1-linoleoyl-2-docosahexaenoyl-GPC (18:2/22:6) levels
Free cholesterol to total lipids ratio in very small VLDL
Total lipid levels in very small VLDL
COVID-19 (severe vs mild)
Cholesteryl ester levels in very small VLDL
Clonal haematopoiesis of indeterminate potential (ASXL1 mutation)
Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration)
Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)
Clonal haematopoiesis of indeterminate potential (JAK2 mutation)
Clonal haematopoiesis of indeterminate potential (TET2 mutation)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels
1-(1-enyl-palmitoyl)-2-oleoyl-GPE (p-16:0/18:1) levels
1-(1-enyl-stearoyl)-2-linoleoyl-GPC (p-18:0/18:2) levels
X-24748 levels
X-24870 levels
1-(1-enyl-oleoyl)-GPC (p-18:1) levels
X-24512 levels
X-24513 levels
High-density lipoprotein levels (MTAG)
Clinical LDL cholesterol levels
3-Hydroxybutyrate levels
Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL
Total esterified cholesterol levels
Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL
Low-density lipoprotein levels (MTAG)
Femoral hernia
Umbilical hernia
Drinks per week
Cigarettes smoked per day
Ventral hernia
Respiratory diseases
Smoking status
